{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "dc3852ca",
   "metadata": {},
   "source": [
    "# Evaluate Classification"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3a2d9fbf",
   "metadata": {},
   "source": [
    "## Setup"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "45140c6e",
   "metadata": {},
   "source": [
    "#### Load the API key and libaries."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "e7bf1b8e",
   "metadata": {
    "height": 115,
    "tags": []
   },
   "outputs": [],
   "source": [
    "from src.Language_Evaluation_LC import llm_language_evaluation\n",
    "from src.data_analysis import run_analysis\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "10e95383",
   "metadata": {
    "height": 30
   },
   "source": [
    "#### Load the Constants"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "464a2aaa",
   "metadata": {
    "height": 47,
    "tags": []
   },
   "outputs": [],
   "source": [
    "PATH = 'data/full_dataset.csv'\n",
    "MODEL = \"meta-llama/Llama-2-70b-chat-hf\"\n",
    "TEMPERATURE = 0.0\n",
    "N_REPETITIONS = 0\n",
    "REASONING = False\n",
    "LANGUAGES = ['spanish', 'tagalog', 'portuguese', 'english']"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "92663014",
   "metadata": {},
   "source": [
    "#### Run The Experiments:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "7c7ccfa1",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "N_REPETITIONS should be a positive integer, not 0\n",
      "N_REPETITIONS will be set to 1\n",
      "**************************************************\n",
      "Question 1: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿En qué región ocular se encuentran fisiológicamente las células caliciformes?\n",
      "a) córnea.\n",
      "b) Limbus corneoscleral.\n",
      "c) Línea gris.\n",
      "d) Pliegue semilunar.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // The correct answer is b) Limbus corneoscleral.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking where physiologically caliciform cells are found in the ocular region. Caliciform cells are specialized epithelial cells that are found in the limbus, which is the region between the cornea and the sclera. Therefore, the correct answer is b) Limbus corneoscleral.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Aling bahagi ng mata ay kung saan matatagpuan ang mga caliciform cells?\n",
      "a) Cornea.\n",
      "b) Corneoscleral limbus.\n",
      "c) Grey line.\n",
      "d) Semilunar fold.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Corneoscleral limbus\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The corneoscleral limbus is the region where the cornea and the sclera meet. It is a thin layer of tissue that forms the junction between the two structures. The caliciform cells are found in this region, specifically in the posterior portion of the corneoscleral limbus, also known as the posterior limbus.\n",
      "\n",
      "Therefore, option b, \"Corneoscleral limbus,\" is the correct answer.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Em qual região ocular células caliciformes são fisiologicamente encontradas?\n",
      "a)Córnea.\n",
      "b)Limbo corneoescleral.\n",
      "c)Linha cinzenta.\n",
      "d)Prega semilunar.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // b) Limbo corneoescleral\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking where caliciform cells are found in the eye. The correct answer is b) Limbo corneoescleral, which is a region in the eye that contains caliciform cells. These cells are responsible for the formation of the corneal epithelium.\n",
      "\n",
      "Here are the options and their explanations:\n",
      "\n",
      "a) Córnea - This is the outermost layer of the eye, but it does not contain caliciform cells.\n",
      "\n",
      "c) Linha cinzenta - This is a layer of the eye that separates the cornea and the iris, but it does not contain caliciform cells.\n",
      "\n",
      "d) Prega semilunar - This is a small area of the eye that is located between the iris and the lens, but it does not contain caliciform cells.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "In which ocular region are caliciform cells physiologically found?\n",
      "a) Cornea.\n",
      "b) Corneoscleral limbus.\n",
      "c) Gray line.\n",
      "d) Semilunar fold.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // b) Corneoscleral limbus\n",
      "}\n",
      "```\n",
      "\n",
      "Caliciform cells are physiologically found in the corneoscleral limbus, which is the region where the cornea and sclera meet.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 2: \n",
      "Language: spanish\n",
      "Question: \n",
      "Marque la alternativa que mejor correlaciona las características histológicas con los respectivos tejidos oculares:\n",
      "\n",
      "I. Monocapa de células estrechamente unidas por complejos de unión.\n",
      "II.Las estrías paralelas y regulares observadas bajo microscopía óptica, perpendicular al epitelio.\n",
      "Iii.Contiene células bipolares, células amacrinas, células horizontales y células Muller.\n",
      "IV.Contiene células magnocelulares, parvocelulares y coniocelulares.\n",
      "\n",
      "A. Fotorreceptores.\n",
      "B. Epitelio pigmentado de la retina.\n",
      "C. Capa ganglionar de la retina.\n",
      "D. Capa nuclear interna.\n",
      "\n",
      "a) I: A, II: C; III: D; IV: B.\n",
      "b) I: B; II:A; III: D; IV: C.\n",
      "c) I: B; II: A; III: C; IV: C.\n",
      "d) I: C; II: A; III: D; IV: B.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "I. Monocapa de células estrechamente unidas por complejos de unión. - This describes the epithelial tissue, which is composed of a single layer of cells that are tightly connected by cell-cell junctions.\n",
      "\n",
      "II. Las estrías paralelas y regulares observadas bajo microscopía óptica, perpendicular al epitelio. - This describes the retina, specifically the photoreceptors, which have parallel and regular arrangements of microvilli.\n",
      "\n",
      "III. Contiene células bipolares, células amacrinas, células horizontales y células Muller. - This describes the inner layer of the retina, specifically the bipolar cells, amacrine cells, horizontal cells, and Müller cells.\n",
      "\n",
      "IV. Contiene células magnocelulares, parvocelulares y coniocelulares. - This describes the inner nuclear layer of the retina, which contains magnocellular, parvocellular, and koniocellular cells.\n",
      "\n",
      "Therefore, the correct answer is option b: I: B; II: A; III: D; IV: C.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ipagpares ang bahagi ng retina sa Hanay B sa tamang paglalarawan ng itong mga katangian sa Hanay A.\n",
      "\n",
      "I. Isang hanay ng mga cells na mahigpit na pinagsasama-sama ng mga junctional complexes\n",
      "II. Pantay at regular na mga hanay ng cells, tadlong sa epithelium\n",
      "III. May iba't ibang klaseng cells ito, katulad ng bipolar cells, amacrine cells, horizontal cells, at Muller cells.\n",
      "IV. Mayroon ito ng magnocellular, parvocellular, at coniocellular cells.\n",
      "\n",
      "A. Photoreceptors.\n",
      "B. Retinal pigment epithelium.\n",
      "C. Retinal ganglionic layer.\n",
      "D. Inner Nuclear Layer.\n",
      "\n",
      "a) I: A, II: C; III: D; IV: B.\n",
      "b) I: B; II:A; III: D; IV: C.\n",
      "c) I: B; II: A; III: C; IV: C.\n",
      "d) I: C; II: A; III: D; IV: B.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c) I: B; II: A; III: C; IV: C.\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "I. Isang hanay ng mga cells na mahigpit na pinagsasama-sama ng mga junctional complexes - This describes the feature of the retina in Hanay B, which is characterized by a single layer of cells that are tightly connected by junctional complexes.\n",
      "\n",
      "II. Pantay at regular na mga hanay ng cells, tadlong sa epithelium - This describes the feature of the retina in Hanay A, which is characterized by a regular and uniform layer of cells that are tightly connected to the epithelium.\n",
      "\n",
      "III. May iba't ibang klaseng cells ito, katulad ng bipolar cells, amacrine cells, horizontal cells, at Muller cells - This describes the feature of the retina in Hanay B, which contains different types of cells, including bipolar cells, amacrine cells, horizontal cells, and Muller cells.\n",
      "\n",
      "IV. Mayroon ito ng magnocellular, parvocellular, at coniocellular cells - This describes the feature of the retina in Hanay A, which contains different types of cells, including magnocellular, parvocellular, and coniocellular cells.\n",
      "\n",
      "Therefore, the correct answer is c) I: B; II: A; III: C; IV: C.\n",
      "{'response': 'c) I: B; II: A; III: C; IV: C.'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Assinale a alternativa que melhor correlaciona as características histológicas com os respectivos tecidos oculares:\n",
      "\n",
      "I. Monocamada de células fortemente unidas por complexos juncionais.\n",
      "II. Estriações paralelas e regulares observadas à microscopia óptica, perpendiculares ao epitélio.\n",
      "III. Contém células bipolares, células amácrinas, células horizontais e células de Muller.\n",
      "IV. Contém células magnocelulares, parvocelulares e coniocelulares.\n",
      "\n",
      "A. Fotorreceptores.\n",
      "B. Epitélio pigmentado da pigmentado da retina.\n",
      "C. Camada ganglionar retiniana.\n",
      "D. Camada nuclear interna.\n",
      "\n",
      "a) I: A, II: C; III: D; IV: B.\n",
      "b) I: B; II:A; III: D; IV: C.\n",
      "c) I: B; II: A; III: C; IV: C.\n",
      "d) I: C; II: A; III: D; IV: B.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "I. Monocamada de células fortemente unidas por complexos juncionais. - This describes the characteristic of the photoreceptors (A), which are strongly connected by junctional complexes.\n",
      "\n",
      "II. Estriações paralelas e regulares observadas à microscopia óptica, perpendiculares ao epitélio. - This describes the characteristic of the retina's epithelial layer (B), which has parallel and regular ridges observed under optical microscopy, perpendicular to the epithelium.\n",
      "\n",
      "III. Contém células bipolares, células amácrinas, células horizontais e células de Muller. - This describes the characteristic of the inner nuclear layer (C), which contains bipolar cells, amacrine cells, horizontal cells, and Müller cells.\n",
      "\n",
      "IV. Contém células magnocelulares, parvocelulares e coniocelulares. - This describes the characteristic of the inner layer of the retina (D), which contains magnocellular, parvocellular, and koniocellular cells.\n",
      "\n",
      "Therefore, the correct answer is option b: I: B; II: A; III: D; IV: C.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Mark the alternative that best correlates the histological characteristics with the respective ocular tissues:\n",
      "\n",
      "I. Monolayer of cells tightly joined together by junctional complexes.\n",
      "II. Parallel and regular striations observed under optical microscopy, perpendicular to the epithelium.\n",
      "III. It contains bipolar cells, amacrine cells, horizontal cells and Muller cells.\n",
      "IV. It contains magnocellular, parvocellular and coniocellular cells.\n",
      "\n",
      "A. Photoreceptors.\n",
      "B. Retinal pigmented epithelium.\n",
      "C. Retinal ganglionic layer.\n",
      "D. Inner nuclear layer.\n",
      "\n",
      "a) I: A, II: C; III: D; IV: B.\n",
      "b) I: B; II:A; III: D; IV: C.\n",
      "c) I: B; II: A; III: C; IV: C.\n",
      "d) I: C; II: A; III: D; IV: B.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "I. Monolayer of cells tightly joined together by junctional complexes. - This describes the retinal pigmented epithelium (RPE), which is a monolayer of cells that forms the outer layer of the retina and is tightly joined together by junctional complexes.\n",
      "\n",
      "II. Parallel and regular striations observed under optical microscopy, perpendicular to the epithelium. - This describes the photoreceptors, which are arranged in a parallel and regular pattern and can be observed under optical microscopy.\n",
      "\n",
      "III. It contains bipolar cells, amacrine cells, horizontal cells and Muller cells. - This describes the inner nuclear layer, which contains these types of cells.\n",
      "\n",
      "IV. It contains magnocellular, parvocellular and coniocellular cells. - This describes the retinal ganglionic layer, which contains these types of cells.\n",
      "\n",
      "Therefore, the correct answer is option b: I: B; II: A; III: D; IV: C.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 3: \n",
      "Language: spanish\n",
      "Question: \n",
      "Ordene los tres nombres de células que se encuentran en el epitelio corneal, comenzando con el má superficial, seguidos por el intermedio y lo profundo.\n",
      "a) Plana, alada, basal.\n",
      "b) Alada, basal, plana.\n",
      "c) Basal, plana, alada.\n",
      "d) Alada, plana, basal.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b) Alada, basal, plana.\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The three layers of cells in the corneal epithelium, starting from the most superficial, are:\n",
      "\n",
      "1. Alada (winged) cells: These cells are found in the outermost layer of the corneal epithelium and are characterized by the presence of microvilli, which give them a wing-like appearance.\n",
      "2. Basal cells: These cells are found in the middle layer of the corneal epithelium and are responsible for the production of new keratinocytes, which are the main cells that make up the epithelium.\n",
      "3. Plana cells: These cells are found in the innermost layer of the corneal epithelium and are characterized by their flat, squamous appearance.\n",
      "\n",
      "Therefore, the correct order of the three layers of cells in the corneal epithelium, starting from the most superficial, is: alada, basal, plana.\n",
      "\n",
      "Note: The term \"plana\" is not used in some sources, and instead, the term \"stratum corneum\" is used to refer to the outermost layer of the corneal epithelium. However, \"plana\" is a commonly used term in ophthalmology and is considered a synonym of \"stratum corneum.\"\n",
      "{'response': 'b) Alada, basal, plana.'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ipagsunud-sunod ang mga cells ng corneal epithelium, mula sa pinakamababaw hanggang sa pinakamalalim.\n",
      "a) Flat, wing, basal.\n",
      "b) Wing, basal, flat.\n",
      "c) Basal, flat, wing.\n",
      "d) Wing, flat, basal.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b) Wing, basal, flat.\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct order of the layers of the corneal epithelium, from superficial to deep, is:\n",
      "\n",
      "1. Wing cells (also known as peripheral cells)\n",
      "2. Basal cells (also known as stem cells)\n",
      "3. Flat cells (also known as squamous cells)\n",
      "\n",
      "Therefore, the correct answer is b) Wing, basal, flat.\n",
      "{'response': 'b) Wing, basal, flat.'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Ordene as três denominações celulares encontradas no epitélio da córnea, iniciando pelo mais superficial, seguido do intermediário e do profundo.\n",
      "a)Plana, alada, basal.\n",
      "b)Alada, basal, plana.\n",
      "c)Basal, plana, alada.\n",
      "d)Alada, plana, basal.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The three denominations of cells found in the epithelium of the cornea, starting from the most superficial, followed by the intermediate, and then the deepest, are:\n",
      "\n",
      "* Alada (winged cells)\n",
      "* Basal (basal cells)\n",
      "* Plana (squamous cells)\n",
      "\n",
      "Therefore, the correct order is b) Alada, basal, plana.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Order the three cell names found in the corneal epithelium, starting with the most superficial, followed by the intermediate and the deep.\n",
      "a) Flat, wing, basal.\n",
      "b) Wing, basal, flat.\n",
      "c) Basal, flat, wing.\n",
      "d) Wing, flat, basal.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c) Basal, flat, wing.\"\n",
      "}\n",
      "```\n",
      "\n",
      "The three cell names found in the corneal epithelium, starting with the most superficial, are:\n",
      "\n",
      "1. Basal cells: These cells are the deepest layer of the corneal epithelium and are responsible for producing new cells to replace damaged or dying cells.\n",
      "2. Flat cells: Also known as squamous cells, these cells are the intermediate layer of the corneal epithelium and are responsible for maintaining the integrity of the corneal surface.\n",
      "3. Wing cells: Also known as cuboidal cells, these cells are the most superficial layer of the corneal epithelium and are responsible for producing the tear film that lubricates the eye.\n",
      "\n",
      "Therefore, the correct order, starting with the most superficial, is:\n",
      "\n",
      "c) Basal, flat, wing.\n",
      "{'response': 'c) Basal, flat, wing.'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 4: \n",
      "Language: spanish\n",
      "Question: \n",
      "Con respecto a la membrana de la córnea de Descemet, es correcto declarar:\n",
      "a) Las células endoteliales no participan en su formación.\n",
      "b) Su grosor en el adulto es de aproximadamente 30 µm.\n",
      "c) Su porción más anterior es de origen embrionario.\n",
      "d) Su grosor se reduce con la edad.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "La respuesta correcta es b) Su grosor en el adulto es de aproximadamente 30 µm.\n",
      "\n",
      "La membrana de la córnea de Descemet es una capa delgada de células epiteliales que recubre la superficie posterior de la córnea. Su grosor en el adulto promedio es de aproximadamente 30 micras (μm), aunque puede variar ligeramente según la edad y otras condiciones. Las células endoteliales no participan en su formación, ya que son células que se encuentran en la superficie posterior de la córnea y son responsables de la regulación del fluido en la cámara posterior del ojo. La porción más anterior de la membrana de la córnea de Descemet es de origen embrionario, y su grosor puede disminuir ligeramente con la edad.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Tama tungkol sa Descemet's membrane ng cornea:\n",
      "a) Ang mga endothelial cells ay hindi nakikilahok sa pagbuo nito.\n",
      "b) Ang kapal nito ay halos 30 µm.\n",
      "c) Ang pinakaharap na bahagi ng Descemet's membrane ay nagmumula sa embryo.\n",
      "d) Kapag tumatanda, mas numinipis ang Descemet's membrane.\n",
      "Test #0: \n",
      "response\n",
      "  Here's my answer:\n",
      "```json\n",
      "{\n",
      "\t\"response\": b // The correct answer is b\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Ang kapal nito ay halos 30 µm.\n",
      "\n",
      "Descemet's membrane is a thin layer of tissue that covers the cornea, the clear dome-shaped surface at the front of the eye. It is composed of a single layer of endothelial cells and has a thickness of approximately 30 micrometers (μm). The other options are incorrect:\n",
      "\n",
      "a) Ang mga endothelial cells ay hindi nakikilahok sa pagbuo nito - This statement is false. Endothelial cells are the cells that line the inner surface of Descemet's membrane and play a crucial role in maintaining the health and function of the cornea.\n",
      "\n",
      "c) Ang pinakaharap na bahagi ng Descemet's membrane ay nagmumula sa embryo - This statement is false. Descemet's membrane is not derived from the embryo, but rather from the mesenchyme, a type of connective tissue that develops during fetal development.\n",
      "\n",
      "d) Kapag tumatanda, mas numinipis ang Descemet's membrane - This statement is false. Descemet's membrane does not become thinner with age. In fact, it is thought to remain relatively constant in thickness throughout life.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Sobre a membrana de Descemet da córnea, é correto afirmar:\n",
      "a)As células endoteliais não participam da sua formação.\n",
      "b)Sua espessura no adulto é de cerca de 30 µm.\n",
      "c)Sua porção mais anterior é de origem embrionária.\n",
      "d)Sua espessura reduz-se com a idade.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Sua espessura no adulto é de cerca de 30 µm.\n",
      "\n",
      "The Descemet membrane is a thin layer of tissue that covers the surface of the cornea, the clear dome-shaped surface at the front of the eye. It is composed of a single layer of cells called endothelial cells, which are responsible for maintaining the proper amount of moisture in the cornea. The Descemet membrane is approximately 30 micrometers thick in adults, and its thickness can decrease with age.\n",
      "\n",
      "Therefore, option b is the correct answer. Option a is incorrect because endothelial cells do play a role in the formation of the Descemet membrane. Option c is also incorrect because the Descemet membrane is not of embryonic origin. Option d is incorrect because the thickness of the Descemet membrane does not necessarily reduce with age.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding Descemet's membrane of the cornea, it is correct to state:\n",
      "a) Endothelial cells do not participate in its formation.\n",
      "b) Its thickness in the adult is about 30 µm.\n",
      "c) Its most anterior portion is of embryonic origin.\n",
      "d) Its thickness reduces with age.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) Its thickness in the adult is about 30 µm.\n",
      "\n",
      "Descemet's membrane is a thin layer of extracellular material that covers the posterior surface of the cornea. It is composed of a variety of components, including collagen, glycoproteins, and proteoglycans, and plays an important role in maintaining the integrity and function of the cornea.\n",
      "\n",
      "According to the statement, the thickness of Descemet's membrane in the adult is about 30 µm. This is a correct statement, as studies have shown that the thickness of Descemet's membrane in the adult human cornea ranges from approximately 20 to 40 µm, with a mean value of around 30 µm.\n",
      "\n",
      "Option a is incorrect, as endothelial cells do participate in the formation of Descemet's membrane. Option c is also incorrect, as the most anterior portion of Descemet's membrane is not of embryonic origin. Option d is incorrect, as the thickness of Descemet's membrane does not reduce with age.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 5: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto a la capa lipídica de la película lagrimal, seleccionar la alternativa correcta.\n",
      "a) Su finalidad básica es estabilizar la película y es secretada por las glándulas de Meibomio y Manz.\n",
      "b) Entre sus componentes se encuentran los ésteres de colesterol y una de sus funciones es retrasar la evaporación de la película lagrimal.\n",
      "c) En la disfunción de las glándulas de Meibomio, el punto de fusión de su secreción disminuye, contribuyendo al estancamiento de estas sustancias.\n",
      "d) Puede valorarse por el tiempo de ruptura de la película lagrimal, permaneciendo intacta menos de cinco segundos en ojos sanos.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "La capa lipídica de la película lagrimal es una capa fina y transparente que cubre la superficie del ojo. La capa lipídica está compuesta por ésteres de colesterol y otras sustancias, y su función principal es retrasar la evaporación de la película lagrimal, lo que ayuda a mantener la humedad y la integridad de la superficie del ojo. La capa lipídica es secretada por las glándulas de Meibomio y Manz, y su funcionamiento correcto es esencial para el bienestar ocular.\n",
      "\n",
      "En la disfunción de las glándulas de Meibomio, el punto de fusión de la secreción de estas glándulas disminuye, lo que puede contribuir al estancamiento de las sustancias que componen la capa lipídica y afectar su capacidad para retrasar la evaporación de la película lagrimal.\n",
      "\n",
      "El tiempo de ruptura de la película lagrimal es una medida importante de su integridad y función adecuada. En ojos sanos, la película lagrimal debe permanecer intacta durante al menos cinco segundos después de la aplicación de un estímulo. Si la película lagrimal se rompe antes de este tiempo, puede indicar una disfunción en la capa lipídica o en la producción de lágrimas.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Piliin ang tamang sagot tungkol sa lipid layer ng lacrimal film.\n",
      "a) Ang lipidic layer ay nagpapatag ng lacrimal film na nanggagaling sa meibomian at manz glands.\n",
      "b) May laman itong mga cholesterol esters na nakakatulong sa pagbabagal ng pagtuyo ng luha.\n",
      "c) Kapag nagkakaroon ng meibomian gland dysfunction, bumababa ang fusion point na nagpapahinto ng produksyon ng lipid.\n",
      "d) Nasusuri ito gamit ang lacrial film break up time, kung saan ay walang lacrimal film break up hanggang 5 na segundo sa normal na mata.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option c: \"Kapag nagkakaroon ng meibomian gland dysfunction, bumababa ang fusion point na nagpapahinto ng produksyon ng lipid.\"\n",
      "\n",
      "The lipid layer of the lacrimal film is produced by the meibomian glands, which are located in the upper eyelid. The meibomian glands produce a lipid-rich secretion that helps to prevent evaporation of the tear film. In cases where there is a dysfunction of the meibomian glands, the fusion point of the lipid layer is lowered, leading to a decrease in the production of lipid. This can cause dry eyes and other ocular surface problems.\n",
      "\n",
      "The other options are incorrect because:\n",
      "\n",
      "* Option a is incorrect because the lipid layer is not produced by the meibomian and manz glands, but rather by the meibomian glands alone.\n",
      "* Option b is incorrect because while cholesterol esters are present in the lipid layer, they do not help to slow down the evaporation of the tear film.\n",
      "* Option d is incorrect because the lacrimal film break-up time is not a measure of the lipid layer, but rather a measure of the tear film's stability.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Sobre a camada lipídica do filme lacrimal, assinale a alternativa correta. \n",
      "a)Tem por propósito básico estabilizar o filme e é secretada pelas glândulas de Meibomius e de Manz.  \n",
      "b)Ésteres de colesterol estão entre seus componentes e uma de suas funções é retardar a evaporação do filme lacrimal. \n",
      "c)Na disfunção das glândulas de Meibomius, o ponto de fusão de sua secreção diminui, colaborando para a estagnação dessas substâncias. \n",
      "d)Pode ser avaliada pelo tempo de ruptura do filme lacrimal, permanecendo intacta por menos de cinco segundos em olhos saudáveis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Ésteres de colesterol estão entre seus componentes e uma de suas funções é retardar a evaporação do filme lacrimal.\n",
      "\n",
      "The lipid layer of the tear film is a thin layer of lipids that covers the surface of the tear film and prevents it from evaporating too quickly. It is composed of cholesterol esters, which are responsible for its stability and function. The lipid layer is secreted by the Meibomian glands and the lacrimal gland, and its dysfunction can lead to dry eye syndrome.\n",
      "\n",
      "Therefore, option b is the correct answer. Option a is incorrect because the lipid layer is not responsible for stabilizing the tear film. Option c is incorrect because the ponto de fusão (melting point) of the lipid layer is not related to its function. Option d is incorrect because the lipid layer cannot be evaluated by the time it takes for the tear film to break, as it is a measure of the tear film's stability and not its lipid content.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "About the lipidic layer of the lacrimal film, choose the right answer. \n",
      "a) its purpose is to stabilize the lacrimal film secreted by the meibomian and manz glans.\n",
      "b) Cholesterol esters are within its components, and one of the functions is to delay the lacrimal film evaporation. \n",
      "c) In meibomian gland dysfunction, the fusion point decrease, leading to stagnation.\n",
      "d) can be evaluated by the lacrimal film break up time, keeping intact less than five seconds in healthy eyes.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "La capa lipídica de la película lacrimar es importante para la función de los glándulos de Meibomio y Manz. La capa lipídica ayuda a evitar la evaporación de la película lacrimar, lo que permite que la película lacrimar se mantenga más tiempo en la superficie del ojo. La función de la capa lipídica es retrasar la evaporación de la película lacrimar, lo que permite que la película lacrimar se mantenga más tiempo en la superficie del ojo.\n",
      "\n",
      "En el caso de la disfunción de los glándulos de Meibomio, la temperatura corporal disminuye, lo que puede afectar la fusión de la capa lipídica y provocar la estagnation de la película lacrimar.\n",
      "\n",
      "La integridad de la capa lipídica se puede evaluar mediante la prueba de tiempo de ruptura de la película lacrimar, que debe mantenerse intacta durante menos de cinco segundos en los ojos saludables.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 6: \n",
      "Language: spanish\n",
      "Question: \n",
      "En cuanto a los músculos externos del ojo, seleccione la alternativa correcta.\n",
      "a) En la ley de Hering, la inervación se distribuye por igual entre los músculos agonistas y antagonistas, para una versión determinada.\n",
      "b) Los movimientos de seguimiento se producen de forma automática, lenta, moviendo el punto de fijación.\n",
      "c) En la ley de Sherrington, el estímulo de la contracción se distribuye entre los agonistas de ambos ojos, de modo que se produce de forma simétrica.\n",
      "d) Los movimientos sacádicos se caracterizan por movimientos bruscos, descoordinados y de carácter totalmente reflejo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La respuesta correcta es la opción c) En la ley de Sherrington, el estímulo de la contracción se distribuye entre los agonistas de ambos ojos, de modo que se produce de forma simétrica.\n",
      "\n",
      "La ley de Sherrington establece que el estímulo de la contracción muscular se distribuye entre los músculos agonistas de ambos lados del cuerpo, lo que produce una contracción simétrica y coordinada. Esta ley se aplica a los músculos externos del ojo, que trabajan juntos para producir movimientos de seguimiento suaves y coordinados.\n",
      "\n",
      "Por lo tanto, la opción c es la respuesta correcta. Las otras opciones no son correctas y no se relacionan con los músculos externos del ojo o la ley de Sherrington.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod ang tama tungkol sa mga extraocular muscles?\n",
      "a) Sa Hering's Law, ang stimulation na nakukuha ng isang ugat ay pantay sa agonist at antagonist muscles papunta sa isang ocular version.\n",
      "b) Ang persecutory movements ay kusang nangyayari, kung saan nag-iiba ang fixation point.\n",
      "c) Inilalahad ng Sherrington's Law na ang agonist muscle sa kaliwa't kanang mata ay makakakuha ng pantay na stimulus mula sa utak.\n",
      "d) Inilalarawan ang saccadic movements na matarik, hindi tugma, at bilang isang reflex movement.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Inilalahad ng Sherrington's Law na ang agonist muscle sa kaliwa't kanang mata ay makakakuha ng pantay na stimulus mula sa utak.\n",
      "\n",
      "Sherrington's Law states that the agonist muscle of the opposing eye receives equal stimulation from the brain. This means that when one eye looks in a certain direction, the muscle that moves the opposing eye in the same direction receives equal stimulation. This helps to maintain binocular vision and prevent eye strain.\n",
      "\n",
      "The other options are incorrect because:\n",
      "\n",
      "a) Hering's Law refers to the equal innervation of agonist and antagonist muscles, but it does not apply to the extraocular muscles.\n",
      "\n",
      "b) Persecutory movements are not related to the extraocular muscles.\n",
      "\n",
      "d) Saccadic movements are fast, irregular, and not related to the extraocular muscles.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Sobre os músculos oculares externos, assinale a alternativa correta.\n",
      "a)Na lei de Hering, a inervação se distribui igualmente para os músculos agonista e antagonista, para determinada versão.\n",
      "b)Os movimentos persecutórios se dão automaticamente, de maneira lenta, ao deslocamento do ponto de fixação.\n",
      "c)Na lei de Sherrington, o estímulo de contração é distribuído entre os agonistas de ambos os olhos, para que ela ocorra simetricamente.\n",
      "d)Os movimentos sacádicos são caracterizados por movimentos bruscos, descoordenados, de natureza totalmente reflexa.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option c. According to Sherrington's law, the stimulus for contraction is distributed between the agonists of both eyes, so that the contraction occurs symmetrically. This means that when one eye moves, the other eye also moves in the opposite direction, allowing for coordinated and smooth eye movements.\n",
      "\n",
      "Option a is incorrect because it refers to Hering's law, which states that the innervation of the extraocular muscles is distributed equally between the agonist and antagonist muscles for a given version. This law does not relate to the coordination of eye movements.\n",
      "\n",
      "Option b is also incorrect because it refers to the slow, automatic movements of the eyes that occur when the point of fixation is displaced, known as persecutory movements. These movements are not related to the coordination of eye movements.\n",
      "\n",
      "Option d is incorrect because it refers to sacadic movements, which are characterized by rapid, coordinated movements of the eyes between fixation points. While these movements are reflexive, they are not necessarily disordered or uncoordinated.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding the external ocular muscles, choose the correct answer. \n",
      "a) in the Hering's law, the innervation is equally distributed to the agosist and antagonist muscles, for a given ocular version. \n",
      "b) The persecutory movements will automatically occur, slowly, with the displacement of the fixation point.\n",
      "c) In the sherrington's law, the contraction stimulus is distributed between the agonists of both eyes, so that it occur symmetrically. \n",
      "d) Saccadic movements are characterized by abrupt, uncoordinated, reflex movments.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "According to Hering's law, the innervation of the external ocular muscles is equally distributed to the agonist and antagonist muscles for a given ocular version. This means that when one eye is looking in a particular direction, the innervation of the muscles that control that eye's movement is equally distributed between the agonist and antagonist muscles. This allows for smooth and coordinated eye movements.\n",
      "\n",
      "Option b is incorrect because persecutory movements are not automatically occurring, slow movements. Persecutory movements are actually rapid, conjugate movements of the eyes that occur when the fixation point is displaced.\n",
      "\n",
      "Option c is incorrect because it refers to Sherrington's law, which states that the contraction stimulus is distributed between the agonists of both eyes, resulting in symmetrical movements. This is not related to the external ocular muscles.\n",
      "\n",
      "Option d is incorrect because saccadic movements are not abrupt, uncoordinated, reflex movements. Saccadic movements are actually fast, coordinated movements of the eyes that allow us to quickly shift our gaze between different points in the visual field.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 7: \n",
      "Language: spanish\n",
      "Question: \n",
      "Sobre la córnea, es correcto decir:\n",
      "a) La disposición de las fibrillas de colágeno corneal no está relacionado con su transparencia.\n",
      "b) El pleomorfismo de las células endoteliales se caracteriza por el tamaño de estas células.\n",
      "c) Las células de estoma anteriores tienen una gran cantidad de mitocondrias, responsables de la producción de energía que suministra la bomba endotelial.\n",
      "d) El endotelio se comporta como una barrera permeable no selectiva entre el humor acuoso y su propia sustancia.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La respuesta correcta es la opción c: Las células de estoma anteriores tienen una gran cantidad de mitocondrias, responsables de la producción de energía que suministra la bomba endotelial.\n",
      "\n",
      "La córnea es una estructura transparente en la superficie del ojo que tiene la función de enfocar la luz y permitir la visión. La transparencia de la córnea se debe a la disposición de las fibrillas de colágeno corneal, que están dispuestas de manera regular y paralela, lo que permite que la luz pase a través de ellas sin ser dispersada.\n",
      "\n",
      "El pleomorfismo de las células endoteliales se refiere a la variación en el tamaño y la forma de estas células, que pueden ser pequeñas y uniformes o grandes y pleomórficas. Sin embargo, esto no está relacionado con la transparencia de la córnea.\n",
      "\n",
      "El endotelio es una capa de células que recubre la superficie posterior de la córnea y tiene la función de regular la cantidad de humor acuoso que entra y sale de la cámara anterior del ojo. Aunque el endotelio actúa como una barrera permeable no selectiva, no es la razón por la cual la córnea es transparente.\n",
      "\n",
      "Por lo tanto, la respuesta correcta es la opción c, que describe la función de las células de estoma anteriores en la producción de energía para la bomba endotelial.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod ang tama tungkol sa cornea?\n",
      "a) Ang pag-aayos ng corneal collagen fibrils ay walang kaugnayan sa pagiging transparent nito.\n",
      "b) Ang pleomorphism ng mga endothelial cells ay nailalarawan sa pagkakaiba sa laki ng mga cell.\n",
      "c) Maraming mitochondria ang mga cell ng anterior stroma. Sila ay responsable para sa paggawa ng enerhiya para sa endothelial pump.\n",
      "d) Ang endothelium ay isang permeable non-selective barrier sa gitna ng aqueous humor at substantia propria.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Maraming mitochondria ang mga cell ng anterior stroma. Sila ay responsable para sa paggawa ng enerhiya para sa endothelial pump.\n",
      "\n",
      "The cornea is a transparent tissue that is responsible for refracting light and allowing us to see. The transparency of the cornea is due to the regular arrangement of collagen fibrils in the stroma, which allows light to pass through without being scattered. The endothelium, a layer of cells on the inner surface of the cornea, plays a crucial role in maintaining the transparency of the cornea by pumping water out of the stroma and keeping it hydrated. The mitochondria in the cells of the anterior stroma are responsible for producing energy for the endothelial pump, which helps maintain the proper thickness and transparency of the cornea.\n",
      "\n",
      "Therefore, option c is the correct answer. Option a is incorrect because the arrangement of collagen fibrils in the stroma is not related to the transparency of the cornea. Option b is also incorrect because pleomorphism refers to the variation in size and shape of cells, which is not related to the function of the endothelium. Option d is incorrect because the endothelium is a selective barrier that regulates the flow of substances between the aqueous humor and the substantia propria, but it is not a non-selective barrier.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Sobre a córnea, é correto afirmar:\n",
      "a)A disposição das fibrilas de colágeno corneanas não tem relação com a sua transparência.\n",
      "b)Pleomorfismo das células endoteliais é caracterizado pela variação do tamanho dessas células.\n",
      "c)As células do estroma anterior possuem grande quantidade de mitocôndrias, responsáveis pela produção de energia que supre a bomba endotelial.\n",
      "d)O endotélio comporta-se como uma barreira permeável não-seletiva entre o humor aquoso e a substância própria.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option c. The cells of the anterior stroma have a large number of mitochondria, which are responsible for producing energy that supports the endothelial pump. This is a characteristic feature of the cornea, and it is important for maintaining the transparency of the tissue.\n",
      "\n",
      "Option a is incorrect because the arrangement of collagen fibers in the cornea does have an impact on its transparency. The fibers are arranged in a specific way to allow light to pass through the tissue with minimal scattering.\n",
      "\n",
      "Option b is also incorrect because pleomorphism of endothelial cells refers to the variation in size and shape of these cells, which can be seen in certain diseases or conditions. It is not a characteristic feature of the normal cornea.\n",
      "\n",
      "Option d is incorrect because the endothelium does not behave as a non-selective barrier between the aqueous humor and the substance proper. It plays a crucial role in regulating the amount of fluid in the cornea and maintaining its transparency.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "About the cornea, it is correct to state. \n",
      "a) The arrangement of corneal collagen fibrils is unrelated to its transparency. \n",
      "b) Pleomorphism of endothelial cells is characterized by the variation in the size of these cells. \n",
      "c) anterior stroma have a large number of mitochondria, responsible for the production of energy that supplies the endothelial pump. \n",
      "d) The endothelium behaves as a permeable non-selective barrier between the aqueous humor and the substantia propria.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "La afirmación correcta es la opción c: El estroma anterior tiene un gran número de mitocondrias, responsables de la producción de energía que suministra la bomba endotelial.\n",
      "\n",
      "Here's the answer in Tagalog:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "Ang tamaan na may korekta ay option c: Ang anterior stroma ay may malaking number ng mitocondria, na responsable sa produksyon ng enerhiya na suministrado ng endotelial pump.\n",
      "\n",
      "Here's the answer in Portuguese:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "A afirmação correta é a opção c: O estroma anterior tem um grande número de mitocôndrias, responsáveis pela produção de energia que fornece a bomba endotelial.\n",
      "\n",
      "Here's the answer in English:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "The correct statement is option c: The anterior stroma has a large number of mitochondria, responsible for the production of energy that supplies the endothelial pump.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 8: \n",
      "Language: spanish\n",
      "Question: \n",
      "Elija la alternativa que llena correctamente los vacíos.La levocicloversión corresponde a ____________ del ojo derecho y ________ del ojo izquierdo y se activa cuando la cabeza está inclinada hacia el hombro___________.\n",
      "a) Excicloducción / incicloducción / izquierdo.\n",
      "b) incicloducción / excicloducción / izquierdo.\n",
      "c) Excicloducción / incicloducción / derecho.\n",
      "d) Incalducción / excicloducción / derecho.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "La levocicloversión corresponde a la excicloducción del ojo derecho y la incicloducción del ojo izquierdo, y se activa cuando la cabeza está inclinada hacia el hombro derecho. Por lo tanto, la respuesta correcta es la opción b.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Piliin ang tamang sagot: Ang levocycloversion ay tumutugma sa ____________ ng kanang mata at ________ ng kaliwang mata. Napapasimuno ito kapag pinaikot ang ulo sa ____ na balikat.\n",
      "a) Excicloduction / incicloduction / kaliwa\n",
      "b) incicloduction / excicloduction / kaliwa\n",
      "c) Excicloduction / incicloduction / kanan\n",
      "d) incicloduction / excicloduction / kanan\n",
      "Test #0: \n",
      "response\n",
      "  Here's my answer:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the direction of the levocycloversion, which is a term used to describe the rotation of the eye during a specific type of eye movement. The correct answer is b) incicloduction / excicloduction / kaliwa.\n",
      "\n",
      "Incicloduction refers to the inward movement of the eye, while excicloduction refers to the outward movement. Kaliwa refers to the left eye. Therefore, the correct answer is b) incicloduction / excicloduction / kaliwa, as the levocycloversion involves the inward movement of the left eye.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Assinale a alternativa que preenche corretamente as lacunas. A levocicloversão corresponde a ____________ do olho direito e ________ do olho esquerdo e é desencadeada quando se inclina a cabeça para o ombro___________.\n",
      "a)Exciclodução / inciclodução / esquerdo.\n",
      "b)Inciclodução / exciclodução / esquerdo.\n",
      "c)Exciclodução / inciclodução / direito.\n",
      "d)Inciclodução / exciclodução / direito.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the correct term for the movement of the eye that corresponds to the movement of the head to the shoulder. The correct answer is \"incycloduction\" which is the movement of the eye inward (towards the nose) and downward, and it occurs when the head is inclined to the shoulder.\n",
      "\n",
      "In Portuguese, the term for incycloduction is \"incyclodução\" and it can be translated to English as \"incycloduction\" or \"inward and downward movement of the eye\".\n",
      "\n",
      "Therefore, the correct answer is option b: \"Inciclodução / exciclodução / esquerdo\".\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Choose the alternative that correctly fills in the gaps. Levocycloversion corresponds to ____________ of the right eye and ________ of the left eye and is triggered when the head is tilted towards the ___ shoulder.\n",
      "a) Excicloduction / incicloduction / left.\n",
      "b) Incicloduction / excicloduction / left.\n",
      "c) Excicloduction / incicloduction / right.\n",
      "d) Incicloduction / excicloduction / right.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in markdown format:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"b\"  // b) Incicloduction / excicloduction / left.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "Levocycloversion is a reflexive movement of the eyes that occurs when the head is tilted towards the left shoulder. It corresponds to incycloduction of the right eye and excicycloduction of the left eye.\n",
      "\n",
      "Incycloduction is the movement of the eye inward, towards the nose, while excicycloduction is the movement of the eye outward, away from the nose.\n",
      "\n",
      "Therefore, the correct answer is option b: Incicloduction / excicloduction / left.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 9: \n",
      "Language: spanish\n",
      "Question: \n",
      "Con respecto a las células del cuerpo vítreo, marque la alternativa correcta.\n",
      "a) Son más numerosas en el adulto que en el vítreo embrionario.\n",
      "b) Están representadas principalmente por linfocitos y neutrófilos maduros.\n",
      "c) Son abundantes en la región de la base vítrea.\n",
      "d) Están ausentes en el recién nacido.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La respuesta correcta es la opción c) Son abundantes en la región de la base vítrea. Las células del cuerpo vítreo son más abundantes en la región de la base vítrea que en otras partes del cuerpo.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin ang tama tungkol sa mga vitreous cells?\n",
      "a) Mas marami ang vitreous cells sa matatanda kumpara sa isang embryo.\n",
      "b) Karamihan sa mga cell na matatagpo sa vitreous ay lymphocytes at mature neutrophils.\n",
      "c) Sila ay sagana sa rehiyon ng vitreous base.\n",
      "d) Walang vitreous cells na matatagpo sa mga bagong panganak.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Sila ay sagana sa rehiyon ng vitreous base.\n",
      "\n",
      "The vitreous humor is a clear, gel-like substance that fills the vitreous cavity of the eye. It is composed of water, proteins, and other substances, and it plays an important role in maintaining the shape and structure of the eye. The vitreous humor is produced by cells called vitreous cells, which are found in the vitreous base, the area where the vitreous humor attaches to the retina.\n",
      "\n",
      "Option a) is incorrect because the number of vitreous cells decreases with age, not increases. Option b) is also incorrect because lymphocytes and mature neutrophils are not found in the vitreous humor. Option d) is incorrect because vitreous cells are present in the vitreous humor of newborns, although their number decreases with age.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação às células do corpo vítreo, assinale a alternativa correta.\n",
      "a)São mais numerosos no adulto, comparativamente às do vítreo embrionário.\n",
      "b)São representadas principalmente por linfócitos e neutrófilos maduros.\n",
      "c)São abundantes na região da base vítrea.\n",
      "d)Estão ausentes no recém-nascido.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option c) São abundantes na região da base vítrea.\n",
      "\n",
      "The cells of the vitreous body are abundant in the region of the vitreous base, which is the part of the eye where the vitreous humor is in contact with the retina. This is a characteristic feature of the vitreous body and distinguishes it from other parts of the eye.\n",
      "\n",
      "Option a) São mais numerosos no adulto, comparativamente às do vítreo embrionário is incorrect because the number of cells in the vitreous body does not change significantly during development.\n",
      "\n",
      "Option b) São representadas principalmente por linfócitos e neutrófilos maduros is incorrect because the vitreous body does not contain mature lymphocytes and neutrophils.\n",
      "\n",
      "Option d) Estão ausentes no recém-nascido is incorrect because the vitreous body is present in the newborn, although it is not fully developed at birth.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding the vitreous body cells, mark the correct alternative.\n",
      "a) They are more numerous in the adult than in the embryonic vitreous.\n",
      "b) They are mainly represented by lymphocytes and mature neutrophils.\n",
      "c) They are abundant in the region of the vitreous base.\n",
      "d) They are absent in the newborn.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c) They are abundant in the region of the vitreous base.\n",
      "\n",
      "According to the article \"The Vitreous Body: A Review of Its Functions and Disorders\" by John M. Woodcock and David G. Hwang, the vitreous body cells are indeed abundant in the region of the vitreous base, which is the part of the vitreous that is closest to the retina. The vitreous base is a specialized area that is characterized by a high concentration of cells, including fibroblasts, glial cells, and inflammatory cells.\n",
      "\n",
      "Option a) They are more numerous in the adult than in the embryonic vitreous is incorrect because the number of cells in the vitreous body decreases with age, and the embryonic vitreous contains more cells than the adult vitreous.\n",
      "\n",
      "Option b) They are mainly represented by lymphocytes and mature neutrophils is incorrect because while lymphocytes and neutrophils are present in the vitreous body, they are not the main types of cells found there.\n",
      "\n",
      "Option d) They are absent in the newborn is incorrect because the vitreous body is present at birth and contains cells, including fibroblasts, glial cells, and inflammatory cells.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 10: \n",
      "Language: spanish\n",
      "Question: \n",
      "Con respecto a la fisiología de los músculos oculomotores, marque la alternativa correcta.\n",
      "a) La contracción muscular es independiente de la disponibilidad de calcio.\n",
      "b) La fibra muscular es una célula multinucleada.\n",
      "c) Cada contracción muscular es el resultado de un ciclo único de formación y destrucción de los puentes de actina-miosina.\n",
      "d) La relajación muscular depende principalmente de la disponibilidad de sodio.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La respuesta correcta es la opción c: Cada contracción muscular es el resultado de un ciclo único de formación y destrucción de los puentes de actina-miosina.\n",
      "\n",
      "Los músculos oculomotores, como todos los músculos esqueléticos, funcionan mediante la contracción y relajación de las fibras musculares. La contracción muscular es el resultado de una serie de eventos que incluyen la formación de puentes de actina-miosina, la hidratación de los filamentos y la subsequentemente contracción de la fibra muscular. Esta contracción es reversible, y la relajación muscular se produce cuando los puentes de actina-miosina se destruyen y los filamentos se deshidratan.\n",
      "\n",
      "La disponibilidad de calcio y sodio es importante para la función muscular, pero no es la única factor que determina la contracción o relajación muscular. La contracción muscular es un proceso complejo que involucra la interacción de múltiples proteínas y iones, y la regulación de la disponibilidad de calcio y sodio es solo una parte de este proceso.\n",
      "\n",
      "Por lo tanto, la opción c es la respuesta correcta.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod ang tama tungkol sa pisyolohiya ng mga extraocular muscles?\n",
      "a) Ang paggalaw ng mga extraocular muscle ay hindi nagdedepende sa karamihan ng calcium sa katawan.\n",
      "b) Ang muscle fiber ay may maraming nucleus.\n",
      "c) Ang bawat muscle contraction ay resulta ng panibagong pagbuo at pagkasira ng mga actin-myosin bridges.\n",
      "d) Ang pagpahinga ng mga oculomotor muscle ay nagdedepende sa karamihan ng sodium sa katawan.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Ang bawat muscle contraction ay resulta ng panibagong pagbuo at pagkasira ng mga actin-myosin bridges.\n",
      "\n",
      "The extraocular muscles are responsible for moving the eyeball and eyelid. These muscles work by contracting and relaxing, which is dependent on the formation and breakage of actin-myosin bridges. The contraction of muscle fibers is not dependent on the amount of calcium in the body, and the muscle fibers have multiple nuclei. The relaxation of the oculomotor muscles, which control the movement of the eyeball, is not dependent on the amount of sodium in the body. Therefore, option c is the correct answer.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação à fisiologia dos músculos oculomotores, assinale a alternativa correta.\n",
      "a)A contração muscular independe da disponibilidade de cálcio.\n",
      "b)A fibra muscular é uma célula multinucleada.\n",
      "c)Cada contração muscular é resultado de um ciclo único de formação e destruição de pontes de actina-miosina.\n",
      "d)O relaxamento muscular depende principalmente da disponibilidade de sódio.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Cada contração muscular é resultado de um ciclo único de formação e destruição de pontes de actina-miosina.\n",
      "\n",
      "The physiology of the oculomotor muscles involves the contraction and relaxation of muscle fibers, which is dependent on the availability of calcium ions (not sodium ions, therefore option d is incorrect). Muscle fibers are multinucleated cells (option b is incorrect), and each contraction is the result of a unique cycle of actin-myosin bridge formation and destruction (option c is correct). The contraction of muscle fibers does not depend on the availability of calcium ions (option a is incorrect). Therefore, the correct answer is option c.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding the physiology of the oculomotor muscles, mark the correct alternative.\n",
      "a) Muscle contraction is independent of calcium availability.\n",
      "b) The muscle fiber is a multinucleated cell.\n",
      "c) Each muscle contraction is the result of a unique cycle of formation and destruction of actin-myosin bridges.\n",
      "d) Muscle relaxation rely mainly on sodium availability.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Each muscle contraction is the result of a unique cycle of formation and destruction of actin-myosin bridges.\n",
      "\n",
      "The oculomotor muscles, like all skeletal muscles, work through a cycle of actin-myosin bridge formation and destruction. When an electrical impulse reaches the muscle fiber, the actin and myosin filaments interact, forming bridges that cause muscle contraction. As the muscle contracts, the actin-myosin bridges are continuously broken and re-formed, allowing the muscle to maintain its contraction. This process is repeated with each muscle contraction, making it a unique cycle of formation and destruction of actin-myosin bridges.\n",
      "\n",
      "Therefore, option c is the correct answer.\n",
      "\n",
      "Option a is incorrect because muscle contraction is not independent of calcium availability. Calcium ions play a crucial role in the contraction of muscles, as they help to regulate the interaction between actin and myosin filaments.\n",
      "\n",
      "Option b is incorrect because while muscle fibers are indeed multinucleated cells, this is not the correct answer for the question.\n",
      "\n",
      "Option d is incorrect because muscle relaxation does not rely mainly on sodium availability. Muscle relaxation occurs when the electrical impulse that causes muscle contraction is removed, and the actin-myosin bridges are broken. While sodium ions are involved in the process of muscle contraction, they are not the primary factor in muscle relaxation.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 11: \n",
      "Language: spanish\n",
      "Question: \n",
      "Con respecto a la lente, marque la alternativa correcta.\n",
      "a) Aunque su volumen aumenta con la edad, su peso permanece constante.\n",
      "b) La proteólisis de sus fibras es el mecanismo principal de su crecimiento celular.\n",
      "c) La síntesis de sus proteínas tiene lugar durante la diferenciación de la célula en fibra.\n",
      "d) Su síntesis de proteínas es continua durante toda la vida, manteniendo la plasticidad y la elasticidad estables desde la infancia hasta el envejecimiento.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is d) Su síntesis de proteínas es continua durante toda la vida, manteniendo la plasticidad y la elasticidad estables desde la infancia hasta el envejecimiento.\n",
      "\n",
      "The lens of the eye is a dynamic structure that undergoes continuous protein synthesis throughout life, which allows it to maintain its plasticity and elasticity from childhood to old age. This means that the lens can continue to change its shape and focus throughout a person's life, allowing for proper vision.\n",
      "\n",
      "Option a) is incorrect because while the volume of the lens does increase with age, its weight remains constant.\n",
      "\n",
      "Option b) is incorrect because proteolysis (the breakdown of proteins) is not the main mechanism for cell growth in the lens.\n",
      "\n",
      "Option c) is incorrect because protein synthesis occurs during cell differentiation, not during the entire life of the cell.\n",
      "{'response': 'd'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga susunod ang tama tungkol sa lente ng mata?\n",
      "a) Sa pagtanda, lumalaki ang lente ng mata pero hindi siya bumibigat.\n",
      "b) Ang paglago ng mga cell ng lente ay dahil sa mekanismo ng proteolysis ng mga fiber.\n",
      "c) Ang paggawa ng mga protina ng lente ay nagaganap sa differentiation stage ng mga fiber.\n",
      "d) Ang paggawa ng lente ng mga protina ay nangyayari habambuhay, kaya nananatili ang plasticity at elasticity ng lente.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Ang paggawa ng mga protina ng lente ay nagaganap sa differentiation stage ng mga fiber.\n",
      "\n",
      "The lens of the eye is formed from fibers that are produced by the differentiation of cells in the lens epithelium. This process occurs during embryonic development and is controlled by a complex interplay of genetic and environmental factors. The fibers are produced in a specific pattern, with the oldest fibers in the center of the lens and the youngest fibers in the periphery. The proteins in the lens fibers are constantly being replaced through a process called proteolysis, which helps to maintain the transparency and flexibility of the lens. However, the lens does not continue to grow in size throughout life, and its size is determined by the balance between the rate of fiber production and the rate of fiber degradation. Therefore, option c is the correct answer.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação ao cristalino, assinale a alternativa correta.\n",
      "a)Embora seu volume aumente com a idade, seu peso mantém-se constante.\n",
      "b)A proteólise de suas fibras é o principal mecanismo de seu crescimento celular.\n",
      "c)A síntese de suas proteínas processa-se durante a diferenciação da célula em fibra.\n",
      "d)Sua síntese proteica é continua ao longo da vida, mantendo plasticidade e elasticidade estáveis da infância ao envelhecimento.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is d) His protein synthesis is continuous throughout life, maintaining stable plasticity and elasticity from childhood to aging.\n",
      "\n",
      "The other options are incorrect because:\n",
      "\n",
      "a) The volume of the crystalline lens does increase with age, but its weight remains constant.\n",
      "\n",
      "b) Proteolysis of its fibers is not the primary mechanism of cell growth.\n",
      "\n",
      "c) Protein synthesis occurs during cell differentiation, not during the entire life of the cell.\n",
      "{'response': 'd'}\n",
      "Language: english\n",
      "Question: \n",
      "With regard to the lens, mark the correct alternative.\n",
      "a) Although its volume increases with age, its weight remains constant.\n",
      "b) The proteolysis of its fibers is the main mechanism of its cellular growth.\n",
      "c) The synthesis of its proteins takes place during the differentiation of the cell into fiber.\n",
      "d) Its protein synthesis is continuous throughout life, maintaining stable plasticity and elasticity from childhood to aging.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "La respuesta correcta es la opción d) Su síntesis de proteínas es continua throughout life, manteniendo la plasticidad y elasticidad estables desde la infancia hasta la vejez.\n",
      "\n",
      "Here's the answer in Tagalog:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "Ang tama ng lens ay hindi natitira sa pagtanda, pero ang weight nito ay hindi natitira.\n",
      "\n",
      "Here's the answer in Portuguese:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "A síntese de proteínas delens é contínua durante toda a vida, mantendo a plasticidade e elasticidade estáveis desde a infância até a idade avançada.\n",
      "\n",
      "Here's the answer in English:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "The protein synthesis of the lens is continuous throughout life, maintaining stable plasticity and elasticity from childhood to aging.\n",
      "{'response': 'd'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 12: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un paciente con artrosis ha estado usando altas dosis de cloroquina durante años.Se cree que este medicamento puede causar mal funcionamiento del epitelio de pigmento retiniano, ya que:\n",
      "a) obstaculiza la síntesis de melanina.\n",
      "b) obstaculiza la fagocitosis de los discos de los segmentos externos del fotorreceptor.\n",
      "c) obstaculiza el transporte de iones intracelulares.\n",
      "d) favorece el intercambio de calor entre los fotorreceptores y el coroides.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) obstaculiza la fagocitosis de los discos de los segmentos externos del fotorreceptor.\n",
      "\n",
      "Chloroquine can cause damage to the retinal pigment epithelium (RPE) by inhibiting the phagocytosis of the outer segment discs of the photoreceptors. This can lead to a accumulation of lipofuscin, a waste product, in the RPE, which can cause damage to the retina and lead to vision loss.\n",
      "\n",
      "The other options are not correct:\n",
      "\n",
      "a) Chloroquine does not affect the synthesis of melanin.\n",
      "\n",
      "c) Chloroquine does not affect the transport of ions intracellularly.\n",
      "\n",
      "d) Chloroquine does not facilitate the exchange of heat between the photoreceptors and the choroid.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "May isang pasyente na may arthrosis na matagal nang rineresetahan ng chloroquine. Ang chloroquine ay nagiging sanhi ng pagkasira ng retinal pigment epithelium sa pamamagitan ng:\n",
      "a) pagpigil ng paggawa ng melanin.\n",
      "b) pagpigil ng pagpapatay ng mga disks ng photoreceptor outer segments.\n",
      "c) pagbabawas ng pagpasok ng mga intracellular ion sa retinal pigment epithelium.\n",
      "d) pagpabor sa matinding heat exchange ng mga photoreceptor at ang choroid.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Chloroquine can cause retinal toxicity, which can lead to retinal pigment epithelial damage. This damage can occur through several mechanisms, including:\n",
      "\n",
      "* Inhibition of melanin production (option a): Chloroquine can inhibit the production of melanin, which can lead to a decrease in the amount of melanin in the retina.\n",
      "* Inhibition of photoreceptor outer segment disk shedding (option b): Chloroquine can also inhibit the shedding of photoreceptor outer segments, which can lead to an accumulation of damaged photoreceptors.\n",
      "* Decrease in intracellular ion transport (option c): Chloroquine can disrupt the transport of ions within the retinal pigment epithelium, leading to cellular damage.\n",
      "* Increased heat exchange between photoreceptors and the choroid (option d): Chloroquine can increase heat exchange between the photoreceptors and the choroid, leading to damage to the retina.\n",
      "\n",
      "Of the options provided, the most correct answer is option c, \"Decrease in intracellular ion transport.\" This is because chloroquine has been shown to disrupt the transport of ions, such as potassium and calcium, within the retinal pigment epithelium, leading to cellular damage and retinal toxicity.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Paciente com artrose faz uso de altas doses de cloroquina há anos. Acredita-se que essa droga pode causar mau funcionamento do epitélio pigmentar retiniano, uma vez que:\n",
      "a)Impede a síntese de melanina.\n",
      "b)Impede a fagocitose dos discos dos segmentos externos dos fotorreceptores.\n",
      "c)Impede o transporte de íons intracelulares.\n",
      "d)Favorece a intensa troca de calor entre os fotorreceptores e a coroide.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Impede a fagocitose dos discos dos segmentos externos dos fotorreceptores.\n",
      "\n",
      "Chloroquine, a drug used to treat malaria, can cause damage to the retinal pigment epithelium (RPE) by inhibiting the phagocytosis of the outer segment discs of the photoreceptors. This can lead to a build-up of waste material in the retina and eventually cause vision loss.\n",
      "\n",
      "The other options are not correct explanations for how chloroquine can cause damage to the RPE:\n",
      "\n",
      "a) Impede a síntese de melanina - Chloroquine does not affect the synthesis of melanin, the pigment responsible for skin and hair color.\n",
      "\n",
      "c) Impede o transporte de íons intracelulares - Chloroquine does not affect the transport of ions within cells.\n",
      "\n",
      "d) Favorece a intensa troca de calor entre os fotorreceptores e a coroide - Chloroquine does not promote heat exchange between the photoreceptors and the choroid, which is the layer of blood vessels and connective tissue between the sclera and retina.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "A patient with arthrosis has been using high doses of chloroquine for years. It is believed that this drug can cause malfunction of the retinal pigment epithelium, since:\n",
      "a) It hinders the synthesis of melanin.\n",
      "b) It hinders phagocytosis of the disks of the photoreceptor outer segments.\n",
      "c) It hinders the transport of intracellular ions.\n",
      "d) It favors intense heat exchange between the photoreceptors and the choroid.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Chloroquine has been associated with retinal toxicity, particularly in patients with prolonged use and high doses. The toxicity is believed to be due to the drug's effect on the retinal pigment epithelium (RPE), which is responsible for phagocytosing the outer segments of the photoreceptors. Chloroquine has been shown to hinder the phagocytosis of the outer segments, leading to their accumulation and subsequent damage to the RPE. This can result in vision loss and other retinal problems.\n",
      "\n",
      "Therefore, the correct answer is (b) It hinders phagocytosis of the disks of the photoreceptor outer segments.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 13: \n",
      "Language: spanish\n",
      "Question: \n",
      "Con respecto al flujo sanguíneo en la coroides, es posible indicar:\n",
      "a) Es responsable de toda nutrición de la retina.\n",
      "b) Es responsable del 95% de la glucosa consumida en la parte interna de la retina.\n",
      "c) Participa en la regulación térmica de los fotorreceptores.\n",
      "d) Los esfínteres precapilares evitan el hiperflojo de la sangre en áreas nobles como la mácula.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": b // La opción correcta es b\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the role of blood flow in the choroids in the eye. The correct answer is b) The choroidal blood flow is responsible for 95% of the glucose consumed in the inner part of the retina. The choroids are a layer of blood vessels between the sclera and retina that supply blood to the retina. The glucose consumed by the retina is mainly supplied by the choroidal blood flow.\n",
      "\n",
      "Option a is incorrect because while the choroidal blood flow does play a role in the nutrition of the retina, it is not responsible for all of the nutrition of the retina.\n",
      "\n",
      "Option c is incorrect because the choroidal blood flow does not participate in the regulation of the thermal environment of the photoreceptors.\n",
      "\n",
      "Option d is incorrect because while the precapillary sphincters do help regulate blood flow in the retina, they do not prevent hyperemia (increased blood flow) in areas such as the macula.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Posibleng masabi tungkol sa pagdaloy ng dugo sa choroid:\n",
      "a) Ito ay nagbibigay ng lahat ng sustansya ng retina.\n",
      "b) Ito ay nagbibigay ng 95% ng glucose para sa panloob na bahagi ng retina.\n",
      "c) Nakikilahok ito sa thermal regulation ng mga photoreceptor.\n",
      "d) Ang mga pre-capillary sphincters ay pumipigil sa lubos na pagdaloy ng dugo sa mga importanteng bahagi ng retina, katulad ng macula.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option b, \"Ito ay nagbibigay ng 95% ng glucose para sa panloob na bahagi ng retina.\"\n",
      "\n",
      "The choroid is a layer of blood vessels between the sclera and retina in the eye. It supplies blood and nutrients to the retina, which is responsible for converting light into electrical signals that are transmitted to the brain. The choroid provides 95% of the glucose needed by the inner parts of the retina, making it a vital structure for maintaining healthy vision.\n",
      "\n",
      "Option a, \"Ito ay nagbibigay ng lahat ng sustansya ng retina,\" is incorrect because while the choroid does provide nutrients to the retina, it does not produce all of the substances needed by the retina.\n",
      "\n",
      "Option c, \"Nakikilahok ito sa thermal regulation ng mga photoreceptor,\" is also incorrect because while the choroid does play a role in regulating the temperature of the retina, it is not its primary function.\n",
      "\n",
      "Option d, \"Ang mga pre-capillary sphincters ay pumipigil sa lubos na pagdaloy ng dugo sa mga importanteng bahagi ng retina, katulad ng macula,\" is incorrect because while pre-capillary sphincters do play a role in regulating blood flow to certain parts of the retina, they are not the primary mechanism by which the choroid supplies blood and nutrients to the retina.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação ao fluxo sanguíneo na coroide, podemos afirmar:\n",
      "a)É responsável por toda nutrição da retina.\n",
      "b)É responsável por 95% da glicose consumida na parte interna da retina.\n",
      "c)Participa da regulação térmica dos fotorreceptores.\n",
      "d)Os esfíncteres pré-capilares previnem o hiperfluxo de sangue em áreas nobres como a mácula.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the role of the choroidal blood flow in the retina.\n",
      "\n",
      "Option A is incorrect because while the choroidal blood flow does provide some nutrients to the retina, it is not responsible for all of the nutrients that the retina needs.\n",
      "\n",
      "Option B is correct. The choroidal blood flow is responsible for providing 95% of the glucose consumed in the inner part of the retina.\n",
      "\n",
      "Option C is incorrect. While the choroidal blood flow does play a role in regulating the temperature of the retina, it does not participate in the regulation of the thermal properties of the photoreceptors.\n",
      "\n",
      "Option D is incorrect. The precapillary sphincters in the choroidal blood flow do not prevent hyperemia (increased blood flow) in areas such as the macula.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding the blood flow in the choroid, it is possible to state:\n",
      "a) It is responsible for all nutrition of the retina.\n",
      "b) It is responsible for 95% of the glucose consumed in the inner part of the retina.\n",
      "c)Participates in the thermal regulation of photoreceptors.\n",
      "d) The pre-capillary sphincters prevent the hyperflow of blood in noble areas such as the macula.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) It is responsible for 95% of the glucose consumed in the inner part of the retina.\n",
      "\n",
      "The choroid is a layer of blood vessels between the sclera and retina that supplies blood to the retina. The choroidal blood flow plays a crucial role in maintaining the metabolic demands of the retina, particularly the inner part of the retina. The retina requires a constant supply of glucose, which is primarily provided by the choroidal blood flow. In fact, the choroidal blood flow is responsible for approximately 95% of the glucose consumed in the inner part of the retina. Therefore, option b is the correct answer.\n",
      "\n",
      "Option a is incorrect because, although the choroidal blood flow does provide nutrients to the retina, it is not responsible for all nutrition of the retina. The retina also receives nutrients from the vitreous humor and the retinal pigment epithelium.\n",
      "\n",
      "Option c is incorrect because, while the choroidal blood flow does play a role in regulating the temperature of the retina, it does not participate in the thermal regulation of photoreceptors.\n",
      "\n",
      "Option d is incorrect because, although the pre-capillary sphincters do play a role in regulating blood flow in the choroid, they do not prevent the hyperflow of blood in noble areas such as the macula.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 14: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto a la embriología de la coroides, es correcto afirmar que:\n",
      "a) La coriocapilar es la primera en formarse, con posterior formación de los grandes vasos.\n",
      "b) La lámina basal da lugar a la membrana de Bruch, que se sitúa entre los coriocapilares y la capa de Sattler.\n",
      "c) La capa vascular intermedia es la última en formarse y se desarrolla desde el cuerpo ciliar hacia el ecuador.\n",
      "d) El estroma coroideo se produce esencialmente a partir de células del mesodermo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "La respuesta correcta es la opción b, La lámina basal da lugar a la membrana de Bruch, que se sitúa entre los coriocapilares y la capa de Sattler. La membrana de Bruch es una capa delgada de tejido conjuntivo que se encuentra entre la capa de Sattler y los coriocapilares en la coroides. La lámina basal es la capa más interna de la coroides y se encuentra en contacto con la membrana de Bruch. La capa de Sattler es la capa más externa de la coroides y se encuentra en contacto con la lámina basal. La capa vascular intermedia es la última en formarse y se desarrolla desde el cuerpo ciliar hacia el ecuador. El estroma coroideo se produce esencialmente a partir de células del mesodermo.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod ang tama tungkol sa embryology ng choroid?\n",
      "a) Nauunang mabuo ang mga choriocapillaris, na sinusundan ng pagbuo ng malalaking ugat.\n",
      "b) Ang Bruch's membrane ay nanggagaling sa basal lamina, na nakalatag sa kalagitnaan ng choriocapillaris at Sattler's layer.\n",
      "c) Ang intermediate vascular layer ay huling nabubuo galing sa ciliary body malapit sa gitna ng mata.\n",
      "d) Ang choroidal stroma ay nanggagaling sa mesoderm cells. \n",
      "Test #0: \n",
      "response\n",
      "  Here's my answer:\n",
      "\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"b\" // Your answer here (A, B, C, or D)\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Ang Bruch's membrane ay nanggagaling sa basal lamina, na nakalatag sa kalagitnaan ng choriocapillaris at Sattler's layer.\n",
      "\n",
      "Bruch's membrane is a layer of the eye that separates the choriocapillaris from the retinal pigment epithelium. It is derived from the basal lamina, which is a layer of extracellular material that separates the choriocapillaris from the Sattler's layer. Therefore, option b is the correct answer.\n",
      "\n",
      "Option a is incorrect because the choriocapillaris is not formed from the uvea.\n",
      "\n",
      "Option c is incorrect because the intermediate vascular layer is not the last to develop.\n",
      "\n",
      "Option d is incorrect because the choroidal stroma is not derived from mesoderm cells.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Sobre a embriologia da coroide, é correto afirmar:\n",
      "a)A coriocapilar é a primeira a se formar, com posterior formação dos grandes vasos.\n",
      "b)A lâmina basal dá origem à membrana de Bruch que se situa entre o coriocapilar e a camada de Sattler.\n",
      "c)A camada vascular intermediária é a última a se formar e desenvolve-se do corpo ciliar em direção ao equador.\n",
      "d)O estroma da coroide é essencialmente produzido a partir de células do mesoderma.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) A lâmina basal dá origem à membrana de Bruch que se situa entre o coriocapilar e a camada de Sattler.\n",
      "\n",
      "The lâmina basal is a layer of cells that forms the inner aspect of the cornea, and it gives rise to the membrana de Bruch, which is a thin layer of connective tissue that separates the coriocapillary layer from the camada de Sattler (Sattler's layer). Therefore, option b is the correct answer.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding the embryology of the choroid, it is correct to state:\n",
      "a) The choriocapillaris is the first to be formed, with subsequent formation of the great vessels.\n",
      "b) The basal lamina originate the Bruch's membrane, which lies between the choriocapillaris and Sattler's layer.\n",
      "c) The intermediate vascular layer is the last to form and develops from the ciliary body towards the equator.\n",
      "d) The choroidal stroma is essentially produced from mesoderm cells.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c: The intermediate vascular layer is the last to form and develops from the ciliary body towards the equator.\n",
      "\n",
      "According to embryology, the choroid is formed from the mesoderm, specifically from the paraxial mesoderm. The intermediate vascular layer, also known as the Haller's layer, is the last to form and develops from the ciliary body towards the equator. This layer is responsible for the formation of the choriocapillaris, which is the first to be formed, and subsequent formation of the great vessels. Therefore, option c is the correct answer.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 15: \n",
      "Language: spanish\n",
      "Question: \n",
      "Con respecto a la embriología ocular, es correcto establecer que:\n",
      "a) El epitelio corneal surge de las células de la cresta neural.\n",
      "b) Al nacer, la córnea y la esclera tienen el mismo radio de curvatura.\n",
      "c) La capa de Bowman aparece entre el primer y el segundo mes de embarazo.\n",
      "d) La córnea se desarrolla a partir de las células de la superficie ectodérmica y la cresta neural.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is d) La córnea se desarrolla a partir de las células de la superficie ectodérmica y la cresta neural.\n",
      "\n",
      "The cornea, the clear dome-shaped surface at the front of the eye, develops from the ectodermal surface cells and the neural crest cells. The neural crest cells are a type of stem cell that gives rise to various cell types in the body, including the cells of the cornea. The cornea forms from the fusion of these cells and then differentiates into its distinct layers, including the epithelium, stroma, and endothelium.\n",
      "\n",
      "Therefore, option d is the correct answer.\n",
      "\n",
      "Option a is incorrect because the epithelium of the cornea does not arise from the neural crest cells, but rather from the surface ectodermal cells.\n",
      "\n",
      "Option b is incorrect because the cornea and sclera do not have the same curvature at birth. The cornea is more curved than the sclera, and this curvature is present at birth.\n",
      "\n",
      "Option c is incorrect because the Bowman's layer does not appear between the first and second month of pregnancy. It is present at birth and is a thin layer of collagen that separates the epithelium from the stroma in the cornea.\n",
      "{'response': 'd'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod ay tama tungkol sa ocular embryology?\n",
      "a) Ang corneal epithelium ay nanggagaling sa neural crest cells.\n",
      "b) Sa panganganak, ang cornea at sclera ay may parehong curvature radius.\n",
      "c) Ang Bowman's layer ay nabubuo sa gitna ng pang-una at pangalawang buwan ng pagbubuntis.\n",
      "d) Ang cornea ay nanggagaling sa ectodermal surface at neural crest cells.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is d) Ang cornea ay nanggagaling sa ectodermal surface at neural crest cells.\n",
      "\n",
      "The cornea, the clear dome-shaped surface at the front of the eye, is derived from the ectodermal surface, specifically from the neural crest cells. The neural crest cells are a type of stem cell that gives rise to various cell types in the body, including the corneal epithelium.\n",
      "\n",
      "Option a) is incorrect because the corneal epithelium is not derived from neural crest cells, but from the ectodermal surface.\n",
      "\n",
      "Option b) is incorrect because the cornea and sclera have different curvature radii. The cornea is more curved than the sclera.\n",
      "\n",
      "Option c) is incorrect because Bowman's layer is formed in the third month of fetal development, not in the first or second month.\n",
      "{'response': 'd'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação à embriologia ocular, é correto afirmar:\n",
      "a)O epitélio da córnea origina-se a partir das células da crista neural.\n",
      "b)Ao nascimento, córnea e esclera apresentam o mesmo raio de curvatura.\n",
      "c)A camada de Bowman surge entre o primeiro e o segundo mês de gestação.\n",
      "d)A córnea desenvolve-se a partir da superfície ectodérmica e das células da crista neural.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is d) A córnea desenvolve-se a partir da superfície ectodérmica e das células da crista neural.\n",
      "\n",
      "The embryology of the eye is a complex process that involves the development of various structures, including the cornea. The cornea is derived from the ectoderm, specifically from the surface ectoderm and the cells of the neural crest. The neural crest is a type of stem cell that gives rise to various cell types, including the epithelial cells that line the surface of the cornea.\n",
      "\n",
      "Therefore, option d is the correct answer. Options a, b, and c are incorrect and do not accurately describe the embryology of the eye.\n",
      "{'response': 'd'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding ocular embryology, it is correct to state:\n",
      "a) Corneal epithelium arises from neural crest cells.\n",
      "b) At birth, the cornea and sclera have the same curvature radius.\n",
      "c) Bowman's layer appears between the first and second month of pregnancy.\n",
      "d) The cornea develops from the ectodermal surface and neural crest cells.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is d) The cornea develops from the ectodermal surface and neural crest cells.\n",
      "\n",
      "Ocular embryology is the study of the development of the eye from conception to birth. The cornea, the clear dome-shaped surface at the front of the eye, develops from the ectodermal surface, which is one of the three primary germ layers in the embryo. The ectoderm gives rise to the epithelial tissue of the cornea, while the neural crest cells, which are a type of cell that arises from the ectoderm, contribute to the formation of the corneal stroma, the thick middle layer of the cornea.\n",
      "\n",
      "Therefore, option d is the correct answer.\n",
      "\n",
      "Option a is incorrect because corneal epithelium does not arise from neural crest cells.\n",
      "\n",
      "Option b is incorrect because the cornea and sclera do not have the same curvature radius at birth. The cornea is more curved than the sclera.\n",
      "\n",
      "Option c is incorrect because Bowman's layer, a thin layer of collagen that lies between the corneal epithelium and stroma, does not appear until after the second month of pregnancy.\n",
      "{'response': 'd'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 16: \n",
      "Language: spanish\n",
      "Question: \n",
      "Con respecto a las enfermedades de herencia dominantes autosómicas, es correcto afirmar que:\n",
      "a) En general, se observan en varias gestaciones.\n",
      "b) Los hombres tienden a verse más afectados que las mujeres.\n",
      "c) La gravedad de la enfermedad es siempre la misma entre las personas afectadas de la misma familia.\n",
      "d) Solo las mujeres transmiten la mutación.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The statement \"Los hombres tienden a verse más afectados que las mujeres\" is correct. In dominant autosomal inheritance, the mutation is present in every cell of the body, and its expression is not influenced by sex. Therefore, both males and females have an equal chance of inheriting the mutation and expressing the disease. However, in some cases, the severity of the disease may vary between individuals, even within the same family, which means that option c is incorrect. Option a is also incorrect because dominant autosomal inheritance does not necessarily mean that the disease will be observed in multiple gestations. Option d is incorrect because the mutation can be transmitted by either parent, regardless of gender.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod ay tama tungkol sa sakit na namamana sa autosomal dominance?\n",
      "a) Sa pangkalahatan, makikita ito sa maraming pagbubuntis.\n",
      "b) Mas apektado ang mga lalaki kaysa sa mga babae.\n",
      "c) Ang kalubhaan ng sakit ay pareho sa lahat ng apektadong tao mula sa isang pamilya.\n",
      "d) Ang mga kababaihan lamang ang may dala ng mutation.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Ang kalubhaan ng sakit ay pareho sa lahat ng apektadong tao mula sa isang pamilya.\n",
      "\n",
      "Autosomal dominant inheritance means that the trait or condition is expressed in all individuals who inherit the mutated gene, regardless of their gender or the number of copies of the gene they inherit. Therefore, option c is the correct answer.\n",
      "\n",
      "Option a is incorrect because the trait or condition may not be visible in all individuals who inherit the mutated gene, especially if the gene is not fully penetrant.\n",
      "\n",
      "Option b is incorrect because the trait or condition is not more severe in one gender than the other.\n",
      "\n",
      "Option d is incorrect because the mutation can be inherited from either parent, and both males and females can transmit the mutated gene to their offspring.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Sobre as doenças de herança autossômica dominante, é correto afirmar:\n",
      "a)Em geral, são observadas em várias gestações.\n",
      "b)Os homens costumam ser mais afetados do que as mulheres.\n",
      "c)A gravidade da doença é sempre a mesma entre as pessoas afetadas da mesma família.\n",
      "d)Apenas as mulheres transmitem a mutação.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Os homens costumam ser mais afetados do que as mulheres.\n",
      "\n",
      "Autosomal dominant disorders are caused by a mutation in a gene on one of the autosomal chromosomes (chromosomes 1-22) and can affect both males and females equally. However, in some cases, the severity of the disease may vary between individuals, even within the same family. Therefore, option c) A gravidade da doença é sempre a mesma entre as pessoas afetadas da mesma família is incorrect.\n",
      "\n",
      "Option a) Em geral, são observadas em várias gestações is also incorrect because autosomal dominant disorders are not necessarily observed in multiple pregnancies.\n",
      "\n",
      "Option d) Apenas as mulheres transmitem a mutação is incorrect because both males and females can transmit the mutated gene to their offspring.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding the autosomal dominant inheritance diseases, it is correct to state:\n",
      "a) In general, they are observed in several gestations.\n",
      "b) Men tend to be more affected than women.\n",
      "c) The severity of the disease is always the same among affected people from the same family.\n",
      "d) Only women transmit the mutation.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is a) In general, they are observed in several gestations.\n",
      "\n",
      "Autosomal dominant inheritance diseases are caused by a mutation in a gene on one of the autosomal chromosomes (chromosomes 1-22) that is dominant, meaning it can cause the disease even if only one copy of the gene is mutated. This means that if one parent has the mutation, each child has a 50% chance of inheriting the mutated gene and developing the disease. Therefore, it is common to see multiple cases of the disease in the same family, which is what the statement a) refers to.\n",
      "\n",
      "The other options are incorrect for the following reasons:\n",
      "\n",
      "* b) Men tend to be more affected than women: This statement is incorrect because autosomal dominant inheritance diseases do not have a gender bias. Both men and women can be equally affected by the disease.\n",
      "* c) The severity of the disease is always the same among affected people from the same family: This statement is incorrect because the severity of autosomal dominant inheritance diseases can vary greatly, even among affected people in the same family.\n",
      "* d) Only women transmit the mutation: This statement is incorrect because both men and women can transmit the mutated gene to their offspring. The mutation can be inherited from either parent, and both men and women can be carriers of the mutated gene.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 17: \n",
      "Language: spanish\n",
      "Question: \n",
      "Con respecto a las enfermedades de la herencia mitocondrial, es correcto declarar:\n",
      "a) El daltonismo es un ejemplo de una enfermedad relacionada con el ADN mitocondrial.\n",
      "b) La herencia ocurre solo a través del linaje materna.\n",
      "c) Los pacientes masculinos asistidos por la enfermedad transmitirán el fenotipo a todos los descendientes.\n",
      "d) La neuropatía óptica hereditaria de Leber es un ejemplo de una enfermedad relacionada con el ADN mitocondrial, generalmente causa ceguera congénita y afecta a los pacientes de ambos sexos en la misma proporción.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about mitochondrial hereditary diseases. The correct answer is option d, \"La neuropatía óptica hereditaria de Leber es un ejemplo de una enfermedad relacionada con el ADN mitocondrial, generalmente causa ceguera congénita y afecta a los pacientes de ambos sexos en la misma proporción.\"\n",
      "\n",
      "This is correct because Leber's hereditary optic neuropathy is indeed a mitochondrial disorder that can cause congenital blindness and affects both males and females equally. The other options are not correct statements about mitochondrial hereditary diseases. Option a is incorrect because daltonismo (color blindness) is not a mitochondrial disorder. Option b is incorrect because mitochondrial inheritance does not only occur through the maternal lineage. Option c is incorrect because males assisted by the disease do not transmit the phenotype to all their descendants.\n",
      "{'response': 'd'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod ay tama tungkol sa mitochondrial inherited diseases?\n",
      "a) Ang Daltonism ay isang halimbawa ng mitochondrial inherited disease.\n",
      "b) Ang pagmana ng mitochondrial inherited diseases ay galing sa mga ina lamang.\n",
      "c) Maipapasa ng isang lalaking apektado ng mitochondrial inherited disease sa lahat ng kanyang anak.\n",
      "d) Ang Leber's hereditary optic neuropathy ay halimbawa ng mitochondrial inherited disease, at karaniwang nagiging sanhi ng maagang pagbubulag sa parehong lalaki at babae.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Maipapasa ng isang lalaking apektado ng mitochondrial inherited disease sa lahat ng kanyang anak.\n",
      "\n",
      "Mitochondrial inherited diseases are passed down from mother to child, as they are caused by mutations in the mitochondrial DNA, which is inherited exclusively from the mother's egg. Therefore, option c is the correct answer.\n",
      "\n",
      "Option a is incorrect because Daltonism is not a mitochondrial inherited disease.\n",
      "\n",
      "Option b is incorrect because the inheritance pattern of mitochondrial inherited diseases is not limited to the mother's side.\n",
      "\n",
      "Option d is incorrect because Leber's hereditary optic neuropathy is a mitochondrial inherited disease, but it is not the result of a father passing it down to all his children.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Sobre as doenças de padrão de herança mitocondrial, é correto afirmar:\n",
      "a)Daltonismo é um exemplo de doença ligada ao DNA mitocondrial.\n",
      "b)A herança ocorre apenas pela linhagem materna.\n",
      "c)Pacientes do sexo masculino afetados pela doença, transmitirão o fenótipo para toda a prole.\n",
      "d)A neuropatia óptica hereditária de Leber é um exemplo de doença ligada ao DNA mitocondrial, causa geralmente cegueira congênita e afeta na mesma proporção pacientes de ambos os sexos.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about mitochondrial DNA diseases, specifically whether Daltonism (a form of color blindness) is an example of a disease linked to mitochondrial DNA, whether the inheritance occurs only through the maternal line, whether male patients affected by the disease will transmit the phenotype to all their offspring, and whether Leber's hereditary optic neuropathy (a form of blindness) is an example of a disease linked to mitochondrial DNA.\n",
      "\n",
      "The correct answer is option d, \"A neuropatia óptica hereditária de Leber é um exemplo de doença ligada ao DNA mitocondrial, causa geralmente cegueira congênita e afeta na mesma proporção pacientes de ambos os sexos.\"\n",
      "\n",
      "This is because Leber's hereditary optic neuropathy is indeed a mitochondrial DNA disease that causes blindness and affects both males and females equally. The other options are incorrect because Daltonism is not a mitochondrial DNA disease, inheritance does not occur only through the maternal line, and male patients affected by a mitochondrial DNA disease will not transmit the phenotype to all their offspring.\n",
      "{'response': 'd'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding mitochondrial inheritance diseases, it is correct to state:\n",
      "a) Daltonism is an example of a disease linked to mitochondrial DNA.\n",
      "b) Inheritance occurs only through maternal lineage.\n",
      "c) Male patients afectados by the disease will transmit the phenotype to all offspring.\n",
      "d) Leber's hereditary optic neuropathy is an example of a disease linked to mitochondrial DNA, it usually causes congenital blindness and affects patients of both sexes in the same proportion.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "La afirmación correcta es la opción d: Leber's hereditary optic neuropathy es un ejemplo de una enfermedad ligada al ADN mitocondrial, que suele causar ceguera congénita y afecta a pacientes de ambos sexos en la misma proporción.\n",
      "\n",
      "Here's the answer in Tagalog:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "Ang tamang pahayag ay option d: Leber's hereditary optic neuropathy ay isang example ng isang sakit na konektado sa ADN mitocondrial, na kadalasan ay sumisira sa mga paciente ng kongenital na blindness at ang mga paciente ng bawat kasarian sa parehong proporcion.\n",
      "\n",
      "Here's the answer in Portuguese:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "A afirmação correta é a opção d: Leber's hereditary optic neuropathy é um exemplo de uma doença ligada ao DNA mitocondrial, que geralmente causa cegueira congênita e afeta pacientes de ambos os sexos na mesma proporção.\n",
      "\n",
      "Here's the answer in English:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "The correct statement is option d: Leber's hereditary optic neuropathy is an example of a disease linked to mitochondrial DNA, which typically causes congenital blindness and affects patients of both sexes in the same proportion.\n",
      "{'response': 'd'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 18: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál de los siguientes lentes corrige mejor el astigmatismo miope simple?\n",
      "a)-3,00 dioptría esférica + 1,00 dioptría cilíndrica X 90°.\n",
      "b)+1,00 dioptría esférica -1,00 dioptría cilíndrica X 90°.\n",
      "c)-3,00 dioptría esférica + 3,00 dioptría cilíndrica X 180°.\n",
      "d)0,00 dioptría esférica +1,00 dioptría cilíndrica X 180°.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) +1,00 dioptría esférica -1,00 dioptría cilíndrica X 90°.\n",
      "\n",
      "This question is asking for the correction of myopic astigmatism, and the correct answer is option b, which has a positive spherical power of +1.00 diopters and a negative cylindrical power of -1.00 diopters, with the axis at 90 degrees. This will correct the myopic astigmatism by reducing the blur caused by the irregular curvature of the cornea.\n",
      "\n",
      "Option a has a negative spherical power of -3.00 diopters and a positive cylindrical power of +1.00 diopter, which will not correct the myopic astigmatism.\n",
      "\n",
      "Option c has a negative spherical power of -3.00 diopters and a positive cylindrical power of +3.00 diopters, which will also not correct the myopic astigmatism.\n",
      "\n",
      "Option d has a spherical power of 0.00 diopters and a cylindrical power of +1.00 diopter, which will not correct the myopic astigmatism.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga lente ay pinakamabuting naitatama ang simpleng myopic astigmatism?\n",
      "a) -3.00 spherical diopter + 1.00 cylindrical diopter x 90 °.\n",
      "b) +1.00 spherical diopter -1.00 cylindrical diopter x 90 °.\n",
      "c) -3.00 spherical diopter + 3.00 cylindrical diopter x 180 °.\n",
      "d) 0.00 spherical diopter +1.00 cylindrical diopter x 180 °.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) +1.00 spherical diopter -1.00 cylindrical diopter x 90 °.\n",
      "\n",
      "Myopic astigmatism is a condition where the patient has a spherical error (nearsightedness) and a cylindrical error (astigmatism) in the same eye. The cylindrical error is always perpendicular to the meridian of the spherical error.\n",
      "\n",
      "In this case, the patient has a spherical error of -3.00 diopters and a cylindrical error of -1.00 diopter. The cylindrical error is in the 90-degree meridian, which means that the astigmatism is horizontal.\n",
      "\n",
      "Therefore, the correct prescription for this patient would be a spherical lens with a power of +1.00 diopter and a cylindrical lens with a power of -1.00 diopter, both aligned at a 90-degree angle to correct the astigmatism.\n",
      "\n",
      "The other options are not correct because they do not match the patient's prescription:\n",
      "\n",
      "* Option a has a spherical power of -3.00 diopters, which is too strong for the patient's myopia, and a cylindrical power of 1.00 diopter, which is in the wrong meridian.\n",
      "* Option c has a spherical power of -3.00 diopters, which is too strong for the patient's myopia, and a cylindrical power of 3.00 diopters, which is too strong for the patient's astigmatism.\n",
      "* Option d has a spherical power of 0.00 diopters, which does not correct the patient's myopia, and a cylindrical power of 1.00 diopter, which does not correct the patient's astigmatism.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual das lentes abaixo melhor corrige um astigmatismo miópico simples?\n",
      "a)-3,00 dioptria esférica + 1,00 dioptria cilindrica X 90°.\n",
      "b)+1,00 dioptria esférica -1,00 dioptria cilindrica X 90°.\n",
      "c)-3,00 dioptria esférica + 3,00 dioptria cilindrica X 180°.\n",
      "d)0,00 dioptria esférica +1,00 dioptria cilindrica X 180°.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) +1,00 dioptria esférica -1,00 dioptria cilindrica X 90°.\n",
      "\n",
      "Astigmatism is a refractive error caused by an irregularly shaped cornea, which results in blurred or distorted vision at all distances. Myopic astigmatism is a type of astigmatism that occurs in people who are nearsighted.\n",
      "\n",
      "In this question, we are asked to choose the best lens prescription to correct a simple myopic astigmatism. The correct prescription is b) +1,00 dioptria esférica -1,00 dioptria cilindrica X 90°.\n",
      "\n",
      "The \"+\" sign in the prescription indicates that the patient is nearsighted and needs a negative power lens to correct their vision. The \"-\" sign in the cylindrical power indicates that the patient has astigmatism and needs a lens that is more powerful in one meridian than in the other. The 90° angle between the cylindrical and spherical powers indicates that the astigmatism is horizontal, meaning that the patient needs a lens that is more powerful in the horizontal meridian.\n",
      "\n",
      "Therefore, option b) is the correct prescription to correct a simple myopic astigmatism.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Which of the lenses below best corrects simple myopic astigmatism?\n",
      "a)-3.00 spherical diopter + 1.00 cylindrical diopter X 90°.\n",
      "b) +1.00 spherical diopter -1.00 cylindrical diopter X 90°.\n",
      "c)-3.00 spherical diopter + 3.00 cylindrical diopter X 180°.\n",
      "d) 0.00 spherical diopter +1.00 cylindrical diopter X 180°.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option a: -3.00 spherical diopter + 1.00 cylindrical diopter X 90°. This lens correction is appropriate for simple myopic astigmatism, which is a combination of myopia (nearsightedness) and astigmatism. The -3.00 spherical diopter corrects the myopia, while the 1.00 cylindrical diopter corrects the astigmatism, with the axis of the cylinder at 90°.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 19: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál es la distancia focal del círculo de menor confusión en el conoide de Sturm de una lente esferocilíndrica de +1,00 DE +2,00 DC X 180°?\n",
      "a)0 metros.\n",
      "b) 0,5 metros.\n",
      "c)1 metros.\n",
      "d) 2 metros.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"  // The correct response is option c\n",
      "}\n",
      "```\n",
      "\n",
      "The question is asking for the focal distance of the circle of least confusion in the Sturm cone of a spherocylindrical lens with a power of +1.00 DS and a cylindrical power of +2.00 DC, and a field of vision of 180 degrees.\n",
      "\n",
      "The correct answer is option c) 1 meter.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ano ang focal length ng circle of least confusion sa Sturm's conoid na may sukat ng +1.00 DS and +2.00 DC x 180 ° spherocylindrical lens?\n",
      "a) 0 m.\n",
      "b) 0.5 m.\n",
      "c) 1 m.\n",
      "d) 2 m.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"  // The correct response is option c\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The circle of least confusion in Sturm's conoid is the circle that passes through the center of the lens and has a radius equal to the focal length of the lens. In this case, the lens has a spherical power of +1.00 DS and +2.00 DC, and the angle of the cone is 180°.\n",
      "\n",
      "To find the focal length of the lens, we can use the formula:\n",
      "\n",
      "Focal Length = (Spherical Power / 2) x (1 / Cos(Angle/2))\n",
      "\n",
      "Plugging in the values given in the question, we get:\n",
      "\n",
      "Focal Length = (+1.00 DS + +2.00 DC) / 2 = 1.50 DS\n",
      "\n",
      "Now, we need to convert the spherical power from diopters to meters. We know that 1 diopter is equal to 1 meter / 1000, so:\n",
      "\n",
      "1.50 DS = 1.50 meters / 1000 = 0.015 meters\n",
      "\n",
      "Therefore, the focal length of the lens is 0.015 meters, which corresponds to option c) 1 m.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual é a distância focal do círculo de menor confusão no conoide de Sturm de uma lente esferocilíndrica de +1,00 DE +2,00 DC X 180°?\n",
      "a)0 metros.\n",
      "b)0,5 metros.\n",
      "c)1 metros.\n",
      "d)2 metros.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking for the focal distance of the circle of least confusion in the Sturm cone of a spherocylindrical lens with a power of +1.00 DS (diopters) and a cylindrical power of +2.00 DC (diopters) at an angle of 180 degrees.\n",
      "\n",
      "The circle of least confusion is the circle that is formed when the light rays passing through the lens are focused onto a point. The focal distance is the distance between the lens and the point where the light rays are focused.\n",
      "\n",
      "According to the formula for the focal distance of a spherocylindrical lens, the focal distance (F) is given by:\n",
      "\n",
      "F = (n-1) / (2 \\* (1/R1 - 1/R2))\n",
      "\n",
      "where n is the refractive index of the lens material, R1 is the radius of the curvature of the spherical surface, and R2 is the radius of the curvature of the cylindrical surface.\n",
      "\n",
      "Using the values given in the question, we can calculate the focal distance as follows:\n",
      "\n",
      "n = 1.5 (refractive index of the lens material)\n",
      "R1 = 1.00 DS (diopters) = 0.01745779 meters (converting diopters to meters)\n",
      "R2 = 2.00 DC (diopters) = 0.03491558 meters (converting diopters to meters)\n",
      "\n",
      "Substituting these values into the formula, we get:\n",
      "\n",
      "F = (1.5 - 1) / (2 \\* (0.01745779 - 0.03491558))\n",
      "F = 0.01745779 meters\n",
      "\n",
      "Therefore, the focal distance of the circle of least confusion in the Sturm cone of the given lens is approximately 0.1745779 meters, which corresponds to option (c) 1 meter.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "What is the focal length of the circle of least confusion on Sturm's conoid of a +1.00 OD +2.00 DC X 180° spherocylindrical lens?\n",
      "a) 0 m.\n",
      "b) 0.5 m.\n",
      "c) 1 m.\n",
      "d) 2 m.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"  // The correct response is option c\n",
      "}\n",
      "```\n",
      "\n",
      "The focal length of the circle of least confusion on Sturm's conoid of a +1.00 OD +2.00 DC X 180° spherocylindrical lens is 1 m.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 20: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un punto objetivo situado a dos metros de una lente convexa 2 DE forma un punto de imagen ¿a qué distancia de la lente?\n",
      "a) 2,0 metros.\n",
      "b) 1,5 metros.\n",
      "c) 0,67 metros.\n",
      "d) 0,4 m.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "A point object placed 2 meters away from a convex lens with a focal length of 2 meters will form an image at a distance of 0.67 meters from the lens. This is because the convex lens has a positive focal length, which means that it converges light rays and forms a real image that is smaller than the object. The image distance can be calculated using the lens equation:\n",
      "\n",
      "1/do + 1/di = 1/f\n",
      "\n",
      "where do is the distance from the lens to the object, di is the distance from the lens to the image, and f is the focal length of the lens.\n",
      "\n",
      "Plugging in the values given in the problem, we get:\n",
      "\n",
      "1/2 + 1/di = 1/2\n",
      "\n",
      "Solving for di, we get:\n",
      "\n",
      "di = 0.67 meters\n",
      "\n",
      "Therefore, the correct answer is option c) 0.67 meters.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang objective point na dalawang metro ang layo mula sa 2 DE convex lens ay gumagawa ng image point sa anong distansya mula sa lente?\n",
      "a) 2.0 m.\n",
      "b) 1.5 m.\n",
      "c) 0.67 m.\n",
      "d) 0.4 m.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The distance between the two metro lines and the 2 DE convex lens is given as 2 meters. According to the lens equation, the image distance (di) is given by:\n",
      "\n",
      "1/di = 1/do + 1/di\n",
      "\n",
      "where do is the distance between the object and the lens, and di is the distance between the lens and the image.\n",
      "\n",
      "Given that the distance between the two metro lines is 2 meters, and the distance between the lens and the image point is also 2 meters, we can set up the lens equation as follows:\n",
      "\n",
      "1/2 = 1/do + 1/2\n",
      "\n",
      "Solving for do, we get:\n",
      "\n",
      "1/do = 1/2 - 1/2\n",
      "\n",
      "1/do = 0\n",
      "\n",
      "do = ∞\n",
      "\n",
      "Therefore, the object distance is infinite, and the image distance is 2 meters. The correct answer is (c) 0.67 m.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Um ponto objetivo situado a dois metros de uma lente convexa de 2 DE forma um ponto imagem a que distância da lente?\n",
      "a)2,0 m.\n",
      "b)1,5 m.\n",
      "c)0,67 m.\n",
      "d)0,4 m.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking for the distance of the image formed by a convex lens with a focal length of 2 meters, when an object is placed 2 meters away from the lens.\n",
      "\n",
      "According to the lens equation, the distance of the image formed by a convex lens is given by:\n",
      "\n",
      "di = (f * do) / (f - do)\n",
      "\n",
      "where di is the distance of the image, f is the focal length of the lens, and do is the distance of the object from the lens.\n",
      "\n",
      "Plugging in the values given in the question, we get:\n",
      "\n",
      "di = (2 * 2) / (2 - 2)\n",
      "di = 4 / 0\n",
      "di = infinity\n",
      "\n",
      "Since the distance of the image is infinite, the correct answer is (c) 0.67 m.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "An objective point located two meters from a 2 DE convex lens forms an image point at what distance from the lens?\n",
      "a)2.0 m.\n",
      "b)1.5 m.\n",
      "c)0.67 m.\n",
      "d)0.4 m.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"  // The correct response is option c\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The distance between the objective point and the image point is given by the lens equation:\n",
      "\n",
      "1/do + 1/di = 1/f\n",
      "\n",
      "where do is the distance from the lens to the objective point, di is the distance from the lens to the image point, and f is the focal length of the lens.\n",
      "\n",
      "Given that the objective point is located 2 meters from a 2 DE convex lens, we can plug in the values:\n",
      "\n",
      "1/2 + 1/di = 1/2\n",
      "\n",
      "Solving for di, we get:\n",
      "\n",
      "di = 0.67 m\n",
      "\n",
      "Therefore, the image point is located 0.67 meters from the lens. The correct response is option c.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 21: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál de los siguientes valores en el logaritmo decimal (logMar) corresponde a la agudeza visual normal (1.0)?\n",
      "a) -1.\n",
      "b) 0.\n",
      "c) 1.\n",
      "d) 2.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Correct answer: b\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The logarithm decimal (logMar) is a measure of the visual acuity, which is the ability to see and distinguish objects at different distances. A higher logMar value indicates better visual acuity.\n",
      "\n",
      "According to the question, the logMar value that corresponds to normal visual acuity is 1.0. Therefore, the correct answer is b) 0, as it is the only option that matches the given value.\n",
      "\n",
      "Note: The other options are not correct, as they do not match the given value of 1.0. Option a) -1 is less than 1.0, option c) 1 is greater than 1.0, and option d) 2 is much greater than 1.0.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na decimal logarithm (LogMAR) ay katugma ng normal na visual acuity (1.0)?\n",
      "a) -1.\n",
      "b) 0.\n",
      "c) 1.\n",
      "d) 2.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // B - 0.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The decimal logarithm (LogMAR) is a method used to measure visual acuity, which is the ability to see and distinguish objects at different distances. The LogMAR chart is a standardized tool used to assess visual acuity, and it consists of a series of letters and numbers that get progressively smaller as the distance increases.\n",
      "\n",
      "The normal visual acuity is typically measured as 1.0, which means that an individual with normal vision can see objects clearly at a distance of 20 feet. The LogMAR chart is used to convert the visual acuity measurement into a decimal logarithm, which allows for easier comparison and analysis of visual acuity data.\n",
      "\n",
      "Therefore, the correct answer is b) 0, as it represents the decimal logarithm of normal visual acuity (1.0).\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual dos valores abaixo em logaritmo decimal (logMAR) corresponde a acuidade visual normal (1,0)?\n",
      "a)-1.\n",
      "b)0.\n",
      "c)1.\n",
      "d)2.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Correto: b\n",
      "}\n",
      "```\n",
      "\n",
      "A resposta correta é b, que corresponde a acuidade visual normal (1,0) em logaritmo decimal (logMAR).\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Which of the following values ​​in decimal logarithm (logMAR) corresponds to normal visual acuity (1.0)?\n",
      "a) -1.\n",
      "b)0.\n",
      "c)1.\n",
      "d)2.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Correct answer: 0\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "In decimal logarithm (logMAR), a value of 0 represents normal visual acuity, which is equivalent to a visual acuity of 1.0.\n",
      "\n",
      "Therefore, the correct answer is b) 0.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 22: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál es el efecto óptico resultante de la interpolación de dos filtros polaroides perpendiculares entre sí?\n",
      "a) Transmisión reducida en un 50%.\n",
      "b) Transmisión ampliada en un 50%.\n",
      "c) Ausencia de transmisión luminosa.\n",
      "D) Sin pérdida de energía luminosa.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) Transmisión ampliada en un 50%.\n",
      "\n",
      "When two polaroid filters are placed perpendicular to each other, they cancel out the transmission of light in that direction. This means that the light that passes through the first filter will be completely blocked by the second filter, resulting in a 50% reduction in transmission. Therefore, option b is the correct answer.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ano ang optical effect na nagreresulta sa interpolation ng dalawang polaroid filters na perpendikular sa bawa't isa?\n",
      "a) Ang pagdaloy ng ilaw ay nabawasan ng 50%.\n",
      "b) Ang  pagdaloy ng ilaw ay nadagdagan ng 50%.\n",
      "c) Walang pagdaloy ng ilaw ang nagaganap.\n",
      "d) Walang light energy ang nababawasan.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the optical effect that results from the interpolation of two Polaroid filters that are perpendicular to each other.\n",
      "\n",
      "Option b) is the correct answer. When two Polaroid filters are perpendicular to each other, they will cancel out the light transmission in the perpendicular direction, resulting in a 50% reduction in light intensity. This is known as the \"Polaroid effect.\"\n",
      "\n",
      "Option a) is incorrect because it suggests that the light transmission is reduced by 50% in both directions, which is not the case.\n",
      "\n",
      "Option c) is incorrect because it suggests that there is no light transmission at all, which is not the case.\n",
      "\n",
      "Option d) is incorrect because it suggests that there is no reduction in light energy, which is not the case.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual o efeito óptico decorrente da interpolação de dois filtros polaroides perpendiculares entre si?\n",
      "a)Transmissão reduzida em 50%.\n",
      "b)Transmissão ampliada em 50%.\n",
      "c)Ausência de transmissão luminosa.\n",
      "d)Nenhuma perda de energia luminosa.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "When two polaroid filters are placed perpendicular to each other, they cancel out the light transmission. This is because the electric field vectors of the light waves are oriented perpendicular to each other, resulting in destructive interference. Therefore, option a) Transmissão reduzida em 50% (Transmission reduced by 50%) is the correct answer.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "What is the optical effect resulting from the interpolation of two polaroid filters perpendicular to each other?\n",
      "a) Transmission is reduced by 50%.\n",
      "b) Transmission is increased by 50%.\n",
      "c) Absence of light transmission.\n",
      "d)No loss of light energy.\n",
      "Test #0: \n",
      "response\n",
      "  Here's my answer:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"  // The correct response is c\n",
      "}\n",
      "```\n",
      "\n",
      "The optical effect resulting from the interpolation of two polaroid filters perpendicular to each other is the absence of light transmission. When two polaroid filters are perpendicular to each other, they cancel out the light transmission, resulting in zero light transmission. Therefore, option c is the correct answer.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 23: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿En cuál de los materiales es la velocidad de la luz más baja?\n",
      "a) aire.\n",
      "b) diamante.\n",
      "c) vidrio.\n",
      "d) La velocidad de la luz es constante independientemente del medio.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "La velocidad de la luz es constante independientemente del medio, por lo que la opción correcta es la opción d. La velocidad de la luz en el vacío es de aproximadamente 299,792,458 metros por segundo, y aunque puede parecer lento en comparación con otros medios, como el aire o el vidrio, no hay un medio conocido en el que la velocidad de la luz sea más baja.\n",
      "{'response': 'd'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Aling materyales ang may pinakamabagal ang daloy ng ilaw?\n",
      "a) Hangin.\n",
      "b) Brilyante.\n",
      "c) Salamin.\n",
      "d) Ang bilis ng ilaw ay pare-pareho anuman ang daluyan nito.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Brilyante\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the material that slows down light the most. The correct answer is b) Brilyante (Brilliant). Brilliant materials have a high refractive index, which means that light travels through them at a slower speed than it does through other materials. This is because the light is bent or refracted more as it passes through the material, which increases the distance it travels and therefore slows it down.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "* a) Hangin (Air) does not slow down light significantly. While air does have a refractive index that is slightly higher than a vacuum, it is not enough to significantly slow down light.\n",
      "* c) Salamin (Mirror) does not slow down light either. Mirrors are designed to reflect light, not slow it down.\n",
      "* d) Ang bilis ng ilaw ay pare-pareho anuman ang daluyan nito (The speed of light is the same in all materials) is incorrect. While the speed of light in a vacuum is a constant, it can be slowed down by the properties of the material it passes through, as explained above.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Em qual dos materiais abaixo a velocidade da luz é a menor?\n",
      "a)Ar.\n",
      "b)Diamante.\n",
      "c)Vidro.\n",
      "d)A velocidade da luz é constante independente do meio.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "A velocidade da luz é constante independente do meio, então a opção correta é d. A velocidade da luz é de aproximadamente 299.792.458 metros por segundo no vácuo. Embora a velocidade da luz possa ser afetada por fatores como a densidade do meio e a temperatura, ela permanece constante em todos os meios. Portanto, não há um material específico em que a velocidade da luz seja a menor.\n",
      "{'response': 'd'}\n",
      "Language: english\n",
      "Question: \n",
      "In which of the materials is the speed of light the lowest?\n",
      "a) Air.\n",
      "b) Diamond.\n",
      "c) Glass.\n",
      "d) The speed of light is constant regardless of the medium.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d) The speed of light is constant regardless of the medium.\"\n",
      "}\n",
      "```\n",
      "\n",
      "(Note: The speed of light is approximately 299,792,458 meters per second in a vacuum. It is a fundamental constant of the universe and is not affected by the medium it passes through.)\n",
      "{'response': 'd) The speed of light is constant regardless of the medium.'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 24: \n",
      "Language: spanish\n",
      "Question: \n",
      "Marque la alternativa que corresponde a un reflejo de un espejo convexo.\n",
      "a) queratoscopia con disco placido.\n",
      "b) Espejo de afeitar.\n",
      "c) Mirror del dentista.\n",
      "d) Lechas de faro reflector.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "A convex mirror is a type of mirror that is curved outward, and it is commonly used in shaving mirrors. Therefore, the correct answer is b) Espejo de afeitar (Shaving mirror).\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin ang katumbas ng repleksyon mula sa isang salamin na convex?\n",
      "a) Keratoscopy na may Placido disc.\n",
      "b) Salamin na ginagamit sa pag-ahit\n",
      "c) Salamin ng dentista.\n",
      "d) Reflector headlamp.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is a) Keratoscopy na may Placido disc.\n",
      "\n",
      "Keratoscopy is a technique used to examine the cornea and surrounding tissues, and a Placido disc is a tool used in keratoscopy to assess the curvature of the cornea.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "* b) Salamin na ginagamit sa pag-ahit is not a valid medical term.\n",
      "* c) Salamin ng dentista refers to a mirror used by dentists, not ophthalmologists.\n",
      "* d) Reflector headlamp is not a tool used in ophthalmology.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Assinale a alternativa que corresponde a uma reflexão de um espelho convexo.\n",
      "a)Ceratoscopia com disco de Plácido.\n",
      "b)Espelho de barbear.\n",
      "c)Espelho do dentista.\n",
      "d)Farol refletor.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Espelho de barbear\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "A convex mirror is a type of mirror that is curved outward, and it is commonly used in barbershops to provide a wider view of the customer's hair and face. Therefore, the correct answer is b) Espelho de barbear (Barber's mirror).\n",
      "\n",
      "Ceratoscopia com disco de Plácido (a) is a technique used to examine the ear canal and eardrum using a specialized scope.\n",
      "\n",
      "Espelho do dentista (c) is a mirror used by dentists to examine the patient's teeth and mouth.\n",
      "\n",
      "Farol refletor (d) is a reflector used to direct light in a specific direction, but it is not related to mirrors or reflections.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Choose which corresponds to a reflection from a convex mirror.\n",
      "a) Keratoscopy with Placido disc.\n",
      "b) Shaving mirror.\n",
      "c) Dentist's mirror.\n",
      "d) Reflector headlamp.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c) Espejo de dentista.\"\n",
      "}\n",
      "```\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Dentist's mirror. A dentist's mirror is a type of convex mirror used in dentistry to visualize the oral cavity and surrounding structures. It is designed to provide a clear, magnified view of the area being examined, making it easier to detect signs of disease or abnormalities.\n",
      "\n",
      "Keratoscopy with Placido disc (a) is a technique used to evaluate the cornea and detect irregularities in its surface. Shaving mirror (b) is a small, handheld mirror used for personal grooming. Reflector headlamp (d) is a lighting device used in various applications, including dentistry, but it is not a type of convex mirror.\n",
      "{'response': 'c) Espejo de dentista.'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 25: \n",
      "Language: spanish\n",
      "Question: \n",
      "Una lente convergente enfoca la luz desde una fuente a 1 m a una distancia de 50 cm.¿Qué tan poderosa es esta lente?\n",
      "a) + 1 diopter.\n",
      "b) + 2 diopter.\n",
      "c) + 3 diopter.\n",
      "d) + 4 diopter.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // The correct answer is b\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "A convergent lens focuses light from a source at 1 meter to a distance of 50 cm. The power of a convergent lens is given by the formula:\n",
      "\n",
      "P = 1/f\n",
      "\n",
      "where P is the power in diopters and f is the focal length in meters.\n",
      "\n",
      "In this case, the focal length is 50 cm = 0.5 m. Plugging this value into the formula, we get:\n",
      "\n",
      "P = 1/0.5 = 2 diopters\n",
      "\n",
      "Therefore, the correct answer is b) + 2 diopter.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang isang converging lens ay nagpopokus ng ilaw na mula 1 metro sa distansya na 50cm. Ano ang power ng lenteng ito?\n",
      "a) + 1 diopter.\n",
      "b) + 2 diopter.\n",
      "c) + 3 diopter.\n",
      "d) + 4 diopter.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Answer: b\n",
      "}\n",
      "```\n",
      "Explanation:\n",
      "\n",
      "The power of a converging lens is given by the formula:\n",
      "\n",
      "Power = (1/f) - (1/d)\n",
      "\n",
      "where f is the focal length of the lens, and d is the distance between the lens and the object.\n",
      "\n",
      "In this case, the focal length of the lens is 1 meter (100 cm), and the distance between the lens and the object is 50 cm. Plugging these values into the formula, we get:\n",
      "\n",
      "Power = (1/100) - (1/50) = +2 diopter\n",
      "\n",
      "Therefore, the correct answer is b) + 2 diopter.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Uma lente convergente foca a luz proveniente de uma fonte situada a 1 m a uma distância de 50 cm. Qual o poder desta lente?\n",
      "a)+ 1 dioptria.\n",
      "b)+ 2 dioptria.\n",
      "c)+ 3 dioptria.\n",
      "d)+ 4 dioptria.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // B - 2 dioptria.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "A convergent lens focuses light from a source located 1 meter away to a distance of 50 cm. To calculate the power of the lens, we can use the formula:\n",
      "\n",
      "P = (1/f) - (1/d)\n",
      "\n",
      "where P is the power of the lens in dioptries, f is the focal length of the lens in meters, and d is the distance between the lens and the image formed in meters.\n",
      "\n",
      "In this case, the focal length of the lens is 50 cm = 0.5 m, and the distance between the lens and the image formed is 1 m. Plugging in these values, we get:\n",
      "\n",
      "P = (1/0.5) - (1/1) = 2 dioptries\n",
      "\n",
      "Therefore, the correct answer is option b: +2 dioptries.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "\n",
      "A converging lens focuses light from a source 1 m away at a distance of 50 cm. How powerful is this lens?\n",
      "a) + 1 diopter.\n",
      "b) + 2 diopter.\n",
      "c) + 3 diopter.\n",
      "d) + 4 diopter.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // The correct answer is +2 diopter.\n",
      "}\n",
      "```\n",
      "\n",
      "In Tagalog:\n",
      "\n",
      "Ang isang lens na nag-aapoy ng liwanag mula sa isang source na 1 metro ang layo ay nag-focus sa isang distansang 50 sentimetro. Magkano ang ginagawang lens na ito?\n",
      "a) + 1 diopter.\n",
      "b) + 2 diopter.\n",
      "c) + 3 diopter.\n",
      "d) + 4 diopter.\n",
      "\n",
      "In Portuguese:\n",
      "\n",
      "Uma lente convergente concentra a luz de uma fonte a 1 metro de distância em uma distância de 50 cm. Quão poderosa é essa lente?\n",
      "a) + 1 dióprio.\n",
      "b) + 2 dióptr.\n",
      "c) + 3 dióptr.\n",
      "d) + 4 dióptr.\n",
      "\n",
      "In English:\n",
      "\n",
      "A converging lens focuses light from a source 1 meter away at a distance of 50 centimeters. How powerful is this lens?\n",
      "a) + 1 diopter.\n",
      "b) + 2 diopter.\n",
      "c) + 3 diopter.\n",
      "d) + 4 diopter.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 26: \n",
      "Language: spanish\n",
      "Question: \n",
      "Si tuviéramos que medir la imagen de potencia focal de la superficie posterior de la córnea después de su extracción del globo ocular, tendríamos un valor alrededor (considérese la curvatura anterior de la córnea de 7,7 mm; la curvatura posterior de la córnea de 6,8 mm; la índice de refracción del estroma corneal 1,376 y el índice de refracción del aire 1,00):\n",
      "a)+ 5,00 Dioptrías.\n",
      "b)0,00 dioptrías.\n",
      "c)- 5,00 Dioptrías.\n",
      "d)- 55,00 Dioptrías.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"  // The correct response is option a: +5,00 dioptrías.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The calculation of the power of the posterior surface of the cornea after its extraction from the eye can be done using the formula:\n",
      "\n",
      "P = (n-1) / (R1 + R2)\n",
      "\n",
      "where:\n",
      "\n",
      "* P is the power of the posterior surface in dioptrías.\n",
      "* n is the refractive index of the cornea.\n",
      "* R1 is the radius of curvature of the anterior surface of the cornea.\n",
      "* R2 is the radius of curvature of the posterior surface of the cornea.\n",
      "\n",
      "Using the given values:\n",
      "\n",
      "* n = 1,376 (refractive index of the corneal stroma)\n",
      "* R1 = 7,7 mm (curvature of the anterior surface of the cornea)\n",
      "* R2 = 6,8 mm (curvature of the posterior surface of the cornea)\n",
      "* índice de refracción del aire = 1,00 (refractive index of air)\n",
      "\n",
      "We can calculate the power of the posterior surface:\n",
      "\n",
      "P = (1,376 - 1) / (7,7 + 6,8) = 5,00 dioptrías\n",
      "\n",
      "Therefore, the correct answer is option a: +5,00 dioptrías.\n",
      "{'response': 'a'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang focal power ng imahe sa posterior surface ng cornea pagkatapos itong tanggalin sa mata ay:\n",
      "Isaalang-alang na ang anterior curvatur ng cornea ay 7.7mm, ang posterior curvature 6.8mm, ang index ng corneal stroma refraction 1.376, at ang refractive index ng hangin ay 1.00\n",
      "a) + 5.00 dioptres.\n",
      "b) 0.00 dioptres.\n",
      "c)- 5.00 dioptres.\n",
      "d)- 55.00 dioptres.\n",
      "Test #0: \n",
      "response\n",
      "  Here's my answer:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"a\"  // Answer: + 5.00 dioptres.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the focal power of the image formed on the posterior surface of the cornea after it has been removed from the eye.\n",
      "\n",
      "Given the anterior curvature of the cornea is 7.7mm, the posterior curvature is 6.8mm, the index of refraction of the corneal stroma is 1.376, and the refractive index of air is 1.00, we can use the lens equation to calculate the focal power:\n",
      "\n",
      "1/f = (n-1)(1/R1 - 1/R2)\n",
      "\n",
      "where n is the refractive index of the lens (in this case, the cornea), R1 is the radius of curvature of the anterior surface, and R2 is the radius of curvature of the posterior surface.\n",
      "\n",
      "Plugging in the values given in the question, we get:\n",
      "\n",
      "1/f = (1.376-1)(1/7.7 - 1/6.8)\n",
      "1/f = 0.0053\n",
      "\n",
      "The focal power is then given by:\n",
      "\n",
      "f = 1/0.0053\n",
      "f = 188.89 diopters\n",
      "\n",
      "Since the question is asking for the focal power in diopters, and we know that 1 diopter = 0.001 meters, we can convert the focal power to meters by multiplying it by 0.001:\n",
      "\n",
      "f = 188.89 diopters x 0.001 meters/diopter = 0.18889 meters\n",
      "\n",
      "Therefore, the correct answer is option a: + 5.00 dioptres, since 0.18889 meters is approximately equal to 5.00 dioptres.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Se fossemos medir o poder focal imagem da face posterior da córnea após sua retirada do globo ocular, teríamos um valor ao redor de (considere a curvatura anterior da córnea 7,7 mm; a curvatura posterior da córnea 6,8 mm; o índice de refração do estroma corneano 1,376 e o índice de refração do ar 1,00):\n",
      "a)+ 5,00 Dioptrias.\n",
      "b)0,00 Dioptrias.\n",
      "c)- 5,00 Dioptrias.\n",
      "d)- 55,00 Dioptrias.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The formula to calculate the power of the posterior corneal surface after its removal from the eye is given by:\n",
      "\n",
      "P = (n-1) / (R1 - R2)\n",
      "\n",
      "where:\n",
      "\n",
      "* P is the power of the posterior corneal surface\n",
      "* n is the refractive index of the corneal stroma (1.376 in this case)\n",
      "* R1 is the radius of curvature of the anterior corneal surface (7.7 mm in this case)\n",
      "* R2 is the radius of curvature of the posterior corneal surface (6.8 mm in this case)\n",
      "\n",
      "Plugging in the values, we get:\n",
      "\n",
      "P = (1.376 - 1) / (7.7 - 6.8) = -5.00 diopters\n",
      "\n",
      "Therefore, the correct answer is option c: -5.00 diopters.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "If we were to measure the focal power of the image of the posterior surface of the cornea after its removal from the eyeball, we would have a value around (consider the anterior curvature of the cornea 7.7 mm; the posterior curvature of the cornea 6.8 mm; the index of corneal stroma refraction 1.376 and the refractive index of air 1.00):\n",
      "a) + 5.00 Dioptres.\n",
      "b) 0.00 Dioptres.\n",
      "c)- 5.00 Dioptres.\n",
      "d)- 55.00 Dioptres.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"  // Answer: +5.00 Dioptres\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The formula to calculate the focal power of the image of the posterior surface of the cornea after its removal from the eyeball is:\n",
      "\n",
      "Focal power = (Anterior curvature / Posterior curvature) \\* (Refractive index of corneal stroma / Refractive index of air)\n",
      "\n",
      "Plugging in the given values:\n",
      "\n",
      "Focal power = (7.7 mm / 6.8 mm) \\* (1.376 / 1.00) = 1.274\n",
      "\n",
      "Rounding to the nearest dioptre, the focal power is approximately +5.00 dioptres. Therefore, the correct answer is option a.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 27: \n",
      "Language: spanish\n",
      "Question: \n",
      "Al reducir la prescripción del cilindro en un paciente que no se ha adaptado a sus gafas con la siguiente prescripción -1.50 dioptría esférica < > -3.50 dioptría cilíndrica X 180°, una posible prescripción manteniendo el equivalente esférico es:\n",
      "a)- 2,50 dioptrías esféricas < > -2,50 dioptrías cilíndricas X 180°.\n",
      "b)+1,50 dioptría esférica < > -2,50 dioptría cilíndrica X 180°.\n",
      "c) -4,50 dioptrías esféricas < > +2,50 dioptrías cilíndricas X 90°.\n",
      "d)-2,50 dioptría esférica < > +3,00 dioptría cilíndrica X 90°.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) +1,50 dioptría esférica < > -2,50 dioptría cilíndrica X 180°.\n",
      "\n",
      "When reducing the prescription of a cylindrical lens in a patient who has not adapted to their glasses with the following prescription -1.50 spherical dioptres < > -3.50 cylindrical dioptres X 180°, one possible prescription maintaining the spherical equivalent is +1,50 spherical dioptres < > -2,50 cylindrical dioptres X 180°. This is because the patient's vision is still corrected with a spherical lens, but the cylindrical component is reduced to minimize the aniseikonia.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "* a) -2,50 spherical dioptres < > -2,50 cylindrical dioptres X 180° would be too strong and would not correct the patient's vision adequately.\n",
      "* c) -4,50 spherical dioptres < > +2,50 cylindrical dioptres X 90° would be too weak and would not provide adequate correction for the patient's vision.\n",
      "* d) -2,50 spherical dioptres < > +3,00 cylindrical dioptres X 90° would have a different axis of orientation (90° instead of 180°) and would not maintain the spherical equivalent.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Hindi nakasanayan ng isang pasyente ang kanyang mga salamin na -1.50 spherical diopter < > -3.50 cylindrical diopter X 180° ang sukat. Alin ang tamang pagbabawas ng cylinder na sukat habang ipanatili ang katumbas niyang sphere?\n",
      "a) - 2.50 spherical diopter <> -2.50 cylindrical diopter x 180 °.\n",
      "b) +1.50 spherical diopter <> -2.50 cylindrical diopter x 180 °.\n",
      "c) -4.50 spherical diopter <> +2.50 cylindrical diopter x 90 °.\n",
      "d) -2.50 spherical diopter <> +3.00 cylindrical diopter x 90 °\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's current prescription is -1.50 spherical diopter and -3.50 cylindrical diopter x 180°. To calculate the correct cylinder power while maintaining the same spherical power, we need to subtract the cylinder power from the spherical power.\n",
      "\n",
      "The correct answer is b) +1.50 spherical diopter <> -2.50 cylindrical diopter x 180 °.\n",
      "\n",
      "This answer maintains the same spherical power of -1.50 diopters while adjusting the cylinder power to -2.50 diopters, which is the correct calculation to neutralize the cylinder component.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Ao reduzirmos a prescrição do cilindro em um paciente que não se adaptou a seus óculos com a seguinte prescrição -1,50 Diotria esferica < > -3,50 dioptria cilindrica X 180°, uma possível prescrição mantendo o equivalente esférico é:\n",
      "a)- 2,50 dioptria esferica < > -2,50 dioptria cilindrica X 180°.\n",
      "b)+1,50 dioptria esferica < > -2,50 dioptria cilindrica X 180°.\n",
      "c)-4,50 dioptria esferica < > +2,50 dioptria cilindrica X 90°.\n",
      "d)-2,50 dioptria esferica < > +3,00 dioptria cilindrica X 90°.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking for the correct prescription for a patient who did not adapt to their previous prescription of -1.50 diopters spherical and -3.50 diopters cylindrical with a 180° axis.\n",
      "\n",
      "The correct answer is b) +1.50 diopters spherical < > -2.50 diopters cylindrical X 180°.\n",
      "\n",
      "This is because the patient's previous prescription was not effective, so we need to change the spherical component to +1.50 diopters to correct for the patient's nearsightedness. The cylindrical component remains the same at -2.50 diopters, but the axis is changed to 180° to correct for the patient's astigmatism.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "When reducing the cylinder prescription in a patient who did not adapt to his glasses with the following prescription -1.50 spherical diopter < > -3.50 cylindrical diopter X 180°, a possible prescription maintaining the spherical equivalent is:\n",
      "a)- 2.50 spherical diopter < > -2.50 cylindrical diopter X 180°.\n",
      "b) +1.50 spherical diopter < > -2.50 cylindrical diopter X 180°.\n",
      "c) -4.50 spherical diopter < > +2.50 cylindrical diopter X 90°.\n",
      "d) -2.50 spherical diopter < > +3.00 cylindrical diopter X 90°\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) +1.50 spherical diopter < > -2.50 cylindrical diopter X 180°.\n",
      "\n",
      "When reducing the cylinder prescription in a patient who did not adapt to their glasses with a prescription of -1.50 spherical diopter and -3.50 cylindrical diopter X 180°, it's possible to maintain the spherical equivalent by prescribing +1.50 spherical diopter and -2.50 cylindrical diopter X 180°. This will reduce the cylinder prescription while keeping the spherical power the same.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "* a) -2.50 spherical diopter < > -2.50 cylindrical diopter X 180° will reduce the spherical power and not maintain the spherical equivalent.\n",
      "* c) -4.50 spherical diopter < > +2.50 cylindrical diopter X 90° will increase the spherical power and not maintain the spherical equivalent.\n",
      "* d) -2.50 spherical diopter < > +3.00 cylindrical diopter X 90° will also increase the spherical power and not maintain the spherical equivalent.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 28: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un rayo de luz se desvía a 20 mm del eje visual a una distancia de 50 cm de un prisma.¿Cuál es el poder del prisma en los diopters-prismáticos?\n",
      "a) 0.4.\n",
      "b) 2.5.\n",
      "c) 4.\n",
      "d) 10.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // The correct answer is b) 2.5 diopters-prismáticos.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The formula to calculate the power of a prism in diopters-prismáticos is:\n",
      "\n",
      "Power (diopters-prismáticos) = (Amount of deviation in mm) / (Distance from the apex to the center of the prism in cm)\n",
      "\n",
      "In this case, the amount of deviation is 20 mm, and the distance from the apex to the center of the prism is 50 cm. Plugging in these values, we get:\n",
      "\n",
      "Power (diopters-prismáticos) = (20 mm) / (50 cm) = 0.4 diopters-prismáticos\n",
      "\n",
      "Therefore, the correct answer is b) 2.5 diopters-prismáticos.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Lumiwas ang isang ilaw ng 20mm mula sa visual axis sa distansya na 50cm mula sa isang prisma. Ano ang power ng primsa sa sukat ng diopters-prismatics?\n",
      "a) 0.4.\n",
      "b) 2.5.\n",
      "c) 4.\n",
      "d) 10.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Answer: b\n",
      "}\n",
      "```\n",
      "Explanation:\n",
      "\n",
      "The power of a prism in diopters is calculated using the formula:\n",
      "\n",
      "Power (diopters) = (Distance in cm x Angle in degrees) / 100\n",
      "\n",
      "In this case, the distance is 50 cm and the angle is 20 mm, which is equivalent to 20/1000 degrees.\n",
      "\n",
      "Plugging in the values, we get:\n",
      "\n",
      "Power (diopters) = (50 x 20/1000) / 100\n",
      "Power (diopters) = 10\n",
      "\n",
      "Therefore, the correct answer is b) 2.5 diopters.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Um raio de luz sofre desvio de 20 mm do eixo visual a uma distância de 50 cm de um prima. Qual é o poder do prisma em dioptrias-prismáticas?\n",
      "a)0,4.\n",
      "b)2,5.\n",
      "c)4.\n",
      "d)10.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Answer: 2,5 dioptrias-prismáticas\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking for the power of a prism in dioptries-prismatic, given the deviation of a ray of light by 20 mm from the visual axis at a distance of 50 cm from the prism.\n",
      "\n",
      "To solve this problem, we can use the formula:\n",
      "\n",
      "Power (in dioptries-prismatic) = (Deviation in mm) / (Distance in cm)\n",
      "\n",
      "Plugging in the values given in the question, we get:\n",
      "\n",
      "Power (in dioptries-prismatic) = (20 mm) / (50 cm)\n",
      "Power (in dioptries-prismatic) = 0.4 dioptries-prismatic\n",
      "\n",
      "Therefore, the correct answer is option b) 2,5 dioptries-prismatic.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "A light ray is deviated by 20 mm from the visual axis at a distance of 50 cm from a prism. What is the power of the prism in diopters-prismatics?\n",
      "a) 0.4.\n",
      "b)2.5.\n",
      "c)4.\n",
      "d) 10.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // The correct answer is b) 2.5 diopters-prismatics.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The power of a prism is given by the equation:\n",
      "\n",
      "Power (diopters-prismatics) = (Distance from the visual axis in cm x Deviation of the light ray in mm) / 100\n",
      "\n",
      "In this case, the distance from the visual axis is 50 cm, and the deviation of the light ray is 20 mm. Plugging these values into the equation, we get:\n",
      "\n",
      "Power (diopters-prismatics) = (50 x 20) / 100\n",
      "Power (diopters-prismatics) = 1000 / 100\n",
      "Power (diopters-prismatics) = 10\n",
      "\n",
      "Therefore, the correct answer is b) 2.5 diopters-prismatics.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 29: \n",
      "Language: spanish\n",
      "Question: \n",
      "Teniendo en cuenta el ojo esquemático de Gullstrand, ¿cuál es la característica de la imagen formada en la retina?\n",
      "a) Real, invertido.\n",
      "b) virtual, invertido.\n",
      "c) Real, directo.\n",
      "d) Virtual, directo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // La característica de la imagen formada en la retina es virtual, invertido.\n",
      "}\n",
      "```\n",
      "\n",
      "According to the Gullstrand schematic eye, the image formed on the retina is virtual and inverted. Therefore, the correct answer is option b.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Sa Gullstrand's schematic eye, paano mailalarawan ang imahe na nabubuo sa retina?\n",
      "a) Tunay, baligtad.\n",
      "b) virtual, baligtad.\n",
      "c) Tunay, direkta.\n",
      "d) virtual, direkta.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c) Tunay, direkta.\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Sa Gullstrand's schematic eye, the image formed on the retina is a real image, not a virtual image. Therefore, the correct answer is (c) Tunay, direkta.\n",
      "\n",
      "Note: \"Tunay\" means \"real\" in Tagalog, and \"direkta\" means \"direct\".\n",
      "{'response': 'c) Tunay, direkta.'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Considerando o olho esquemático de Gullstrand, qual a característica da imagem formada na retina?\n",
      "a)Real, invertida.\n",
      "b)Virtual, invertida.\n",
      "c)Real, direta.\n",
      "d)Virtual, direta.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Characteristic of the image formed on the retina according to Gullstrand's schematic eye: Virtual, inverted.\n",
      "}\n",
      "```\n",
      "\n",
      "Explicação:\n",
      "\n",
      "De acordo com o olho esquemático de Gullstrand, a imagem formada na retina é virtual e invertida. Isso significa que a imagem está \"virada\" em relação à posição real do objeto, e é formada no sentido oposto àquele em que a luz entra no olho. Essa característica é importante para a percepção de profundidade e para a capacidade de enfocar objetos em diferentes planos.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "\n",
      "Considering Gullstrand's schematic eye, what is the characteristic of the image formed on the retina?\n",
      "a) Real, inverted.\n",
      "b) Virtual, inverted.\n",
      "c) Real, direct.\n",
      "d) Virtual, direct.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // b) Virtual, inverted.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "According to Gullstrand's schematic eye, the image formed on the retina is virtual and inverted. This means that the image is not a real image, but rather a projection of the light rays onto the retina, and it appears upside down. Therefore, the correct answer is option b) Virtual, inverted.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 30: \n",
      "Language: spanish\n",
      "Question: \n",
      "Seleccione la alternativa que correlacione correctamente las clases de antibacterianos con sus respectivos sitios principales de acción.\n",
      "\n",
      "I- Cefalosporinas\n",
      "II- Tetraciclinas\n",
      "III- Quinolonas\n",
      "IV- Macrólidos\n",
      "\n",
      "A- Síntesis de proteínas (inhibidor de los 30)\n",
      "B- Síntesis de proteínas (inhibidor de los años 50)\n",
      "C-ADN girasa\n",
      "D- Síntesis de la pared celular\n",
      "\n",
      "a)I: A; II: D; III: D; IV: B.\n",
      "b)I: D; II: A; III: C; IV: B.\n",
      "c)I: A; II: D; III: B; IV: C.\n",
      "d)I: D; II: B; III: A; IV: C.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option b:\n",
      "\n",
      "* I - Cefalosporinas: Síntesis de proteínas (inhibidor de los 30) (A)\n",
      "* II - Tetraciclinas: Síntesis de proteínas (inhibidor de los años 50) (B)\n",
      "* III - Quinolonas: ADN girasa (C)\n",
      "* IV - Macrólidos: Síntesis de la pared celular (D)\n",
      "\n",
      "Therefore, the correct answer is b)I: D; II: A; III: C; IV: B.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ipagpares ang mga klase ng antibiotics sa kanilang pangunahing site of action.\n",
      "\n",
      "I- Cephalosporins\n",
      "II- Tetracyclines\n",
      "III- quinolones\n",
      "IV- Macrolides\n",
      "\n",
      "A- Protein Synthesis (30S Inhibitor)\n",
      "B- Protein Synthesis (50s Inhibitor)\n",
      "C- DNA Gyrase\n",
      "D- Cell Wall Synthesis\n",
      "\n",
      "a)I: A; II: D; III: D; IV: B.\n",
      "b)I: D; II: A; III: C; IV: B.\n",
      "c)I: A; II: D; III: B; IV: C.\n",
      "d)I: D; II: B; III: A; IV: C.\n",
      "Test #0: \n",
      "response\n",
      "  Here's my answer:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c)I: A; II: D; III: B; IV: C.\"\n",
      "}\n",
      "```\n",
      "Explanation:\n",
      "\n",
      "1. Cephalosporins (I) inhibit protein synthesis by binding to the 50S ribosomal subunit, which is why the correct answer for this class is B (Protein Synthesis (50S Inhibitor)).\n",
      "2. Tetracyclines (II) also inhibit protein synthesis, but they bind to the 30S ribosomal subunit. Therefore, the correct answer for this class is A (Protein Synthesis (30S Inhibitor)).\n",
      "3. Quinolones (III) inhibit DNA gyrase, which is why the correct answer for this class is C (DNA Gyrase).\n",
      "4. Macrolides (IV) inhibit protein synthesis by binding to the 50S ribosomal subunit, just like cephalosporins. Therefore, the correct answer for this class is B (Protein Synthesis (50S Inhibitor)).\n",
      "\n",
      "So, the correct answer is option c:\n",
      "\n",
      "c)I: A; II: D; III: B; IV: C.\n",
      "{'response': 'c)I: A; II: D; III: B; IV: C.'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Assinale a alternativa que correlaciona corretamente as classes de antibacterianos aos seus respectivos principais sítios de ação.\n",
      "\n",
      "I- Cefalosporinas\n",
      "II- Tetraciclínicas\n",
      "III- Quinolonas\n",
      "IV- Macrolídeos\n",
      "\n",
      "A- Síntese proteica (inibidor 30s)\n",
      "B- Síntese proteica (inibidor 50s)\n",
      "C- DNA girase\n",
      "D- Síntese de parede celular\n",
      "\n",
      "a)I: A; II: D; III: D; IV: B.\n",
      "b)I: D; II: A; III: C; IV: B.\n",
      "c)I: A; II: D; III: B; IV: C.\n",
      "d)I: D; II: B; III: A; IV: C.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option b:\n",
      "\n",
      "* I - Cefalosporinas: Síntese proteica (inibidor 50s)\n",
      "* II - Tetraciclínicas: Síntese proteica (inibidor 30s)\n",
      "* III - Quinolonas: DNA girase\n",
      "* IV - Macrolídeos: Síntese de parede celular\n",
      "\n",
      "This is the most appropriate correlation between antibacterial classes and their main sites of action.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Match the classes of antibacterials to their respective main sites of action.\n",
      "\n",
      "I- Cephalosporins\n",
      "II- Tetracyclines\n",
      "III- Quinolones\n",
      "IV- Macrolides\n",
      "\n",
      "A- Protein synthesis (30s inhibitor)\n",
      "B- Protein synthesis (50s inhibitor)\n",
      "C- DNA gyrase\n",
      "D- Cell wall synthesis\n",
      "\n",
      "a)I: A; II: D; III: D; IV: B.\n",
      "b)I: D; II: A; III: C; IV: B.\n",
      "c)I: A; II: D; III: B; IV: C.\n",
      "d)I: D; II: B; III: A; IV: C.\n",
      "Test #0: \n",
      "response\n",
      "  Here's my answer:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "Explanation:\n",
      "\n",
      "* I - Cephalosporins: These antibiotics work by inhibiting the synthesis of the bacterial cell wall. Therefore, the correct answer is D - Cell wall synthesis.\n",
      "* II - Tetracyclines: These antibiotics work by inhibiting protein synthesis at the 50S ribosomal subunit. Therefore, the correct answer is B - Protein synthesis (50s inhibitor).\n",
      "* III - Quinolones: These antibiotics work by inhibiting the activity of the bacterial enzyme DNA gyrase, which is involved in DNA replication and repair. Therefore, the correct answer is C - DNA gyrase.\n",
      "* IV - Macrolides: These antibiotics work by inhibiting protein synthesis at the 30S ribosomal subunit. Therefore, the correct answer is A - Protein synthesis (30s inhibitor).\n",
      "\n",
      "So, the correct matching of classes of antibacterials to their respective main sites of action is:\n",
      "\n",
      "* I - Cephalosporins: D - Cell wall synthesis\n",
      "* II - Tetracyclines: B - Protein synthesis (50s inhibitor)\n",
      "* III - Quinolones: C - DNA gyrase\n",
      "* IV - Macrolides: A - Protein synthesis (30s inhibitor)\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 31: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un paciente con síndrome de Sjogren comenzó a experimentar mejoras en sus síntomas bucales (aumento de la salivación) después de que un no oftalmólogo le recetara:\n",
      "a) Brimonidina, sin embargo, desarrolló miosis puntiforme y mala visión.\n",
      "b) La tetracaína, sin embargo, evolucionó con el desprendimiento de retina tradicional.\n",
      "c) La atropina, sin embargo, evolucionó con midriasis leve y dificultades de acomodación.\n",
      "d) La pilocarpina, sin embargo, evolucionó con espasmo acomodativo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) La atropina, sin embargo, evolucionó con midriasis leve y dificultades de acomodación.\n",
      "\n",
      "Atropine is a parasympatholytic drug that can be used to treat dry mouth in patients with Sjogren's syndrome. However, it can cause side effects such as mild mydriasis and accommodation difficulties.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "* a) Brimonidine is an alpha-agonist that can also be used to treat dry mouth in Sjogren's syndrome, but it can cause miosis and blurred vision as side effects.\n",
      "* b) Tetracaine is a local anesthetic that is not commonly used to treat dry mouth in Sjogren's syndrome.\n",
      "* d) Pilocarpine is a cholinergic agent that can be used to treat dry mouth in Sjogren's syndrome, but it can cause acomodative spasms as a side effect.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Nawala ang labis na paglalaway ng isang pasyenteng may Sjogren's syndrome pagkatapos siyang resetahan ng:\n",
      "a) Brimonidine, ngunit nagkaroon ng punctiform miosis at malabong paningin.\n",
      "B) Tetracaine, ngunit nagkaroon ng traditional retinal detachment.\n",
      "c) Atropine, ngunit nagkaroon ng kaunting pagdilat ng balintataw at hirap sa accommodation ng mata.\n",
      "d) Pilocarpine, ngunit nagkaroon ng accommodative spasms.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient with Sjogren's syndrome experienced a significant decrease in salivary flow after using pilocarpine, which is a cholinergic agent that stimulates the salivary glands. This is a common side effect of pilocarpine, especially in patients with Sjogren's syndrome. Therefore, option C is the correct response.\n",
      "\n",
      "Option A, brimonidine, is an alpha-agonist that can cause pupillary constriction and miotic effects, but it is not associated with a significant decrease in salivary flow.\n",
      "\n",
      "Option B, tetracaine, is a local anesthetic that can cause traditional retinal detachment, but it is not associated with a decrease in salivary flow.\n",
      "\n",
      "Option D, atropine, is an anticholinergic agent that can cause dilated pupils and difficulty with accommodation, but it is not associated with a significant decrease in salivary flow.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Paciente com síndrome Sjogren passou a ter melhoras dos seus sintomas orais (aumento da salivação) após o médico não-oftalmologista prescrever:\n",
      "a)Brimonidina, todavia, evoluiu com miose puntiforme e baixa de visão.\n",
      "b)Tetracaína, todavia, evoluiu com descolamento de retina tradicional.\n",
      "c)Atropina, todavia, evoluiu com média midríase e dificuldades de acomodação.\n",
      "d)Pilocarpina, todavia, evoluiu com espasmo acomodativo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient with Sjogren's syndrome experienced improvement in their oral symptoms (increased salivation) after the non-ophthalmologist doctor prescribed atropine. Therefore, the correct answer is option c.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "A patient with Sjogren's syndrome started to have improvements in his oral symptoms (increased salivation) after the non-ophthalmologist prescribed:\n",
      "a) Brimonidine, however, evolved with punctiform miosis and low vision.\n",
      "b) Tetracaine, however, evolved with traditional retinal detachment.\n",
      "c) Atropine, however, evolved with medium mydriasis and accommodation difficulties.\n",
      "d) Pilocarpine, however, evolved with accommodative spasm.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "  \"response\": \"c\"\n",
      "}\n",
      "```\n",
      "La respuesta correcta es la opción c: Atropine, however, evolved with medium mydriasis and accommodation difficulties.\n",
      "\n",
      "Here's the answer in Tagalog:\n",
      "```json\n",
      "{\n",
      "  \"response\": \"c\"\n",
      "}\n",
      "```\n",
      "Ang tama na sagot ay ang opsiyon c: Atropine, however, evolved with medium mydriasis and accommodation difficulties.\n",
      "\n",
      "Here's the answer in Portuguese:\n",
      "```json\n",
      "{\n",
      "  \"response\": \"c\"\n",
      "}\n",
      "```\n",
      "A resposta correta é a opção c: Atropine, however, evolved with medium mydriasis and accommodation difficulties.\n",
      "\n",
      "Here's the answer in English:\n",
      "```json\n",
      "{\n",
      "  \"response\": \"c\"\n",
      "}\n",
      "```\n",
      "The correct answer is option c: Atropine, however, evolved with medium mydriasis and accommodation difficulties.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 32: \n",
      "Language: spanish\n",
      "Question: \n",
      "Con respecto al uso del factor activador del plasminógeno tisular, es correcto afirmar:\n",
      "a) Está prohibido este medicamento en el espacio intracameral.\n",
      "b) La activación de la plasmina en plasminógeno ayuda a la descomposición de la sangre.\n",
      "c) La activación del plasminógeno en plasmina ayuda a la descomposición de la sangre.\n",
      "d) Su mayor indicación es el sangrado en el espacio vítreo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) La activación del plasminógeno en plasmina ayuda a la descomposición de la sangre.\n",
      "\n",
      "The question is asking about the use of tissue plasminogen activator (tPA), which is a medication used to break down blood clots. The correct statement is that tPA activates plasminogen to form plasmina, which helps to decompose blood clots.\n",
      "\n",
      "Therefore, option c is the correct answer.\n",
      "\n",
      "Option a is incorrect because tPA is not prohibited in the intracameral space.\n",
      "\n",
      "Option b is incorrect because the activation of plasminogen does not help to decompose blood.\n",
      "\n",
      "Option d is incorrect because while tPA is used to treat bleeding in the vitreous space, it is not its major indication.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Tama tungkol sa tissue plasminogen activating factor:\n",
      "a) Ang tamang pagbigay ng drogang ito ay nasa loob ng anterior chamber, o intracameral.\n",
      "b) Ang pagbago ng plasmin na maging plasminogen ay nakakatulong sa pagsira ng mga blood cell.\n",
      "c) Ang pagbago ng plasminogen na maging plasmin ay nakakatulong sa pagsira ng mga blood cell.\n",
      "d) Ang pangunahing indikasyon nito ay ang pagdurugo sa vitreous space.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option c) Ang pagbago ng plasminogen na maging plasmin ay nakakatulong sa pagsira ng mga blood cell.\n",
      "\n",
      "Tissue plasminogen activating factor (tPA) is a protein that plays a crucial role in the breakdown of blood clots. It works by converting plasminogen, an inactive protein, into plasmin, an active enzyme that helps dissolve blood clots. This process is essential in maintaining healthy blood flow and preventing complications such as stroke or pulmonary embolism.\n",
      "\n",
      "Therefore, option c is the correct answer, as it accurately describes the role of tPA in the breakdown of blood clots.\n",
      "\n",
      "Option a is incorrect because the correct location of tPA is in the extracellular matrix, not in the anterior chamber or intracameral.\n",
      "\n",
      "Option b is incorrect because plasminogen is not involved in the breakdown of blood cells. Instead, it is converted into plasmin, which helps break down blood clots.\n",
      "\n",
      "Option d is incorrect because while tPA can cause bleeding in the vitreous space, it is not its primary indication.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação ao uso de fator ativador do plasminogênio tecidual, é correto afirmar:\n",
      "a)Essa medicação no espaço intracameral é proscrita.\n",
      "b)A ativação da plasmina em plaminogênio ajuda na degradação do sangue.\n",
      "c)A ativação do plasminogênio em plasmina ajuda na degradação do sangue.\n",
      "d)Sua maior indicação é em sangramentos no espaço vítreo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) A ativação do plasminogênio em plasmina ajuda na degradação do sangue.\n",
      "\n",
      "Plasminogen is an inactive precursor of the enzyme plasmin, which plays a crucial role in fibrinolysis, the process of breaking down blood clots. The activation of plasminogen to plasmin occurs through various mechanisms, including the use of tissue plasminogen activator (tPA).\n",
      "\n",
      "Therefore, option c is the correct answer, as it states that the activation of plasminogen to plasmin helps in the degradation of blood.\n",
      "\n",
      "Option a is incorrect, as the use of tPA in the intracameral space is not prohibited.\n",
      "\n",
      "Option b is also incorrect, as the activation of plasminogen to plasmin does not directly help in the degradation of blood.\n",
      "\n",
      "Option d is incorrect, as the major indication of tPA is not in bleeding in the vitreous space, but rather in the treatment of acute ischemic stroke, pulmonary embolism, and other thrombotic disorders.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding the use of tissue plasminogen activating factor, it is correct to state:\n",
      "a) This medication in the intracameral space is prohibited.\n",
      "b) Activation of plasmin into plaminogen helps in the degradation of blood.\n",
      "c) Activation of plasminogen to plasmin helps in the degradation of blood.\n",
      "d) Its main indication is in bleeding in the vitreous space.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Tissue plasminogen activating factor (tPA) is a medication that activates plasminogen to plasmin, which helps in the degradation of blood clots. It is commonly used to treat acute ischemic stroke, pulmonary embolism, and other thrombotic disorders.\n",
      "\n",
      "Option c) \"Activation of plasminogen to plasmin helps in the degradation of blood\" is the correct statement.\n",
      "\n",
      "Option a) \"This medication in the intracameral space is prohibited\" is incorrect. While tPA is not typically used in the intracameral space, it is not explicitly prohibited.\n",
      "\n",
      "Option b) \"Activation of plasmin into plaminogen helps in the degradation of blood\" is incorrect. Plasmin is already an active enzyme that can degrade blood clots, so activation of plasminogen to plasmin is not necessary for its degradation.\n",
      "\n",
      "Option d) \"Its main indication is in bleeding in the vitreous space\" is incorrect. While tPA has been used to treat vitreous hemorrhage, its main indications are for the treatment of acute ischemic stroke and pulmonary embolism.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 33: \n",
      "Language: spanish\n",
      "Question: \n",
      "Con respecto al uso de mitomicina-C en la trabeculectomía, es correcto afirmar:\n",
      "a) Al ser análogo de la pirimidina, su acción resulta de bloquear la síntesis de timina, impidiendo la producción de ADN/ARN.\n",
      "b) El adelgazamiento escleral, la ampolla avascular, el dolor postoperatorio y el edema corneal son complicaciones relacionadas con su uso.\n",
      "c) En mujeres embarazadas se debe aumentar la concentración debido a la mayor tendencia a la fibrosis.\n",
      "d) No debe utilizarse en pacientes melanodermicos.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Mitomycin-C is a chemotherapy drug that is used in trabeculectomy, a surgical procedure to treat glaucoma. It works by blocking the synthesis of DNA/RNA, which is necessary for cell division and growth.\n",
      "\n",
      "Option b) is correct. The adverse effects of mitomycin-C include thinning of the sclera, avascular ampulla, postoperative pain, and corneal edema. These complications are related to its use in trabeculectomy.\n",
      "\n",
      "Option a) is incorrect. Mitomycin-C does not block the synthesis of thymine, but rather it inhibits the synthesis of DNA/RNA.\n",
      "\n",
      "Option c) is incorrect. There is no evidence to suggest that the concentration of mitomycin-C should be increased in pregnant women.\n",
      "\n",
      "Option d) is incorrect. Mitomycin-C can be used in patients with melanodermatosis, but it should be used with caution and close monitoring due to the risk of hypersensitivity reactions.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Tama tungkol sa paggamit ng mitomycin-C sa trabeculectomy:\n",
      "a) Sapagkat ito ay isang pyrimidine analogue, napapahinto nya ang paggawa ng thymin upang mapapigil ang paggawa ng DNA/RNA.\n",
      "b) Ang mga komplikasyon na kasama ng paggamit ng mitomycin-C ay scleral thinning, avascular bleb, pagkirot pagkatapos ng operasyon, at pamamaga ng cornea.\n",
      "c) Sa mga buntis, dapat damihan ang dose ng mitomycin-C dahil mas malaki ang pagkakataon na magkaroon ng fibrosis.\n",
      "d) Hindi ito dapat gamitin sa mga pasyenteng melanodermic.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Mitomycin-C is a pyrimidine analogue that inhibits the synthesis of DNA/RNA by blocking the production of thymine. Therefore, option a is the correct answer.\n",
      "\n",
      "Option b is incorrect because while scleral thinning, avascular bleb, and corneal edema are complications associated with mitomycin-C use, they are not the primary mechanism of action of the drug.\n",
      "\n",
      "Option c is incorrect because the dose of mitomycin-C should not be increased in pregnant women. In fact, the use of mitomycin-C in pregnant women is generally avoided due to the potential risks to the developing fetus.\n",
      "\n",
      "Option d is incorrect because mitomycin-C can be used in patients with melanodermic skin, but it may require careful monitoring and dose adjustment due to the risk of hypersensitivity reactions.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação ao uso de mitomicina-C na trabeculectomia, é correto afirmar:\n",
      "a)Por ser um análogo da pirimidina, sua ação decorre do bloqueio da síntese de timina, evitando a produção de DNA/RNA.\n",
      "b)Afinamento escleral, bolha avascular, dor pós-operatória e edema de córnea são complicações relacionadas ao seu uso.\n",
      "c)Nas gestantes, a concentração deve ser aumentada pela maior tendência à fibrose.\n",
      "d)Não deve ser usada em pacientes melanodérmicos.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Mitomycin-C is a chemotherapy drug that is used in trabeculectomy, a surgical procedure to treat glaucoma. It works by blocking the synthesis of DNA and RNA, which inhibits the proliferation of cells and reduces the pressure in the eye.\n",
      "\n",
      "Option a is correct because mitomycin-C is an analogue of purine, and its action is based on the blockage of the synthesis of DNA and RNA.\n",
      "\n",
      "Option b is incorrect because while it is true that finasteride, another drug used in trabeculectomy, can cause complications such as scleral thinning, avascular bleb, postoperative pain, and corneal edema, these complications are not related to the use of mitomycin-C.\n",
      "\n",
      "Option c is incorrect because there is no evidence to suggest that the concentration of mitomycin-C should be increased in pregnant women.\n",
      "\n",
      "Option d is incorrect because there is no contraindication for the use of mitomycin-C in patients with melanodermic skin.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding the use of mitomycin-C in trabeculectomy, it is correct to state:\n",
      "a) Because it is a pyrimidine analogue, its action stems from the blockage of thymine synthesis, preventing the production of DNA/RNA.\n",
      "b) Scleral thinning, avascular bleb, postoperative pain and corneal edema are complications related to its use.\n",
      "c) In pregnant women, the concentration should be increased due to a greater tendency to fibrosis.\n",
      "d) It should not be used in melanodermic patients.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "Mitomycin-C is a pyrimidine analogue that works by blocking the synthesis of thymine, which is essential for DNA and RNA production. This blockage leads to a decrease in the production of cells, which is useful in the treatment of certain types of cancer. In trabeculectomy, mitomycin-C is used to reduce the production of fibroblasts, which are cells that contribute to the formation of scar tissue. By reducing the production of fibroblasts, mitomycin-C helps to prevent the formation of a thick, avascular bleb, which can lead to complications such as scleral thinning, avascular bleb, postoperative pain, and corneal edema.\n",
      "\n",
      "Therefore, option a) is the correct answer.\n",
      "\n",
      "Option b) is incorrect because, although scleral thinning, avascular bleb, postoperative pain, and corneal edema are complications related to the use of mitomycin-C in trabeculectomy, they are not the primary mechanism of action of the drug.\n",
      "\n",
      "Option c) is incorrect because there is no evidence to suggest that the concentration of mitomycin-C should be increased in pregnant women. In fact, the use of mitomycin-C in pregnant women is generally avoided due to its potential teratogenic effects.\n",
      "\n",
      "Option d) is incorrect because there is no evidence to suggest that mitomycin-C should not be used in melanodermic patients. However, it is important to note that the use of mitomycin-C in patients with darker skin tones may require adjustments in the dosage and duration of treatment due to the increased risk of hypopigmentation.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 34: \n",
      "Language: spanish\n",
      "Question: \n",
      "Los pacientes con retinopatía diabética proliferativa complementarán su tratamiento con anti-VEGF intravítreo. Podemos afirmar que:\n",
      "a) Se debe dar prioridad a la inhibición de las isoformas B del VEGF, ya que son las principales formadoras de neovasos.\n",
      "b) Ranibizumab inhibe todas las isoformas de VEGF-B, pero no VEGF-A.\n",
      "c) Bevacizumab no permite que las isoformas VEFG-A se unan a sus receptores.\n",
      "d) Ya no se utiliza el pegaptanib, ya que el fármaco no penetra las capas de la retina.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Ranibizumab is a medication that is used to treat retinopathy, including diabetic retinopathy. It works by inhibiting the growth of new blood vessels, which can help to prevent vision loss. Ranibizumab specifically inhibits the activity of VEGF-B, which is a protein that promotes the growth of new blood vessels. It does not inhibit VEGF-A, which is a different protein that also promotes the growth of new blood vessels.\n",
      "\n",
      "Therefore, the correct answer is b) Ranibizumab inhibe todas las isoformas de VEGF-B, pero no VEGF-A.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang mga pasyenteng may proliferative diabetic retinopathy ay puwedeng bigyan ng intravitreal anti-VEGF. Maaari nating sabihin na:\n",
      "a) Dapat bigyan ng prioridad ang paghinto ng B isoforms ng VEG-F, dahil sila ang pangunahing taga-buo ng mga bagong ugat.\n",
      "b) Ang ranibizumab ay nagpipigil sa lahat ng B isoforms ng VEG-F, pero walang epekto sa A isoforms ng VEG-F.\n",
      "c) Ang bevacizumab ay naghaharang ng A isoforms ng VEG-F upang hindi nila maka-ugnay ang kanilang mga receptors.\n",
      "d) Hindi na ginagamit ang pegapatanib dahil hindi ito tumatagos sa mga layer ng retina.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the treatment for proliferative diabetic retinopathy (PDR) using intravitreal anti-VEGF. The correct answer is (b) Ranibizumab inhibits all B isoforms of VEGF, but has no effect on A isoforms of VEGF.\n",
      "\n",
      "Ranibizumab is a monoclonal antibody fragment that binds to and inhibits the activity of VEGF-A, which is the primary mediator of angiogenesis in PDR. It does not affect the A isoforms of VEGF, which are not involved in angiogenesis.\n",
      "\n",
      "Option (a) is incorrect because while it is true that B isoforms of VEGF are involved in the formation of new blood vessels, ranibizumab does not prioritize the inhibition of B isoforms over A isoforms.\n",
      "\n",
      "Option (c) is incorrect because bevacizumab is a different anti-VEGF drug that works by blocking the binding of VEGF-A to its receptors, but it does not affect the A isoforms of VEGF.\n",
      "\n",
      "Option (d) is incorrect because pegaptanib is not used for PDR treatment because it does not penetrate the retinal layers effectively.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Paciente com retinopatia diabética proliferativa complementará seu tratamento com anti-VEGF intravítreo. Podemos afirmar que:\n",
      "a)Deve-se priorizar a inibição das isoformas B do VEGF, uma vez que são as principais formadoras de neovasos.\n",
      "b)O ranibizumabe inibe todas as isoformas do VEGF-B, mas não as de VEGF-A.\n",
      "c)O bevacizumabe não permite que as isoformas de VEFG-A se liguem aos seus receptores.\n",
      "d)O uso de pegaptanibe não é mais utilizado, pois a droga não penetra nas camadas da retina.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) O ranibizumabe inibe todas as isoformas do VEGF-B, mas não as de VEGF-A.\n",
      "\n",
      "Ranibizumab is a medication used to treat diabetic retinopathy and other eye conditions. It works by blocking the growth of new blood vessels and reducing the amount of fluid in the retina. Ranibizumab inhibits all isoforms of VEGF-B, but not VEGF-A.\n",
      "\n",
      "Option a is incorrect because while it is true that VEGF-B is a major form of VEGF in the retina, ranibizumab does not prioritize the inhibition of VEGF-B over VEGF-A.\n",
      "\n",
      "Option c is incorrect because bevacizumab, not ranibizumab, is the medication that prevents VEGF-A from binding to its receptors.\n",
      "\n",
      "Option d is incorrect because pegaptanib, not ranibizumab, is the medication that does not penetrate the retinal layers.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Patients with proliferative diabetic retinopathy will complement their treatment with intravitreal anti-VEGF. We can state that:\n",
      "a) Priority should be given to the inhibition of the B isoforms of VEGF, since they are the main new vessel formers.\n",
      "b)Ranibizumab inhibits all VEGF-B isoforms, but not VEGF-A.\n",
      "c) Bevacizumab does not allow VEGF-A isoforms to bind to their receptors.\n",
      "d) The use of pegaptanib is no longer used, as the drug does not penetrate the retinal layers.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Ranibizumab is a monoclonal antibody fragment that inhibits the activity of all VEGF-B isoforms, but not VEGF-A. It is used to treat proliferative diabetic retinopathy by blocking the growth of new blood vessels and reducing the risk of vision loss. Therefore, option b is the correct answer.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 35: \n",
      "Language: spanish\n",
      "Question: \n",
      "Considerando los tumores conjuntivales, ¿cuál de los siguientes parámetros se utiliza para diferenciar entre displasia conjuntival y carcinoma invasivo?\n",
      "a) Atipia celular.\n",
      "b) Afectación del epitelio en todo su espesor.\n",
      "c) Aumento del número de nucléolos atípicos.\n",
      "d) Invasión de la membrana basal.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is d) Invasión de la membrana basal.\n",
      "\n",
      "The parameter used to differentiate between displasia conjuntival and carcinoma invasivo is the invasion of the basement membrane. Displasia conjuntival is a precancerous condition characterized by abnormal cell growth on the surface of the conjunctiva, whereas carcinoma invasivo is a type of cancer that has invaded the deeper tissues. The invasion of the basement membrane is a key feature of carcinoma invasivo, and its presence can help distinguish it from displasia conjuntival.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "a) Atipia celular refers to abnormal cell growth, which can be a feature of both displasia conjuntival and carcinoma invasivo.\n",
      "\n",
      "b) Afectación del epitelio en todo su espesor refers to the involvement of the entire epithelial layer, which can also be a feature of both displasia conjuntival and carcinoma invasivo.\n",
      "\n",
      "c) Aumento del número de nucléolos atípicos refers to an increase in the number of abnormal nuclei, which can be a feature of both displasia conjuntival and carcinoma invasivo.\n",
      "{'response': 'd'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Sa mga bukol ng conjunctiva, aling sukat ang nakakatulong sa pagkakaiba ng conjunctival dysplasia at invasive carcinoma?\n",
      "a) Atypia ng mga cells\n",
      "b) Pagka-apekto sa epithelial full thickness\n",
      "c) Pagkarami ng mga nucleoli na hindi typikal\n",
      "d) Pagsalakay ng basement membrane\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Pagka-apekto sa epithelial full thickness.\n",
      "\n",
      "Conjunctival dysplasia and invasive carcinoma are both conditions that affect the conjunctiva, which is the mucous membrane that covers the white part of the eye and the inside of the eyelids. The main difference between these two conditions is the extent of the abnormal cell growth.\n",
      "\n",
      "Conjunctival dysplasia is a condition where there is abnormal growth of cells in the conjunctiva, but the cells are still confined to the epithelial layer, which is the outermost layer of the conjunctiva. This condition is typically characterized by the presence of atypical cells, which are cells that are not normal but are not yet cancerous.\n",
      "\n",
      "Invasive carcinoma, on the other hand, is a type of cancer that has spread beyond the epithelial layer and into the deeper tissues of the conjunctiva. This condition is characterized by the presence of abnormal cells that have invaded the deeper tissues, such as the stroma, which is the layer of tissue beneath the epithelial layer.\n",
      "\n",
      "Therefore, the correct answer is b) Pagka-apekto sa epithelial full thickness, as this option accurately describes the difference between conjunctival dysplasia and invasive carcinoma.\n",
      "\n",
      "Option a) Atypia ng mga cells is incorrect because while atypical cells are present in both conditions, they are not the main distinguishing feature between the two.\n",
      "\n",
      "Option c) Pagkarami ng mga nucleoli na hindi typikal is incorrect because the presence of abnormal nucleoli is not a key differentiating factor between conjunctival dysplasia and invasive carcinoma.\n",
      "\n",
      "Option d) Pagsalakay ng basement membrane is incorrect because the basement membrane is not a key factor in the difference between these two conditions.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Considerando os tumores conjuntivais, a presença de qual parâmetro abaixo é utilizado para a diferenciação entre displasia da conjuntiva e carcinoma invasivo?\n",
      "a)Atipia celular.\n",
      "b)Envolvimento da espessura total epitelial.\n",
      "c)Aumento do número de nucleolos atípicos.\n",
      "d)Invasão da membrana basal.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Envolvimento da espessura total epitelial.\n",
      "\n",
      "The presence of this parameter, which refers to the involvement of the entire epithelial thickness, is used to differentiate between dysplasia of the conjunctiva and invasive carcinoma.\n",
      "\n",
      "In dysplasia, there is abnormal cell growth, but the cells are still confined to the epithelial layer. In invasive carcinoma, the abnormal cells have invaded the deeper tissues, including the stroma. The involvement of the entire epithelial thickness is a characteristic feature of invasive carcinoma and helps to distinguish it from dysplasia.\n",
      "\n",
      "Therefore, option b is the correct answer.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Considering conjunctival tumors, the presence of which parameter below is used to differentiate between conjunctival dysplasia and invasive carcinoma?\n",
      "a) Cellular atypia.\n",
      "b) Involvement of the epithelial full thickness.\n",
      "c)Increase in the number of atypical nucleoli.\n",
      "d) Invasion of the basement membrane.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is d) Invasion of the basement membrane.\n",
      "\n",
      "Conjunctival dysplasia is a precancerous condition that affects the conjunctiva, the thin membrane that covers the white part of the eye. In contrast, invasive carcinoma is a type of cancer that has invaded the surrounding tissue.\n",
      "\n",
      "One of the key factors that distinguish conjunctival dysplasia from invasive carcinoma is the involvement of the basement membrane. In conjunctival dysplasia, the epithelial cells are abnormal, but they have not invaded the basement membrane. In contrast, invasive carcinoma has invaded the basement membrane, which is a sign of more aggressive disease.\n",
      "\n",
      "Therefore, option d) Invasion of the basement membrane is the correct answer.\n",
      "\n",
      "Option a) Cellular atypia is not specific enough to differentiate between conjunctival dysplasia and invasive carcinoma, as both conditions can show cellular atypia.\n",
      "\n",
      "Option b) Involvement of the epithelial full thickness is also not specific enough, as both conditions can involve the full thickness of the epithelium.\n",
      "\n",
      "Option c) Increase in the number of atypical nucleoli is not a reliable parameter to differentiate between conjunctival dysplasia and invasive carcinoma, as the number of atypical nucleoli can vary in both conditions.\n",
      "{'response': 'd'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 36: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Para cuál de los agentes enumerados a continuación son los anticuerpos monoclonales marcados con fluoresceína (FITC) y dirigidos contra la membrana proteica externa de la pared celular un mejor método de diagnóstico?\n",
      "a) C. trachomatis.\n",
      "b) Acanthamoeba sp.\n",
      "c) Criptococos sp.\n",
      "d) Neisseria meningitidis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) Criptococos sp.\n",
      "\n",
      "Criptococos sp. is a fungus that can cause opportunistic infections in people with compromised immune systems, such as those with HIV/AIDS or undergoing chemotherapy. The membrane protein external to the cell wall is a target for FITC-labeled monoclonal antibodies, which can be used for diagnosis.\n",
      "\n",
      "A) Chlamydia trachomatis is a bacterium that can cause sexually transmitted infections and eye infections. While it has a cell membrane, it is not typically targeted by FITC-labeled monoclonal antibodies for diagnosis.\n",
      "\n",
      "B) Acanthamoeba sp. is a protozoan that can cause opportunistic infections in people with compromised immune systems. However, it does not have a cell membrane proteins that are typically targeted by FITC-labeled monoclonal antibodies for diagnosis.\n",
      "\n",
      "D) Neisseria meningitidis is a bacterium that can cause meningitis and other invasive infections. While it has a cell membrane, it is not typically targeted by FITC-labeled monoclonal antibodies for diagnosis.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang flourescein-labelled monoclonal antibodies (FITC) patungo sa outer membrane cell wall protein ay magandang eksaminasyon upang makompirma ang alin sa mga bakteryang ito?\n",
      "a) C. trachomatis.\n",
      "b) Acanthamoeba sp.\n",
      "c) Cryptococcus sp.\n",
      "d) Neisseria meningitidis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "FITC (Fluorescein-labelled monoclonal antibodies) is a technique used to detect the presence of specific proteins on the surface of cells. In this case, the question is asking which bacteria can be confirmed using FITC-labelled monoclonal antibodies targeting outer membrane cell wall protein.\n",
      "\n",
      "Cryptococcus sp. is a fungus, not a bacteria, and therefore cannot be confirmed using FITC-labelled monoclonal antibodies targeting outer membrane cell wall protein.\n",
      "\n",
      "Neisseria meningitidis is a bacteria, but it does not have outer membrane cell wall protein, so FITC-labelled monoclonal antibodies cannot be used to confirm its presence.\n",
      "\n",
      "Acanthamoeba sp. is a protozoan, not a bacteria, and therefore cannot be confirmed using FITC-labelled monoclonal antibodies targeting outer membrane cell wall protein.\n",
      "\n",
      "C. trachomatis is a bacteria that has outer membrane cell wall protein, and FITC-labelled monoclonal antibodies can be used to confirm its presence. Therefore, option a) C. trachomatis is the correct answer.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Anticorpos monoclonais marcados com fluoresceína (FITC) e dirigidos contra a membrana externa proteica da parede celular são um método diagnóstico mais bem indicado para qual dos agentes listados abaixo?\n",
      "a)C. tracomatis.\n",
      "b)Acanthamoeba sp.\n",
      "c)Cryptococcus sp.\n",
      "d)Neisseria meningitidis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the best diagnostic method for identifying the agent C. tracomatis, which is a bacteria that causes trachoma, a sexually transmitted infection.\n",
      "\n",
      "Option A, \"C. tracomatis,\" is the correct answer because FITC-labeled monoclonal antibodies directed against the outer membrane protein of the bacterial cell wall are a specific and sensitive diagnostic method for detecting C. tracomatis.\n",
      "\n",
      "Option B, Acanthamoeba sp., is a protozoan that can cause keratitis and granulomatous amoebic encephalitis, but it is not the best answer for the given question.\n",
      "\n",
      "Option C, Cryptococcus sp., is a fungus that can cause cryptococcosis, but it is not the best answer for the given question.\n",
      "\n",
      "Option D, Neisseria meningitidis, is a bacteria that can cause meningitis and other invasive infections, but it is not the best answer for the given question.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "Fluorescein-labelled monoclonal antibodies (FITC) directed against the outer membrane cell wall protein are a better diagnostic method for which of the agents listed below?\n",
      "a) C. trachomatis.\n",
      "b) Acanthamoeba sp.\n",
      "c)Cryptococcus sp.\n",
      "d) Neisseria meningitidis.\n",
      "Test #0: \n",
      "response\n",
      "  Here's my answer:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"a\"  // Correct answer: C. trachomatis\n",
      "}\n",
      "```\n",
      "Explanation:\n",
      "Fluorescein-labelled monoclonal antibodies (FITC) directed against the outer membrane cell wall protein are a better diagnostic method for Chlamydia trachomatis (a) than the other options. This is because Chlamydia trachomatis has an outer membrane cell wall protein that can be targeted by FITC-labelled monoclonal antibodies, allowing for specific and sensitive detection of the bacteria.\n",
      "\n",
      "In contrast, Acanthamoeba sp. (b) and Cryptococcus sp. (c) are eukaryotic pathogens that lack an outer membrane cell wall protein, making them less suitable for detection with FITC-labelled monoclonal antibodies. Neisseria meningitidis (d) is a bacterium, but it does not have an outer membrane cell wall protein that can be targeted by FITC-labelled monoclonal antibodies.\n",
      "\n",
      "Therefore, the correct answer is (a) C. trachomatis.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 37: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿La inervación de la córnea se realiza principalmente por los nervios ciliares?\n",
      "a) anterior anterior.\n",
      "b) Posterior corto.\n",
      "c) Anterior largo.\n",
      "d) largo posterior.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // b) Posterior corto.\n",
      "}\n",
      "```\n",
      "\n",
      "La inervación de la córnea se realiza principalmente por los nervios ciliares, específicamente por el nervio ciliar posterior corto. Este nervio proveniente del ganglio ciliar, se distribuye en la superficie posterior de la córnea y se encarga de la sensibilidad y la innervación autonómica de la córnea.\n",
      "\n",
      "Por lo tanto, la respuesta correcta es b) Posterior corto.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Aling bahagi ng ciliary nerve ay ang pangunahing ugat ng cornea?\n",
      "a) Short anterior.\n",
      "b) Short posterior.\n",
      "c) Long anterior.\n",
      "d) Long posterior.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Short posterior\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The ciliary nerve is responsible for innervating the cornea, and its short posterior branch is the main nerve supply of the cornea. Therefore, the correct answer is (b) Short posterior.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "A inervação da córnea é feita, principalmente, por quais nervos ciliares?\n",
      "a)Anteriores curtos.\n",
      "b)Posteriores curtos.\n",
      "c)Anteriores longos.\n",
      "d)Posteriores longos.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c)Anteriores longos.\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The corneal innervation is mainly provided by the long anterior ciliary nerves. These nerves are responsible for transmitting sensory information from the cornea to the brain, allowing us to perceive sensations such as touch, pressure, and pain. The short anterior ciliary nerves and the short and long posterior ciliary nerves also play a role in corneal innervation, but to a lesser extent. Therefore, option C is the correct answer.\n",
      "{'response': 'c)Anteriores longos.'}\n",
      "Language: english\n",
      "Question: \n",
      "The innervation of the cornea is mainly done by which ciliary nerves?\n",
      "a) Short anterior.\n",
      "b) Short posterior.\n",
      "c) Long anterior.\n",
      "d) Long posterior.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c) Long anterior\"\n",
      "}\n",
      "```\n",
      "\n",
      "The long anterior ciliary nerves are responsible for innervating the cornea. They arise from the ophthalmic division of the trigeminal nerve and provide sensation to the cornea, as well as controlling the muscles that control the shape of the lens. The short anterior and short posterior ciliary nerves are not involved in the innervation of the cornea.\n",
      "{'response': 'c) Long anterior'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 38: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál de los siguientes músculos oculares extrínsecos está inervado por la división superior del nervio oculomotor?\n",
      "a) Oblique superior.\n",
      "b) recto inferior.\n",
      "c) recto medial\n",
      "d) recto superior.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) recto medial. The rectus medialis muscle is innervated by the superior division of the oculomotor nerve.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Aling extraocular muscle ang pinapaggalaw ng superior division ng oculomotor nerve?\n",
      "a) Superior oblique.\n",
      "b) Inferior rectum.\n",
      "c) Medial rectus\n",
      "d) Superior rectum.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is a) Superior oblique.\n",
      "\n",
      "The superior oblique muscle is the extraocular muscle that is innervated by the superior division of the oculomotor nerve.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual dos músculos oculares extrínsecos abaixo é inervado pela divisão superior do nervo oculomotor?\n",
      "a)Oblíquo superior.\n",
      "b)Reto inferior.\n",
      "c)Reto medial\n",
      "d)Reto superior.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is a) Oblíquo superior.\n",
      "\n",
      "The obliques are a group of muscles that control eye movement. The superior oblique muscle is innervated by the superior division of the oculomotor nerve.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "Which of the following extraocular muscle is innervated by the superior division of the oculomotor nerve?\n",
      "a) Superior oblique.\n",
      "b) Inferior rectum.\n",
      "c) medial rectus\n",
      "d) Superior rectum.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The superior oblique muscle is innervated by the superior division of the oculomotor nerve.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 39: \n",
      "Language: spanish\n",
      "Question: \n",
      "Basándose en el conocimiento anatómico, elija la alternativa más probable.\n",
      "a) La fractura del hueso etmoides puede provocar enfisema orbitario.\n",
      "b) La fractura de la parte lateral de la órbita puede provocar hemorragia intraorbitaria, por rotura de las arterias etmoidales anterior y posterior.\n",
      "c) La fractura del suelo orbitario puede provocar alteración de los movimientos de masticación, debido al daño del nervio maxilar, una rama del nervio trigémino.\n",
      "d) La fractura del hueso lagrimal puede reducir la excreción de lágrimas por la glándula lagrimal principal, debido al deterioro del nervio lagrimal.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "La fractura de la parte lateral de la órbita puede provocar hemorragia intraorbitaria, por rotura de las arterias etmoidales anterior y posterior. Esta respuesta es la más probable, ya que la fractura de la órbita puede causar daño a las arterias que se encuentran en la región, lo que puede provocar una hemorragia. Las otras opciones no son correctas, ya que no se relacionan con la fractura de la órbita y sus efectos en la región.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin ang tama tungkol sa anatomya ng mata?\n",
      "a) Ang pagbali ng ethmoid bone ay maaaring maging sanhi ng orbital emphysema.\n",
      "b) Ang pagbali ng lateral orbit ay maaaring maging sanhi ng pagdugo sa loob ng orbit dahil sa pagsugat sa anterior at posterior ethmoidal arteries.\n",
      "c) Ang pagbali ng orbital floor ay maaaring maging sanhi ng kahinaan ng mga paggalaw ng masticatory muscles dahil sa pinsala sa maxillary nerve, isang sangay ng trigeminal nerve.\n",
      "d) Ang pagbali ng lacrimal bone ay maaaring maging sanhi ng pagbawas ng luha mula sa lacrimal gland dahil sa pagsugat sa lacrimal nerve.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option b, \"Ang pagbali ng lateral orbit ay maaaring maging sanhi ng pagdugo sa loob ng orbit dahil sa pagsugat sa anterior at posterior ethmoidal arteries.\"\n",
      "\n",
      "The lateral orbit is the bony cavity that contains the eyeball and the surrounding soft tissues. The ethmoid bone is a thin, flat bone that forms the roof of the orbit. The anterior and posterior ethmoidal arteries are branches of the ophthalmic artery that supply blood to the orbit. If the lateral orbit is fractured, it can cause damage to these arteries, leading to bleeding within the orbit. This bleeding can cause the eyeball to be pushed forward, leading to protrusion of the eye and potentially causing double vision or other visual disturbances.\n",
      "\n",
      "Option a is incorrect because the ethmoid bone is not involved in the formation of the orbit. Option c is incorrect because the maxillary nerve is not involved in the movement of the masticatory muscles. Option d is incorrect because the lacrimal bone is not involved in the formation of the orbit.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com base em conhecimentos anatômicos, escolha a alternativa mais provável.\n",
      "a)Fratura do osso etmoidal pode causar enfisema orbitário.\n",
      "b)Fratura da parte lateral da órbita pode causar hemorragia intraorbital, por ruptura das artérias etmoidais anteriores e posteriores.\n",
      "c)Fratura do assoalho da órbita pode causar comprometimento dos movimentos mastigatórios, por lesão no nervo maxilar, ramo do nervo trigêmeo.\n",
      "d)Fratura do osso lacrimal pode diminuir a excreção de lágrima pela glândula lacrimal principal, por comprometimento do nervo lacrimal.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Fratura da parte lateral da órbita pode causar hemorragia intraorbital, por ruptura das artérias etmoidais anteriores e posteriores.\n",
      "\n",
      "A fratura da parte lateral da órbita pode causar hemorragia intraorbital, pois as artérias etmoidais anteriores e posteriores estão localizadas na região da órbita e podem ser danificadas pela fratura. Isso pode resultar em sangue no interior da órbita, o que é conhecido como hemorragia intraorbital.\n",
      "\n",
      "As outras opções não são corretas:\n",
      "\n",
      "* a) Fratura do osso etmoidal pode causar enfisema orbitário, mas não é a resposta correta para esta pergunta.\n",
      "* c) Fratura do assoalho da órbita pode comprometer os movimentos mastigatórios, mas não é relacionado à hemorragia intraorbital.\n",
      "* d) Fratura do osso lacrimal pode diminuir a excreção de lágrima, mas não é a resposta correta para esta pergunta.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Based on anatomical knowledge, choose the most likely alternative.\n",
      "a) Fracture of the ethmoid bone can cause orbital emphysema.\n",
      "b) Fracture of the lateral part of the orbit can cause intraorbital hemorrhage, due to rupture of the anterior and posterior ethmoidal arteries.\n",
      "c) Fracture of the orbital floor can cause impairment of masticatory movements, due to damage to the maxillary nerve, a branch of the trigeminal nerve.\n",
      "d) Fracture of the lacrimal bone may decrease tear excretion by the main lacrimal gland, by compromising the lacrimal nerve.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "  \"response\": \"b\"\n",
      "}\n",
      "```\n",
      "La fractura de la parte lateral de la órbita puede causar hemorragia intraorbital debido al rompimiento de las arterias etmoidales anteriores y posteriores.\n",
      "\n",
      "Here's the answer in Tagalog:\n",
      "```json\n",
      "{\n",
      "  \"response\": \"b\"\n",
      "}\n",
      "```\n",
      "Ang fracture ng lateral part ng orbita ay maaaring magkaroon ng hemoragia intraorbital dahil sa pagkakaroon ng anterior at posterior ethmoidal arteries.\n",
      "\n",
      "Here's the answer in Portuguese:\n",
      "```json\n",
      "{\n",
      "  \"response\": \"b\"\n",
      "}\n",
      "```\n",
      "A fratura da parte lateral da órbita pode causar hemorragia intraorbital devido à ruptura das artérias etmoidais anteriores e posteriores.\n",
      "\n",
      "Here's the answer in English:\n",
      "```json\n",
      "{\n",
      "  \"response\": \"b\"\n",
      "}\n",
      "```\n",
      "A fracture of the lateral part of the orbit can cause intraorbital hemorrhage due to the rupture of the anterior and posterior ethmoidal arteries.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 40: \n",
      "Language: spanish\n",
      "Question: \n",
      "Hay muchos factores que contribuyen a la transparencia de la córnea, pero los principales son:\n",
      "a) Ausencia de proteoglicanos de adhesión, aumentando el espacio interfibrilar laxo y permitiendo el libre paso de la luz.\n",
      "b)Baja demanda metabólica, que permite la nutrición a través de una red reticular de capilares estromales extremadamente finos.\n",
      "c) Característica hiperosmótica de la membrana de Descemet, que reduce la hidratación estromal.\n",
      "d)Organización de las fibrillas de colágeno de forma regular, uniforme y paralela entre sí.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option a, \"Ausencia de proteoglicanos de adhesión, aumentando el espacio interfibrilar laxo y permitiendo el libre paso de la luz.\"\n",
      "\n",
      "Proteoglycans are molecules that play a crucial role in maintaining the transparency of the cornea. They are responsible for the adhesion between corneal fibers and the maintenance of the extracellular matrix. However, an excessive amount of proteoglycans can lead to the formation of aggregates that scatter light and reduce corneal transparency. Therefore, the absence of proteoglycans of adhesion, which increases the space between corneal fibers and allows for the free passage of light, is a key factor in maintaining corneal transparency.\n",
      "\n",
      "Option b, \"Baja demanda metabólica, que permite la nutrición a través de una red reticular de capilares estromales extremadamente finos,\" is incorrect because while the cornea does have a low metabolic demand, this is not a primary factor in maintaining its transparency.\n",
      "\n",
      "Option c, \"Característica hiperosmótica de la membrana de Descemet, que reduce la hidratación estromal,\" is also incorrect. While the Descemet's membrane is indeed hyperosmotic, this characteristic does not contribute significantly to corneal transparency.\n",
      "\n",
      "Option d, \"Organización de las fibrillas de colágeno de forma regular, uniforme y paralela entre sí,\" is incorrect because while the organization of collagen fibers is important for corneal strength and stability, it is not a primary factor in maintaining corneal transparency.\n",
      "{'response': 'a'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Maraming mga kadahilanan na nag-aambag sa transparency ng cornea, ngunit ang pangunahing dahilan ay:\n",
      "a) Ang kawalan ng adhesion proteoglycans, na nagpapalago ng loose interfibrillar space upang makadaan ang ilaw.\n",
      "b) Ang mababang demanda ng metabolismo, upang makapasok ang sustansya sa pamamagitan ng reticular mesh sa loob ng maliliit na stromal capillaries.\n",
      "c) Ang hyperosmolarity ng Descemet's membrane, upang mabawasan ang stromal hydration.\n",
      "d) Ang pagka-ayos ng mga collagen fibrils ng regular, pare-pareho, at nakalinya sa isa't isa.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option a) The lack of adhesion proteoglycans, which creates a loose interfibrillar space that allows light to pass through.\n",
      "\n",
      "The other options do not accurately describe the main reason for the transparency of the cornea:\n",
      "\n",
      "b) The low metabolic demand of the cornea does not play a significant role in its transparency.\n",
      "\n",
      "c) The hyperosmolarity of Descemet's membrane does not have a significant impact on the transparency of the cornea.\n",
      "\n",
      "d) The regular, parallel, and aligned arrangement of collagen fibrils in the cornea is important for its mechanical strength and stability, but it does not contribute to its transparency.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Muitos são os fatores que contribuem para a transparência da córnea, mas o principal deles é:\n",
      "a)Ausência de proteoglicanos de adesão, aumentando o espaço interfibrilar frouxo e permitindo a passagem livre da luz.\n",
      "b)Baixa demanda metabólica, que permite a nutrição por uma malha reticular de capilares estromais extremamente finos.\n",
      "c)Característica hiperosmótica da membrana de Descemet, que reduz a hidratação estromal.\n",
      "d)Organização das fibrilas de colágeno de forma regular, uniforme e paralela umas às outras.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option a) Ausência de proteoglicanos de adesão, aumentando o espaço interfibrilar frouxo e permitindo a passagem livre da luz.\n",
      "\n",
      "Proteoglycans are molecules that play a crucial role in maintaining the transparency of the cornea. They are responsible for the adhesion between corneal fibers and help to maintain the regular, uniform organization of the collagen fibers. The absence of proteoglycans in the cornea leads to an increase in the interfibrillar space, allowing for the free passage of light and maintaining transparency.\n",
      "\n",
      "Therefore, option a is the correct answer.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "There are many factors that contribute to the transparency of the cornea, but the main one is:\n",
      "a) Absence of adhesion proteoglycans, increasing the loose interfibrillar space and allowing free passage of light.\n",
      "b) Low metabolic demand, which allows nutrition by a reticular mesh of extremely fine stromal capillaries.\n",
      "c) Hyperosmotic characteristic of Descemet's membrane, which reduces stromal hydration.\n",
      "d) Organization of collagen fibrils in a regular, uniform and parallel way to each other.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option a) Absence of adhesion proteoglycans, increasing the loose interfibrillar space and allowing free passage of light.\n",
      "\n",
      "Explanation:\n",
      "The cornea is a transparent tissue that allows light to pass through and focus on the retina. One of the main factors that contribute to its transparency is the absence of adhesion proteoglycans, such as aggrecan and versican, which are typically found in other connective tissues. The lack of these proteoglycans in the cornea creates a loose interfibrillar space that allows light to pass through unimpeded, contributing to the cornea's transparency.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "* Option b) Low metabolic demand, which allows nutrition by a reticular mesh of extremely fine stromal capillaries, is not the main factor that contributes to the transparency of the cornea. While it is true that the cornea has a low metabolic demand and is nourished by a reticular mesh of fine capillaries, this is not the primary factor that contributes to its transparency.\n",
      "* Option c) Hyperosmotic characteristic of Descemet's membrane, which reduces stromal hydration, is not the main factor that contributes to the transparency of the cornea. While Descemet's membrane does have a hyperosmotic characteristic that helps to maintain the cornea's transparency, it is not the primary factor that contributes to its transparency.\n",
      "* Option d) Organization of collagen fibrils in a regular, uniform and parallel way to each other, is not the main factor that contributes to the transparency of the cornea. While the organization of collagen fibrils in the cornea is important for its structural integrity, it is not the primary factor that contributes to its transparency.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 41: \n",
      "Language: spanish\n",
      "Question: \n",
      "Seleccionar la alternativa correcta respecto a la anatomía del segmento posterior del ojo.\n",
      "a) La aparición de los dos nervios ciliares largos en el ecuador del ojo, aproximadamente a las doce y a las seis, explica una mayor sensibilidad al dolor en estos cuadrantes durante la panfotocoagulación.\n",
      "b) Las arterias vórtices subretinianas dan la apariencia de encaje de “tigre” en el examen oftalmoscópico de personas con atrofia difusa del epitelio pigmentado de la retina.\n",
      "c) En la ora serrata existen pequeños pliegues meridionales radiales junto a las apófisis dentadas con, posiblemente, un pequeño agujero retiniano atrófico en su base, que no es necesario bloquear.\n",
      "d) La foveola, zona de mayor actividad metabólica debido a la alta concentración de fotorreceptores, presenta una intensa red vascular formada por anastomosis de las arcadas temporales superior e inferior.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "La respuesta correcta es la opción d) La foveola, zona de mayor actividad metabólica debido a la alta concentración de fotorreceptores, presenta una intensa red vascular formada por anastomosis de las arcadas temporales superior e inferior.\n",
      "\n",
      "La foveola es una depresión en la retina que se encuentra en el centro del ojo y es la zona donde se encuentra la máxima concentración de conos, los fotorreceptores responsables de la visión colorida y del detalle visual. Debido a la alta actividad metabólica de esta zona, existe una intensa red vascular que la irriga, formada por anastomosis de las arcadas temporales superior e inferior. Esta característica es importante para garantizar la adecuada perfusión sanguínea y oxigenación de la retina en esta zona crítica para la visión.\n",
      "\n",
      "Las otras opciones no son correctas:\n",
      "\n",
      "* La opción a) se refiere a la distribución de los nervios ciliares largos en el ecuador del ojo, lo que no está relacionado con la anatomía del segmento posterior del ojo.\n",
      "* La opción b) se refiere a la apariencia de las arterias vórtices subretinianas en el examen oftalmoscópico de personas con atrofia difusa del epitelio pigmentado de la retina, lo que tampoco está relacionado con la anatomía del segmento posterior del ojo.\n",
      "* La opción c) se refiere a la presencia de pliegues meridionales radiales en la ora serrata, lo que no es una característica de la anatomía del segmento posterior del ojo.\n",
      "{'response': 'd'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod ang tama tungkol sa anatomya ng posterior segment ng mata?\n",
      "a) Mas sensitibo ang alas dose at alas sais na rehiyon ng equator ng mata sa panphotocoagulation dahil may dalawang long ciliary nerves na dumadaan dito.\n",
      "b) Ang mga subretinal vorticose artery ang nagbubuo ng \"tiger\" o makabuluhang itsura sa mga taong may diffuse atrophy ng retinal pigment epithelium.\n",
      "c) Sa loob ng ora serrata, may maliliit na radial meridional folds na katabi ng dentate processes, na mayroong maliit na atrophic retinal hole na hindi kinakailangan harangan.\n",
      "d) Ang foveola ay isang rehiyon na mataas ang metabolismo dahil sa karamihan ng kanyang mga photoreceptor. Ito ay mayroong makabuluhang koneksyon ng mga ugat dahil sa mga superior at inferior temporal arcade.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option a) Mas sensitibo ang alas dose at alas sais na rehiyon ng equator ng mata sa panphotocoagulation dahil may dalawang long ciliary nerves na dumadaan dito.\n",
      "\n",
      "The posterior segment of the eye includes the retina, choroid, and sclera. The retina contains specialized photoreceptors (rods and cones) that convert light into electrical signals, which are transmitted to the brain through the optic nerve. The choroid is a layer of blood vessels that supplies the retina with oxygen and nutrients. The sclera is the white, tough outer layer of the eye that provides protection and structure.\n",
      "\n",
      "Option a is correct because the long ciliary nerves that pass through the equator of the eye are responsible for transmitting visual information from the retina to the brain. These nerves are sensitive to damage from panphotocoagulation, a laser treatment used to treat various eye conditions, including retinal detachment and glaucoma.\n",
      "\n",
      "Option b is incorrect because the subretinal vorticose artery does not play a role in the formation of the \"tiger\" or \"makabuluhang itsura\" (a Filipino term for a specific type of retinal degeneration) in people with diffuse atrophy of the retinal pigment epithelium.\n",
      "\n",
      "Option c is incorrect because while there are small radial meridional folds in the ora serrata, a region of the retina near the optic disc, these folds are not associated with retinal atrophy or holes.\n",
      "\n",
      "Option d is incorrect because while the foveola is a region of high metabolic activity in the retina due to its high concentration of photoreceptors, it does not have a direct connection to the superior and inferior temporal arcade, which are blood vessels that supply the retina.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Marque a alternativa correta quanto à anatomia do segmento posterior do olho.\n",
      "a)A emergência dos dois nervos ciliares longos no equador do olho, aproximadamente às doze e seis horas, explica maior sensibilidade à dor nesses quadrantes durante a panfotocoagulação.\n",
      "b)As artérias vorticosas sub-retinianas conferem o aspecto rendilhado \"em tigre\" no exame oftalmoscópico de pessoas com atrofia difusa do epitélio pigmentado da retina.\n",
      "c)Na ora serrata encontram-se pequenas pregas meridionais radiais junto aos processos denteados com, eventualmente pequeno buraco retiniano atrófico na sua base, que não necessita ser bloqueado.\n",
      "d)A fovéola, área de maior atividade metabólica devido a alta concentração de fotorreceptores, apresenta intensa rede vascular formada por anastomoses das arcadas temporais superiores e inferiores.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option a: \"A emergência dos dois nervos ciliares longos no equador do olho, aproximadamente às doze e seis horas, explica maior sensibilidade à dor nesses quadrantes durante a panfotocoagulação.\"\n",
      "\n",
      "This answer is correct because the emergence of the two long ciliary nerves at the equator of the eye, around 12 and 6 o'clock, can explain the greater sensitivity to pain in those quadrants during photocoagulation.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "Mark the correct alternative regarding the anatomy of the posterior segment of the eye.\n",
      "a) The emergence of the two long ciliary nerves at the equator of the eye, approximately at twelve and six o'clock, explains greater sensitivity to pain in these quadrants during panphotocoagulation.\n",
      "b) The subretinal vorticose arteries give the lacy \"tiger\" appearance in the ophthalmoscopic examination of people with diffuse atrophy of the retinal pigment epithelium.\n",
      "c) In the ora serrata, there are small radial meridional folds next to the dentate processes, with, eventually, a small atrophic retinal hole at its base, which does not need to be blocked.\n",
      "d) The foveola, area of ​​greater metabolic activity due to the high concentration of photoreceptors, presents an intense vascular network formed by anastomoses of the superior and inferior temporal arcades.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option d, \"The foveola, area of ​​greater metabolic activity due to the high concentration of photoreceptors, presents an intense vascular network formed by anastomoses of the superior and inferior temporal arcades.\"\n",
      "\n",
      "The foveola is a small, specialized area in the center of the retina that is responsible for central vision and has a high concentration of photoreceptors. It is known for its high metabolic activity and is nourished by an extensive vascular network that includes the superior and inferior temporal arcades. This vascular network is important for maintaining the health and function of the photoreceptors in the foveola.\n",
      "\n",
      "Option a is incorrect because the emergence of the two long ciliary nerves at the equator of the eye does not explain greater sensitivity to pain in these quadrants during panphotocoagulation.\n",
      "\n",
      "Option b is incorrect because the subretinal vorticose arteries do not give the lacy \"tiger\" appearance in the ophthalmoscopic examination of people with diffuse atrophy of the retinal pigment epithelium.\n",
      "\n",
      "Option c is incorrect because the ora serrata does not have small radial meridional folds next to the dentate processes, and there is no small atrophic retinal hole at its base that does not need to be blocked.\n",
      "{'response': 'd'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 42: \n",
      "Language: spanish\n",
      "Question: \n",
      "Seleccionar la alternativa correcta respecto a la anatomía del seno camerular.\n",
      "a) La línea de Schwalbe corresponde a la proyección gonioscópica del espolón escleral.\n",
      "b) La banda del cuerpo ciliar generalmente no puede observarse mediante gonioscopia.\n",
      "c) Los procesos pectíneos del iris que llegan a la línea de Schwalbe no están presentes en ojos normales; y cuando se encuentran, son indicativos de iridociclitis previa.\n",
      "d) El flujo de drenaje del humor acuoso se produce principalmente en la porción posterior de la malla trabecular, que está más pigmentada.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La respuesta correcta es la opción c: Los procesos pectíneos del iris que llegan a la línea de Schwalbe no están presentes en ojos normales; y cuando se encuentran, son indicativos de iridociclitis previa.\n",
      "\n",
      "La línea de Schwalbe es una línea curva que se encuentra en la parte posterior de la cámara anterior del ojo y que corresponde a la proyección gonioscópica del espolón escleral, por lo que la opción a no es correcta.\n",
      "\n",
      "La banda del cuerpo ciliar es una estructura que se encuentra en la parte posterior del ojo y que no puede observarse mediante gonioscopia, por lo que la opción b no es correcta.\n",
      "\n",
      "El flujo de drenaje del humor acuoso se produce principalmente en la porción posterior de la malla trabecular, que está más pigmentada, por lo que la opción d no es correcta.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod ang tama tungkol sa camerular sinus?\n",
      "a) Ang Schwabe's line ay katumbas ng gonioscopic projection ng scleral spur.\n",
      "b) Karaniwang hindi nakikita sa gonioscopy ang ciliary body band.\n",
      "c) Sa normal na mata, walang pectineal iris processes na umaabot sa Scwabe's line. Kapag sila'y nakita, ito'y indikasyon ng nakaraang iridocyclitis.\n",
      "d) Ang pagdaloy ng aqueous humor ay karaniwang nasa likuran ng trabecular meshwork kung saan mas marami ang mga pigment.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the correct statement regarding the camerular sinus.\n",
      "\n",
      "Option A is incorrect because Schwabe's line is not the gonioscopic projection of the scleral spur.\n",
      "\n",
      "Option B is incorrect because the ciliary body band is not typically visible on gonioscopy.\n",
      "\n",
      "Option C is correct because in a normal eye, the pectineal iris processes do not extend to Schwabe's line. If they do, it is an indication of previous iridocyclitis.\n",
      "\n",
      "Option D is incorrect because the flow of aqueous humor is typically away from the trabecular meshwork, where there are more pigments.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Assinale a alternativa correta quanto à anatomia do seio camerular.\n",
      "a)A linha de Schwalbe corresponde à projeção gonioscópica do esporão escleral.\n",
      "b)A banda do corpo ciliar geralmente não pode ser observada pela gonioscopia.\n",
      "c)Processos irianos pectíneos que alcançam a linha de Schwalbe não estão presentes em olhos normais; e quando encontrados são indicativos de iridociclite prévia.\n",
      "d)O fluxo de drenagem do humor aquoso ocorre principalmente na porção posterior da malha trabecular, que é mais pigmentada.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c: Processos irianos pectíneos que alcançam a linha de Schwalbe não estão presentes em olhos normais; e quando encontrados são indicativos de iridociclite prévia.\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The iris is a structure in the eye that controls the amount of light that enters the eye by adjusting the size of the pupil. The iris has a layer of smooth muscle called the stroma, which is surrounded by a layer of connective tissue called the pecten. The pecten is made up of thin, branching processes that extend from the periphery of the iris towards the center.\n",
      "\n",
      "In normal eyes, the pecten processes do not reach the line of Schwalbe, which is a imaginary line that marks the boundary between the anterior and posterior chambers of the eye. However, in eyes with iridociclitis, the pecten processes can become inflamed and extend beyond the line of Schwalbe, which can be observed through gonioscopy. Therefore, option c is the correct answer.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Mark the correct alternative regarding the anatomy of the camerular sinus.\n",
      "a) Schwalbe's line corresponds to the gonioscopic projection of the scleral spur.\n",
      "b) The ciliary body band usually cannot be seen by gonioscopy.\n",
      "c) pectineal iris processes reaching Schwalbe's line are not present in normal eyes; and when found, they are indicative of previous iridocyclitis.\n",
      "d) The drainage flow of aqueous humor occurs mainly in the posterior portion of the trabecular meshwork, which is more pigmented.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct alternative regarding the anatomy of the camerular sinus is option a) Schwalbe's line corresponds to the gonioscopic projection of the scleral spur.\n",
      "\n",
      "Schwalbe's line is a visible line that can be seen on gonioscopy, which is a technique used to examine the anterior chamber angle of the eye. It represents the projection of the scleral spur, which is a bony projection on the inner surface of the sclera (the white part of the eye) that marks the boundary between the anterior and posterior chambers of the eye.\n",
      "\n",
      "Option b) is incorrect because the ciliary body band can be seen by gonioscopy, and it is a useful landmark for identifying the location of the trabecular meshwork, which is responsible for draining aqueous humor from the eye.\n",
      "\n",
      "Option c) is also incorrect because pectineal iris processes reaching Schwalbe's line are not always indicative of previous iridocyclitis, and they can be present in normal eyes as well.\n",
      "\n",
      "Option d) is incorrect because while the drainage flow of aqueous humor does occur in the posterior portion of the trabecular meshwork, which is more pigmented, it is not the main location of aqueous humor drainage. The main drainage pathway for aqueous humor is through the anterior chamber angle, which is located anterior to the iris and is formed by the cornea, iris, and lens.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 43: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Las oraciones siguientes se refieren a qué estructura del ojo humano?\n",
      "\n",
      "1- Extensión más anterior del tracto uveal.\n",
      "2- Formado por vasos sanguíneos, tejido conectivo y malanocitos.\n",
      "3- Presenta epitelio pigmentado cuyo extremo basal de las células mira hacia la cámara posterior.\n",
      "4- Tiene fibras musculares lisas con inervación simpática.\n",
      "\n",
      "a) Cuerpo ciliar.\n",
      "b) Iris.\n",
      "c) Seno camerular.\n",
      "d) Tracto coroideo de la ora serrata.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) Iris.\n",
      "\n",
      "The description provided in the question matches the characteristics of the iris, which is a structure in the eye that is formed by blood vessels, connective tissue, and melanocytes. The iris presents pigmented epithelium, and its basal extremity faces the posterior chamber. Additionally, the iris has smooth muscle fibers with sympathetic innervation. Therefore, option b is the correct answer.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang mga pahayag ay tumutukoy sa aling bahagi ng mata?\n",
      "\n",
      "1- Pinakaharap na bahagi ng uveal tract.\n",
      "2- Binuo ng mga ugat, connective tissue, at melanocytes.\n",
      "3- Mayroong pigmented epithelium, kung saan ang talikuran ng mga cell ay nakaharap sa posterior chamber.\n",
      "4- Mayroong mga smooth muscle fiber na may sympathetic innervation.\n",
      "\n",
      "a) Ciliary body.\n",
      "b) iris.\n",
      "c) Camerular sinus.\n",
      "d) Choroidal tract ng Ora serrata.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) Iris.\n",
      "\n",
      "The iris is the colored part of the eye that surrounds the pupil and controls the amount of light that enters the eye by adjusting the size of the pupil. It is made up of connective tissue, smooth muscle fibers, and melanocytes. The iris is also known as the uveal tract, and it is the second layer of the eye, located between the cornea and the lens. Therefore, option b is the correct answer.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "As sentenças abaixo dizem respeito a qual estrutura do olho humano?\n",
      "\n",
      "1- Extensão mais anterior do trato uveal.\n",
      "2- Formada por vasos sanguíneos, tecido conjuntivo e malanócitos.\n",
      "3- Apresenta epitélio pigmentado cuja extremidade basal das células está voltada para a câmara posterior.\n",
      "4- Possui fibras musculares lisas de inervação simpática.\n",
      "\n",
      "a)Corpo ciliar.\n",
      "b)Íris.\n",
      "c)Seio camerular.\n",
      "d)Trato coroidal da ora serrata.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "A estrutura do olho humano que possui epitélio pigmentado com extremidade basal das células voltada para a câmara posterior é o seio camerular. Portanto, a resposta correta é a opção c.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "The sentences below refer to which structure of the human eye?\n",
      "\n",
      "1- Most anterior extension of the uveal tract.\n",
      "2- Formed by blood vessels, connective tissue and melanocytes.\n",
      "3- Presents pigmented epithelium whose basal end of the cells is facing the posterior chamber.\n",
      "4- It has smooth muscle fibers of sympathetic innervation.\n",
      "\n",
      "a) ciliary body.\n",
      "b) iris.\n",
      "c) Camerular sinus.\n",
      "d) Choroidal tract of ora serrata.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // b) iris\n",
      "}\n",
      "```\n",
      "\n",
      "The sentences describe the structure of the iris, which is formed by blood vessels, connective tissue, and melanocytes, and presents pigmented epithelium whose basal end of the cells is facing the posterior chamber. The iris also has smooth muscle fibers of sympathetic innervation. Therefore, option b is the correct answer.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 44: \n",
      "Language: spanish\n",
      "Question: \n",
      "En cuanto a la anatomía de la retina, elija la alternativa que contenga la correlación correcta entre las dos columnas a continuación:\n",
      "\n",
      "I- Capa plexiforme externa\n",
      "II- Limitación externa\n",
      "III- Capa nuclear interna\n",
      "IV- Limitación interna\n",
      "V- Capa de fibras nerviosas\n",
      "\n",
      "A- Está en contacto con el vítreo.\n",
      "B- Está entre los fotorreceptores y las células bipolares.\n",
      "C- Contiene células amacrinas y horizontales.\n",
      "D- Estos son procesos de las células de Muller.\n",
      "E- Contiene axones de células ganglionares.\n",
      "\n",
      "a)A: II; B: III; C: I; D: V; E: IV.\n",
      "b)A: IV; B: I; C: III; D: II; E: V.\n",
      "c)A: IV; B: V; C: III; D: I; E: II.\n",
      "d)A: V; B: II; C: III; D: IV; E: I.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c)A: IV; B: V; C: III; D: I; E: II.\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option c.\n",
      "\n",
      "The external limiting membrane (II) is in contact with the vitreous humor, so option A is incorrect.\n",
      "The external plexiform layer (I) contains synapses between photoreceptors and bipolar cells, so option B is incorrect.\n",
      "The internal nuclear layer (III) contains amacrine and horizontal cells, so option C is correct.\n",
      "The internal limiting membrane (IV) is the boundary between the inner and outer segments of the retina, so option D is incorrect.\n",
      "The layer of fibers (V) contains the axons of ganglion cells, so option E is incorrect.\n",
      "\n",
      "Therefore, the correct correlation is:\n",
      "\n",
      "A: IV (external limiting membrane)\n",
      "B: V (layer of fibers)\n",
      "C: III (internal nuclear layer)\n",
      "D: I (external plexiform layer)\n",
      "E: II (internal limiting membrane)\n",
      "{'response': 'c)A: IV; B: V; C: III; D: I; E: II.'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ipagpares ang mga layer ng retina sa tamang paglalarawan nito.\n",
      "\n",
      "I - outer plexiform layer\n",
      "II - External limit\n",
      "III - inner nuclear layer\n",
      "IV - Internal limit\n",
      "V - Nerve fiber layer\n",
      "\n",
      "A- Nakadikit sa vitreous\n",
      "B- Nasa gitna ng mga photoreceptor at bipolar cells\n",
      "C- Mayroong mga amacrine at horizontal cells\n",
      "D- May mga Muller cell process\n",
      "E- May axons ng mga ganglion cell\n",
      "\n",
      "a) A: II; B: III; C: I; D: V; I: IV.\n",
      "b) A: IV; B: I; C: III; D: II; E: V.\n",
      "c) A: IV; B: V; C: III; D: I; I: II.\n",
      "d) A: V; B:II; C: III; D: IV; E:I.\n",
      "Test #0: \n",
      "response\n",
      "  Here's my answer:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Answer: b\n",
      "}\n",
      "```\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) A: IV; B: I; C: III; D: II; E: V.\n",
      "\n",
      "The layers of the retina, from outer to inner, are:\n",
      "\n",
      "* Outer plexiform layer (I)\n",
      "* External limit (II)\n",
      "* Inner nuclear layer (III)\n",
      "* Internal limit (IV)\n",
      "* Nerve fiber layer (V)\n",
      "\n",
      "The layers can be paired as follows:\n",
      "\n",
      "* A: IV (Internal limit)\n",
      "* B: I (Outer plexiform layer)\n",
      "* C: III (Inner nuclear layer)\n",
      "* D: II (External limit)\n",
      "* E: V (Nerve fiber layer)\n",
      "\n",
      "Therefore, the correct answer is b) A: IV; B: I; C: III; D: II; E: V.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "A respeito da anatomia da retina, escolha a alternativa que contenha a correlação correta entre as duas colunas abaixo:\n",
      "\n",
      "I- Camada plexiforme externa\n",
      "II- Limitante externa\n",
      "III- Camada nuclear interna\n",
      "IV- Limitante interna\n",
      "V- Camada de fibras nervosas\n",
      "\n",
      "A- Está em contato com o vítreo\n",
      "B- Está entre os fotorreceptores e as células bipolares\n",
      "C- Contém células amácrinas e horizontais\n",
      "D- São processos das células de Muller\n",
      "E- Contém axônios de células ganglionares\n",
      "\n",
      "a)A: II; B: III; C: I; D: V; E: IV.\n",
      "b)A: IV; B: I; C: III; D: II; E: V.\n",
      "c)A: IV; B: V; C: III; D: I; E: II.\n",
      "d)A: V; B: II; C: III; D: IV; E: I.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c)A: IV; B: V; C: III; D: I; E: II.\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option c.\n",
      "\n",
      "The external limiting membrane (II) is in contact with the vitreous humor, so option A is incorrect.\n",
      "The external plexiform layer (I) contains synapses between photoreceptors and bipolar cells, so option B is incorrect.\n",
      "The internal nuclear layer (III) contains amacrine and horizontal cells, so option C is correct.\n",
      "The internal limiting membrane (IV) is the boundary between the inner and outer layers of the retina, so option D is incorrect.\n",
      "The layer of fibers (V) contains the axons of ganglion cells, so option E is incorrect.\n",
      "\n",
      "Therefore, the correct answer is option c:\n",
      "A: IV (external limiting membrane);\n",
      "B: V (layer of fibers);\n",
      "C: III (internal nuclear layer);\n",
      "D: I (external plexiform layer);\n",
      "E: II (internal limiting membrane).\n",
      "{'response': 'c)A: IV; B: V; C: III; D: I; E: II.'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding the anatomy of the retina, choose the alternative that contains the correct correlation between the two columns below:\n",
      "\n",
      "I - outer plexiform layer\n",
      "II - External limit\n",
      "III - inner nuclear layer\n",
      "IV - Internal limit\n",
      "V - Nerve fiber layer\n",
      "\n",
      "A- It is in contact with the vitreous\n",
      "B- It is between the photoreceptors and the bipolar cells\n",
      "C- Contains amacrine and horizontal cells\n",
      "D - Muller cell processes\n",
      "E- Contains axons of ganglion cells\n",
      "\n",
      "a) A: II; B: III; C: I; D: V; I: IV.\n",
      "b) A: IV; B: I; C: III; D: II; E: V.\n",
      "c) A: IV; B: V; C: III; D: I; I: II.\n",
      "d) A: V; B:II; C: III; D: IV; E:I.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\" // b) A: IV; B: I; C: III; D: II; E: V.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct correlation between the two columns is as follows:\n",
      "\n",
      "* A: IV - The outer plexiform layer is in contact with the vitreous.\n",
      "* B: I - The inner nuclear layer contains amacrine and horizontal cells.\n",
      "* C: III - The nerve fiber layer contains axons of ganglion cells.\n",
      "* D: II - The internal limit is between the photoreceptors and the bipolar cells.\n",
      "* E: V - The inner limit is in contact with the vitreous.\n",
      "\n",
      "Therefore, the correct answer is option b.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 45: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un paciente fáquico desarrolló un aumento significativo de la presión intraocular y atalamia 15 horas después de la trabeculectomía. Es correcto afirmar que:\n",
      "a) Esta grave afección ocular es más prevalente en pacientes afáquicos.\n",
      "b) El uso de ciclopléjicos tópicos durante el postoperatorio inmediato es un factor de riesgo para esta afección.\n",
      "c) Si hay iridotomía permeable, esta condición no ocurre.\n",
      "d) Normalmente, esta afección se presenta en ojos con un diámetro anteroposterior menor que los de la población general.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) El uso de ciclopléjicos tópicos durante el postoperatorio inmediato es un factor de riesgo para esta afección.\n",
      "\n",
      "Cicloplegics are medications that are used to dilate the pupil and reduce intraocular pressure. However, their use in the immediate postoperative period after trabeculectomy can increase the risk of developing hypotony (low intraocular pressure) and atony (loss of muscle tone in the eye). This can lead to complications such as shallow anterior chamber, choroidal effusion, and vision loss.\n",
      "\n",
      "Therefore, option b is the correct answer.\n",
      "\n",
      "The other options are not correct for the following reasons:\n",
      "\n",
      "* Option a is incorrect because the question states that the patient developed hypotony and atony 15 hours after trabeculectomy, which suggests that the condition is not related to the patient's race or ethnicity.\n",
      "* Option c is incorrect because the presence of iridotomy (a surgical procedure that creates a hole in the iris to improve drainage) does not prevent hypotony and atony from occurring.\n",
      "* Option d is incorrect because there is no evidence to suggest that hypotony and atony are more common in eyes with a smaller diameter than the general population.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Labing-limang oras pagkatapos ngtrabeculectomy, tumaas ang presyon ng mata ng isang phakic na pasyente na may kasamang athalamia. Alin sa mga sumusunod ang tama?\n",
      "a) Ang malubhang kondisyon na ito ay mas karaniwan sa mga pasyenteng walang lente.\n",
      "b) Ang paggamit ng pinapatak na cycloplegic pagkatapos ng operasyon ay isang dahilan kung bakit nangyayari ang komplikasyong ito.\n",
      "c) Kapag may dating iridotomy na ginawa sa pasyente, hindi ito mangyayari.\n",
      "d) Mas nasa panganib ang mga matang mas maliit ang anteroposterior diameter sa kondisyong ito.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) The use of a cycloplegic drug after surgery is a factor that can cause this complication.\n",
      "\n",
      "After a trabeculectomy, the pressure in the eye of a phakic patient with athalamia increased. This complication is more common in patients without lenses. The use of a cycloplegic drug after surgery can cause this complication, as it can increase the pressure in the eye. There is no evidence to suggest that performing an iridotomy in the patient would prevent this complication. The size of the anterior-posterior diameter of the eye is not a factor in this condition.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Paciente fácico evoluiu com quadro de aumento importante da pressão intraocular e atalamia 15 horas após uma trabeculectomia. É correto afirmar que:\n",
      "a)Esse quadro ocular grave é mais prevalente em pacientes afácicos.\n",
      "b)O uso de cicloplégico tópico durante o pós-operatório imediato é fator de risco para esse quadro.\n",
      "c)Se há iridotomia pérvia, esse quadro não ocorre.\n",
      "d)Tipicamente, esse quadro ocorre em olhos com diâmetro anteroposterior menor que os da população em geral.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) The use of topical cycloplegic during the immediate postoperative period is a risk factor for this severe ocular condition.\n",
      "\n",
      "Trabeculectomy is a surgical procedure that creates a new drainage channel in the eye to treat glaucoma. One of the potential complications of this procedure is an increase in intraocular pressure (IOP) and atony, which can lead to vision loss. The use of topical cycloplegics during the immediate postoperative period can increase the risk of this complication.\n",
      "\n",
      "Option a is incorrect because this severe ocular condition is not more prevalent in aflacic patients.\n",
      "\n",
      "Option c is incorrect because the presence of iridotomy does not prevent this condition from occurring.\n",
      "\n",
      "Option d is incorrect because this condition can occur in eyes with a wide range of sizes, not just those with a smaller diopter size than the general population.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Phakic patient evolved with a significant increase in intraocular pressure and athalamia 15 hours after a trabeculectomy. It is correct to say that:\n",
      "a) This severe ocular condition is more prevalent in aphakic patients.\n",
      "b) The use of topical cycloplegic during the immediate postoperative period is a risk factor for this condition.\n",
      "c) If there is a pervious iridotomy, this would not occur.\n",
      "d) Typically, this condition occurs in eyes with an anteroposterior diameter smaller than those of the general population.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) The use of topical cycloplegic during the immediate postoperative period is a risk factor for this condition.\n",
      "\n",
      "Trabeculectomy is a surgical procedure that creates a new drainage channel in the eye to reduce intraocular pressure (IOP) in patients with glaucoma. Athalamia is a complication that can occur after trabeculectomy, characterized by a significant increase in IOP and a shallow anterior chamber. The use of topical cycloplegics during the immediate postoperative period can increase the risk of athalamia, as it can reduce the ability of the ciliary muscles to contract and help maintain the anterior chamber depth.\n",
      "\n",
      "Option a is incorrect because athalamia can occur in both phakic and aphakic patients. Option c is incorrect because the presence of a previous iridotomy may not prevent the occurrence of athalamia. Option d is incorrect because there is no evidence to suggest that eyes with a smaller anteroposterior diameter are more likely to develop athalamia.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 46: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto al glaucoma inducido por corticoides es correcto afirmar que:\n",
      "a) Ocurre en todas las edades.\n",
      "b) Los corticosteroides en bajas concentraciones no aumentan la presión intraocular.\n",
      "c) El glaucoma suele ser de ángulo cerrado.\n",
      "d) Es más común por el uso de corticoides orales que en forma de colirios.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) El glaucoma suele ser de ángulo cerrado.\n",
      "\n",
      "Glaucoma induced by corticosteroids is a type of secondary glaucoma that can occur as a result of the use of corticosteroids, either orally or topically. It is characterized by an increase in intraocular pressure, which can lead to damage to the optic nerve and vision loss.\n",
      "\n",
      "The statement \"El glaucoma suele ser de ángulo cerrado\" is correct because glaucoma induced by corticosteroids typically presents with closed-angle glaucoma, which is characterized by a blockage in the eye's drainage channels, leading to an increase in intraocular pressure.\n",
      "\n",
      "The other options are incorrect because:\n",
      "\n",
      "* a) Ocurre en todas las edades: While glaucoma can occur at any age, it is more common in older adults.\n",
      "* b) Los corticosteroides en bajas concentraciones no aumentan la presión intraocular: This statement is incorrect because even low concentrations of corticosteroids can increase intraocular pressure.\n",
      "* d) Es más común por el uso de corticoides orales que en forma de colirios: This statement is incorrect because the use of corticosteroids in the form of eye drops (colirios) is more likely to cause glaucoma than oral corticosteroids.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod ang tama tungkol sa corticosonic glaucoma?\n",
      "a) Puwedeng mangyari kahit anong edad ng pasyente.\n",
      "b) Kapag mababa ang dose ng corticosteroids, hindi ito nakakataas ng presyon ng mata.\n",
      "c) Ang pangkaraniwang klase ng corticosonic glaucoma ay angle-closure.\n",
      "d) Ito'y madalas dahil sa paggamit ng iniinom na corticosteroids kaysa sa mga pinapatak sa mata.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Corticosonic glaucoma is a type of glaucoma that is caused by the use of corticosteroids, which can increase the pressure in the eye. The correct answer is b) Kapag mababa ang dose ng corticosteroids, hindi ito nakakataas ng presyon ng mata. This means that if the dose of corticosteroids is low, it will not increase the pressure in the eye.\n",
      "\n",
      "The other options are incorrect because:\n",
      "\n",
      "a) Puwedeng mangyari kahit anong edad ng pasyente - This means that corticosonic glaucoma can occur at any age, which is not a correct statement.\n",
      "\n",
      "c) Ang pangkaraniwang klase ng corticosonic glaucoma ay angle-closure - This means that the most common type of corticosonic glaucoma is angle-closure, which is not a correct statement.\n",
      "\n",
      "d) Ito'y madalas dahil sa paggamit ng iniinom na corticosteroids kaysa sa mga pinapatak sa mata - This means that corticosonic glaucoma is often caused by the use of oral corticosteroids rather than topical corticosteroids applied to the eye, which is not a correct statement.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Sobre o glaucoma induzido por corticoesteroide, é correto afirmar que:\n",
      "a)Ocorre em todas as idades.\n",
      "b)Os corticoides em concentrações baixas não elevam a pressão intraocular.\n",
      "c)O glaucoma é tipicamente de ângulo fechado.\n",
      "d)É mais frequente por uso de corticoide via oral do que na forma de colírio.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) O glaucoma é tipicamente de ângulo fechado.\n",
      "\n",
      "Glaucoma induced by corticosteroids is typically closed-angle glaucoma. This is because corticosteroids can cause the angle between the iris and the cornea to become narrow or closed, leading to an increase in intraocular pressure.\n",
      "\n",
      "The other options are incorrect because:\n",
      "\n",
      "a) Glaucoma can occur at any age, not just in older adults.\n",
      "\n",
      "b) Corticosteroids in low concentrations can still elevate intraocular pressure, although the risk is lower compared to higher concentrations.\n",
      "\n",
      "d) Corticosteroid-induced glaucoma is more common with topical application (collyrium) than with oral administration.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding steroid induced glaucoma, it is correct to state that:\n",
      "a) Occurs at all ages.\n",
      "b) Corticosteroids in low concentrations do not increase intraocular pressure.\n",
      "c) Glaucoma is typically angle-closure.\n",
      "d) It is more frequent due to the use of oral corticosteroids than in the form of eye drops.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "La afirmación correcta es: a) Ocurre en todas las edades.\n",
      "\n",
      "Here's the answer in Tagalog:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "Ang tamaan na kasagutan ay: a) Kaya nangyayari sa lahat ng edad.\n",
      "\n",
      "Here's the answer in Portuguese:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "A afirmação correta é: a) Ocorre em todas as idades.\n",
      "\n",
      "Here's the answer in English:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "The correct statement is: a) Occurs at all ages.\n",
      "\n",
      "Explanation: Steroid-induced glaucoma can occur at any age, including children and adults. While corticosteroids in low concentrations may not increase intraocular pressure, prolonged use of these medications can still lead to glaucoma. The type of glaucoma associated with steroid use is typically closed-angle glaucoma, and the risk is higher with oral corticosteroids than with eye drops.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 47: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál de los siguientes defectos del campo visual se correlaciona mejor con la pérdida localizada de la capa de fibras nerviosas peripapilares (signo de Hoyt) en el sector temporal inferior?\n",
      "a) Centrocecal temporal inferior.\n",
      "b) Nasal superior.\n",
      "c) Cuña temporal superior.\n",
      "d) Vertical inferior.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"  // Option c\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) Cuña temporal superior.\n",
      "\n",
      "The Hoyt sign is a clinical sign used in ophthalmology to detect damage to the temporal crescent of the retina, which is associated with the loss of the nasal fibers of the optic nerve. The cuña temporal superior (superior temporal crescent) is the area of the retina that is most closely correlated with the loss of the nasal fibers of the optic nerve and is therefore the best answer.\n",
      "\n",
      "The other options are not correct because they refer to different areas of the visual field or do not relate to the Hoyt sign:\n",
      "\n",
      "* a) Centrocecal temporal inferior (inferior temporal crescent) is a different area of the retina.\n",
      "* b) Nasal superior (superior nasal field) is not specifically related to the Hoyt sign.\n",
      "* d) Vertical inferior (inferior vertical field) is also not specifically related to the Hoyt sign.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga visual field defects na ito ang pangkaraniwang nakikita sa kawalan ng peripapillary nerve fiber layer o Hoyt's sign sa inferior temporal sector?\n",
      "a) Inferior temporal cecal center.\n",
      "b) Upper nasal.\n",
      "c) Wedge-shaped upper temporal.\n",
      "d) Lower vertical.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"  // Wedge-shaped upper temporal\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Hoyt's sign is a clinical sign used in ophthalmology to detect damage to the optic nerve. It is characterized by a wedge-shaped defect in the superior temporal visual field, which can be observed when the patient looks down and inwards. The defect is caused by damage to the peripapillary nerve fiber layer, specifically the inferior temporal sector. Therefore, the correct answer is (c) Wedge-shaped upper temporal.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual dos defeitos de campo visual abaixo melhor se correlaciona com perda localizada da camada de fibras nervosas peripapilar (sinal de Hoyt) no setor temporal inferior?\n",
      "a)Centro-cecal temporal inferior.\n",
      "b)Nasal superior.\n",
      "c)Temporal superior em cunha.\n",
      "d)Vertical inferior.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking which visual field defect best correlates with a localized loss of the papillary fibers in the temporal inferior sector (Hoyt's sign).\n",
      "\n",
      "Option c, \"Temporal superior em cunha,\" is the correct answer. This is because Hoyt's sign is characterized by a localized loss of the papillary fibers in the temporal inferior sector, which can cause a superior temporal quadrantanopia or scotoma.\n",
      "\n",
      "Option a, \"Centro-cecal temporal inferior,\" is incorrect because it refers to a different type of visual field defect, namely a centro-cecal scotoma, which is not associated with Hoyt's sign.\n",
      "\n",
      "Option b, \"Nasal superior,\" is also incorrect because it does not relate to the description of Hoyt's sign.\n",
      "\n",
      "Option d, \"Vertical inferior,\" is incorrect because it does not match the description of Hoyt's sign, which is characterized by a localized loss of papillary fibers in the temporal inferior sector, not a vertical defect.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Which of the visual field defects below best correlates with localized loss of the peripapillary nerve fiber layer (Hoyt's sign) in the inferior temporal sector?\n",
      "a) Inferior temporal cecal center.\n",
      "b) Upper nasal.\n",
      "c) Wedge-shaped upper temporal.\n",
      "d) Lower vertical.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"  // Wedge-shaped upper temporal\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "Hoyt's sign is a localized loss of the peripapillary nerve fiber layer in the inferior temporal sector. This sign is often associated with a wedge-shaped defect in the upper temporal visual field, which is option c.\n",
      "\n",
      "Inferior temporal cecal center (option a) is not typically associated with Hoyt's sign.\n",
      "\n",
      "Upper nasal (option b) is not typically associated with Hoyt's sign.\n",
      "\n",
      "Lower vertical (option d) is not typically associated with Hoyt's sign.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 48: \n",
      "Language: spanish\n",
      "Question: \n",
      "El glaucoma hemosiderótico es causado por:\n",
      "a) Acumulación de macrófagos en la red trabecular.\n",
      "b) Acumulación de células sanguíneas incapaces de diapédesis en la red trabecular.\n",
      "c) Acumulación de hierro presente en la hemoglobina en la red trabecular.\n",
      "d) Obstrucción de la red trabecular por glóbulos rojos frescos, fibrina y plasma.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Glaucoma hemosiderótico is caused by the accumulation of iron in the trabecular meshwork, which is part of the eye's drainage system. This accumulation leads to the formation of iron-containing pigments, which can cause damage to the cells in the area and lead to vision loss. Therefore, option C is the correct answer.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang hemosiderotic glaucoma ay sanhi ng:\n",
      "a) Pag-ipon ng mga macrophage sa trabecular meshwork.\n",
      "b) Pag-ipon ng dugo na walang kakayahang ng diapedesis sa trabecular meshwork.\n",
      "c) Pag-ipon ng iron mula sa hemoglobin sa trabecular meshwork.\n",
      "d) Pagbara ng trabecular meshwork ng mga sariwang red blood cell, fibrin, at plasma.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Ang hemosiderotic glaucoma ay sanhi ng pag-ipon ng iron mula sa hemoglobin sa trabecular meshwork. This is because the trabecular meshwork, which is responsible for draining aqueous humor from the eye, can become clogged with iron from the breakdown of hemoglobin, leading to increased intraocular pressure and potentially causing glaucoma.\n",
      "\n",
      "Therefore, option c) Pag-ipon ng iron mula sa hemoglobin sa trabecular meshwork is the correct answer.\n",
      "\n",
      "Option a) Pag-ipon ng mga macrophage sa trabecular meshwork is incorrect because while macrophages may play a role in the development of glaucoma, they are not the primary cause of hemosiderotic glaucoma.\n",
      "\n",
      "Option b) Pag-ipon ng dugo na walang kakayahang ng diapedesis sa trabecular meshwork is also incorrect because while poor blood flow may contribute to the development of glaucoma, it is not the primary cause of hemosiderotic glaucoma.\n",
      "\n",
      "Option d) Pagbara ng trabecular meshwork ng mga sariwang red blood cell, fibrin, at plasma is incorrect because while inflammation and blood vessel damage may contribute to the development of glaucoma, they are not the primary cause of hemosiderotic glaucoma.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "O glaucoma hemossiderótico é causado por: \n",
      "a) Acúmulo de macrófagos na malha trabecular. \n",
      "b) Acúmulo de células sanguíneas incapazes de diapedese na malha trabecular.  \n",
      "c) Acúmulo de ferro presente na hemoglobina na malha trabecular. \n",
      "d) Entupimento da malha trabecular por hemácias frescas, fibrina e plasma.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c: Acúmulo de ferro presente na hemoglobina na malha trabecular.\n",
      "\n",
      "Glaucoma hemossiderótico is caused by the accumulation of iron in the trabecular meshwork, which is a part of the eye's drainage system. This accumulation can lead to the formation of iron-containing pigments, such as hemosiderin, which can damage the cells in the trabecular meshwork and lead to vision loss.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "* Option a: Acúmulo de macrófagos na malha trabecular (Accumulation of macrophages in the trabecular meshwork) is not the primary cause of glaucoma hemossiderótico. Macrophages are immune cells that can accumulate in the eye in response to inflammation or injury, but they are not the main cause of the condition.\n",
      "* Option b: Acúmulo de células sanguíneas incapazes de diapedese na malha trabecular (Accumulation of blood cells unable to diapedese in the trabecular meshwork) is also not the primary cause of glaucoma hemossiderótico. While blood cells can accumulate in the eye and contribute to the development of the condition, the main cause is the accumulation of iron.\n",
      "* Option d: Entupimento da malha trabecular por hemácias frescas, fibrina e plasma (Blockage of the trabecular meshwork by fresh red blood cells, fibrin, and plasma) is not a correct description of glaucoma hemossiderótico. While inflammation and blockage of the eye's drainage system can contribute to the development of the condition, the primary cause is the accumulation of iron.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Hemosiderotic glaucoma is caused by: \n",
      "a) Accumulation of macrophages in the trabecular meshwork. \n",
      "b) Accumulation of blood cells incapable of diapedesis in the trabecular meshwork. \n",
      "c) Accumulation of iron present in hemoglobin in the trabecular meshwork. \n",
      "d) Clogging of the trabecular meshwork by fresh red blood cells, fibrin and plasma.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "La glaucoma hemosiderótica es causada por:\n",
      "c) Acumulación de hierro presente en la hemoglobina en la red trabecular.\n",
      "\n",
      "Here's the answer in Tagalog:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "Ang glaucoma na may kadahilanan sa dugo ay caused by:\n",
      "c) Acumulación ng hierro na nasa hemoglobina sa trabecular meshwork.\n",
      "\n",
      "Here's the answer in Portuguese:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "A glaucoma hemossiderótica é causada por:\n",
      "c) Acumulação de ferro presente na hemoglobina na rede trabecular.\n",
      "\n",
      "And here's the answer in English:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "Hemosiderotic glaucoma is caused by:\n",
      "c) Accumulation of iron present in hemoglobin in the trabecular meshwork.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 49: \n",
      "Language: spanish\n",
      "Question: \n",
      "Los siguientes son factores de riesgo clásicos para el desarrollo de glaucoma primario de ángulo abierto:\n",
      "a) Asiáticos, antecedentes familiares positivos, jóvenes.\n",
      "b) Presión intraocular elevada, raza caucásica, edad entre 25 y 45 años.\n",
      "c) Presión intraocular elevada, raza negra, antecedentes familiares positivos.\n",
      "d) Sexo femenino, espesor corneal elevado, presión intraocular con amplias fluctuaciones.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option b, \"Presión intraocular elevada, raza caucásica, edad entre 25 y 45 años.\"\n",
      "\n",
      "Glaucoma primario de ángulo abierto (open-angle glaucoma) is a type of glaucoma that is caused by an increase in intraocular pressure (IOP) due to slowed drainage of aqueous humor from the eye. The risk factors for developing open-angle glaucoma include:\n",
      "\n",
      "* Elevated intraocular pressure\n",
      "* Caucasian race\n",
      "* Age between 25 and 45 years\n",
      "\n",
      "Therefore, option b is the correct answer.\n",
      "\n",
      "Option a is incorrect because Asians and young people are not typically considered to be at higher risk for open-angle glaucoma.\n",
      "\n",
      "Option c is incorrect because while African Americans are at higher risk for glaucoma, the risk factor mentioned in this option (antecedentes familiares positivos) refers to a family history of glaucoma, which is not specifically related to open-angle glaucoma.\n",
      "\n",
      "Option d is incorrect because while women are at higher risk for glaucoma, the risk factor mentioned in this option (sexo femenino) is not specifically related to open-angle glaucoma. Additionally, espesor corneal elevado (elevated corneal thickness) and presión intraocular con amplias fluctuaciones (wide fluctuations in intraocular pressure) are not typically considered to be risk factors for open-angle glaucoma.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang mga karaniwang panganib ng pagkaroon ng primary open-angle glaucoma ay:\n",
      "a) Mga Asyano, lahi ng glaucoma, at mga kabataan.\n",
      "b) Mataas na presyon sa mata, mga Caucasian, at ang edad sa pagitan ng 25 hanggang 45 na taon.\n",
      "c) Mataas na presyon sa mata, mga African-American, at may lahi ng glaucoma.\n",
      "d) Mga kababaihan, makapal na corneal thickness, at pabago-bago na presyon ng mata.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option b, \"Mataas na presyon sa mata, mga Caucasian, at ang edad sa pagitan ng 25 hanggang 45 na taon.\"\n",
      "\n",
      "Primary open-angle glaucoma (POAG) is a type of glaucoma that is characterized by an increase in intraocular pressure (IOP) due to the slow flow of aqueous humor out of the eye. The risk factors for developing POAG include:\n",
      "\n",
      "* Elevated IOP\n",
      "* Caucasian race\n",
      "* Age between 25 and 45 years old\n",
      "\n",
      "It is important to note that POAG can affect anyone, regardless of race or ethnicity, but the prevalence is higher among Caucasians. Additionally, the risk of developing POAG increases with age, with the majority of cases occurring in people over the age of 40.\n",
      "\n",
      "Therefore, option b is the correct answer.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "São fatores de risco clássicos para o desenvolvimento de glaucoma primário de ângulo aberto: \n",
      "a) Asiáticos, história familiar positiva, jovens. \n",
      "b) Pressão intraocular elevada, raça caucasiana, idade entre 25 e 45 anos. \n",
      "c) Pressão intraocular elevada, raça negra, história familiar positiva. \n",
      "d) Sexo feminino, espessura corneal elevada, pressão intraocular com ampla flutuação.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Pressão intraocular elevada, raça caucasiana, idade entre 25 e 45 anos.\n",
      "\n",
      "Glaucoma primário de ângulo aberto é uma condição oftalmológica caracterizada por uma elevação da pressão intraocular, que pode levar a danos irreversíveis na retina e ao nervo óptico. Os fatores de risco clássicos para o desenvolvimento de glaucoma primário de ângulo aberto incluem:\n",
      "\n",
      "* Pressão intraocular elevada\n",
      "* Raça caucasiana\n",
      "* Idade entre 25 e 45 anos\n",
      "\n",
      "Portanto, a opção b é a resposta correta.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "The classic risk factors for the development of primary open-angle glaucoma are: \n",
      "a) Asians, positive family history, young people. \n",
      "b) Elevated intraocular pressure, Caucasian race, age between 25 and 45 years. \n",
      "c) Elevated intraocular pressure, black race, positive family history. \n",
      "d) Female gender, increased corneal thickness, intraocular pressure with wide fluctuation.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) Elevated intraocular pressure, Caucasian race, age between 25 and 45 years.\n",
      "\n",
      "Here's the answer in Tagalog:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) Elevated intraocular pressure, Caucasian race, age between 25 and 45 years.\n",
      "\n",
      "Here's the answer in Portuguese:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) Elevated intraocular pressure, Caucasian race, age between 25 and 45 years.\n",
      "\n",
      "And here's the answer in English:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) Elevated intraocular pressure, Caucasian race, age between 25 and 45 years.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 50: \n",
      "Language: spanish\n",
      "Question: \n",
      "Paciente masculino, 25 años, con hipertensión ocular recurrente (entre 40 y 60 mmHg), indolora, unilateral y de corta duración, sin pérdida de visión. ¿Cuáles son los diagnósticos más probables?\n",
      "a) Uveítis heterocrómica de Fuchs.\n",
      "b) Crisis aguda de glaucoma con iris bombé.\n",
      "c) Crisis aguda de glaucoma con iris meseta.\n",
      "d) Crisis glaucomatocíclica.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The patient's symptoms of recurrent unilateral eye pressure between 40 and 60 mmHg, without pain or vision loss, suggest a diagnosis of crisis aguda de glaucoma con iris meseta (acute glaucoma crisis with meseta iris). This is the most likely diagnosis among the options provided.\n",
      "\n",
      "Uveítis heterocrómica de Fuchs (Fuchs' heterochromic uveitis) is a type of uveitis that affects the iris and can cause glaucoma, but it is not typically associated with the sudden onset of eye pressure symptoms as described in the patient's history.\n",
      "\n",
      "Crisis aguda de glaucoma con iris bombé (acute glaucoma crisis with bombe iris) is a medical emergency that requires immediate attention, but it is not the most likely diagnosis based on the patient's symptoms.\n",
      "\n",
      "Crisis glaucomatocíclica (glaucomatous crisis) is a term used to describe a sudden increase in intraocular pressure that can occur in patients with glaucoma, but it is not a specific diagnosis.\n",
      "\n",
      "Therefore, the most appropriate response is option c) Crisis aguda de glaucoma con iris meseta.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "May lalaking pasyente, 25 na taong gulang, na mayroong pabalik-balik na mataas na presyon ng isang mata (40 hanggang 60 mmHg) sa maiikling panahon. Wala siyang kirot na nararamdaman at hindi lumalabo ang paningin. Ano siguro ang diagnosis ng pasyenteng ito?\n",
      "\n",
      "a) Fuchs heterochromic uveitis. \n",
      "b) Atake ng acute glaucoma na may kasamang bombé iris. \n",
      "c) Atake ng acute glaucoma na may kasamang plateau iris. \n",
      "d) Glaucomatocyclic crisis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of recurring high intraocular pressure (40-60 mmHg) over a short period of time, without any noticeable pain or redness, suggest a diagnosis of acute glaucoma with a bombé iris. This is a medical emergency that requires immediate attention to prevent permanent vision loss.\n",
      "\n",
      "Therefore, the correct response is option b) Atake ng acute glaucoma na may kasamang bombé iris.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Paciente masculino, 25 anos, com quadros reincidentes de hipertensão ocular (entre 40 e 60 mmHg), indolor, unilateral e de curta duração, sem baixa de visão. Qual o diagnóstico mais provável? \n",
      "a) Uveíte heterocrômica de Fuchs. \n",
      "b) Crise de glaucoma agudo com íris bombé. \n",
      "c) Crise de glaucoma agudo com íris em plateau. \n",
      "d) Crise glaucomatocíclica.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The most likely diagnosis for a 25-year-old male patient with recurrent episodes of unilateral ocular hypertension (between 40 and 60 mmHg), without pain or vision loss, is a crisis of acute glaucoma with bombé iris. This is a medical emergency that requires immediate attention to prevent permanent vision loss.\n",
      "\n",
      "Therefore, the correct answer is option b) Crise de glaucoma agudo com íris bombé.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Male patient, 25 years old, with recurrent ocular hypertension (between 40 and 60 mmHg), painless, unilateral and of short duration, without loss of vision. Which are the most probable diagnostics? \n",
      "a) Fuchs heterochromic uveitis. \n",
      "b) Attack of acute glaucoma with bombé iris. \n",
      "c) Attack of acute glaucoma with plateau iris. \n",
      "d) Glaucomatocyclic crisis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of recurrent ocular hypertension (between 40 and 60 mmHg), painless, unilateral and of short duration, without loss of vision, are consistent with an attack of acute glaucoma. The bombé iris is a type of glaucoma that is characterized by a sudden and significant increase in intraocular pressure, which can cause pain and blurred vision. Therefore, option b) Attack of acute glaucoma with bombé iris is the most probable diagnosis.\n",
      "\n",
      "It is important to note that Fuchs heterochromic uveitis (option a) is a type of uveitis that affects the iris and can cause hypertension, but it is not typically associated with the sudden and significant increase in intraocular pressure that is characteristic of acute glaucoma. Glaucomatocyclic crisis (option d) refers to a sudden increase in intraocular pressure that can occur in patients with glaucoma, but it is not typically associated with the painless, unilateral, and short-duration symptoms described in the patient's history.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 51: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un paciente diabético de 60 años refiere dolor y mala agudeza visual en el ojo derecho. Al examen oftalmológico la agudeza visual fue de 0,1, la presión intraocular de 45 mmHg, edema corneal, neovascularización del iris, ángulo abierto en todos los cuadrantes en la gonioscopia, relación copa/disco de 0,3 y retinopatía diabética proliferativa. Tras iniciar tratamiento clínico hipotensor presentó buena respuesta. Entre las opciones siguientes, ¿cuál es la conducta más adecuada a seguir?\n",
      "a) Ciclofotocoagulación.\n",
      "b) Implante de drenaje.\n",
      "c) Fotocoagulación panretiniana.\n",
      "d) Trabeculectomía con mitomicina C.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c) Fotocoagulación panretiniana\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms and examination findings are consistent with proliferative diabetic retinopathy (PDR). The patient has severe vision loss, elevated intraocular pressure (45 mmHg), corneal edema, neovascularization of the iris, and an open angle in all quadrants on gonioscopy. The cup-to-disc ratio is 0.3, indicating advanced disease.\n",
      "\n",
      "The best course of action would be to perform panretinal photocoagulation (Option C). This is a laser treatment that targets the peripheral retina to reduce the risk of further vision loss and prevent complications such as retinal detachment or glaucoma.\n",
      "\n",
      "Option A, cyclophotocoagulation, is a laser treatment that targets the ciliary body to reduce intraocular pressure. While this may be necessary in some cases of PDR, it is not the most appropriate treatment for this patient's presentation.\n",
      "\n",
      "Option B, implant of drainage, is not a suitable treatment for PDR.\n",
      "\n",
      "Option D, trabeculectomy with mitomycin C, is a surgical procedure that creates a new drainage channel in the eye to reduce intraocular pressure. While this may be necessary in some cases of glaucoma, it is not the most appropriate treatment for PDR.\n",
      "{'response': 'c) Fotocoagulación panretiniana'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Isang 60 taong gulang na pasyente na may diyabetis ay dumadaing ng kirot at paglabo ng kanang mata. Sa pagsusuri napag-alamang ang visual acuity ay 0.1, intraocular pressure na 45 mmHg, may pamamaga ng cornea, pagbuo ng bagong ugat sa iris, open angle sa lahat ng kwadrant sa gonioscopy, cup:disc ratio na 0.3, at mayroong proliferative diabetic retinopathy. Pagkatapos bigyan ng gamot sa mababang presyon, naging mainam ang pagtanggap ng kanyang katawan dito. Alin sa mga sumusunod ang pinakaangkop na gawain pagkatapos?\n",
      "a) Cyclophotocoagulation.\n",
      "b) Drainage implant.\n",
      "c) Panretinal photocoagulation.\n",
      "d) Trabeculectomy na may mitomycin C.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms and examination findings suggest proliferative diabetic retinopathy (PDR) with severe vision loss. The most appropriate next step would be panretinal photocoagulation (PRP), which is a laser treatment that targets the peripheral retina to reduce the risk of further vision loss.\n",
      "\n",
      "Option a, cyclophotocoagulation, is a laser treatment that targets the ciliary body and is used to reduce intraocular pressure in patients with glaucoma. It is not appropriate for this patient's condition.\n",
      "\n",
      "Option b, drainage implant, is a surgical procedure that involves placing a device in the eye to help drain aqueous humor and reduce intraocular pressure. It is not appropriate for this patient's condition.\n",
      "\n",
      "Option d, trabeculectomy with mitomycin C, is a surgical procedure that involves creating a new drainage channel in the eye and using a medication to prevent scarring. It may be considered in patients with advanced glaucoma, but it is not the most appropriate option for this patient's condition.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Paciente diabético com 60 anos queixa-se de dor e baixa de acuidade visual no olho direito. Ao exame oftalmológico apresenta acuidade visual 0,1, pressão intraocular 45 mmHg, edema de cornea, neovascularização de íris, ângulo aberto em todos os quadrantes na gonioscopia, relação escavação/disco 0,3 e retinopatia diabética proliferativa. Após iniciar tratamento clínico hipotensor, apresentou boa resposta. Dentre as opções abaixo, qual é a conduta mais adequada a seguir? \n",
      "a) Ciclofotocoagulação. \n",
      "b) Implante de drenagem. \n",
      "c) Panfotocoagulação retiniana. \n",
      "d) Trabeculectomia com mitomicina C.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms and examination findings are consistent with diabetic retinopathy, specifically proliferative diabetic retinopathy (PDR). The presence of neovascularization of the iris, open angles in all quadrants on gonioscopy, and retinopathy suggest this diagnosis.\n",
      "\n",
      "The best course of action would be to perform panretinal photocoagulation (option c), which is a laser treatment that targets the peripheral retina to reduce the risk of further neovascularization and prevent vision loss.\n",
      "\n",
      "Ciclofotocoagulation (option a) is a laser treatment that targets the ciliary body and is used to treat glaucoma, not diabetic retinopathy. Implantation of a drainage device (option b) is not indicated for this patient's condition. Trabeculectomia with mitomycin C (option d) is a surgical procedure that is used to treat glaucoma and is not appropriate for diabetic retinopathy.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "A 60-year-old diabetic patient complains of pain and low visual acuity in the right eye. On ophthalmological examination, visual acuity was 0.1, intraocular pressure 45 mmHg, corneal edema, iris neovascularization, open angle in all quadrants on gonioscopy, cup/disc ratio 0.3, and proliferative diabetic retinopathy. After initiating hypotensive clinical treatment, the patient had a good response. Among the options below, which is the most appropriate course of action to follow? \n",
      "a) Cyclophotocoagulation. \n",
      "b) Drainage implant. \n",
      "c) Panretinal photocoagulation. \n",
      "d) Trabeculectomy with mitomycin C.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms and examination findings suggest advanced proliferative diabetic retinopathy (PDR) with severe vision loss. The most appropriate course of action would be panretinal photocoagulation (PRP), which is a laser treatment that targets the peripheral retina to reduce the risk of further vision loss.\n",
      "\n",
      "Option a, cyclophotocoagulation, is a laser treatment that targets the ciliary body and is used to reduce intraocular pressure in patients with glaucoma. It is not appropriate for this patient's condition.\n",
      "\n",
      "Option b, drainage implant, is a surgical procedure that involves placing a device in the eye to help drain aqueous humor and reduce intraocular pressure. It is not appropriate for this patient's condition.\n",
      "\n",
      "Option d, trabeculectomy with mitomycin C, is a surgical procedure that involves creating a new drainage channel in the eye and using mitomycin C to prevent scarring. It may be considered in patients with advanced glaucoma, but it is not the most appropriate option for this patient's condition.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 52: \n",
      "Language: spanish\n",
      "Question: \n",
      "Entre las opciones siguientes, ¿cuál sería el hallazgo más sugerente para un glaucoma?\n",
      "a) Asimetría de excavación de 0,2 entre los ojos.\n",
      "b) Atrofia peripapilar con zona alfa en la región temporal del nervio.\n",
      "c) Relación copa/disco bilateral de 0,5.\n",
      "d) Relación copa/disco del nervio óptico de 0,4 con presencia de una escotadura temporal inferior.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option b: Atrofia peripapilar con zona alfa en la región temporal del nervio.\n",
      "\n",
      "Glaucoma is a group of eye conditions that damage the optic nerve, leading to vision loss and blindness. One of the common findings in glaucoma is the presence of atrophy of the retinal nerve fiber layer, which can be detected by imaging tests such as optical coherence tomography (OCT). The presence of atrophy in the peripapillary region (around the optic disc) with a zone of alpha (a ring-shaped area of increased signal intensity) in the temporal (side) region of the optic nerve head is a suggestive finding for glaucoma.\n",
      "\n",
      "Therefore, option b is the correct answer.\n",
      "\n",
      "Option a, asymmetry of excavation of 0.2 between the eyes, may also be a sign of glaucoma, but it is not as specific as option b.\n",
      "\n",
      "Option c, ratio of cup/disc bilateral of 0.5, is a normal finding and does not suggest glaucoma.\n",
      "\n",
      "Option d, ratio of cup/disc of the optic nerve of 0.4 with the presence of a temporal inferior notch, may also be a sign of glaucoma, but it is not as specific as option b.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod ang pinakanagpapahiwatig ng glaucoma?\n",
      "a) Cupping asymmetry na 0.2 sa pagitan ng mga mata.\n",
      "b) Peripapillary atrophy na may alpha zone sa temporal na parte ng nerve. \n",
      "c) Bilateral excavation/disk ratio na 0.5.\n",
      "d) Optic nerve cup/disk ratio na 0.4 na may kasamang inferior temporal notch.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Peripapillary atrophy na may alpha zone sa temporal na parte ng nerve.\n",
      "\n",
      "Glaucoma is a group of eye conditions that damage the optic nerve, which carries visual information from the eye to the brain. One of the most common forms of glaucoma is open-angle glaucoma, which is often asymptomatic in its early stages. The question asks about the most characteristic feature of open-angle glaucoma, and the correct answer is b) Peripapillary atrophy na may alpha zone sa temporal na parte ng nerve.\n",
      "\n",
      "Peripapillary atrophy refers to the degeneration of the retinal cells around the optic disc, which can be seen in open-angle glaucoma. The alpha zone is a specific area of the retina that is often affected in glaucoma, and it is located in the temporal (outer) part of the retina. Therefore, option b is the correct answer.\n",
      "\n",
      "Option a, cupping asymmetry, is not a characteristic feature of open-angle glaucoma. Option c, bilateral excavation/disk ratio, is also not a characteristic feature of open-angle glaucoma. Option d, optic nerve cup/disk ratio, may be seen in glaucoma, but it is not the most characteristic feature of open-angle glaucoma.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Dentre as opções abaixo, qual seria o achado mais sugestivo de glaucoma? \n",
      "a) Assimetria de escavação de 0,2 entre os olhos. \n",
      "b) Atrofia peripapilar com zona alfa na região temporal do nervo. \n",
      "c) Relação escavação/disco bilateral de 0,5. \n",
      "d) Relação escavação/disco do nervo óptico de 0,4 com a presença de um notch temporal inferior.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) Atrofia peripapilar com zona alfa na região temporal do nervo.\n",
      "\n",
      "Glaucoma is a group of eye conditions that damage the optic nerve, leading to vision loss and blindness. One of the most common forms of glaucoma is open-angle glaucoma, which is often asymptomatic in its early stages. The query in Portuguese asks for the most suggestive finding of glaucoma, and the correct answer is b) Atrofia peripapilar com zona alfa na região temporal do nervo.\n",
      "\n",
      "Atrofia peripapilar refers to the degeneration of the retinal ganglion cells in the peripapillary region, which is the area surrounding the optic disc. This degeneration can lead to a loss of vision in the peripheral field. The presence of a zona alfa, which is a ring-shaped area of increased reflectivity in the fundus of the eye, is also a common finding in glaucoma. The combination of atrofia peripapilar and zona alfa in the temporal region of the optic nerve is a strong indication of glaucoma.\n",
      "\n",
      "Therefore, option b) Atrofia peripapilar com zona alfa na região temporal do nervo is the most appropriate response.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Among the options below, which would be the most suggestive finding of glaucoma? \n",
      "a) Cupping asymmetry of 0.2 between the eyes. \n",
      "b) Peripapillary atrophy with alpha zone in the temporal region of the nerve. c) Bilateral excavation/disk ratio of 0.5. \n",
      "d) Optic nerve cup/disk ratio of 0.4 with the presence of an inferior temporal notch.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The most suggestive finding of glaucoma would be peripapillary atrophy with alpha zone in the temporal region of the nerve. This is because peripapillary atrophy is a common finding in glaucoma and the presence of an alpha zone in the temporal region is highly specific for the disease. Cupping asymmetry and bilateral excavation/disk ratio can also be indicative of glaucoma, but they are not as specific as peripapillary atrophy with an alpha zone. Optic nerve cup/disk ratio is a useful diagnostic indicator, but it is not as sensitive as the other findings mentioned. Therefore, option b is the most suggestive finding of glaucoma.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 53: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿En cuál de las siguientes situaciones se debe evitar el uso tópico de colirios con alfa-2-agonista, como el tartarato de brimonidina?\n",
      "a) Niños menores de dos años.\n",
      "b) Litiasis renal.\n",
      "c) Asma.\n",
      "d) Anemia falciforme.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question asks in which situation the use of topical alpha-2 agonists, such as brimonidine tartrate, should be avoided. The correct answer is b) Litiasis renal (kidney stones). Alpha-2 agonists can increase the risk of kidney stones by increasing the concentration of certain minerals in the urine, such as calcium and oxalate. Therefore, it is not recommended to use these medications in patients with kidney stones.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "* a) Niños menores de dos años (children under two years old): There is no specific contraindication for the use of alpha-2 agonists in this age group.\n",
      "* c) Asma (asthma): Alpha-2 agonists can be used to treat asthma, and brimonidine tartrate is actually used to treat asthma and other respiratory conditions.\n",
      "* d) Anemia falciforme (sickle cell anemia): There is no specific contraindication for the use of alpha-2 agonists in patients with sickle cell anemia.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang paggamit ng alpha-2-agonist na pampatak sa mata, tulad ng brimonidine tartrate, ay dapat iwasan sa aling sitwasyon?\n",
      "a) Mga batang wala pang dalawang taong gulang.\n",
      "b) Renal lithiasis\n",
      "c) Hika\n",
      "d) Sickle cell anemia\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Brimonidine tartrate, an alpha-2-agonist, is contraindicated in patients with renal lithiasis (kidney stones) because it may increase the risk of stone formation. Therefore, option b) Renal lithiasis is the correct answer.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "a) Mga batang wala pang dalawang taong gulang (Children under the age of two) is not a contraindication for brimonidine tartrate.\n",
      "\n",
      "c) Hika (Hiccup) is not a contraindication for brimonidine tartrate.\n",
      "\n",
      "d) Sickle cell anemia is not a contraindication for brimonidine tartrate.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "O uso tópico de colírio de alfa-2-agonista, como tartarato de brimonidina, deve ser evitado em qual situação, dentre as abaixo? \n",
      "a) Crianças abaixo de dois anos. \n",
      "b) Litíase renal. \n",
      "c) Asma. \n",
      "d) Anemia falciforme.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option A, \"Crianças abaixo de dois anos\" (Children under the age of two). Topical alpha-2 agonists, such as brimonidine tartrate, should be avoided in this age group due to the risk of systemic absorption and potential adverse effects on the developing brain and nervous system.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "\n",
      "Topical use of alpha-2-agonist eye drops, such as brimonidine tartrate, should be avoided in which of the following situations? \n",
      "a) Children under two years old. \n",
      "b) Renal lithiasis. \n",
      "c) Asthma. \n",
      "d) Sickle cell anemia.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Topical alpha-2-agonist eye drops, such as brimonidine tartrate, should be avoided in children under two years old because their tear ducts are not fully developed, and the medication may not be effective or safe for use in this age group.\n",
      "\n",
      "In renal lithiasis (kidney stones), asthma, and sickle cell anemia, topical alpha-2-agonist eye drops may be used with caution and under the guidance of a healthcare professional. However, it is important to note that the medication may not be appropriate for all patients with these conditions, and the decision to use it should be made on a case-by-case basis.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 54: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Qué hallazgo se asocia más comúnmente con el glaucoma congénito primario?\n",
      "a) Edema del nervio óptico.\n",
      "b) Roturas de la membrana de Descemet.\n",
      "c) Luxación del cristalino.\n",
      "d) Sinequias periféricas anteriores en tienda.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option A: Edema del nervio óptico (Optic nerve edema). Glaucoma congénito primario (Primary congenital glaucoma) is a rare condition that occurs when the eye's drainage channels do not develop properly, leading to increased intraocular pressure and damage to the optic nerve. Optic nerve edema is a common finding in patients with primary congenital glaucoma.\n",
      "{'response': 'a'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod ang pinakakaraniwang pahiwatig ng pangunahing konhenital na glaucoma?\n",
      "a) Pamamaga ng optic nerve\n",
      "b) Pagkasira ng Descemet's membrane\n",
      "c) Dislokasyon ng lente\n",
      "d) Tent-like peripheral anterior synechiae.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The most common complication of primary congenital glaucoma is damage to the optic nerve, which can lead to vision loss. This is option (a) in the question.\n",
      "\n",
      "Option (b) refers to a complication that can occur in some cases of primary congenital glaucoma, which is a tear in the Descemet's membrane.\n",
      "\n",
      "Option (c) is not a complication of primary congenital glaucoma, but rather a possible symptom of the condition, which is the dislocation of the lens.\n",
      "\n",
      "Option (d) is also not a complication of primary congenital glaucoma, but rather a sign that can be observed in some cases, which is the tent-like peripheral anterior synechiae.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual achado é mais comumente associado ao glaucoma congênito primário? \n",
      "a) Edema de nervo óptico. \n",
      "b) Rupturas na membrana de Descemet. \n",
      "c) Luxação do cristalino. \n",
      "d) Sinéquias anteriores periféricas em tenda.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option A: Edema de nervo óptico (Optic nerve edema). Glaucoma congênito primário (Primary congenital glaucoma) is a rare condition that affects the development of the eye's drainage system, leading to increased intraocular pressure and damage to the optic nerve. Optic nerve edema is a common finding in patients with primary congenital glaucoma.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "Which finding is most commonly associated with primary congenital glaucoma? \n",
      "a) Optic nerve edema. \n",
      "b) Ruptures in Descemet's membrane. \n",
      "c) Dislocation of the lens. \n",
      "d) Tent-like peripheral anterior synechiae.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is d) Tent-like peripheral anterior synechiae.\n",
      "\n",
      "Primary congenital glaucoma is a rare condition that occurs when the eye's drainage system does not develop properly during fetal development. This can lead to increased pressure in the eye, which can cause damage to the optic nerve and result in vision loss. Tent-like peripheral anterior synechiae, which are adhesions between the iris and the cornea, are a common finding in primary congenital glaucoma. They are caused by the abnormal growth of the iris and can help to diagnose the condition.\n",
      "\n",
      "The other options are not as commonly associated with primary congenital glaucoma:\n",
      "\n",
      "* a) Optic nerve edema is a possible complication of primary congenital glaucoma, but it is not a defining characteristic.\n",
      "* b) Ruptures in Descemet's membrane are a possible complication of primary congenital glaucoma, but they are not a common finding.\n",
      "* c) Dislocation of the lens is not a common finding in primary congenital glaucoma.\n",
      "\n",
      "Therefore, the correct answer is d) Tent-like peripheral anterior synechiae.\n",
      "{'response': 'd'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 55: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto al ensayo del agujero estenopeico, es correcto afirmar:\n",
      "a) Si la agudeza visual del paciente no mejora, se trata de ambliopía.\n",
      "b) Disminuye la profundidad de enfoque, debido a la reducción de la pupila.\n",
      "c) Reduce los círculos de difusión en la retina.\n",
      "d) El tamaño del agujero estenopeico debe estar entre 4 y 5 mm.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Disminuye la profundidad de enfoque, debido a la reducción de la pupila.\n",
      "\n",
      "The Stenopic hole test is used to assess the visual acuity of a patient, and it works by reducing the size of the pupil, which in turn reduces the depth of focus. This allows the examiner to assess the patient's visual acuity at a specific distance.\n",
      "\n",
      "Option a is incorrect because amblyopia is a condition where the visual acuity of one eye is significantly worse than the other, and it is not related to the size of the pupil or the depth of focus.\n",
      "\n",
      "Option c is incorrect because the Stenopic hole test does not affect the circles of diffusion in the retina.\n",
      "\n",
      "Option d is incorrect because the size of the Stenopic hole should be between 3 and 4 mm, not between 4 and 5 mm.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod ang tamang pahayag patungkol sa pinhole test?\n",
      "a) Kung hindi bumuti ang kalagayan ng panlalabo ng mata, ito ay amblyopia\n",
      "b) Ang pagbawas sa lalim ng pokus ay dahil sa pagbawas sa pupil\n",
      "c) Nababawasan ng mga diffusion circles sa retina\n",
      "d) Ang laki ng butas ng pinhole ay dapat nasa pagitan ng 4 at 5 mm.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option C, \"Nababawasan ng mga diffusion circles sa retina.\"\n",
      "\n",
      "The pinhole test is used to assess the visual acuity of a patient, particularly in children. It involves covering one eye and using a pinhole to occlude the pupil of the other eye. The patient is then asked to read an eye chart or identify objects at a distance. The pinhole creates a diffuse image on the retina, which can help to identify amblyopia or other visual problems.\n",
      "\n",
      "Option A, \"Kung hindi bumuti ang kalagayan ng panlalabo ng mata, ito ay amblyopia,\" is incorrect because amblyopia is not the only possible cause of poor visual acuity.\n",
      "\n",
      "Option B, \"Ang pagbawas sa lalim ng pokus ay dahil sa pagbawas sa pupil,\" is incorrect because the size of the pupil is not the only factor that affects the visual acuity.\n",
      "\n",
      "Option D, \"Ang laki ng butas ng pinhole ay dapat nasa pagitan ng 4 at 5 mm,\" is incorrect because the size of the pinhole is not the only factor that affects the visual acuity.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Sobre o teste do buraco estenopeico, é correto afirmar: \n",
      "a) Se a acuidade visual do paciente não melhorar, trata-se de um caso de ambliopia. \n",
      "b) Diminui a profundidade de foco, por haver redução da pupila. \n",
      "c) Reduz os círculos de difusão na retina. \n",
      "d) O tamanho do buraco estenopeico deve ser entre 4 e 5 mm.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Diminui a profundidade de foco, por haver redução da pupila.\n",
      "\n",
      "The Stenopic hole test is used to assess the visual acuity of a patient, and it works by reducing the size of the pupil, which in turn reduces the amount of light that enters the eye. This allows the patient to see the object being observed more clearly. Therefore, option b is the correct answer.\n",
      "\n",
      "Option a is incorrect because amblyopia is a condition where the brain favors one eye over the other, leading to poorer vision in the non-dominant eye. While the Stenopic hole test can help diagnose amblyopia, it is not directly related to the condition.\n",
      "\n",
      "Option c is also incorrect because the Stenopic hole test does not affect the circulation of diffusion in the retina.\n",
      "\n",
      "Option d is incorrect because the size of the Stenopic hole is not a diagnostic criterion for amblyopia. The size of the hole can vary depending on the individual and the severity of the condition.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding the pinhole test, it is correct to state: \n",
      "a) If the patient's visual acuity does not improve, it is a case of amblyopia. \n",
      "b) Decrease the depth of focus, due to the reduction of the pupil. \n",
      "c) Reduces diffusion circles on the retina. \n",
      "d) The size of the pinhole hole should be between 4 and 5 mm.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "La respuesta correcta es b) Disminuir la profundidad de enfocamiento, debido a la reducción de la pupila.\n",
      "\n",
      "The correct answer is b) Decrease the depth of focus, due to the reduction of the pupil.\n",
      "\n",
      "Here's the answer in Tagalog:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "Ang tamaan na korekto ay b) Ang pagsasama ng profundidad ng enfocamiento, dahil sa pagsubok ng pupila.\n",
      "\n",
      "The correct answer is b) Decrease the depth of focus, due to the reduction of the pupil.\n",
      "\n",
      "Here's the answer in Portuguese:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "A resposta correta é b) Diminuir a profundidade de foco, devido à redução da pupila.\n",
      "\n",
      "The correct answer is b) Decrease the depth of focus, due to the reduction of the pupil.\n",
      "\n",
      "And here's the answer in English:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "The correct answer is b) Decrease the depth of focus, due to the reduction of the pupil.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 56: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto a la tabla de Snellen, es correcto afirmar:\n",
      "a) Agudeza visual de 0,05 en un ojo permite tener permiso de conducir profesional letra D.\n",
      "b) La facectomía con implante de lente intraocular es necesaria en pacientes fáquicos con agudezas visuales de 1,5 con mejor corrección.\n",
      "c) El paciente con una agudeza visual de 0,25 tiene un ángulo visual de 0,5 minutos.\n",
      "d) El paciente con una agudeza visual de 0,2 tiene baja visión.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "According to the Snellen chart, it is correct to say that a patient with a visual acuity of 1.5 with better correction requires a facectomy with intraocular lens implant. This is option B.\n",
      "\n",
      "Option A is incorrect because a visual acuity of 0.05 in one eye does not permit professional driving, as the legal requirement is a visual acuity of at least 0.3 in the better eye for driving.\n",
      "\n",
      "Option C is incorrect because a visual acuity of 0.25 does not correspond to an angle of 0.5 minutes. The angle of vision is calculated as 360/agudeza visual, so for a visual acuity of 0.25, the angle would be 360/0.25 = 1440 minutes, not 0.5 minutes.\n",
      "\n",
      "Option D is incorrect because a visual acuity of 0.2 does not necessarily mean that the patient has low vision. Low vision is typically defined as a visual acuity of 20/200 or worse, which corresponds to an agudeza visual of 0.125 in the Snellen chart.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod ang tamang pahayag patungkol sa Snellen chart?\n",
      "a) Pinapayagang magkaroon ng propesyonal na lisensyang pangmaneho, class D ang isang tao kung ang visual acuity ng isang mata ay 0.05 \n",
      "b) Ang facectomy na may pagtatanim ng isang intraocular lens ay kinakailangan sa mga pasyente ng phakic na may visual acuity na 1.5 na may pinakamahusay na pagkakaayos.\n",
      "c) Ang pasyente na may visual acuity na 0.25 ay may isang visual na anggulo na 0.5 minuto.\n",
      "d) Ang pasyente na may visual acuity na 0.2 ay may subnormal na paningin.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the correct statement regarding the Snellen chart.\n",
      "\n",
      "Option A is incorrect because it refers to the requirement for a professional driver's license, which is not related to the Snellen chart.\n",
      "\n",
      "Option B is incorrect because it refers to the need for cataract surgery with an intraocular lens implant for patients with a visual acuity of 1.5, which is not related to the Snellen chart.\n",
      "\n",
      "Option C is correct because it states that a patient with a visual acuity of 0.25 has a visual angle of 0.5 minute, which is a correct interpretation of the Snellen chart.\n",
      "\n",
      "Option D is incorrect because it states that a patient with a visual acuity of 0.2 has subnormal vision, which is not a correct interpretation of the Snellen chart.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação à tabela de Snellen, é correto afirmar: \n",
      "a) A acuidade visual de 0,05 em um olho permite a carteira profissional de direção letra D. \n",
      "b) É necessária a facectomia com implante de lente intraocular em pacientes fácicos com acuidades visuais de 1,5 com a melhor correção. \n",
      "c) O paciente com acuidade visual de 0,25 tem um ângulo visual de 0,5 minuto. \n",
      "d) O paciente com acuidade visual de 0,2 tem visão subnormal.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the Snellen chart, which is a chart used to measure visual acuity. The chart has a series of letters and numbers that get progressively smaller as you move down the chart. The line with the smallest letters that a person can read accurately is used to determine their visual acuity.\n",
      "\n",
      "The correct answer is b) É necessária a facectomia com implante de lente intraocular em pacientes fácicos com acuidades visuais de 1,5 com a melhor correção.\n",
      "\n",
      "This answer choice states that patients with a visual acuity of 1.5 with the best correction (i.e., using glasses or contact lenses) require a facectomy with implantation of an intraocular lens. This is because a visual acuity of 1.5 is considered subnormal and cannot be corrected with glasses or contact lenses alone. A facectomy is a surgical procedure that involves removing the natural lens of the eye and replacing it with an artificial lens to improve vision.\n",
      "\n",
      "The other answer choices are not correct for the following reasons:\n",
      "\n",
      "a) A acuidade visual de 0,05 em um olho permite a carteira profissional de direção letra D. - This answer choice states that a visual acuity of 0.05 in one eye allows for a professional driver's license with a restriction to drive only during the day. However, this is not correct, as a visual acuity of 0.05 is considered severely impaired and would not meet the requirements for a driver's license.\n",
      "\n",
      "c) O paciente com acuidade visual de 0,25 tem um ângulo visual de 0,5 minuto. - This answer choice states that a patient with a visual acuity of 0.25 has a visual angle of 0.5 minutes. However, this is not correct, as the visual angle is not directly related to the visual acuity. The visual angle is the angle subtended by the object being viewed, while the visual acuity is a measure of the sharpness of vision.\n",
      "\n",
      "d) O paciente com acuidade visual de 0,2 tem visão subnormal. - This answer choice states that a patient with a visual acuity of 0.2 has subnormal vision. While it is true that a visual acuity of 0.2 is considered subnormal, it is not the most appropriate answer choice for the question being asked. The question is asking about the appropriate treatment for a patient with a visual acuity of 1.5, not about the definition of subnormal vision.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "With regard to the Snellen chart, it is correct to state: \n",
      "a) A visual acuity of 0.05 in one eye allows for a professional D driver's license. \n",
      "b) Facectomy with implantation of an intraocular lens is necessary in phakic patients with visual acuity of 1.5 with the best fix. \n",
      "c) The patient with a visual acuity of 0.25 has a visual angle of 0.5 minutes.\n",
      "d) The patient with a visual acuity of 0.2 has subnormal vision.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "La respuesta correcta es d) El paciente con una agudeza visual de 0.2 tiene una visión subnormal.\n",
      "\n",
      "Here's the answer in Tagalog:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "Ang tamang sagot ay d) Ang pasyente na may agudeza visual na 0.2 ay may isang subnormal na vision.\n",
      "\n",
      "Here's the answer in Portuguese:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "A resposta correta é d) O paciente com uma agudeza visual de 0.2 tem uma visão subnormal.\n",
      "\n",
      "Here's the answer in English:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "The correct answer is d) The patient with a visual acuity of 0.2 has subnormal vision.\n",
      "{'response': 'd'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 57: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál de los siguientes materiales tiene el índice de Abbe más alto?\n",
      "a) resina CR-39\n",
      "b) Trivex.\n",
      "c) Resina de alto índice.\n",
      "d) Policarbonato.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c) Resina de alto índice\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question asks for the material with the highest Abbe number, which is a measure of the refractive index of a material. The correct answer is (c) Resina de alto índice, which means \"high-index resin\" in Spanish. This material has a higher refractive index than the other options, making it the best choice for correcting vision problems.\n",
      "\n",
      "Note:\n",
      "\n",
      "* (a) Resina CR-39 is a type of plastic lens material that has a relatively low Abbe number.\n",
      "* (b) Trivex is a type of plastic lens material that has a slightly higher Abbe number than CR-39 but still lower than high-index resin.\n",
      "* (d) Policarbonato is a type of plastic lens material that has a lower Abbe number than high-index resin.\n",
      "{'response': 'c) Resina de alto índice'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga materyales ang may pinakamataas na Abbe index?\n",
      "a) CR-39 dagta\n",
      "b) Tivex.\n",
      "c) High index resin.\n",
      "d) Polycarbonate.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c) High index resin.\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The Abbe index is a measure of the refractive index of a material, with higher values indicating a greater ability to bend light. High index resin has a higher Abbe index than the other options, making it the best choice for correcting vision problems that require a high refractive index.\n",
      "\n",
      "CR-39 dagta and polycarbonate are both materials used in ophthalmic lenses, but they have lower Abbe indices than high index resin. Trivex is a brand name for a type of high index resin, but it is not the correct answer in this case.\n",
      "{'response': 'c) High index resin.'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual dos materiais abaixo apresenta maior índice Abbe? \n",
      "a) Resina CR-39 \n",
      "b) Trivex. \n",
      "c) Resina de alto índice. \n",
      "d) Policarbonato.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c) Resina de alto índice\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking which material has the highest Abbe number. The Abbe number is a measure of the refractive index of a material.\n",
      "\n",
      "Option a, Resina CR-39, has an Abbe number of 58.\n",
      "\n",
      "Option b, Trivex, has an Abbe number of 45.\n",
      "\n",
      "Option c, Resina de alto índice, has an Abbe number of 65.\n",
      "\n",
      "Option d, Policarbonato, has an Abbe number of 45.\n",
      "\n",
      "Therefore, the correct answer is option c, Resina de alto índice, which has the highest Abbe number.\n",
      "{'response': 'c) Resina de alto índice'}\n",
      "Language: english\n",
      "Question: \n",
      "Which of the materials below has the highest Abbe index? \n",
      "a) CR-39 resin \n",
      "b) Trivex. \n",
      "c) High index resin. \n",
      "d) Polycarbonate.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c) High index resin\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The Abbe index is a measure of the refractive index of a material, with higher values indicating a greater ability to bend light. Of the options listed, high index resin has the highest Abbe index, typically ranging from 45 to 55.\n",
      "\n",
      "CR-39 resin has an Abbe index of around 39, Trivex has an Abbe index of around 40, and polycarbonate has an Abbe index of around 30.\n",
      "\n",
      "Therefore, the correct answer is (c) High index resin.\n",
      "{'response': 'c) High index resin'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 58: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un paciente de 65 años, miope -1,00 dioptrías esféricas en ambos ojos, puede leer a 66 cm, sin corrección cristalina. ¿Cuál es su rango de acomodación y qué grado de gafas le basta para leer a 33 cm, respectivamente?\n",
      "a) 0,50 dioptrías esféricas; +1,00 dioptrías esféricas.\n",
      "b) 0,50 dioptrías esféricas; +1,50 dioptrías esféricas.\n",
      "c) 1,00 dioptrías esféricas; +1,50 dioptrías esféricas.\n",
      "d) 1,00 dioptrías esféricas; +2,00 dioptrías esféricas.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's current prescription is -1.00 diopters spherical in both eyes, and they can read at 66 cm without correction. To determine the range of accommodation, we need to calculate the near point of the patient.\n",
      "\n",
      "The near point is calculated using the formula:\n",
      "\n",
      "Near point = (Patient's age in years x 0.02) + 20\n",
      "\n",
      "In this case, the patient is 65 years old, so the near point would be:\n",
      "\n",
      "Near point = (65 x 0.02) + 20 = 33 cm\n",
      "\n",
      "The patient can read at 66 cm without correction, which means they have a remaining accommodation of 33 - 66 = -33 cm.\n",
      "\n",
      "To determine the degree of correction needed to read at 33 cm, we can use the following formula:\n",
      "\n",
      "Correction = (Near point - Far point) / 2\n",
      "\n",
      "In this case, the far point is 66 cm, so the correction would be:\n",
      "\n",
      "Correction = (33 - 66) / 2 = -0.50 diopters\n",
      "\n",
      "Therefore, the patient needs a correction of -0.50 diopters to read at 33 cm.\n",
      "\n",
      "The correct answer is option b: 0.50 dioptrías esféricas; +1.00 dioptrías esféricas. This means that the patient needs a spherical correction of 0.50 diopters in both eyes to read at 33 cm, and a spherical correction of +1.00 diopter in both eyes to read at a distance of 66 cm.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang isang 65 taong gulang na pasyenteng myopic na may sukat -1.00 spherical diopters sa parehong mga mata, at nakakapagbasa sa layo na 66 cm nang walang pagwawasto ng lens. Ano ang kanyang accommodative range at kung ano ang sapat na salamin sa mata na basahin ng siya ay makapagbasa sa layo na 33 cm? \n",
      "a) 0.50 spherical diopters; +1.00 spherical diopters.\n",
      "b) 0.50 spherical diopters; +1.50 spherical diopters.\n",
      "c) 1.00 spherical diopters; +1.50 spherical diopters.\n",
      "d) 1.00 spherical diopters; +2.00 spherical diopters.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient is myopic, which means they have a negative spherical diopter value. The patient's spherical diopter value is -1.00, and they can read at a distance of 66 cm without any correction.\n",
      "\n",
      "To calculate the accommodative range, we need to subtract the near vision distance (33 cm) from the far vision distance (66 cm). This gives us a range of 33 cm.\n",
      "\n",
      "Since the patient's spherical diopter value is negative, we need to add a positive diopter value to their near vision correction to calculate the accommodative range. We can add +1.50 spherical diopters to their near vision correction, which gives us a total of +0.50 spherical diopters (1.50 - 1.00 = 0.50).\n",
      "\n",
      "Therefore, the patient's accommodative range is 0.50 spherical diopters, and their near vision correction is +1.50 spherical diopters.\n",
      "\n",
      "The correct answer is option b: 0.50 spherical diopters; +1.50 spherical diopters.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Um paciente de 65 anos, míope de -1,00 dioptrias esfericas em ambos olhos, consegue ler a 66 cm, sem correção de lentes. Qual a sua amplitude acomodativa e qual grau de óculos é suficiente para ele ler a 33 cm, respectivamente? \n",
      "a) 0,50 dioptrias esfericas; +1,00 dioptrias esfericas. \n",
      "b) 0,50 dioptrias esfericas; +1,50 dioptrias esfericas. \n",
      "c) 1,00 dioptrias esfericas; +1,50 dioptrias esfericas. \n",
      "d) 1,00 dioptrias esfericas; +2,00 dioptrias esfericas.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient is 65 years old, myopic with -1.00 diopters spherical in both eyes, and can read at 66 cm without correction. To calculate the amplitude of accommodation, we need to subtract the near vision distance (33 cm) from the far vision distance (66 cm):\n",
      "\n",
      "Amplitude of accommodation = 66 cm - 33 cm = 33 cm\n",
      "\n",
      "Since the patient's near vision is already corrected with -1.00 diopters spherical lenses, we need to add the amplitude of accommodation to the near vision correction to determine the sufficient correction for reading at 33 cm:\n",
      "\n",
      "Sufficient correction = -1.00 diopters spherical + 33 cm = -1.00 + 33 = 32 diopters spherical\n",
      "\n",
      "Therefore, the correct answer is option b: 0.50 diopters espherical; +1.50 diopters espherical. This means that the patient needs a prescription of 0.50 diopters spherical for distance vision and +1.50 diopters spherical for near vision to read at 33 cm.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "A 65-year-old patient, myopic to -1.00 spherical diopters in both eyes, can read at 66 cm without lens correction. What is his accommodative range and what eyeglasses are sufficient for him to read at 33 cm, respectively? \n",
      "a) 0.50 spherical diopters; +1.00 spherical diopters. \n",
      "b) 0.50 spherical diopters; +1.50 spherical diopters. \n",
      "c) 1.00 spherical diopters; +1.50 spherical diopters. \n",
      "d) 1.00 spherical diopters; +2.00 spherical diopters.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "  \"response\": \"b\"\n",
      "}\n",
      "```\n",
      "La respuesta correcta es b) 0.50 spherical diopters; +1.50 spherical diopters.\n",
      "\n",
      "Explanation:\n",
      "The patient's current accommodative range is 66 cm - 33 cm = 33 cm. To calculate the accommodative power, we need to divide the accommodative range by the patient's age: 33 cm / 65 years = 0.50 spherical diopters.\n",
      "\n",
      "To determine the corrective lens power needed for the patient to read at 33 cm, we can use the formula:\n",
      "\n",
      "Corrective lens power = Accommodative power + (Near vision add - Far vision add)\n",
      "\n",
      "In this case, the near vision add is 1.00 spherical diopters (33 cm), and the far vision add is 0.00 spherical diopters (66 cm). Therefore, the corrective lens power needed is:\n",
      "\n",
      "Corrective lens power = 0.50 spherical diopters + (1.00 - 0.00) = 0.50 spherical diopters + 1.00 = 1.50 spherical diopters.\n",
      "\n",
      "Therefore, the answer is b) 0.50 spherical diopters; +1.50 spherical diopters.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 59: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Qué tipo de comodación se espera para una persona de 30 años?\n",
      "a) 1,00 dioptría esférica.\n",
      "b) 4,00 dioptrías esféricas.\n",
      "c) 7,00 dioptrías esféricas.\n",
      "d) 12,00 dioptrías esféricas.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // The correct answer is b\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question asks for the expected accommodation for a 30-year-old person. The answer is b) 4,00 dioptrías esféricas. This is because at the age of 30, the average person's near vision begins to decline, and they may need reading glasses with a power of around +4.00 dioptries to compensate for this decline.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Anong range of accomodation ang inaasahan para sa isang 30 taong gulang?\n",
      "a) 1.00 spherical diopters.\n",
      "b) 4.00 spherical diopters.\n",
      "c) 7.00 spherical diopters.\n",
      "d) 12.00 spherical diopters.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // B - 4.00 spherical diopters\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking for the appropriate range of accommodation for a 30-year-old person. Accommodation is the ability of the eye to focus on near objects. The normal range of accommodation for a healthy adult is between 4.00 and 7.00 diopters. Therefore, the best answer is option B, 4.00 spherical diopters.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual amplitude de acomodação esperada para uma pessoa de 30 anos de idade? \n",
      "a) 1,00 dioptria esferica. \n",
      "b) 4,00 dioptria esferica. \n",
      "c) 7,00 dioptria esferica. \n",
      "d) 12,00 dioptria esferica.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // B - 4,00 dioptria esferica\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "The expected accommodation amplitude for a 30-year-old person is 4.00 diopters spherical. This is because the accommodation ability of the human eye decreases with age, and at the age of 30, the near point of the eye has moved outward, making it more difficult to focus on close objects. Therefore, a correction of 4.00 diopters is needed to bring the near point back to its original position, allowing the person to see clearly at near distances.\n",
      "\n",
      "Note: The other options, 1.00, 7.00, and 12.00 diopters, are not the correct responses for a 30-year-old person. They may be appropriate for different age groups or individuals with different visual acuity.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "What range of accommodation is expected for a 30-year-old? \n",
      "a) 1.00 spherical diopters. \n",
      "b) 4.00 spherical diopters. \n",
      "c) 7.00 spherical diopters. \n",
      "d) 12.00 spherical diopters.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // The correct answer is b\n",
      "}\n",
      "```\n",
      "\n",
      "The expected range of accommodation for a 30-year-old is 4.00 spherical diopters. This is because the ability of the eye to focus on near objects decreases with age, and a 30-year-old person may need to use reading glasses or bifocal lenses to correct presbyopia, a common age-related condition that affects the eye's ability to focus on near objects.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 60: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un técnico en electrónica realiza, sin corrección, un esfuerzo acomodativo de 6.00 DE cuando trabaja a 20 cm. ¿Qué alternativa representa mejor la refracción de este paciente?\n",
      "a) +1,50 dioptrías esféricas -2,00 dioptrías cilíndricas x 180°.\n",
      "b) +1,50 dioptrías esféricas -3,00 dioptrías cilíndricas x 90°.\n",
      "c) +2,50 dioptrías esféricas -3,00 dioptrías cilíndricas x 180°.\n",
      "d) +3,50 dioptrías esféricas -3,00 dioptrías cilíndricas x 90°.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "La respuesta correcta es la opción c) +2,50 dioptrías esféricas -3,00 dioptrías cilíndricas x 180°.\n",
      "\n",
      "La fórmula para calcular la refracción es:\n",
      "\n",
      "R = (1/2) \\* (D - d) \\* (1/f)\n",
      "\n",
      "Donde:\n",
      "\n",
      "* R es la refracción en dioptrías\n",
      "* D es la distancia de trabajo en metros\n",
      "* d es la distancia de lectura en metros\n",
      "* f es la frecuencia de la luz en Hz\n",
      "\n",
      "En este caso, la distancia de trabajo es de 20 cm, lo que equivale a 0.2 metros. La distancia de lectura es de 6.00 DE, lo que equivale a 0.6 metros. La frecuencia de la luz es de 540 x 10^12 Hz.\n",
      "\n",
      "Sustituyendo los valores en la fórmula, tenemos:\n",
      "\n",
      "R = (1/2) \\* (0.2 - 0.6) \\* (1/540 x 10^12)\n",
      "R = -0.2 \\* (1/540 x 10^12)\n",
      "R = -3.78 dioptrías\n",
      "\n",
      "Como la refracción no puede ser negativa, se redondea a la siguiente dioptría entera más cercana, que es +2.50 dioptrías.\n",
      "\n",
      "Por lo tanto, la respuesta correcta es la opción c) +2,50 dioptrías esféricas -3,00 dioptrías cilíndricas x 180°.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang isang electronics technician ay may accomodative effort ng 6.00 DE, nang walang salamin, kapag nagtatrabaho ng 20 cm. Aling sukat ang pinaka-angkop na maglalarawan sa kanyang refraction?\n",
      "a) +1.50 spherical diopters -2.00 cylindrical diopters x 180 °.\n",
      "b) +1.50 spherical diopters -3.00 cylindrical diopters x 90 °.\n",
      "c) +2.50 spherical diopters -3.00 cylindrical diopters x 180 °.\n",
      "d) +3.50 spherical diopters -3.00 cylindrical diopters x 90 °.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking for the correct refraction prescription for an electronics technician who has an accommodative effort of 6.00 DE and works 20 cm away from the object.\n",
      "\n",
      "Option A has a spherical diopter power of +1.50, which is too weak to correct the technician's vision.\n",
      "\n",
      "Option C has a spherical diopter power of +2.50, which is too strong to correct the technician's vision.\n",
      "\n",
      "Option D has a cylindrical diopter power of -3.00, which is too strong to correct the technician's vision.\n",
      "\n",
      "Therefore, the correct answer is option B, which has a spherical diopter power of +1.50 and a cylindrical diopter power of -2.00, and the axis is 90 degrees. This prescription will provide the technician with clear vision at 20 cm distance.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Um técnico em eletrônica realiza, sem correção, esforço acomodativo de 6,00 DE quando trabalha a 20 cm. Qual alternativa melhor representa a refração deste paciente? \n",
      "a) +1,50 dioptrias esfericas -2,00 dioptrias cilindricas x 180°. \n",
      "b) +1,50 dioptrias esfericas -3,00 dioptrias cilindricas x 90°. \n",
      "c) +2,50 dioptrias esfericas -3,00 dioptrias cilindricas x 180°. \n",
      "d) +3,50 dioptrias esfericas -3,00 dioptrias cilindricas x 90°.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking for the best representation of the refraction of a patient who has a spherical equivalent of 6.00 diopters and a cylindrical equivalent of 20 cm.\n",
      "\n",
      "Option A has a spherical equivalent of 1.50 diopters, which is not enough to correct the patient's myopia.\n",
      "\n",
      "Option B has a cylindrical equivalent of 3.00 diopters, which is too strong and would overcorrect the patient's astigmatism.\n",
      "\n",
      "Option C has a spherical equivalent of 2.50 diopters and a cylindrical equivalent of 3.00 diopters, which is the closest to the patient's actual refraction.\n",
      "\n",
      "Option D has a spherical equivalent of 3.50 diopters, which is too strong and would overcorrect the patient's myopia.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "An electronics technician performs, without correction, an accommodative effort of 6.00 DE when working at 20 cm. Which alternative best represents this patient's refraction? \n",
      "a) +1.50 spherical diopters -2.00 cylindrical diopters x 180°. \n",
      "b) +1.50 spherical diopters -3.00 cylindrical diopters x 90°. \n",
      "c) +2.50 spherical diopters -3.00 cylindrical diopters x 180°. \n",
      "d) +3.50 spherical diopters -3.00 cylindrical diopters x 90°.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The accommodative effort of 6.00 DE at a working distance of 20 cm indicates that the patient has a high degree of myopia. The correct response is option c: +2.50 spherical diopters -3.00 cylindrical diopters x 180°. This refraction represents a high degree of nearsightedness with a slight astigmatism, which is consistent with the patient's accommodative effort.\n",
      "\n",
      "Option a: +1.50 spherical diopters -2.00 cylindrical diopters x 180° is a possible refraction for a patient with a lower degree of myopia and astigmatism.\n",
      "\n",
      "Option b: +1.50 spherical diopters -3.00 cylindrical diopters x 90° is a possible refraction for a patient with a higher degree of astigmatism, but the spherical power is too low for this patient's accommodative effort.\n",
      "\n",
      "Option d: +3.50 spherical diopters -3.00 cylindrical diopters x 90° is a possible refraction for a patient with a very high degree of myopia and astigmatism, but the spherical power is too high for this patient's accommodative effort.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 61: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un niño de tres años tiene una esotropía de 70 dioptrías prismáticas (sin corregir), una relación convergencia/acomodación acomodativa de 6 y una refracción bajo cicloplejía de +3,50 dioptrías esféricas en ambos ojos. Después de la prescripción de la refracción, lo más probable es que la desviación con el uso de gafas, en dioptrías prismáticas, sea aproximadamente:\n",
      "a) Cero.\n",
      "b) 20.\n",
      "c) 50.\n",
      "d) 70.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": b // La respuesta correcta es b) 20.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The child has a strabismus of 70 prismatic diopters (without correction), a convergence/accommodation ratio of 6, and a refraction under cycloplegia of +3.50 spherical diopters in both eyes. After prescribing the refraction, the most likely deviation with the use of glasses, in prismatic diopters, would be approximately 20 diopters.\n",
      "\n",
      "The calculation to determine the deviation is as follows:\n",
      "\n",
      "Deviation = (Refraction - Pre-correction) x (Convergence/Accommodation ratio)\n",
      "\n",
      "In this case, the pre-correction is 70 prismatic diopters, and the refraction is +3.50 spherical diopters. The convergence/accommodation ratio is 6.\n",
      "\n",
      "Deviation = (3.50 - 70) x 6 = 20\n",
      "\n",
      "Therefore, the correct answer is b) 20.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang tatlong taong gulang na bata ay may esotropia ng 70 prismatic diopters (hindi pa naitatama), accommodative convergence/accommodation ratio ng 6, at pagwawasto sa ilalim ng cycloplegia ng +3.50 spherical diopters sa parehong mga mata. Matapos ang pagwawasto, malaki ang posibilidad na ang paglihis ng imahe, kapag ginagamit ang salamin ay mayroong sukat na\n",
      "a) 0.\n",
      "b) 20.\n",
      "c) 50.\n",
      "d) 70.\n",
      "Test #0: \n",
      "response\n",
      "  Here's my answer:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"  // The correct response is option C.\n",
      "}\n",
      "```\n",
      "Explanation:\n",
      "\n",
      "The patient has a significant esotropia of 70 prismatic diopters that is not fully corrected with a accommodative convergence/accommodation ratio of 6. This suggests that the patient has a high degree of strabismus. After cycloplegia of +3.50 spherical diopters in both eyes, the patient's vision may still be blurry, especially at near distances. Therefore, the best answer is option C, 50, which indicates a moderate to high probability of the image being blurry when viewed through a magnifying glass.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Criança de três anos apresenta esotropia de 70 dioptrias prismáticas (sem correção), relação convergência acomodativa/acomodação de 6, e refração sob cicloplegia de +3.50 dioptrias esfericas em ambos os olhos. Após a prescrição da refração, é mais provável que o desvio com o uso dos óculos, em dioptrias prismáticas, seja de aproximadamente: \n",
      "a) Zero. \n",
      "b) 20. \n",
      "c) 50. \n",
      "d) 70.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c) 50.\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The child has a strabismus of 70 prism diopters (without correction), a convergence/accommodation ratio of 6, and a refraction under cycloplegia of +3.50 spherical diopters in both eyes. After prescribing the refraction, the deviation with the use of glasses, in prism diopters, is likely to be around 50.\n",
      "\n",
      "Option A (Zero) is incorrect because the child already has a strabismus of 70 prism diopters without correction.\n",
      "\n",
      "Option B (20) is incorrect because the deviation with the use of glasses would be less than 20 prism diopters, as the refraction under cycloplegia is +3.50 spherical diopters, which is less than the strabismus of 70 prism diopters.\n",
      "\n",
      "Option D (70) is incorrect because the deviation with the use of glasses would not be equal to the strabismus, as the refraction under cycloplegia is less than the strabismus.\n",
      "\n",
      "Therefore, the correct answer is Option C (50).\n",
      "{'response': 'c) 50.'}\n",
      "Language: english\n",
      "Question: \n",
      "A three-year-old child has an esotropia of 70 prismatic diopters (uncorrected), an accommodative convergence/accommodation ratio of 6, and refraction under cycloplegia of +3.50 spherical diopters in both eyes. After prescription of refraction, it is more likely that the deviation with the use of glasses, in prismatic diopters, is approximately: \n",
      "a) 0. \n",
      "b) 20. \n",
      "c) 50. \n",
      "d) 70.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The accommodative convergence/accommodation ratio of 6 and the uncorrected esotropia of 70 prismatic diopters suggest that the child has a high accommodative convergence. After prescription of refraction, the deviation with the use of glasses is likely to be reduced.\n",
      "\n",
      "Assuming the refraction under cycloplegia is accurate, the deviation with glasses can be estimated using the \"rule of 10s\":\n",
      "\n",
      "Deviation with glasses = Uncorrected deviation x (10 - Accommodative convergence/accommodation ratio)\n",
      "\n",
      "Plugging in the values, we get:\n",
      "\n",
      "Deviation with glasses = 70 x (10 - 6) = 70 x 4 = 280\n",
      "\n",
      "Therefore, the correct answer is (c) 50, as the deviation with glasses is likely to be around 50 prismatic diopters.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 62: \n",
      "Language: spanish\n",
      "Question: \n",
      "La medición de la amplitud de convergencia fusional se realiza colocando prismas delante de los ojos. ¿Cuál de las siguientes alternativas representa mejor la posición adecuada de los prismas, considerando un paciente sin estrabismo?\n",
      "a) Base temporal en el ojo con mejor agudeza visual y base nasal en el otro ojo.\n",
      "b) Base temporal en el ojo derecho.\n",
      "c) Base nasal en el ojo con mejor agudeza visual y base temporal en el otro ojo.\n",
      "d) Base nasal en el ojo izquierdo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "La medición de la amplitud de convergencia fusional se realiza colocando prismas delante de los ojos. La opción correcta es colocar la base nasal en el ojo con mejor agudeza visual y la base temporal en el otro ojo. Esto permite evaluar la capacidad del paciente para fusionar las imágenes y medir la amplitud de convergencia fusional.\n",
      "\n",
      "La opción a) es incorrecta porque la base temporal debe estar en el ojo con mejor agudeza visual. La opción b) es incorrecta porque la base temporal debe estar en el ojo derecho. La opción d) es incorrecta porque la base nasal debe estar en el ojo con mejor agudeza visual.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Sinusukat ang amplitude ng fusional convergence sa pamamagitan ng paglalagay ng mga prismo sa harap ng mga mata. Alin sa sumusunod ang pinakaangkop na posisyon ng mga prismo, para sa isang pasyente na walang strabismus?\n",
      "a) Temporal base sa mata na may mas malinaw na visual acuity at nasal base ng kabilang mata.\n",
      "b) Temporal base sa kanang mata.\n",
      "c) Nasal base sa mata na may  mas malinaw na visual acuity at temporal base sa kabilang mata.\n",
      "d) Nasal base sa kaliwang mata.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Nasal base sa mata na may mas malinaw na visual acuity at temporal base sa kabilang mata.\n",
      "\n",
      "Sinusukat ang amplitude ng fusional convergence sa pamamagitan ng paglalagay ng mga prismo sa harap ng mga mata. In this case, the patient does not have strabismus, so the prisms should be placed in a way that allows for the best possible fusion of the images seen by each eye.\n",
      "\n",
      "Option c) Nasal base sa mata na may mas malinaw na visual acuity at temporal base sa kabilang mata is the correct answer because it allows for the image seen by the eye with better visual acuity to be placed in the nasal field of the non-dominant eye, while the image seen by the other eye is placed in the temporal field of the dominant eye. This allows for better fusion of the images and alleviates the symptoms of diplopia.\n",
      "\n",
      "Option a) Temporal base sa mata na may mas malinaw na visual acuity at nasal base ng kabilang mata is incorrect because it would place the image seen by the eye with better visual acuity in the temporal field of the dominant eye, which would not allow for proper fusion of the images.\n",
      "\n",
      "Option b) Temporal base sa kanang mata is incorrect because it would place the image seen by the eye with better visual acuity in the temporal field of the non-dominant eye, which would also not allow for proper fusion of the images.\n",
      "\n",
      "Option d) Nasal base sa kaliwang mata is incorrect because it would place the image seen by the eye with better visual acuity in the nasal field of the non-dominant eye, which would not allow for proper fusion of the images.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "A medida da amplitude de convergência fusional é feita pela colocação de prismas diante dos olhos. Qual das alternativas abaixo melhor representa a posição adequada dos prismas, considerando um paciente sem estrabismo? \n",
      "a) Base temporal no olho de melhor acuidade visual e base nasal no outro olho. \n",
      "b) Base temporal no olho direito. \n",
      "c) Base nasal no olho de melhor acuidade visual e base temporal no outro olho. \n",
      "d) Base nasal no olho esquerdo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) Base nasal no olho de melhor acuidade visual e base temporal no outro olho.\n",
      "\n",
      "In fusional convergence, the prisms are placed in front of the eyes to measure the amplitude of convergence. The correct position of the prisms for a patient without strabismus is option c, with the base of the prism on the nasal side of the eye with better visual acuity and the base of the other prism on the temporal side of the other eye. This allows for the measurement of the full range of convergence.\n",
      "\n",
      "Option a is incorrect because it places the prisms in the wrong position, with the base of the prism on the temporal side of the eye with better visual acuity and the base of the other prism on the nasal side of the other eye.\n",
      "\n",
      "Option b is incorrect because it only places the prism in front of one eye, and does not allow for the measurement of convergence.\n",
      "\n",
      "Option d is incorrect because it places the prism in front of the wrong eye, and does not allow for the measurement of convergence.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "The measurement of the amplitude of fusional convergence is made by placing prisms in front of the eyes. Which of the alternatives below best represents the proper position of the prisms, considering a patient without strabismus? \n",
      "a) Temporal base in the eye with better visual acuity and nasal base in the other eye. \n",
      "b) Temporal base in the right eye. \n",
      "c) Nasal base in the eye with better visual acuity and temporal base in the other eye. \n",
      "d) Nasal base in the left eye.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c: Nasal base in the eye with better visual acuity and temporal base in the other eye.\n",
      "\n",
      "When performing a fusional convergence test, the prisms are placed in front of the eyes to measure the amplitude of convergence. The proper position of the prisms for a patient without strabismus is to have the nasal base of the prism in the eye with better visual acuity, and the temporal base in the other eye. This allows for the assessment of the patient's ability to converge their eyes towards the nasal side, which is a critical aspect of binocular vision.\n",
      "\n",
      "Option a is incorrect because it reverses the position of the prisms, with the temporal base in the eye with better visual acuity and the nasal base in the other eye.\n",
      "\n",
      "Option b is incorrect because it only specifies the position of the prism in one eye (the right eye), without considering the position of the prism in the other eye.\n",
      "\n",
      "Option d is incorrect because it places the nasal base of the prism in the left eye, which is not the eye with better visual acuity.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 63: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto al colirio de atropina al 1%, seleccione la alternativa correcta.\n",
      "a) Está contraindicado para el tratamiento de la ambliopía.\n",
      "b) Provoca buena cicloplejía, pero midriasis leve.\n",
      "c) Provoca cicloplejía prolongada, con un efecto que se prolonga hasta 15 días después de la instilación.\n",
      "d) Su máxima acción se produce cuatro horas después de la instilación.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option c) Provoca cicloplejía prolongada, con un efecto que se prolonga hasta 15 días después de la instilación. Atropine 1% eye drops are known to cause prolonged cycloplegia, which can last up to 15 days after instillation. This is because atropine is a long-acting anticholinergic agent that can cause sustained dilatation of the pupil and reduced accommodation for an extended period.\n",
      "\n",
      "Option a) Está contraindicado para el tratamiento de la ambliopía is incorrect because atropine 1% eye drops are not contraindicated for the treatment of amblyopia.\n",
      "\n",
      "Option b) Provoca buena cicloplejía, pero midriasis leve is incorrect because while atropine 1% eye drops do cause cycloplegia, they do not cause mild mydriasis.\n",
      "\n",
      "Option d) Su máxima acción se produce cuatro horas después de la instilación is incorrect because the maximum effect of atropine 1% eye drops does not occur four hours after instillation. The peak effect of atropine 1% eye drops typically occurs within 1-2 hours after instillation.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga pahayag ang tama patungkol sa atropine 1% eye drops:\n",
      "a) Ito ay bawal upang gamutin ang amblyopia\n",
      "b) Nagdudulot ito ng mahusay na cycloplegia, ngunit may katamtamang mydriasis.\n",
      "c) Nagdudulot ito ng matagal na cycloplegia, na tumatagal hanggang sa 15 araw pagkatapos ng ipatak.\n",
      "d) Ang maximum action nito ay nangyayari apat na oras pagkatapos ng pagpatak.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Atropine 1% eye drops are used to dilate the pupil and provide a cycloplegic effect, which means it paralyzes the muscles that control the eye's focus. The correct answer is b) Nagdudulot ito ng mahusay na cycloplegia, ngunit may katamtamang mydriasis. This means that the drug produces a good cycloplegic effect, but may also cause some mydriasis (enlargement of the pupil).\n",
      "\n",
      "Option a) Ito ay bawal upang gamutin ang amblyopia is incorrect because amblyopia is a condition where the eye has reduced vision due to various causes, and atropine 1% eye drops are not used to treat amblyopia.\n",
      "\n",
      "Option c) Nagdudulot ito ng matagal na cycloplegia, na tumatagal hanggang sa 15 araw pagkatapos ng ipatak is incorrect because the cycloplegic effect of atropine 1% eye drops does not last for 15 days after administration.\n",
      "\n",
      "Option d) Ang maximum action nito ay nangyayari apat na oras pagkatapos ng pagpatak is incorrect because the maximum effect of atropine 1% eye drops occurs within 4 hours after administration, not 15 days.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação ao colírio de atropina 1%, assinale a alternativa correta. \n",
      "a) É contraindicado para tratamento de ambliopia \n",
      "b) Provoca boa cicloplegia, mas midríase discreta. \n",
      "c) Provoca cicloplegia prolongada, com efeito que se estende por, até, 15 dias após a instilação. \n",
      "d) Sua ação máxima ocorre quatro horas após a instilação.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Provoca boa cicloplegia, mas midríase discreta.\n",
      "\n",
      "Atropine 1% eye drops are commonly used to dilate the pupils and paralyze the accommodation in order to perform a thorough eye examination, especially in children. The option b) Provoca boa cicloplegia, mas midríase discreta, which means \"It provides good cycloplegia, but mild mydriasis,\" accurately describes the effect of atropine 1% eye drops.\n",
      "\n",
      "Option a) É contraindicado para tratamento de ambliopia, which means \"It is contraindicated for the treatment of amblyopia,\" is incorrect because atropine 1% eye drops are not contraindicated for the treatment of amblyopia.\n",
      "\n",
      "Option c) Provoca cicloplegia prolongada, com efeito que se estende por, até, 15 dias após a instilação, which means \"It provides prolonged cycloplegia, with an effect that lasts up to 15 days after installation,\" is also incorrect because the effect of atropine 1% eye drops does not last that long.\n",
      "\n",
      "Option d) Sua ação máxima ocorre quatro horas após a instilação, which means \"Its maximum action occurs four hours after installation,\" is incorrect because the maximum effect of atropine 1% eye drops occurs within 1-2 hours after installation, not four hours.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding atropine 1% eye drops, mark the correct alternative. \n",
      "a) It is contraindicated for the treatment of amblyopia \n",
      "b) It causes good cycloplegia, but mild mydriasis. \n",
      "c) It causes prolonged cycloplegia, with an effect that lasts for up to 15 days after instillation. \n",
      "d) Its maximum action occurs four hours after instillation.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "La respuesta correcta es la opción c: \"It causes prolonged cycloplegia, with an effect that lasts for up to 15 days after instillation.\"\n",
      "\n",
      "Atropina 1% eye drops are used to dilate the pupil and paralyze the accommodation, which helps in the diagnosis and treatment of various eye conditions such as amblyopia, strabismus, and uveitis. The effect of atropine 1% eye drops can last for up to 15 days after instillation, making it a useful tool for eye exams and treatments.\n",
      "\n",
      "Therefore, the correct answer is option c.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 64: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un niño emétrope de 6 años presenta exoforia de 6 dioptrías prismáticas (PD). Tras inserción de lentes negativos de -2,00 dioptrías esféricas presentó esoforia de 2 DE. Su relación convergencia acomodativa/acomodación es:\n",
      "a) 2.\n",
      "b) 4.\n",
      "c) 6.\n",
      "d) 8.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient has a exophoria of 6 prismatic diopters (PD) and after inserting negative lenses of -2.00 diopters spherical, they presented with esophoria of 2 diopters. This means that the patient has a convergence excess of 4 diopters (6 - 2 = 4).\n",
      "\n",
      "Therefore, the correct answer is b) 4.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Isang 6-taong-gulang na emmetropic na bata ay may exophoria ng 6 prismatic diopters (PD). Matapos ang paglalagay ng mga minus lens na -2.00 spherical diopters, naging 2SD ang kanyang esophoria. Ang accommodative convergence/accommodation ratio nito ay:\n",
      "a) 2.\n",
      "b) 4.\n",
      "c) 6.\n",
      "d) 8.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The accommodative convergence/accommodation ratio is defined as the ratio of the change in convergence to the change in accommodation. In this case, the patient's esophoria decreased from 6 prismatic diopters to 2SD after placing a -2.00 spherical diopter lens, indicating that the accommodation increased.\n",
      "\n",
      "Therefore, the accommodative convergence/accommodation ratio can be calculated as follows:\n",
      "\n",
      "Accommodative convergence/accommodation ratio = (change in convergence) / (change in accommodation)\n",
      "= (6 - 2) / (-2)\n",
      "= 4 / -2\n",
      "= 2\n",
      "\n",
      "So, the correct answer is b) 4.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Criança de 6 anos de idade, emétrope, apresenta exoforia de 6 dioptrias prismáticas (DP). Após colocação de lentes negativas de -2,00 dioptrias esféricas, apresentou esoforia de 2 DP. Sua relação convergência acomodativa/acomodação é: \n",
      "a) 2. \n",
      "b) 4. \n",
      "c) 6. \n",
      "d) 8.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The child has a exophoria of 6 dioptries prismatic (DP) and after putting on negative lenses of -2.00 dioptries spherical, they have an esophoria of 2 DP. This means that the child has a convergence excess of 4 dioptries (6-2=4).\n",
      "\n",
      "The ratio of convergence to accommodation is the amount of convergence (in dioptries) that occurs for every 1 dioptry of accommodation. In this case, the child has a convergence excess of 4 dioptries, which means that for every 1 dioptry of accommodation, they have 4 dioptries of convergence. Therefore, the correct answer is b) 4.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "A 6-year-old emmetropic child has an exophoria of 6 prismatic diopters (PD). After placement of minus lenses of -2.00 spherical diopters, he presented esophoria of 2 SD. Its accommodative convergence/accommodation ratio is: \n",
      "a) 2. \n",
      "b) 4. \n",
      "c) 6. \n",
      "d) 8.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The accommodative convergence/accommodation ratio is calculated as follows:\n",
      "\n",
      "Accommodative convergence/accommodation ratio = (esophoria in seconds) / (exophoria in seconds)\n",
      "\n",
      "In this case, the esophoria is 2 seconds (2 SD), and the exophoria is 6 seconds (6 PD). Therefore, the accommodative convergence/accommodation ratio would be:\n",
      "\n",
      "Accommodative convergence/accommodation ratio = (2) / (6) = 0.33 or 1/3\n",
      "\n",
      "The correct answer is option B, 4.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 65: \n",
      "Language: spanish\n",
      "Question: \n",
      "En cuanto a los prismas de Fresnel, seleccione la respuesta correcta.\n",
      "a) Aquellos con valores elevados se asocian con una agudeza visual reducida.\n",
      "b) Se obtienen a partir de prismas de igual potencia unidos por sus bases.\n",
      "c) Se obtienen a partir de prismas de igual potencia unidos por sus vértices.\n",
      "d) Son poco utilizados, principalmente por las molestias que provoca su elevado peso.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Se obtienen a partir de prismas de igual potencia unidos por sus vértices.\n",
      "\n",
      "Fresnel prisms are used to redirect light by refracting it through a series of triangular prisms. The prisms are arranged with their vertices touching, which allows the light to pass through the prism and be redirected by the refractive surfaces. This design allows for a more compact and lightweight device compared to traditional prisms, which are often made of glass or plastic and have a larger size and weight. Therefore, option d) Son poco utilizados, principalmente por las molestias que provoca su elevado peso is incorrect.\n",
      "\n",
      "Option a) Aquellos con valores elevados se asocian con una agudeza visual reducida is also incorrect. Fresnel prisms are designed to redirect light, not to affect visual acuity.\n",
      "\n",
      "Option b) Se obtienen a partir de prismas de igual potencia unidos por sus bases is incorrect. Fresnel prisms are not created by uniting prisms of equal power by their bases. Instead, they are created by uniting prisms of equal power by their vertices.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga pahayag ang tama tungkol sa Fresnel prisms?\n",
      "a) Ang pagkakaroon ng mataas na iskor ay may kaugnayan sa mas mababang visual acuity.\n",
      "b) Nakukuha ang mga ito mula sa mga prismo ng pantay na lakas na sinamahan ng kanilang mga base.\n",
      "c) Nakukuha ang mga ito mula sa mga prismo ng pantay na lakas na sinamahan ng kanilang mga tuktok.\n",
      "d) Ang mga ito ay bihirang nagagamit dahil sa kakulangan sa ginhawa na dulot ng kanilang mabigat na timbang.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Nakukuha ang mga ito mula sa mga prismo ng pantay na lakas na sinamahan ng kanilang mga base.\n",
      "\n",
      "Fresnel prisms are used to redirect light by refracting it through a series of parallel ridges or grooves on the surface of the prism. The ridges or grooves are typically arranged in a specific pattern, such as a chevron or hexagonal shape, to refract light in a particular direction. The angle of refraction depends on the angle of incidence and the refractive index of the prism material.\n",
      "\n",
      "Therefore, option b is the correct answer, as it states that Fresnel prisms are made from a series of parallel ridges or grooves on the surface of the prism, which refract light in a specific direction.\n",
      "\n",
      "Option a is incorrect, as it suggests that Fresnel prisms are used to magnify objects, which is not their primary function.\n",
      "\n",
      "Option c is also incorrect, as it suggests that Fresnel prisms are used to refract light through the tips of the prism, rather than the base.\n",
      "\n",
      "Option d is incorrect, as it suggests that Fresnel prisms are not used because they are heavy, which is not a valid reason for not using them.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação aos prismas de Fresnel, assinale a alternativa correta. \n",
      "a) Os de altos valores são associados à redução da acuidade visual. \n",
      "b) São obtidos a partir de prismas de igual poder unidos por suas bases. \n",
      "c) São obtidos a partir de prismas de igual poder unidos por seus ápices.\n",
      "d) São pouco usados, principalmente pelo desconforto causado pelo seu alto peso.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) São obtidos a partir de prismas de igual poder unidos por seus ápices.\n",
      "\n",
      "Fresnel prisms are used to redirect light by refracting it through a triangular-shaped prism. The prisms are typically made of glass or plastic and have a triangular shape with equal angles at the corners. When light passes through the prism, it is refracted and redirected, allowing the user to see an image that would otherwise be hidden from view.\n",
      "\n",
      "Option a is incorrect because Fresnel prisms do not reduce acuity. In fact, they can help improve vision by allowing the user to see objects that would otherwise be hidden.\n",
      "\n",
      "Option b is also incorrect because Fresnel prisms are not obtained by joining two prisms of equal power together by their bases. The prisms are typically made of a single piece of material and are not joined together.\n",
      "\n",
      "Option d is incorrect because Fresnel prisms are widely used and are not known for causing discomfort due to their weight. They are commonly used in optical instruments such as binoculars, telescopes, and periscopes.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding Fresnel prisms, mark the correct alternative. \n",
      "a) Those with high values ​​are associated with reduced visual acuity. \n",
      "b) They are obtained from prisms of equal power joined by their bases. \n",
      "c) They are obtained from prisms of equal power joined by their apexes. \n",
      "d) They are rarely, mainly due to the discomfort caused by their high weight.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option c: They are obtained from prisms of equal power joined by their apexes. Fresnel prisms are a type of prism that is used to correct vision problems, particularly in cases of strabismus (crossed eyes). They work by redirecting the light that enters the eye, allowing the image to be focused correctly on the retina. The prisms are made up of two triangular pieces of glass that are joined together at their apexes, creating a wedge-shaped prism. This design allows the prism to bend light in a specific way, enabling the correction of vision problems.\n",
      "\n",
      "Therefore, option c is the correct answer. Options a, b, and d are incorrect and do not accurately describe Fresnel prisms.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 66: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un paciente hipermétrope de 45 años con +1,00 dioptrías esféricas ya no tiene tolerancia acomodativa. Por tanto, para realizar una actividad a 25 cm, ¿qué corrección a continuación necesitarás?\n",
      "a) +1,00 dioptrías esféricas.\n",
      "b) +2,00 dioptrías esféricas.\n",
      "c) +4,00 dioptrías esféricas.\n",
      "d) +5,00 dioptrías esféricas.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // The correct response is option B.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient is hypermetropic, meaning they have a difficulty focusing on close objects. They have a current correction of +1.00 diopters spherical. To perform an activity at 25 cm, they will need a stronger correction to compensate for their lack of accommodation.\n",
      "\n",
      "Option A (+1.00 diopters spherical) is not strong enough to compensate for the patient's hypermetropia and lack of accommodation.\n",
      "\n",
      "Option C (+4.00 diopters spherical) is too strong and would cause the patient to see distant objects too clearly, leading to discomfort and eye strain.\n",
      "\n",
      "Option D (+5.00 diopters spherical) is also too strong and would cause the patient to see distant objects even more clearly, leading to discomfort and eye strain.\n",
      "\n",
      "Therefore, the best option is B (+2.00 diopters spherical), which provides a moderate increase in correction to help the patient focus on close objects without causing discomfort or eye strain.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang 45 taong gulang na may +1.00 spherical diopter hyperopic pasyente ay walang accommodative tolerance. Upang magsagawa ng isang aktibidad na 25 cm ang layo, aling pagwawasto ang kakailanganin?\n",
      "a) +1.00 spherical diopters.\n",
      "b) +2.00 spherical diopters.\n",
      "c) +4.00 spherical diopters.\n",
      "d) +5.00 spherical diopters.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // The correct response is option B.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient is a 45-year-old male with a +1.00 spherical diopter hyperopic prescription and no accommodative tolerance. To perform an activity at a distance of 25 cm, the patient will require a magnifying power of +2.00 spherical diopters to bring the image into focus.\n",
      "\n",
      "Therefore, the correct answer is option B, +2.00 spherical diopters.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Um paciente hipermétrope de +1,00 dioptrias esfericas de 45 anos não possui mais tolerância acomodativa. Logo, para exercer uma atividade a 25 cm necessitará de qual correção abaixo? \n",
      "a) +1,00 Dioptrias esfericas. \n",
      "b) +2,00 dioptrias esfericas. \n",
      "c) +4,00 dioptrias esfericas. \n",
      "d) +5,00 dioptrias esfericas.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Correção correto: +2,00 dioptrias esfericas\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient is hypermetropic, meaning they have a difficulty focusing on close objects. The patient's age is 45 years old, and they no longer have accommodative tolerance. Therefore, they will need a correction that allows them to focus on objects at a distance of 25 cm.\n",
      "\n",
      "Option A, +1,00 dioptrias esfericas, is not enough to correct the patient's hypermetropia, as it only provides a correction of +1,00 dioptries, which is not sufficient for the patient's needs.\n",
      "\n",
      "Option C, +4,00 dioptrias esfericas, is too strong and would cause the patient to see objects at a distance of 25 cm as if they were much closer.\n",
      "\n",
      "Option D, +5,00 dioptrias esfericas, is also too strong and would cause the patient to see objects at a distance of 25 cm as if they were much closer.\n",
      "\n",
      "Therefore, the best option is B, +2,00 dioptrias esfericas, which provides a correction of +2,00 dioptries, allowing the patient to focus on objects at a distance of 25 cm.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "A 45-year-old +1.00 spherical diopter hyperopic patient no longer has accommodative tolerance. Therefore, to carry out an activity at 25 cm, which correction below will you need? \n",
      "a) +1.00 spherical diopters. \n",
      "b) +2.00 spherical diopters. \n",
      "c) +4.00 spherical diopters. \n",
      "d) +5.00 spherical diopters.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // The correct response is option B\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "A 45-year-old patient with a +1.00 spherical diopter hyperopic prescription has a focal length that is too long, causing blurry vision at near distances. As they no longer have accommodative tolerance, they will need a stronger correction to bring the near point closer.\n",
      "\n",
      "Option A, +1.00 spherical diopters, is the patient's current prescription, which is not strong enough to correct their hyperopia at near distances.\n",
      "\n",
      "Option B, +2.00 spherical diopters, is the correct answer. This prescription will provide a stronger correction, allowing the patient to see clearly at 25 cm.\n",
      "\n",
      "Option C, +4.00 spherical diopters, is too strong and would cause the patient to see clearly at a much closer distance than 25 cm.\n",
      "\n",
      "Option D, +5.00 spherical diopters, is also too strong and would cause the patient to see clearly at an even closer distance than 25 cm.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 67: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un niño de seis años con dificultades de aprendizaje tiene una refracción estática de +2,00 DE en ambos ojos, alcanzando una agudeza visual de 1,0. No hay desviación ocular. ¿Cuál es el mejor curso de acción en este caso?\n",
      "a) No es necesaria prescripción médica para gafas.\n",
      "b) Prescripción completa.\n",
      "c) Prescripción de +1,00 dioptrías esféricas en ambos ojos.\n",
      "d) Prescripción de gafas de lectura.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "A six-year-old child with learning difficulties and a static refraction of +2.00 diopters in both eyes, achieving a visual acuity of 1.0, does not require a prescription for glasses (option a). A complete prescription is necessary to correct the child's vision (option b). Prescribing +1.00 diopter spherical lenses in both eyes (option c) would not be sufficient to correct the child's vision, and prescribing reading glasses (option d) would not be appropriate for a child of this age. Therefore, the best course of action is to prescribe a complete pair of glasses with the correct prescription to help the child see clearly and potentially improve their learning abilities.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang anim na taong gulang na bata na may learning disability at may static na repraksyon ng +2.00 spherical diopter sa kaniyang dalawang mata, ay may visual acuity ng 1.0 at walang paglihis sa paningin. Ano ang pinakaangkop gawin sa kasong ito?\n",
      "a) Hindi kinakailangang magpasalamin\n",
      "b) Buong reseta.\n",
      "c) Reseta ng +1.00 pherical diopters sa parehong mga mata.\n",
      "d) Reseta ng pagbabasa ng baso.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient has a learning disability and a static refraction of +2.00 spherical diopters in both eyes, with a visual acuity of 1.0 and no astigmatism. In this case, the best option is to prescribe a reseta of +1.00 cylindrical diopters in both eyes (option c). This will help improve the patient's visual acuity and reduce the symptoms of blurry vision.\n",
      "\n",
      "Option a is not correct because the patient's visual acuity is already 1.0, which means they have perfect vision. Option b is not correct because a full reseta is not necessary, as the patient's refraction is already static. Option d is not correct because the patient's issue is not related to reading, but rather to their overall visual acuity.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Uma criança de seis anos de idade com dificuldade de aprendizado, apresenta refração estática de +2,00 DE em ambos os olhos, alcançando acuidade visual 1,0. Não apresenta desvio ocular. Qual a melhor conduta neste caso? \n",
      "a) Não é necessária a prescrição de óculos. \n",
      "b) Prescrição total. \n",
      "c) Prescrição de +1,00 dioptrias esfericas em ambos os olhos. \n",
      "d) Prescrição de óculos de leitura.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient, a 6-year-old child with difficulty learning, has a static refraction of +2.00 diopters in both eyes, achieving visual acuity of 1.0. There is no ocular deviation. The best course of action in this case would be to prescribe glasses with a power of +1.00 diopters spherical in both eyes. This will help to correct the child's refractive error and improve their visual acuity.\n",
      "\n",
      "Option A, not prescribing glasses, is not appropriate as the child has a refractive error that needs to be corrected. Option B, prescribing total, is also not appropriate as the child's refractive error is not that severe and does not require a total prescription. Option D, prescribing reading glasses, is also not appropriate as the child's refractive error is not related to reading.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "A six-year-old child with a learning disability has a static refraction of +2.00 spherical diopters in both eyes, achieving a visual acuity of 1.0. No ocular deviation. What is the best course of action in this case? \n",
      "a) It is not necessary to prescribe glasses. \n",
      "b) Full prescription. \n",
      "c) Prescription of +1.00 pherical diopters in both eyes. \n",
      "d) Prescription of reading glasses.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "A six-year-old child with a learning disability and a static refraction of +2.00 spherical diopters in both eyes should be prescribed full glasses (option b) to achieve the best possible visual acuity. The child's visual acuity is already 1.0, which means they have perfect vision, but prescribing glasses will help them see clearly and comfortably, especially for near work, such as reading and writing.\n",
      "\n",
      "Option a is not correct because, although the child's visual acuity is already good, they still require correction to achieve comfortable vision.\n",
      "\n",
      "Option c is not correct because a prescription of +1.00 pherical diopters in both eyes would not provide the child with the best possible vision.\n",
      "\n",
      "Option d is not correct because reading glasses are not necessary for a child of this age, and the child's visual acuity is already good.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 68: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál es la anisometropía del paciente que utiliza -3.00 dioptrías esféricas en el ojo derecho y +1.00 dioptrías esféricas -2.00 dioptrías cilíndricas x 90° en el ojo izquierdo?\n",
      "a) 0DE.\n",
      "b) 1 dioptrías esféricas.\n",
      "c) 2 dioptrías esféricas.\n",
      "d) 3 dioptrías esféricas.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The patient has a anisometropia of 1 dioptria, which is the difference between the refractive power of the two eyes. In this case, the right eye has a refractive power of -3.00 dioptries spherical, and the left eye has a refractive power of +1.00 dioptries spherical and -2.00 dioptries cylindrical x 90°. The difference between the two eyes is 1 dioptria, which is the correct answer.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ano ang anisometropia ng pasyente na gumagamit ng -3.00 spherical diopters sa kanang mata at +1.00 spherical diopters -2.00 cylindrical diopters x 90 ° sa kaliwang mata?\n",
      "a) 0 de.\n",
      "b) 1 spherical diopters.\n",
      "c) 2 spherical diopters.\n",
      "d) 3 spherical diopters.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Answer: 1 spherical diopter\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Anisometropia is the difference in the refractive power of the two eyes. In this case, the patient is using a -3.00 spherical diopter lens in one eye and a +1.00 spherical diopter lens in the other eye, with a cylindrical diopter of -2.00 x 90°.\n",
      "\n",
      "To calculate the anisometropia, we need to subtract the refractive power of the two eyes. The refractive power of the left eye is -3.00, and the refractive power of the right eye is +1.00, so the difference is -3.00 - +1.00 = -4.00 diopters.\n",
      "\n",
      "Therefore, the correct answer is b) 1 spherical diopter, as the anisometropia is 4.00 diopters, which rounds to 1 diopter.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual a anisometropia do paciente que usa -3,00 dioptrias esfericas no olho direito e +1,00 dioptrias esfericas -2,00 dioptrias cilindricas x 90° no olho esquerdo? \n",
      "a) 0 DE. \n",
      "b) 1 dioptrias esfericas. \n",
      "c) 2 dioptrias esfericas. \n",
      "d) 3 dioptrias esfericas.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Anisometropia is the difference in the refractive power of the two eyes. In this case, the patient has a refractive power of -3.00 diopters in the right eye and +1.00 diopter in the left eye, with a cylindrical component of -2.00 diopters at 90°.\n",
      "\n",
      "To calculate the anisometropia, we need to subtract the refractive power of the left eye from the refractive power of the right eye:\n",
      "\n",
      "Anisometropia = Refractive power of right eye - Refractive power of left eye\n",
      "= -3.00 - (+1.00)\n",
      "= -4.00 diopters\n",
      "\n",
      "Therefore, the correct answer is option b) 1 dioptria esferica, as the anisometropia is 4.00 diopters, which rounds to 1 dioptria esferica.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "What is the anisometropia of the patient who uses -3.00 spherical diopters in the right eye and +1.00 spherical diopters -2.00 cylindrical diopters x 90° in the left eye? \n",
      "a) 0 DE. \n",
      "b) 1 spherical diopters. \n",
      "c) 2 spherical diopters. \n",
      "d) 3 spherical diopters.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // The correct response is option B\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Anisometropia is the difference in the refractive power of the two eyes. In this case, the patient has a difference of 2 spherical diopters between the two eyes (3.00 - 1.00 = 2.00). Therefore, the correct answer is option B, 1 spherical diopters.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 69: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un examinador situado a 0,67 m del ojo examinado utiliza un retinoscopio y escanea el meridiano horizontal (eje vertical), observando un movimiento a favor. Después de añadir lentes positivos, el reflejo se neutraliza con +1,50 dioptrías. Con esta lente, al escanear el meridiano vertical (eje horizontal), se observa un movimiento a favor. ¿Cuál de las siguientes podría ser una receta para el paciente?\n",
      "a) +1,00 dioptría esférica - 1,00 x 90°.\n",
      "b) +1,00 dioptría esférica - 1,00 x 180°.\n",
      "c) -1,00 dioptría esférica + 1,00 X 90°.\n",
      "d) -1,00 dioptría esférica + 1,00 X 180°.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The given question is in Spanish, and it describes a scenario where an examiner is using a retinoscope to assess the refractive error of a patient's eye. The examiner observes a movement in favor of the meridian horizontal (vertical eyeball) and then adds positive lenses to neutralize the reflex. After adding +1.50 diopters, the reflex is neutralized, and the examiner observes a movement in favor of the meridian vertical (horizontal eyeball).\n",
      "\n",
      "Based on this information, the correct response is option B: +1.00 diopter spherical - 1.00 x 180°. This response indicates that the patient has a nearsightedness (myopia) refractive error, and the prescribed lens is a positive spherical lens with a power of +1.00 diopters and an axis of 180°.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Nasa may layo na 0.67 ang isang examiner mula sa mata ng pasyente gamit ang isang retinoscope and tintignan ang horizontal meridian (vertical axis), at nakapagtala ng paggalaw. Pagkatapos magdagdag ng lente, nanyutralisa ang flare sa pamamagitan ng +1.5 diopter. Gamit ang lens na ito, kapag naii-sweep ang vertical meridian (horizontal axis) at mayroong nakikitang paggalaw, anong sukat ang dapat ibigay sa pasyente? \n",
      "a) +1.00 spherical diopter - 1.00 x 90°. \n",
      "b) +1.00 spherical diopter - 1.00 x 180°. \n",
      "c) -1.00 spherical diopter + 1.00 X 90°. \n",
      "d) -1.00 spherical diopter + 1.00 X 180°.\n",
      "\n",
      "Test #0: \n",
      "response\n",
      "  Here's my response:\n",
      "\n",
      "```json\n",
      "{\n",
      "    \"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking for the correct prescription to give to a patient who has a strabismus (lazy eye) and is being examined with a retinoscope. The examiner is holding the retinoscope at a 0.67 angle from the patient's eye and observing the horizontal meridian (vertical axis). After adding a lens, the flare is neutralized with a +1.5 diopter lens. The patient has a vertical strabismus (esotropia) and the examiner is sweeping the vertical meridian (horizontal axis) and observing a deviation.\n",
      "\n",
      "The correct answer is option c: -1.00 spherical diopter + 1.00 x 90°. This is because the patient has a vertical strabismus, and the negative spherical diopter (-1.00) will correct for the inward deviation of the eye, while the 90° angle will align the eye properly.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Um examinador localizado a 0,67 m do olho examinado utiliza um retinoscópio e varre o meridiano horizontal (eixo vertical), observando um movimento a favor. Após adicionar lentes positivas, o reflexo é neutralizado com +1,50 dioptria. Com esta lente, ao varrer o meridiano vertical (eixo horizontal), observa-se um movimento a favor. Qual das alternativas abaixo pode ser uma prescrição para o paciente? \n",
      "a) +1,00 dioptria esferica - 1,00 x 90°. \n",
      "b) +1,00 dioptria esferica - 1,00 x 180°. \n",
      "c) -1,00 dioptria esferica + 1,00 X 90°. \n",
      "d) -1,00 dioptria esferica + 1,00 X 180°.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c) -1,00 dioptria esferica + 1,00 X 90°.\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The given question is in Portuguese, and it describes a scenario where an examiner is using a retinoscope to assess the refractive error of a patient. The examiner observes a movement in favor of the patient when the meridian is horizontal (eixo vertical) and the lens is positive. When the meridian is vertical (eixo horizontal), the movement is still in favor of the patient.\n",
      "\n",
      "Based on this information, the correct prescription for the patient would be option c: -1,00 dioptria esferica + 1,00 X 90°. This prescription would neutralize the refractive error and allow the patient to see clearly.\n",
      "\n",
      "The other options are not correct because they do not take into account the movement observed in the vertical meridian. Option a is a spherical lens with a power of +1,00 dioptria, which would not correct the refractive error. Option b is a spherical lens with a power of +1,00 dioptria and a axis of 180°, which would actually make the refractive error worse. Option d is a spherical lens with a power of -1,00 dioptria and a axis of 180°, which would also make the refractive error worse.\n",
      "{'response': 'c) -1,00 dioptria esferica + 1,00 X 90°.'}\n",
      "Language: english\n",
      "Question: \n",
      "An examiner located 0.67 m from the examined eye uses a retinoscope and scans the horizontal meridian (vertical axis), observing a movement in favor. After adding plus lenses, the flare is neutralized with +1.50 diopter. With this lens, when sweeping the vertical meridian (horizontal axis), a movement in favor is observed. Which of the following could be a prescription for the patient? \n",
      "a) +1.00 spherical diopter - 1.00 x 90°. \n",
      "b) +1.00 spherical diopter - 1.00 x 180°. \n",
      "c) -1.00 spherical diopter + 1.00 X 90°. \n",
      "d) -1.00 spherical diopter + 1.00 X 180°.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The given query is in Spanish, and it describes a scenario where an examiner uses a retinoscope to assess the refractive error of a patient's eye. The examiner observes a movement in favor (i.e., towards the center of the eye) when scanning the horizontal meridian (vertical axis) and adds a plus lens to neutralize the flare. When sweeping the vertical meridian (horizontal axis), the examiner observes a movement in favor again.\n",
      "\n",
      "Based on these observations, the correct prescription for the patient would be option b: +1.00 spherical diopter - 1.00 x 180°. This prescription takes into account the patient's nearsightedness (represented by the positive spherical diopter) and the axis of the astigmatism (180°).\n",
      "\n",
      "The other options do not match the observations made by the examiner:\n",
      "\n",
      "* Option a: +1.00 spherical diopter - 1.00 x 90° would not account for the observed movement in favor when sweeping the vertical meridian.\n",
      "* Option c: -1.00 spherical diopter + 1.00 x 90° would be appropriate if the examiner observed a movement against (away from the center of the eye) when scanning the horizontal meridian, which is not the case.\n",
      "* Option d: -1.00 spherical diopter + 1.00 x 180° would also not account for the observed movement in favor when sweeping the vertical meridian.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 70: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un paciente de 40 años previamente emétrope con antecedentes de epilepsia refiere aparición repentina de visión borrosa a distancia en ambos ojos. Presenta miopía de -4,50 dioptrías esféricas en ambos ojos, logrando agudeza visual normal. ¿Cuál es la causa probable?\n",
      "a) Accidente cerebrovascular.\n",
      "b) Uso de topiramato.\n",
      "c) Ectopia lenticular.\n",
      "d) Catarata.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c) Ectopia lenticular\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of sudden onset of blurred vision at a distance in both eyes, along with myopia of -4.50 diopters spherical in both eyes, suggest a possible ectopia lenticular (dislocation of the lens in the eye). This is a common complication in patients with a history of epilepsy, as the patient has.\n",
      "\n",
      "Option A, accident cerebrovascular (stroke), is not related to the patient's symptoms or medical history.\n",
      "\n",
      "Option B, use of topiramate, is a medication that can cause vision problems, but it is not typically associated with sudden onset of blurred vision at a distance.\n",
      "\n",
      "Option D, catarata (cataract), is a possible cause of blurred vision, but it is not typically associated with myopia.\n",
      "{'response': 'c) Ectopia lenticular'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang dating emmetropic 40 taong gulang na pasyente na may dating epilepsy ay biglaang nagrereklamo ng panlalabo ng paningin sa kaparehas na mata. Mayroon siyang myopia ng -4.50 spherical diopters sa parehong mga mata na umaabot sa normal na visual acuity. Ano ang pwedeng naging sanhi?\n",
      "a) Stroke.\n",
      "b) Paggamit ng topiramate.\n",
      "c) Ectopia lentis.\n",
      "d) Katarata.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of sudden onset of blurred vision in both eyes, with a history of epilepsy, suggest a possible diagnosis of ectopia lentis. Ectopia lentis is a condition where the lens in the eye shifts out of its normal position, causing blurred vision. The patient's myopia of -4.50 spherical diopters in both eyes, which is within normal visual acuity, supports this diagnosis.\n",
      "\n",
      "The other options are less likely to cause sudden onset of blurred vision in both eyes:\n",
      "\n",
      "* Stroke (option a) can cause vision loss or blurred vision, but it is less likely to affect both eyes simultaneously.\n",
      "* Paggamit ng topiramate (option b) is a medication used to treat epilepsy, but it is not known to cause sudden onset of blurred vision.\n",
      "* Katarata (option d) is a condition where the lens in the eye becomes cloudy, causing vision loss or blurred vision, but it is less likely to cause sudden onset of blurred vision in both eyes.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Um paciente previamente emétrope de 40 anos de idade com histórico de epilepsia refere visão embaçada para longe de aparecimento súbito em ambos os olhos. Apresenta miopia de -4,50 dioptrias esfericas em ambos os olhos atingindo acuidade visual normal. Qual a provável causa? \n",
      "a) Acidente vascular cerebral. \n",
      "b) Uso de topiramato. \n",
      "c) Ectopia lentis. \n",
      "d) Catarata.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of sudden vision loss in both eyes, along with a history of epilepsy, suggest a possible diagnosis of ocular migraine or retinal migraine. Topiramate is a medication that is sometimes associated with this condition, thus the correct answer is (b) Uso de topiramato.\n",
      "\n",
      "It's important to note that this is a hypothetical scenario and a thorough medical evaluation would be necessary to determine the actual cause of the patient's symptoms.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "A previously emmetropic 40-year-old patient with a history of epilepsy reports sudden onset blurred vision in both eyes. He has myopia of -4.50 spherical diopters in both eyes, reaching normal visual acuity. What is the likely cause? \n",
      "a) Stroke. \n",
      "b) Use of topiramate. \n",
      "c) Ectopia lentis. \n",
      "d) Cataract.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c) Ectopia lentis.\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Ectopia lentis, also known as dislocation of the lens, is a likely cause of sudden onset blurred vision in a patient with a history of myopia, especially if they have a history of epilepsy. The patient's age and history of myopia also increase the likelihood of this condition.\n",
      "\n",
      "Stroke (option a) is not a likely cause of sudden onset blurred vision in a previously emmetropic patient, especially in the absence of other neurological symptoms.\n",
      "\n",
      "Topiramate (option b) is a medication commonly used to treat epilepsy, but it is not typically associated with sudden onset blurred vision.\n",
      "\n",
      "Cataract (option d) is a possible cause of blurred vision, but it is less likely in a 40-year-old patient with a history of myopia.\n",
      "{'response': 'c) Ectopia lentis.'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 71: \n",
      "Language: spanish\n",
      "Question: \n",
      "Seleccione la alternativa que correlacione correctamente las columnas.\n",
      "I - Astigmatismo hipermétrope compuesto a favor de la regla.\n",
      "II - Astigmatismo miope compuesto contra la regla.\n",
      "III- Anisometropía astigmática.\n",
      "IV - Anisometropía antimetrópica.\n",
      "\n",
      "A - Ojo derecho: -1,00 dioptrías esféricas -1,50 dioptrías cilíndricas x 90° Ojo izquierdo: -1,00 dioptrías esféricas -1,50 dioptrías cilíndricas x 90°.\n",
      "B - Ojo derecho: +5,00 dioptrías esféricas Ojo izquierdo: -1,00 dioptrías esféricas.\n",
      "C - Ojo derecho: +5,00 dioptrías esféricas -5,00 dioptrías cilíndricas x 90° ojo izquierdo: +1,00 dioptrías esféricas -1,00 dioptrías cilíndricas x 90°.\n",
      "D - Ojo derecho: +5,00 dioptrías esféricas +2,50 dioptrías cilíndricas x 90° ojo izquierdo: +5,00 dioptrías esféricas +2,50 dioptrías cilíndricas x 90°.\n",
      "\n",
      "a)I: C / II: A / III: D / IV: B.\n",
      "b)I: C / II : B / III: A / IV: D.\n",
      "c)I: D / II: A / III: C / IV: B.\n",
      "d)I: D / II: C / III: B / IV: A.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option II: II: B / III: A / IV: D.\n",
      "\n",
      "Explanation:\n",
      "\n",
      "* II: B - The patient has a hypermetropic astigmatism in the right eye and a myopic astigmatism in the left eye, which is consistent with the rule.\n",
      "* III: A - The patient has anisometropic astigmatism, which means that the refractive error is different in each eye.\n",
      "* IV: D - The patient has anisometropic antimetropia, which means that the refractive error is different in each eye and the eye with the larger refractive error is the one that is not favored by the rule.\n",
      "\n",
      "Therefore, the correct answer is option II: II: B / III: A / IV: D.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Pagtambalin ang tugmang kondisyon sa mata sa Hanay A at ang angkop nitong sukat sa Column B\n",
      "\n",
      "I - Compound hypermetropic astigmatism in favor of the rule\n",
      "II - Compound myopic astigmatism against the rule\n",
      "III.- Astigmatic anisometropia.\n",
      "IV - Antimetropic Anisometropia.\n",
      "\n",
      "A- Kanang mata: -1.00 spherical diopter -1.50 cylindrical diopters x 90 ° Kaliwang mata: -1.00 spherical diopter -1.50 cylindrical diopters x 90 °.\n",
      "B- Kanang mata: +5.00 spherical diopters Kaliwang mata: -1.00 spherical diopters.\n",
      "C- Kanang mata: +5.00 spherical diopters -5.00 cylindrical diopters x 90 ° Kaliwang mata: +1.00 spherical diopters -1.00 cylindrical diopters x 90 °.\n",
      "D- Kanang mata: +5.00 spherical diopters +2.50 cylindrical diopters x 90 ° Kaliwang mata: +5.00 spherical diopters +2.50 cylindrical diopters x 90 °.\n",
      "\n",
      "a)I: C / II: A / III: D / IV: B.\n",
      "b)I: C / II : B / III: A / IV: D.\n",
      "c)I: D / II: A / III: C / IV: B.\n",
      "d)I: D / II: C / III: B / IV: A.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking for the correct pair of glasses prescriptions for a patient with astigmatism, given the patient's eye conditions and the available options.\n",
      "\n",
      "Option A is incorrect because it has a spherical diopter value of -1.00, which is not appropriate for astigmatism.\n",
      "\n",
      "Option B is incorrect because it has a cylindrical diopter value of -1.50, which is not appropriate for astigmatism.\n",
      "\n",
      "Option C is incorrect because it has a spherical diopter value of +5.00, which is too strong and would cause hypermetropia.\n",
      "\n",
      "Option D is the correct option because it has a spherical diopter value of +5.00 and a cylindrical diopter value of +2.50, which would correct the patient's astigmatism.\n",
      "\n",
      "Therefore, the correct answer is b) I: C / II: A / III: D / IV: B.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Assinale a alternativa que correlaciona corretamente as colunas.\n",
      "\n",
      "I - Astigmatismo hipermetrópico composto a favor da regra.\n",
      "II - Astigmatismo miópico composto contra a regra.\n",
      "III- Anisometropia astigmática.\n",
      "IV - Anisometropia antimetrópica.\n",
      "\n",
      "A - OD: -1,00 DE -1,50 DC x 90°\n",
      "OE: -1,00DE -1,50 DC x 90°.\n",
      "\n",
      "B - OD: +5,00 DE\n",
      "OE: -1,00 DE.\n",
      "\n",
      "C - OD: +5,00 DE -5,00 DC x 90°\n",
      "OE: +1,00 DE -1,00 DC x 90°.\n",
      "\n",
      "D - OD: +5,00 DE +2,50 DC x 90°\n",
      "OE: +5,00 DE +2,50 DC x 90°.\n",
      "\n",
      "a)I: C / II: A / III: D / IV: B.\n",
      "b)I: C / II : B / III: A / IV: D.\n",
      "c)I: D / II: A / III: C / IV: B.\n",
      "d)I: D / II: C / III: B / IV: A.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking for the correct correlation between the columns. The correct answer is option b:\n",
      "\n",
      "I - Astigmatismo hipermetrópico composto a favor da regra. (OD: +5,00 DE, OE: -1,00 DE)\n",
      "II - Astigmatismo miópico composto contra a regra. (OD: -1,00 DE, OE: -1,50 DE)\n",
      "III - Anisometropia astigmática. (OD: +5,00 DE -5,00 DC x 90°, OE: +1,00 DE -1,00 DC x 90°)\n",
      "IV - Anisometropia antimetrópica. (OD: +5,00 DE +2,50 DC x 90°, OE: +5,00 DE +2,50 DC x 90°)\n",
      "\n",
      "Therefore, the correct answer is b)I: C / II: B / III: A / IV: D.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Mark the alternative that correctly correlates the columns. \n",
      "I - Compound hypermetropic astigmatism in favor of the rule. \n",
      "II - Compound myopic astigmatism against the rule. \n",
      "III- Astigmatic anisometropia. \n",
      "IV - Antimetropic anisometropia. \n",
      "\n",
      "A - Right eye: -1.00 spherical diopters -1.50 cylindrical diopters x 90° Left eye: -1.00 spherical diopters -1.50 cylindrical diopters x 90°. \n",
      "B - Right eye: +5.00 spherical diopters Left eye: -1.00 spherical diopters. \n",
      "C - Right eye: +5.00 spherical diopters -5.00 cylindrical diopters x 90° left eye: +1.00 spherical diopters -1.00 cylindrical diopters x 90°. \n",
      "D - Right eye: +5.00 spherical diopters +2.50 cylindrical diopters x 90° left eye: +5.00 spherical diopters +2.50 cylindrical diopters x 90°.\n",
      "\n",
      "a)I: C / II: A / III: D / IV: B.\n",
      "b)I: C / II : B / III: A / IV: D.\n",
      "c)I: D / II: A / III: C / IV: B.\n",
      "d)I: D / II: C / III: B / IV: A.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "\n",
      "Respuesta: c) I: D / II: A / III: C / IV: B\n",
      "\n",
      "Explicación:\n",
      "\n",
      "I - Compound hypermetropic astigmatism in favor of the rule:\n",
      "\n",
      "* Derecho: +5.00 esférico\n",
      "* Izquierdo: -1.00 esférico -1.50 cilíndrico x 90°\n",
      "\n",
      "II - Compound myopic astigmatism against the rule:\n",
      "\n",
      "* Derecho: -1.00 esférico -1.50 cilíndrico x 90°\n",
      "* Izquierdo: -1.00 esférico\n",
      "\n",
      "III - Astigmatic anisometropia:\n",
      "\n",
      "* Derecho: +5.00 esférico -5.00 cilíndrico x 90°\n",
      "* Izquierdo: +1.00 esférico -1.00 cilíndrico x 90°\n",
      "\n",
      "IV - Antimetropic anisometropia:\n",
      "\n",
      "* Derecho: +5.00 esférico +2.50 cilíndrico x 90°\n",
      "* Izquierdo: +5.00 esférico +2.50 cilíndrico x 90°\n",
      "\n",
      "Por lo tanto, la respuesta correcta es la opción c.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 72: \n",
      "Language: spanish\n",
      "Question: \n",
      "Clasifica los astigmatismos a continuación según la queratometría central. Considere el astigmatismo interno insignificante.\n",
      "\n",
      "I- 44,00 @ 90° x 42,00 @ 180°.\n",
      "II- 44,00 @ 180° x 42,00 @ 90°.\n",
      "III- 44,00 @ 45° x 42,00 @ 135°.\n",
      "\n",
      "A- Astigmatismo a favor de la regla.\n",
      "B- Astigmatismo contra la regla.\n",
      "C- Astigmatismo oblicuo.\n",
      "\n",
      "a)I: A, II: B, III: C.\n",
      "b)I: A, II: C, III: B.\n",
      "c)I: B, II: A, III: C.\n",
      "d)I: B, II: C, III: A.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b)I: A, II: C, III: B\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The query is asking for the classification of astigmatism based on keratometry readings. The options are:\n",
      "\n",
      "A - Astigmatism in favor of the rule (with the cylinder axis at 90° or 180°)\n",
      "B - Astigmatism against the rule (with the cylinder axis at 45° or 135°)\n",
      "C - Oblique astigmatism (with the cylinder axis at 45° or 135°)\n",
      "\n",
      "The correct answer is option b)I: A, II: C, III: B.\n",
      "\n",
      "I - 44,00 @ 90° x 42,00 @ 180° is Astigmatism in favor of the rule, as the cylinder axis is at 90°.\n",
      "II - 44,00 @ 180° x 42,00 @ 90° is Astigmatism against the rule, as the cylinder axis is at 180°.\n",
      "III - 44,00 @ 45° x 42,00 @ 135° is Oblique astigmatism, as the cylinder axis is at 45°.\n",
      "{'response': 'b)I: A, II: C, III: B'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Pagtambalin ayon sa central keratometry sa Hanay A at ang uri ng astigmatism sa Hanay B. Alalahanin ang inisignifant internal astigmatism.\n",
      "\n",
      "I- 44.00 @ 90 ° x 42.00 @ 180 °.\n",
      "II- 44.00 @ 180 ° x 42.00 @ 90 °.\n",
      "III- 44.00 @ 45 ° x 42.00 @ 135 °.\n",
      "\n",
      "A- Astigmatism in favor of the rule.\n",
      "B- Astigmatism against the rule\n",
      "C- Oblique astigmatism.\n",
      "\n",
      "a) I: A, II: B, III: C.\n",
      "b) I: A, II: C, III: B.\n",
      "c) I: B, II: A, III: C.\n",
      "d) I: B, II: C, III: A.\n",
      "Test #0: \n",
      "response\n",
      "  Here's my answer:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the orientation of astigmatism in relation to the central keratometry reading.\n",
      "\n",
      "Option A states that the astigmatism is in favor of the rule, which means that the steepest meridian of the astigmatism is parallel to the 90-degree meridian. This is not the case for any of the given options.\n",
      "\n",
      "Option B states that the astigmatism is against the rule, which means that the steepest meridian of the astigmatism is perpendicular to the 90-degree meridian. This is the case for option II, where the astigmatism is 44.00 @ 180 ° x 42.00 @ 90 °.\n",
      "\n",
      "Option C states that the astigmatism is oblique, which means that the steepest meridian of the astigmatism is not parallel or perpendicular to the 90-degree meridian. This is the case for options I and III, where the astigmatism is not aligned with the 90-degree meridian.\n",
      "\n",
      "Therefore, the correct answer is option b, where the astigmatism is against the rule.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Classifique os astigmatismos abaixo de acordo com a ceratometria central. Considere o astigmatismo interno insignificante.\n",
      "\n",
      "I- 44,00 @ 90° x 42,00 @ 180°.\n",
      "II- 44,00 @ 180° x 42,00 @ 90°.\n",
      "III- 44,00 @ 45° x 42,00 @ 135°.\n",
      "\n",
      "A- Astigmatismo a favor da regra.\n",
      "B- Astigmatismo contra a regra.\n",
      "C- Astigmatismo oblíquo.\n",
      "\n",
      "a)I: A, II: B, III: C.\n",
      "b)I: A, II: C, III: B.\n",
      "c)I: B, II: A, III: C.\n",
      "d)I: B, II: C, III: A.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b)I: A, II: C, III: B.\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The given query is in Portuguese and asks for the classification of astigmatism based on keratometry readings. The options are:\n",
      "\n",
      "A - Astigmatism in the direction of the rule (with the steepest meridian at 90° or 180°).\n",
      "B - Astigmatism against the rule (with the steepest meridian at 45° or 135°).\n",
      "C - Oblique astigmatism (with the steepest meridian between 45° and 135°).\n",
      "\n",
      "The correct answer is option b, as the keratometry readings for case I are 44.00 @ 90° x 42.00 @ 180°, which indicates astigmatism in the direction of the rule. For case II, the readings are 44.00 @ 180° x 42.00 @ 90°, which indicates astigmatism against the rule. For case III, the readings are 44.00 @ 45° x 42.00 @ 135°, which indicates oblique astigmatism.\n",
      "\n",
      "Therefore, the correct classification is:\n",
      "\n",
      "* Case I: A (Astigmatism in the direction of the rule)\n",
      "* Case II: C (Astigmatism against the rule)\n",
      "* Case III: B (Oblique astigmatism)\n",
      "{'response': 'b)I: A, II: C, III: B.'}\n",
      "Language: english\n",
      "Question: \n",
      "Classify the astigmatisms below according to the central keratometry. Consider insignificant internal astigmatism.\n",
      "\n",
      "I- 44.00 @ 90° x 42.00 @ 180°.\n",
      "II- 44.00 @ 180° x 42.00 @ 90°.\n",
      "III- 44.00 @ 45° x 42.00 @ 135°.\n",
      "\n",
      "A- Astigmatism in favor of the rule.\n",
      "B- Astigmatism against the rule.\n",
      "C- Oblique astigmatism.\n",
      "\n",
      "a) I: A, II: B, III: C.\n",
      "b) I: A, II: C, III: B.\n",
      "c) I: B, II: A, III: C.\n",
      "d) I: B, II: C, III: A.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b) I: A, II: C, III: B.\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "I- 44.00 @ 90° x 42.00 @ 180°: The vertical meridian (90°) has a steeper keratometry reading (44.00) than the horizontal meridian (180°) with a reading of 42.00, indicating astigmatism in favor of the rule.\n",
      "\n",
      "II- 44.00 @ 180° x 42.00 @ 90°: The horizontal meridian (180°) has a steeper keratometry reading (44.00) than the vertical meridian (90°) with a reading of 42.00, indicating astigmatism against the rule.\n",
      "\n",
      "III- 44.00 @ 45° x 42.00 @ 135°: The keratometry readings are not in the same meridian, so it is an oblique astigmatism.\n",
      "\n",
      "Therefore, the correct answer is option b: I: A, II: C, III: B.\n",
      "{'response': 'b) I: A, II: C, III: B.'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 73: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un paciente se aleja de los refractores Greens para evitar que se empañen los lentes debido al uso de una mascarilla durante el examen. ¿Cuál de las siguientes alternativas es la correcta si se mantiene alejado de los Greens y el oftalmólogo no se da cuenta?\n",
      "a) Si es miope, su prescripción estará subcorregida.\n",
      "b) Si es miope habrá sobrecorrección en su prescripción.\n",
      "c) Si es miope, no habrá cambio en su prescripción.\n",
      "d) Si es previsor, necesitará un mayor esfuerzo de acomodación.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "If the patient moves away from the Greens refractors and the ophthalmologist does not notice, the correct answer is (c) If the patient is myopic, there will be no change in their prescription.\n",
      "\n",
      "In this scenario, the patient's myopia is not being corrected as they are not using the refractors properly. Therefore, their prescription will remain the same.\n",
      "\n",
      "Option (a) is incorrect because the patient's prescription will not be under-corrected. Option (b) is also incorrect because there will not be an overcorrection in their prescription. Option (d) is not relevant to the scenario as the patient is not presbyopic.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Lumayo ang isang pasyente mula sa Greens upang hindi lumabo ang kanyang suot na salamin dala ng pagsusuot ng mask habang siya ay nagsusulit. Alin sa mga sumusunod na pahayag ang tama kung siya ay lumayo sa Greens at hindi napansin ng ophthalmologist?\n",
      "a) Kung siya ay myopic, magkakaroon ng undercorrection sa kanyang preskripsyon\n",
      "b) Kung siya ay myopic, magkakaroon ng overcorrection sa kanyang preskripsyon\n",
      "c) Kung siya ay nearsighted, walang pagbabago sa kanyang presktipston.\n",
      "d) Kung siya ay farsighted, kakailanganin niya ng mas mataas na accommodative effort. \n",
      "Test #0: \n",
      "response\n",
      "  Here's my answer:\n",
      "\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"b\"  // This is the option of the correct response. Could be only any of these: A, B, C, D\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "If the patient is myopic and the ophthalmologist did not notice that the patient's glasses were not properly adjusted, then the patient's prescription would likely result in overcorrection. This is because the patient's myopia would not be properly corrected, leading to blurry vision.\n",
      "\n",
      "Option A is incorrect because undercorrection occurs when the prescription is too weak, and the patient's vision is still blurry. Option C is incorrect because the patient's nearsightedness would not be affected by the adjustment of their glasses. Option D is incorrect because farsightedness is not related to the issue of improperly adjusted glasses.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Um paciente se afasta do Greens para não embaçar as lentes devido ao uso de máscara durante o exame. Qual das alternativas abaixo é correta caso ele permaneça afastado do Greens e o oftalmologista não perceba? \n",
      "a) Se ele for míope, haverá hipocorreção em sua prescrição. \n",
      "b) Se ele for míope, haverá hipercorreção em sua prescrição. \n",
      "c) Se ele for míope, não haverá mudança em sua prescrição. \n",
      "d) Se ele for hipermetrope, necessitará de maior esforço acomodativo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "If the patient moves away from the Greens and the ophthalmologist does not notice, and the patient is myopic, then there will be no change in their prescription. Therefore, the correct answer is option c.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "A patient moves away from the Greens so as not to fog up his lenses due to the use of a mask during the exam. Which of the following is correct if he stays away from the Greens and the ophthalmologist doesn't notice? \n",
      "a) If he is myopic, there will be undercorrection in his prescription. \n",
      "b) If he is myopic, there will be overcorrection in his prescription. \n",
      "c) If he is nearsighted, there will be no change in his prescription. \n",
      "d) If he is farsighted, he will need greater accommodative effort.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "If the patient moves away from the Greens and the ophthalmologist doesn't notice, there will be no change in his prescription if he is nearsighted. The patient's distance vision will not be affected, and his prescription will remain the same.\n",
      "\n",
      "Option A is incorrect because if the patient is myopic and moves away from the Greens, there will be undercorrection in his prescription.\n",
      "\n",
      "Option B is incorrect because if the patient is myopic and moves away from the Greens, there will be overcorrection in his prescription.\n",
      "\n",
      "Option D is incorrect because if the patient is farsighted, he will not need greater accommodative effort. Farsightedness means that the patient can see far objects clearly, but may have difficulty seeing near objects. Moving away from the Greens will not affect his ability to see far objects.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 74: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál es la función del ajuste \"P\" en el refractor Greens?\n",
      "a) Aumente la potencia esférica positiva para probar la refracción cercana.\n",
      "b) Aumentar la potencia esférica negativa para reducir la distancia de trabajo en skiascopia.\n",
      "c) Insertar un prisma de 6 DP y permitir la evaluación de la balanza refractométrica.\n",
      "d) Separar las imágenes y permitir la valoración del equilibrio refractométrico y la estereopsis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "La función del ajuste \"P\" en el refractor Greens es insertar un prisma de 6 DP y permitir la evaluación de la balanza refractométrica. Por lo tanto, la respuesta correcta es la opción c.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ano ang gamit ng \"P\" setting sa Greens refractor?\n",
      "a) Dinadagdagan ang positibong spherical power upang suriin ang near refraction.\n",
      "b) Dinadagdagan ang negatibong spherical power upang bawasan ang working distance o sa skiascopy.\n",
      "c) Ilagay ang isang 6 DP prism at payagan ang pagsusuri ng refractometric balance.\n",
      "d) Paghiwalayin ang mga imahe at payagan ang pagsusuri ng refractometric na balanse at stereopsis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The \"P\" setting on a Greens refractor is used to adjust the positive spherical power to improve the near refraction. Therefore, option A is the correct answer.\n",
      "\n",
      "In Tagalog:\n",
      "\n",
      "Ang \"P\" setting sa Greens refractor ay ginagamit upang iyakap ang positibong spherical power upang suriin ang near refraction. Dahil dito, ang opsiyon A ay ang tama.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual a função do ajuste \"P\" no refrator de Greens? \n",
      "a) Aumentar o poder esférico positivo para testar a refração para perto. \n",
      "b) Aumentar o poder esférico negativo para descontar a distância de trabalho na esquiascopia. \n",
      "c) Inserir um prisma de 6 DP e possibilitar a avaliação do balanço refratométrico. \n",
      "d) Separar as imagens e possibilitar avaliação do balanço refratométrico e da estereopsia.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "A função do ajuste \"P\" no refrator de Greens é inserir um prisma de 6 DP e possibilitar a avaliação do balanço refratométrico. Portanto, a resposta correta é a opção C.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "What is the function of the \"P\" setting on the Greens refractor? \n",
      "a) Increase positive spherical power to test near refraction. \n",
      "b) Increase the negative spherical power to discount the working distance in skiascopy. \n",
      "c) Insert a 6 DP prism and allow the evaluation of the refractometric balance.\n",
      "d) Separate the images and allow evaluation of refractometric balance and stereopsis.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "La función del ajuste \"P\" en el refractor de Greens es insertar un prisma de 6 DP y permitir la evaluación de la balance refractométrica.\n",
      "\n",
      "Here's the answer in Tagalog:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "Ang tungkulin ng setting na \"P\" sa Greens refractor ay ang pagpapasok ng isang prisma na 6 DP at ang pahintulot sa evaluación ng balance refractométrica.\n",
      "\n",
      "Here's the answer in Portuguese:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "A função do ajuste \"P\" no refractor de Greens é inserir um prisma de 6 DP e permitir a avaliação da balance refractométrica.\n",
      "\n",
      "Here's the answer in English:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "The function of the \"P\" setting on the Greens refractor is to insert a 6 DP prism and allow the evaluation of the refractometric balance.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 75: \n",
      "Language: spanish\n",
      "Question: \n",
      "Una persona miope con corrección insuficiente suele inclinar sus gafas para ver mejor. ¿Qué efecto tiene esta maniobra en tus lentes correctivos?\n",
      "a) Aumento de la divergencia óptica e inducción de un cilindro positivo en el eje de inclinación.\n",
      "b) Mayor convergencia óptica e inducción de un cilindro negativo en el eje de inclinación.\n",
      "c) Aumento de la divergencia óptica e inducción de un cilindro negativo en el eje de inclinación.\n",
      "d) Mayor convergencia óptica e inducción de un cilindro positivo en el eje de inclinación.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "When a myope (nearsighted person) tilts their glasses to see better, it has an effect on the corrective lenses. The tilting action induces a cylindrical power in the direction of the inclination, which means that the lenses become more divergent or convergent depending on the angle of inclination.\n",
      "\n",
      "Option c) Aumento de la divergencia óptica e inducción de un cilindro negativo en el eje de inclinación (Increase in optical divergence and induction of a negative cylinder in the inclination axis) is the correct answer. This option correctly describes the effect of tilting the glasses on the corrective lenses, which is an increase in divergence and a negative cylindrical power in the direction of inclination.\n",
      "\n",
      "Option a) Aumento de la divergencia óptica e inducción de un cilindro positivo en el eje de inclinación (Increase in optical divergence and induction of a positive cylinder in the inclination axis) is incorrect because it describes the opposite effect, which is a decrease in divergence and a positive cylindrical power in the direction of inclination.\n",
      "\n",
      "Option b) Mayor convergencia óptica e inducción de un cilindro negativo en el eje de inclinación (Increase in optical convergence and induction of a negative cylinder in the inclination axis) is also incorrect because it describes the opposite effect, which is a decrease in convergence and a negative cylindrical power in the direction of inclination.\n",
      "\n",
      "Option d) Mayor convergencia óptica e inducción de un cilindro positivo en el eje de inclinación (Increase in optical convergence and induction of a positive cylinder in the inclination axis) is incorrect because it describes the opposite effect, which is an increase in convergence and a positive cylindrical power in the direction of inclination.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang isang undercorrected myopic na tao ay madalas na nagkikiling ng salamin upang makita nang mas malinaw. Ano ang epekto nito sa kanyang mga corrective lens?\n",
      "a) Nadagdagan ang optical divergence at positibong cylinder induction sa tilting axis\n",
      "b) Nadagdagan ang optical convergence at negatibong cylinder induction sa tilting axis\n",
      "c) Nadagdagan ang optical divergence at negatibong cylinder induction sa tilting axis\n",
      "d) Nadagdagan ang optical convergence at positibong cylinder induction sa tilting axis\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "An undercorrected myopic person often tilts their head to see clearer. This action causes the corrective lens to work differently, specifically, it increases the optical convergence at the tilting axis, which is represented by option B, \"Nadagdagan ang optical convergence at negatibong cylinder induction sa tilting axis.\"\n",
      "\n",
      "Therefore, option B is the correct answer.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Um míope hipocorrigido frequentemente inclina seus óculos para enxergar melhor. Qual o efeito desta manobra em suas lentes corretoras? \n",
      "a) Aumento da divergência óptica e indução de cilindro positivo no eixo da inclinação. \n",
      "b) Aumento da convergência óptica e indução de cilindro negativo no eixo da inclinação. \n",
      "c) Aumento da divergência óptica e indução de cilindro negativo no eixo da inclinação. \n",
      "d) Aumento da convergência óptica e indução de cilindro positivo no eixo da inclinação.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "When a myope (nearsighted person) frequently tilts their glasses to see better, the effect on their corrective lenses is an increase in optical divergence and the induction of a positive cylinder in the axis of inclination. This is option A.\n",
      "\n",
      "Option B is incorrect because it describes the opposite effect, which would be a decrease in optical divergence and the induction of a negative cylinder in the axis of inclination.\n",
      "\n",
      "Option C is also incorrect because it describes a different effect, which would be an increase in optical divergence and the induction of a negative cylinder in the axis of inclination.\n",
      "\n",
      "Option D is incorrect because it describes a different effect, which would be a decrease in optical divergence and the induction of a positive cylinder in the axis of inclination.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "An undercorrected myopic person often tilts his glasses to see better. What effect does this maneuver have on your corrective lenses? \n",
      "a) Increased optical divergence and positive cylinder induction on the tilt axis. \n",
      "b) Increased optical convergence and negative cylinder induction on the tilt axis. \n",
      "c) Increased optical divergence and negative cylinder induction on the tilt axis. \n",
      "d) Increased optical convergence and positive cylinder induction on the tilt axis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "When an myopic person tilts their glasses, it causes the corrective lenses to become decentered, which can lead to a change in the optical convergence and cylinder induction. The tilted position of the lenses will cause the light rays to converge more than they should, resulting in increased optical convergence and negative cylinder induction on the tilt axis.\n",
      "\n",
      "Therefore, the correct answer is option b: Increased optical convergence and negative cylinder induction on the tilt axis.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 76: \n",
      "Language: spanish\n",
      "Question: \n",
      "Durante la práctica clínica de refracción, el residente de primer año instiló gotas ciclopléjicas para los ojos a los pacientes, pero perdió el frasco. Su preceptor decidió medir el efecto de acomodación para saber qué colirios se utilizaban y observó que los pacientes tenían buena midriasis y presentaban una reducción máxima de la acomodación entre 20 y 30 minutos después de la instilación, con un efecto fugaz. ¿Qué gotas para los ojos le puso el residente?\n",
      "a) Atropina.\n",
      "b) Ciclopentolato.\n",
      "c) Fenilefrina.\n",
      "d) Tropicamida.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // The correct answer is b) Ciclopentolato.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The resident instilled cyclopentolate drops, which caused a reduction in accommodation and a good mydriasis (dilation of the pupil) that lasted for 20-30 minutes. Cyclopentolate is a parasympatholytic drug that inhibits the activity of the parasympathetic nervous system, leading to a decrease in the production of tears and a reduction in the accommodation reflex.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "* Atropina (a) is an anticholinergic drug that also inhibits the parasympathetic nervous system, but it has a longer duration of action and is not typically used for refraction testing.\n",
      "* Fenilefrina (c) is an alpha-agonist that increases the production of tears and is used to treat dry eyes.\n",
      "* Tropicamida (d) is a anticholinergic drug that also inhibits the parasympathetic nervous system, but it has a shorter duration of action than cyclopentolate and is not typically used for refraction testing.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Sa refraction outpatient clinic, ang first year resident ay nagpatak ng cycloplegic eye drop sa mata ng mga pasyente, ngunit nawala ang bote. Nagpasya ang kanyang preceptor na sukatin ang accomodation effect upang malaman kung aling bote ang ginamit, napansin nila na ang mga pasyente ay may mainamna mydriasis at nagkaroon ng maximum na pagbawas sa accomodation pagkatapos ng 20 hanggang 30 minuto pagkatapos ng pagpatak sa kanil na mabilis ding mawala ang epekto. Anong eyedrop ang ginamit ng resident?\n",
      "a) Atropine.\n",
      "b) Cyclopentolate.\n",
      "c) Phenylephrine.\n",
      "d) Tropicamide.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // b) Cyclopentolate\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Cyclopentolate is a cycloplegic eye drop that is commonly used to dilate the pupils and reduce accommodation. It works by paralyzing the ciliary muscles, which are responsible for accommodation. The effects of cyclopentolate can last for 20-30 minutes, which is consistent with the time frame mentioned in the question.\n",
      "\n",
      "Atropine (option a) is an anticholinergic agent that can also dilate the pupils, but it does not have a direct effect on accommodation. Phenylephrine (option c) is a vasoconstrictor that can increase intraocular pressure, but it does not have a significant effect on pupil dilation or accommodation. Tropicamide (option d) is a anticholinergic agent that can dilate the pupils, but it has a shorter duration of action compared to cyclopentolate.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Durante o ambulatório de refração o residente do primeiro ano instilou um colírio cicloplégico nos pacientes, mas perdeu o frasco. Seu preceptor resolveu medir o efeito de acomodação para descobrir qual colírio foi usado e notou que os pacientes estavam com boa midríase e tiveram redução máxima na acomodação 20 a 30 minutos após a instilação, com efeito fugaz. Qual colírio o residente instilou? \n",
      "a) Atropina. \n",
      "b) Ciclopentolato. \n",
      "c) Fenilefrina. \n",
      "d) Tropicamida.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // b) Ciclopentolato\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The resident instilled a cycloplegic drops (ciclopentolato) in the patients during the refraction clinic, which caused a temporary reduction in accommodation, as observed by the preceptor. The other options (atropine, phenylephrine, and tropicamide) are also cycloplegics, but they have different effects and durations.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "During the refraction outpatient clinic, the first-year resident instilled a cycloplegic eye drop in the patients, but lost the bottle. His preceptor decided to measure the accommodation effect to find out which drops were used and noticed that the patients had good mydriasis and had a maximum reduction in accommodation 20 to 30 minutes after instillation, with a fleeting effect. What eye drops did the resident instill? \n",
      "a) Atropine. \n",
      "b) Cyclopentolate. \n",
      "c) Phenylephrine. \n",
      "d) Tropicamide.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // b) Cyclopentolate\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The symptoms described, good mydriasis and a maximum reduction in accommodation 20 to 30 minutes after instillation, with a fleeting effect, are consistent with the effects of cyclopentolate eye drops. Cyclopentolate is a cycloplegic agent that causes pupillary dilation and reduces accommodation, and its effects can last for several hours.\n",
      "\n",
      "Atropine (option a) is an anticholinergic agent that can also cause pupillary dilation, but its effects on accommodation are less pronounced than cyclopentolate. Phenylephrine (option c) is an alpha-agonist that can cause pupillary dilation, but it has a shorter duration of action compared to cyclopentolate. Tropicamide (option d) is a anticholinergic agent that can cause pupillary dilation, but its effects on accommodation are less pronounced than cyclopentolate.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 77: \n",
      "Language: spanish\n",
      "Question: \n",
      "Durante la skiascopia de un paciente, ¿cuál de las siguientes características indica que el examinador está más cerca del punto de neutralidad?\n",
      "a) Velocidad de haz rápida, alto brillo, haz amplio.\n",
      "b) Velocidad de haz rápida, brillo bajo, haz estrecho.\n",
      "c) Velocidad de haz lenta, alto brillo, haz amplio.\n",
      "d) Velocidad de haz lenta, brillo bajo, haz estrecho.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) Velocidad de haz rápida, brillo bajo, haz estrecho.\n",
      "\n",
      "During a skiascopy examination, the characteristic that indicates the examiner is closer to the neutrality point is a rapid beam speed, low brightness, and a narrow beam. This is because the neutrality point is the area on the skin where the beam of light is perpendicular to the skin surface, and the examiner is looking for the point where the light is scattered the least, which is indicative of a lower brightness and a narrower beam.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Sa tuwing sumasailalim sa skiascopy ang pasyente, aling katangian ang nagpapahiwatig na ang tagasuri ay pinakamalapit sa point of neutrality?\n",
      "a) Mabilis na beam speed, mataas na katingkaran, malawak na beam.\n",
      "b) Mabilis na beam speed, mababang katingkaran, makitid na bean.\n",
      "c) Mabagal na beam speed, mataas na katingkaran, malawak na beam.\n",
      "d) Mabagal na beam speed, mababang na katingkaran, makitid na beam.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the characteristic that makes the tagasuri (surgeon) closest to the point of neutrality during a skiascopy procedure.\n",
      "\n",
      "Option A describes a situation where the beam speed is fast, the katingkaran (focus) is high, and the beam is wide. This would result in a more aggressive procedure, which would not be ideal for a skiascopy.\n",
      "\n",
      "Option B describes a situation where the beam speed is fast, the katingkaran is low, and the beam is narrow. This would result in a more precise and controlled procedure, which would be ideal for a skiascopy.\n",
      "\n",
      "Option C describes a situation where the beam speed is slow, the katingkaran is high, and the beam is wide. This would result in a less aggressive procedure, but the wide beam could still cause damage to the surrounding tissue.\n",
      "\n",
      "Option D describes a situation where the beam speed is slow, the katingkaran is low, and the beam is narrow. This would result in a less aggressive and more precise procedure, but the slow beam speed could make the procedure less effective.\n",
      "\n",
      "Therefore, the correct answer is option B.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Durante a esquiascopia de um paciente, qual das características abaixo indica que o examinador está mais próximo do ponto de neutralidade? \n",
      "a) Velocidade do feixe rápida, brilho alto, feixe largo. \n",
      "b) Velocidade do feixe rápida, brilho baixo, feixe estreito. \n",
      "c) Velocidade do feixe lenta, brilho alto, feixe largo. \n",
      "d) Velocidade do feixe lenta, brilho baixo, feixe estreito.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "During an ultrasound examination, the characteristic that indicates the examiner is closer to the neutrality point is a rapid beam speed, low brightness, and a narrow beam. This is option b.\n",
      "\n",
      "In ultrasound, the neutrality point refers to the point at which the ultrasound beam is perpendicular to the skin surface, allowing for the best possible image quality. A rapid beam speed and low brightness help to achieve this neutrality point by reducing the amount of time the beam spends on the skin surface, thus reducing the risk of overheating and improving image quality. A narrow beam also helps to concentrate the ultrasound energy on a smaller area, making it easier to obtain a clear image.\n",
      "\n",
      "Therefore, option b, \"Velocidade do feixe rápida, brilho baixo, feixe estreito,\" is the correct answer.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "During a patient's skiascopy, which of the following characteristics indicates that the examiner is closest to the point of neutrality? \n",
      "a) Fast beam speed, high brightness, wide beam. \n",
      "b) Fast beam speed, low brightness, narrow beam. \n",
      "c) Slow beam speed, high brightness, wide beam. \n",
      "d) Slow beam speed, low brightness, narrow beam.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) Fast beam speed, low brightness, narrow beam.\n",
      "\n",
      "When performing a skiascopy, the examiner is closest to the point of neutrality when the beam is fast, but the brightness is low and the beam is narrow. This allows the examiner to visualize the deeper structures of the eye without being overwhelmed by the bright light.\n",
      "\n",
      "In option a, the fast beam speed and high brightness may cause the examiner to miss subtle details in the deeper structures of the eye. In option c, the slow beam speed and high brightness may cause the examiner to lose focus on the deeper structures. In option d, the slow beam speed and low brightness may make it difficult to visualize the deeper structures.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 78: \n",
      "Language: spanish\n",
      "Question: \n",
      "En el examen de un paciente fáquico, el punto cercano de acomodación se encontró en el ojo derecho a 30 cm y en el ojo izquierdo a 50 cm. En este caso se puede afirmar que:\n",
      "a) El ojo izquierdo debe ser más miope que el derecho.\n",
      "b) Lo más probable es que sea necesario ajustar la refracción del paciente.\n",
      "c) Es una condición común, ya que la acomodación rara vez es similar en ambos ojos.\n",
      "d) Una enfermedad que hace avanzar la retina, como la coriorretinopatía serosa central, es la causa de esta menor distancia en el ojo derecho.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Lo más probable es que sea necesario ajustar la refracción del paciente.\n",
      "\n",
      "The patient's near point of accommodation was found to be 30 cm in the right eye and 50 cm in the left eye. This suggests that the patient has a difference in refractive power between the two eyes, with the left eye being more hyperopic than the right eye. Therefore, it is likely that the patient will need a refractive correction to achieve clear vision.\n",
      "\n",
      "Option a) El ojo izquierdo debe ser más miope que el derecho is incorrect because the near point of accommodation is not a measure of the degree of myopia or hyperopia, but rather a measure of the eye's ability to focus on near objects.\n",
      "\n",
      "Option c) Es una condición común, ya que la acomodación rara vez es similar en ambos ojos is incorrect because while it is true that the near point of accommodation can vary between eyes, a difference of 20 cm (50 cm - 30 cm) is not considered a normal variation.\n",
      "\n",
      "Option d) Una enfermedad que hace avanzar la retina, como la coriorretinopatía serosa central, es la causa de esta menor distancia en el ojo derecho is incorrect because there is no mention of any retinal disease or abnormality in the patient's history.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Sa pagsusuri ng pasyente na phakic, ang pinakamalapit na punto ng accomodation ay natagpuan sa kanang mata na may 30 cm na layo at sa kaliwang mata sa 50 cm. Sa kasong ito, ipinapahiwatig na:\n",
      "a) Ang kaliwang mata ay dapat na mas myopic kaysa sa kanang mata.\n",
      "b) Inaasahan na may pangangailangan upang iakma ang refraction ng mata ng pasyente\n",
      "c) Ito ay isang pangkaraniwang kondisyon, sapagkat ang accommodation ng mata ay madalang na magkatulad sa parehong mata\n",
      "d) Ang mga karamdamang guamagalaw papaharap ang retina, tulad ng central serous chorioretinopathy, ay nagdulot ng mas maikling distansya sa kanang mata\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's accommodation is the ability of the eye to focus on near objects. The near point of accommodation is the closest distance at which the eye can focus on an object. In this case, the near point of accommodation is 30 cm for the right eye and 50 cm for the left eye. This means that the left eye has a longer near point of accommodation than the right eye.\n",
      "\n",
      "Option b is the correct answer because it states that the patient may have a refractive error that needs to be corrected. The difference in the near point of accommodation between the two eyes could indicate that the patient has a refractive error, such as myopia or hyperopia, that affects one eye more than the other. A comprehensive eye exam would be necessary to determine the specific refractive error and the appropriate correction.\n",
      "\n",
      "Option a is incorrect because it states that the left eye should be more myopic than the right eye, which is not supported by the given information.\n",
      "\n",
      "Option c is incorrect because it states that the accommodation of the eye is normal, but the given information indicates that there is a difference in the near point of accommodation between the two eyes.\n",
      "\n",
      "Option d is incorrect because it mentions retinal conditions that can cause vision problems, but the given information does not suggest any retinal abnormalities.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "No exame de um paciente fácico, foi encontrado o ponto próximo de acomodação no olho direito a 30 cm e no olho esquerdo a 50 cm. Neste caso, pode-se afirmar: \n",
      "a) O olho esquerdo deve ser mais míope que o olho direito. \n",
      "b) Mais provavelmente há necessidade de se ajustar a refração do paciente. \n",
      "c) É uma condição comum, já que a acomodação é raramente semelhante nos dois olhos. \n",
      "d) Uma doença que desloque a retina para frente, como a coriorretinopatia central serosa, é causa dessa menor distância no olho direito.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The given information states that the near point of accommodation in the right eye is 30 cm, while in the left eye it is 50 cm. This means that the left eye has a longer near point than the right eye, indicating that the left eye is more hyperopic (farsighted) than the right eye. Therefore, option b, \"Mais provavelmente há necessidade de se ajustar a refração do paciente\" (More likely, the patient's refraction needs to be adjusted), is the correct answer.\n",
      "\n",
      "Note: The other options are not correct because:\n",
      "\n",
      "* Option a, \"O olho esquerdo deve ser mais míope que o olho direito\" (The left eye should be more myopic than the right eye), is incorrect because the given information states the opposite.\n",
      "* Option c, \"É uma condição comum, já que a acomodação é raramente semelhante nos dois olhos\" (It's a common condition, since accommodation is rarely similar in both eyes), is incorrect because it doesn't address the specific situation described in the question.\n",
      "* Option d, \"Uma doença que desloque a retina para frente, como a coriorretinopatia central serosa, é causa dessa menor distância no olho direito\" (A disease that displaces the retina forward, such as central serous chorioretinopathy, is the cause of the shorter distance in the right eye), is incorrect because there is no mention of any disease or abnormality in the given information.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "On examination of a phakic patient, the closest point of accommodation was found in the right eye at 30 cm and in the left eye at 50 cm. In this case, it can be stated: \n",
      "a) The left eye must be more myopic than the right eye. \n",
      "b) More likely there is a need to adjust the patient's refraction. \n",
      "c) It is a common condition, as accommodation is rarely similar in both eyes. \n",
      "d) A disease that moves the retina forward, such as central serous chorioretinopathy, is the cause of this shorter distance in the right eye.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The given information states that the closest point of accommodation in the right eye is 30 cm, while in the left eye it is 50 cm. This means that the left eye has a longer accommodation distance than the right eye. This can be a normal variation and not necessarily a sign of myopia or the need for refraction adjustment. Therefore, option c is the best answer.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 79: \n",
      "Language: spanish\n",
      "Question: \n",
      "Si la refracción del paciente es de +1,50 dioptrías esféricas y -0,50 dioptrías cilíndricas x 180° y su queratometría es de 42,00 dioptrías x 180° y 44,00 dioptrías x 90°, podemos decir que el astigmatismo interno es:\n",
      "a) +1,50 dioptrías cilíndricas x 90°.\n",
      "b) +2,50 dioptrías cilíndricas x 180°.\n",
      "c) -1,50 dioptrías cilíndricas x 90°.\n",
      "d) -2,50 dioptrías cilíndricas x 180°.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's refraction is +1,50 spherical diopters and -0,50 cylindrical diopters x 180°, and their keratometry is 42,00 diopters x 180° and 44,00 diopters x 90°. Based on these measurements, the internal astigmatism can be calculated as follows:\n",
      "\n",
      "Internal astigmatism = (keratometry - refraction) / 2\n",
      "\n",
      "= (42,00 - 1,50) / 2\n",
      "= (44,00 - 1,50) / 2\n",
      "= 21,00 / 2\n",
      "= 10,50 diopters\n",
      "\n",
      "Since the astigmatism is positive, it is a hyperopic astigmatism. Therefore, the correct answer is option b) +2,50 dioptrías cilíndricas x 180°.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Kung ang refraction ng mata ng pasyente ay +1.50 spherical diopters at -0.50 cylindrical diopters x 180 ° at ang kanyang keratometry ay 42.00 diopters x 180 ° at 44.00 diopters x 90 °, maaaring sabihin na ang internal astigmatism ay:\n",
      "a) +1.50 cylindrical diopters x 90 °.\n",
      "b) +2.50 cylindrical diopters x 180 °.\n",
      "c) -1.50 cylindrical diopters x 90 °.\n",
      "d) -2.50 cylindrical diopters x 180 °.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's refraction is +1.50 spherical diopters and -0.50 cylindrical diopters x 180 °, and their keratometry is 42.00 diopters x 180 ° and 44.00 diopters x 90 °. To calculate the internal astigmatism, we need to subtract the cylindrical diopter value from the spherical diopter value, and then convert the result to cylindrical diopters x 90 °.\n",
      "\n",
      "Using the formula:\n",
      "\n",
      "Internal Astigmatism = (Spherical Diopter - Cylindrical Diopter) x 90 °\n",
      "\n",
      "Substituting the values:\n",
      "\n",
      "Internal Astigmatism = (+1.50 - (-0.50)) x 90 °\n",
      "= +1.50 + 0.50\n",
      "= +2.00 diopters x 90 °\n",
      "\n",
      "Therefore, the correct answer is option b: +2.50 cylindrical diopters x 180 °.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Se a refração do paciente é +1,50 dioptrias esfericas e -0,50 dioptrias cilindricas x 180° e sua ceratometria é 42,00 Dioptrias x 180° e 44,00 Dioptrias x 90°, podemos afirmar que o astigmatismo interno é: \n",
      "a) +1,50 dioptrias cilindricas x 90°. \n",
      "b) +2,50 dioptrias cilindricas x 180°. \n",
      "c) -1,50 dioptrias cilindricas x 90°. \n",
      "d) -2,50 dioptrias cilindricas x 180°.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's refraction is +1,50 dioptrias spherical and -0,50 dioptrias cylindrical x 180°, and their keratometry is 42,00 dioptrias x 180° and 44,00 dioptrias x 90°. Based on these measurements, we can calculate the astigmatism as follows:\n",
      "\n",
      "Astigmatism = (cylinder power x axis) - (sphere power x axis)\n",
      "\n",
      "In this case, the cylinder power is -0,50 dioptrias and the axis is 180°. The sphere power is +1,50 dioptrias. Therefore, the astigmatism is:\n",
      "\n",
      "Astigmatism = (-0,50 x 180°) - (+1,50 x 180°) = -2,50 dioptrias x 180°\n",
      "\n",
      "Therefore, the correct answer is option b: +2,50 dioptrias cilindricas x 180°.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "If the patient's refraction is +1.50 spherical diopters and -0.50 cylindrical diopters x 180° and his keratometry is 42.00 diopters x 180° and 44.00 diopters x 90°, we can say that the internal astigmatism is : \n",
      "a) +1.50 cylindrical diopters x 90°. \n",
      "b) +2.50 cylindrical diopters x 180°. \n",
      "c) -1.50 cylindrical diopters x 90°. \n",
      "d) -2.50 cylindrical diopters x 180°.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The internal astigmatism can be calculated by taking the difference between the keratometry readings at 180° and 90°.\n",
      "\n",
      "Keratometry reading at 180°: 42.00 diopters\n",
      "Keratometry reading at 90°: 44.00 diopters\n",
      "\n",
      "The difference between the two readings is: 44.00 - 42.00 = 2.00 diopters\n",
      "\n",
      "Since the difference is positive, the internal astigmatism is with-the-rule (WTR) and the cylindrical power is 2.50 diopters. The axis of the astigmatism is 180°.\n",
      "\n",
      "Therefore, the correct answer is option b: +2.50 cylindrical diopters x 180°.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 80: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un paciente pseudofáquico con una refracción de +1,00 dioptrías esféricas y -3,00 dioptrías cilíndricas x 180° probablemente notará una visión menos borrosa en:\n",
      "a) 0,5 metros.\n",
      "b) 1m.\n",
      "c) 2 metros.\n",
      "d) 4 metros.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "A pseudophakic patient with a refraction of +1.00 spherical diopters and -3.00 cylindrical diopters x 180° will likely notice a less blurry vision at a distance of 1 meter (b). The positive spherical refraction will help correct the patient's nearsightedness, while the negative cylindrical refraction will help correct astigmatism.\n",
      "\n",
      "At 0.5 meters (a), the patient may still experience some blurriness due to the proximity of the object. At 2 meters (c), the patient may experience some improvement in vision, but it may not be as clear as at 1 meter. At 4 meters (d), the patient may experience a clearer vision, but it may not be the best possible vision for the patient.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang pseudophakic na pasyente na may refraction na +1.00 spherical diopters at -3.00 cylindrical diopters x 180 ° ay mas mapapansin ang kaunting panlalabo ng paningin sa distansyang:\n",
      "a) 0.5 m.\n",
      "b) 1 m.\n",
      "c) 2 m.\n",
      "d) 4 m.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient has a refraction of +1.00 spherical diopters and -3.00 cylindrical diopters at an axis of 180 degrees. This means that the patient is nearsighted and has astigmatism. The nearest vision point for this patient would be at a distance of 1 meter, which is option b.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Um paciente pseudofácico com refração de +1,00 dioptrias esfericas e -3,00 dioptrias cilindricas x 180° provavelmente notará um visão menos borrada a: \n",
      "a) 0,5 m. \n",
      "b) 1 m. \n",
      "c) 2 m. \n",
      "d) 4 m.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient has a pseudophakic refraction of +1.00 diopters spherical and -3.00 diopters cylindrical x 180°. This means that the patient has a astigmatism correction of -3.00 diopters in the vertical meridian and a spherical correction of +1.00 diopters.\n",
      "\n",
      "The question asks for the distance at which the patient will notice a less blurred vision. The correct answer is 1 meter (b). At this distance, the patient will have a clear vision of objects, as the astigmatism and spherical corrections will be effective in reducing the blur caused by the patient's vision problems.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "* 0.5 meters (a) is too close, and the patient may not notice a significant improvement in vision at this distance.\n",
      "* 2 meters (c) is too far, and the patient may notice a decrease in vision clarity due to the astigmatism and spherical corrections not being effective at this distance.\n",
      "* 4 meters (d) is too far, and the patient may notice a significant decrease in vision clarity due to the astigmatism and spherical corrections not being effective at this distance.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "A pseudophakic patient with a refraction of +1.00 spherical diopters and -3.00 cylindrical diopters x 180° is likely to notice less blurry vision at: \n",
      "a) 0.5 m. \n",
      "b) 1 m. \n",
      "c) 2 m. \n",
      "d) 4 m.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "La respuesta correcta es la opción c) 2 m.\n",
      "\n",
      "Aquí está la explicación:\n",
      "\n",
      "La refracción del paciente es +1.00 esferas y -3.00 cilindros x 180°. Esto significa que el paciente tiene una miopía leve y un astigmatismo moderado. La distancia de la visión menos borrosa para un paciente con miopía y astigmatismo depende de la fuerza de la refracción. En este caso, la distancia de la visión menos borrosa sería de aproximadamente 2 metros.\n",
      "\n",
      "Por lo tanto, la opción c) 2 m es la respuesta correcta.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 81: \n",
      "Language: spanish\n",
      "Question: \n",
      "El paciente regresa quejándose de diplopía después de fabricar sus gafas. Tiene anisometropía, pero anteriormente usaba gafas sin problemas. No hubo cambios en la prescripción. Los centros ópticos están correctamente montados. La explicación más probable es:\n",
      "a) Cambio en la curva base de una de las lentes.\n",
      "b) Cambio en la forma del marco.\n",
      "c) Desaparición del escotoma de supresión central.\n",
      "d) Pérdida de la capacidad cerebral de compensación por la diferencia de aniseiconía.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "La explicación más probable es a) Cambio en la curva base de una de las lentes.\n",
      "\n",
      "La diplopía puede ser causada por una variedad de factores, incluyendo un cambio en la curva base de una de las lentes. Si el paciente tiene anisometropía y no hubo cambios en la prescripción, es probable que el problema sea causado por un cambio en la forma de la lente, lo que puede afectar la forma en que la luz se enfoca en el ojo.\n",
      "\n",
      "La opción b) Cambio en la forma del marco, no es probable que sea la causa del problema, ya que el paciente tiene gafas sin problemas anteriormente.\n",
      "\n",
      "La opción c) Desaparición del escotoma de supresión central, se refiere a la capacidad del cerebro para suprimir la visión doble en ciertas condiciones, pero no es probable que sea la causa del problema en este caso, ya que el paciente tiene anisometropía.\n",
      "\n",
      "La opción d) Pérdida de la capacidad cerebral de compensación por la diferencia de aniseiconía, es menos probable, ya que no se ha mencionado ningún cambio en la capacidad del paciente para compensar la diferencia de aniseiconía.\n",
      "{'response': 'a'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Bumalik ang isang pasyente dahil inirereklamo nag nagdodobleng bisyon dulot ng kanyang bagong salamin. Mayroon siyang anisometropia at dati nang nagsusuot ng salamin nang walang problema Walang nagbago sa kanyang preskripsyon at ang mga optical centers ay maayos na nailagay. Ang nararanasan ng pasyente ay maipapaliwanag ng: \n",
      "a) Pagbabago sa base curve ng isa sa mga lente.\n",
      "b) Pagbabago sa frame format.\n",
      "c) Pagkawala ng sentral ng central suppression scotoma.\n",
      "d) Pagkawala ng cerebral compensation capacity para sa pagkakaiba sa aniseikonia.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's complaint of double vision after recently getting a new pair of glasses suggests that there may have been a change in the base curve of one of the lenses. This is because the base curve is responsible for the alignment of the lenses in relation to the eye, and a change in the curve can affect the way the light enters the eye, leading to double vision.\n",
      "\n",
      "Option A, \"Pagbabago sa base curve ng isa sa mga lente,\" is the correct answer because it addresses the possible cause of the patient's symptoms.\n",
      "\n",
      "Option B, \"Pagbabago sa frame format,\" is not relevant to the patient's symptoms and is therefore not a correct answer.\n",
      "\n",
      "Option C, \"Pagkawala ng sentral ng central suppression scotoma,\" is also not relevant to the patient's symptoms and is therefore not a correct answer.\n",
      "\n",
      "Option D, \"Pagkawala ng cerebral compensation capacity para sa pagkakaiba sa aniseikonia,\" is not a correct answer because it refers to a condition where the brain has difficulty compensating for the difference in image size between the two eyes, which is not related to the patient's symptoms.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Paciente retorna com queixa de diplopia após confeccionar óculos. Tem anisometropia, mas usava óculos anteriormente sem problemas. Não houve modificação na prescrição. Os centros ópticos estão montados adequadamente. A explicação mais provável é: \n",
      "a) Mudança na curva base de uma das lentes. \n",
      "b) Mudança no formato da armação. \n",
      "c) Desaparecimento do escotoma central de supressão. \n",
      "d) Perda da capacidade de compensação cerebral da diferença da aniseiconia.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's complaint of diplopia after getting new glasses, despite having anisometropia and previously wearing glasses without issues, suggests that the problem is likely due to a loss of suppression of the central scotoma. This is option (c) Desaparecimento do escotoma central de supressão.\n",
      "\n",
      "Option (a) Mudança na curva base de uma das lentes is not the most likely explanation, as the patient had no issues with their previous glasses and the centers of the lenses are mounted properly.\n",
      "\n",
      "Option (b) Mudança no formato da armação is also not the most likely explanation, as the patient had no issues with their previous glasses and the centers of the lenses are mounted properly.\n",
      "\n",
      "Option (d) Perda da capacidade de compensação cerebral da diferença da aniseiconia is not a valid explanation, as the patient had no issues with their previous glasses and the centers of the lenses are mounted properly.\n",
      "{'response': 'd'}\n",
      "Language: english\n",
      "Question: \n",
      "Patient returns complaining of diplopia after making eyeglasses. Has anisometropia, but previously wore glasses without problems. There was no change in the prescription. Optical centers are properly mounted. The most likely explanation is: \n",
      "a) Change in the base curve of one of the lenses. \n",
      "b) Change in frame format. \n",
      "c) Disappearance of the central suppression scotoma. \n",
      "d) Loss of cerebral compensation capacity for the difference in aniseikonia.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of diplopia after making eyeglasses, despite no change in the prescription, suggests that the issue is likely due to a loss of cerebral compensation capacity for the difference in aniseikonia. Aniseikonia is the difference in the size of the images seen by each eye, which can cause diplopia. The patient previously wore glasses without problems, indicating that they had developed cerebral compensation for the aniseikonia. However, the change in frame format or base curve of one of the lenses may have disrupted this compensation, leading to the symptoms. Therefore, option d) Loss of cerebral compensation capacity for the difference in aniseikonia is the most likely explanation.\n",
      "{'response': 'd'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 82: \n",
      "Language: spanish\n",
      "Question: \n",
      "La mejor alternativa para incluir prismas basados ​​en el tiempo en lentes de gafas para un paciente miope de -4,00 dioptrías esféricas con diplopía binocular de 4 dioptrías prismáticas es:\n",
      "a) Prescripción de una lente con filtro neutro en un ojo.\n",
      "b) Prescripción de lentes con filtros polarizados en ambos ojos.\n",
      "c) Reducción de la distancia entre los centros ópticos de las lentes.\n",
      "d) No prescribir refracción en uno de los ojos para promover la supresión de ese ojo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La mejor alternativa para incluir prismas basados ​​en el tiempo en lentes de gafas para un paciente miope de -4,00 dioptrías esféricas con diplopía binocular de 4 dioptrías prismáticas es la opción c) Reducción de la distancia entre los centros ópticos de las lentes.\n",
      "\n",
      "La diplopía binocular es causada por la falta de alineación entre los ejes visuales de los dos ojos. La reducción de la distancia entre los centros ópticos de las lentes puede ayudar a alinear mejor los ejes visuales y reducir la diplopía.\n",
      "\n",
      "La opción a) Prescripción de una lente con filtro neutro en un ojo no es adecuada ya que no se está tratando de una condición de visión monocular, sino de una condición de visión binocular.\n",
      "\n",
      "La opción b) Prescripción de lentes con filtros polarizados en ambos ojos puede ayudar a reducir la cantidad de luz que entra en los ojos, pero no es adecuada para tratar la diplopía binocular.\n",
      "\n",
      "La opción d) No prescribir refracción en uno de los ojos para promover la supresión de ese ojo no es adecuada ya que no es una opción segura y puede afectar negativamente la visión del paciente.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang pinakaangkop na gawin para maisama ang time-based prism sa salamin para sa  -4.00 spherical diopters myopic pasyente na may 4 na prism diopters binocular diplopia ay:\n",
      "a) Preskripsyon ng isang lens na may isang neutral na filter sa isang mata.\n",
      "b) Preskripsyon ng mga lente na may polarized filter sa parehong mga mata.\n",
      "c) Pagbawas ng distansya sa pagitan ng mga optical center at ng mga lente.\n",
      "d) Huwag magbigay ng salamin na may refraction sa isang mata upang painamin ang suppression ng nasabing mata\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option C, \"Pagbawas ng distansya sa pagitan ng mga optical center at ng mga lente.\"\n",
      "\n",
      "The question is asking for the best way to reduce the time-based prism in a patient with myopia and 4 prism diopters of binocular diplopia. The correct answer is to reduce the distance between the optical centers of the lenses, which will help to reduce the amount of prism and alleviate the symptoms of diplopia.\n",
      "\n",
      "Option A, \"Preskripsyon ng isang lens na may isang neutral na filter sa isang mata,\" is not the best answer because it does not address the issue of the time-based prism.\n",
      "\n",
      "Option B, \"Preskripsyon ng mga lente na may polarized filter sa parehong mga mata,\" is also not the best answer because polarized filters are not typically used to treat myopia or diplopia.\n",
      "\n",
      "Option D, \"Huwag magbigay ng salamin na may refraction sa isang mata upang painamin ang suppression ng nasabing mata,\" is not the best answer because it suggests not giving any correction to the patient, which would not help to alleviate the symptoms of diplopia.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "A melhor alternativa à inclusão de prismas de base temporal nas lentes dos óculos para paciente míope de -4,00 dioptrias esfericas com diplopia binocular de 4 dioptrias prismaticas é: \n",
      "a) Prescrição de lente com filtro neutro em um dos olhos. \n",
      "b) Prescrição de lentes com filtros polarizados em ambos os olhos. \n",
      "c) Redução da distância entre os centros ópticos das lentes. \n",
      "d) Não prescrever a refração em um dos olhos para promover a supressão deste olho.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "A melhor alternativa para incluir prismas de base temporal nas lentes dos óculos para um paciente míope de -4,00 dioptrias esfericas com diplopia binocular de 4 dioptrias prismáticas é reduzir a distância entre os centros ópticos das lenses. Isso ajudará a alinhar os eixos das lentes com os olhos do paciente, reduzindo a diplopia e melhorando a visão.\n",
      "\n",
      "A opção a) Prescrição de lente com filtro neutro em um dos olhos não é adequada, pois o filtro neutro não ajudará a alinhar os eixos das lenses com os olhos do paciente.\n",
      "\n",
      "A opção b) Prescrição de lentes com filtros polarizados em ambos os olhos pode ajudar a reduzir a diplopia, mas não é a melhor opção, pois o paciente ainda pode experimentar problemas de visão com luzes brilhantes.\n",
      "\n",
      "A opção d) Não prescrever a refração em um dos olhos para promover a supressão deste olho não é adequada, pois isso pode levar a problemas de visão e conforto para o paciente.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "The best alternative to including time-based prisms in eyeglass lenses for a -4.00 spherical diopters myopic patient with 4 prism diopters binocular diplopia is: \n",
      "a) Prescription of a lens with a neutral filter in one eye. \n",
      "b) Prescription of lenses with polarized filters in both eyes. \n",
      "c) Reduction of the distance between the optical centers of the lenses. \n",
      "d) Do not prescribe refraction in one eye to promote suppression of that eye.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The best alternative to including time-based prisms in eyeglass lenses for a -4.00 spherical diopters myopic patient with 4 prism diopters binocular diplopia is to reduce the distance between the optical centers of the lenses. This option will help to minimize the conflict between the two images seen by the patient, and thus reduce the diplopia.\n",
      "\n",
      "It is not appropriate to prescribe a lens with a neutral filter in one eye (option a) or lenses with polarized filters in both eyes (option b) for this patient, as these options do not address the underlying issue of diplopia.\n",
      "\n",
      "Additionally, it is not recommended to not prescribe refraction in one eye to promote suppression of that eye (option d), as this can lead to amblyopia and other visual problems.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 83: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál de las siguientes condiciones se asocia más típicamente con el hallazgo de una silla turca \"parcialmente vacía\" en la resonancia magnética?\n",
      "a) Glioma del nervio óptico.\n",
      "b) Macroadenoma hipofisario.\n",
      "c) Pseudotumor cerebral.\n",
      "d) Síndrome de Tolosa-Hunt.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La respuesta correcta es c) Pseudotumor cerebral.\n",
      "\n",
      "Un pseudotumor cerebral es una condición en la cual el tejido cerebral appears to be tumoral but actually is not. It can cause a variety of symptoms, including headaches, seizures, and changes in vision, and can be difficult to diagnose. A \"partially empty\" chair on an MRI scan, also known as a \"Turkish chair\" sign, is a common finding in patients with pseudotumor cerebral.\n",
      "\n",
      "The other options are not typically associated with this finding:\n",
      "\n",
      "* a) Glioma del nervio óptico: A glioma is a type of brain tumor that originates from the supporting cells of the brain called glial cells. It is not typically associated with the Turkish chair sign.\n",
      "* b) Macroadenoma hipofisario: A macroadenoma is a large benign tumor that originates from the pituitary gland. It can cause a variety of symptoms, including vision problems, headaches, and hormonal imbalances, but is not typically associated with the Turkish chair sign.\n",
      "* d) Síndrome de Tolosa-Hunt: This is a rare syndrome characterized by recurrent episodes of headache, fever, and meningismus (inflammation of the meninges, the protective coverings of the brain and spinal cord). It is not typically associated with the Turkish chair sign.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga kondisyon ang pinaka-karaniwang nauugnay sa paghahanap ng isang \"partially empty\" na sella turcica sa Magnetic Resonance Imaging?\n",
      "a) Optic nerve glioma.\n",
      "b) Pituitary MacRoadenoma.\n",
      "c) Cerebral pseudotumor.\n",
      "d) Tolosa-hunt syndrome.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Cerebral pseudotumor.\n",
      "\n",
      "Cerebral pseudotumor is a condition where there is an abnormal accumulation of cerebrospinal fluid (CSF) in the brain, which can cause the sella turcica to appear \"partially empty\" on a Magnetic Resonance Imaging (MRI) scan. This condition can mimic a tumor and can cause similar symptoms, hence the name \"pseudotumor.\"\n",
      "\n",
      "Optic nerve glioma (a) is a type of brain tumor that can cause vision problems and can also affect the sella turcica, but it is not typically associated with a \"partially empty\" sella turcica on MRI.\n",
      "\n",
      "Pituitary MacRoadenoma (b) is a type of pituitary tumor that can cause a variety of hormonal imbalances and can also affect the sella turcica, but it is not typically associated with a \"partially empty\" sella turcica on MRI.\n",
      "\n",
      "Tolosa-Hunt syndrome (d) is a rare condition characterized by a unilateral painless vision loss, and it is not typically associated with a \"partially empty\" sella turcica on MRI.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual das condições abaixo está mais tipicamente associada ao achado de sela túrcica \"parcialmente vazia\" em um exame de imagem por ressonância nuclear magnética? \n",
      "a) Glioma de nervo óptico. \n",
      "b) Macroadenoma de hipófise. \n",
      "c) Pseudotumor cerebral. \n",
      "d) Síndrome de Tolosa-Hunt.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) Pseudotumor cerebral.\n",
      "\n",
      "A pseudotumor cerebral, also known as a false brain tumor, is a condition where there is an abnormal accumulation of cerebrospinal fluid (CSF) in the brain, which can cause symptoms similar to those of a brain tumor. This condition is sometimes associated with a \"partially empty\" sella turcica, which is a finding that can be observed on an MRI scan.\n",
      "\n",
      "The other options are not typically associated with a partially empty sella turcica:\n",
      "\n",
      "* a) Glioma de nervo óptico: A glioma is a type of brain tumor that originates from the supportive tissue of the brain called glial cells. It is not typically associated with a partially empty sella turcica.\n",
      "* b) Macroadenoma de hipófise: A macroadenoma is a type of pituitary tumor that originates from the cells of the pituitary gland. It can cause a variety of symptoms, including vision problems, headaches, and hormonal imbalances, but is not typically associated with a partially empty sella turcica.\n",
      "* d) Síndrome de Tolosa-Hunt: This is a rare condition characterized by recurrent episodes of headache, fever, and meningismus (stiffness of the neck, back, and legs). It is not typically associated with a partially empty sella turcica.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Which of the conditions below is most typically associated with finding a \"partially empty\" sella turcica on magnetic resonance imaging? \n",
      "a) Optic nerve glioma. \n",
      "b) Pituitary macroadenoma. \n",
      "c) Cerebral pseudotumor. \n",
      "d) Tolosa-Hunt syndrome.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Pituitary macroadenoma\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) Pituitary macroadenoma. A partially empty sella turcica, also known as an empty sella, is a common finding on magnetic resonance imaging (MRI) in patients with pituitary macroadenomas. This is because the tumor can compress or destroy the pituitary gland, leading to a decrease in the production of hormones and an empty sella.\n",
      "\n",
      "Optic nerve glioma (a) and cerebral pseudotumor (c) are not typically associated with an empty sella turcica. Tolosa-Hunt syndrome (d) is a rare condition characterized by recurrent attacks of unilateral pain and swelling of the eye, but it is not typically associated with an empty sella turcica on MRI.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 84: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto a la parálisis del cuarto par craneal, es correcto decir:\n",
      "a) Frecuentemente hay parálisis del nervio facial asociada.\n",
      "b) En el examen de la motricidad ocular se observa un aumento de la excursión del ojo paralizado al mirar hacia abajo.\n",
      "c) El paciente desarrolla diplopía vertical, posición viciosa de la cabeza e hipotropía del ojo paralizado.\n",
      "d) La afectación nuclear o infranuclear del IV nervio puede tener el mismo cuadro clínico.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the clinical features of a fourth cranial nerve palsy.\n",
      "\n",
      "Option a is incorrect because, although facial weakness or paralysis is a common association with fourth cranial nerve palsy, it is not a universal feature.\n",
      "\n",
      "Option b is incorrect because the affected eye may have limited or absent abduction, but there would not be an increase in the excursion of the eye when looking down.\n",
      "\n",
      "Option c is correct because fourth cranial nerve palsy can cause diplopia (double vision), vertical misalignment of the eyes, and hypotropia (downward deviation) of the affected eye.\n",
      "\n",
      "Option d is incorrect because although the fourth cranial nerve has both nuclear and infranuclear components, the clinical features described in the question are more consistent with an infranuclear lesion.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na pahayag ang nagsasaad ng katotohanan paungkol sa fourth cranial nerve palsy:\n",
      "a) Kadalasan ay may kasama itong sa facial nerve palsy.\n",
      "b) Sa pagsusuri ng ocular motricity, mayroong isang pagtaas sa ekskursiyon ng paralisadong mata kapag lumilingon pababa.\n",
      "c) Ang pasyente ay nagkakaroon ng vertical diplopia, vicious head position at hypotropia ng paralisadong mata.\n",
      "d) Pareho ng klinikal na manipestasyon nito sa nuclear o infranculear involvement ng IV nerve\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The fourth cranial nerve palsy is associated with a lesion in the trochlear nerve, which is responsible for controlling the superior oblique muscle that is involved in downward and outward movement of the eye. The symptoms of fourth cranial nerve palsy include vertical diplopia (seeing two images of a single object, one above the other), vicious head position (tilting the head to one side to see clearly), and hypotropia (weakness or paralysis) of the affected eye.\n",
      "\n",
      "Therefore, option C is the correct answer, as it describes the symptoms of fourth cranial nerve palsy.\n",
      "\n",
      "Option A is incorrect because facial nerve palsy is not a symptom of fourth cranial nerve palsy.\n",
      "\n",
      "Option B is incorrect because the ocular motricity test is not specific to fourth cranial nerve palsy.\n",
      "\n",
      "Option D is incorrect because nuclear or infranuclear involvement of the IV nerve is not related to fourth cranial nerve palsy.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Sobre a paralisia do IV nervo craniano, é correto afirmar: \n",
      "a) Frequentemente, apresenta-se paralisia de nervo facial associada. \n",
      "b) No exame da motricidade ocular, existe um aumento da excursão do olho paralisado no olhar para baixo. \n",
      "c) O paciente evolui com diplopia vertical, posição viciosa de cabeça e hipotropia do olho paralisado. \n",
      "d) O acometimento nuclear ou infranuclear do IV nervo pode ter o mesmo quadro clínico.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the symptoms of paralysis of the IV cranial nerve.\n",
      "\n",
      "Option a is incorrect because, although facial paralysis is a common symptom of IV cranial nerve paralysis, it is not always present.\n",
      "\n",
      "Option b is incorrect because the increased excursion of the paralyzed eye on downward gaze is a sign of III cranial nerve paralysis, not IV.\n",
      "\n",
      "Option c is correct because diplopia vertical (double vision in the vertical plane), torticollis (twisted neck), and hypotropia (downward deviation) of the paralyzed eye are all common symptoms of IV cranial nerve paralysis.\n",
      "\n",
      "Option d is incorrect because although both nuclear and infranuclear lesions of the IV nerve can cause similar symptoms, they are not identical and can have different clinical presentations.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "About fourth cranial nerve palsy, it is correct to state: \n",
      "a) Associated facial nerve palsy is often present. \n",
      "b) In the examination of ocular motricity, there is an increase in the excursion of the paralyzed eye when looking down. \n",
      "c) The patient evolves with vertical diplopia, vicious head position and hypotropia of the paralyzed eye. \n",
      "d) Nuclear or infranuclear involvement of the IV nerve may have the same clinical picture.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient with fourth cranial nerve palsy may present with vertical diplopia, vicious head position, and hypotropia of the paralyzed eye. This is because the fourth cranial nerve is responsible for controlling the superior oblique muscle, which is involved in downward gaze. When the nerve is damaged, the muscle becomes weak or paralyzed, leading to an inability to look down and a tendency to hold the head in an abnormal position to compensate for the weakness.\n",
      "\n",
      "Associated facial nerve palsy is not always present in fourth cranial nerve palsy, so option a is not always correct.\n",
      "\n",
      "In the examination of ocular motricity, there may be a decrease in the excursion of the paralyzed eye when looking down, rather than an increase, so option b is not correct.\n",
      "\n",
      "Nuclear or infranuclear involvement of the IV nerve may have a different clinical picture, so option d is not correct.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 85: \n",
      "Language: spanish\n",
      "Question: \n",
      "Niño de ocho años con síntomas bilaterales subagudos de parálisis de la mirada vertical, papiledema y disociación de la luz cercana. Es correcto decir:\n",
      "a) Deben investigarse las lesiones mesencefálicas, como los tumores.\n",
      "b) Este es un caso clásico de sífilis neurológica de transmisión vertical.\n",
      "c) Lo más probable es que se trate de una lesión del quiasma óptico.\n",
      "d) La lesión del lóbulo frontal es la principal hipótesis diagnóstica.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The symptoms described, including bilateral subacute paralysis of the vertical gaze, papilledema, and dissociation of near light, suggest a problem with the oculomotor nerve. The most likely cause of this condition is a lesion in the optic chiasm, which is option C.\n",
      "\n",
      "It is not appropriate to investigate mesencephalic lesions, such as tumors, as the primary cause of this condition, as the symptoms do not suggest a problem in that location. Option A is incorrect.\n",
      "\n",
      "Syphilitic neurológica de transmisión vertical is not a known condition, and it is not a likely diagnosis for this patient's symptoms. Option B is incorrect.\n",
      "\n",
      "A lesion in the frontal lobe could potentially cause some of the symptoms, but it is not the most likely diagnosis. Option D is incorrect.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang walong taong gulang na bata na may subacute bilateral vertical gaze palsy, papilledema at light-near dissociation. Ipinapahiwatig nito na: \n",
      "a) Ang mga mesencephalic lesion, tulad ng mga tumor, ay dapat na imbestigahan.\n",
      "b) Ito ay isang kaso ng vertically transmitted neurological syphilis.\n",
      "c) Ito ay isang problema sa optic chiasm.\n",
      "d) Ang frontal lobe lesion ay ang pangunahing diagnostic hypothesis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of subacute bilateral vertical gaze palsy, papilledema, and light-near dissociation suggest a brainstem lesion. The mesencephalic lesion, which can be caused by tumors, should be investigated. Therefore, option A is the correct response.\n",
      "\n",
      "Note:\n",
      "\n",
      "* Option B is incorrect because vertically transmitted neurological syphilis is not a common cause of bilateral vertical gaze palsy, papilledema, and light-near dissociation.\n",
      "* Option C is incorrect because the optic chiasm is not typically affected in mesencephalic lesions.\n",
      "* Option D is incorrect because a frontal lobe lesion is not typically associated with these symptoms.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Criança de oito anos de idade com quadro bilateral subagudo de paralisia do olhar vertical, papiledema e dissociação luz-perto. É correto afirmar: \n",
      "a) Lesões mesencefálicas, como tumores, devem ser investigadas. \n",
      "b) Trata-se de um caso clássico de sífilis neurológica de transmissão vertical. \n",
      "c) Trata-se, mais provavelmente, de uma lesão de quiasma óptico. \n",
      "d) Lesão do lobo frontal é a principal hipótese diagnóstica.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) Trata-se, mais provavelmente, de uma lesão de quiasma óptico.\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of bilateral subacute paralysis of the vertical gaze, papilledema, and dissociation of light and near vision suggest a problem with the oculomotor nerve, which is responsible for controlling eye movements. The most likely cause of this condition is a lesion in the optic chiasm, which is the part of the brain that connects the two optic nerves and is responsible for integrating visual information from both eyes. Therefore, option c is the most appropriate answer.\n",
      "\n",
      "It is important to note that option a, lesões mesencefálicas, such as tumors, should also be considered and investigated, but based on the symptoms described, a lesion in the optic chiasm is a more likely diagnosis. Option b, sífilis neurológica de transmissão vertical, is not a likely diagnosis based on the patient's age and symptoms. Option d, lesão do lobo frontal, is not a likely diagnosis based on the patient's symptoms, as the frontal lobe is not typically associated with oculomotor function.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Eight-year-old child with subacute bilateral vertical gaze palsy, papilledema and light-near dissociation. It is correct to state: \n",
      "a) Mesencephalic lesions, such as tumors, should be investigated. \n",
      "b) This is a classic case of vertically transmitted neurological syphilis. \n",
      "c) It is most likely a lesion of the optic chiasm. \n",
      "d) Frontal lobe lesion is the main diagnostic hypothesis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of subacute bilateral vertical gaze palsy, papilledema, and light-near dissociation suggest a brainstem lesion. The mesencephalon is the part of the brainstem responsible for controlling vertical gaze, and lesions in this area can cause the symptoms described. Therefore, option a) Mesencephalic lesions, such as tumors, should be investigated is the correct response.\n",
      "\n",
      "Option b) This is a classic case of vertically transmitted neurological syphilis is incorrect because the patient's age and symptoms do not suggest syphilis as the likely cause.\n",
      "\n",
      "Option c) It is most likely a lesion of the optic chiasm is incorrect because the patient's symptoms do not suggest a lesion in the optic chiasm.\n",
      "\n",
      "Option d) Frontal lobe lesion is the main diagnostic hypothesis is incorrect because the patient's symptoms do not suggest a lesion in the frontal lobe.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 86: \n",
      "Language: spanish\n",
      "Question: \n",
      "Paciente femenina de 35 años, tras pérdida sensitiva en miembro superior derecho, desarrolló diplopía. Entre las hipótesis diagnósticas la más probable es:\n",
      "a) Adenoma hipofisario.\n",
      "b) Esclerosis múltiple.\n",
      "c) Hipertensión intracraneal idiopática.\n",
      "d) Meningioma del nervio óptico.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is d) Meningioma del nervio óptico.\n",
      "\n",
      "Meningioma del nervio óptico es un tumor benigno que se desarrolla en la membrana que cubre el nervio óptico, y puede causar diplopía debido a la presión sobre el nervio óptico. La diplopía es un síntoma común en los pacientes con meningioma del nervio óptico.\n",
      "\n",
      "Adenoma hipofisario (a) es un tumor benigno que se desarrolla en la glándula pituitaria, y puede causar síntomas como diplopía, pero no es la opción más probable en este caso.\n",
      "\n",
      "Esclerosis múltiple (b) es una enfermedad autoinmunitaria que afecta el sistema nervioso central, y puede causar síntomas como diplopía, pero no es la opción más probable en este caso.\n",
      "\n",
      "Hipertensión intracraneal idiopática (c) es un aumento de la presión en el cráneo, y puede causar síntomas como dolor de cabeza, pero no es la opción más probable en este caso.\n",
      "{'response': 'd'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Isang 35-taong-gulang na babaeng pasyente ang nawalan ng pandama sa kanang braso na may diplopia. Sa lahat ng maaaring mga diagnostic hypothesis, ang pinakamaaari ay:\n",
      "a) Pituitary adenoma. \n",
      "b) Multiple sclerosis. \n",
      "c) Idiopathic intracranial hypertension. \n",
      "d) Meningioma of the optic nerve.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) Idiopathic intracranial hypertension.\n",
      "\n",
      "Idiopathic intracranial hypertension (IIH) is a condition characterized by increased pressure in the skull, which can cause symptoms such as headache, diplopia (double vision), and vision loss. It is a possible diagnosis for a 35-year-old female patient who presents with diplopia and loss of vision in one eye, especially if there are no other neurological symptoms or signs of a more severe condition such as a pituitary adenoma, multiple sclerosis, or meningioma of the optic nerve.\n",
      "\n",
      "It's important to note that this is a hypothetical scenario and a thorough medical evaluation and diagnostic workup would be necessary to determine the underlying cause of the patient's symptoms.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Paciente de 35 anos, sexo feminino, após quadro de perda sensitiva no membro superior direito, evoluiu com diplopia. Dentre as hipóteses diagnósticas a mais provável é: \n",
      "a) Adenoma hipofisário. \n",
      "b) Esclerose múltipla. \n",
      "c) Hipertensão intracraniana idiopática. \n",
      "d) Meningeoma do nervo óptico.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "The correct answer is d) Meningeoma do nervo óptico.\n",
      "\n",
      "Meningeoma do nervo óptico é um tumor benigno que afeta a membrana que reveste o nervo óptico, pode causar diplopia (visão dupla) e outros sintomas oculares, além de problemas de visão. A perda sensitiva no membro superior direito pode indicar uma lesão no nervo óptico. As outras opções não estão relacionadas às symptoms apresentadas.\n",
      "{'response': 'd'}\n",
      "Language: english\n",
      "Question: \n",
      "\n",
      "A 35-year-old female patient, after sensory loss in the right upper limb, evolved with diplopia. Among the diagnostic hypotheses, the most likely is: \n",
      "a) Pituitary adenoma. \n",
      "b) Multiple sclerosis. \n",
      "c) Idiopathic intracranial hypertension. \n",
      "d) Meningioma of the optic nerve.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // The correct response is b) Multiple sclerosis.\n",
      "}\n",
      "```\n",
      "\n",
      "Rationale:\n",
      "\n",
      "The patient's symptoms of sensory loss in the right upper limb and diplopia suggest a neurological disorder. Multiple sclerosis is a chronic autoimmune disease that affects the central nervous system, including the brain and spinal cord. It can cause a variety of symptoms, including sensory loss, weakness, and vision problems, such as diplopia. The other options, pituitary adenoma, idiopathic intracranial hypertension, and meningioma of the optic nerve, can also cause vision problems, but are less likely given the patient's symptoms.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 87: \n",
      "Language: spanish\n",
      "Question: \n",
      "El paciente presenta parálisis unilateral del tercer, cuarto y sexto par craneal. Es correcto decir:\n",
      "a) Cuando es indoloro se denomina síndrome de Tolosa-Hunt.\n",
      "b) La afectación del nervio olfatorio sugiere afectación del seno cavernoso.\n",
      "c) Una forma de localizar si hay daño en el seno cavernoso es realizar una prueba de sensibilidad del trigémino.\n",
      "d) Si la visión es normal, pero las tres ramas del trigémino están afectadas, la lesión posiblemente esté restringida al vértice de la órbita.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La afectación del nervio trigémino (tercer, cuarto y sexto par craneal) sugiere una lesión en el seno cavernoso. Una forma de localizar si hay daño en el seno cavernoso es realizar una prueba de sensibilidad del trigémino. Por lo tanto, la opción correcta es la opción C.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang pasyente ay may unilateral na pagkaparalisa sa ikatlo, ikaapat, at ikaanim na cranial nerves. Maaring sabihin na:\n",
      "a) Kung walang kirot, tinatawag itong Tolosa-Hunt Syndrome.\n",
      "b) Ang pagkakasangkot ng olfactory nerve ay nagmumungkahi din ng problema sa cavernous sinus.\n",
      "c) Isang paraan upang malaman kung mayroong problema sa cavernous sinus ay ang pagsusuri sa ang pagiging sensitibo ng trigeminal nerve\n",
      "d) Kung ang paningin ay normal, ngunit ang tatlong sanga ng trigeminal nerve ay apektado, marahil ang problema ay makikita lamang sa tuktok ng orbit. \n",
      "Test #0: \n",
      "response\n",
      "  Here's my answer:\n",
      "\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"  // This is the option of the correct response. Could be only any of these: A, B, C, D\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of unilateral paralysis of the third, fourth, and sixth cranial nerves suggest a problem with the cavernous sinus. The cavernous sinus is a group of veins in the brain that can become inflamed or compressed, leading to symptoms such as headache, facial pain, and paralysis of the cranial nerves.\n",
      "\n",
      "Option C is the correct answer because it suggests that the patient's symptoms could be due to a problem with the cavernous sinus, which is consistent with the patient's symptoms of unilateral paralysis of the third, fourth, and sixth cranial nerves.\n",
      "\n",
      "Option A, \"Kung walang kirot, tinatawag itong Tolosa-Hunt Syndrome,\" is incorrect because Tolosa-Hunt Syndrome is a condition characterized by unilateral paralysis of the third, fourth, and sixth cranial nerves due to inflammation or compression of the cavernous sinus, which is not necessarily associated with a headache.\n",
      "\n",
      "Option B, \"Ang pagkakasangkot ng olfactory nerve ay nagmumungkahi din ng problema sa cavernous sinus,\" is incorrect because the olfactory nerve is not involved in the cavernous sinus.\n",
      "\n",
      "Option D, \"Kung ang paningin ay normal, ngunit ang tatlong sanga ng trigeminal nerve ay apektado, marahil ang problema ay makikita lamang sa tuktok ng orbit,\" is incorrect because the patient's symptoms of unilateral paralysis of the third, fourth, and sixth cranial nerves are not consistent with a problem limited to the top of the orbit.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Paciente apresenta paralisia unilateral do terceiro, quarto e sexto nervos cranianos. É correto afirmar: \n",
      "a) Quando indolor, denomina-se síndrome de Tolosa-Hunt. \n",
      "b) O envolvimento do nervo olfatório sugere acometimento do seio cavernoso. \n",
      "c) Uma maneira de localizar se há lesão no seio cavernoso é testar a sensibilidade trigeminal. \n",
      "d) Se a visão está normal, mas os três ramos do trigêmeo estiverem afetados, possivelmente a lesão está restrita ao ápice da órbita.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient presents with unilateral paralysis of the third, fourth, and sixth cranial nerves. The correct statement is:\n",
      "\n",
      "c) A way to localize whether there is a lesion in the cavernous sinus is to test the trigeminal sensibility.\n",
      "\n",
      "The cavernous sinus is a structure that contains the third, fourth, and sixth cranial nerves, among others. Therefore, if there is a lesion in the cavernous sinus, it can affect these nerves and cause the symptoms described in the patient's presentation. Testing the trigeminal sensibility can help localize the lesion and determine if it is indeed affecting the cavernous sinus.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "a) The patient's symptoms do not match the criteria for Tolosa-Hunt syndrome, which is characterized by unilateral painful ophthalmoplegia, diplopia, and ptosis, due to a lesion in the superior orbital fissure.\n",
      "\n",
      "b) The involvement of the olfactory nerve does not necessarily suggest a lesion in the cavernous sinus, as the olfactory nerve can be affected by various conditions, including tumors, trauma, and inflammatory processes.\n",
      "\n",
      "d) The absence of visual changes does not rule out a lesion in the cavernous sinus, as the visual pathway is not necessarily affected by a lesion in this location.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "The patient has unilateral paralysis of the third, fourth and sixth cranial nerves. It is correct to state: \n",
      "a) When painless, it is called Tolosa-Hunt syndrome. \n",
      "b) Involvement of the olfactory nerve suggests involvement of the cavernous sinus. \n",
      "c) One way to find out if there is a lesion in the cavernous sinus is to test the trigeminal sensitivity. \n",
      "d) If the vision is normal, but the three branches of the trigeminal are affected, possibly the lesion is restricted to the apex of the orbit.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of unilateral paralysis of the third, fourth, and sixth cranial nerves suggest a possible lesion in the cavernous sinus. The cavernous sinus is a compartment in the skull that contains the third, fourth, and sixth cranial nerves, as well as other structures.\n",
      "\n",
      "Option c) \"One way to find out if there is a lesion in the cavernous sinus is to test the trigeminal sensitivity\" is the correct statement. Testing the trigeminal sensitivity can help determine if there is a lesion in the cavernous sinus, as the trigeminal nerve is also located in the cavernous sinus and can be affected by a lesion in that area.\n",
      "\n",
      "Option a) \"When painless, it is called Tolosa-Hunt syndrome\" is incorrect. Tolosa-Hunt syndrome is a condition characterized by painless paralysis of the third, fourth, and sixth cranial nerves, but it is not necessarily associated with a lesion in the cavernous sinus.\n",
      "\n",
      "Option b) \"Involvement of the olfactory nerve suggests involvement of the cavernous sinus\" is incorrect. The olfactory nerve is not located in the cavernous sinus, so involvement of the olfactory nerve does not necessarily suggest a lesion in the cavernous sinus.\n",
      "\n",
      "Option d) \"If the vision is normal, but the three branches of the trigeminal are affected, possibly the lesion is restricted to the apex of the orbit\" is incorrect. While it is true that a lesion in the apex of the orbit can affect the three branches of the trigeminal nerve, this statement does not take into account the patient's symptoms of unilateral paralysis of the third, fourth, and sixth cranial nerves, which suggest a lesion in the cavernous sinus.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 88: \n",
      "Language: spanish\n",
      "Question: \n",
      "Después de la cirugía bariátrica, el paciente desarrolló niveles séricos bajos de vitamina B12. En este caso, es correcto afirmar que:\n",
      "a) La discromatopsia es un hallazgo atípico.\n",
      "b) La mejora visual no es posible ni siquiera con la reposición de vitaminas.\n",
      "c) En la perimetría son típicos los escotomas periféricos y la preservación del área foveal.\n",
      "d) La anemia perniciosa se asocia con pérdida visual bilateral, simétrica, indolora y progresiva.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "La opción correcta es d) La anemia perniciosa se asocia con pérdida visual bilateral, simétrica, indolora y progresiva.\n",
      "\n",
      "La anemia perniciosa es una enfermedad causada por la deficiencia de vitamina B12, que puede provocar una pérdida visual progresiva y simétrica en ambos ojos. Esta pérdida visual puede ser bilateral y puede ser acompañada de dolor de cabeza, fatiga y debilidad. La discromatopsia y la mejora visual con la reposición de vitaminas no son hallazgos típicos de la anemia perniciosa. En cuanto a la perimetría, la preservación del área foveal es típica en la anemia perniciosa, pero no es exclusiva de esta enfermedad. Por lo tanto, la opción d) es la respuesta correcta.\n",
      "{'response': 'd'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Matapos ang operasyon ng bariatric, ang pasyente ay mayroong mababang serum levels ng vitamin B12. Gamit ang impormasyong ito, maaring sabihan na:\n",
      "a) Ang dyschromatopsia ay hindi kadalasang nahahanap\n",
      "b) Hindi lilinaw ang paningin kahit pa hanapan ng pamalit na bitamina\n",
      "c) Ang peripheral scotomas at pangangalaga ng foveal area ay karaniwan sa perimetry.\n",
      "d) Ang pernicious anemia ay may kaugnayan sa bilateral, symmetrical, painless, at progresibong pagkawala ng paningin.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's low serum levels of vitamin B12 after bariatric surgery suggest a possible diagnosis of pernicious anemia, which is characterized by a gradual, painless, and progressive loss of vision, often affecting both eyes symmetrically. This condition is related to a deficiency of vitamin B12, which is essential for the production of myelin, the fatty substance that protects and insulates nerve fibers, including those in the optic nerve.\n",
      "\n",
      "Option A is incorrect because dyschromatopsia, or difficulty perceiving colors, is not a common symptom of pernicious anemia.\n",
      "\n",
      "Option B is incorrect because while vitamin B12 deficiency can cause neurological symptoms, it does not typically affect the visual acuity or clarity of vision.\n",
      "\n",
      "Option C is incorrect because peripheral scotomas and foveal area damage are not typical symptoms of pernicious anemia.\n",
      "{'response': 'd'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Após cirurgia bariátrica, paciente evoluiu com níveis séricos baixos de vitamina B12. Nesse caso, é correto afirmar que: \n",
      "a) A discromatopsia é um achado atípico. \n",
      "b) Não é possível a melhora visual mesmo com a reposição da vitamina. \n",
      "c) Escotomas periféricos e preservação da área foveal são típicos nas campimetrias. \n",
      "d) A anemia perniciosa está associada a perda visual bilateral, simétrica, indolor e progressiva.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question states that the patient had low levels of vitamin B12 after bariatric surgery and asks which statement is correct regarding the patient's visual symptoms.\n",
      "\n",
      "Option d) \"A anemia perniciosa está associada a perda visual bilateral, simétrica, indolor e progressiva\" is the correct answer. Anemia perniciosa, a condition caused by vitamin B12 deficiency, can cause bilateral, symmetrical, painless, and progressive visual loss, which is consistent with the patient's symptoms.\n",
      "\n",
      "Option a) \"A discromatopsia é um achado atípico\" is incorrect because discromatopsia, or abnormal color vision, is not typically associated with vitamin B12 deficiency or anemia perniciosa.\n",
      "\n",
      "Option b) \"Não é possível a melhora visual mesmo com a reposição da vitamina\" is incorrect because while vitamin B12 supplementation may not improve visual acuity in all cases, it can help to halt or slow down the progression of visual loss in some cases.\n",
      "\n",
      "Option c) \"Escotomas periféricos e preservação da área foveal são típicos nas campimetrias\" is incorrect because while peripheral scotomas and preservation of the central visual field may be seen in some cases of vitamin B12 deficiency, they are not typical of anemia perniciosa.\n",
      "{'response': 'd'}\n",
      "Language: english\n",
      "Question: \n",
      "After bariatric surgery, the patient evolved with low serum levels of vitamin B12. In this case, it is correct to state that: \n",
      "a) Dyschromatopsia is an atypical finding. \n",
      "b) Visual improvement is not possible even with vitamin replacement. \n",
      "c) Peripheral scotomas and preservation of the foveal area are typical in perimetry. \n",
      "d) Pernicious anemia is associated with bilateral, symmetrical, painless and progressive visual loss.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in markdown format:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"d\" // Pernicious anemia is associated with bilateral, symmetrical, painless and progressive visual loss.\n",
      "}\n",
      "```\n",
      "Explanation:\n",
      "\n",
      "Pernicious anemia is a condition where the body is unable to absorb vitamin B12 from food, leading to a deficiency. One of the symptoms of vitamin B12 deficiency is bilateral, symmetrical, painless, and progressive visual loss. This is because vitamin B12 plays a crucial role in the health of the optic nerve and the visual pathway.\n",
      "\n",
      "The other options are not correct statements about vitamin B12 deficiency and its effects on vision:\n",
      "\n",
      "* Option a is incorrect because dyschromatopsia (difficulty perceiving colors) is not a typical finding in vitamin B12 deficiency.\n",
      "* Option b is incorrect because visual improvement is possible with vitamin replacement therapy, especially if the deficiency is caught early.\n",
      "* Option c is incorrect because peripheral scotomas (blind spots) and preservation of the foveal area (the central part of the visual field) are not typical in perimetry (a test that measures the visual field) for vitamin B12 deficiency.\n",
      "{'response': 'd'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 89: \n",
      "Language: spanish\n",
      "Question: \n",
      "Tras un accidente vascular que afectó la porción lateral de la médula cervical (síndrome de Wallenberg), el paciente desarrolló anisocoria. Es correcto afirmar que:\n",
      "a) La anisocoria empeorará en la oscuridad.\n",
      "b) Habrá empeoramiento de la anisocoria a la luz.\n",
      "c) No responderá a la instilación de colirios simpaticomiméticos.\n",
      "d) La afectación del ganglio estrellado es el diagnóstico más probable.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient developed anisocoria (unequal pupils) due to a vascular accident affecting the lateral part of the cervical medulla (Wallenberg's syndrome). In this condition, the pupil on the affected side is larger and reacts less to light. Therefore, the correct answer is b) The anisocoria will worsen in the light.\n",
      "\n",
      "In option a, the statement suggests that the anisocoria will worsen in the dark, which is incorrect.\n",
      "\n",
      "In option c, the statement suggests that the patient will not respond to the instillation of sympathomimetic eye drops, which is also incorrect.\n",
      "\n",
      "Option d is not the most probable diagnosis, as the patient's symptoms are more consistent with Wallenberg's syndrome.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Matapos magkaroon ng sira sa ugat sa lateral na bahagi ng cervical spinal cord dulot ng Wallenberg syndrome, nagkaroon ng aniscoria ang pasdyente. Maaaring sabihin na:\n",
      "a) Ang anisocoria ay mas lalala sa dilim\n",
      "b) Magkakaroon ng paglala ng anisocoria kapag maliwanag \n",
      "c) Hindi siya makatugon sa tuwing gagamit ng sympathomimetic eye drops.\n",
      "d) May problema sa stellate ganglion ang marahil na diagnosis\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Wallenberg syndrome is a condition that affects the lateral part of the cervical spinal cord, leading to symptoms such as anisocoria (unequal pupils). In this case, the patient's anisocoria is not responding to sympathomimetic eye drops, which suggests that the problem may be related to the stellate ganglion. Therefore, option d) May problema sa stellate ganglion ang marahil na diagnosis is the correct response.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Após acidente vascular acometendo a porção lateral da medula cervical (síndrome de Wallenberg), o paciente desenvolveu anisocoria. É correto afirmar que: \n",
      "a) Haverá piora da anisocoria no escuro. \n",
      "b) Haverá piora da anisocoria no claro. \n",
      "c) Será não responsivo à instilação de colírios simpatomiméticos. \n",
      "d) O acometimento do gânglio estrelado é o diagnóstico mais provável.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient developed anisocoria (unequal pupil size) after a vascular accident affecting the lateral part of the cervical medulla (Wallenberg's syndrome). In this condition, the pupil that is affected by the syndrome will not respond to sympathomimetic eye drops (option c).\n",
      "\n",
      "Option a is incorrect because anisocoria can worsen in bright light, not in the dark.\n",
      "\n",
      "Option b is incorrect because anisocoria can worsen in bright light, not in the dark.\n",
      "\n",
      "Option d is incorrect because the affected ganglion is not the most likely diagnosis, it could be a symptom of the Wallenberg's syndrome.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "After a vascular accident affecting the lateral portion of the cervical spinal cord (Wallenberg syndrome), the patient developed anisocoria. It is correct to state that: \n",
      "a) Anisocoria will worsen in the dark. \n",
      "b) There will be worsening of anisocoria in light. \n",
      "c) Will be unresponsive to the instillation of sympathomimetic eye drops. \n",
      "d) Involvement of the stellate ganglion is the most likely diagnosis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Wallenberg syndrome is a condition that affects the lateral portion of the cervical spinal cord and can cause anisocoria, which is an unequal pupil size. In this case, the correct answer is b) There will be worsening of anisocoria in light. Anisocoria can worsen in light due to the dilation of the pupil, which can be affected by the sympathetic nervous system. Therefore, option b is the correct answer.\n",
      "\n",
      "Note:\n",
      "\n",
      "* A) Anisocoria will worsen in the dark: This is incorrect because anisocoria can worsen in light, not in the dark.\n",
      "* C) Will be unresponsive to the instillation of sympathomimetic eye drops: This is incorrect because anisocoria can be affected by the sympathetic nervous system, and instillation of sympathomimetic eye drops can help to dilate the pupil and worsen anisocoria.\n",
      "* D) Involvement of the stellate ganglion is the most likely diagnosis: This is incorrect because the stellate ganglion is not typically affected in Wallenberg syndrome.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 90: \n",
      "Language: spanish\n",
      "Question: \n",
      "El paciente llega a urgencias quejándose de dolor, visión reducida e hiperemia en el ojo derecho desde hace dos días. A la exploración presenta agudeza visual de 0,1, reacción de cámara anterior de dos cruces de cuatro, precipitados queráticos granulomatosos y lesión blanco amarillenta de límites mal definidos en la periferia de la retina en ojo derecho. El ojo izquierdo no ha cambiado. ¿Cuál es el curso de acción inicial más apropiado?\n",
      "a) Ecografía ocular.\n",
      "b) Uso de corticoides tópicos y ciclopléjicos.\n",
      "c) Uso de corticoides orales.\n",
      "d) Serología para toxoplasmosis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "La opción b) Uso de corticoides tópicos y ciclopléjicos es la opción más adecuada como curso de acción inicial para el paciente que presenta dolor, visión reducida, hiperemia en el ojo derecho y síntomas de enfermedad ocular. Los corticoides tópicos y ciclopléjicos pueden ayudar a reducir la inflamación y el dolor, mientras que los corticoides orales pueden ser necesarios si la enfermedad es grave o difusa. La ecografía ocular puede ser útil para evaluar la gravedad de la enfermedad, pero no es la opción inicial más adecuada. La serología para toxoplasmosis no es necesaria en este caso, ya que no hay síntomas o signos que sugieran una enfermedad de transmisión parasitaria.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Isang pasyento emergency room na nagrereklamo ng sakit sa mata, malabong paningin at hyperemia sa kanang mata sa loob ng dalawang araw. Nasiyasat na mayroon siyang visual acuity na 0.1, dalawa sa apat na anterior chamber reaction, granulomatous keratic precipitates at isang mamuti-muting dilaw na sugat na hindi matukoy ang hangganan sa retina ng kanang kamay. Walang pagbabago ang nakita sa kaliwang mata. Ano ang pinaka-angkop na unang gawin:\n",
      "a) Ultrasound ng mata.\n",
      "b) Paggamit ng mga topical corticosteroids at cycloplegic.\n",
      "c) Paggamit ng oral corticosteroids.\n",
      "d) Serology para sa toxoplasmosis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Based on the patient's symptoms and physical examination findings, the most appropriate initial step would be to prescribe topical corticosteroids and cycloplegics. The patient's symptoms of sakit sa mata (eye pain), malabong paningin (blurred vision), and hyperemia (redness) suggest inflammation in the eye, which can be caused by various conditions such as uveitis, conjunctivitis, or keratitis. The presence of granulomatous keratic precipitates and a mamuti-muting dilaw na sugat (yellowish discharge) in the eye suggests a possible diagnosis of uveitis or keratitis.\n",
      "\n",
      "Topical corticosteroids can help reduce inflammation in the eye and alleviate symptoms such as eye pain and redness. Cycloplegics, such as atropine, can help dilate the pupil and reduce inflammation in the eye by blocking the parasympathetic nervous system. These medications can also help prevent further damage to the eye and improve visual acuity.\n",
      "\n",
      "Ultrasound of the eye (option a) may be necessary if the diagnosis is not clear, but it is not the most appropriate initial step. Oral corticosteroids (option c) may be considered if the inflammation is severe or persistent, but they are not the first line of treatment for eye inflammation. Serology for toxoplasmosis (option d) is not relevant to the patient's symptoms and physical examination findings.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Paciente chega ao pronto-socorro com queixa de dor, redução da visão e hiperemia do olho direito há dois dias. Ao exame, apresenta acuidade visual 0,1, reação de câmara anterior duas cruzes em quatro, precipitados ceráticos granulomatosos e lesão branco-amarelada de limites pouco definidos na periferia da retina no olho direito. O olho esquerdo não tem alterações. Qual a conduta inicial mais apropriada? \n",
      "a) Ultrassonografia ocular. \n",
      "b) Uso de corticoide e cicloplégico tópicos. \n",
      "c) Uso de corticoide oral. \n",
      "d) Sorologia para toxoplasmose.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of eye pain, vision loss, and hyperemia, along with the physical examination findings of decreased visual acuity, anterior chamber reaction, and granulomatous precipitates in the right eye, suggest a possible diagnosis of uveitis. Uveitis is a condition characterized by inflammation in the uvea, the middle layer of the eye, and can cause vision loss if left untreated.\n",
      "\n",
      "The most appropriate initial course of action would be to prescribe topical corticosteroids and cycloplegics, which can help reduce inflammation and prevent further damage to the eye. Option b, \"Uso de corticoide e cicloplégico tópicos,\" is therefore the correct response.\n",
      "\n",
      "Option a, \"Ultrassonografia ocular,\" may be necessary later on in the diagnosis and treatment of uveitis, but it is not the most appropriate initial course of action.\n",
      "\n",
      "Option c, \"Uso de corticoide oral,\" may be considered in severe cases of uveitis that do not respond to topical treatment, but it is not the most appropriate initial course of action.\n",
      "\n",
      "Option d, \"Sorologia para toxoplasmose,\" is not relevant to the patient's symptoms and physical examination findings, and is therefore not the correct response.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "A patient arrives at the emergency room complaining of pain, reduced vision and hyperemia in the right eye for two days. On examination, he has a visual acuity of 0.1, anterior chamber reaction two crosses out of four, granulomatous keratic precipitates and a white-yellowish lesion with poorly defined limits on the periphery of the retina in the right eye. The left eye has no changes. What is the most appropriate initial course of action? \n",
      "a) Eye ultrasound. \n",
      "b) Use of topical corticosteroids and cycloplegic. \n",
      "c) Use of oral corticosteroids. \n",
      "d) Serology for toxoplasmosis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct response is b) Use of topical corticosteroids and cycloplegic.\n",
      "\n",
      "The patient's symptoms of pain, reduced vision, and hyperemia in the right eye, along with the physical examination findings of anterior chamber reaction, granulomatous keratic precipitates, and a white-yellowish lesion on the periphery of the retina, suggest a possible diagnosis of uveitis. Uveitis is a inflammatory condition that affects the uvea, the middle layer of the eye.\n",
      "\n",
      "The initial course of action for uveitis is typically to treat the inflammation with topical corticosteroids and cycloplegic agents. Topical corticosteroids will help to reduce the inflammation and swelling in the eye, while cycloplegic agents will help to reduce the pain and discomfort by paralyzing the ciliary muscles.\n",
      "\n",
      "Eye ultrasound (a) may be considered later on in the evaluation process to further assess the extent of the inflammation and to rule out other possible causes of uveitis, such as a cataract or a retinal detachment.\n",
      "\n",
      "Oral corticosteroids (c) may also be considered in severe cases of uveitis, but are not the first line of treatment.\n",
      "\n",
      "Serology for toxoplasmosis (d) is not necessary in this case, as the patient does not have any symptoms or signs suggestive of toxoplasmosis, such as fever, headache, or retinochoroiditis.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 91: \n",
      "Language: spanish\n",
      "Question: \n",
      "Paciente de 8 años diagnosticado de artritis juvenil idiopática, sin otras comorbilidades, aún sin tratamiento, presenta uveítis anterior recurrente asociada a sinequias posteriores, queratopatía en banda y cataratas. ¿Cuál es el curso de acción más apropiado en este momento entre las alternativas siguientes?\n",
      "a) Faceectomía con implante de lente intraocular acrílica.\n",
      "b) Uso de inmunomodulador sistémico.\n",
      "c) Uso de corticoides orales.\n",
      "d) Uso de EDTA tópico.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's history of recurrent anterior uveitis associated with posterior synechiae, keratopathy, and cataracts suggests that they have a high risk of developing complications from surgery. Therefore, the best course of action would be to use systemic immunomodulators to control the inflammation and prevent further damage to the eye.\n",
      "\n",
      "Option A, facetectomy with implantation of an acrylic intraocular lens, is not the best option as it is a surgical procedure that carries a higher risk of complications in this patient population.\n",
      "\n",
      "Option C, use of oral corticosteroids, may be effective in reducing inflammation, but it is not a long-term solution and may have systemic side effects.\n",
      "\n",
      "Option D, use of EDTA topically, is not effective in treating uveitis and is not a recommended treatment for this condition.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Isang 8 taong gulang na pasyente na may diagnosis ng juvenile idiopathic arthritis, walang ibang mga comorbidities, ngunit hindi  pa nabibigyan ng lunas, ay nagpunta sa ospital at napag-alaman na mayroon siyang recurrent anterior uveitis associated with posterior synechiae, band keratopathy and cataract. Ano ang pinakaakmang gawin? \n",
      "a) Facectomy na may acrylic intraocular lens implantation.\n",
      "b) Paggamit ng Systemic Immunomodulator.\n",
      "c) Paggamit ng Oral Corticosteroids.\n",
      "d) Paggamit ng topical na EDTA.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient has juvenile idiopathic arthritis with recurrent anterior uveitis associated with posterior synechiae, band keratopathy, and cataract. The best course of action would be to use a systemic immunomodulator (b) to manage the underlying autoimmune disease.\n",
      "\n",
      "Facectomy with acrylic intraocular lens implantation (a) may be necessary in some cases, but it is not the most appropriate option for this patient's condition.\n",
      "\n",
      "Oral corticosteroids (c) may be used to manage inflammation, but they are not the most effective option for managing the underlying autoimmune disease.\n",
      "\n",
      "Topical EDTA (d) is not a viable treatment option for this patient's condition.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Paciente de 8 anos com diagnóstico de artrite juvenil idiopática, sem outras comorbidades, ainda sem tratamento, apresenta quadro recidivante de uveíte anterior associada a sinéquias posteriores, ceratopatia em faixa e catarata. Qual conduta mais apropriada neste momento dentre as alternativas abaixo? \n",
      "a) Facectomia com implante de lente intraocular acrílica. \n",
      "b) Uso de imunomodulador sistêmico. \n",
      "c) Uso de corticoide oral. \n",
      "d) Uso de EDTA tópico.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's history of recurrent anterior uveitis associated with posterior synechiae, ceratopathy, and cataract suggests that the patient has a high risk of developing glaucoma. The best course of action would be to start the patient on a systemic immunomodulator, such as methotrexate or azathioprine, to reduce the inflammation and prevent further damage to the eye.\n",
      "\n",
      "Option A, facetomia with implantation of an acrylic intraocular lens, is not appropriate at this time as it is a surgical procedure that is usually reserved for advanced cases of glaucoma that have not responded to medical treatment.\n",
      "\n",
      "Option C, oral corticosteroid use, may be considered as a temporary measure to reduce inflammation, but it is not a long-term solution and may have side effects.\n",
      "\n",
      "Option D, topical EDTA use, is not a recommended treatment for uveitis or glaucoma.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "An 8-year-old patient with a diagnosis of juvenile idiopathic arthritis, without other comorbidities, still untreated, presents with recurrent anterior uveitis associated with posterior synechiae, band keratopathy and cataract. What is the most appropriate conduct at this time among the alternatives below? \n",
      "a) Facectomy with acrylic intraocular lens implantation. \n",
      "b) Use of systemic immunomodulator. \n",
      "c) Use of oral corticosteroids. \n",
      "d) Use of topical EDTA.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of recurrent anterior uveitis associated with posterior synechiae, band keratopathy, and cataract are indicative of a severe inflammatory response. The most appropriate conduct at this time would be to use a systemic immunomodulator (option b) to reduce the inflammation and prevent further damage to the eye.\n",
      "\n",
      "While surgical intervention (option a) may be necessary in some cases, it is not the most appropriate first line of treatment in this case, as the patient has not yet been treated with medication. Oral corticosteroids (option c) may also be considered, but they may have more side effects compared to systemic immunomodulators. Topical EDTA (option d) is not effective in treating uveitis and is not a suitable option for this patient.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 92: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál es el inmunosupresor de elección en niños con uveítis anterior secundaria a artritis idiopática juvenil?\n",
      "a) Azatioprina.\n",
      "b) Tacrolimús.\n",
      "c) Ciclofosfamida.\n",
      "d) Metotrexato.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // b) Tacrolimús.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Tacrolimus is the immunosuppressant of choice in children with anterior uveitis secondary to juvenile idiopathic arthritis (JIA). It has been shown to be effective in reducing inflammation and preventing recurrences of uveitis in this patient population.\n",
      "\n",
      "Azathioprine (option a) is an immunosuppressant that has been used in the treatment of JIA, but it has not been shown to be as effective as tacrolimus in preventing uveitis recurrences.\n",
      "\n",
      "Cyclophosphamide (option c) is a chemotherapy drug that has been used in the treatment of severe JIA, but it is not typically used as a first-line agent for uveitis.\n",
      "\n",
      "Methotrexate (option d) is a disease-modifying anti-rheumatic drug (DMARD) that is commonly used in the treatment of JIA, but it has not been shown to be effective in preventing uveitis recurrences.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Aling immunosuppressant ang pwede gamitin para sa mga bata na may anterior uveitis dala ng juvenile idiopathic arthritis?\n",
      "a) Azathioprine.\n",
      "b) Tacrolimus.\n",
      "c) Cyclophosphamide.\n",
      "d) Methotrexate.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // B - Tacrolimus\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Tacrolimus is an immunosuppressant that is commonly used to treat juvenile idiopathic arthritis (JIA) associated anterior uveitis. It works by inhibiting the activation of T-cells, which are involved in the inflammatory process that causes uveitis. Tacrolimus has been shown to be effective in reducing inflammation and preventing recurrences of uveitis in patients with JIA.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "* Azathioprine is an immunosuppressant that is also used to treat JIA, but it has not been shown to be effective in treating anterior uveitis.\n",
      "* Cyclophosphamide is a chemotherapy drug that is sometimes used to treat severe cases of JIA, but it is not typically used to treat anterior uveitis.\n",
      "* Methotrexate is a disease-modifying anti-rheumatic drug (DMARD) that is commonly used to treat JIA, but it has not been shown to be effective in treating anterior uveitis.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual é o imunossupressor de escolha para crianças com uveíte anterior secundária à artrite juvenil idiopática? \n",
      "a) Azatioprina. \n",
      "b) Tacrolimus. \n",
      "c) Ciclofosfamida. \n",
      "d) Metotrexato.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"  // Metotrexato\n",
      "}\n",
      "```\n",
      "Explanation:\n",
      "\n",
      "The question is asking for the immunosuppressor of choice for children with anterior uveitis secondary to juvenile idiopathic arthritis. The correct answer is d) Metotrexate. Metotrexate is a disease-modifying anti-rheumatic drug (DMARD) that is commonly used to treat juvenile idiopathic arthritis and has been shown to be effective in reducing inflammation in the eyes and joints. Azathioprine (a), tacrolimus (b), and cyclophosphamide (c) are also immunosuppressants, but they are not as commonly used to treat juvenile idiopathic arthritis as metotrexate.\n",
      "{'response': 'd'}\n",
      "Language: english\n",
      "Question: \n",
      "What is the immunosuppressant of choice for children with anterior uveitis secondary to juvenile idiopathic arthritis? \n",
      "a) Azathioprine. \n",
      "b) Tacrolimus. \n",
      "c) Cyclophosphamide. \n",
      "d) Methotrexate.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a) Azathioprine\"\n",
      "}\n",
      "```\n",
      "\n",
      "Azathioprine is the immunosuppressant of choice for children with anterior uveitis secondary to juvenile idiopathic arthritis. It is effective in reducing inflammation and preventing recurrences of uveitis, and has a relatively low risk of side effects compared to other immunosuppressants. Tacrolimus, cyclophosphamide, and methotrexate may also be used in certain cases, but azathioprine is generally considered the first-line treatment.\n",
      "{'response': 'a) Azathioprine'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 93: \n",
      "Language: spanish\n",
      "Question: \n",
      "Entre las alternativas siguientes, ¿cuál prueba es la más adecuada para el seguimiento de un paciente con panuveítis secundaria a enfermedad de Behçet, utilizando ciclosporina?\n",
      "a) Creatinina.\n",
      "b) Ferritina.\n",
      "c) Glicemia en ayunas.\n",
      "d) HLA-B51.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "La prueba más adecuada para el seguimiento de un paciente con panuveítis secundaria a enfermedad de Behçet, utilizando ciclosporina, es la determinación de HLA-B51. La enfermedad de Behçet es una enfermedad autoinmune que se asocia con la presencia del antígeno HLA-B51, por lo que su determinación es útil para el diagnóstico y el seguimiento de la enfermedad. La creatinina (a), ferritina (b) y la glicemia en ayunas (c) no son pruebas adecuadas para el seguimiento de la panuveítis en este caso.\n",
      "{'response': 'd'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Aling test ang pinaka-angkop para sa pag-follow-up ng pasyente na may panuveitis dala ng sa sakit na Behçet, gamit ang cyclosporine?\n",
      "a) Creatinine.\n",
      "b) Ferritin.\n",
      "c) Fasting Blood Glucose\n",
      "d) HLA-B51.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // HLA-B51\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "HLA-B51 is the most appropriate test to follow up a patient with Behçet's disease who has been treated with cyclosporine. This is because HLA-B51 is a genetic marker that is associated with an increased risk of developing Behçet's disease, and cyclosporine is known to increase the risk of HLA-B51-associated diseases. Monitoring the patient's HLA-B51 status can help healthcare providers assess the effectiveness of the treatment and make informed decisions about further management.\n",
      "\n",
      "The other options are not as relevant for follow-up testing in this scenario:\n",
      "\n",
      "* Creatinine is a marker of kidney function and is not directly related to Behçet's disease or cyclosporine therapy.\n",
      "* Ferritin is a marker of iron stores and is not specific to Behçet's disease or cyclosporine therapy.\n",
      "* Fasting Blood Glucose is a marker of blood sugar control and is not directly related to Behçet's disease or cyclosporine therapy.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Dentre as alternativas abaixo, qual exame é o mais apropriado para o seguimento de um paciente com panuveite secundária à doença de Behçet, em uso de ciclosporina? \n",
      "a) Creatinina. \n",
      "b) Ferritina. \n",
      "c) Glicemia de jejum. \n",
      "d) HLA-B51.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is d) HLA-B51.\n",
      "\n",
      "Panuveitis secondary to Behçet's disease is an inflammatory eye disease that can cause vision loss if left untreated. HLA-B51 is a genetic marker that is associated with an increased risk of developing Behçet's disease, and it is often used as a diagnostic marker for the disease. Monitoring the patient's HLA-B51 status can help in assessing the risk of disease progression and response to treatment.\n",
      "\n",
      "Creatinina (a) and ferritina (b) are not directly related to the patient's uveitis or Behçet's disease. Glicemia de jejum (c) may be relevant for patients with diabetes, but it is not directly related to the patient's uveitis or Behçet's disease.\n",
      "{'response': 'd'}\n",
      "Language: english\n",
      "Question: \n",
      "\n",
      "Among the alternatives below, which exam is the most appropriate for the follow-up of a patient with panuveitis secondary to Behçet's disease, using cyclosporine? \n",
      "a) Creatinine. \n",
      "b) Ferritin. \n",
      "c) Fasting blood glucose. \n",
      "d) HLA-B51.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"  // HLA-B51\n",
      "}\n",
      "```\n",
      "\n",
      "Rationale:\n",
      "\n",
      "HLA-B51 is the most appropriate exam for follow-up of a patient with panuveitis secondary to Behçet's disease, using cyclosporine. Behçet's disease is a systemic vasculitis that can affect the eyes, and HLA-B51 is a genetic marker that is associated with an increased risk of developing the disease. Cyclosporine is a medication that is commonly used to treat Behçet's disease, and monitoring the patient's HLA-B51 status can help to assess the effectiveness of the treatment and predict the risk of recurrence.\n",
      "\n",
      "The other options are not directly related to the patient's condition or treatment:\n",
      "\n",
      "* Creatinine is a marker of kidney function, which may be monitored in patients with renal involvement, but it is not directly related to the patient's uveitis or Behçet's disease.\n",
      "* Ferritin is a marker of iron storage, which may be elevated in patients with inflammation, but it is not specific to Behçet's disease or panuveitis.\n",
      "* Fasting blood glucose is a measure of blood sugar levels, which may be monitored in patients with diabetes, but it is not directly related to the patient's uveitis or Behçet's disease.\n",
      "{'response': 'd'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 94: \n",
      "Language: spanish\n",
      "Question: \n",
      "Paciente de sexo femenino de 25 años refiere desde hace unos días una reducción de la agudeza visual, precedida de fiebre, dolor de cabeza y malestar general. Al examen presenta reacción de dos cruces en cámara anterior, vitriitis de uno en cuatro y desprendimiento de retina en polo posterior comprometiendo la mácula, sin lagrimas en ambos ojos. ¿Cuál es el tratamiento más adecuado para el desprendimiento de retina?\n",
      "a) Vitrectomía posterior con infusión de SF6 y posición de la cabeza.\n",
      "b) Corticoides orales.\n",
      "c) Retinopexia neumática.\n",
      "d) Introflexión escleral con explante macular.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option a) Vitrectomía posterior con infusión de SF6 y posición de la cabeza.\n",
      "\n",
      "Vitrectomía posterior es una cirugía que se utiliza para tratar el desprendimiento de retina en la parte posterior del ojo. La infusión de SF6 (sulfuro de xenón) ayuda a mantener la retina en su lugar y evita que se desprenda más tejido. La posición de la cabeza es importante para evitar que el desprendimiento de retina se extienda a la mácula, la parte más sensitiva de la retina.\n",
      "\n",
      "Las otras opciones no son adecuadas para tratar el desprendimiento de retina en este caso:\n",
      "\n",
      "* Corticoides orales pueden ser útiles para reducir la inflamación, pero no tratan el desprendimiento de retina directamente.\n",
      "* Retinopexia neumática es una técnica que se utiliza para tratar la retinosis pigmentaria, pero no es adecuada para el desprendimiento de retina.\n",
      "* Introflexión escleral con explante macular es una técnica que se utiliza para tratar la degeneración macular, pero no es adecuada para el desprendimiento de retina.\n",
      "{'response': 'a'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Isang 25-taong-gulang na babaeng pasyente ay nakapansin na lumalabong mata sa loob ng ilang araw pagkatapos niyang lagnatin, makaranas ng sakit sa ulo at kawalan ng ginhawa. Sa pagsusuri, mayroon siyang two-cross anterior chamber reaction, vitreitis, a four-cross, and retinal detachment sa likurang bahagi ng pole na binubuo ng macula, nang walang butas sa parehong mata. Ano ang pinakaakmang gamot ang maaaring ibigay para sa retinal detachment?\n",
      "a) Posterior vitrectomy na may SF6 at akmang posisyon ng ulo.\n",
      "b) Oral corticosteroid.\n",
      "c) Pneumatic retinopexy.\n",
      "d) Scleral introflexion na may macular explant.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Retinal detachment is a medical emergency that requires prompt treatment to prevent permanent vision loss. The most appropriate treatment for retinal detachment is posterior vitrectomy with SF6 gas injection and proper positioning of the head. This procedure involves removing the vitreous gel and injecting SF6 gas into the eye to flatten the retina and reattach it to the back of the eye.\n",
      "\n",
      "Option A, posterior vitrectomy with SF6 gas injection, is the correct answer.\n",
      "\n",
      "Option B, oral corticosteroid, is not appropriate for treating retinal detachment as it does not address the underlying cause of the condition.\n",
      "\n",
      "Option C, pneumatic retinopexy, is a less invasive procedure that may be used for certain types of retinal detachment, but it is not the most appropriate treatment for all cases.\n",
      "\n",
      "Option D, scleral introflexion with macular explant, is a surgical procedure that involves removing a portion of the sclera and retina and is not commonly used for retinal detachment.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Paciente de 25 anos, sexo feminino, refere redução da acuidade visual há poucos dias, precedida de febre, cefaleia e mal-estar. Ao exame, apresenta reação de câmara anterior duas cruzes, vitreíte uma cruz em quatro e descolamento da retina no polo posterior comprometendo a mácula, sem roturas em ambos os olhos. Qual o tratamento mais apropriado para o descolamento de retina? \n",
      "a) Vitrectomia posterior com infusão de SF6 e posição de cabeça. \n",
      "b) Corticoide oral. \n",
      "c) Retinopexia pneumática. \n",
      "d) Introflexão escleral com explante macular.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms and examination findings suggest a retinal detachment, which is a medical emergency that requires prompt treatment. The most appropriate treatment for retinal detachment is vitrectomy, which is the removal of the vitreous gel that is pulling the retina away from the back of the eye. This can be done through a posterior approach, and an injection of sulfur hexafluoride (SF6) gas can be used to help flatten the retina and reduce the risk of further detachment. The patient should also be positioned in a way that allows the gas to spread evenly and help reattach the retina.\n",
      "\n",
      "Therefore, option (a) Vitrectomia posterior com infusão de SF6 e posição de cabeça is the correct answer.\n",
      "\n",
      "Option (b) Corticoide oral may be used to reduce inflammation, but it will not reattach the retina.\n",
      "\n",
      "Option (c) Retinopexia pneumática is a surgical procedure that uses a gas bubble to reattach the retina, but it is not the most appropriate treatment for this case.\n",
      "\n",
      "Option (d) Introflexão escleral com explante macular is a surgical procedure that involves removing a portion of the sclera and replacing it with a piece of healthy tissue, but it is not the most appropriate treatment for retinal detachment.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "A 25-year-old female patient reported reduced visual acuity for a few days, preceded by fever, headache and malaise. On examination, she has a two-cross anterior chamber reaction, vitreitis, a four-cross, and retinal detachment at the posterior pole, compromising the macula, without holes in both eyes. What is the most appropriate treatment for retinal detachment? \n",
      "a) Posterior vitrectomy with SF6 infusion and head position. \n",
      "b) oral corticosteroid. \n",
      "c) Pneumatic retinopexy. \n",
      "d) Scleral introflexion with macular explant.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms and examination findings suggest a diagnosis of retinal detachment, which is a medical emergency that requires prompt treatment. The most appropriate treatment for retinal detachment is posterior vitrectomy with SF6 infusion and head positioning. This surgical procedure involves removing the vitreous gel and replacing it with a gas (SF6) to help the retina reattach. Head positioning is also used to help the gas bubble stay in place and promote reattachment.\n",
      "\n",
      "Option A is the correct answer.\n",
      "\n",
      "Option B (oral corticosteroid) is not appropriate for retinal detachment, as it does not address the underlying cause of the condition.\n",
      "\n",
      "Option C (pneumatic retinopexy) is a less invasive procedure that may be used for certain types of retinal detachment, but it is not the most appropriate treatment for the patient's symptoms and examination findings.\n",
      "\n",
      "Option D (scleral introflexion with macular explant) is a surgical procedure that involves removing a portion of the sclera and retina, but it is not the most appropriate treatment for retinal detachment.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 95: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un paciente con antecedentes de traumatismo ocular abierto en el ojo derecho hace un año presenta una reacción cruzada en la cámara anterior, cambio de color del iris, opacidad vítrea leve y retina pegada. El electrorretinograma muestra respuestas extinguidas en las fases fotópica y escotópica. El ojo izquierdo no muestra cambios. ¿Cuál es la causa más probable?\n",
      "a) Endoftalmitis bacteriana.\n",
      "b) Endoftalmitis fúngica.\n",
      "c) Oftalmía simpática.\n",
      "d) Retención de cuerpo extraño intraocular metálico.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Endoftalmitis fúngica\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of a crossed reaction in the anterior chamber, change in iris color, mild vitreous opacification, and retinal adhesion, along with extinguished electroretinogram responses in both photopic and scotopic phases, suggest a diagnosis of endophthalmitis. The absence of changes in the left eye supports this diagnosis. Endophthalmitis can be caused by bacteria, fungi, or other microorganisms. Given the patient's history of traumatic ocular injury, the most probable cause is endophthalmitis fúngica (b).\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Isang pasyente na may kasaysayan ng bukas na ocular trauma sa kanang mata isang taon na ang nakalilipas, ay nagpapakita ng anterior chamber reaction sa cross, pagbabago sa kulay ng iris, katamtamang vitrous clouding, at glued retina. Ipinapakita ng electroetinogram na mayroong extinguished responses sa photopic at scopotic phases. Wala namang pagbabago sa kanyang kaliwang mata.Ano ang malamang na sanhi?\n",
      "a) Bacterial endophthalmitis. \n",
      "b) Fungal endophthalmitis. \n",
      "c) Sympathetic ophthalmia. \n",
      "d) Pananatili ng metallic intraocular na bagay\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of anterior chamber reaction, change in iris color, vitreous clouding, and retinal detachment, along with the electrophysiological findings of extinguished responses in the photopic and scotopic phases, suggest a diagnosis of sympathetic ophthalmia. This is a rare condition that occurs when there is a sympathetic response in the fellow eye after a traumatic injury to one eye. The patient's history of a penetrating ocular trauma in the right eye one year ago and the absence of any changes in the left eye support this diagnosis.\n",
      "\n",
      "Therefore, option c) Sympathetic ophthalmia is the most likely diagnosis.\n",
      "\n",
      "Option a) Bacterial endophthalmitis and option b) Fungal endophthalmitis are possibilities, but they are less likely given the patient's history and symptoms.\n",
      "\n",
      "Option d) Pananatili ng metallic intraocular na bagay (retention of a metallic intraocular foreign body) is not a likely diagnosis based on the patient's symptoms and history.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Paciente com história de trauma ocular aberto no olho direito há um ano apresenta reação de câmara anterior uma cruz, alteração da cor da íris, turvação vítrea leve e retina colada. O eletrorretinograma apresenta respostas extintas nas fases fotópica e escotópica. O olho esquerdo não apresenta alterações. Qual a causa mais provável? \n",
      "a) Endoftalmite bacteriana. \n",
      "b) Endoftalmite fúngica. \n",
      "c) Oftalmia simpática. \n",
      "d) Retenção de corpo estranho intraocular metálico.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of a reaction in the anterior chamber, changes in the iris color, mild vitreous turbidity, and retinal detachment, along with the absence of responses in the electroretinogram in both photopic and scotopic phases, suggest a possible diagnosis of endophthalmitis, which is an inflammation of the inner eye.\n",
      "\n",
      "Endophthalmitis can be caused by bacterial, fungal, or viral infections. Given the patient's history of trauma to the right eye, the most likely cause is a bacterial infection, which can enter the eye through the traumatic wound. Therefore, option b) Endoftalmite bacteriana is the most appropriate response.\n",
      "\n",
      "It is important to note that the patient should be referred to an ophthalmologist for further evaluation and treatment, as endophthalmitis is a serious condition that can lead to vision loss if left untreated.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Patient with a history of open ocular trauma in the right eye one year ago, presents anterior chamber reaction to a cross, iris color change, mild vitreous clouding and glued retina. The electroretinogram shows extinguished responses in the photopic and scotopic phases. The left eye shows no alterations. What is the most likely cause? \n",
      "a) Bacterial endophthalmitis. \n",
      "b) Fungal endophthalmitis. \n",
      "c) Sympathetic ophthalmia. \n",
      "d) Retention of metallic intraocular foreign body.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of anterior chamber reaction, iris color change, mild vitreous clouding, and glued retina, along with the absence of alterations in the left eye, suggest a diagnosis of sympathetic ophthalmia. This is a condition where the eye reacts to a previous injury or inflammation in the other eye, leading to inflammation and scarring in the affected eye. The electroretinogram showing extinguished responses in both photopic and scotopic phases supports this diagnosis.\n",
      "\n",
      "Bacterial or fungal endophthalmitis would likely present with more severe symptoms, such as pain, redness, and vision loss, and would not be limited to one eye. Retention of a metallic intraocular foreign body would also likely cause more severe symptoms and would require imaging studies to confirm the presence of the foreign body.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 96: \n",
      "Language: spanish\n",
      "Question: \n",
      "Entre las alternativas siguientes, ¿qué microorganismo está asociado con la enfermedad de Eales?\n",
      "a) Bartonella henselae.\n",
      "b) Micobacteria tuberculosis.\n",
      "c) Toxoplasma gondii.\n",
      "d) Virus de Epstein-Barr.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is a) Bartonella henselae.\n",
      "\n",
      "Bartonella henselae is a gram-negative bacterium that is associated with the disease Eales, which is also known as bartonellosis. This disease is a vector-borne infection that is transmitted through the bite of an infected flea. The bacteria can cause a variety of symptoms, including fever, headache, and swollen lymph nodes.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "* Micobacteria tuberculosis is a gram-positive bacterium that is associated with tuberculosis, not Eales.\n",
      "* Toxoplasma gondii is a protozoan parasite that can cause toxoplasmosis, but it is not associated with Eales.\n",
      "* Virus de Epstein-Barr is a virus that is associated with infectious mononucleosis, but it is not associated with Eales.\n",
      "{'response': 'a'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na microorganism ang nauugnay sa Eales disease?\n",
      "a) Bartonella Henselae.\n",
      "b) Mycobacterium tuberculosis.\n",
      "c) Toxoplasma gondii.\n",
      "d) Virus ng Epstein-Barr.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Mycobacterium tuberculosis\n",
      "}\n",
      "```\n",
      "\n",
      "Eales disease is a rare condition characterized by the inflammation of the blood vessels, particularly the veins. It is caused by the bacteria Mycobacterium tuberculosis, which is also responsible for tuberculosis. Therefore, the correct answer is (b) Mycobacterium tuberculosis.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Dentre as alternativas abaixo, qual microorganismo está associado à doença de Eales? \n",
      "a)Bartonella henselae. \n",
      "b)Mycobacterium tuberculosis. \n",
      "c)Toxoplasma gondii. \n",
      "d) Vírus Epstein-Barr.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "The correct answer is a) Bartonella henselae.\n",
      "\n",
      "Bartonella henselae is a gram-negative bacterium that is associated with the disease Eales, also known as cat-scratch disease. It is transmitted through the scratch or bite of an infected cat, and can cause symptoms such as fever, swollen lymph nodes, and skin lesions.\n",
      "\n",
      "The other options are not associated with Eales disease:\n",
      "\n",
      "* Mycobacterium tuberculosis is the bacterium that causes tuberculosis.\n",
      "* Toxoplasma gondii is a parasite that can cause toxoplasmosis, a disease that can affect people with weakened immune systems.\n",
      "* Vírus Epstein-Barr is a virus that causes infectious mononucleosis, also known as glandular fever.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "\n",
      "Among the alternatives below, which microorganism is associated with Eales disease? \n",
      "a) Bartonella henselae. \n",
      "b) Mycobacterium tuberculosis. \n",
      "c) Toxoplasma gondii. \n",
      "d) Epstein-Barr virus.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is a) Bartonella henselae. Eales disease is a rare condition characterized by the proliferation of Bartonella henselae, a bacterium that is transmitted through the scratch or bite of an infected cat.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 97: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto a la afectación ocular en la espondilitis anquilosante, es correcto afirmar:\n",
      "a) Es bilateral, no simultánea, en la mayoría de los casos.\n",
      "b) El cuadro más característico corresponde a episodios de uveítis intermedia.\n",
      "c) La sinequia posterior del iris es una complicación rara.\n",
      "d) Es un proceso inflamatorio granulomatoso.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Respecto a la afectación ocular en la espondilitis anquilosante, es correcto afirmar que es bilateral, no simultánea, en la mayoría de los casos.\n",
      "{'response': 'a'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod ang nagpapahayag ng katotohanan tungkol sa pagkakasangkot sa ocular sa ankylosing spondylitis?\n",
      "a) Ito ay bilateral, hindi magkakasabay, sa karamihan ng mga kaso.\n",
      "b) Ang pinakamadalas na katangian nito ay may kinalaman sa paulit-ulit na intermediate uveitis.\n",
      "c) Ang likurang bahagi ng synechiae ng Iris ay isang bihirang komoplikasyon\n",
      "d) Ito ay isang granulomatous inflammatory process\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Ang pinakamadalas na katangian nito ay may kinalaman sa paulit-ulit na intermediate uveitis.\n",
      "\n",
      "Ankylosing spondylitis (AS) is a type of inflammatory arthritis that affects the spine and sacroiliac joints. It can also affect other parts of the body, including the eyes. Ocular involvement in AS is not uncommon, and the most common manifestation is intermediate uveitis, which is an inflammation of the uvea (the middle layer of the eye) that can cause vision problems.\n",
      "\n",
      "Option a) Ito ay bilateral, hindi magkakasabay, sa karamihan ng mga kaso is incorrect because while AS can affect both eyes, it is not always bilateral (affecting both eyes simultaneously) and can have different manifestations in each eye.\n",
      "\n",
      "Option c) Ang likurang bahagi ng synechiae ng Iris ay isang bihirang komoplikasyon is also incorrect. Synechiae are adhesions between the iris and the lens, and while they can be a complication of AS, they are not the most common ocular manifestation of the disease.\n",
      "\n",
      "Option d) Ito ay isang granulomatous inflammatory process is incorrect because while granulomas (clusters of immune cells) can form in the eyes of people with AS, they are not the most common ocular manifestation of the disease.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Sobre o acometimento ocular na espondilite ancilosante, é correto afirmar: \n",
      "a) É bilateral, não simultâneo, na maioria dos casos. \n",
      "b) O quadro mais característico corresponde a episódios de uveíte intermediária. \n",
      "c) Sinéquia posterior da íris é complicação rara. \n",
      "d) Trata-se de processo inflamatório granulomatoso.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option a) É bilateral, não simultâneo, na maioria dos casos.\n",
      "\n",
      "Spondylitis ankylosans is a condition that affects the spine and can cause ocular manifestations. The most common ocular manifestation is bilateral, non-simultaneous uveitis, which means that the inflammation affects one eye at a time. The other options are not accurate descriptions of the ocular manifestations of spondylitis ankylosans.\n",
      "\n",
      "Option b) O quadro mais característico corresponde a episódios de uveíte intermediária is incorrect because uveitis is not the most characteristic feature of ocular involvement in spondylitis ankylosans.\n",
      "\n",
      "Option c) Sinéquia posterior da íris é complicação rara is incorrect because synechiae (adhesions) between the iris and the lens or between the iris and the cornea are not a rare complication of spondylitis ankylosans.\n",
      "\n",
      "Option d) Trata-se de processo inflamatório granulomatoso is incorrect because spondylitis ankylosans is not a granulomatous inflammatory process.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding ocular involvement in ankylosing spondylitis, it is correct to state: \n",
      "a) It is bilateral, not simultaneous, in most cases. \n",
      "b) The most characteristic picture corresponds to episodes of intermediate uveitis. \n",
      "c) Posterior synechiae of the iris is a rare complication. \n",
      "d) It is a granulomatous inflammatory process.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) The most characteristic picture corresponds to episodes of intermediate uveitis.\n",
      "\n",
      "Ankylosing spondylitis (AS) is a type of inflammatory arthritis that can also affect the eyes, particularly the anterior segment. Intermediate uveitis, also known as paracentesis, is the most common form of ocular involvement in AS, and it is characterized by inflammation in the vitreous cavity and the ciliary body. This can lead to symptoms such as blurred vision, pain, and sensitivity to light.\n",
      "\n",
      "Option a is incorrect because ocular involvement in AS can be bilateral, but it is not necessarily simultaneous. Option c is also incorrect because posterior synechiae of the iris is a rare complication of AS. Option d is incorrect because while granulomatous inflammation can occur in some cases of AS, it is not a characteristic feature of ocular involvement in the disease.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 98: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál de los siguientes hallazgos, en el examen de tomografía de coherencia óptica, representa un mayor riesgo de rotura del epitelio pigmentado de la retina en el tratamiento antiangiogénico de las membranas neovasculares?\n",
      "a) Anastomosis retinocoroidea con hemorragia retiniana.\n",
      "b) Alto desprendimiento del epitelio pigmentado de la retina.\n",
      "c) Aumento marcado y difuso del espesor de la coroides y coriocapilares.\n",
      "d) Gran cantidad de líquido subretiniano con pocos quistes intrarretinianos.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) Alto desprendimiento del epitelio pigmentado de la retina.\n",
      "\n",
      "In the treatment of neovascular membranes with anti-angiogenic therapy, high displacement of the pigmented epithelium of the retina represents a greater risk of retinal pigment epithelial tear. This is because the pigmented epithelium plays a critical role in maintaining the structural integrity of the retina, and any significant displacement or disruption of this layer can lead to retinal tears and potential vision loss.\n",
      "\n",
      "Option a) Anastomosis retinocoroidea with retinal hemorrhage, while a potential complication of anti-angiogenic therapy, is not directly related to the risk of retinal pigment epithelial tear.\n",
      "\n",
      "Option c) Marked and diffuse increase in the thickness of the choroids and coriocapillaries, may be a sign of disease activity, but it is not directly related to the risk of retinal pigment epithelial tear.\n",
      "\n",
      "Option d) Large amount of subretinal fluid with few intrarretinal cysts, may be a sign of disease activity, but it is not directly related to the risk of retinal pigment epithelial tear.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na impormasyon na mula sa optical coherence tomography ay maaring maging isang malaking panganib ng retinal pigment epithelium rupture sa antiangiogenic treatment ng mga neovascular membrane?\n",
      "a) retinochoroidal anastomosis na may retinal hemorrhage.\n",
      "b) nakataas na detatsment ng retinal pigment epithelium.\n",
      "c) minarkahan at nagkakalat ng pagtaas sa kapal ng choroid at choriocapillaries.\n",
      "d) malaking halaga ng subretinal fluid na may kaunting mga cyst ng intraretinal.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Optical coherence tomography (OCT) is a non-invasive imaging test that uses light waves to take cross-sectional pictures of the retina. It can help diagnose and monitor various eye conditions, including retinal pigment epithelium (RPE) rupture.\n",
      "\n",
      "According to the given question, the patient has undergone anti-angiogenic treatment for neovascular membranes. The question asks which of the following information obtained from OCT can be a significant risk factor for RPE rupture.\n",
      "\n",
      "Option c, \"marked increase in choroidal thickness and choriocapillaris,\" is the correct answer. Studies have shown that an increase in choroidal thickness and the formation of choriocapillaris can be associated with a higher risk of RPE rupture. This is because the increased blood flow and fluid accumulation in the choroid can lead to increased pressure on the RPE, which can cause it to rupture.\n",
      "\n",
      "Option a, \"retinochoroidal anastomosis with retinal hemorrhage,\" is not a risk factor for RPE rupture. Retinochoroidal anastomosis is a surgical procedure that creates a connection between the retina and the choroid to treat certain eye conditions. Retinal hemorrhage can be a complication of this procedure, but it is not directly related to RPE rupture.\n",
      "\n",
      "Option b, \"elevated detachment of the retinal pigment epithelium,\" can also be a risk factor for RPE rupture. However, it is not the most appropriate answer in this case because the question specifically mentions anti-angiogenic treatment, which is typically used to treat neovascular membranes, not RPE detachment.\n",
      "\n",
      "Option d, \"small amount of subretinal fluid with some intraretinal cysts,\" is not a significant risk factor for RPE rupture. Subretinal fluid and intraretinal cysts can be seen in various eye conditions, but they are not directly related to RPE rupture.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual dos achados abaixo, ao exame de tomografia de coerência óptica, representa maior risco de ruptura do epitélio pigmentado da retina no tratamento com antiangiogênico de membranas neovasculares? \n",
      "a) Anastomose retinocoroidal com hemorragia retiniana. \n",
      "b) Descolamento elevado do epitélio pigmentado da retina. \n",
      "c) Aumento acentuado e difuso da espessura da coroide e coriocapilares. \n",
      "d) Grande quantidade de líquido subretiniano com poucos cistos intraretinianos.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) Descolamento elevado do epitélio pigmentado da retina.\n",
      "\n",
      "In English:\n",
      "\n",
      "The correct answer is b) Elevated detachment of the retinal pigmented epithelium.\n",
      "\n",
      "In Spanish:\n",
      "\n",
      "La respuesta correcta es b) Descolgamiento elevado del epitelio pigmentado de la retina.\n",
      "\n",
      "In Tagalog:\n",
      "\n",
      "Ang korektong sagot ay b) Lumilitaw na pag-aayos ng epitelio pigmentado ng retina.\n",
      "\n",
      "In Portuguese:\n",
      "\n",
      "A resposta correta é b) Descolamento elevado do epitélio pigmentado da retina.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Which of the following findings, on optical coherence tomography, represents a greater risk of retinal pigment epithelium rupture in antiangiogenic treatment of neovascular membranes? \n",
      "a) Retinochoroidal anastomosis with retinal hemorrhage. \n",
      "b) Elevated detachment of the retinal pigment epithelium. \n",
      "c) Marked and diffuse increase in the thickness of the choroid and choriocapillaries. \n",
      "d) Large amount of subretinal fluid with few intraretinal cysts.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) Elevated detachment of the retinal pigment epithelium.\n",
      "\n",
      "Optical coherence tomography (OCT) is a non-invasive imaging test that uses light waves to take cross-sectional pictures of the retina. It can help diagnose and monitor various eye conditions, including neovascular membranes.\n",
      "\n",
      "In antiangiogenic treatment of neovascular membranes, the risk of retinal pigment epithelium (RPE) rupture is higher with certain OCT findings. Of the options given, b) Elevated detachment of the retinal pigment epithelium represents a greater risk of RPE rupture. This is because elevated detachment can lead to a greater risk of RPE tears, which can cause vision loss.\n",
      "\n",
      "Option a) Retinochoroidal anastomosis with retinal hemorrhage may also be associated with a higher risk of RPE rupture, but it is not the most correct answer.\n",
      "\n",
      "Option c) Marked and diffuse increase in the thickness of the choroid and choriocapillaries is not typically associated with an increased risk of RPE rupture.\n",
      "\n",
      "Option d) Large amount of subretinal fluid with few intraretinal cysts may also be associated with a higher risk of RPE rupture, but it is not the most correct answer.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 99: \n",
      "Language: spanish\n",
      "Question: \n",
      "La fase aguda de algunas enfermedades de la retina típicamente se presenta sólo con borrado reversible de la zona elipsoide en el examen de la mácula con tomografía de coherencia óptica. Seleccione la alternativa que mejor ejemplifique una de estas condiciones.\n",
      "a) Maculopatía medial aguda paracentral.\n",
      "b) Oclusión de la arteria central de la retina.\n",
      "c) Neurorretinopatía macular aguda.\n",
      "d) Oclusión venosa de la retina.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "La respuesta correcta es c) Neurorretinopatía macular aguda.\n",
      "\n",
      "La neurorretinopatía macular aguda es una enfermedad que afecta la capa de células nerviosas de la retina, incluyendo la mácula, y puede causar un borrado reversible de la zona elipsoide en el examen de la mácula con tomografía de coherencia óptica. La maculopatía medial aguda paracentral (a) y la oclusión de la arteria central de la retina (b) pueden también presentarse con borrado de la mácula, pero no son las opciones más precisas para esta descripción clínica. La oclusión venosa de la retina (d) no suele presentarse con borrado de la mácula.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Sa acute phase ng ilang mga sakit sa retina ay madalas nakikita lamang na mayroong reversible glare of the ellipsoid zone sa optical coherence tomography ng macula. Alin sa mga sumusunod na sakit ang kumakatawan dito?\n",
      "a) Paracentral acute medium maculopathy. \n",
      "b) Pagbabara sa central retinal artery. \n",
      "c) Acute macular neuroretinopathy. \n",
      "d) Retinal venous na pagbabara\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The query is in Tagalog, and it asks about the acute phase of certain retinal diseases that can cause a reversible glare of the ellipsoid zone in the optical coherence tomography of the macula.\n",
      "\n",
      "The correct answer is c) Acute macular neuroretinopathy. This is a condition that can cause a sudden loss of vision due to inflammation in the retina, particularly in the macula. It can cause a reversible glare in the ellipsoid zone, which is a layer of the retina that can be seen in optical coherence tomography.\n",
      "\n",
      "The other options are not correct because they refer to different conditions:\n",
      "\n",
      "a) Paracentral acute medium maculopathy refers to a condition that affects the central part of the retina and can cause a sudden loss of vision, but it is not associated with a reversible glare in the ellipsoid zone.\n",
      "\n",
      "b) Pagbabara sa central retinal artery refers to a blockage of the central retinal artery, which can cause a sudden loss of vision, but it is not associated with a reversible glare in the ellipsoid zone.\n",
      "\n",
      "d) Retinal venous na pagbabara refers to a blockage of the retinal veins, which can cause a sudden loss of vision, but it is not associated with a reversible glare in the ellipsoid zone.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "A fase aguda de algumas doenças da retina apresenta-se tipicamente, apenas, com apagamento reversível da zona elipsoide ao exame de tomografia de coerência óptica da mácula. Assinale a alternativa que melhor exemplifica uma destas condições. \n",
      "a) Maculopatia média aguda paracentral. \n",
      "b) Oclusão da artéria central da retina. \n",
      "c) Neurorretinopatia macular aguda. \n",
      "d) Oclusão venosa retiniana.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) Neurorretinopatia macular aguda.\n",
      "\n",
      "Neurorretinopatia macular aguda é uma condição médica que afeta a retina e pode causar perda de visão. Ela é caracterizada por uma lesão inflamatória na mácula, que pode ser detectada por meio de exames de tomografia de coerência óptica da mácula. Apresenta-se tipicamente com apagamento reversível da zona elipsoide ao exame de tomografia de coerência óptica da mácula, como mencionado na pergunta.\n",
      "\n",
      "As outras opções não são correto. Maculopatia média aguda paracentral é uma condição diferente que afeta a mácula e pode causar perda de visão, mas não é relacionada à neurorretinopatia macular aguda. Oclusão da artéria central da retina é uma emergência médica que pode causar perda de visão irreversível, mas não é a condição descrita na pergunta. Oclusão venosa retiniana é uma condição que afeta a retina e pode causar perda de visão, mas não é relacionada à neurorretinopatia macular aguda.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "The acute phase of some retinal diseases typically presents only with reversible glare of the ellipsoid zone on optical coherence tomography of the macula. Mark the alternative that best exemplifies one of these conditions. \n",
      "a) Paracentral acute medium maculopathy. \n",
      "b) Occlusion of the central retinal artery. \n",
      "c) Acute macular neuroretinopathy. \n",
      "d) Retinal venous occlusion.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"  // Paracentral acute medium maculopathy\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The acute phase of some retinal diseases typically presents only with reversible glare of the ellipsoid zone on optical coherence tomography (OCT) of the macula. This description matches the characteristics of paracentral acute medium maculopathy (PAMM), which is a condition that affects the central part of the retina and causes a sudden loss of vision. PAMM is usually diagnosed by OCT, which shows a characteristic \"glare\" or \"snowflake\" pattern in the ellipsoid zone.\n",
      "\n",
      "The other options do not match the description:\n",
      "\n",
      "* Occlusion of the central retinal artery (b) can cause vision loss, but it does not typically present with a glare or snowflake pattern on OCT.\n",
      "* Acute macular neuroretinopathy (c) is a condition that affects the macula and can cause vision loss, but it is not typically associated with a glare or snowflake pattern on OCT.\n",
      "* Retinal venous occlusion (d) is a blockage of the small veins that carry blood away from the retina, and it can cause vision loss, but it does not typically present with a glare or snowflake pattern on OCT.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 100: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál de las siguientes distrofias retinianas se asocia más típicamente con espacios cistoideos maculares centrales en un patrón radial?\n",
      "a) Coroideremia.\n",
      "b) Distrofia de conos.\n",
      "c) Fondo flavimaculato.\n",
      "d) Retinosquisis congénita ligada al cromosoma X.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Distrofia de conos\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking which type of retinal dystrophy is most commonly associated with central macular cystoid spaces in a radial pattern. The answer is b) Distrofia de conos. This is a type of retinal dystrophy that affects the cone cells in the retina and can cause central vision loss, including macular cystoid spaces.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "* a) Coroideremia is a type of retinal dystrophy that affects the choriocapillaris, the blood vessels between the sclera and retina, and is not typically associated with central macular cystoid spaces.\n",
      "* c) Fondo flavimaculato is a type of retinal dystrophy that affects the retinal pigment epithelium and can cause yellowish deposits in the fundus of the eye, but it is not typically associated with central macular cystoid spaces.\n",
      "* d) Retinosquisis congénita ligada al cromosoma X is a type of retinal dystrophy that is caused by a genetic mutation and can cause a variety of retinal changes, including macular cystoid spaces, but it is not typically associated with a radial pattern.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na retinal dystrophies ang karaniwang naiuugnay sa central macular cystoid spaces sa anyong radiyal?\n",
      "a) Choroideremia.\n",
      "b) Cone Dystrophy.\n",
      "c) Fundus flavimaculatus.\n",
      "d) Congenital X-link na retinoschisis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // B - Cone Dystrophy\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Cone dystrophy is a group of inherited retinal diseases that affect the cone cells in the retina, which are responsible for central vision and color perception. One of the common findings in cone dystrophy is the presence of central macular cystoid spaces, which are fluid-filled spaces in the macula, the area of the retina responsible for central vision.\n",
      "\n",
      "Choroideremia (a) is a rare inherited disorder that affects the retina and choroid, the layer of blood vessels and connective tissue between the sclera and retina. It can cause macular degeneration and blind spots, but it is not typically associated with central macular cystoid spaces.\n",
      "\n",
      "Fundus flavimaculatus (c) is a condition characterized by yellowish spots or patches in the fundus, the area at the back of the eye. It is usually associated with age-related macular degeneration, but it can also be seen in other conditions such as retinal dystrophies. However, it is not typically associated with central macular cystoid spaces.\n",
      "\n",
      "Congenital X-linked retinoschisis (d) is a rare inherited disorder that affects the retina and is caused by a mutation in the RS1 gene. It can cause vision loss, blind spots, and other visual disturbances, but it is not typically associated with central macular cystoid spaces.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual das distrofias retinianas abaixo está mais tipicamente associada a espaços cistoides maculares centrais em padrão radial? \n",
      "a) Coroideremia. \n",
      "b) Distrofia de cones. \n",
      "c) Fundus flavimaculatus. \n",
      "d) Retinosquise congênita ligada ao X.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Distrofia de cones\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking which retinal dystrophy is most typically associated with central macular cystoid spaces in a radial pattern.\n",
      "\n",
      "The correct answer is (b) Distrofia de cones. This is a type of retinal dystrophy that affects the cones in the retina, leading to progressive vision loss, particularly in the central vision. It is often associated with cystoid macular edema, which can cause central vision loss.\n",
      "\n",
      "The other options are not typically associated with central macular cystoid spaces in a radial pattern:\n",
      "\n",
      "* (a) Coroideremia is a rare inherited disorder that affects the retina and choroid, but it is not typically associated with cystoid macular edema.\n",
      "* (c) Fundus flavimaculatus is a condition characterized by yellowish spots in the fundus of the eye, but it is not associated with cystoid macular edema.\n",
      "* (d) Retinosquise congênita ligada ao X is a rare genetic disorder that affects the retina and can cause vision loss, but it is not typically associated with cystoid macular edema.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Which of the following retinal dystrophies is most typically associated with central macular cystoid spaces in a radial pattern? \n",
      "a) Choroideremia. \n",
      "b) Cone dystrophy. \n",
      "c) Fundus flavimaculatus. \n",
      "d) Congenital X-linked retinoschisis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"  // Fundus flavimaculatus\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "Fundus flavimaculatus is a rare retinal dystrophy characterized by cystoid spaces in the central macula, typically arranged in a radial pattern. It is caused by mutations in the RDS gene and is usually diagnosed in the first decade of life. The condition progresses slowly, leading to gradual loss of central vision.\n",
      "\n",
      "The other options are not typically associated with central macular cystoid spaces in a radial pattern:\n",
      "\n",
      "* Choroideremia is a rare X-linked retinal dystrophy that affects the retinal pigment epithelium and choroid, leading to progressive vision loss. It is not typically associated with cystoid spaces in the central macula.\n",
      "* Cone dystrophy is a group of rare inherited retinal disorders that affect the cone photoreceptors, leading to distorted vision and blind spots. It is not typically associated with cystoid spaces in the central macula.\n",
      "* Congenital X-linked retinoschisis is a rare inherited retinal disorder that affects the retinoschisis, leading to vision loss and other complications. It is not typically associated with cystoid spaces in the central macula.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 101: \n",
      "Language: spanish\n",
      "Question: \n",
      "La proliferación melanocítica uveal difusa bilateral se clasifica mejor como:\n",
      "a) Trastorno paraneoplásico.\n",
      "b) Presentación grave de melanoma coroideo.\n",
      "c) Variante del síndrome de Vogt-Koyanagi-Harada.\n",
      "d) Trastorno secundario al tratamiento del desprendimiento de retina.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "La proliferación melanocítica uveal difusa bilateral se clasifica mejor como una variante del síndrome de Vogt-Koyanagi-Harada.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang bilateral diffuse uveal melanocytic proliferation ay isang uri ng:\n",
      "a) Paraneoplastic disorder.\n",
      "b) Malalang presentasyon ng choroidal melanoma.\n",
      "c) Variant ng Vogt-Koyanagi-Harada syndrome.\n",
      "d) Isang disorder dala ng retinal detachment treatment\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Bilateral diffuse uveal melanocytic proliferation is a characteristic feature of Vogt-Koyanagi-Harada syndrome, which is a rare autoimmune disorder that affects the uvea, retina, and choroid. Therefore, the correct answer is (c) Variant ng Vogt-Koyanagi-Harada syndrome.\n",
      "\n",
      "Note: The question and answer are in Tagalog, which is the language used in the Philippines.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "A proliferação melanocítica uveal difusa bilateral é melhor classificada como: \n",
      "a) Desordem paraneoplásica. \n",
      "b) Apresentação grave do melanoma de coroide. \n",
      "c) Variante da síndrome de Vogt-Koyanagi-Harada. \n",
      "d) Desordem secundária a tratamento de descolamento de retina.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "A proliferação melanocítica uveal difusa bilateral é melhor classificada como uma variante da síndrome de Vogt-Koyanagi-Harada. Essa síndrome é uma condição autoimune que afeta o sistema nervoso e o sistema visual, e pode causar manifestações como cegueira parcial ou total, dor de cabeça, problemas de visão dupla e outros sintomas. A proliferação melanocítica uveal difusa bilateral é uma característica comum dessa síndrome.\n",
      "\n",
      "A opção a é incorrecta, pois a desordem paraneoplásica é um termo que se refere a uma condição em que o sistema imunológico ataca células normais do corpo, mas não é relacionado à proliferação melanocítica uveal difusa bilateral.\n",
      "\n",
      "A opção b é incorrecta, pois o melanoma de coroide é um tipo de câncer que afeta a camada de células pigmentadas da íntima da coroide, e não é relacionado à proliferação melanocítica uveal difusa bilateral.\n",
      "\n",
      "A opção d é incorrecta, pois a desordem secundária a tratamento de descolamento de retina é uma complicação que pode ocorrer após um tratamento para recolocar a retina em casos de descolamento de retina, mas não é relacionado à proliferação melanocítica uveal difusa bilateral.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Bilateral diffuse uveal melanocytic proliferation is best classified as: \n",
      "a) Paraneoplastic disorder. \n",
      "b) Severe presentation of choroidal melanoma. \n",
      "c) Variant of Vogt-Koyanagi-Harada syndrome. \n",
      "d) Disorder secondary to retinal detachment treatment.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "Bilateral diffuse uveal melanocytic proliferation is best classified as a variant of Vogt-Koyanagi-Harada syndrome. This is a rare autoimmune disorder that affects the uvea and can cause bilateral diffuse uveal melanocytic proliferation, along with other symptoms such as vitiligo, alopecia, and poliosis. It is not a paraneoplastic disorder, severe presentation of choroidal melanoma, or a disorder secondary to retinal detachment treatment.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 102: \n",
      "Language: spanish\n",
      "Question: \n",
      "Al examinar la periferia de la retina, para evaluar una región específica:\n",
      "a) El paciente debe mirar al lado opuesto de la región a observar y el médico debe posicionarse del mismo lado.\n",
      "b) El paciente debe mirar hacia el lado de la región a observar y el médico debe posicionarse en el lado opuesto.\n",
      "c) El paciente debe mirar hacia el lado de la región a observar y el médico también debe posicionarse del mismo lado.\n",
      "d) El paciente debe mirar al lado opuesto de la región a observar y el médico también debe posicionarse en el lado opuesto.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "When examining the periphery of the retina, it is important to position the patient and the medical professional in a way that allows for clear visualization of the specific region being evaluated. Option b) is the correct answer because it allows the medical professional to view the region of interest while the patient looks towards it. This positioning allows for the best visualization of the retina and helps the medical professional to detect any abnormalities or issues.\n",
      "\n",
      "In option a), the patient would be looking away from the region of interest, making it difficult for the medical professional to visualize it properly. In option c), both the patient and the medical professional would be looking towards the same side, which could result in the medical professional missing any issues on the opposite side of the retina. Option d) is also incorrect because it would result in the medical professional looking away from the region of interest.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Sa pagsusuri sa paligid ng retina, kung nais na siyasatin ang partikular na rehiyon, kinakailangan na: \n",
      "a) Ang pasyente ay dapat tumingin sa kabaligtaran ng rehiyon upang sundin at ang doktor ay dapat iposisyon ang kanyang sarili sa parehong panig.\n",
      "b) Ang pasyente ay dapat tumingin sa gilid ng rehiyon upang sundin at dapat na iposisyon ng doktor ang kanyang sarili baliktad sa posisyon ng pasyente.\n",
      "c) Ang pasyente ay dapat tumingin sa gilid ng rehiyon upang sundin at ang doktor ay nagpoposisyon din sa kanyang sarili sa parehong panig.\n",
      "d) Ang pasyente ay dapat tumingin sa kabaligtaran ng rehiyon upang sundin at dapat ding iposisyon ng doktor ang kanyang sarili baliktad sa posisyon ng pasyente.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the proper positioning of a patient and a doctor during a retinal examination using a slit lamp.\n",
      "\n",
      "Option b is the correct answer. The patient should be positioned facing the side of the slit lamp, while the doctor should position themselves opposite the patient, so that they can both see the same side of the eye. This allows the doctor to examine the eye properly and document any findings.\n",
      "\n",
      "Option a is incorrect because it suggests that the patient should face the opposite side of the slit lamp, which would make it difficult for the doctor to examine the eye.\n",
      "\n",
      "Option c is also incorrect because it suggests that the patient should face the same side as the doctor, which would also make it difficult for the doctor to examine the eye.\n",
      "\n",
      "Option d is incorrect because it suggests that the patient should face the opposite side of the slit lamp, and the doctor should position themselves on the same side as the patient, which would also make it difficult for the doctor to examine the eye.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "No exame da periferia da retina, para avaliar uma determinada região: \n",
      "a) O paciente deve olhar para o lado oposto da região que se deseja observar e o médico se posicionar no mesmo lado. \n",
      "b) O paciente deve olhar para o lado da região que se deseja observar e o médico se posicionar no lado oposto. \n",
      "c) O paciente deve olhar para o lado da região que se deseja observar e o médico se posicionar também no mesmo lado. \n",
      "d) O paciente deve olhar para o lado oposto da região que se deseja observar e o médico se posicionar também no lado oposto.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) O paciente deve olhar para o lado da região que se deseja observar e o médico se posicionar no lado oposto.\n",
      "\n",
      "When performing a peripheral retinal examination, the patient should look towards the side of the region that the doctor wants to observe, while the doctor positions themselves on the opposite side. This allows the doctor to assess the retina in the desired region without the patient's gaze interfering with the examination.\n",
      "\n",
      "Therefore, option b is the correct answer.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "In the examination of the periphery of the retina, in order to evaluate a certain region: \n",
      "a) The patient must look to the opposite side of the region to be observed and the doctor should position himself on the same side. \n",
      "b) The patient should look to the side of the region to be observed and the doctor should position himself on the opposite side. \n",
      "c) The patient must look to the side of the region to be observed and the doctor also position himself on the same side. \n",
      "d) The patient should look at the opposite side of the region to be observed and the doctor should also position himself on the opposite side.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "When examining the periphery of the retina, it is important to have the patient look towards the side of the region to be observed, while the doctor positions himself on the opposite side. This allows the doctor to view the region of interest without any obstruction from the patient's head or body.\n",
      "\n",
      "Therefore, the correct answer is option b: The patient should look to the side of the region to be observed and the doctor should position himself on the opposite side.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 103: \n",
      "Language: spanish\n",
      "Question: \n",
      "Seleccionar la alternativa que correlacione correctamente la alteración en el examen de angiografía fluoresceínica y su descripción.\n",
      "a) Acumulación: aparición tardía, el área aumenta a lo largo del examen.\n",
      "b) Tinción: aparición temprana, el área aumenta a lo largo del examen.\n",
      "c) Defecto de ventana: aparición temprana, área mantenida durante todo el examen.\n",
      "d) Extravasación: aparición tardía, área mantenida durante todo el examen.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c) Defecto de ventana: aparición temprana, área mantenida durante todo el examen.\n",
      "\n",
      "In this case, the alteration in the fluorescein angiography exam is described as an early appearance of a maintained area throughout the exam, which is consistent with a defect in the window. Therefore, option c is the correct response.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Piliin ang tamabng tambal na nagpapahayag ng ugnayan ng pagbabago sa luorescein angiography exam at deskripsyon nito. \n",
      "a) Accumulation (pooling): Huling nakikita, paglaki ng saklaw sa kabuuan ng eksamen\n",
      "b) Staining: Maagang nakikita, paglaki ng saklaw sa kabuuan ng eksamen.\n",
      "c) Window Defect: Maagang nakikita, nanatili sa orihinal na saklaw sa kabuuan ng eksamen\n",
      "d) Extravasation: Huling nakikita, nanatili sa orihinal na saklaw sa kabuuan ng eksamen\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // B - Staining\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Staining refers to the accumulation of contrast material in the tissues, which can be seen early in the examination, and persists throughout the examination. This is the most appropriate description of the change in the luorescein angiography exam.\n",
      "\n",
      "Accumulation (pooling) refers to the collection of contrast material in a specific area, such as a pool of blood, and is not the best description of the change in the luorescein angiography exam.\n",
      "\n",
      "Window Defect refers to a defect in the imaging window, which can cause a loss of information in the image, and is not related to the change in the luorescein angiography exam.\n",
      "\n",
      "Extravasation refers to the leakage of contrast material out of the blood vessels, which can be seen in some cases, but is not the best description of the change in the luorescein angiography exam.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Assinale a alternativa que correlaciona corretamente a alteração no exame de angiofluoresceinografia e sua descrição. \n",
      "a) Acúmulo (pooling): aparecimento tardio, área aumenta ao longo do exame. \n",
      "b) Impregnação (staining): aparecimento precoce, área aumenta ao longo do exame. \n",
      "c) Defeito em janela: aparecimento precoce, área mantida ao longo do exame. \n",
      "d) Extravazamento: aparecimento tardio, área mantida ao longo do exame.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": b // Impregnação (staining): aparecimento precoce, área aumenta ao longo do exame.\n",
      "}\n",
      "```\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "Check the alternative that correctly correlates the change in the fluorescein angiography exam and its description. \n",
      "a) Accumulation (pooling): late appearance, area increases throughout the exam. \n",
      "b) Staining: early appearance, area increases throughout the exam. \n",
      "c) Window defect: early appearance, area maintained throughout the exam. \n",
      "d) Extravasation: late appearance, area maintained throughout the examination.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "La respuesta correcta es la opción c) Ventana defectuosa: aparición temprana, área mantiene durante todo el examen.\n",
      "\n",
      "Here's the answer in Tagalog:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "Ang tamang sagot ay ang opsiyon c) Window defect: early appearance, area maintained throughout the exam.\n",
      "\n",
      "Here's the answer in Portuguese:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "A resposta correta é a opção c) Defeito de janela: aparição precoce, área mantida durante todo o exame.\n",
      "\n",
      "Here's the answer in English:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "The correct answer is option c) Window defect: early appearance, area maintained throughout the exam.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 104: \n",
      "Language: spanish\n",
      "Question: \n",
      "Considerando la clasificación de la retinopatía diabética en función de los hallazgos funduscópicos y su importancia pronóstica, podemos afirmar:\n",
      "a) Si no hay neovasos en el examen del fondo de ojo, el riesgo de desarrollar retinopatía diabética proliferativa en un año es inferior al 20%.\n",
      "b) La presencia únicamente de microhemorragias y microaneurismas en tres cuadrantes permite afirmar que este paciente no desarrollará retinopatía diabética proliferativa dentro de un año.\n",
      "c) La presencia de venas congestionadas asociadas con microaneurismas y microhemorragias en todos los cuadrantes se considera un hallazgo normal en la retinopatía diabética y sugiere un riesgo inferior al 10% de desarrollar retinopatía diabética proliferativa dentro de un año.\n",
      "d) La presencia de cambios microvasculares intrarretinianos moderados (IRMA) en dos cuadrantes indica que más de la mitad de los pacientes desarrollarán retinopatía diabética proliferativa en un plazo de cinco años.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "According to the classification of diabetic retinopathy based on funduscopic findings and its prognostic importance, we can say that:\n",
      "\n",
      "* Option a: If there are no neovascularizations in the fundus examination, the risk of developing proliferative diabetic retinopathy within a year is less than 20%. This is incorrect, as the absence of neovascularizations does not necessarily mean that the patient will not develop proliferative retinopathy.\n",
      "* Option b: The presence of only microhemorrhages and microaneurysms in three quadrants allows us to say that this patient will not develop proliferative diabetic retinopathy within a year. This is incorrect, as the presence of microhemorrhages and microaneurysms can indicate early signs of proliferative retinopathy.\n",
      "* Option c: The presence of congested veins associated with microaneurysms and microhemorrhages in all quadrants is considered a normal finding in diabetic retinopathy and suggests a risk of less than 10% of developing proliferative retinopathy within a year. This is incorrect, as the presence of congested veins can indicate more advanced stages of retinopathy.\n",
      "* Option d: The presence of moderate intrarretinal microvascular abnormalities (IRMA) in two quadrants indicates that more than half of the patients will develop proliferative diabetic retinopathy within a period of five years. This is the correct answer, as IRMA is a sign of early proliferative retinopathy and is associated with a higher risk of progression to more advanced stages.\n",
      "{'response': 'd'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Sa pagsasaalang-alang ng mga kalsipikasyon ng diabetic retinopathy ayon sa mga funduscopic findings at kahalagahang prognostiko nito, maari nating sabihin na: \n",
      "a) Kung walang bagong ugat ang nakita sa fundus eksamen, ang posibilidad na magkaroon ng proliferative diabetic retinopathy sa loob ng isang taon ay mas mababa sa 20%. \n",
      "b) Ang tanging pagkakaroon ng microhemorrhage at microaneurysms sa tatlong quadrants ay pangitain na hindi magkakaroon ng proliferative diabetic retinopathy ang pasyente sa loob ng isang taon. \n",
      "c) Ang pagkakaroon ng mga lumaking ugat na nauugnay sa microaneurysms at microhemorrhages sa lahat ng quadrant ay nangangahulugang, normal para sa mga may diabetic retinopathy at mababa rin (10%) ang posibilidad na magkakaroon ng proliferative diabetic retinopathy ang pasyente sa loob ng isang taon. \n",
      "d) Ang pagkakaroon ng intraretinal microvascular alterations (IRMA), makikita sa dalawang quadrants, ay nangangahulugang higit sa kalahati ng mga pasyente ay magkakaroon ng proliferative diabetic retinopathy in five years.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Based on the given information, the correct answer is option c. The presence of numerous small hemorrhages and microaneurysms in all quadrants, with no new vessels observed on the fundus examination, suggests that the patient has non-proliferative diabetic retinopathy. According to the given information, the probability of developing proliferative diabetic retinopathy within one year is low (10%) for patients with non-proliferative diabetic retinopathy. Therefore, option c is the best answer.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Considerando a classificação da retinopatia diabética a partir dos achados fundoscópicos e seu significado prognóstico, podemos afirmar: \n",
      "a) Se não existem neovasos no exame de fundo de olho, o risco de desenvolver retinopatia diabética proliferativa em um ano é menor que 20%. \n",
      "b) A presença apenas de microhemorragias e microaneurismas em três quadrantes permite afirmar que este paciente não desenvolverá retinopatia diabética proliferativa em um ano. \n",
      "c) A presença de veias ingurgitadas associada a microaneurismas e microhemorragias em todos os quadrantes é considerada achado normal na retinopatia diabética e sugere um risco abaixo de 10% de desenvolver retinopatia diabética proliferativa em um ano. \n",
      "d) A presença de alterações microvasculares intrarretinianas (IRMA), moderadas, em dois quadrantes, indica que mais da metade dos pacientes desenvolverá retinopatia diabética proliferativa em cinco anos.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the classification of diabetic retinopathy based on fundoscopic findings and its prognostic significance.\n",
      "\n",
      "Option a is incorrect because the absence of neovascularization on fundoscopy does not necessarily mean that the risk of developing proliferative diabetic retinopathy (PDR) is less than 20% in one year.\n",
      "\n",
      "Option b is incorrect because the presence of microhemorrhages and microaneurysms in three quadrants does not rule out the development of PDR in one year.\n",
      "\n",
      "Option c is correct because the presence of engorged veins associated with microaneurysms and microhemorrhages in all quadrants is considered a normal finding in diabetic retinopathy and suggests a lower risk (below 10%) of developing PDR in one year.\n",
      "\n",
      "Option d is incorrect because moderate intrarretinal microvascular abnormalities (IRMA) in two quadrants indicate that more than half of the patients will develop PDR in five years, not one year.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Considering the classification of diabetic retinopathy based on funduscopic findings and its prognostic significance, we can state: \n",
      "a) If there are no new vessels in the fundus examination, the risk of developing proliferative diabetic retinopathy in one year is less than 20%. \n",
      "b) The presence of only microhemorrhages and microaneurysms in three quadrants allows us to state that this patient will not develop proliferative diabetic retinopathy in one year. \n",
      "c) The presence of engorged veins associated with microaneurysms and microhemorrhages in all quadrants is considered a normal finding in diabetic retinopathy and suggests a risk below 10% of developing proliferative diabetic retinopathy in one year. \n",
      "d) The presence of intraretinal microvascular alterations (IRMA), moderate, in two quadrants, indicates that more than half of the patients will develop proliferative diabetic retinopathy in five years.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The presence of intraretinal microvascular alterations (IRMA), moderate, in two quadrants, indicates that more than half of the patients will develop proliferative diabetic retinopathy in five years. This is the most severe classification of diabetic retinopathy and has a poor prognosis.\n",
      "\n",
      "Therefore, the correct answer is option d.\n",
      "{'response': 'd'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 105: \n",
      "Language: spanish\n",
      "Question: \n",
      "En un examen de tomografía de coherencia óptica ¿cuál es la correlación correcta entre la clasificación y descripción de las membranas neovasculares?\n",
      "a) Las membranas situadas debajo del epitelio pigmentado de la retina se denominan tipo 1.\n",
      "b) Las membranas de tipo 2 se encuentran debajo del epitelio pigmentado de la retina, pero se extienden hacia la región entre el epitelio pigmentado de la retina y la retina neurosensorial.\n",
      "c) Las membranas situadas debajo del epitelio pigmentado de la retina se denominan tipo 3.\n",
      "d) Las membranas que crecen bien definidas en el espacio entre la retina neurosensorial y el epitelio pigmentado de la retina se denominan tipo 3.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "La respuesta correcta es b) Las membranas de tipo 2 se encuentran debajo del epitelio pigmentado de la retina, pero se extienden hacia la región entre el epitelio pigmentado de la retina y la retina neurosensorial.\n",
      "\n",
      "En una tomografía de coherencia óptica, las membranas neovasculares pueden clasificarse en tres tipos según su ubicación y características. El tipo 1 se encuentra debajo del epitelio pigmentado de la retina y no se extiende hacia la región entre el epitelio pigmentado de la retina y la retina neurosensorial. El tipo 2 se encuentra debajo del epitelio pigmentado de la retina, pero se extiende hacia la región entre el epitelio pigmentado de la retina y la retina neurosensorial. El tipo 3 se encuentra debajo del epitelio pigmentado de la retina y se extiende hacia la región entre el epitelio pigmentado de la retina y la retina neurosensorial, y puede crecer bien definido en el espacio entre la retina neurosensorial y el epitelio pigmentado de la retina.\n",
      "\n",
      "Por lo tanto, la opción b) es la correcta, ya que describe la ubicación y características de las membranas de tipo 2.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Sa isang optical coherence tomography exam, ano ang tamang ugnayan sa pagitan ng pag-uuri at ang paglalarawan ng mga neovascular membranes?\n",
      "a) Ang mga membrane na matatagpuan sa ilalim ng retinal pigment epithelium ay tinatawag na Type 1.\n",
      "b) Type 2 membane ay makikita sa ilalim ng retinal pigment epithelium, ngunit ito ay lumalagpas sa rehiyon sa pagitan ng retinal pigment epithelium at sensorineural retina\n",
      "c) Ang mga membrane na makikita sa ilalim ng retinal pigment epithelium ay tinatawag na Type 3.\n",
      "d) Ang mga membranes na nabubuo sa espasyo sa pagitan ng sensorineural retina at ng retinal pigment epithelium ay tinatawag na Type 3\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "In an optical coherence tomography (OCT) exam, the correct relationship between the location of the neovascular membranes and the retinal pigment epithelium (RPE) is:\n",
      "\n",
      "* Type 2 membranes are located beneath the RPE, but extend beyond the boundary of the RPE and sensorineural retina.\n",
      "\n",
      "Therefore, the correct answer is (b) Type 2 membranes.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Num exame de tomografia de coerência óptica, qual a correlação correta entre a classificação e a descrição das membranas neovasculares? \n",
      "a) As membranas localizadas abaixo do epitélio pigmentado da retina são denominadas tipo 1. \n",
      "b) As membranas do tipo 2 localizam-se abaixo do epitélio pigmentado da retina, mas se estendem para a região entre o epitélio pigmentado da retina e a retina neurossensorial. \n",
      "c) As membranas localizadas abaixo do epitélio pigmentado da retina são denominadas tipo 3. \n",
      "d) As membranas que crescem bem delimitadas no espaço entre a retina neurossensorial e o epitélio pigmentado da retina são denominadas tipo 3.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) As membranas do tipo 2 localizam-se abaixo do epitélio pigmentado da retina, mas se estendem para a região entre o epitélio pigmentado da retina e a retina neurossensorial.\n",
      "\n",
      "In optical coherence tomography (OCT) examination, the classification of neovascular membranes is as follows:\n",
      "\n",
      "* Type 1: Membranes located below the pigmented epithelium of the retina.\n",
      "* Type 2: Membranes that extend from below the pigmented epithelium of the retina to the region between the pigmented epithelium and the neurosensory retina.\n",
      "* Type 3: Membranes located below the neurosensory retina.\n",
      "\n",
      "Therefore, the correct answer is b) As membranas do tipo 2 localizam-se abaixo do epitélio pigmentado da retina, mas se estendem para a região entre o epitélio pigmentado da retina e a retina neurossensorial.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "In an optical coherence tomography exam, what is the correct correlation between the classification and the description of neovascular membranes? \n",
      "a) Membranes located below the retinal pigment epithelium are called type 1. \n",
      "b) Type 2 membranes are located below the retinal pigment epithelium, but extend into the region between the retinal pigment epithelium and the sensorineural retina. \n",
      "c) The membranes located below the retinal pigment epithelium are called type 3. \n",
      "d) The membranes that grow well delimited in the space between the sensorineural retina and the retinal pigment epithelium are called type 3.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "In optical coherence tomography (OCT), the classification of neovascular membranes is as follows:\n",
      "\n",
      "* Type 1 membranes are located below the retinal pigment epithelium (RPE) and do not extend into the space between the RPE and the sensorineural retina.\n",
      "* Type 2 membranes are located below the RPE, but extend into the space between the RPE and the sensorineural retina.\n",
      "* Type 3 membranes are located below the RPE and extend well delimited into the space between the sensorineural retina and the RPE.\n",
      "\n",
      "Therefore, the correct answer is (b) Type 2 membranes.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 106: \n",
      "Language: spanish\n",
      "Question: \n",
      "Al considerar el tratamiento de un paciente con degeneración macular relacionada con la edad, el mejor enfoque basado en los hallazgos de los estudios AREDS es:\n",
      "a) La suplementación con vitaminas y antioxidantes está indicada en pacientes con antecedentes familiares, incluso antes de que aparezcan cambios retinianos.\n",
      "b) La presencia de drusas intermedias y grandes es indicación de suplementación vitamínica y antioxidante.\n",
      "c) La suplementación en pacientes fumadores debe incluir betacaroteno.\n",
      "d) Cuando hay daño avanzado en alguno de los ojos no se recomienda la suplementación con vitaminas y antioxidantes.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "La respuesta correcta es a) La suplementación con vitaminas y antioxidantes está indicada en pacientes con antecedentes familiares, incluso antes de que aparezcan cambios retinianos.\n",
      "\n",
      "El estudio AREDS (Age-Related Eye Disease Study) demostró que la suplementación con vitaminas y antioxidantes reduce el riesgo de progresión de la degeneración macular relacionada con la edad en pacientes con antecedentes familiares. Por lo tanto, la opción a) es la respuesta correcta.\n",
      "\n",
      "Las opciones b) y c) son incorrectas, ya que la presencia de drusas intermedias y grandes no es una indicación para la suplementación vitamínica y antioxidante, y el betacaroteno no es necesario en todos los pacientes fumadores.\n",
      "\n",
      "La opción d) es incorrecta, ya que la suplementación con vitaminas y antioxidantes no está contraindicada en pacientes con daño avanzado en alguno de los ojos.\n",
      "{'response': 'a'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Sa pagsasaalang-alang ng mga pangagagamot sa mga pasyenteng mayroong age-related macular degeneration (ARMD), ang pinakamainam na lapit ng pangagagamot batay sa mga pag-aaral ng AREDS:\n",
      "a) Ang pagdaragdag ng vmga bitamina at antioxidant ay mainam para sa mga pasyenteng may kasaysayan ng ARMD sa pamilya, bago pa makita ang mga pagbabago sa retina.\n",
      "b) Ang pagkakaroon ng mga intermediate at large drusen ay isang indikasyon para gumamit ng mga bitamina at antioxidants\n",
      "c) Dapat na bigyan ng mga supplements na mmayaman sa beta-carotene ang mga naninigarilyo.\n",
      "d) Kapagh mayroong malalang lesyon sa isa sa mga mata, hindi inirerekomendang magbigay ng bitamina at antioxidant.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the appropriate treatment for patients with age-related macular degeneration (ARMD) based on the AREDS study.\n",
      "\n",
      "Option a is the correct answer. According to the AREDS study, adding vitamins and antioxidants is beneficial for patients with a family history of ARMD, before any retinal changes are visible.\n",
      "\n",
      "Option b is incorrect because while intermediate and large drusen are indicators of ARMD, they are not a reason to prescribe vitamins and antioxidants.\n",
      "\n",
      "Option c is incorrect because beta-carotene supplements are not recommended for patients with ARMD.\n",
      "\n",
      "Option d is incorrect because while there may be some lesions in one eye, it is still recommended to prescribe vitamins and antioxidants to the patient.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Quando consideramos o tratamento de um paciente com degeneração macular relacionada à idade, a melhor conduta baseada nos achados dos estudos AREDS é: \n",
      "a) A suplementação de vitaminas e antioxidantes está indicada em pacientes com histórico familiar, mesmo antes de aparecerem alterações retinianas. \n",
      "b) A presença de drusas intermediárias e grandes é indicação de suplementação de vitaminas e antioxidantes. \n",
      "c) A suplementação em pacientes fumantes deve incluir betacaroteno. \n",
      "d) Quando há lesão avançada em um dos olhos, não se recomenda a suplementação de vitaminas e antioxidantes.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "A suplementação de vitaminas e antioxidantes é recomendada para pacientes com degeneração macular relacionada à idade, apenas quando há presença de drusas intermediárias e grandes, como indicado na opção b. A suplementação em pacientes com histórico familiar não é recomendada, a menos que haja outras indicações médicas. A suplementação em pacientes fumantes pode incluir betacaroteno, mas não é a única opção correta. A suplementação não é recomendada quando há lesão avançada em um dos olhos.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "When considering the treatment of a patient with age-related macular degeneration, the best approach based on the findings of the AREDS studies is: \n",
      "a) Vitamin and antioxidant supplementation is indicated in patients with a family history, even before retinal changes appear. \n",
      "b) The presence of intermediate and large drusen is an indication of vitamin and antioxidant supplementation.\n",
      "c) Supplementation in smokers should include beta-carotene. \n",
      "d) When there is an advanced lesion in one of the eyes, vitamin and antioxidant supplementation is not recommended.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) The presence of intermediate and large drusen is an indication of vitamin and antioxidant supplementation.\n",
      "\n",
      "The AREDS (Age-Related Eye Disease Study) found that vitamin and antioxidant supplementation can reduce the risk of progression to advanced age-related macular degeneration (AMD) in people with early or intermediate stages of the disease. The study recommended supplementation with vitamin C, vitamin E, lutein, and zeaxanthin for patients with intermediate and large drusen, as well as those with early AMD. Therefore, option b is the correct answer.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 107: \n",
      "Language: spanish\n",
      "Question: \n",
      "La respuesta eléctrica de la celda de Müller se representa mejor por:\n",
      "a) Onda \"a\" del electrorretinograma.\n",
      "b) Onda \"b\" del electrorretinograma.\n",
      "c) Onda \"c\" del electrorretinograma.\n",
      "d) Relación de Arden en el electrooculograma.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "La respuesta eléctrica de la celda de Müller se representa mejor por la onda \"a\" del electrorretinograma.\n",
      "{'response': 'a'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang elektrikal na manipestasyon ng cell ng Müller ay naipapakita ng:\n",
      "a) \"isang\" alon ng electroretinogram.\n",
      "b) Wave \"b\" ng electroretinogram.\n",
      "c) Wave \"c\" ng electroretinogram.\n",
      "d) Ratio ng Arden sa electro-oculogram.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the electrical stimulation of the Müller cells, which can be observed using electroretinography (ERG). The correct answer is b) Wave \"b\" ng electroretinogram, as it represents the b-wave, which is the positive deflection in the ERG waveform that corresponds to the activation of the Müller cells.\n",
      "\n",
      "Note:\n",
      "\n",
      "* a) \"isang\" alon ng electroretinogram refers to the a-wave, which is the negative deflection in the ERG waveform that corresponds to the activation of the photoreceptors.\n",
      "* c) Wave \"c\" ng electroretinogram refers to the c-wave, which is the negative deflection in the ERG waveform that corresponds to the inhibition of the bipolar cells.\n",
      "* d) Ratio ng Arden sa electro-oculogram refers to the Arden ratio, which is a measure of the amplitude of the a-wave to the b-wave in the ERG waveform. It is not related to the electrical stimulation of the Müller cells.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "A resposta elétrica da célula de Müller está melhor representada pela: \n",
      "a) Onda \"a\" do eletrorretinograma. \n",
      "b) Onda \"b\" do eletrorretinograma. \n",
      "c) Onda \"c\" do eletrorretinograma. \n",
      "d) Relação de Arden no eletro-oculograma.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option A: Onda \"a\" do eletrorretinograma.\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The electrical response of the Müller cell is best represented by the a-wave of the electroretinogram (ERG). The a-wave is a negative deflection in the ERG waveform that occurs in response to a light stimulus and represents the activity of the photoreceptors in the retina. It is the earliest component of the ERG waveform and is generated by the photoreceptors themselves.\n",
      "\n",
      "The b-wave, on the other hand, is a positive deflection in the ERG waveform that occurs later than the a-wave and represents the activity of the bipolar cells in the retina. The c-wave is a negative deflection that occurs even later and represents the activity of the amacrine cells. The Arden ratio, which is a measure of the amplitude of the a-wave to the b-wave, is not a component of the ERG waveform and is not relevant to the question.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "The electrical response of the Müller cell is best represented by: \n",
      "a) \"a\" wave of the electroretinogram. \n",
      "b) Wave \"b\" of the electroretinogram. \n",
      "c) Wave \"c\" of the electroretinogram. \n",
      "d) Arden ratio on the electro-oculogram.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "La respuesta eléctrica de la célula de Müller se representa mejor con:\n",
      "a) Ola \"a\" del electroretinograma.\n",
      "\n",
      "Here's the answer in Tagalog:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "Ang elektrikong tugon ng Müller cell ay pinakamakatutulong na nasa:\n",
      "a) Ola \"a\" ng electroretinograma.\n",
      "\n",
      "Here's the answer in Portuguese:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "A resposta elétrica da célula de Müller é melhor representada por:\n",
      "a) Onda \"a\" do electroretinograma.\n",
      "\n",
      "Here's the answer in English:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "The electrical response of the Müller cell is best represented by:\n",
      "a) Wave \"a\" of the electroretinogram.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 108: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál es el mejor tratamiento, entre los siguientes, para un paciente de 65 años con desprendimiento total de retina resultante de un desgarro periférico arqueado de retina a 155 grados superior, con un borde posterior enrollado?\n",
      "a) Fotocoagulación con láser seguida de introflexión escleral, con explante colocado superiormente.\n",
      "b) Introflexión escleral, con explante posicionado superiormente y uso de gas SF6 al final de la cirugía.\n",
      "c) Retinopexia neumática seguida de crioterapia o fotocoagulación con láser.\n",
      "d) Vitrectomía posterior mediante perfluorocarbono y fotocoagulación con láser.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The best treatment option for a 65-year-old patient with total retinal detachment resulting from a peripheral retinal tear with a 155-degree superior arc, with a rolled posterior border, would be introflexion scleral with an explant placed superiorly and the use of SF6 gas at the end of the surgery. This option, b) Introflexión escleral, con explante posicionado superiormente y uso de gas SF6 al final de la cirugía, is the most appropriate choice for this specific condition.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na pahayag ang dapat tunguhin kung ang isang 65 taong gulang na pasyente na may total retinal detachment dahil sa 155-degree arcuate peripheral retinal tear na may rolled-up posterior edge? \n",
      "a) Laser photocoagulation na susundan ng scleral introflexion, na may explant na nakaposisyon sa itaas\n",
      "b) Scleral introflexion na may explant na nakaposisyon sa itaas, at paggamit ng SF6 gas sa pagtatapos ng operasyon.\n",
      "c) Pneumatic retinopexy na susundan ng cryotherapy o laser photocoagulation.\n",
      "d) Posterior vitrectomy gamit ang perfluorocarbon at laser photocoagulation.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option b, Scleral introflexion na may explant na nakaposisyon sa itaas, at paggamit ng SF6 gas sa pagtatapos ng operasyon.\n",
      "\n",
      "This is because the patient has a total retinal detachment due to a 155-degree arcuate peripheral retinal tear with a rolled-up posterior edge. Scleral introflexion is a procedure that involves folding the sclera towards the retina to create a pocket for the retinal reattachment. The use of SF6 gas helps to maintain the retinal reattachment and prevent further detachment.\n",
      "\n",
      "Option a, Laser photocoagulation na susundan ng scleral introflexion, na may explant na nakaposisyon sa itaas, is not the best option as it does not address the rolled-up posterior edge of the retinal tear.\n",
      "\n",
      "Option c, Pneumatic retinopexy na susundan ng cryotherapy o laser photocoagulation, is not the best option as it is not suitable for total retinal detachment.\n",
      "\n",
      "Option d, Posterior vitrectomy gamit ang perfluorocarbon at laser photocoagulation, is not the best option as it involves a more invasive procedure and may not be necessary for this specific case.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual a melhor conduta, entre as abaixo, para um paciente de 65 anos com descolamento de retina total decorrente de rasgadura retiniana periférica arqueada em 155 graus superiores, com borda posterior enrolada? \n",
      "a) Fotocoagulação a laser seguido de introflexão escleral, com explante posicionado superiormente. \n",
      "b) Introflexão escleral, com explante posicionado superiormente e uso de gás SF6 ao final da cirurgia. \n",
      "c) Retinopexia pneumática seguida de crioterapia ou fotocoagulação a laser. \n",
      "d) Vitrectomia posterior com uso de perfluorcarbono e fotocoagulação laser.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "A melhor conduta para um paciente de 65 anos com descolamento de retina total decorrente de rasgadura retiniana periférica arqueada em 155 graus superiores, com borda posterior enrolada, é a opção b) Introflexão escleral, com explante posicionado superiormente e uso de gás SF6 ao final da cirurgia.\n",
      "\n",
      "A rasgadura retiniana periférica arqueada é uma lesão que afeta a parte posterior da retina, e o descolamento de retina total é uma complicação comum dessa lesão. A introflexão escleral é uma técnica que consiste em dobrar a parte superior da esclera em direção ao sulco retinal, para garantir que a retina seja colocada em sua posição original.\n",
      "\n",
      "O uso de gás SF6 ao final da cirurgia é importante para manter a posição da retina e evitar que ela se desloque novamente. Além disso, a introflexão escleral é uma técnica menos invasiva que a fotocoagulação a laser ou a retinopexia pneumática, o que pode reduzir o risco de complicações adicionais.\n",
      "\n",
      "Portanto, a opção b) Introflexão escleral, com explante posicionado superiormente e uso de gás SF6 ao final da cirurgia, é a melhor opção para o paciente descrito.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Which of the following is the best course of action for a 65-year-old patient with total retinal detachment due to a superior 155-degree arcuate peripheral retinal tear with a rolled-up posterior edge? \n",
      "a) Laser photocoagulation followed by scleral introflexion, with explant positioned superiorly. \n",
      "b) Scleral introflexion, with explant positioned superiorly and use of SF6 gas at the end of surgery. \n",
      "c) Pneumatic retinopexy followed by cryotherapy or laser photocoagulation. \n",
      "d) Posterior vitrectomy using perfluorocarbon and laser photocoagulation.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The best course of action for a 65-year-old patient with total retinal detachment due to a superior 155-degree arcuate peripheral retinal tear with a rolled-up posterior edge would be scleral introflexion, with explant positioned superiorly and use of SF6 gas at the end of surgery. This is option b.\n",
      "\n",
      "Scleral introflexion is a surgical procedure that involves folding the sclera towards the retina to create a pocket for the retinal reattachment. The explant should be positioned superiorly to ensure proper alignment of the retina. The use of SF6 gas at the end of surgery helps to maintain the retinal reattachment and prevent further detachment.\n",
      "\n",
      "Laser photocoagulation followed by scleral introflexion (option a) may not be effective in this case as the retinal tear is too large and the retina is already detached. Pneumatic retinopexy followed by cryotherapy or laser photocoagulation (option c) may not be effective as well, as the retinal detachment is too extensive and the retina is already rolled up. Posterior vitrectomy using perfluorocarbon and laser photocoagulation (option d) may be a more invasive procedure than necessary for this case.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 109: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál de las enfermedades sistémicas siguientes se asocia con mayor frecuencia con estrías angioides?\n",
      "a) Anemia falciforme.\n",
      "b) Anemia megaloblástica\n",
      "c) Artritis reumatoide.\n",
      "d) Poliarteritis nudosa.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La respuesta correcta es c) Artritis reumatoide. La artritis reumatoide es una enfermedad sistémica que se asocia con mayor frecuencia con estrías angioides, que son pequeñas lesiones sanguíneas que se producen en la piel y en los órganos internos. La anemia falciforme (a) y la anemia megaloblástica (b) son enfermedades sanguíneas, pero no se asocian con estrías angioides. La poliarteritis nudosa (d) es una enfermedad inflamatoria que afecta las paredes de las arterias y no se asocia con estrías angioides.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sakit sa ibaba ang madalas na nauugnay sa angioid striae?\n",
      "a) Sickle cell anemia.\n",
      "b) Megaloblastic anemia\n",
      "c) Rheumatoid arthritis.\n",
      "d) Polyarteritis nodosa.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "Angioid streaks are a common finding in sickle cell anemia, a genetic disorder that affects the production of hemoglobin in red blood cells. The streaks are caused by the accumulation of sickled red blood cells in the small blood vessels of the kidneys, which can lead to kidney damage and other complications.\n",
      "\n",
      "The other options are not related to angioid streaks:\n",
      "\n",
      "* Megaloblastic anemia is a type of anemia caused by a deficiency in vitamin B12 or folate.\n",
      "* Rheumatoid arthritis is an autoimmune disorder that affects the joints and can cause inflammation in various parts of the body.\n",
      "* Polyarteritis nodosa is a type of vasculitis that affects the medium-sized blood vessels and can cause inflammation in various organs, including the kidneys.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual das doenças sistêmicas abaixo está mais frequentemente associada a um quadro de estrias angioides? \n",
      "a) Anemia falciforme. \n",
      "b) Anemia megaloblástica \n",
      "c) Artrite reumatoide.\n",
      "d) Poliarterite nodosa.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Artrite reumatoide.\n",
      "\n",
      "Artrite reumatoide (rheumatoid arthritis) is a systemic disease that is characterized by inflammation in the joints and can also cause skin rashes, fever, and fatigue. It is associated with the formation of autoantibodies and immune complexes, which can deposit in the skin and cause vasculitis, leading to the formation of angioid streaks.\n",
      "\n",
      "Anemia falciforme (sickle cell anemia) and anemia megaloblástica (pernicious anemia) are both blood disorders, but they are not typically associated with angioid streaks. Poliarterite nodosa is a vasculitis that affects medium-sized arteries and can cause skin lesions, but it is not typically associated with angioid streaks.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "\n",
      "Which of the systemic diseases below is most often associated with angioid striae? \n",
      "a) Sickle cell anemia. \n",
      "b) Megaloblastic anemia \n",
      "c) Rheumatoid arthritis. \n",
      "d) Polyarteritis nodosa.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) Rheumatoid arthritis. Angioid striae are a common complication of RA, and they are caused by the deposition of calcium in the walls of small blood vessels.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 110: \n",
      "Language: spanish\n",
      "Question: \n",
      "Además de la tríada clásica de blefaroptosis, epicanto inverso y telecanto, ¿cuál de los siguientes hallazgos aparece con frecuencia en el síndrome de blefarofimosis?\n",
      "a) Triquiasis mayor.\n",
      "b) Ectropión lateral del párpado inferior.\n",
      "c) Obstrucción lagrimal por imperforación de la válvula de Hasner.\n",
      "d) Acortamiento del fondo de saco conjuntival superior.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) Ectropión lateral del párpado inferior.\n",
      "\n",
      "Blefarofimosis is a syndrome characterized by a triad of symptoms: blepharoptosis (droopy eyelid), epicanthus inversus (a fold of skin running from the nose to the inner canthus), and telecanthus (a wide distance between the inner canthi). In addition to these classic findings, ectropion of the lower eyelid is a common associated feature of blepharofimosis.\n",
      "\n",
      "Therefore, the correct answer is option b) Ectropión lateral del párpado inferior.\n",
      "\n",
      "The other options are not correct:\n",
      "\n",
      "* Option a) Triquiasis mayor refers to a condition where there is an excessive growth of the eyelashes, but it is not a common finding in blepharofimosis.\n",
      "* Option c) Obstrucción lagrimal por imperforación de la válvula de Hasner refers to a blockage of the lacrimal duct due to an imperforation of the Hasner valve, which is not a common feature of blepharofimosis.\n",
      "* Option d) Acortamiento del fondo de saco conjuntival superior refers to a shortening of the superior conjunctival sac, which is not a common finding in blepharofimosis.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Bilang karagdagan sa klasikong triad ng blepharoptosis, epicanthus inversus, at telecanthus, alin sa mga natuklasan sa mga pahayag sa ibaba ang madalas na lumitaw sa Blepharophimosis syndrome?\n",
      "a) Trichiasis major.\n",
      "b) Lateral ectropion ng ilalim na talukap ng mata\n",
      "c) Lacrimal obstruction dahil sa imperforation ng Hasner valve\n",
      "d) Pag-ikli o pag-urong ng itaas na bahagi ng conjuctival cul-de-sac\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Blepharophimosis syndrome is a rare genetic disorder characterized by bilateral ptosis, epicanthus inversus, and telecanthus. The question asks which of the following findings is most commonly associated with Blepharophimosis syndrome.\n",
      "\n",
      "Option A, Trichiasis major, is incorrect because trichiasis is a condition where eyelashes are directed towards the eye and can cause irritation, but it is not a feature of Blepharophimosis syndrome.\n",
      "\n",
      "Option B, Lateral ectropion of the lower eyelid, is incorrect because lateral ectropion is a condition where the lower eyelid turns outward, but it is not a feature of Blepharophimosis syndrome.\n",
      "\n",
      "Option C, Lacrimal obstruction due to imperforation of the Hasner valve, is the correct answer. The Hasner valve is a small valve that regulates the flow of tears from the lacrimal sac to the nasal cavity. Imperforation of the Hasner valve can cause lacrimal obstruction, which is a common feature of Blepharophimosis syndrome.\n",
      "\n",
      "Option D, Ptosis or retroposition of the upper part of the conjunctival cul-de-sac, is incorrect because ptosis or retroposition of the upper part of the conjunctival cul-de-sac is not a feature of Blepharophimosis syndrome.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Além da tríade clássica de blefaroptose, epicanto inverso e telecanto, qual dos achados abaixo aparece com frequência na síndrome da blefarofimose? \n",
      "a) Triquíase maior. \n",
      "b) Ectrópio lateral da pálpebra inferior. \n",
      "c) Obstrução lacrimal por imperfuração da válvula de Hasner. \n",
      "d) Encurtamento do fundo de saco conjuntival superior.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the frequency of certain findings in the syndrome of blepharophimosis. The correct answer is b) Ectropion of the lower eyelid.\n",
      "\n",
      "Blepharophimosis is a rare genetic disorder characterized by bilateral ptosis, inverted upper eyelid crease, and telecanthus (wide distance between the inner canthi). Ectropion of the lower eyelid is a common associated feature of blepharophimosis.\n",
      "\n",
      "Triquiasis ( answer a) refers to the excessive growth of the eyelashes, which can cause eye irritation and blepharospasm. While it is a common finding in blepharophimosis, it is not the most frequent associated feature.\n",
      "\n",
      "Obstruction of the lacrimal passage due to imperforation of the Hasner valve ( answer c) is a rare complication of blepharophimosis.\n",
      "\n",
      "Encurtamento do fundo de saco conjuntival superior ( answer d) refers to the shortening of the superior conjunctival sac, which can cause exposure keratopathy and dry eye. While it is a possible complication of blepharophimosis, it is not the most frequent associated feature.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "In addition to the classic triad of blepharoptosis, epicanthus inversus, and telecanthus, which of the findings below appears frequently in blepharophimosis syndrome? \n",
      "a) Trichiasis major. \n",
      "b) Lateral ectropion of the lower eyelid. \n",
      "c) Lacrimal obstruction due to imperforation of the Hasner valve. \n",
      "d) Shortening of the superior conjunctival cul-de-sac.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // b) Lateral ectropion of the lower eyelid.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "Blepharophimosis syndrome is a rare genetic disorder characterized by a triad of facial features, including blepharoptosis (droopy eyelids), epicanthus inversus (a fold of skin running from the nose to the inner canthus), and telecanthus (wide distance between the inner canthi). In addition to these classic findings, lateral ectropion of the lower eyelid is a common feature of blepharophimosis syndrome. Trichiasis major (a) and lacrimal obstruction due to imperforation of the Hasner valve (c) are not typically associated with this condition. Shortening of the superior conjunctival cul-de-sac (d) is a possible finding in blepharophimosis syndrome, but it is not as common as lateral ectropion.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 111: \n",
      "Language: spanish\n",
      "Question: \n",
      "Seleccionar la alternativa correcta en cuanto a cirugía de blefaroplastia inferior con fines estéticos.\n",
      "a) La extirpación de la bolsa grasa lateral tiene como principal complicación la diplopía postoperatoria por lesión del oblicuo inferior.\n",
      "b) Cuando se realiza por vía transconjuntival, existe mayor riesgo de retracción palpebral.\n",
      "c) Mayor flacidez horizontal del párpado en la valoración preoperatoria indica la necesidad de asociación con cantoplastia lateral.\n",
      "d) En pacientes jóvenes, que tienen una mayor respuesta curativa, la vía preferida es la transcutánea.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La opción correcta es la opción c: Mayor flacidez horizontal del párpado en la valoración preoperatoria indica la necesidad de asociación con cantoplastia lateral.\n",
      "\n",
      "La blefaroplastia inferior con fines estéticos es una cirugía que se utiliza para mejorar la apariencia de las bolsas grises y caídas debajo de los ojos. La opción c es la correcta porque la flacidez horizontal del párpado puede indicar la necesidad de una cantoplastia lateral para lograr un resultado estético adecuado. La asociación de estas dos técnicas puede ayudar a mejorar la apariencia de la región periocular y reducir la sensación de cansancio y fatiga en el rostro.\n",
      "\n",
      "Las otras opciones no son correctas por las siguientes razones:\n",
      "\n",
      "* La opción a es incorrecta porque la extirpación de la bolsa grasa lateral no es una complicación de la blefaroplastia inferior. La diplopía postoperatoria puede ocurrir en algunas cirugías de blefaroplastia, pero no es una complicación directa de la extirpación de la bolsa grasa lateral.\n",
      "* La opción b es incorrecta porque la vía transconjuntival no tiene un mayor riesgo de retracción palpebral. De hecho, la vía transconjuntival es una técnica menos invasiva que puede reducir el riesgo de complicaciones y mejorar la recuperación posquirúrgica.\n",
      "* La opción d es incorrecta porque la vía preferida para la blefaroplastia inferior no depende de la edad del paciente, sino de la gravedad de la flacidez del párpado y otras características individuales del paciente. La vía transcutánea puede ser adecuada para algunos pacientes jóvenes, pero no es la vía preferida en todos los casos.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga pahayag sa ibaba ang naglalahad ng katotohanan patungkol sa lower blepharoplasty surgery na may layong makapagpaganda? \n",
      "a) Pagtanggal sa lateral fat pad ay nagdulot ng post-operative diplopia dulot ng pinsala sa inferior oblique\n",
      "b) Kung gagawin ang operasyon sa pamamagitan ng transconjunctival route, may mas malaking panganib para sa eyelid retraction\n",
      "c) Ang labis na horizontal flaccidity ng ulo sa pre-surgical evaluation ay nagpapahiwatig na mayroong pangangailan para sa lateral canthoplasty\n",
      "d) Sa mga batang pasyente, dahil mas mabilis maghilom ang sugat, mas mainam gumamait ng transcutaneous na ruta\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option c: Ang labis na horizontal flaccidity ng ulo sa pre-surgical evaluation ay nagpapahiwatig na mayroong pangangailan para sa lateral canthoplasty.\n",
      "\n",
      "This statement suggests that excessive horizontal flaccidity of the eyelid during pre-surgical evaluation may indicate the need for a lateral canthoplasty procedure in addition to the lower blepharoplasty surgery. This is because the lateral canthoplasty procedure can help to address any issues with the lateral aspect of the eyelid, such as excessive skin or fat, which may be contributing to the post-operative diplopia.\n",
      "\n",
      "Option a is incorrect because the statement suggests that the post-operative diplopia is caused by the removal of the lateral fat pad, which is not related to the lateral canthoplasty procedure.\n",
      "\n",
      "Option b is incorrect because the statement suggests that the transconjunctival route is associated with a higher risk of eyelid retraction, which is not related to the lateral canthoplasty procedure.\n",
      "\n",
      "Option d is incorrect because the statement suggests that the transcutaneous route is more appropriate for younger patients, which is not related to the lateral canthoplasty procedure.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Assinale a alternativa correta quanto a cirurgia de blefaroplastia inferior para fins estéticos.  \n",
      "a) Remoção da bolsa de gordura lateral tem como principal complicação a diplopia pós-operatória por lesão no obliquo inferior. \n",
      "b) Quando realizada por via transconjuntival há maior risco de retração palpebral. \n",
      "c) Maior flacidez horizontal da pálpebra na avaliação pré-operatória indica a necessidade de associação de cantoplastia lateral. \n",
      "d) Em pacientes jovens, que possuem maior resposta cicatricial, a via preferencial é a transcutânea.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option c: Maior flacidez horizontal da pálpebra na avaliação pré-operatória indica a necessidade de associação de cantoplastia lateral.\n",
      "\n",
      "Blepharoplasty is a surgical procedure that aims to remove excess skin and fat from the eyelids. When performed for aesthetic purposes, the goal is to improve the appearance of the eyes and reduce the signs of aging.\n",
      "\n",
      "Option a is incorrect because the removal of the lateral fat pad is not the primary complication of blepharoplasty. Diplopia (double vision) can occur after surgery, but it is not directly related to the removal of the fat pad.\n",
      "\n",
      "Option b is incorrect because when performed through a transconjunctival approach, there is no greater risk of palpebral retraction. This approach is considered safer and less invasive than other methods.\n",
      "\n",
      "Option d is incorrect because the transcutaneous approach is not the preferred method for young patients with greater cicatricial response. The transcutaneous approach may be associated with a higher risk of complications and is generally not recommended for blepharoplasty.\n",
      "\n",
      "Therefore, the correct answer is option c: Maior flacidez horizontal da pálpebra na avaliação pré-operatória indica a necessidade de associação de cantoplastia lateral. This statement indicates that a patient with a greater degree of horizontal flaccidity in the eyelid may require a cantoplasty procedure in addition to blepharoplasty to achieve the best aesthetic results.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Check the correct alternative regarding lower blepharoplasty surgery for aesthetic purposes. \n",
      "a) Removal of the lateral fat pad mainly suffered postoperative diplopia due to an injury to the inferior oblique. \n",
      "b) When performed via the transconjunctival route, there is a greater risk of eyelid retraction. \n",
      "c) Greater horizontal flaccidity of the head in the pre-surgical evaluation indicates the need for a lateral canthoplasty. \n",
      "d) In young patients, who have a greater healing response, the preferred route is transcutaneous.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option b, \"When performed via the transconjunctival route, there is a greater risk of eyelid retraction.\"\n",
      "\n",
      "Lower blepharoplasty surgery, also known as eyelid surgery, is a procedure that aims to improve the appearance of the lower eyelids by removing excess skin, fat, and muscle. One of the risks associated with this surgery is eyelid retraction, which is more likely to occur when the surgery is performed via the transconjunctival route. This route involves making an incision in the conjunctiva, the thin membrane that covers the white part of the eye, to access the lower eyelid.\n",
      "\n",
      "Option a is incorrect because the removal of the lateral fat pad is not a risk factor for eyelid retraction. Option c is also incorrect because greater horizontal flaccidity of the head in the pre-surgical evaluation does not necessarily indicate the need for a lateral canthoplasty. Option d is incorrect because the preferred route for lower blepharoplasty surgery is not determined by the patient's age, but rather by the individual's specific anatomy and needs.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 112: \n",
      "Language: spanish\n",
      "Question: \n",
      "Seleccione la alternativa correcta.\n",
      "a) Se pueden considerar efectos secundarios de la aplicación de toxina botulínica periocular: blefaroptosis aponeurótica, entropión espástico y estrabismo restrictivo.\n",
      "b) A diferencia del blefaroespasmo esencial, el tratamiento con fármacos miorrelajantes orales proporciona una buena respuesta al espasmo hemifacial.\n",
      "c) La aplicación de toxina botulínica tipo B es el tratamiento más utilizado para el blefaroespasmo esencial.\n",
      "d) La aplicación coadyuvante de toxina botulínica en casos de parálisis facial periférica se realiza en el lado no afectado.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c: La aplicación de toxina botulínica tipo B es el tratamiento más utilizado para el blefaroespasmo esencial.\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Blepharospasm is a type of involuntary eyelid spasm that can cause discomfort, pain, and vision problems. Botulinum toxin type B is a commonly used treatment for blepharospasm, as it can relax the muscles involved in the spasm and provide relief for patients.\n",
      "\n",
      "Option a is incorrect because blepharoptosis aponeurótica, entropión espástico, and estrabismo restrictivo are not effects of botulinum toxin type B.\n",
      "\n",
      "Option b is incorrect because, while oral miorelaxants can provide some relief for blepharospasm, they are not as effective as botulinum toxin type B.\n",
      "\n",
      "Option d is incorrect because coadjuvanate application of botulinum toxin in cases of peripheral facial paralysis is not a recognized treatment.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga pahayag ang totoo?\n",
      "a) Ang mga sumusunod na salang-epekto ng paglalagay ng botulinum toxin ay: aponeurotic blepharoptosis, spastic entropion, at restrictive strasbismus\n",
      "b) Di gaya ng essential blepharospasm, ang paggamit ng oral myorelaxant na gamot ay mainam para sa hemifacial spasm\n",
      "c) Ang paglalagay ng botulinum toxis type B ang pinaka madalas na ibinibigay para sa essential blepharospasm\n",
      "d) Ang paglalagay ng pinalakas na botulinum toxin para sa mga pasyenteng may peripheral facial paralysis ay inilalagay sa parte ng mukha na hindi apektado\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Ang paglalagay ng botulinum toxin type B ang pinaka madalas na ibinibigay para sa essential blepharospasm.\n",
      "\n",
      "Essential blepharospasm is a condition characterized by involuntary contraction of the eyelid muscles, leading to forced closure of the eyelids. Botulinum toxin type B is the most commonly used treatment for essential blepharospasm, as it can effectively relax the muscles and reduce the frequency and severity of spasms.\n",
      "\n",
      "Option a is incorrect because the statement lists the effects of botulinum toxin on the eyelids, but not the specific type of botulinum toxin used for essential blepharospasm. Option b is also incorrect because oral myorelaxants are not the most effective treatment for essential blepharospasm, and may have side effects. Option d is incorrect because the statement describes the use of botulinum toxin for peripheral facial paralysis, which is not related to essential blepharospasm.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Escolha a alternativa correta. \n",
      "a) Podem ser considerados efeitos colaterais da aplicação da toxina botulínica periocular: blefaroptose aponeurótica, entrópio espástico e estrabismo restritivo. \n",
      "b) Diferentemente do blefaroespasmo essencial, o tratamento com drogas miorrelaxantes orais apresenta boa resposta para o espasmo hemifacial. \n",
      "c) A aplicação de toxina botulínica tipo B é o tratamento mais realizado para blefaroespasmo essencial. \n",
      "d) A aplicação adjuvante de toxina botulínica em caso de paralisia facial periférica é realizada no lado não acometido.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c: A aplicação de toxina botulínica tipo B é o tratamento mais realizado para blefaroespasmo essencial.\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Blepharospasm is a type of eye movement disorder characterized by involuntary contraction of the eyelid muscles. Botulinum toxin type B is a commonly used treatment for blepharospasm, as it can temporarily weaken the muscles involved in the spasms, providing relief from symptoms.\n",
      "\n",
      "Option a is incorrect because blepharoptosis aponeurotica, entropion spastic, and restrictive strabismus are not effects of botulinum toxin periocular application, but rather potential complications of the treatment.\n",
      "\n",
      "Option b is incorrect because, while oral miorelaxants may be effective in treating blepharospasm, they are not as effective as botulinum toxin type B injections.\n",
      "\n",
      "Option d is incorrect because the application of botulinum toxin type B as an adjunctive treatment for peripheral facial paralysis is typically done on the affected side, not the non-affected side.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Choose the correct alternative. \n",
      "a) The following side effects of the application of periocular botulinum toxin can be considered: aponeurotic blepharoptosis, spastic entropion and restrictive strabismus. \n",
      "b) Unlike essential blepharospasm, treatment with oral myorelaxant drugs shows a good response to hemifacial spasm. \n",
      "c) The application of botulinum toxin type B is the most common treatment for essential blepharospasm. \n",
      "d) The adjuvant application of botulinum toxin in case of peripheral facial paralysis is performed on the unaffected side.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c) The application of botulinum toxin type B is the most common treatment for essential blepharospasm.\n",
      "\n",
      "Essential blepharospasm is a neurological disorder characterized by involuntary contractions of the eyelid muscles, leading to forced closure of the eyelids. Botulinum toxin type B is a commonly used treatment for this condition, as it can relax the muscles and reduce the frequency and severity of the spasms.\n",
      "\n",
      "Option a) Aponeurotic blepharoptosis, spastic entropion, and restrictive strabismus are potential side effects of periocular botulinum toxin application, but they are not directly related to the treatment of essential blepharospasm.\n",
      "\n",
      "Option b) Unlike essential blepharospasm, treatment with oral myorelaxant drugs may show a good response to hemifacial spasm, but this is not the most common treatment for essential blepharospasm.\n",
      "\n",
      "Option d) The adjuvant application of botulinum toxin in case of peripheral facial paralysis is performed on the affected side, not the unaffected side.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 113: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Qué hilo de sutura utilizado en la cirugía de párpados tiene el mayor potencial de reacción inflamatoria del tejido?\n",
      "a) La seda, por ser orgánica.\n",
      "b) Poliéster (Mersilene®), por ser absorbible.\n",
      "c) Poliamida (Nylon®), al ser monofilamento.\n",
      "d) Polipropileno (Prolene®), al ser multifilamento trenzado.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Poliéster (Mersilene®), por ser absorbible.\n",
      "\n",
      "Poliéster (Mersilene®) is a synthetic absorbable suture that is commonly used in ophthalmic surgery, including pterygium surgery. It has a lower inflammatory potential compared to other sutures, which makes it a good choice for this type of surgery.\n",
      "\n",
      "Seda (a) is an organic suture made from silk, which has been used in surgery for centuries. However, it has a higher inflammatory potential compared to Poliéster (Mersilene®) and may not be the best choice for pterygium surgery.\n",
      "\n",
      "Poliamida (Nylon®) (c) is a monofilament suture that is also commonly used in surgery. However, it has a higher inflammatory potential compared to Poliéster (Mersilene®) and may not be the best choice for pterygium surgery.\n",
      "\n",
      "Polipropileno (Prolene®) (d) is a multifilament trenzado suture that is also commonly used in surgery. However, it has a higher inflammatory potential compared to Poliéster (Mersilene®) and may not be the best choice for pterygium surgery.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Anong suture thread ang ginagamit sa mga operasyon ng talukap na maaring makapagbigay ng malaking panganib para sa tissue inflammatory reaction?\n",
      "a) Sutla, dahil ito ay organic.\n",
      "b) Polyester (Mersilene®), dahil ito ay absorbable\n",
      "c) Polyamide (Nylon®), dahil ito ay monofilament.\n",
      "d) polypropylene (Prolene®), dahil ito ay multifilament braided\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Polyester (Mersilene®), because it is absorbable and can minimize tissue inflammatory reaction.\n",
      "\n",
      "Sutla (a) is an organic suture thread, but it is not the best option for minimizing tissue inflammatory reaction.\n",
      "\n",
      "Polyamide (Nylon®) (c) is a monofilament suture thread, but it is not absorbable and may cause more tissue inflammation.\n",
      "\n",
      "Polypropylene (Prolene®) (d) is a multifilament braided suture thread, but it is not absorbable and may also cause tissue inflammation.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual fio de sutura utilizado em cirurgias palpebrais tem maior potencial de reação inflamatória tecidual? \n",
      "a) Seda, por ser orgânico. \n",
      "b) Poliester (Mersilene®), por ser absorvível. \n",
      "c) Poliamida (Nylon®), por ser monofilamentar. \n",
      "d) Polipropilene (Prolene®), por ser multifilamentar trançado.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking which type of suture used in eyelid surgeries has the highest potential for tissue inflammatory reaction.\n",
      "\n",
      "Option A, seda (silk), is an organic material and is not commonly used in surgical sutures due to its potential for inflammation and tissue reaction.\n",
      "\n",
      "Option B, poliester (Mersilene®), is a synthetic, absorbable suture material that is commonly used in ophthalmic surgery, including eyelid surgery. It has a lower potential for tissue inflammatory reaction compared to other synthetic materials.\n",
      "\n",
      "Option C, poliamida (Nylon®), is a monofilament suture material that is also commonly used in ophthalmic surgery. It has a higher potential for tissue inflammatory reaction compared to poliester.\n",
      "\n",
      "Option D, polipropilene (Prolene®), is a multifilament suture material that is commonly used in general surgery, but not typically used in ophthalmic surgery due to its higher potential for tissue inflammatory reaction.\n",
      "\n",
      "Therefore, the correct answer is option B, poliester (Mersilene®).\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "\n",
      "Which suture thread used in eyelid surgeries has the greatest potential for tissue inflammatory reaction? \n",
      "a) Silk, as it is organic. \n",
      "b) Polyester (Mersilene®), as it is absorbable. \n",
      "c) Polyamide (Nylon®), as it is monofilament. \n",
      "d) Polypropylene (Prolene®), as it is multifilament braided.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\" // The correct answer is b) Polyester (Mersilene®), as it is absorbable.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Polyester (Mersilene®) is a synthetic absorbable suture material that has a greater potential for tissue inflammatory reaction compared to the other options. This is because it is made of a polymer that is more likely to cause an immune response and inflammation in the body.\n",
      "\n",
      "Silk (option a) is an organic material that is less likely to cause inflammation, but it is not as strong as synthetic materials and may not be suitable for eyelid surgeries that require a stronger suture.\n",
      "\n",
      "Polyamide (Nylon®) (option c) is a monofilament material that is strong and resistant to breakage, but it may cause more tissue reaction than polyester.\n",
      "\n",
      "Polypropylene (Prolene®) (option d) is a multifilament braided material that is strong and less likely to cause inflammation, but it may not be as absorbable as polyester.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 114: \n",
      "Language: spanish\n",
      "Question: \n",
      "Seleccione la respuesta correcta con respecto al chalazión.\n",
      "a) En pacientes de edad avanzada es frecuente la transformación maligna a carcinoma sebáceo.\n",
      "b) Histológicamente se caracteriza por inflamación lipogranulomatosa crónica.\n",
      "c) La mayoría de las veces se origina en una glándula apocrina adherida a las pestañas.\n",
      "d) El uso de pomada tópica de ivermectina es el tratamiento clínico preferido debido a la asociación demostrada con el ácaro Demodex folliculorum.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La respuesta correcta es la opción c: La mayoría de las veces se origina en una glándula apocrina adherida a las pestañas.\n",
      "\n",
      "Un chalazión es una inflamación de una glándula apocrina del párpado, que puede causar dolor, molestias y secreción. La opción c es la respuesta correcta ya que la mayoría de los chalaziones se originan en una glándula apocrina adherida a las pestañas.\n",
      "\n",
      "La opción a es incorrecta ya que, aunque es cierto que los pacientes de edad avanzada pueden desarrollar carcinoma sebáceo, no es una característica común de los chalaziones.\n",
      "\n",
      "La opción b es incorrecta ya que, aunque la inflamación lipogranulomatosa crónica es una característica histológica de los chalaziones, no es la respuesta más adecuada.\n",
      "\n",
      "La opción d es incorrecta ya que, aunque el uso de pomada tópica de ivermectina puede ser útil en el tratamiento de ciertas afecciones relacionadas con ácaros, no es el tratamiento clínico preferido para los chalaziones.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na pahayag ang tama patungkol sa chalazion?\n",
      "a) Sa mga matatandang pasyente, pangkaraniwan ang pagbabagong-anyo ng sebaceious carcinoma bilang mapaminsala\n",
      "b) Sa histolohikal na aspeto, mailalarawan ito sa pamamagitan ng matagalang lipogranulomatous inflammation\n",
      "c) Kadalasan, ito ay nagmumula sa apocrine gland na nakadikit sa mga pilikmata\n",
      "d) Ang paggamit ng ivermectin bilang pamahid ang inirerekomentang pamamahala dahil sa kaugnauyan nito sa Demodex folluculorum mite\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Chalazion is a type of eyelid lesion that can be caused by various factors, including inflammation of the meibomian gland, which is located in the eyelid and produces an oily substance called meibum. The correct answer is option c, \"Kadalasan, ito ay nagmumula sa apocrine gland na nakadikit sa mga pilikmata,\" which means \"It usually originates from the apocrine gland attached to the eyelashes.\"\n",
      "\n",
      "Option a, \"Sa mga matatandang pasyente, pangkaraniwan ang pagbabagong-anyo ng sebaceious carcinoma bilang mapaminsala,\" is incorrect because sebaceous carcinoma is a type of skin cancer that affects the sebaceous glands, not the meibomian glands.\n",
      "\n",
      "Option b, \"Sa histolohikal na aspeto, mailalarawan ito sa pamamagitan ng matagalang lipogranulomatous inflammation,\" is also incorrect because while histiocytic inflammation can be a feature of chalazion, it is not the primary cause.\n",
      "\n",
      "Option d, \"Ang paggamit ng ivermectin bilang pamahid ang inirerekomentang pamamahala dahil sa kaugnauyan nito sa Demodex folluculorum mite,\" is incorrect because ivermectin is not used to treat chalazion, and Demodex mites are not involved in its pathogenesis.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Assinale a alternativa correta quanto ao calázio. \n",
      "a) Em pacientes idosos é comum a transformação maligna para carcinoma sebáceo. \n",
      "b) Histologicamente caracteriza-se por inflamação crônica lipogranulomatosa. \n",
      "c) Na maioria das vezes origina-se de glândula apócrina atrelada aos cílios. \n",
      "d) Uso de ivermectina tópica em pomada é o tratamento clínico preferido devido a associação demonstrada com o ácaro Demodex foliculorum.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option c. The majority of cases of calazio originate from apocrine glands associated with eyelashes.\n",
      "\n",
      "Apocrine glands are specialized glands found in the eyelids that produce a type of sweat that helps to lubricate and protect the eyes. They are responsible for the formation of calazio, which is a benign tumor that grows slowly and is usually painless.\n",
      "\n",
      "Option a is incorrect because malignant transformation to sebaceous carcinoma is not common in elderly patients.\n",
      "\n",
      "Option b is incorrect because histologically, calazio is characterized by chronic inflammation and lipogranulomatous changes, not by the presence of apocrine glands.\n",
      "\n",
      "Option d is incorrect because while ivermectin topical cream has been associated with the treatment of demodicosis, a condition caused by the Demodex folliculorum mite, it is not the preferred clinical treatment for calazio.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Mark the correct alternative regarding the chalazion. \n",
      "a) In elderly patients, malignant transformation to sebaceous carcinoma is common. \n",
      "b) Histologically, it is characterized by chronic lipogranulomatous inflammation. \n",
      "c) In most cases, it originates from the apocrine gland attached to the eyelashes. \n",
      "d) Use of topical ivermectin in ointment is the preferred clinical treatment due to the demonstrated association with the Demodex folliculorum mite.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "  \"response\": \"c\"\n",
      "}\n",
      "```\n",
      "La respuesta correcta es la opción c: En la mayoría de los casos, se origina en la glándula apocrina adherida a las pestañas.\n",
      "\n",
      "Here's the answer in Tagalog:\n",
      "```json\n",
      "{\n",
      "  \"response\": \"c\"\n",
      "}\n",
      "```\n",
      "Ang tamaan na opsiyon ay ang opsiyon c: Sa karamihan ng mga kaso, ang pinagmumulan nito ay ang glándula apocrina na kasama sa pestañas.\n",
      "\n",
      "Here's the answer in Portuguese:\n",
      "```json\n",
      "{\n",
      "  \"response\": \"c\"\n",
      "}\n",
      "```\n",
      "A resposta correta é a opção c: Em la maioria dos casos, ela origina-se na glândula apocrina aderida às pestanas.\n",
      "\n",
      "Here's the answer in English:\n",
      "```json\n",
      "{\n",
      "  \"response\": \"c\"\n",
      "}\n",
      "```\n",
      "The correct answer is option c: In most cases, it originates from the apocrine gland attached to the eyelashes.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 115: \n",
      "Language: spanish\n",
      "Question: \n",
      "Mujer de 60 años con contracciones tónico-clónicas que iniciaron en músculos perioculares derechos y en tres meses progresaron a todo el hemifacial. Aunque las contracciones varían durante el día, generalmente no dejan dormir, ya que “no cesan por la noche”. Seleccione la alternativa correcta.\n",
      "a) Se trata de un caso de blefaroespasmo esencial benigno.\n",
      "b) Las contracciones tienden a afectar progresivamente al lado contralateral y volverse bilaterales y simétricas.\n",
      "c) Una posible causa es la compresión vascular intracraneal del nervio facial ipsilateral.\n",
      "d) Los medicamentos que modulan la producción de serotonina en los ganglios basales, aunque no del todo eficaces, ayudan a controlar las contracciones.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of tonic-clonic contractions starting in the right periocular muscles and progressing to the entire hemifacial region over three months, with varying intensity throughout the day but not ceasing at night, suggest a possible cause of compression of the ipsilateral facial nerve. This is consistent with option C, \"Una posible causa es la compresión vascular intracraneal del nervio facial ipsilateral.\"\n",
      "\n",
      "Therefore, option C is the correct response.\n",
      "\n",
      "Option A, \"Se trata de un caso de blefaroespasmo esencial benigno,\" is incorrect because the patient's symptoms have progressed over time and affect the entire hemifacial region, which is not consistent with benign essential blepharospasm.\n",
      "\n",
      "Option B, \"Las contracciones tienden a afectar progresivamente al lado contralateral y volverse bilaterales y simétricas,\" is incorrect because the patient's symptoms have not been described as affecting the contralateral side.\n",
      "\n",
      "Option D, \"Los medicamentos que modulan la producción de serotonina en los ganglios basales, aunque no del todo eficaces, ayudan a controlar las contracciones,\" is incorrect because while medications that modulate serotonin production in the basal ganglia may help control contractions, they are not the underlying cause of the patient's symptoms.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Isang 60-taong-gulang na babae na may tonic-clonic contractions na nagsimula sa mga kanang periocular muscles na kumalat sa buong kalahati ng mukha sa loob ng tatlong buwan. Bagaman nag-iiba ang contractions sa umaga, hindi nito pinapapatulog ang pasyente sa gabi. Alin sa mga pahayag ang tama. \n",
      "a) Ito ay isang kaso ng benign essential blepharospasm.\n",
      "b) Ang mga contractions ay may posibilidad na progresibong kumalat sa kabilang bahagi at maging bilateral at simetriko.\n",
      "c) Ang isang posibleng sanhi ay intracranial vascular compression ng ipsilateral facial nerve.\n",
      "d) Ang mga gamot na siyang nag-momodulate sa produksyon ng serotonin sa basal nuclei, bagaman hindi mainam, ay nakakatulong upang kontrolin ang mga contractions\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of tonic-clonic contractions starting from the periocular muscles and spreading to the entire face over the course of three months, with variations in the severity of the contractions throughout the day but not relieving the patient's sleep at night, are consistent with the diagnosis of benign essential blepharospasm (BEB).\n",
      "\n",
      "BEB is a neurological disorder characterized by involuntary contractions of the eyelid muscles, which can progress to bilateral and symmetrical involvement, as described in option b. The condition is usually associated with dysfunction in the basal ganglia, which can lead to abnormalities in the regulation of movement and the production of serotonin, a neurotransmitter involved in the modulation of muscle contractions.\n",
      "\n",
      "While option a is a possible diagnosis, it does not fully match the patient's symptoms, as the contractions are not limited to the eyelids and are not necessarily associated with eye movement. Option c is an unlikely diagnosis, as intracranial vascular compression of the facial nerve would not explain the patient's symptoms of tonic-clonic contractions. Option d is incorrect, as the medications that modulate serotonin production in the basal nuclei are not effective in controlling the contractions in BEB.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Mulher de 60 anos com contrações tônico-clônicas que se iniciaram na musculatura periocular à direita e em três meses evoluiram para toda a hemiface. Embora as contrações variem durante o dia, geralmente não a deixam dormir, pois \"não param a noite\". Assinale a alternativa correta. \n",
      "a) Trata-se de um caso de blefaroespasmo essencial benigno. \n",
      "b) As contrações tendem a acometer progressivamente o lado contralateral e tornarem-se bilaterais e simétricas. \n",
      "c) Uma possível causa é compressão intracraniana vascular do nervo facial ipsolateral. \n",
      "d) Medicações que modulam produção de serotonina nos núcleos da base, embora não sejam completamente efetivas, auxiliam no controle das contrações.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of tonic-clonic contractions starting in the right periocular musculature and spreading to the entire hemiface over three months, with variations in intensity throughout the day but not allowing her to sleep, are consistent with hemifacial spasm (HFS). HFS is a neurological disorder characterized by involuntary contractions of the facial muscles, typically affecting one side of the face. The contractions can be triggered by various factors, including compression of the facial nerve, which is the likely cause in this case. Therefore, option c is the correct response.\n",
      "\n",
      "Option a is incorrect because blepharospasm is a different condition that affects the eyelid muscles, although it can sometimes coexist with HFS. Option b is incorrect because the contractions do not tend to become bilateral and symmetrical in HFS. Option d is incorrect because while medications that modulate serotonin production can help control HFS symptoms, they are not a definitive solution.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "A 60-year-old woman with tonic-clonic contractions that started in the periocular muscles on the right and in three months progressed to the entire hemiface. Although the contractions vary during the day, they usually don't let her sleep, as they \"don't stop at night\". Tick ​​the correct alternative. \n",
      "a) This is a case of benign essential blepharospasm. \n",
      "b) Contractions tend to progressively affect the contralateral side and become bilateral and symmetrical. \n",
      "c) A possible cause is intracranial vascular compression of the ipsilateral facial nerve. \n",
      "d) Medications that modulate serotonin production in the basal nuclei, although not completely effective, help control contractions.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms of tonic-clonic contractions that started in the periocular muscles and progressed to the entire hemiface over three months, and the fact that they do not stop at night, suggest that the condition is likely caused by intracranial vascular compression of the ipsilateral facial nerve. This is a common cause of hemifacial spasm, which is a neurological disorder characterized by involuntary muscle contractions on one side of the face.\n",
      "\n",
      "Therefore, option c) A possible cause is intracranial vascular compression of the ipsilateral facial nerve, is the correct response.\n",
      "\n",
      "Option a) This is a case of benign essential blepharospasm, is incorrect because the patient's symptoms do not match the characteristics of benign essential blepharospasm, which is a condition characterized by involuntary blinking or spasms of the eyelid muscles.\n",
      "\n",
      "Option b) Contractions tend to progressively affect the contralateral side and become bilateral and symmetrical, is incorrect because the patient's symptoms do not mention any progression to the contralateral side.\n",
      "\n",
      "Option d) Medications that modulate serotonin production in the basal nuclei, although not completely effective, help control contractions, is incorrect because while medications that modulate serotonin production may be used to treat hemifacial spasm, they are not a definitive solution and may not completely eliminate the contractions.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 116: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Para qué tipo de entropión palpebral, entre los siguientes, está más indicada la técnica de fractura del tarso con rotación marginal?\n",
      "a) Involucional (senil).\n",
      "b) Espástico.\n",
      "c) Congénito.\n",
      "d) Cicatricial.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Espástico\n",
      "}\n",
      "```\n",
      "\n",
      "La técnica de fractura del tarso con rotación marginal se utiliza comúnmente para tratar el entropión palpebral espástico, que es causado por una contracción involuntaria de los músculos de la pestaña que pueden hacer que las pestañas se doblen hacia adentro y chocen con la esclerótica. La fractura del tarso con rotación marginal puede ayudar a aliviar la tensión en los músculos de la pestaña y a corregir la posición de las pestañas.\n",
      "\n",
      "La opción a) Involucional (senil) no es correcta porque el entropión senil no es una forma de entropión palpebral espástico y no se beneficia de la técnica de fractura del tarso con rotación marginal.\n",
      "\n",
      "La opción c) Congénito no es correcta porque el entropión congénito es una afección presente desde el nacimiento y no se puede tratar con la técnica de fractura del tarso con rotación marginal.\n",
      "\n",
      "La opción d) Cicatricial no es correcta porque el entropión cicatricial es causado por una cicatriz en la pestaña o en la esclerótica, y no se puede tratar con la técnica de fractura del tarso con rotación marginal.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang technique sa tarsal fracture na mayroong marginal rotation ay inirerekomendang pamamaraan para sa anong klase ng eyelid entropion?\n",
      "a) Involutional (Senile).\n",
      "b) Spastic.\n",
      "c) congenital.\n",
      "d) pagkakapilat.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Spastic\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's symptoms and physical examination findings, including a tarsal fracture with marginal rotation, suggest that the most likely diagnosis is spastic entropion. This is a type of entropion that occurs when the eyelid is paralyzed and the muscles that control eyelid movement become imbalanced, causing the eyelid to turn inward. Spastic entropion can be caused by various neurological conditions, such as cranial nerve palsy, and is more common in older adults.\n",
      "\n",
      "Involutional (senile) entropion is a type of entropion that occurs due to age-related changes in the eyelid and is more common in older adults. It is characterized by a lax eyelid and a prominent eye.\n",
      "\n",
      "Congenital entropion is a rare condition that is present at birth and is caused by a genetic mutation. It is characterized by a failure of the eyelid to properly form or function.\n",
      "\n",
      "Pagkakapilat is a Tagalog term that refers to a condition where the eyelid is turned outward, away from the eye. It is not related to the patient's symptoms or physical examination findings.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "A técnica de fratura tarsal com rotação marginal é mais indicada para tratamento de qual tipo de entrópio palpebral, dentre os abaixo? \n",
      "a) Involucional (senil). \n",
      "b) Espástico. \n",
      "c) Congênito. \n",
      "d) Cicatricial.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // B - Espástico\n",
      "}\n",
      "```\n",
      "A técnica de fratura tarsal com rotação marginal é mais indicada para o tratamento de entropia palpebral de tipo espástico, ou seja, aquela que ocorre devido a uma lesão ou doença que afeta a musculatura ou nervos dos olhos, causando uma falta de controle dos músculos que levam ao fechamento do olho. Essa técnica é menos invasiva e pode ser realizada em pacientes com enfermidades graves ou idosos, que não podem suportar uma cirurgia mais complexa.\n",
      "\n",
      "As outras opções não são corretas, pois:\n",
      "\n",
      "* a) Involucional (senil) se refere a uma condição em que a pele ao redor dos olhos se torna excessivamente flácida e cai para baixo, mas não é uma entropia palpebral.\n",
      "* c) Congênito se refere a uma condição presente desde o nascimento, e não é relacionado à entropia palpebral.\n",
      "* d) Cicatricial se refere a uma condição em que a pele ao redor dos olhos se torna cicatrizada devido a uma lesão ou doença, mas não é uma entropia palpebral.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "The technique of tarsal fracture with marginal rotation is most indicated for the treatment of which type of eyelid entropion, among the following? \n",
      "a) Involutional (senile). \n",
      "b) Spastic. \n",
      "c) Congenital. \n",
      "d) Scarring.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The technique of tarsal fracture with marginal rotation is most indicated for the treatment of involutional (senile) eyelid entropion. This type of entropion is caused by the aging process and results in a drooping of the eyelid, which can cause discomfort, redness, and vision problems. The tarsal fracture with marginal rotation technique involves breaking the bony plate of the tarsus and rotating it to correct the entropion. This technique is not suitable for other types of entropion, such as spastic, congenital, or scarring entropion, which may require different treatments.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 117: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál de las opciones se correlaciona mejor con las mediciones de la siguiente tabla? Fisura palpebral 09 mm Distancia de reflexión margen superior 01 mm Distancia de reflexión margen inferior 08 mm Función del músculo elevador del párpado 14 mm Altura del pliegue palpebral superior 16 mm\n",
      "a) Posible caso de blefaroptosis senil asociada a ectropión senil.\n",
      "b) Posible caso de ptosis palpebral inversa congénita.\n",
      "c) Caso probable de retracción palpebral por orbitopatía inflamatoria de Graves\n",
      "d) Si el paciente es caucásico, estas mediciones pueden considerarse normales.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c: \"Caso probable de retracción palpebral por orbitopatía inflamatoria de Graves.\"\n",
      "\n",
      "The measurements provided in the table suggest that the patient has a condition that affects the eyelids, specifically the lower eyelid. The distance of the reflexion margin inferior (08 mm) and the height of the palpebral fold superior (16 mm) indicate that the lower eyelid is positioned higher than normal, which can be a sign of retracción palpebral. Additionally, the function of the músculo elevador del párpado (14 mm) is within the normal range, which suggests that the muscle is not affected.\n",
      "\n",
      "Orbitopatía inflamatoria de Graves is an autoimmune disorder that affects the eyes and can cause retracción palpebral, among other symptoms. It is more common in women and has a higher prevalence in Caucasian populations. Therefore, option d, \"Si el paciente es caucásico, estas mediciones pueden considerarse normales,\" is not the best answer.\n",
      "\n",
      "Option a, \"Posible caso de blefaroptosis senil asociada a ectropión senil,\" is not the best answer because blefaroptosis senil is a condition that affects the upper eyelid, not the lower eyelid. Ectropión senil is a condition that causes the lower eyelid to turn outward, which is not indicated by the measurements provided.\n",
      "\n",
      "Option b, \"Posible caso de ptosis palpebral inversa congénita,\" is not the best answer because ptosis palpebral inversa congénita is a congenital condition that affects the upper eyelid, not the lower eyelid.\n",
      "\n",
      "Therefore, the best answer is option c, \"Caso probable de retracción palpebral por orbitopatía inflamatoria de Graves.\"\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga pahayag ang pinakaangkop sa mga sukat na sumusunod: \n",
      "Palpebral fissure 09 mm\n",
      "Upper margin-reflex distance 01 mm\n",
      "Lower margin-reflex distance 08 mm\n",
      "Function of the eyelid levator muscl: 14 mm\n",
      "Upper eyelid crease height: 16 mm\n",
      "\n",
      "a) Posibleng kaso ng senile blepharoptosis na konektado sa senile ectropion.\n",
      "b) Posibleng kaso ng congenital reverse eyelid ptosis.\n",
      "c) Posibleng kaso ng pag-urong ng eyelid dahil sa Graves' inflammatory orbitopathy\n",
      "d) Kung ang pasyente ay Caucasian, ang mga sukat na ito ay maaaring ituring na normal.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The given measurements indicate that the palpebral fissure is 09 mm, which is slightly shorter than the normal range for adults (10-14 mm). The upper margin-reflex distance is 01 mm, which is within the normal range (0-2 mm). The lower margin-reflex distance is 08 mm, which is also within the normal range (0-2 mm). The function of the eyelid levator muscle is 14 mm, which is within the normal range (10-16 mm). The upper eyelid crease height is 16 mm, which is within the normal range (12-18 mm).\n",
      "\n",
      "Based on these measurements, the most likely diagnosis is senile blepharoptosis connected to senile ectropion, which is a condition where the eyelid droops and the eyelid margin is lower than normal. This condition is common in older adults and is often associated with other conditions such as dry eye, conjunctivitis, and corneal abrasions.\n",
      "\n",
      "Therefore, option a) Posibleng kaso ng senile blepharoptosis na konektado sa senile ectropion is the correct response.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual das alternativas melhor se correlaciona com as medidas da tabela abaixo? Fenda palpebral 09 mm Distância margem-reflexo superior 01 mm Distância margem-reflexo inferior 08 mm Função do músculo levantador da pálpebra 14 mm Altura da prega palpebral superior 16 mm \n",
      "a) Possível caso de blefaroptose senil associada a ectrópio senil. \n",
      "b) Possível caso de ptose palpebral reversa congênita. \n",
      "c) Provável caso de retração palpebral por orbitopatia inflamatória de Graves \n",
      "d) Caso o paciente seja caucasiano, essas medidas podem ser consideradas normais.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c: Provável caso de retração palpebral por orbitopatia inflamatória de Graves.\n",
      "\n",
      "The measurements provided in the question correspond to the following:\n",
      "\n",
      "* Fenda palpebral (09 mm): This is the distance between the upper and lower eyelids when the eye is in the primary position.\n",
      "* Distância margem-reflexo superior (01 mm): This is the distance between the superior border of the eyelid and the corneal limbus (the edge of the cornea) when the eye is in the primary position.\n",
      "* Distância margem-reflexo inferior (08 mm): This is the distance between the inferior border of the eyelid and the corneal limbus when the eye is in the primary position.\n",
      "* Função do músculo levantador da pálpebra (14 mm): This is the distance between the upper eyelid and the eyebrow when the eye is in the primary position.\n",
      "* Altura da prega palpebral superior (16 mm): This is the distance between the upper eyelid and the superior border of the eyelid when the eye is in the primary position.\n",
      "\n",
      "Given these measurements, the most likely diagnosis is orbitopatia inflamatória de Graves (Graves' orbitopathy), which is an autoimmune disorder that affects the tissues surrounding the eyes, leading to inflammation and swelling of the eyelids, among other symptoms. This condition can cause retraction of the eyelids, which is consistent with the measurements provided.\n",
      "\n",
      "Therefore, option c is the correct answer.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Which of the alternatives best correlates with the measurements in the table below? Palpebral fissure09 mm Upper margin-reflex distance 01 mm Lower margin-reflex distance 08 mm Function of the eyelid levator muscle 14 mm Upper eyelid crease height 16 mm \n",
      "a) Possible case of senile blepharoptosis associated with senile ectropion. \n",
      "b) Possible case of congenital reverse eyelid ptosis. \n",
      "c) Probable case of eyelid retraction due to Graves' inflammatory orbitopathy \n",
      "d) If the patient is Caucasian, these measurements can be considered normal.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The measurements provided in the table suggest that the patient has a significant difference in the height of the upper and lower eyelid margins, with a larger upper margin-reflex distance and a smaller lower margin-reflex distance. This, combined with a relatively short palpebral fissure and a high upper eyelid crease height, is consistent with eyelid retraction, which can be caused by Graves' inflammatory orbitopathy. Therefore, option c is the best answer.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 118: \n",
      "Language: spanish\n",
      "Question: \n",
      "Marque la respuesta correcta respecto al sistema lagrimal.\n",
      "a) Aproximadamente el 50% de los recién nacidos mantienen obstrucción de la válvula de Hasner hasta el sexto mes de vida, requiriendo el 90% de ellos cateterismo.\n",
      "b) En la mayoría de los recién nacidos la secreción lagrimal es menor que la de un adulto sano.\n",
      "c) La canalización completa del conducto nasolagrimal generalmente ocurre alrededor de la sexta semana de vida extrauterina.\n",
      "d) El recién nacido generalmente presenta canalización completa del saco y conducto nasolagrimal; sin embargo, los canalículos se abren alrededor de la sexta semana de vida extrauterina.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La respuesta correcta es la opción c: La canalización completa del conducto nasolagrimal generalmente ocurre alrededor de la sexta semana de vida extrauterina.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na pahayag ang nagsasaad ng katotohanan tungkol sa lacrimal system?\n",
      "a) Tinatayang 50% ng mga bagong panganak na sanggol ay nanatiling mayroong harang sa kanilang Hasner valve hanggang sa ikaanim na buwan ng kanlang buhay at 90% sa kanila ay nangangailangan ng karagdagang pag-uusisa\n",
      "b) Karamihan sa mga bagong silang na sanggol ay mayroong madalang na sekresyon ng luha kumpara sa mga matatanda\n",
      "c) Ang complete canalization ng lacrimal duct ay nangyayari anim na linggo pagkatapos isilang ang sanggol.\n",
      "d) Pagkasilang, nagkaroon ng complete canalization ng nasolacrimal sac at duct ang sanggol, subalit ang canaliculi ay nagbubukas lamang anim na linggo pagkatapos isilang ang sanggol.\n",
      "\n",
      "Test #0: \n",
      "response\n",
      "  Here's my response:\n",
      "\n",
      "```json\n",
      "{\n",
      "    \"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "The complete canalization of the lacrimal duct occurs 6 weeks after birth. Therefore, option C is the correct answer.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Assinale a alternativa correta quanto ao sistema lacrimal. \n",
      "a) Aproximadamente 50% dos recém-nascidos mantém obstrução da valva de Hasner até o sexto mês de vida, sendo que 90% deles necessitam de sondagem. \n",
      "b) Na maioria dos recém-nascidos a secreção lacrimal é menor que a do adulto saudável. \n",
      "c) A canalização completa do ducto nasolacrimal geralmente ocorre por volta da sexta semana de vida extrauterina. \n",
      "d) O recém-nascido geralmente apresenta canalização completa do saco e ducto nasolacrimal; no entanto os canalículos abrem-se por volta da sexta semana de vida extrauterina.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c: A canalização completa do ducto nasolacrimal geralmente ocorre por volta da sexta semana de vida extrauterina.\n",
      "\n",
      "This answer is correct because the complete canalization of the nasolacrimal duct usually occurs around the sixth week of extrauterine life. This is a normal developmental milestone in infants, and it allows for the proper drainage of tears from the eye to the nasal cavity.\n",
      "\n",
      "Option a is incorrect because it refers to the obstruction of the Hasner valve, which is a different structure in the lacrimal system. Option b is also incorrect because it states that the secretion of lacrimal fluid is lower in newborns compared to healthy adults, but this is not necessarily true. Option d is incorrect because it states that the sac and duct are completely canalized at birth, but this is not accurate. The canalization of the nasolacrimal duct typically occurs around the sixth week of life, as stated in option c.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Mark the correct alternative regarding the lacrimal system. \n",
      "a) Approximately 50% of newborns maintain obstruction of the Hasner valve until the sixth month of life, and 90% of them require probing. \n",
      "b) In most newborns, tear secretion is less than in healthy adults. \n",
      "c) Complete canalization of the nasolacrimal duct usually occurs around the sixth week of extrauterine life. \n",
      "d) The newborn generally presents complete canalization of the nasolacrimal sac and duct; however, the canaliculi open around the sixth week of extrauterine life.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c: Complete canalization of the nasolacrimal duct usually occurs around the sixth week of extrauterine life.\n",
      "\n",
      "According to the query, the complete canalization of the nasolacrimal duct occurs around the sixth week of extrauterine life. This means that before this age, the nasolacrimal duct is not fully developed, and obstruction of the Hasner valve is common in newborns. Therefore, option c is the correct answer.\n",
      "\n",
      "Option a is incorrect because, although obstruction of the Hasner valve is common in newborns, it is not true that 50% of newborns maintain this obstruction until the sixth month of life.\n",
      "\n",
      "Option b is also incorrect because tear secretion in newborns is not necessarily less than in healthy adults.\n",
      "\n",
      "Option d is incorrect because, although the nasolacrimal sac and duct are present at birth, they are not fully developed and do not function properly until around the sixth week of extrauterine life.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 119: \n",
      "Language: spanish\n",
      "Question: \n",
      "Escoja la opción que mejor llene el vacío: En adultos, __________ sólo se realiza para el diagnóstico, mientras que para el tratamiento es potencialmente traumático y rara vez es eficaz para aliviar permanentemente la obstrucción lagrimal.\n",
      "a) Intubación con sonda de silicona.\n",
      "b) Irrigación con solución mucolítica.\n",
      "c) Sondeo con una varilla metálica.\n",
      "d) Uso de una sonda láser de argón.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "La opción correcta es b) Irrigación con solución mucolítica.\n",
      "\n",
      "En adultos, la irrigación con solución mucolítica es la opción más adecuada para el diagnóstico y el tratamiento de la obstrucción lagrimal. La intubación con sonda de silicona (opción a) puede ser utilizada para el diagnóstico, pero no es tan efectiva para el tratamiento. El sondeo con una varilla metálica (opción c) puede ser doloroso y no es comúnmente utilizado. El uso de una sonda láser de argón (opción d) es una opción más invasiva y no es necesaria para el tratamiento de la obstrucción lagrimal.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Punan ang patlang: Sa mga matatanda, ginagawa lamang ang ___________ upang mabuo ang dayagnosis. Hindi ito ginagawa bilang panlunas sapagkat ito ay traumatic at bihirang mainam upang permanenteng paginhawain ang lacrimal obstruction.\n",
      "a) Intubation gamit ang isang silicone probe.\n",
      "b) Irigasyon na may mucolytic na solusyon.\n",
      "c) Pageeksamen gamit ang metal na baras.\n",
      "d) Paggamit ng argon laser probe.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Irigasyon na may mucolytic na solusyon.\n",
      "\n",
      "In the given scenario, the patient is an elderly person with a diagnosis of chronic rhinosinusitis. The best approach for treating this condition is through irrigation with a mucolytic solution, which helps to break down and clear out the thick mucus in the nasal passages. This method is preferred over intubation with a silicone probe (a), as it is less invasive and reduces the risk of complications. Additionally, using a metal bar (c) or argon laser probe (d) may not be necessary or appropriate for this condition.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Escolha a alternativa que melhor preencha a lacuna: Em adultos, a __________ é apenas realizada para diagnóstico, pois para tratamento é potencialmente traumática e raramente efetiva para aliviar permanentemente a obstrução lacrimal. \n",
      "a) Intubação com sonda de silicone. \n",
      "b) Irrigação com solução mucolítica. \n",
      "c) Sondagem com haste metálica. \n",
      "d) Utilização de sonda de laser de argônio.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is b) Irrigação com solução mucolítica.\n",
      "\n",
      "In adults, the preferred method for diagnosing nasolacrimal duct obstruction is irrigation with a mucolytic solution, as it is less invasive and potentially less traumatic than other methods. This method can help to loosen and clear out mucus and debris that may be causing the obstruction, and can be performed in a doctor's office or clinic setting.\n",
      "\n",
      "Intubation with a silicone probe (a) may be necessary in some cases, but is typically reserved for more severe or persistent cases of nasolacrimal duct obstruction, as it is a more invasive procedure. Sondage with a metal probe (c) is not typically used for diagnosing nasolacrimal duct obstruction, and the use of a laser argon sonda (d) is also not typically used for this purpose.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Choose the best choice that best fills the gap: In adults, __________ is only performed for diagnosis, as for treatment it is potentially traumatic and rarely effective in permanently relieving lacrimal obstruction. \n",
      "a) Intubation with a silicone probe. \n",
      "b) Irrigation with mucolytic solution. \n",
      "c) Probing with metallic rod. \n",
      "d) Use of argon laser probe.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "La opción correcta es c) Probing with metallic rod. En adultos, la probing con barra metálica es la técnica de elección para el diagnóstico de obstrucción lacrimal, ya que la intubación con probeta de silicona (opción a) puede ser traumática y rara vez efectiva en aliviar la obstrucción lacrimal de forma permanente. La irrigación con solución mucolítica (opción b) puede ser útil en algunos casos, pero no es la técnica más adecuada para el diagnóstico. El uso de proba de argón (opción d) no es recomendado en la práctica clínica debido a su potencial riesgo de lesión ocular.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 120: \n",
      "Language: spanish\n",
      "Question: \n",
      "En la semiótica de las obstrucciones del tracto de drenaje lagrimal, la prueba que utiliza la instilación de tecnecio-99m en el fondo de saco lagrimal es:\n",
      "a) Zapata-Milder.\n",
      "b) Jones II modificado.\n",
      "c) Dacriocistografía.\n",
      "d) Dacrioscintigrafía.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c) Dacriocistografía.\"\n",
      "}\n",
      "```\n",
      "\n",
      "La prueba que utiliza la instilación de tecnecio-99m en el fondo de saco lagrimal para evaluar las obstrucciones del tracto de drenaje lagrimal es la dacriocistografía. Esta prueba permite visualizar la anatomía del tracto lagrimal y detectar posibles obstrucciones o anomalías en la drenaje de las lágrimas.\n",
      "\n",
      "La opción a) Zapata-Milder es una prueba de función lacrimal que evalúa la función de las glándulas lacrimales y el drenaje nasal. La opción b) Jones II modificado es una técnica de cirugía reconstructiva para el tratamiento de la obstrucción nasal. La opción d) Dacrioscintigrafía es una prueba que utiliza la scintigrafía para evaluar la función del drenaje lagrimal, pero no es la prueba más comúnmente utilizada para evaluar las obstrucciones del tracto de drenaje lagrimal.\n",
      "{'response': 'c) Dacriocistografía.'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Sa semyotiko ng mga obstruksyon sa lacrimal drainage pathways, aling panuri ang gumagamit ng technetium 99-m na inilalagay sa lacrimal cul-de-sac?\n",
      "a) Zapata-milder.\n",
      "b) Binago ni Jones II.\n",
      "c) Dacryocystography.\n",
      "d) Dacryocintigraphy.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the diagnostic test that uses technetium 99-m and is placed in the lacrimal cul-de-sac to visualize the lacrimal drainage pathways. The correct answer is c) Dacryocystography.\n",
      "\n",
      "Dacryocystography is a diagnostic test that uses a small amount of a radioactive substance, technetium 99-m, to visualize the lacrimal drainage pathways. It is used to diagnose and evaluate lacrimal drainage disorders, such as nasolacrimal duct obstruction. The test involves placing a small amount of the radioactive substance into the lacrimal cul-de-sac, which is located at the inner corner of the eye. The substance then flows through the lacrimal drainage pathways and is visualized using a special camera that detects the radioactive substance. This test can help identify any blockages or obstructions in the lacrimal drainage pathways.\n",
      "\n",
      "The other options are not correct because they are not diagnostic tests that use technetium 99-m and are not used to visualize the lacrimal drainage pathways. Zapata-milder is a surgical procedure that is used to treat nasolacrimal duct obstruction. Binago ni Jones II is a surgical procedure that is used to treat lacrimal drainage disorders. Dacryocintigraphy is a diagnostic test that uses a special camera to visualize the lacrimal drainage pathways, but it does not use technetium 99-m.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Na semiótica das obstruções das vias lacrimais de drenagem, o teste que usa a instilação de tecnécio-99m no fundo de saco lacrimal é de: \n",
      "a) Zapata-Milder. \n",
      "b) Jones II modificado. \n",
      "c) Dacriocistografia. \n",
      "d) Dacriocintilografia.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) Dacriocistografia.\n",
      "\n",
      "Dacriocistografia is a diagnostic test used to evaluate the patency of the lacrimal drainage system. It involves instilling a radioactive tracer, such as technetium-99m, into the lacrimal sac and observing its flow through the nasolacrimal ducts using a gamma camera. This test can help identify obstructions or abnormalities in the lacrimal drainage system, which can cause symptoms such as excessive tearing, redness, and discharge.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "* a) Zapata-Milder is a surgical procedure used to treat nasolacrimal duct obstruction, but it is not a diagnostic test.\n",
      "* b) Jones II modified is a surgical procedure used to treat nasolacrimal duct obstruction, but it is not a diagnostic test.\n",
      "* d) Dacriocintilografia is not a recognized medical term. It appears to be a misspelling or variation of the term \"dacriocistografia.\"\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "In the semiotics of obstructions of the lacrimal drainage pathways, the test that uses technetium-99m instillation in the lacrimal cul-de-sac is: \n",
      "a) Zapata-Milder. \n",
      "b) Jones II modified. \n",
      "c) Dacryocystography. \n",
      "d) Dacryocintigraphy.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) Dacryocystography.\n",
      "\n",
      "Dacryocystography is a diagnostic test used to evaluate the patency of the lacrimal drainage pathways. It involves instilling a radioactive tracer, such as technetium-99m, into the lacrimal cul-de-sac, which allows visualization of the lacrimal drainage system using imaging techniques. This test can help identify obstructions or other abnormalities in the lacrimal drainage pathways.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "* a) Zapata-Milder is a surgical procedure used to treat nasolacrimal duct obstruction, but it does not involve technetium-99m instillation.\n",
      "* b) Jones II modified is a surgical procedure used to treat nasolacrimal duct obstruction, but it does not involve technetium-99m instillation.\n",
      "* d) Dacryocintigraphy is a diagnostic test used to evaluate the function of the lacrimal drainage system, but it does not involve technetium-99m instillation.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 121: \n",
      "Language: spanish\n",
      "Question: \n",
      "Seleccionar la alternativa que contenga un tratamiento para la obstrucción adquirida de la vía nasal lagrimal.\n",
      "a) Dacriorrinostomía transnasal.\n",
      "b) Implantación de tubo Pyrex.\n",
      "c) Ampliación del punto de desgarro.\n",
      "d) Masaje hidrostático Crigler.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "La opción correcta es a) Dacriorrinostomía transnasal.\n",
      "\n",
      "Esta es una técnica quirúrgica que se utiliza para tratar la obstrucción adquirida de la vía nasal lagrimal, que es cuando la vía nasal lagrimal se obstruye debido a una enfermedad, lesión o another cause. La dacriorrinostomía transnasal implica la creación de una nueva conexión entre la vía nasal lagrimal y el conducto nasal para permitir el flujo de lágrimas hacia el exterior.\n",
      "\n",
      "Las otras opciones no son correctas:\n",
      "\n",
      "* b) Implantación de tubo Pyrex: Esta opción se refiere a la implantación de un tubo de Pyrex en la vía nasal lagrimal para permitir el flujo de lágrimas. Esta técnica no es adecuada para tratar la obstrucción adquirida de la vía nasal lagrimal.\n",
      "* c) Ampliación del punto de desgarro: Esta opción se refiere a la ampliación del punto de desgarro en la vía nasal lagrimal para permitir el flujo de lágrimas. Esta técnica no es adecuada para tratar la obstrucción adquirida de la vía nasal lagrimal.\n",
      "* d) Masaje hidrostático Crigler: Esta opción se refiere a un tipo de masaje que se utiliza para tratar la obstrucción adquirida de la vía nasal lagrimal. Sin embargo, no es la opción más adecuada para tratar esta condición.\n",
      "{'response': 'a'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Piliin ang angkop na panlunas sa acquired obstruction ng nasolacrimal duct.\n",
      "a) Transnasal dacrhinostomy.\n",
      "b) Pyrex tube implant.\n",
      "c) Pagpapalaki ng lacrimal point.\n",
      "d) Crigler hydrostatic massage.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is a) Transnasal dacrhinostomy.\n",
      "\n",
      "Transnasal dacrhinostomy is a surgical procedure that involves creating a new opening in the nasal cavity to allow the flow of tears from the lacrimal sac into the nasal cavity, bypassing the blocked nasolacrimal duct. This procedure is typically recommended for cases of acquired obstruction of the nasolacrimal duct, such as those caused by trauma, infection, or tumors.\n",
      "\n",
      "The other options are not appropriate for treating acquired obstruction of the nasolacrimal duct:\n",
      "\n",
      "* Pyrex tube implant is not a recognized treatment for nasolacrimal duct obstruction.\n",
      "* Pagpapalaki ng lacrimal point (enlargement of the lacrimal point) is not a valid medical term or procedure.\n",
      "* Crigler hydrostatic massage is a technique used to clear nasal congestion, but it is not effective for treating nasolacrimal duct obstruction.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Assinale a alternativa que contenha um tratamento para obstrução adquirida do ducto lacrimonasal. \n",
      "a) Dacriorrinostomia transnasal. \n",
      "b) Implante de tubo de pirex. \n",
      "c) Ampliação do ponto lacrimal. \n",
      "d) Massagem hidrostática de Crigler.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"  // Dacriorrinostomia transnasal\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Dacriorrinostomia transnasal is a surgical procedure that involves creating a new opening in the nasal cavity to drain the tears from the lacrimal sac. This procedure is used to treat obstructions in the nasolacrimal duct, which can cause excessive tearing, redness, and discharge.\n",
      "\n",
      "The other options are not correct treatments for obstructions in the nasolacrimal duct:\n",
      "\n",
      "* Implante de tubo de pirex (b) is a procedure that involves inserting a small tube made of pyrex glass into the nasal cavity to help drain the tears. This procedure is not commonly used to treat obstructions in the nasolacrimal duct.\n",
      "* Ampliação do ponto lacrimal (c) means enlarging the lacrimal point, which is the opening that drains tears from the eye into the nasal cavity. This procedure may be used to treat nasolacrimal duct obstruction, but it is not the most appropriate option in this case.\n",
      "* Massagem hidrostática de Crigler (d) is a technique that involves using a special device to massage the nasal cavity and help drain the tears. This procedure may be used to treat nasolacrimal duct obstruction, but it is not as effective as dacriorrinostomia transnasal.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "Which choice contains a treatment for acquired obstruction of the nasolacrimal duct?\n",
      "a) Transnasal dacrhinostomy. \n",
      "b) Pyrex tube implant. \n",
      "c) Enlargement of the lacrimal point. \n",
      "d) Crigler hydrostatic massage.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is a) Transnasal dacrhinostomy. This is a surgical procedure that involves creating a new opening in the nasal cavity to allow the tears to drain properly, and is used to treat acquired obstruction of the nasolacrimal duct.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 122: \n",
      "Language: spanish\n",
      "Question: \n",
      "La celulitis orbitaria preseptal en adultos en general:\n",
      "a) Se produce por la extensión continua de la sinusitis etmoidal.\n",
      "b) No provoca estrabismo ni edema del disco óptico.\n",
      "c) Debe tratarse con antibioterapia intravenosa durante la estancia hospitalaria.\n",
      "d) Su etiología son gérmenes Gram negativos y anaerobios.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La celulitis orbitaria preseptal en adultos en general se debe tratar con antibioterapia intravenosa durante la estancia hospitalaria, por lo que la opción correcta es la opción c.\n",
      "\n",
      "La celulitis orbitaria preseptal es una inflamación de las células de la órbita que puede ser causada por una infección bacteriana, generalmente de gérmenes Gram positivos. La enfermedad puede comenzar como una sinusitis etmoidal, pero finalmente se extiende a la órbita y puede causar estrabismo y edema del disco óptico, por lo que la opción a no es correcta. La opción b es incorrecta ya que la celulitis orbitaria preseptal puede causar estrabismo y edema del disco óptico. La opción d es incorrecta ya que los gérmenes Gram negativos y anaerobios no son los principales causantes de la celulitis orbitaria preseptal.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang preseptal orbital cellulitis sa mga matatanda ay karaniwang:\n",
      "a) Sanhi ng pagpapakalat sa pamamagitan ng continuity ng etmoidal sinusitis.\n",
      "b) Hindi nagsasanhi ng strabismus o optic disc edema.\n",
      "c) Dapat gamitan ng intravenous antibiotic therapy habang nasa ospital\n",
      "d) Nagmula ito sa mga gramo-negatibo at anaerobikong mikrobyo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The statement \"Ang preseptal orbital cellulitis sa mga matatanda ay karaniwang\" is in Tagalog, and it means \"Preseptal orbital cellulitis is commonly caused by\" in English.\n",
      "\n",
      "The correct answer is option A, \"Sanhi ng pagpapakalat sa pamamagitan ng continuity ng etmoidal sinusitis.\" This means that preseptal orbital cellulitis is often caused by the spread of infection from the etmoidal sinusitis.\n",
      "\n",
      "The other options are not correct:\n",
      "\n",
      "* Option B, \"Hindi nagsasanhi ng strabismus o optic disc edema,\" means \"Does not cause strabismus or optic disc edema,\" which is not a characteristic of preseptal orbital cellulitis.\n",
      "* Option C, \"Dapat gamitan ng intravenous antibiotic therapy habang nasa ospital,\" means \"Should be treated with intravenous antibiotic therapy while in the hospital,\" which is a treatment option for preseptal orbital cellulitis, but not a cause.\n",
      "* Option D, \"Nagmula ito sa mga gramo-negatibo at anaerobikong mikrobyo,\" means \"It is caused by gram-negative and anaerobic microorganisms,\" which is not a correct statement about preseptal orbital cellulitis.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "A celulite orbitaria pré-septal no adulto geralmente: \n",
      "a) É causada por disseminação por continuidade de sinusite etmoidal. \n",
      "b) Não causa estrabismo ou edema de disco óptico. \n",
      "c) Deve ser tratada com antibioticoterapia endovenosa durante internação hospitalar. \n",
      "d) Tem como etiologia germes Gram-negativos e anaeróbios.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "A celulite orbitaria pré-septal no adulto geralmente é causada por disseminação por continuidade de sinusite etmoidal. Therefore, option A is the correct answer.\n",
      "\n",
      "Note:\n",
      "\n",
      "* Option B is incorrect because celulite orbitaria can cause strabismus or edema of the optic disc.\n",
      "* Option C is incorrect because antibiotic therapy is not always necessary for celulite orbitaria and may not require hospitalization.\n",
      "* Option D is incorrect because the etiology of celulite orbitaria is not limited to Gram-negative and anaerobic bacteria.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "Preseptal orbital cellulitis in adults is usually: \n",
      "a) Caused by dissemination by continuity of ethmoidal sinusitis. \n",
      "b) Does not cause strabismus or optic disc edema. \n",
      "c) Should be treated with intravenous antibiotic therapy during hospitalization. \n",
      "d) Its etiology is Gram-negative and anaerobic germs.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "La celulitis orbitaria presbíblica en adultos suele ser:\n",
      "c) Debida a la diseminación por continuidad de la sinusitis etmoidal.\n",
      "\n",
      "Here's the answer in Tagalog:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "Ang presbial na orbital na cellulitis sa mga adulto ay karaniwan na:\n",
      "c) Dahil sa pagdisseminasyon ng continuity ng sinusitis na etmoidal.\n",
      "\n",
      "Here's the answer in Portuguese:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "A celulite orbitária presbiral em adultos é geralmente:\n",
      "c) Causada pela disseminação por continuidade da sinusite etmoidal.\n",
      "\n",
      "Here's the answer in English:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "Preseptal orbital cellulitis in adults is usually:\n",
      "c) Caused by dissemination by continuity of ethmoidal sinusitis.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 123: \n",
      "Language: spanish\n",
      "Question: \n",
      "La aplicación tópica o sistémica de betabloqueantes presenta resultados terapéuticos positivos en las enfermedades orbitarias, entre las siguientes:\n",
      "a) Fístula carotídeo-cavernosa de bajo gasto.\n",
      "b) Linfoma asociado al tejido de las mucosas (MALT).\n",
      "c) Hemangioma capilar infantil.\n",
      "d) Orbitopatía de Graves en fase aguda.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "La aplicación tópica o sistémica de betabloqueantes presenta resultados terapéuticos positivos en las enfermedades orbitarias, entre las siguientes:\n",
      "a) Fístula carotídeo-cavernosa de bajo gasto.\n",
      "\n",
      "La fístula carotídeo-cavernosa de bajo gasto es una enfermedad orbitaria que se caracteriza por una comunicación anormal entre la arteria carótida interna y la vena cavernosa. Los betabloqueantes son medicamentos que se utilizan comúnmente para tratar esta condición, ya que pueden reducir la frecuencia cardíaca y la presión arterial, lo que puede aliviar los síntomas como la dolor de cabeza, la visión doble y la debilidad facial. Por lo tanto, la opción a) Fístula carotídeo-cavernosa de bajo gasto es la respuesta correcta.\n",
      "{'response': 'a'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang paggamit ng mga beta blockers ay mainam para sa anong karamdaman sa mata:\n",
      "a) Mababang output ng carotid-cavernous fistula.\n",
      "b) Lymphoma na nauugnay sa mucosal tissue (MALT).\n",
      "c) Capillary hemangioma sa pagkabata.\n",
      "d) Graves orbitopathy in the acute phase\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Beta blockers are commonly used to treat hypertension, angina, and certain heart rhythm disorders. However, they are not typically used to treat the conditions mentioned in options b, c, and d.\n",
      "\n",
      "Option a, \"Mababang output ng carotid-cavernous fistula,\" is incorrect because beta blockers do not have a direct effect on the output of a carotid-cavernous fistula.\n",
      "\n",
      "Option b, \"Lymphoma na nauugnay sa mucosal tissue (MALT),\" is incorrect because beta blockers are not used to treat lymphoma.\n",
      "\n",
      "Option c, \"Capillary hemangioma sa pagkabata,\" is incorrect because beta blockers are not used to treat capillary hemangioma.\n",
      "\n",
      "Option d, \"Graves orbitopathy in the acute phase,\" is incorrect because beta blockers are not used to treat Graves orbitopathy.\n",
      "\n",
      "Therefore, the correct answer is option a, \"Mababang output ng carotid-cavernous fistula.\"\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Aplicação tópica ou sistêmica de betabloqueadores apresenta resultados terapêuticos positivos em qual doença orbitária, entre as abaixo: \n",
      "a) Fístula carótido-cavernosa de baixo débito. \n",
      "b) Linfoma associado a tecido mucoso (MALT). \n",
      "c) Hemangioma capilar da infância. \n",
      "d) Orbitopatia de Graves na fase aguda.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the effectiveness of topical or systemic beta-blockers in treating certain orbital diseases. The correct answer is c) Hemangioma capilar da infância.\n",
      "\n",
      "Hemangioma capilar da infância is a benign vascular tumor that affects children, and it can cause proptosis (bulging eye) and other orbital symptoms. Topical or systemic beta-blockers can be used to treat this condition, as they can help reduce the size of the tumor and alleviate symptoms.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "a) Fístula carótido-cavernosa de baixo débito is a type of vascular malformation that can cause orbital symptoms, but it is not treated with beta-blockers.\n",
      "\n",
      "b) Linfoma associado a tecido mucoso (MALT) is a type of lymphoma that can affect the orbit, but it is not treated with beta-blockers.\n",
      "\n",
      "d) Orbitopatia de Graves na fase aguda is a type of thyroid eye disease that can cause orbital symptoms, but it is not treated with beta-blockers.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Topical or systemic application of beta-blockers presents positive therapeutic results in which orbital disease, among the following: \n",
      "a) Low-output carotid-cavernous fistula. \n",
      "b) Lymphoma associated with mucosal tissue (MALT). \n",
      "c) Capillary hemangioma of childhood. \n",
      "d) Graves orbitopathy in the acute phase.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is d) Graves orbitopathy in the acute phase.\n",
      "\n",
      "Beta-blockers are commonly used to treat Graves orbitopathy, also known as thyroid eye disease, in its acute phase. The topical or systemic application of beta-blockers can help reduce inflammation and alleviate symptoms such as swelling, redness, and pain in the eyes.\n",
      "\n",
      "Low-output carotid-cavernous fistula (a) and lymphoma associated with mucosal tissue (MALT) (b) are not typically treated with beta-blockers. Capillary hemangioma of childhood (c) is a rare condition that may not require treatment, but beta-blockers would not be the first line of therapy.\n",
      "{'response': 'd'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 124: \n",
      "Language: spanish\n",
      "Question: \n",
      "En la enfermedad inflamatoria orbitaria asociada a alteraciones tiroideas existe un signo oftalmológico típico, conocido como brote temporal, que corresponde a:\n",
      "a) Exotropía por fibrosis del recto lateral.\n",
      "b) Quemosis y conjuntivocalasia en la región lateral de la conjuntiva bulbar inferior.\n",
      "c) Exoftalmos marcado que causa distopía lateral del ojo.\n",
      "d) Patrón de retracción del párpado con la región lateral del párpado más retraída que la región medial.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c) Exoftalmos marcado que causa distopía lateral del ojo.\n",
      "\n",
      "Exoftalmos is a bulging of the eye that can occur due to various causes, including inflammatory orbital diseases associated with thyroid alterations. This sign is characterized by a marked protrusion of the eye, which can cause lateral displacement of the eyeball, resulting in a visible deviation of the eye.\n",
      "\n",
      "Therefore, option c is the correct answer.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Sa inflammatory orbital disease na may kinalaman sa sakit sa teroydeo, isa sa mga ginagamit na tanda ay ang temporal flare. Alin sa mga sumusunod na pahayag ang tugma sa nasabing tanda?\n",
      "a) Exotropia dala ng lateral rectus fibrosis.\n",
      "b) Chemosis at conjunctivochalasis sa lateral ng rehiyon ng ibabang bahagi ng bulbar conjunctiva.\n",
      "c) Marked exophthalmos na nagdudulot ng lateral na dystopia ng mata.\n",
      "d) Pattern ng eyelid retraction kung saan mas umuurong ang lateral na bahagi kaysa sa medial na bahagi ng talukap ng mata\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the symptoms of inflammatory orbital disease, specifically regarding the temporal flare. The correct answer is b) Chemosis at conjunctivochalasis sa lateral ng rehiyon ng ibabang bahagi ng bulbar conjunctiva.\n",
      "\n",
      "Chemosis is a symptom of inflammatory orbital disease, which is characterized by swelling of the conjunctiva, and conjunctivochalasis is a condition where the conjunctiva becomes thin and fragile. The lateral region of the bulbar conjunctiva is the area that is most commonly affected. This symptom is often seen in patients with thyroid-associated orbitopathy, which is a common form of inflammatory orbital disease.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "a) Exotropia dala ng lateral rectus fibrosis is a symptom of a different condition called thyroid-related orbitopathy, which is not related to inflammatory orbital disease.\n",
      "\n",
      "c) Marked exophthalmos na nagdudulot ng lateral na dystopia ng mata is a symptom of a more severe form of inflammatory orbital disease, but it is not specifically related to the temporal flare.\n",
      "\n",
      "d) Pattern ng eyelid retraction kung saan mas umuurong ang lateral na bahagi kaysa sa medial na bahagi ng talukap ng mata is not a symptom of inflammatory orbital disease.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Na doença orbitária inflamatória associada a distúrbios da tireoide existe um sinal oftalmológico típico, conhecido como flare temporal, que corresponde a: \n",
      "a) Exotropia por fibrose do reto lateral. \n",
      "b) Quemose e conjuntivocalase na região lateral da conjuntiva bulbar inferior. \n",
      "c) Exoftalmia acentuada causando distopia lateral do olho. \n",
      "d) Padrão de retração palpebral com a região lateral da pálpebra mais retraída que a medial.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the typical ocular sign of orbital inflammatory disease associated with thyroid disorders, specifically Graves' disease. The correct answer is option b, \"Quemose and conjunctivocalase in the lateral region of the conjunctiva bulbar inferior.\" This is a characteristic sign of Graves' ophthalmopathy, also known as thyroid eye disease, which is an autoimmune condition that affects the tissues surrounding the eyes. The other options are not accurate descriptions of this condition.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "In inflammatory orbital disease associated with thyroid disorders, there is a typical ophthalmological sign, known as temporal flare, which corresponds to: \n",
      "a) Exotropia due to lateral rectus fibrosis. \n",
      "b) Chemosis and conjunctivochalasis in the lateral region of the inferior bulbar conjunctiva. \n",
      "c) Marked exophthalmos causing lateral dystopia of the eye. \n",
      "d) Pattern of eyelid retraction with the lateral region of the eyelid more retracted than the medial.\n",
      "Test #0: \n",
      "response\n",
      "  Here's my answer:\n",
      "```json\n",
      "{\n",
      "\t\"response\": b // b) Chemosis and conjunctivochalasis in the lateral region of the inferior bulbar conjunctiva.\n",
      "}\n",
      "```\n",
      "\n",
      "In inflammatory orbital disease associated with thyroid disorders, there is a typical ophthalmological sign, known as temporal flare, which corresponds to option b) Chemosis and conjunctivochalasis in the lateral region of the inferior bulbar conjunctiva.\n",
      "\n",
      "Chemosis is the swelling of the conjunctiva, and conjunctivochalasis is the relaxation of the conjunctiva, which can cause it to become redundant and fold inward, especially in the lateral region. This sign is often seen in Graves' ophthalmopathy, an autoimmune condition that affects the tissues surrounding the eyes in people with hyperthyroidism.\n",
      "\n",
      "The other options do not accurately describe the temporal flare sign:\n",
      "\n",
      "a) Exotropia is a condition where the eye turns outward, which is not related to the temporal flare sign.\n",
      "\n",
      "c) Marked exophthalmos, or protrusion of the eyeball, can be a feature of Graves' ophthalmopathy, but it is not the same as the temporal flare sign.\n",
      "\n",
      "d) Pattern of eyelid retraction, with the lateral region of the eyelid more retracted than the medial, is not a typical feature of the temporal flare sign.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 125: \n",
      "Language: spanish\n",
      "Question: \n",
      "Escoja la opción que mejor llene el vacío: En __________, la sinusitis maxilar crónica causa enoftalmos debido al colapso del piso orbitario.\n",
      "a) Síndrome del seno silencioso.\n",
      "b) Síndrome de Tolosa-Hunt.\n",
      "c) Mucocele.\n",
      "d) Displasia fibrosa.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Síndrome de Tolosa-Hunt\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Síndrome de Tolosa-Hunt is a condition characterized by painless vision loss or blindness in one eye due to compression of the optic nerve by an enlarged superior ophthalmic vein. This condition is associated with chronic maxillary sinusitis and is caused by the collapse of the orbital floor. Therefore, option b is the correct answer.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Punan ang patlang. Sa __________, ang chronic na maxillary sinusitis ay nagdudulot ng enophthalmos dala ng pagbagsak ng orbital floor.\n",
      "a) Silent sinus syndrome\n",
      "b) Tolosa-hunt syndrome\n",
      "c) Mucocele\n",
      "d) Fibrous dysplasia\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Tolosa-Hunt syndrome\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Tolosa-Hunt syndrome is a condition characterized by the expansion of the maxillary sinus into the orbit, leading to enophthalmos (protrusion of the eyeball) and other ocular symptoms. This condition can cause chronic maxillary sinusitis, which can lead to the destruction of the orbital floor and result in enophthalmos.\n",
      "\n",
      "Therefore, option b (Tolosa-Hunt syndrome) is the correct response.\n",
      "\n",
      "Silent sinus syndrome (option a) refers to a condition where the maxillary sinus becomes obstructed, leading to a buildup of mucus and pressure within the sinus. This can cause symptoms such as headaches, facial pain, and nasal congestion, but it does not typically cause enophthalmos.\n",
      "\n",
      "Mucocele (option c) is a benign tumor that arises from the nasal cavity or paranasal sinuses. It can cause nasal obstruction, headaches, and facial pain, but it does not typically cause enophthalmos.\n",
      "\n",
      "Fibrous dysplasia (option d) is a condition where abnormal growth of fibrous tissue in the bones can cause deformities and other symptoms. It can affect various bones, including the skull, but it does not typically cause enophthalmos.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Escolha a alternativa que melhor preencha a lacuna: Na __________ , uma sinusite maxilar crônica causa enoftalmo pelo colapso do assoalho da órbita. \n",
      "a) Síndrome do seio silencioso. \n",
      "b) Síndrome de Tolosa-Hunt. \n",
      "c) Mucocele. \n",
      "d) Displasia fibrosa.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // b) Síndrome de Tolosa-Hunt.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the cause of enophthalmos (a condition where the eyeball is sunken into the socket) due to a chronic maxillary sinusitis. The correct answer is b) Síndrome de Tolosa-Hunt, which is a condition characterized by inflammation of the cavernous sinus, which can cause enophthalmos.\n",
      "\n",
      "Option a) Síndrome do seio silencioso is not related to enophthalmos or sinusitis.\n",
      "\n",
      "Option c) Mucocele is a benign tumor that arises from the nasal mucosa, but it does not cause enophthalmos.\n",
      "\n",
      "Option d) Displasia fibrosa is a condition where there is abnormal growth of fibrous tissue in the orbit, but it does not cause enophthalmos.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Choose the alternative that best fills in the blank: In __________ , chronic maxillary sinusitis causes enophthalmos by collapsing the orbital floor. \n",
      "a) Silent sinus syndrome. \n",
      "b) Tolosa-Hunt syndrome. \n",
      "c) Mucocele. \n",
      "d) Fibrous dysplasia.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // b) Tolosa-Hunt syndrome.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Tolosa-Hunt syndrome is a rare condition characterized by the inflammation of the dura mater and its extension into the orbit, causing enophthalmos (a condition where the eyeball is pushed back into the orbit). One of the causes of Tolosa-Hunt syndrome is chronic maxillary sinusitis, which can lead to the collapse of the orbital floor.\n",
      "\n",
      "The other options do not accurately fill in the blank:\n",
      "\n",
      "* Silent sinus syndrome is a condition where the sinuses become inflamed without any obvious symptoms. It is not associated with enophthalmos.\n",
      "* Mucocele is a benign tumor that arises from the nasal cavity or paranasal sinuses. It can cause enophthalmos, but it is not related to chronic maxillary sinusitis.\n",
      "* Fibrous dysplasia is a condition where abnormal growth of fibrous tissue in the bones can cause deformities. It is not related to enophthalmos or chronic maxillary sinusitis.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 126: \n",
      "Language: spanish\n",
      "Question: \n",
      "Durante la refracción subjetiva del paciente con baja visión, la mejor agudeza visual se obtuvo utilizando lentes -5,00 dioptrías esféricas -2,00 dioptrías cilíndricas x 180° en el marco de prueba con la mesa de agudeza visual colocada a 1 m del paciente. ¿Cuál de las siguientes alternativas representa la prescripción más adecuada para la corrección de distancia?\n",
      "a) -3,00 dioptrías esféricas -2,00 dioptrías cilíndricas x 180°.\n",
      "b) -4,00 dioptrías esféricas -2,00 dioptrías cilíndricas x 180°.\n",
      "c) -2,00 dioptrías cilíndricas x 180°.\n",
      "d) -6,00 dioptrías esféricas -2,00 dioptrías cilíndricas x 180°.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option b: -4,00 dioptrías esféricas -2,00 dioptrías cilíndricas x 180°.\n",
      "\n",
      "This is because the patient's best visual acuity was achieved using a -5,00 dioptric spherical lens and a -2,00 dioptric cylindrical lens with a 180° axis in the trial frame. To correct for distance vision, a more negative spherical power and a similar cylindrical power would be needed. Option b has a more negative spherical power (-4,00 vs -3,00) and a similar cylindrical power (-2,00) compared to option a, making it the best choice for correcting distance vision.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Sa subjective refraction ng pasyenteng may malabong paningin, ang pinakamainam na visual acuity ay nakuha gamit ang isang -5.00 spherical diopter -2.00 cylindrical diopter x 180 ° lens sa trial frame gamit ang visual acuity table na isang metro ang layo sa pasyente. Alin sa mga sumusunod ang pinakamainam na preskripsyon para sa pagwawasto ng distansya?\n",
      "a) -3.00 spherical diopter -2.00 cylindrical diopter x 180 °.\n",
      "b) -4.00 spherical diopter -2.00 cylindrical diopter x 180 °.\n",
      "c) -2.00 cylindrical diopter x 180 °.\n",
      "d) -6.00 spherical diopter -2.00 cylindrical diopter x 180 °.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's subjective refraction result showed a best-corrected visual acuity of 20/200 with a -5.00 spherical diopter -2.00 cylindrical diopter x 180° lens using a trial frame. To correct the patient's distance vision, the best prescription would be:\n",
      "\n",
      "b) -4.00 spherical diopter -2.00 cylindrical diopter x 180°.\n",
      "\n",
      "This prescription is 1 diopter more myopic than the lens used during the subjective refraction, which should adequately correct the patient's distance vision.\n",
      "\n",
      "Option a) -3.00 spherical diopter -2.00 cylindrical diopter x 180° is not strong enough to correct the patient's distance vision.\n",
      "\n",
      "Option c) -2.00 cylindrical diopter x 180° is a cylindrical correction only and does not take into account the patient's spherical error.\n",
      "\n",
      "Option d) -6.00 spherical diopter -2.00 cylindrical diopter x 180° is too strong and would likely result in over-correction.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Durante a refração subjetiva do paciente com baixa visão, obteve-se a melhor acuidade visual utilizando-se lentes -5,00 dioptria esferica -2,00 dioptria cilindrica x 180° na armação de prova com a tabela de acuidade visual posicionada a 1 m do paciente. Qual dentre as alternativas abaixo representa a prescrição mais adequada da correção para longe? \n",
      "a) -3,00 dioptria esferica -2,00 dioptria cilindrica x 180°. \n",
      "b) -4,00 dioptria esferica -2,00 dioptria cilindrica x 180°. \n",
      "c) -2,00 dioptria cilindrica x 180°. \n",
      "d) -6,00 dioptria esferica -2,00 dioptria cilindrica x 180°.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking for the most appropriate prescription for a patient with low vision, based on the results of a subjective refraction test. The patient's best visual acuity was achieved using a -5.00 dioptria spherical lens and a -2.00 dioptria cylindrical lens with a 180° axis in the trial frame, placed 1 meter away from the patient.\n",
      "\n",
      "The correct answer is option b, -4.00 dioptria spherical -2.00 dioptria cylindrical x 180°. This prescription takes into account the patient's existing visual acuity and provides a more appropriate correction for distance vision.\n",
      "\n",
      "Option a, -3.00 dioptria spherical -2.00 dioptria cylindrical x 180°, is not the best option as it undercorrects the patient's nearsightedness.\n",
      "\n",
      "Option c, -2.00 dioptria cylindrical x 180°, only corrects the patient's astigmatism but does not address their nearsightedness.\n",
      "\n",
      "Option d, -6.00 dioptria spherical -2.00 dioptria cylindrical x 180°, overcorrects the patient's nearsightedness and may cause discomfort or eye strain.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "During the subjective refraction of the patient with low vision, the best visual acuity was obtained using a -5.00 spherical diopter -2.00 cylindrical diopter x 180° lens in the trial frame with the visual acuity table positioned at 1 m of the patient. Which of the alternatives below represents the most appropriate prescription for correction for distance? \n",
      "a) -3.00 spherical diopter -2.00 cylindrical diopter x 180°. \n",
      "b) -4.00 spherical diopter -2.00 cylindrical diopter x 180°. \n",
      "c) -2.00 cylindrical diopter x 180°. \n",
      "d) -6.00 spherical diopter -2.00 cylindrical diopter x 180°.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question asks for the most appropriate prescription for correction for distance. The given options are:\n",
      "\n",
      "a) -3.00 spherical diopter -2.00 cylindrical diopter x 180°\n",
      "b) -4.00 spherical diopter -2.00 cylindrical diopter x 180°\n",
      "c) -2.00 cylindrical diopter x 180°\n",
      "d) -6.00 spherical diopter -2.00 cylindrical diopter x 180°\n",
      "\n",
      "The correct answer is b) -4.00 spherical diopter -2.00 cylindrical diopter x 180°.\n",
      "\n",
      "The patient's best visual acuity was obtained using a -5.00 spherical diopter -2.00 cylindrical diopter x 180° lens in the trial frame with the visual acuity table positioned at 1 m of the patient. This means that the patient's refractive error is -5.00 spherical diopter -2.00 cylindrical diopter.\n",
      "\n",
      "Therefore, the most appropriate prescription for correction for distance would be -4.00 spherical diopter -2.00 cylindrical diopter x 180°, which is option b.\n",
      "\n",
      "The other options are not correct because they do not match the patient's refractive error:\n",
      "\n",
      "a) -3.00 spherical diopter -2.00 cylindrical diopter x 180° is less than the patient's refractive error, and would not provide adequate correction.\n",
      "\n",
      "c) -2.00 cylindrical diopter x 180° only corrects for astigmatism, but does not address the patient's myopia.\n",
      "\n",
      "d) -6.00 spherical diopter -2.00 cylindrical diopter x 180° is more than the patient's refractive error, and would overcorrect the patient's vision, potentially causing discomfort or blurred vision.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 127: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto a las ayudas no ópticas, evalúe las siguientes afirmaciones como verdaderas (V) o falsas (F) y seleccione la alternativa correcta:\n",
      "I. También llamadas ayudas funcionales de adaptación, son aquellas que modifican materiales y condiciones ambientales.\n",
      "II. Ampliar letras es la ayuda más común y reduce la frecuencia espacial de la imagen.\n",
      "III. El tiposcopio es una guía de lectura cuya función es reducir la luz reflejada sobre el papel blanco y así reducir los reflejos y aumentar el contraste de la línea del texto con el fondo.\n",
      "IV. Un paciente de 65 años prefiere aproximadamente tres veces menos iluminación que una persona de 20 años para realizar las mismas tareas.\n",
      "\n",
      "a) I: Verdadero; II: Falso; III: Verdadero; IV: Falso. \n",
      "b) I: Verdadero; II: Verdadero; III: Falso; IV: Verdadero. \n",
      "c) I: Verdadero; II: Verdadero; III: Verdadero; IV: Falso. \n",
      "d) I: Falso; II: Falso; III: Falso; IV: Verdadero.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "I. Verdadero. Ayudas no ópticas también son conocidas como ayudas funcionales de adaptación y modifican materiales y condiciones ambientales.\n",
      "\n",
      "II. Falso. Ampliar letras no es la ayuda más común y no reduce la frecuencia espacial de la imagen.\n",
      "\n",
      "III. Verdadero. El tiposcopio es una guía de lectura que reduce la luz reflejada sobre el papel blanco y aumenta el contraste de la línea del texto con el fondo.\n",
      "\n",
      "IV. Falso. Un paciente de 65 años no necesariamente prefiere aproximadamente tres veces menos iluminación que una persona de 20 años para realizar las mismas tareas.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Patungkol sa mga non-optical na pantulong, suriin kung tama o mali ang mga sumusunod na pahayag:\n",
      "I. Tinatawag din bilang functional adaptation aids, ang mga ito ay nababago ayon sa materyal at kondisyon ng kapaligiran.\n",
      "II. Ang pagpapalaki ng mga letra ang pinakakaraniwang pantulong at binabawasan nito ang spatial frequency ng imahe.\n",
      "III. Ang typoscope ay isang gabay para sa pagbabasa na siyang nagbabawas ng liwanag na narereplekta sa puting papel kaya\n",
      "nababawasan nito ang glare at gumaganda ang contrast ng teksto sa background,\n",
      "IV. Ang isang 65 taong gulang na pasyente ay mas pinipili ang halos na tatlong beses na mas madilim na kapaligiran kaysa sa isang 20 taong gulang kapag magsasagawa ng parehong mga gawain.\n",
      "\n",
      "a) I: Tama; II: Mali; III: Tama; IV: Mali. \n",
      "b) I: Tama; II: Tama; III: Mali; IV: Tama. \n",
      "c) I: Tama; II: Tama; III: Tama; IV: Mali. \n",
      "d) I: Mali; II: Mali; III: Mali; IV: Tama.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "I. Tinatawag din bilang functional adaptation aids - Tama. Ang mga non-optical aids ay tinatawag din bilang functional adaptation aids dahil sila ay nababago ayon sa materyal at kondisyon ng kapaligiran.\n",
      "\n",
      "II. Ang pagpapalaki ng mga letra ang pinakakaraniwang pantulong - Mali. Ang pagpapalaki ng mga letra ay hindi ang pinakakaraniwang pantulong para sa mga taong may visual impairment. Ang pinakakaraniwang pantulong ay ang mga optical aids tulad ng eyeglasses o contact lenses.\n",
      "\n",
      "III. Ang typoscope ay isang gabay para sa pagbabasa - Tama. Ang typoscope ay isang gabay para sa pagbabasa na siyang nagbabawas ng liwanag na narereplekta sa puting papel kaya nababawasan nito ang glare at gumaganda ang contrast ng teksto sa background.\n",
      "\n",
      "IV. Ang isang 65 taong gulang na pasyente ay mas pinipili ang halos na tatlong beses na mas madilim na kapaligiran - Mali. Ang isang 65 taong gulang na pasyente ay mas pinipili ang halos na tatlong beses na mas madilim na kapaligiran kaysa sa isang 20 taong gulang kapag magsasagawa ng parehong mga gawain.\n",
      "\n",
      "Therefore, the correct answer is option c: I: Tama; II: Tama; III: Tama; IV: Mali.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Sobre os auxílios não-ópticos, avalie as assertivas a seguir como verdadeiras (V) ou falsas (F) e assinale a alternativa correta: \n",
      "I. Também denominados auxílios de adaptação funcional, são aqueles que modificam materiais e condições do ambiente. \n",
      "II. A ampliação de letras é o auxílio mais comum e reduz a frequência espacial da imagem. \n",
      "III. O tiposcópio é um guia para leitura cuja função é diminuir a luz refletida sobre o papel branco e assim diminuir o ofuscamento e aumentar o contraste da linha de texto com o fundo. \n",
      "IV. Um paciente com 65 anos prefere aproximadamente três vezes menos iluminação que uma pessoa com 20 anos para realizar as mesmas tarefas. \n",
      "\n",
      "a) I: Verdadeiro; II: Falso; III: Verdadeiro; IV: Falso. \n",
      "b) I: Verdadeiro; II: Verdadeiro; III: Falso; IV: Verdadeiro. \n",
      "c) I: Verdadeiro; II: Verdadeiro; III: Verdadeiro; IV: Falso. \n",
      "d) I: Falso; II: Falso; III: Falso; IV: Verdadeiro.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "I. Verdadeiro - Auxílios não-ópticos, also known as functional adaptation aids, modify materials and environmental conditions to assist individuals with visual impairments.\n",
      "\n",
      "II. Falso - The statement \"A ampliação de letras é o auxílio mais comum e reduz a frequência espacial da imagem\" is false. While letter amplification is a common auxiliary, it does not reduce the spatial frequency of the image.\n",
      "\n",
      "III. Verdadeiro - The statement \"O tiposcópio é um guia para leitura cuja função é diminuir a luz refletida sobre o papel branco e assim diminuir o ofuscamento e aumentar o contraste da linha de texto com o fundo\" is true. A tiposcópio is a reading guide that helps to reduce glare on a white background and increase the contrast between the text and the background.\n",
      "\n",
      "IV. Falso - The statement \"Um paciente com 65 anos prefere aproximadamente três vezes menos iluminação que uma pessoa com 20 anos para realizar as mesmas tarefas\" is false. While age can affect the amount of light needed for a task, the statement's claim that a 65-year-old person needs three times less light than a 20-year-old person is not accurate.\n",
      "\n",
      "Therefore, the correct answer is option c: I: Verdadeiro; II: Verdadeiro; III: Verdadeiro; IV: Falso.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "\n",
      "Regarding non-optical aids, evaluate the following statements as true (T) or false (F) and mark the correct alternative:\n",
      "I. Also called functional adaptation aids, they are those that modify materials and environmental conditions. \n",
      "II. Enlarging letters is the most common aid and reduces the spatial frequency of the image. \n",
      "III. The typoscope is a guide for reading whose function is to reduce the light reflected on the white paper and thus reduce glare and increase the contrast of the line of text with the background. \n",
      "IV. A 65-year-old patient prefers approximately three times less lighting than a 20-year-old person to perform the same tasks. \n",
      "\n",
      "a) I: True; II: False; III: True; IV: False. \n",
      "b) I: True; II: True; III: False; IV: True. \n",
      "c) I: True; II: True; III: True; IV: False. \n",
      "d) I: False; II: False; III: False; IV: True.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "  \"response\": \"c) I: Verdadero; II: Verdadero; III: Verdadero; IV: Falso.\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "I. Verdadero. Los auxiliares de adaptación funcional son aquellos que modifican materiales y condiciones ambientales para ayudar a las personas con discapacidad visual a realizar tareas cotidianas.\n",
      "\n",
      "II. Falso. Aunque es cierto que agrandar letras es una forma de ayuda, no es la más común. La afirmación es falsa.\n",
      "\n",
      "III. Verdadero. El typoscope es un dispositivo que ayuda a leer reduciendo la frecuencia spatial de la imagen y mejorando la contraste entre el texto y el fondo.\n",
      "\n",
      "IV. Falso. Aunque la percepción de la luz disminuye con la edad, no es cierto que una persona de 65 años necesite tres veces menos luz que una de 20 años para realizar las mismas tareas.\n",
      "{'response': 'c) I: Verdadero; II: Verdadero; III: Verdadero; IV: Falso.'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 128: \n",
      "Language: spanish\n",
      "Question: \n",
      "La refracción subjetiva de un paciente con baja visión consigue la mejor agudeza binocular a distancia sin la interposición de lentes correctoras. A corta distancia, el mejor resultado se logra con la adición de +8,00 dioptrías esféricas en ambos ojos. Para mejorar la comodidad durante la lectura, se decidió prescribir lentes esferoprismáticas. ¿Cuál es el valor más apropiado para los prismas en cada ojo?\n",
      "a) Base de tiempo de 4 dioptrías prismáticas.\n",
      "b) 4 dioptrías prismáticas en la base nasal.\n",
      "c) Base de tiempo de 10 dioptrías prismáticas.\n",
      "d) 10 dioptrías prismáticas en la base nasal.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // The correct answer is option B\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient has low vision and the best binocular visual acuity at distance without corrective lenses is achieved with a subjective refraction. At near distance, the best result is achieved with an addition of +8.00 diopters spherical lenses in both eyes. To improve comfort during reading, it was decided to prescribe spheroprismatic lenses. The appropriate value for the prisms in each eye would be 4 diopters prismatic in the nasal base, which is option B.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang subjective refraction ng isang pasyenteng may malabong paningin ay kayang magkamit ng pinakamainam na binocular acuity kahit na walang interposition ng corrective lenses. Sa malapitan, ang pinakamainam ay nakukuha sa pagdaragdag ng +8.00 spherical diopters sa parehong mga mata. Upang mas maginhawa ang pagbabasa, napagpasyahan na magbigay ng spheroprismatic lens. Ano ang pinaka-angkop na value ng prisms sa bawat mata?\n",
      "a) 4 prismatic diopters time base. \n",
      "b) 4 prismatic diopters sa nasal base. \n",
      "c) 10 prismatic diopters time base. \n",
      "d) 10 prismatic diopters sa nasal base.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking for the appropriate prismatic lens prescription for a patient with a subjective refraction result of +8.00 spherical diopters in both eyes, and a desire to improve the patient's binocular acuity.\n",
      "\n",
      "Option A, 4 prismatic diopters time base, is not the correct answer because it would not provide enough prism to align the images seen by each eye.\n",
      "\n",
      "Option C, 10 prismatic diopters time base, is also not the correct answer because it would provide too much prism and could cause discomfort or eye strain for the patient.\n",
      "\n",
      "Option D, 10 prismatic diopters nasal base, is not the correct answer because it would not provide the appropriate direction of prism to align the images seen by each eye.\n",
      "\n",
      "Therefore, the correct answer is Option B, 4 prismatic diopters nasal base. This would provide the appropriate amount of prism to align the images seen by each eye and improve the patient's binocular acuity.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "À refração subjetiva de um paciente com visão subnormal, atinge-se a melhor acuidade binocular para distância sem a interposição de lentes corretivas. Já para perto, o melhor resultado é atingido com adição de +8,00 Dioptrias esferiacs em ambos os olhos. Para melhorar o conforto durante a leitura, optou-se por prescrever lentes esferoprismáticas. Qual o valor mais adequado dos prismas em cada olho? \n",
      "a) 4 Dioptrias prismaticas base temporal. \n",
      "b) 4 Dioptrias prismaticas base nasal. \n",
      "c) 10 Dioptrias prismaticas base temporal. \n",
      "d) 10 Dioptrias prismaticas base nasal.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking for the best prism prescription for a patient with subnormal vision who has a better acuity for distance vision without corrective lenses, but needs a +8.00 diopter spherical lens for near vision. The patient has opted for espheroprismatic lenses for comfort during reading.\n",
      "\n",
      "The correct answer is b) 4 diopter prismatic lenses base nasal.\n",
      "\n",
      "Nasal prism is used to correct esophoria (eyes that turn inward), which is the condition of the patient. The base of the prism should be nasal to direct the eyes outward. A 4 diopter prism is the appropriate strength to correct the patient's esophoria.\n",
      "\n",
      "Therefore, the response is \"b\" - 4 diopter prismatic lenses base nasal.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "The subjective refraction of a patient with low vision achieves the best binocular acuity for distance without the interposition of corrective lenses. At close range, the best result is achieved with the addition of +8.00 spherical diopters in both eyes. To improve comfort while reading, it was decided to prescribe spheroprismatic lenses. What is the most appropriate value of the prisms in each eye? \n",
      "a) 4 prismatic diopters time base. \n",
      "b) 4 prismatic diopters at the nasal base. \n",
      "c) 10 prismatic diopters time basis. \n",
      "d) 10 prismatic diopters at the nasal base.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient has low vision and the best binocular acuity for distance is achieved without corrective lenses. At close range, the best result is achieved with the addition of +8.00 spherical diopters in both eyes. This suggests that the patient has a high degree of myopia.\n",
      "\n",
      "To improve comfort while reading, spheroprismatic lenses are prescribed. The appropriate value of the prisms in each eye would be 4 prismatic diopters at the nasal base (option b). This will help to reduce the amount of convergence required for near vision, thereby improving comfort and reducing eye strain.\n",
      "\n",
      "Option a (4 prismatic diopters time base) would not provide sufficient prismatic power to correct for the patient's high myopia.\n",
      "\n",
      "Option c (10 prismatic diopters time basis) would provide too much prismatic power and could potentially cause discomfort or eye strain.\n",
      "\n",
      "Option d (10 prismatic diopters at the nasal base) would also provide too much prismatic power and could potentially cause discomfort or eye strain.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 129: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿En qué concentración se utilizan colirios de nitrato de plata en el método Credé?\n",
      "a 1%.\n",
      "b) 5%.\n",
      "c) 10%.\n",
      "d) 20%.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // The correct answer is b) 5%.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The Credé method uses silver nitrate solution at a concentration of 5% for the application of silver nitrate colloidal solution. This is the most appropriate concentration for effective disinfection and antisepsis.\n",
      "\n",
      "Reference:\n",
      "\n",
      "* Credé, C. (1884). Über eine neue Methode zur Anwendung des Silber-Nitrats in der Medicin. Archiv für experimentelle Pathologie und Pharmakologie, 10(1), 1-14. doi: 10.1007/BF02121966\n",
      "\n",
      "Note:\n",
      "\n",
      "* Silver nitrate solution is also known as lunar caustic.\n",
      "* The Credé method is a technique used for applying silver nitrate solution to the eyes to treat conjunctivitis and other eye infections.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Gumagamit ng Silver nitrate eyedrops ang Crede method, ano ang konsenstrasyon nito? \n",
      "\n",
      "a) 1%.\n",
      "b) 5%.\n",
      "c) 10%.\n",
      "d) 20%.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Answer: 5%\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The Crede method, also known as the Silver Nitrate Eye Drop Test, is a diagnostic test used to assess the tear production in patients with suspected dry eye syndrome. The test involves instilling a 5% solution of silver nitrate into the eye and measuring the amount of time it takes for the silver nitrate to disappear from the eye. The normal duration for the silver nitrate to disappear is 5-10 minutes. If the silver nitrate disappears more quickly than 5 minutes, it may indicate excessive tear evaporation and dry eye syndrome. Therefore, the correct answer is b) 5%.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "O método de Credé utiliza colírio de nitrato de prata em qual concentração? \n",
      "a) 1%. \n",
      "b) 5%. \n",
      "c) 10%. \n",
      "d) 20%.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Answer: b\n",
      "}\n",
      "```\n",
      "Explanation:\n",
      "\n",
      "The method of Credé uses a 5% silver nitrate solution.\n",
      "\n",
      "References:\n",
      "\n",
      "* Credé, C. (1884). Über eine neue Methode zur Heilung von Neuralgie. Wiener Medizinische Wochenschrift, 34(10), 165-167.\n",
      "* Silver Nitrate. (n.d.). In Chemical Elements (6th ed.). Retrieved from <https://www.chemicalelements.com/elements/silver-nitrate.html>\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "The Credé method uses silver nitrate eye drops at what concentration? \n",
      "a) 1%. \n",
      "b) 5%. \n",
      "c) 10%. \n",
      "d) 20%.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Answer: b) 5%\n",
      "}\n",
      "```\n",
      "El método de Credé utiliza gotas de nitrato de plata a una concentración de 5%.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 130: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál de los siguientes fármacos tópicos es el más indicado para el tratamiento inicial de la queratitis fúngica causada por Fusarium?\n",
      "a) Terbinafina.\n",
      "b) Natamicina.\n",
      "c) Miconazol.\n",
      "d) Anfotericina B.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La opción correcta es c) Miconazol. La miconazol es un antifúngico que se utiliza comúnmente para tratar infecciones fúngicas de la piel, incluyendo la queratitis fúngica causada por Fusarium. La terbinafina (opción a) y la anfotericina B (opción d) también son antifúngicos, pero no son tan efectivos contra Fusarium como la miconazol. La natamicina (opción b) es un antibiótico que no es efectivo contra infecciones fúngicas.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na gamot ang angkop at mainam sa paglunas ng fungal keratitis na dala ng Fusarium?\n",
      "a) Terbinafine\n",
      "b) Natamycin\n",
      "c) Miconazole\n",
      "d) Amphotericin B\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Natamycin\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Fusarium keratitis is a type of fungal infection that affects the cornea, the clear dome-shaped surface at the front of the eye. Natamycin is an antifungal medication that is effective against Fusarium, which is why it is the best option for treating Fusarium keratitis. Terbinafine is an antifungal medication that is used to treat fungal infections of the skin and nails, but it is not effective against Fusarium. Miconazole is an antifungal medication that is used to treat skin and mucous membrane infections, but it is not effective against Fusarium. Amphotericin B is an antifungal medication that is effective against a wide range of fungi, but it is not the first line treatment for Fusarium keratitis.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual das drogas de uso tópico, abaixo, é a mais indicada para o tratamento inicial de ceratite fúngica causada por Fusarium? \n",
      "a) Terbinafina. \n",
      "b) Natamicina. \n",
      "c) Miconazol. \n",
      "d) Anfotericina B.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking for the most appropriate topical drug for the initial treatment of fungal keratitis caused by Fusarium.\n",
      "\n",
      "Option c) Miconazol is the correct answer. Miconazol is an antifungal medication that is effective against a wide range of fungal pathogens, including Fusarium. It is commonly used to treat fungal infections of the skin, hair, and nails, and is also effective in treating fungal keratitis.\n",
      "\n",
      "Option a) Terbinafina is an antifungal medication that is effective against some types of fungi, but it is not effective against Fusarium.\n",
      "\n",
      "Option b) Natamicina is an antifungal medication that is effective against some types of fungi, but it is not effective against Fusarium.\n",
      "\n",
      "Option d) Anfotericina B is an antifungal medication that is effective against some types of fungi, but it is not effective against Fusarium.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Which of the topical drugs below is most indicated for the initial treatment of fungal keratitis caused by Fusarium? \n",
      "a) Terbinafine. \n",
      "b) Natamycin. \n",
      "c) Miconazole. \n",
      "d) Amphotericin B.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Natamycin is the most indicated topical drug for the initial treatment of fungal keratitis caused by Fusarium.\n",
      "}\n",
      "```\n",
      "\n",
      "Fusarium keratitis is a type of fungal infection that affects the cornea, and Natamycin is a topical antifungal medication that is effective against a wide range of fungal pathogens, including Fusarium. It is often used as the first line of treatment for fungal keratitis, as it has been shown to be effective in reducing the severity of the infection and promoting corneal healing.\n",
      "\n",
      "Terbinafine is an antifungal medication that is primarily used to treat fungal infections of the skin and nails. While it may have some activity against Fusarium, it is not as effective as Natamycin for treating fungal keratitis.\n",
      "\n",
      "Miconazole is another topical antifungal medication that may be used to treat fungal keratitis, but it is not as effective as Natamycin against Fusarium.\n",
      "\n",
      "Amphotericin B is an antifungal medication that is effective against a wide range of fungal pathogens, but it is not typically used as the first line of treatment for fungal keratitis due to its potential toxicity and the availability of other effective treatments.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 131: \n",
      "Language: spanish\n",
      "Question: \n",
      "Seleccionar la alternativa correcta en relación al trasplante penetrante de córnea realizado en niños menores de dos años.\n",
      "a) Normalmente, la curación entre el lecho y el injerto se produce más lentamente que en los adultos.\n",
      "b) La incidencia de rechazo es significativamente menor que la observada en trasplantes de adultos.\n",
      "c) En un postoperatorio sin complicaciones, las suturas deben retirarse antes que en adultos.\n",
      "d) Generalmente se utilizan injertos de gran tamaño, de más de 10 mm de diámetro.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "La opción correcta es a) Normalmente, la curación entre el lecho y el injerto se produce más lentamente que en los adultos.\n",
      "\n",
      "En niños menores de dos años, el trasplante penetrante de córnea puede tener una curación más lenta debido a la mayor actividad celular y la mayor capacidad de regeneración del tejido corneal en esta población. Además, los niños pueden tener una mayor incidencia de rechazo del injerto, lo que puede requerir un tratamiento más prolongado y cuidadoso. Por lo tanto, la opción a) es la respuesta correcta.\n",
      "{'response': 'a'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Piliin ang angkop na pahayag patungkol sa penetrating corneal transplantation na ginagawa sa mga batang may edad na hindi lalagpas sa 2 taong gulang.\n",
      "a) Kadalasan, ang paggaling sa pagitan ng bed at ng graft ay mas mabagal sa mga batang edad 2 pababa, kaysa sa mga matatanda.\n",
      "b) Ang incidence ng rejection ay. mas mababa kumapara sa mga transplants na ginagawa sa matatanda\n",
      "c) Sa uneventful postoperative period, ang pagtanggal ng suture ay dapat na sa mabilis kumpara sa mga matatanda\n",
      "d) Kadalasan, gumagamit ng mga large graft na may lapad na higit sa 10 mm.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the appropriate statement regarding penetrating corneal transplantation in children under the age of 2.\n",
      "\n",
      "Option A states that the healing process of the graft and the bed is slower in children under 2 years old compared to older individuals. This is the correct answer.\n",
      "\n",
      "Option B states that the incidence of rejection is lower in transplants performed on older individuals. This is incorrect, as the incidence of rejection is not directly related to the age of the patient.\n",
      "\n",
      "Option C states that the removal of sutures should be done more quickly in children under 2 years old compared to older individuals. This is incorrect, as the postoperative period and suture removal should be uneventful and not dependent on the patient's age.\n",
      "\n",
      "Option D states that large grafts with a size greater than 10 mm are commonly used in children under 2 years old. This is incorrect, as the size of the graft is not directly related to the patient's age.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Assinale a alternativa correta com relação ao transplante penetrante de córnea realizado em crianças abaixo de dois anos de idade. \n",
      "a) Tipicamente, a cicatrização entre o leito e o enxerto ocorre mais lentamente do que no adulto. \n",
      "b) A incidência de rejeição é significativamente menor que a observada nos transplantes de adultos. \n",
      "c) Em um pós-operatório sem intercorrências, a remoção das suturas deve ocorrer mais precocemente do que nos adultos. \n",
      "d) Geralmente são utilizados enxertos grandes, com mais de 10 mm de diâmetro.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option a, \"Tipicamente, a cicatrização entre o leito e o enxerto ocorre mais lentamente do que no adulto.\"\n",
      "\n",
      "In children under the age of 2, the corneal transplant healing process is slower compared to adults. This is because children's eyes are still developing and their immune systems are not fully mature, which can lead to a higher risk of rejection and slower wound healing. Therefore, option a is the correct answer.\n",
      "\n",
      "Option b is incorrect because the incidence of rejection in corneal transplants in children is not significantly lower than in adults.\n",
      "\n",
      "Option c is incorrect because the removal of sutures in the post-operative period should not occur earlier in children than in adults.\n",
      "\n",
      "Option d is incorrect because enxertos large, with a diameter of more than 10 mm, are not typically used in corneal transplants in children.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "Mark the correct alternative regarding penetrating corneal transplantation performed in children under two years of age. \n",
      "a) Typically, healing between the bed and the graft occurs more slowly than in adults. \n",
      "b) The incidence of rejection is significantly lower than that observed in adult transplants. \n",
      "c) In an uneventful postoperative period, suture removal should occur earlier than in adults. \n",
      "d) Generally, large grafts with more than 10 mm in diameter are used.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "La respuesta correcta es a) Típicamente, la curación entre la cama y el injerto ocurre más lentamente en niños menores de dos años que en adultos.\n",
      "\n",
      "Here's the answer in Tagalog:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "Ang tamang sagot ay a) Hindi gaano kadaling-daling ang paggaling sa pagitan ng kama at ng injerto sa mga batang nasa bawat dalawang taon ng edad.\n",
      "\n",
      "Here's the answer in Portuguese:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "A resposta correta é a) Tipicamente, a curação entre a cama e o enxerto ocorre mais lentamente em crianças com menos de dois anos do que em adultos.\n",
      "\n",
      "Here's the answer in English:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "The correct answer is a) Typically, healing between the bed and the graft occurs more slowly in children under two years of age than in adults.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 132: \n",
      "Language: spanish\n",
      "Question: \n",
      "Seleccione la alternativa correcta respecto al trasplante de córnea lamelar posterior mediante la técnica \"DSEK\" (Descemet Stripping Endothelial Keratoplasty):\n",
      "a) Inmediatamente después de la cirugía, el paciente debe permanecer en decúbito prono durante aproximadamente veinte a treinta minutos.\n",
      "b) En el ojo receptor sólo se injertan endotelio y membrana de Descemet.\n",
      "c) La queratitis lamelar difusa (también conocida como “síndrome de la arena sahariana”), es una complicación de este procedimiento.\n",
      "d) La presencia de la laminilla correctamente posicionada probablemente inducirá un grado esférico positivo que se sumará a la refracción previa del paciente (\"desplazamiento hiperópico\").\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c: La queratitis lamelar difusa (también conocida como “síndrome de la arena sahariana”), es una complicación de este procedimiento.\n",
      "\n",
      "Explanation:\n",
      "\n",
      "a) Incorrect. The patient should not remain in the prone position for 20-30 minutes after surgery.\n",
      "\n",
      "b) Incorrect. Only the endothelium and Descemet's membrane are transplanted in the recipient eye.\n",
      "\n",
      "d) Incorrect. The correctly positioned laminilla will likely induce a positive spherical refraction that will be added to the patient's pre-existing refraction (\"hyperopic shift\").\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Piliin ang angkop na pahayag patungkol sa posterior lamellar corneal transplantation gamit ang pamamaraang DSEK (Descemet Stripping Endothelial Keratoplasty)\n",
      "a) Kagyat na pagkatapos ng operasyon, dapat manatili ang pasyente sa posisyong prone nang 20 hanggang 30 minuto\n",
      "b) Tanging ang endothelium at Descemet's membrane lamang ang iginagraft sa pasyenteng tatanggap ng mata. \n",
      "c) Diffuse lamellar keratitis ay isang komplikasyon ng operasyon at pamamaraang ito.\n",
      "d) Ang mahusay na pagkakaposisyon ng lamella ay maaaring magdala ng positibong spherical degree na idaragdag sa dating refraction ng pasyente (\"hypermetropic shift\").\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Tanging ang endothelium at Descemet's membrane lamang ang iginagraft sa pasyenteng tatanggap ng mata.\n",
      "\n",
      "Descemet's Stripping Endothelial Keratoplasty (DSEK) is a surgical procedure that involves transplanting a thin layer of endothelial cells from a donor cornea to a recipient cornea. The grafted endothelial cells will then replace the damaged endothelial cells in the recipient cornea, restoring its proper function.\n",
      "\n",
      "Option a) is incorrect because the patient should not be placed in a prone position after the operation.\n",
      "\n",
      "Option c) is incorrect because diffuse lamellar keratitis is not a complication of DSEK surgery, but rather a condition that can occur after other types of corneal transplantation.\n",
      "\n",
      "Option d) is incorrect because a hypermetropic shift can occur after DSEK surgery, but it is not a result of the lamellar grafting procedure itself.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Assinale a alternativa correta com relação ao transplante de córnea lamelar posterior pela técnica \"DSEK\" (Descemet Stripping Endothelial Keratoplasty): \n",
      "a) Imediatamente após a cirurgia o paciente deve permanecer em decúbito ventral por cerca de vinte a trinta minutos. \n",
      "b) Apenas endotélio e membrana de Descemet são enxertados no olho receptor. \n",
      "c) Ceratite lamelar difusa (também conhecida como \"síndrome das areias do Saara\"), é uma complicação desse procedimento. \n",
      "d) A presença da lamela corretamente posicionada provavelmente induzirá grau esférico positivo que se somará à refração prévia do paciente (\"shift hipermetrópico\").\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is d) A presença da lamela corretamente posicionada provavelmente induzirá grau esférico positivo que se somará à refração prévia do paciente (\"shift hipermetrópico\").\n",
      "\n",
      "The question is asking about the outcome of Descemet Stripping Endothelial Keratoplasty (DSEK) surgery, specifically regarding the positioning of the corneal lamella and its effect on the patient's refraction.\n",
      "\n",
      "Option d is the correct answer because it states that the properly positioned lamella will likely induce a positive spherical power addition to the patient's pre-existing refraction, which is known as a \"hypermetropic shift.\" This is a common outcome of DSEK surgery and is considered a successful result.\n",
      "\n",
      "The other options are incorrect because:\n",
      "\n",
      "* Option a states that the patient should remain in a decubitus position for 20-30 minutes after surgery, which is not a standard protocol for DSEK surgery.\n",
      "* Option b states that only the endothelium and Descemet's membrane are transplanted in the recipient eye, which is an incomplete description of the DSEK procedure.\n",
      "* Option c mentions a complication of DSEK surgery called \"síndrome das areias do Saara\" (diffuse lamellar keratitis), which is not directly related to the question.\n",
      "{'response': 'd'}\n",
      "Language: english\n",
      "Question: \n",
      "Mark the correct alternative regarding posterior lamellar corneal transplantation using the \"DSEK\" technique (Descemet Stripping Endothelial Keratoplasty): \n",
      "a) Immediately after the surgery, the patient must remain in the prone position for about twenty to thirty minutes. \n",
      "b) Only endothelium and Descemet's membrane are grafted into the recipient eye. \n",
      "c) Diffuse lamellar keratitis (also known as \"sands of the Sahara syndrome\"), is a complication of this procedure. \n",
      "d) The presence of a correctly positioned lamella will probably induce a positive spherical degree that will be added to the patient's previous refraction (\"hypermetropic shift\").\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option d, \"The presence of a correctly positioned lamella will probably induce a positive spherical degree that will be added to the patient's previous refraction ('hypermetropic shift').\"\n",
      "\n",
      "Posterior lamellar corneal transplantation using the DSEK technique involves grafting a lamella of endothelial tissue and Descemet's membrane into the recipient eye. This procedure is used to treat endothelial diseases, such as Fuchs' dystrophy, and can also be used to treat corneal swelling and high myopia.\n",
      "\n",
      "One of the potential complications of DSEK is diffuse lamellar keratitis (also known as \"sands of the Sahara syndrome\"), which is an inflammatory condition that can occur in the grafted tissue. However, this is not the correct answer for the given question.\n",
      "\n",
      "Option a is incorrect because the patient does not need to remain in the prone position for any specific amount of time after the surgery.\n",
      "\n",
      "Option b is incorrect because only endothelium and Descemet's membrane are grafted into the recipient eye, and not the entire cornea.\n",
      "\n",
      "Therefore, the correct answer is option d, \"The presence of a correctly positioned lamella will probably induce a positive spherical degree that will be added to the patient's previous refraction ('hypermetropic shift').\" This statement accurately describes the effect of a successful DSEK procedure on the patient's refraction.\n",
      "{'response': 'd'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 133: \n",
      "Language: spanish\n",
      "Question: \n",
      "La parálisis del quinto par craneal puede desencadenar la córnea, más comúnmente:\n",
      "a) Úlcera neurotrófica.\n",
      "b) Endotelitis disciforme.\n",
      "c) Queratitis por exposición.\n",
      "d) Queratitis intersticial.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "La parálisis del quinto par craneal puede desencadenar la córnea, más comúnmente:\n",
      "a) Úlcera neurotrófica.\n",
      "\n",
      "La úlcera neurotrófica es una lesión que afecta la capa de células epiteliales de la córnea, y puede ser causada por la parálisis del quinto par craneal, que puede afectar la función de las células epiteliales de la córnea y provocar una úlcera. Las otras opciones, endotelitis disciforme, queratitis por exposición y queratitis intersticial, son enfermedades oculares diferentes que no están directamente relacionadas con la parálisis del quinto par craneal.\n",
      "{'response': 'a'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang paralisis ng ikalimang cranial nerve ay maaaring maka-trigger sa cornea, na kadalasang:\n",
      "a) Neurotrophic ulcer.\n",
      "b) Disciform endothelitis.\n",
      "c) Exposure keratitis.\n",
      "d) Interstitial keratitis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The paralysis of the sixth cranial nerve can cause a neurotrophic ulcer in the cornea. This is because the sixth cranial nerve is responsible for innervating the lacrimal gland, which produces tears to keep the cornea moist. When the nerve is paralyzed, the lacrimal gland becomes dysfunctional, leading to dryness and ulceration of the cornea. Therefore, option A (Neurotrophic ulcer) is the correct response.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Paralisia do quinto nervo craniano pode desencadear na córnea, mais comumente: \n",
      "a) Úlcera neurotrófica. \n",
      "b) Endotelite disciforme. \n",
      "c) Ceratite de exposição. \n",
      "d) Ceratite intersticial.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Paralisia do quinto nervo craniano (also known as abducens nerve palsy) can cause a variety of eye problems, including:\n",
      "\n",
      "* Úlcera neurotrófica (neurotrophic ulcer): A type of ulcer that occurs due to a loss of sensation in the cornea, leading to a failure of the corneal epithelium to heal properly.\n",
      "* Endotelite disciforme (disciform keratopathy): A condition characterized by a thinning and clouding of the cornea, resulting in vision loss.\n",
      "* Ceratite de exposição (exposure keratitis): A type of keratitis that occurs when the cornea is exposed to excessive dryness or irritation, leading to inflammation and vision problems.\n",
      "* Ceratite intersticial (interstitial keratitis): A type of keratitis that occurs when there is inflammation in the stroma, the middle layer of the cornea, leading to vision problems.\n",
      "\n",
      "Therefore, the correct answer is option a) Úlcera neurotrófica.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "Paralysis of the fifth cranial nerve can trigger in the cornea, most commonly: \n",
      "a) Neurotrophic ulcer. \n",
      "b) Disciform endothelitis. \n",
      "c) Exposure keratitis. \n",
      "d) Interstitial keratitis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Paralysis of the fifth cranial nerve can cause exposure keratitis, which is a condition where the cornea becomes dry and inflamed due to a lack of tears. This can lead to pain, redness, and blurred vision. The other options, neurotrophic ulcer, disciform endothelitis, and interstitial keratitis, are not related to paralysis of the fifth cranial nerve.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 134: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto a la distrofia endotelial de la córnea congénita y hereditaria, es correcto afirmar:\n",
      "a) El patrón de transmisión más común es autosómico dominante.\n",
      "b) La mayoría de los pacientes presentan nistagmo asociado y, raramente, glaucoma.\n",
      "c) Los pacientes suelen presentar fotofobia intensa y epífora inmediatamente después del nacimiento.\n",
      "d) Suele ser unilateral, con un aumento progresivo de la opacidad corneal desde el nacimiento.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "La mayoría de los pacientes con distrofia endotelial de la córnea congénita y hereditaria presentan nistagmo asociado y, raramente, glaucoma. Esta afirmación es correcta.\n",
      "\n",
      "La distrofia endotelial de la córnea congénita y hereditaria es una enfermedad genética que afecta a la capa de células endoteliales que recubre la superficie posterior de la córnea. Esta capa de células es responsable de mantener la transparencia de la córnea, y cuando se daña, puede provocar una opacidad en la córnea que puede afectar la visión.\n",
      "\n",
      "El patrón de transmisión más común de esta enfermedad es autosómico dominante, lo que significa que un solo copia del gen defectuoso es suficiente para causar la enfermedad. Sin embargo, en algunos casos, la enfermedad puede ser causada por una mutación en el gen y no tener una historia familiar de la enfermedad.\n",
      "\n",
      "En cuanto a los síntomas, los pacientes con distrofia endotelial de la córnea congénita y hereditaria pueden presentar nistagmo (movimientos involuntarios de los ojos) y, en algunos casos, glaucoma. La fotofobia intensa y la epífora inmediatamente después del nacimiento son síntomas menos comunes en esta enfermedad.\n",
      "\n",
      "Por último, la opacidad corneal en la distrofia endotelial de la córnea congénita y hereditaria suele ser bilateral, es decir, afecta a ambos ojos. Aunque puede haber un aumento progresivo de la opacidad corneal a lo largo del tiempo, no es necesariamente unilateral.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na pahayag ang totoo patungkol sa konhenital at namamanag coreneal endothelial dystrophy?\n",
      "a) Ang pinakakaraniwang pattern ng transmisyon ay dominant autosomal\n",
      "b) Karamihan sa mga pasyente ay mayroon ding nystagmus at minsan ay glaucoma\n",
      "c) Ang mga pasyente ay kadalasang mayroong matinding photophobia at epiphora pagkatapos ng kapanganakan.\n",
      "d) Karaniwan itong unilateral, na may progresibong pagtaas sa opacity ng cornea mula sa kapanganakan.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is (a) Ang pinakakaraniwang pattern ng transmisyon ay dominant autosomal.\n",
      "\n",
      "Konhenital at namamanag coreneal endothelial dystrophy (CECD) is a genetic disorder that affects the corneal endothelium, which is the inner layer of the cornea. The disorder is caused by mutations in the genes that code for proteins involved in the structure and function of the corneal endothelium.\n",
      "\n",
      "The transmission pattern of CECD is typically dominant autosomal, meaning that a single copy of the mutated gene is enough to cause the condition. This means that if one parent has the mutated gene, each child has a 50% chance of inheriting the mutation.\n",
      "\n",
      "Option (b) Karamihan sa mga pasyente ay mayroon ding nystagmus at minsan ay glaucoma is incorrect because while some patients with CECD may have nystagmus (involuntary eye movements) or glaucoma, these are not the primary symptoms of the disorder.\n",
      "\n",
      "Option (c) Ang mga pasyente ay kadalasang mayroong matinding photophobia at epiphora pagkatapos ng kapanganakan is also incorrect because photophobia (sensitivity to light) and epiphora (excessive tearing) are not the primary symptoms of CECD.\n",
      "\n",
      "Option (d) Karaniwan itong unilateral, na may progresibong pagtaas sa opacity ng cornea mula sa kapanganakan is incorrect because CECD typically affects both eyes, although one eye may be more severely affected than the other. Additionally, the opacity of the cornea does not necessarily progress over time.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação à distrofia endotelial congênita e hereditária da córnea, é correto afirmar: \n",
      "a) O padrão de transmissão mais comum é o autossômico dominante. \n",
      "b) A maioria dos pacientes apresenta nistagmo associado e, raramente, glaucoma. \n",
      "c) Os pacientes costumam apresentar intensa fotofobia e epífora imediatamente após o nascimento. \n",
      "d) Geralmente é unilateral, com aumento progressivo da opacidade da córnea a partir do nascimento.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is a) O padrão de transmissão mais comum é o autossômico dominante.\n",
      "\n",
      "Distrofia endotelial congênita e hereditária da córnea is a genetic disorder that affects the cornea, which is the clear outer layer of the eye. The most common pattern of inheritance for this disorder is autosomal dominant, meaning that a single copy of the mutated gene is enough to cause the condition. This means that if one parent has the mutated gene, each child has a 50% chance of inheriting the gene and developing the condition.\n",
      "\n",
      "The other options are not correct:\n",
      "\n",
      "* b) A maioria dos pacientes apresenta nistagmo associado e, raramente, glaucoma. (Most patients have associated nystagmus and, rarely, glaucoma.) This is not a characteristic of distrofia endotelial congênita e hereditária da córnea.\n",
      "* c) Os pacientes costumam apresentar intensa fotofobia e epífora imediatamente após o nascimento. (Patients usually present with intense photophobia and epiphora immediately after birth.) This is not a characteristic of distrofia endotelial congênita e hereditária da córnea.\n",
      "* d) Geralmente é unilateral, com aumento progressivo da opacidade da córnea a partir do nascimento. (It is usually unilateral, with progressive increase in corneal opacity from birth.) This is not a characteristic of distrofia endotelial congênita e hereditária da córnea.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding congenital and hereditary corneal endothelial dystrophy, it is correct to state: \n",
      "a) The most common pattern of transmission is the dominant autosomal one. \n",
      "b) Most patients have associated nystagmus and, rarely, glaucoma. \n",
      "c) Patients usually present with intense photophobia and epiphora immediately after birth. \n",
      "d) It is usually unilateral, with progressive increase in corneal opacity from birth onwards.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Congenital and hereditary corneal endothelial dystrophy (CHED) is a group of rare genetic disorders that affect the corneal endothelium, which is the inner layer of the cornea. The most common pattern of transmission is autosomal dominant, which means that a single copy of the mutated gene is enough to cause the condition. Associated nystagmus and glaucoma are common findings in patients with CHED. However, intense photophobia and epiphora are not typically present immediately after birth. Instead, patients usually experience gradual vision loss and glare over time. The condition typically affects both eyes, although one eye may be more severely affected than the other. Progressive increase in corneal opacity can occur over time, but it is not always present from birth onwards. Therefore, the correct answer is option b.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 135: \n",
      "Language: spanish\n",
      "Question: \n",
      "En un paciente con queratopatía ampollosa y edema corneal secundario a insuficiencia endotelial, ¿cuál de los siguientes productos tópicos debe evitarse?\n",
      "a) hialuronato de sodio.\n",
      "b) cloruro de sodio.\n",
      "c) Inhibidores de la anhidasa carbónica.\n",
      "d) ciclopentolato.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "In a patient with bullous keratopathy and secondary corneal edema due to endothelial insufficiency, the product that should be avoided is c) carbonic anhydrase inhibitors. These medications, such as acetazolamide, can further reduce endothelial function and exacerbate the edema.\n",
      "\n",
      "Hyaluronic acid (a) and sodium chloride (b) may be used to help manage the edema, while ciclopentolate (d) is an anticholinergic that can help reduce pain and inflammation. However, it is important to note that the use of these medications should be carefully evaluated on a case-by-case basis and guided by a qualified medical professional.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Sa pasyenteng may bullous keratopathy at pamamaga ng cornea dala ng endothelial insufficiency, alin sa mga sumusunod na produkto ang dapat iwasan?\n",
      "a) Sodium hyaluronate\n",
      "b) Sodium chloride\n",
      "c) Mga inhibitor ng Carbonic anhydrase\n",
      "d) Cyclopentolate\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Bullous keratopathy is a condition characterized by the formation of bullae (fluid-filled blisters) on the cornea, which can be caused by endothelial insufficiency. Sodium hyaluronate is a medication that can help to reduce the symptoms of bullous keratopathy by increasing the amount of fluid in the cornea and promoting healing. The other options, sodium chloride, carbonic anhydrase inhibitors, and cyclopentolate, are not effective in treating bullous keratopathy and may even worsen the condition.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Em paciente com ceratopatia bolhosa e edema de córnea secundário à insuficiência endotelial, qual dos produtos de uso tópico, dentre os abaixo, deve ser evitado?\n",
      "a)Hialuronato de sódio.\n",
      "b)Cloreto de sódio.\n",
      "c)Inibidores da anidrase carbônica.\n",
      "d)Ciclopentolato.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Answer: b\n",
      "}\n",
      "```\n",
      "Explanation:\n",
      "\n",
      "The patient has bullous keratopathy and corneal edema secondary to endothelial insufficiency. The correct answer is b) Chloreto de sódio (sodium chloride) should be avoided. This is because sodium chloride can further damage the already compromised corneal endothelium and exacerbate the edema.\n",
      "\n",
      "Hialuronato de sódio (sodium hyaluronate) is a natural component of the corneal endothelium and can help to replenish the depleted hyaluronic acid in the cornea, improving its hydration and reducing the edema. Inibidores da anidrase carbônica (carbonic anhydrase inhibitors) can also be used to reduce the edema by inhibiting the enzyme that regulates the hydration of the cornea. Ciclopentolato (cyclopentolate) is an anticholinergic drug that can reduce the edema by decreasing the activity of the cholinergic system in the cornea. However, it is not the most appropriate option for this patient's condition.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "In a patient with bullous keratopathy and corneal edema secondary to endothelial insufficiency, which of the following topical products should be avoided?\n",
      "a) Sodium hyaluronate.\n",
      "b) Sodium chloride.\n",
      "c) Inhibitors of carbonic anhydrase.\n",
      "d) Cyclopentolate.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Answer: b\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Sodium chloride (b) should be avoided in patients with bullous keratopathy and corneal edema secondary to endothelial insufficiency, as it can further increase corneal edema and worsen the patient's symptoms.\n",
      "\n",
      "Sodium hyaluronate (a) is a topical medication that can help to reduce corneal edema and relieve symptoms.\n",
      "\n",
      "Inhibitors of carbonic anhydrase (c) are not relevant to the management of bullous keratopathy and corneal edema.\n",
      "\n",
      "Cyclopentolate (d) is a topical medication that can help to reduce corneal edema and relieve symptoms, but it is not as effective as sodium hyaluronate.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 136: \n",
      "Language: spanish\n",
      "Question: \n",
      "La infestación de párpados por Phtirus pubis se puede tratar, preferiblemente, ¿con cuál de las siguientes opciones?\n",
      "\n",
      "a) Doxiciclina oral.\n",
      "b) Champú a base de aceite de árbol de té.\n",
      "c) Múltiples sesiones de aplicación de luz pulsada regulada de alta intensidad (IRPL) en la región periocular.\n",
      "d) Ivermectina por vía oral.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La infestación de párpados por Phtirus pubis se puede tratar, preferiblemente, con múltiples sesiones de aplicación de luz pulsada regulada de alta intensidad (IRPL) en la región periocular. Esta opción es la más efectiva y segura para tratar la infestación de párpados, ya que la luz pulsada regulada de alta intensidad puede matar los ácaros y sus huevos, y también puede reducir la inflamación y el dolor. Las otras opciones, como la doxiciclina oral, el champú a base de aceite de árbol de té y la ivermectina por vía oral, no son tan efectivas o seguras para tratar la infestación de párpados.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang Palpebral infestation ng Phtirus pubi ay mainam na gamitan ng alin sa mga sumusunod?\n",
      "a) Doxycycline orally.\n",
      "b) Tea tree oil-based shampoo.\n",
      "c) Makaulit na paglalagay ng high-intensity regulated pulsed light (IRPL) sa periocular region.\n",
      "d) Ivermectin orally. \n",
      "Test #0: \n",
      "response\n",
      "  Here's my response:\n",
      "\n",
      "```json\n",
      "{\n",
      "    \"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "My explanation:\n",
      "\n",
      "The question is asking about the treatment of Phthirus pubis, also known as crabs or pubic lice. The correct answer is c) Makaulit na paglalagay ng high-intensity regulated pulsed light (IRPL) sa periocular region. This is because IRPL therapy has been shown to be effective in treating pubic lice infestations. Doxycycline (a) is an antibiotic that is not effective against lice. Tea tree oil-based shampoo (b) may help with lice treatment, but it is not as effective as IRPL. Ivermectin (d) is effective against lice, but it is not the best option for treating Phthirus pubis.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Infestação palpebral pelo Phtirus pubis, pode ser tratada, preferencialmente, com qual das opções abaixo?\n",
      "\n",
      "a)Doxiciclina via oral.\n",
      "b)Xampu a base de óleo de melaleuca (tea tree oil).\n",
      "c)Múltiplas sessões de aplicação de luz pulsada regulada, de alta intensidade (IRPL), na região periocular.\n",
      "d)Ivermectina via oral.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Infestação palpebral pelo Phtirus pubis, also known as eyelash lice, can be treated with multiple sessions of applying pulsed light, high intensity (IRPL), in the periocular region. This is the most effective treatment option, as it targets the lice and their eggs, and can be done in a doctor's office or clinic.\n",
      "\n",
      "Option A, doxycycline via oral, is not the best option as it is an antibiotic and does not target the lice directly.\n",
      "\n",
      "Option B, shampoo with tea tree oil, may not be effective in treating eyelash lice as it may not reach the lice in the eye area.\n",
      "\n",
      "Option D, ivermectina via oral, is not a recommended treatment for eyelash lice.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Palpebral infestation by Phtirus pubis, is preferably treated with which of the options below?\n",
      "\n",
      "a) Doxycycline orally.\n",
      "b) Tea tree oil-based shampoo.\n",
      "c) Multiple sessions of application of high-intensity regulated pulsed light (IRPL) in the periocular region.\n",
      "d) Ivermectin orally. \n",
      "Test #0: \n",
      "response\n",
      "  Here's my response:\n",
      "\n",
      "```json\n",
      "{\n",
      "    \"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Palpebral infestation by Phthirus pubis, also known as crab lice, is an ectoparasitic infection that affects the eyelashes and surrounding areas. The preferred treatment for this condition is doxycycline, which is an oral antibiotic that targets the bacteria that cause the infection.\n",
      "\n",
      "While tea tree oil-based shampoo may help alleviate symptoms, it is not a reliable treatment option for palpebral infestation. High-intensity regulated pulsed light (IRPL) therapy may be effective in eliminating the lice, but it requires multiple sessions, and the periocular region is a sensitive area that requires careful consideration before using such a treatment. Ivermectin is also not the best option, as it is primarily used to treat parasitic infections such as river blindness and scabies, not crab lice infestations.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 137: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto a las manifestaciones de la conjuntivitis, es correcto afirmar:\n",
      "a) En la queratoconjuntivitis vernal la hipertrofia papilar se produce con frecuencia tanto en la conjuntiva tarsal superior como en la inferior, con apariencia e intensidad similares.\n",
      "b) En la conjuntivitis papilar gigante secundaria al uso de prótesis oculares, lentes de contacto y suturas, la conjuntiva tarsal inferior rara vez presenta hipertrofia papilar.\n",
      "c) En la dermatoqueratoconjuntivitis atópica, la hipertrofia papilar se produce característicamente en la conjuntiva tarsal superior.\n",
      "d) La conjuntivitis alérgica perenne suele desarrollar papilas, generalmente situadas en la conjuntiva tarsal superior, con un diámetro superior a un milímetro.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La opción correcta es c) En la dermatoqueratoconjuntivitis atópica, la hipertrofia papilar se produce característicamente en la conjuntiva tarsal superior.\n",
      "\n",
      "La dermatoqueratoconjuntivitis atópica es una enfermedad crónica que afecta la piel y las membranas mucosas, incluyendo la conjuntiva. Una de sus características es la hipertrofia papilar, que se produce en la conjuntiva tarsal superior. Por lo tanto, la opción c es la correcta.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Patungkol sa mga sintomas ng conjunctivitis, alin sa mga sumusunod ang tama?\n",
      "a) Sa vernal keratoconjunctivits, madalas nangyayari ang papillary hypertrophy sa parehong itaas at ibabang tarsal conjunctiva na may parehong hitsura at sidhi\n",
      "b) Sa malalaking papillary conjunctivitis dala ng paggamit ng ocular prostheses, contact lenses, at suture threads, madalang magkaroon ng papillary hypoertrophy ang ilalim na tarsal conjunctiva\n",
      "c) Sa atopic dermatokeratoconjunctivitis, nagkakaroon ng papillary hypertrophy sa itaas na tarsal conjunctiva\n",
      "d) Nagdudulot ang perrenial allergic conjunctivitis ng pagkakaroon ng papillae na makikita sa itaas na tarsal conjunctiva na may lapad na higit sa 1 mm \n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Sa atopic dermatokeratoconjunctivitis, nagkakaroon ng papillary hypertrophy sa itaas na tarsal conjunctiva.\n",
      "\n",
      "Atopic dermatokeratoconjunctivitis is a type of conjunctivitis that occurs in people with atopic dermatitis. It is characterized by papillary hypertrophy of the upper tarsal conjunctiva, which can be seen as small, flesh-colored or white papillae on the surface of the eye. The papillae are usually smaller than 1 mm in diameter.\n",
      "\n",
      "Option a) is incorrect because vernal keratoconjunctivitis is a different type of conjunctivitis that occurs in children and young adults, and is characterized by papillary hypertrophy of the upper tarsal conjunctiva, but not necessarily on the lower tarsal conjunctiva.\n",
      "\n",
      "Option b) is incorrect because malalaking papillary conjunctivitis is a type of conjunctivitis that occurs in people who wear ocular prostheses, contact lenses, or suture threads, and is characterized by papillary hypertrophy of the lower tarsal conjunctiva, not the upper tarsal conjunctiva.\n",
      "\n",
      "Option d) is incorrect because perennial allergic conjunctivitis is a type of conjunctivitis that occurs throughout the year and is caused by an allergic reaction, but it does not cause papillary hypertrophy on the upper tarsal conjunctiva.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação às manifestações das conjuntivites, é correto afirmar:\n",
      "a)Na ceratoconjuntivite vernal, a hipertrofia papilar ocorre frequentemente tanto na conjuntiva tarsal superior quanto na inferior, com aspecto e intensidade semelhantes.\n",
      "b)Na conjuntivite papilar gigante secundária ao uso de próteses oculares, lentes de contato e fios de sutura, raramente a conjuntiva tarsal inferior apresenta hipertrofia papilar.\n",
      "c)Na dermatoceratoconjuntivite atópica a hipertrofia papilar ocorre caracteristicamente na conjuntiva tarsal superior.\n",
      "d)Conjuntivite alérgica perene frequentemente desenvolve papilas, localizadas geralmente na conjuntiva tarsal superior, com diâmetro superior a um milímetro.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option c, \"Na dermatoceratoconjuntivite atópica a hipertrofia papilar ocorre caracteristicamente na conjuntiva tarsal superior.\"\n",
      "\n",
      "Dermatoceratoconjuntivite atópica is a type of conjunctivitis that is associated with atopic dermatitis. One of the characteristic features of this condition is the presence of papillary hypertrophy in the superior tarsal conjunctiva. Therefore, option c is the correct answer.\n",
      "\n",
      "Option a is incorrect because it refers to ceratoconjuntivitis vernal, which is a different condition. Option b is also incorrect because it refers to a rare complication of prosthetic eye implantation, and is not related to the topic of conjunctivitis. Option d is incorrect because it refers to allergic conjunctivitis, which can cause papillary hypertrophy, but the location of the papillae is not specific to the superior tarsal conjunctiva.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding the manifestations of conjunctivitis, it is correct to state:\n",
      "a) In vernal keratoconjunctivitis, papillary hypertrophy often occurs in both the upper and lower tarsal conjunctiva, with similar appearance and intensity.\n",
      "b) In giant papillary conjunctivitis secondary to the use of ocular prostheses, contact lenses and suture threads, the lower tarsal conjunctiva rarely presents papillary hypertrophy.\n",
      "c) In atopic dermatokeratoconjunctivitis, papillary hypertrophy characteristically occurs in the upper tarsal conjunctiva.\n",
      "d) Perennial allergic conjunctivitis often develops papillae, usually located in the upper tarsal conjunctiva, with a diameter greater than one millimeter.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) In atopic dermatokeratoconjunctivitis, papillary hypertrophy characteristically occurs in the upper tarsal conjunctiva.\n",
      "\n",
      "Here's the answer in Tagalog:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) In atopic dermatokeratoconjunctivitis, papillary hypertrophy characteristically occurs in the upper tarsal conjunctiva.\n",
      "\n",
      "Here's the answer in Portuguese:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) In atopic dermatokeratoconjunctivitis, papillary hypertrophy characteristically occurs in the upper tarsal conjunctiva.\n",
      "\n",
      "Here's the answer in English:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) In atopic dermatokeratoconjunctivitis, papillary hypertrophy characteristically occurs in the upper tarsal conjunctiva.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 138: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto a la conjuntivitis adenoviral, es correcto afirmar:\n",
      "a) La eliminación de pseudomembranas se asocia con un mayor riesgo de formación de simbléfaron y, por tanto, debe evitarse.\n",
      "b) El uso de corticoides tópicos de baja concentración está indicado para prevenir la aparición de pseudomembranas, por lo que se prescriben poco después del inicio de los síntomas.\n",
      "c) Los corticoides tópicos, utilizados en la fase aguda, favorecen la replicación viral con un aumento de la carga viral en la superficie ocular.\n",
      "d) Estudios controlados han demostrado la eficacia del uso de ketorolaco al 0,5% en la fase aguda de la conjuntivitis para aliviar los síntomas, con una reducción de la duración del período de contagio, en comparación con el uso de colirios lubricantes.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Respecto a la conjuntivitis adenoviral, es correcto afirmar que el uso de corticoides tópicos de baja concentración está indicado para prevenir la aparición de pseudomembranas, por lo que se prescriben poco después del inicio de los síntomas.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Patungkol sa mga sintomas ng conjunctivitis, alin sa mga sumusunod ang tama:\n",
      "a) Ang pagtanggal ng pseudomembranes ay nauugnay sa mas mas malaking posibilidad ng symblepharon formation kaya dapat itong iwasan.\n",
      "b) Ang paggamit ng mga topical corticosteroids na may mababang konsentrasyon ay ginagamit upang mapigilan ang pagkakaroon ng pseudomembranes, kaya dapat ito ibigay kagyat na pagkatapos makita ang sintomas. \n",
      "c) Ang paggamit ng topical corticosteroids ay nagpapaibayo ng viral replication dala ng mas pinaraming viral load sa ocular surface\n",
      "d) Ayon sa mga pag-aaral, epektibo ang paggamit ng ketorolac 0.5% sa bilang panlunas sa sintomas ng conjunctivitis at pagpapaikli ng contagion period nito kumpara sa paggamit lamang ng lubricating eye drops.\n",
      "\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option d. According to studies, the use of ketorolac 0.5% is effective in reducing the symptoms of conjunctivitis and shortening the contagion period compared to using only lubricating eye drops.\n",
      "\n",
      "Option a is incorrect because removing pseudomembranes increases the risk of symblepharon formation.\n",
      "\n",
      "Option b is incorrect because using topical corticosteroids with low concentration can help prevent the formation of pseudomembranes, but it should be used cautiously after seeing the symptoms.\n",
      "\n",
      "Option c is incorrect because using topical corticosteroids can increase viral replication and load on the ocular surface.\n",
      "{'response': 'd'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação às conjuntivites adenovirais, é correto afirmar:\n",
      "a)A remoção de pseudomembranas está associada a maior risco de formação de simbléfaro e por isso deve ser evitada.\n",
      "b)Uso de corticosteroides tópicos de baixa concentração está indicado para prevenção do aparecimento de pseudomembranas, e por isso, eles são prescritos logo após o início dos sintomas.\n",
      "c)Corticosteroides tópicos, utilizados na fase aguda, favorecem replicação viral com aumento da carga viral na superfície ocular.\n",
      "d)Estudos controlados demonstraram eficácia do uso do cetorolaco 0,5% na fase aguda da conjuntivite para alívio dos sintomas, com redução da duração do período de contágio, em comparação ao uso de colírios lubrificantes.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is d) Estudos controlados demonstraram eficácia do uso do cetorolaco 0,5% na fase aguda da conjuntivite para alívio dos sintomas, com redução da duração do período de contágio, em comparação ao uso de colírios lubrificantes.\n",
      "\n",
      "Cetorolaco 0,5% has been shown to be effective in controlled studies for alleviating symptoms of acute conjunctivitis, reducing the duration of the contagious period, compared to the use of lubricating eye drops.\n",
      "\n",
      "The other options are incorrect for the following reasons:\n",
      "\n",
      "a) Removing pseudomembranes is not associated with a higher risk of symblepharon formation, and it is not necessary to avoid it.\n",
      "\n",
      "b) Topical corticosteroids of low concentration are not indicated for preventing the appearance of pseudomembranes. They are prescribed after the onset of symptoms to reduce inflammation.\n",
      "\n",
      "c) Topical corticosteroids used in the acute phase do not favor viral replication with an increase in the viral load on the ocular surface.\n",
      "{'response': 'd'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding adenoviral conjunctivitis, it is correct to state:\n",
      "a) The removal of pseudomembranes is associated with a higher risk of symblepharon formation and therefore should be avoided.\n",
      "b) Use of low-concentration topical corticosteroids is indicated to prevent the appearance of pseudomembranes, and therefore, they are prescribed soon after the onset of symptoms.\n",
      "c) Topical corticosteroids, used in the acute phase, favor viral replication with increased viral load on the ocular surface.\n",
      "d) Controlled studies have shown the effectiveness of using ketorolac 0.5% in the acute phase of conjunctivitis to relieve symptoms, with a reduction in the duration of the contagion period, compared to the use of lubricating eye drops.\n",
      "Test #0: \n",
      "response\n",
      "  Here's the answer in Spanish:\n",
      "```json\n",
      "{\n",
      "  \"response\": \"b\"\n",
      "}\n",
      "```\n",
      "La respuesta correcta es b) El uso de corticosteroides tópicos de baja concentración se indica para prevenir la aparición de pseudomembranas, por lo que se recetan poco después del inicio de los síntomas.\n",
      "\n",
      "Here's the answer in Tagalog:\n",
      "```json\n",
      "{\n",
      "  \"response\": \"b\"\n",
      "}\n",
      "```\n",
      "Ang tamaan na sanggaling na may kinalaman sa adenoviral conjunctivitis ay b) Ang gamit ng mababa na concentrasyon ng corticosteroides tópicos ay para mapigilan ang pagkakakitaan ng pseudomembranas, at ang gamit nito ay hindi dapat delayed.\n",
      "\n",
      "Here's the answer in Portuguese:\n",
      "```json\n",
      "{\n",
      "  \"response\": \"b\"\n",
      "}\n",
      "```\n",
      "A resposta correta é b) O uso de corticosteroides tópicos de baixa concentração é indicado para prevenir a formação de pseudomembranas, e portanto, devem ser prescritos logo após o início dos sintomas.\n",
      "\n",
      "Here's the answer in English:\n",
      "```json\n",
      "{\n",
      "  \"response\": \"b\"\n",
      "}\n",
      "```\n",
      "The correct answer is b) The use of low-concentration topical corticosteroids is indicated to prevent the formation of pseudomembranes, and therefore, they should be prescribed soon after the onset of symptoms.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 139: \n",
      "Language: spanish\n",
      "Question: \n",
      "Teniendo en cuenta los trasplantes corneales realizados con fines ópticos, ¿cuál es la asociación más apropiada?\n",
      "\n",
      "I. Distrofia Fuchs.\n",
      "II.Distrofia granular.\n",
      "Iii.Opacidad después de la hidropiedad.\n",
      "IV.queratopatía ampollosa.\n",
      "\n",
      "A- Indicación para el trasplante lamelar posterior.\n",
      "B- Contraindicación para realizar un trasplante lamelar anterior profundo.\n",
      "C-contraindicación para realizar un trasplante lamelar anterior superficial.\n",
      "D-indicación para un trasplante lamelar anterior profundo.\n",
      "\n",
      "a) I: A, II: B, III: D, IV: C.\n",
      "b) I: B, II: D, III: C, IV: A.\n",
      "c) I: C, II: A, III: D, IV: B.\n",
      "d) I: D, II: C, III: A, IV: B.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking for the most appropriate association between corneal transplants and their respective indications or contraindications.\n",
      "\n",
      "Option A is incorrect because Distrofia Fuchs is not a contraindication for a deep anterior lamellar keratoplasty (DALK), but rather an indication for a posterior lamellar keratoplasty (PLK).\n",
      "\n",
      "Option B is incorrect because Distrofia granular is not a contraindication for a deep anterior lamellar keratoplasty (DALK), but rather an indication for a superficial anterior lamellar keratoplasty (SALK).\n",
      "\n",
      "Option C is incorrect because Opacidad después de la hidropiedad is not a contraindication for a deep anterior lamellar keratoplasty (DALK), but rather an indication for a superficial anterior lamellar keratoplasty (SALK).\n",
      "\n",
      "Option D is incorrect because Queratopatía ampollosa is not an indication for a deep anterior lamellar keratoplasty (DALK), but rather a contraindication for any type of keratoplasty.\n",
      "\n",
      "Therefore, the correct answer is option b, which associates Distrofia Fuchs with the indication for a posterior lamellar keratoplasty (PLK), Distrofia granular with the indication for a superficial anterior lamellar keratoplasty (SALK), Opacidad después de la hidropiedad with the indication for a superficial anterior lamellar keratoplasty (SALK), and Queratopatía ampollosa with the contraindication for any type of keratoplasty.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Pagtambalin ang mga kondisyon sa mata sa Hanay A at ang mga angkop na pahayag sa Hanay B\n",
      "\n",
      "I. Fuchs Dystrophy.\n",
      "II. Granular Dystrophy.\n",
      "III. Opacity pagkatapos ng hydrops.\n",
      "IV. Bullous keratopathy.\n",
      "\n",
      "A- Indikasyon para sa posterior lamellar transplantation\n",
      "B- Kontraindikasyon para sa pagsasagawa ng deep anterior lamellar transplant\n",
      "C- Kontraindikasyon para sa pagsasagawa ng superficial anterior lamellar transplant\n",
      "D- Indikasyon para sa deep anterior lamellar transplant\n",
      "\n",
      "a) I: A, II: B, III: D, IV: C.\n",
      "b) I: B, II: D, III: C, IV: A.\n",
      "c) I: C, II: A, III: D, IV: B.\n",
      "d) I: D, II: C, III: A, IV: B.\n",
      "Test #0: \n",
      "response\n",
      "  Here's my answer:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"b) I: B, II: D, III: C, IV: A.\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "I. Fuchs Dystrophy - This is a condition where the corneal epithelium thinning and irregularity, which can cause vision problems. It is a contraindication for deep anterior lamellar transplantation (DALT) because the thinning of the epithelium may compromise the success of the transplant.\n",
      "\n",
      "II. Granular Dystrophy - This is a condition where there is a accumulation of granular material in the corneal stroma, which can cause vision problems. It is a contraindication for deep anterior lamellar transplantation (DALT) because the granular material may compromise the success of the transplant.\n",
      "\n",
      "III. Opacity after hydrops - This is a condition where there is an opacity in the cornea after hydrops, which can cause vision problems. It is a contraindication for superficial anterior lamellar transplantation (SALT) because the opacity may compromise the success of the transplant.\n",
      "\n",
      "IV. Bullous keratopathy - This is a condition where there are bullae in the corneal epithelium, which can cause vision problems. It is an indication for deep anterior lamellar transplantation (DALT) because the transplant can help to replace the damaged epithelium and improve vision.\n",
      "\n",
      "Therefore, the correct answer is b) I: B, II: D, III: C, IV: A.\n",
      "{'response': 'b) I: B, II: D, III: C, IV: A.'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Considerando os transplantes de córnea realizados com finalidade óptica, qual a associação mais adequada?\n",
      "\n",
      "I. Distrofia de Fuchs.\n",
      "II. Distrofia granular.\n",
      "III. Opacidade após hidrópsia.\n",
      "IV. Ceratopatia bolhosa.\n",
      "\n",
      "A- Indicação para realização de transplante lamelar posterior.\n",
      "B- Contraindicação para a realização de transplante lamelar anterior profundo.\n",
      "C- Contraindicação para realização de transplante lamelar anterior superficial.\n",
      "D- Indicação para a realização de transplante lamelar anterior profundo.\n",
      "\n",
      "a)I: A, II: B, III: D, IV: C.\n",
      "b)I: B, II: D, III: C, IV: A.\n",
      "c)I: C, II: A, III: D, IV: B.\n",
      "d)I: D, II: C, III: A, IV: B.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking for the most appropriate association between a condition and a type of corneal transplant. The correct answer is option b:\n",
      "\n",
      "* I. Distrofia de Fuchs - Contraindication for deep anterior lamellar transplant (B)\n",
      "* II. Distrofia granular - Indication for deep anterior lamellar transplant (A)\n",
      "* III. Opacidade após hidrópsia - Contraindication for superficial anterior lamellar transplant (C)\n",
      "* IV. Ceratopatia bolhosa - Indication for deep anterior lamellar transplant (D)\n",
      "\n",
      "Therefore, the correct association is:\n",
      "\n",
      "b)I: B, II: D, III: C, IV: A.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Considering corneal transplants performed for optical purposes, what is the most appropriate association?\n",
      "\n",
      "I. Fuchs dystrophy.\n",
      "II. granular dystrophy.\n",
      "III. Opacity after hydrops.\n",
      "IV. bullous keratopathy.\n",
      "\n",
      "A- Indication for posterior lamellar transplantation.\n",
      "B- Contraindication for performing a deep anterior lamellar transplant.\n",
      "C- Contraindication for performing a superficial anterior lamellar transplant.\n",
      "D- Indication for deep anterior lamellar transplantation.\n",
      "\n",
      "a) I: A, II: B, III: D, IV: C.\n",
      "b) I: B, II: D, III: C, IV: A.\n",
      "c) I: C, II: A, III: D, IV: B.\n",
      "d) I: D, II: C, III: A, IV: B.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "I. Fuchs dystrophy is a contraindication for performing a deep anterior lamellar transplant, therefore, option B is the correct association.\n",
      "\n",
      "II. Granular dystrophy is a contraindication for performing a superficial anterior lamellar transplant, therefore, option D is the correct association.\n",
      "\n",
      "III. Opacity after hydrops is an indication for deep anterior lamellar transplantation, therefore, option A is the correct association.\n",
      "\n",
      "IV. Bullous keratopathy is an indication for posterior lamellar transplantation, therefore, option C is the correct association.\n",
      "\n",
      "Therefore, the correct answer is option b: I: B, II: D, III: A, IV: C.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 140: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto al herpes zoster oftálmico es correcto afirmar:\n",
      "a) En el tratamiento de pacientes adultos inmunocompetentes cuando se realiza con valaciclovir se utiliza una dosis total diaria de 3 g.\n",
      "b) La endotelitis disciforme, seguida de las úlceras neurotróficas, son las dos manifestaciones clínicas más frecuentes de afectación corneal, considerando los dos primeros meses del inicio de la infección.\n",
      "c) El signo de Hutchinson indica afectación de las ramas maxilar y mandibular del nervio trigémino y señala una mayor probabilidad de afectación ocular durante la infección.\n",
      "d) Un solo dermatoma se verá afectado en la misma aparición de infección.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) El signo de Hutchinson indica afectación de las ramas maxilar y mandibular del nervio trigémino y señala una mayor probabilidad de afectación ocular durante la infección.\n",
      "\n",
      "Explanation:\n",
      "\n",
      "a) Incorrect. The correct dosage of valaciclovir for treating herpes zoster in immunocompetent adults is 1 g three times a day for 7-10 days.\n",
      "\n",
      "b) Incorrect. While endothelitis disciforme and neurotrophic ulcers are indeed common manifestations of herpes zoster infection, they are not the most frequent clinical manifestations in the first two months of the infection.\n",
      "\n",
      "d) Incorrect. Herpes zoster typically affects multiple dermatomes, not just one.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na pahayag tungkol sa ophthalmic herpes zoster ang totoo?\n",
      "a) Sa paggamot ng immunocompetent na pasyente gamit ang valaciclovir, 3 g ang inirerekomendang pang-araw-araw na dosage.\n",
      "b) Ang disciform endothelitis na susundan ng neurotrophic ulcer, ang dalawang madalas na klinikal na manipestasyon ng corneal involvement, sa loob ng dalawang buwan pagkatapos ng onset ng impeksyon\n",
      "c) Ipinapahiwatig ng Hutchinson sign ang kinalaman ng maxillary at mandibular na mga sanga ng trigeminal nerve at nagpapahiwatig din ito pagtaas ng posibilidad ng oculae involvement habang nagkakaimpeksyon.\n",
      "d) Isang single dermatome ang maaapektuhan kasabay ng manipestasyon ng impeksyon\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option c, \"Ipinapahiwatig ng Hutchinson sign ang kinalaman ng maxillary at mandibular na mga sanga ng trigeminal nerve at nagpapahiwatig din ito pagtaas ng posibilidad ng oculae involvement habang nagkakaimpeksyon.\"\n",
      "\n",
      "Hutchinson sign is a clinical sign used to assess the likelihood of ophthalmic herpes zoster involvement. It is characterized by a vesicular eruption on the tip of the nose and/or the peripheral limbs, which are innervated by the maxillary and mandibular branches of the trigeminal nerve. The presence of Hutchinson sign increases the likelihood of ocular involvement during herpes zoster infection.\n",
      "\n",
      "Option a is incorrect because it refers to the dosage of valaciclovir for treating immunocompetent patients with herpes zoster, which is not related to the question.\n",
      "\n",
      "Option b is incorrect because disciform endothelitis and neurotrophic ulcer are not specific to ophthalmic herpes zoster, but rather are complications that can occur in the cornea due to various causes.\n",
      "\n",
      "Option d is incorrect because a single dermatome is not a characteristic of ophthalmic herpes zoster, but rather a feature of herpes zoster infection in general.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação ao herpes zoster oftálmico, é correto afirmar:\n",
      "a)No tratamento de pacientes adultos imunocompetentes quando realizado com o valaciclovir, é utilizada a dose total diária de 3 g.\n",
      "b)A endotelite disciforme, seguida da úlcera neurotrófica, são as duas manifestações clínicas mais frequentes do comprometimento da córnea, considerando os dois primeiros meses após o início da infecção.\n",
      "c)O sinal de Hutchinson indica comprometimento dos ramos maxilar e mandibular do nervo trigêmeo e sinaliza aumento de probabilidade do acometimento ocular durante a infecção.\n",
      "d)Um único dermátomo será acometido numa mesma ocorrência da infecção.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the correct statement regarding herpes zoster ophthalmicus.\n",
      "\n",
      "Option A is incorrect because the recommended dose of valaciclovir for treating herpes zoster in immunocompetent adults is 1000 mg three times a day for 7-10 days, not 3 g per day.\n",
      "\n",
      "Option C is incorrect because Hutchinson's sign, which is a sign of paralysis of the facial nerve, does not indicate an increased probability of ocular involvement during the infection.\n",
      "\n",
      "Option D is incorrect because multiple dermatomes can be affected in a single occurrence of herpes zoster.\n",
      "\n",
      "Therefore, the correct answer is option B, which states that endothelial disciforme followed by neurotrophic ulcer are the two most common clinical manifestations of corneal involvement in herpes zoster, considering the first two months after the onset of infection.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding ophthalmic herpes zoster, it is correct to state:\n",
      "a) In the treatment of immunocompetent adult patients when performed with valaciclovir, a total daily dose of 3 g is used.\n",
      "b) Disciform endothelitis, followed by neurotrophic ulcer, are the two most frequent clinical manifestations of corneal involvement, considering the first two months after the onset of infection.\n",
      "c) Hutchinson's sign indicates involvement of the maxillary and mandibular branches of the trigeminal nerve and indicates an increased probability of ocular involvement during infection.\n",
      "d) A single dermatome will be affected in the same occurrence of the infection.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Hutchinson's sign is a clinical sign that indicates involvement of the maxillary and mandibular branches of the trigeminal nerve in patients with ophthalmic herpes zoster. It is characterized by a vesicular eruption on the tip of the nose and/or the peripheral part of the upper lip, and is associated with an increased probability of ocular involvement during infection. Therefore, option c is the correct answer.\n",
      "\n",
      "Option a is incorrect because the total daily dose of valaciclovir for the treatment of immunocompetent adult patients with ophthalmic herpes zoster is 1 g, not 3 g.\n",
      "\n",
      "Option b is incorrect because disciform endothelitis and neurotrophic ulcer are not the two most frequent clinical manifestations of corneal involvement in ophthalmic herpes zoster. Disciform endothelitis is a type of corneal endothelial disease that can occur in the setting of herpes zoster, but it is not the most common clinical manifestation.\n",
      "\n",
      "Option d is incorrect because a single dermatome is not always affected in the same occurrence of ophthalmic herpes zoster. The virus can affect multiple dermatomes, and the extent of the dermatomal involvement can vary.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 141: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto a los exámenes preoperatorios en cirugía refractiva, seleccionar la alternativa correcta.\n",
      "a) La topografía del disco de Plácido genera el mapa paquimétrico o de espesor corneal.\n",
      "b) La topografía del disco de Plácido y el sistema de Scheimpflug son capaces de generar mapas tanto axiales como tangenciales de la córnea.\n",
      "c) Los mapas generados por la topografía del disco de Plácido se derivan del reflejo de la superficie anterior y posterior de la córnea.\n",
      "d) El sistema Scheimpflug evalúa la curvatura anterior, el mapa de espesor, pero no la cara posterior.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "La opción correcta es b) La topografía del disco de Plácido y el sistema de Scheimpflug son capaces de generar mapas tanto axiales como tangenciales de la córnea.\n",
      "\n",
      "La topografía del disco de Plácido es una técnica que utiliza un dispositivo llamado topógrafo para medir la forma y la curvatura de la córnea. El sistema de Scheimpflug, por otro lado, utiliza un dispositivo llamado Scheimpflug Camera para medir la curvatura de la córnea en diferentes planos. Ambos dispositivos son capaces de generar mapas detallados de la córnea, incluyendo mapas axiales y tangenciales, que son útiles para la planificación de la cirugía refractiva.\n",
      "\n",
      "La opción a) es incorrecta porque el mapa paquimétrico o de espesor corneal se genera a partir de la medición de la altura de la córnea en diferentes puntos, mientras que la topografía del disco de Plácido se utiliza para medir la forma y la curvatura de la córnea.\n",
      "\n",
      "La opción c) es incorrecta porque los mapas generados por la topografía del disco de Plácido se derivan de la medición de la forma y la curvatura de la córnea, pero no directamente del reflejo de la superficie anterior y posterior de la córnea.\n",
      "\n",
      "La opción d) es incorrecta porque el sistema Scheimpflug evalúa la curvatura anterior y el mapa de espesor de la córnea, pero no la cara posterior.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na pahayag patungkol sa preoperative exams sa refractive surgery ang totoo?\n",
      "a) Ang topograpikong disc ng Placido ay lumilikha ng mapa ng pachymetric o kapal ng cornea\n",
      "b) Ang topograpiya ng disc ng Placido at ang Scheimpflug system ay may kakayahang makabuo ng parehong mga axial at tangential na mga mapa ng cornea.\n",
      "c) Ang mga mapa na nabuo ng topograpikong disk ng plácido ay nagmula sa repleksyin ng anterior at posterior surface ng cornea\n",
      "d) Sinusuri ng Scheimpflug system ang anterior curvature, ang kapal ng namapa, ngunit hindi ang posterior face.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Ang topograpiya ng disc ng Placido at ang Scheimpflug system ay may kakayahang makabuo ng parehong mga axial at tangential na mga mapa ng cornea.\n",
      "\n",
      "The Placido disc and Scheimpflug system are both used in refractive surgery to create maps of the cornea. The Placido disc creates a map of the corneal surface, while the Scheimpflug system creates a map of the anterior and posterior surfaces of the cornea. These maps are used to guide the surgery and ensure that the cornea is properly aligned during the procedure.\n",
      "\n",
      "Option a is incorrect because the Placido disc only creates a map of the corneal surface, and does not create a map of the pachymetric or thickness of the cornea.\n",
      "\n",
      "Option c is incorrect because the maps created by the Placido disc are not based on the reflections of the anterior and posterior surfaces of the cornea, but rather on the surface of the disc itself.\n",
      "\n",
      "Option d is incorrect because the Scheimpflug system does measure the anterior curvature and the thickness of the cornea, but it does not measure the posterior face of the cornea.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Em relação aos exames pré-operatórios em cirurgia refrativa, assinale a alternativa correta.\n",
      "a)A topografia de disco de Plácido gera o mapa paquimétrico ou de espessura corneana.\n",
      "b)A topografia de disco de Plácido e o sistema de Scheimpflug são capazes de gerar tanto os mapas axiais como os tangenciais da córnea.\n",
      "c)Os mapas gerados pela topografia de disco de Plácido são derivados da reflexão da face anterior e posterior da córnea.\n",
      "d)O sistema de Scheimpflug avalia a curvatura anterior, o mapa de espessura, mas não a face posterior.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) A topografia de disco de Plácido e o sistema de Scheimpflug são capazes de gerar tanto os mapas axiais como os tangenciais da córnea.\n",
      "\n",
      "Topografia de disco de Plácido and Scheimpflug system are both capable of generating both axial and tangential maps of the cornea. The Plácido disk topography generates a map of the corneal surface, while the Scheimpflug system measures the curvature of the anterior surface of the cornea. Therefore, option b is the correct answer.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding preoperative exams in refractive surgery, mark the correct alternative.\n",
      "a) Placido disc topography generates the pachymetric or corneal thickness map.\n",
      "b) Placido's disc topography and the Scheimpflug system are capable of generating both axial and tangential maps of the cornea.\n",
      "c) The maps generated by Plácido's disk topography are derived from the reflection of the anterior and posterior surface of the cornea.\n",
      "d) The Scheimpflug system evaluates the anterior curvature, the thickness map, but not the posterior face.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option c) The maps generated by Plácido's disk topography are derived from the reflection of the anterior and posterior surface of the cornea.\n",
      "\n",
      "Plácido's disk topography is a technique used in refractive surgery to measure the curvature of the cornea. It uses a disk-shaped device that is placed on the cornea and measures the reflection of light off the anterior and posterior surfaces of the cornea. This produces a map of the cornea's curvature, which is used to guide the surgery.\n",
      "\n",
      "Option a) is incorrect because while Placido disc topography does generate a pachymetric or corneal thickness map, it is not the only option.\n",
      "\n",
      "Option b) is incorrect because while the Scheimpflug system is capable of generating both axial and tangential maps of the cornea, it is not the same as Plácido's disk topography.\n",
      "\n",
      "Option d) is incorrect because the Scheimpflug system does evaluate the anterior curvature and thickness map, but not the posterior face.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 142: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál de las condiciones a continuación tiene un mayor riesgo después de la cirugía LASIK?\n",
      "a) catarata.\n",
      "b) Glaucoma.\n",
      "c) ojo seco.\n",
      "d) Detapa de la retina.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is d) Detapa de la retina.\n",
      "\n",
      "LASIK surgery can increase the risk of retinal detachment, which is a serious complication that can lead to vision loss. The other options, cataracts, glaucoma, and dry eye, are also potential complications of LASIK surgery, but they are not as strongly associated with retinal detachment as option d.\n",
      "{'response': 'd'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga kundisyon sa ibaba ang puwedeng maging komplikasyon pagkatapos ng isang LASIK na operasyon?\n",
      "a) Katarata\n",
      "b) Glaucoma\n",
      "c) Nanunuyong mata\n",
      "d) Retinal detachment\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\" // Retinal detachment\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Retinal detachment is a possible complication after LASIK surgery. It occurs when the retina separates from the underlying tissue, leading to vision loss or distortion. The other options, cataract (a), glaucoma (b), and dry eye (c), are also potential complications of LASIK, but they are not the most likely option in this case.\n",
      "{'response': 'd'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual das condições abaixo tem seu risco aumentado após cirurgia de LASIK?\n",
      "a)Catarata.\n",
      "b)Glaucoma.\n",
      "c)Olho seco.\n",
      "d)Descolamento de retina.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking which condition has an increased risk after LASIK surgery. The correct answer is d) Descolamento de retina (Retinal detachment). LASIK surgery can increase the risk of retinal detachment, which is a serious complication that can lead to vision loss if left untreated. The other options, a) Catarata (Cataract), b) Glaucoma, and c) Olho seco (Dry eye), are not associated with an increased risk after LASIK surgery.\n",
      "{'response': 'd'}\n",
      "Language: english\n",
      "Question: \n",
      "Which of the conditions below is at increased risk after LASIK surgery?\n",
      "a) Cataract.\n",
      "b) Glaucoma.\n",
      "c) Dry eye.\n",
      "d) retinal detachment.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\" // The correct response is c) Dry eye.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "LASIK surgery can increase the risk of dry eye, as the surgery can disrupt the nerves that control tear production. This is a common complication of LASIK surgery and can last for several months after the procedure.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "* a) Cataract: LASIK surgery is used to treat cataracts, so it would not increase the risk of developing cataracts.\n",
      "* b) Glaucoma: LASIK surgery does not increase the risk of glaucoma.\n",
      "* d) Retinal detachment: LASIK surgery does not increase the risk of retinal detachment. However, it is important to note that retinal detachment can be a complication of any eye surgery, including LASIK.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 143: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto al uso de lentes de contacto terapéuticos, seleccionar la alternativa correcta.\n",
      "a) Las lentes de hidrogel de silicona mejoran la acción de los medicamentos.\n",
      "b) En caso de perforación ocular, la lente no debe usarse sin asociación con adhesivo tisular o sutura.\n",
      "c) En los casos de defectos epiteliales, el intercambio es diario.\n",
      "d) Su adaptación se realiza con cambios mayores que los habituales.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) En caso de perforación ocular, la lente no debe usarse sin asociación con adhesivo tisular o sutura.\n",
      "\n",
      "Lentes de contacto terapéuticos are designed to be used in the treatment of various eye conditions, including perforating ocular injuries. In such cases, it is important to note that the lens should not be used without proper association with tissue adhesive or sutures, as this can lead to further complications.\n",
      "\n",
      "Option a) is incorrect because hydrogels made of silicone do not improve the action of medications.\n",
      "\n",
      "Option c) is incorrect because the lens exchange is not necessarily daily in cases of epithelial defects.\n",
      "\n",
      "Option d) is incorrect because the adaptation of the lens does not require larger changes than usual.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Kaugnay sa paggamit ng mga therapeutic contact lens, alin sa mga sumusunod na pahayag ang tama:\n",
      "a) Ang mga lente ng silicone-hydrogel ay nagpapalakas ng bisa ng mga gamot\n",
      "b) Sa kaso ng ocular perforation, ang lens ay hindi dapat gamitin nang walang kaugnayan sa tissue adhesive o suture.\n",
      "c) Sa mga kaso ng mga epithelial defects, araw-araw dapat palitan ang lente\n",
      "d) Malaki ang pagbabago sa adaptasyon nito\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Sa kaso ng ocular perforation, ang lens ay hindi dapat gamitin nang walang kaugnayan sa tissue adhesive o suture.\n",
      "\n",
      "Therapeutic contact lenses are designed to provide a therapeutic effect to the eye, such as promoting healing, reducing inflammation, or managing pain. In the case of ocular perforation, it is important to note that therapeutic contact lenses should not be used without proper attachment to the tissue adhesive or suture. This is because the lens may not stay in place properly and may cause further irritation or damage to the eye.\n",
      "\n",
      "Therefore, option b is the correct answer.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Em relação ao uso de lente de contato terapêutica, assinale a alternativa correta.\n",
      "a)As lentes de silicone-hidrogel potencializam a ação de medicamentos.\n",
      "b)No caso de perfuração ocular a lente não deve ser utilizada sem a associação com adesivo tecidual ou sutura.\n",
      "c)Nos casos de defeitos epiteliais a troca é diária.\n",
      "d)Sua adaptação é realizada com maiores trocas que a habitual.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) No caso de perfuração ocular a lente não deve ser utilizada sem a associação com adesivo tecidual ou sutura.\n",
      "\n",
      "In the case of ocular perforation, the use of a therapeutic contact lens should not be done without associating it with tissue adhesive or sutures. This is because the lens can move around and potentially worsen the perforation, and the adhesive or sutures help to keep the lens in place and promote healing.\n",
      "\n",
      "The other options are incorrect because:\n",
      "\n",
      "* a) As lentes de silicone-hidrogel potencializam a ação de medicamentos - This statement is false. Silicone-hydrogel lenses do not potentiate the action of medications.\n",
      "* c) Nos casos de defeitos epiteliais a troca é diária - This statement is false. In cases of epithelial defects, the lens should be replaced every 2-4 weeks, not daily.\n",
      "* d) Sua adaptação é realizada com maiores trocas que a habitual - This statement is false. The adaptation of a therapeutic contact lens is not done with more frequent changes than usual.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding the use of therapeutic contact lenses, mark the correct alternative.\n",
      "a) Silicone-hydrogel lenses potentiate the action of medications.\n",
      "b) In the case of ocular perforation, the lens must not be used without association with tissue adhesive or suture.\n",
      "c) In cases of epithelial defects, the change is daily.\n",
      "d) Its adaptation is carried out with greater changes than usual.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) In the case of ocular perforation, the lens must not be used without association with tissue adhesive or suture.\n",
      "\n",
      "Therapeutic contact lenses are designed to provide a therapeutic effect to the eye, such as drug delivery or wound healing. In the case of ocular perforation, using a therapeutic contact lens without proper association with tissue adhesive or suture can lead to further complications, such as infection or worsening of the perforation.\n",
      "\n",
      "Option a is incorrect because silicone-hydrogel lenses do not potentiate the action of medications. They are designed to allow for better oxygen flow and comfort, but they do not enhance the effectiveness of medications.\n",
      "\n",
      "Option c is incorrect because the change in therapeutic contact lenses for epithelial defects is not necessarily daily. The frequency of change depends on the severity of the defect and the individual patient's response to treatment.\n",
      "\n",
      "Option d is incorrect because the adaptation of therapeutic contact lenses is not necessarily carried out with greater changes than usual. The adaptation process depends on various factors, such as the patient's comfort level and the severity of the eye condition.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 144: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un paciente con queratometría de 44,00/48,00 optó por la adaptación de lentes de contacto. Se adaptó uno con una curva base de 45.00. Es correcto afirmar que:\n",
      "a) La lente lagrimal formada será de +3,00 dioptrías, ya que a este valor corresponde la diferencia entre el meridiano más curvo de la lente y la curva base.\n",
      "b) El concepto de K se aplica al meridiano más plano, y su diferencia con la curva base da como resultado una lente positiva de +1,00 dioptría.\n",
      "c) El paciente con este valor de queratometría no podría utilizar lentes de contacto, ya que presenta una ectasia corneal muy importante.\n",
      "d) El valor del meridiano más curvado del cristalino corneal se denomina K, y las lentes adaptadas con una curva de base más curvada que K forman una lente lagrimal con poder dióptrico de -1,00 Dioptría.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) El concepto de K se aplica al meridiano más plano, y su diferencia con la curva base da como resultado una lente positiva de +1,00 dioptría.\n",
      "\n",
      "In this case, the patient's keratometry reading is 44.00/48.00, and the base curve of the contact lens is 45.00. The difference between the flattest meridian of the cornea (K) and the base curve is 1.00 diopter, which means the lens will be positive. Therefore, option b is the correct answer.\n",
      "\n",
      "Option a is incorrect because the lens power would be +3.00 diopters, not +1.00 diopter.\n",
      "\n",
      "Option c is incorrect because the patient's keratometry reading does not indicate a significant ectasia corneal that would prevent the use of contact lenses.\n",
      "\n",
      "Option d is incorrect because the concept of K refers to the flattest meridian of the cornea, not the steepest meridian. Additionally, the lens power would be positive, not negative.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Isang pasyente na may keratometry na 44.00/48.00 ang dumulog para magpasukat ng contact lens. Ang isa na may base curve na 45.00 ay ginamit. Kaugnay nito, alin sa mga sumusunod na pahayag ang angkop na sabihin:\n",
      "a) Ang lacrimal lens na mabubuo ay +3.00 diopters, dahil ang pagkakaiba sa pagitan ng pinakamakurbang meridian ng lente at ng base curve ay tugma sa sukat na ito.\n",
      "b) Ang konsepto ng K ay para sa patag na meridian, at ang pagkakaiba nito sa base curve ay nagreresulta sa isang positibong lens na +1.00 diopter.\n",
      "c) Ang pasyente na may kapantay na keratometry ay hindi maaaring magsuot ng mga contact lens, dahil sa corneal ectasia.\n",
      "d) Ang sukat ng pinakamakurbang meridian ng contact lens ay tinatawag na K, at ang adapted na mga lente na mas makurba kaysa sa K ay bumubuonng lacrimal na lente na may dioptric power na -1.00 diopter\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient has a keratometry reading of 44.00/48.00 and a base curve of 45.00. The correct response is option a, which states that the lacrimal lens that should be used is +3.00 diopters, as the difference between the flattest meridian of the lens and the base curve is equal to the reading of 44.00/48.00.\n",
      "\n",
      "Option b is incorrect because the concept of K is for the steepest meridian, not the flattest meridian. Option c is also incorrect because the patient's keratometry reading does not indicate corneal ectasia. Option d is incorrect because the adapted lenses that are more curved than the K reading would result in a lacrimal lens with a dioptric power of -1.00 diopter, which is not the correct prescription for the patient.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Um paciente com a ceratometria de 44,00/48,00 optou por adaptação de lente de contato. Foi adaptada uma de curva base 45,00. É correto afirmar que:\n",
      "a)A lente lacrimal formada será de +3,00 dioptrias, uma vez que a diferença entre o meridiano mais curvo da lente e a curva base corresponde a esse valor.\n",
      "b)O conceito de K se aplica ao meridiano mais plano, e sua diferença com a curva base resulta em uma lente positiva de +1,00 dioptria.\n",
      "c)O paciente com esse valor de ceratometria não poderia usar lentes de contato, uma vez que há ectasia corneana muito importante.\n",
      "d)O valor do meridiano mais curvo da lente da córnea é chamado de K, e lentes adaptadas com curva base mais curva que K formam uma lente lacrimal com poder dióptrico de -1,00 Dioptria.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the correct statement regarding the adaptation of a contact lens for a patient with a keratometry reading of 44.00/48.00.\n",
      "\n",
      "Option A is incorrect because the lens lacrimal formed will not be +3.00 diopters, as the difference between the meridian and the base curve does not correspond to that value.\n",
      "\n",
      "Option C is incorrect because the patient's keratometry reading does not indicate ectasia corneana (keratoconus), which would contraindicate the use of contact lenses.\n",
      "\n",
      "Option D is incorrect because the meridian with the steepest curvature of the cornea is not called K, and lenses adapted with a base curve steeper than K would not form a lens lacrimal with a negative diopter power.\n",
      "\n",
      "Therefore, the correct answer is option B, which states that the concept of K applies to the flattest meridian, and the difference between the base curve and the flattest meridian results in a positive lens power of +1.00 diopter.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "One patient with a keratometry of 44.00/48.00 opted for contact lens fitting. One with a base curve of 45.00 was adapted. It is correct to say that:\n",
      "a) The lacrimal lens formed will be +3.00 diopters, since the difference between the most curved meridian of the lens and the base curve corresponds to this value.\n",
      "b) The concept of K applies to the flattest meridian, and its difference with the base curve results in a positive lens of +1.00 diopter.\n",
      "c) The patient with this keratometry value could not wear contact lenses, since there is very important corneal ectasia.\n",
      "d) The value of the most curved meridian of the corneal lens is called K, and adapted lenses with a base curve more curved than K form a lacrimal lens with a dioptric power of -1.00 Diopter.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option b. The concept of K (Keratometry) applies to the flattest meridian, and its difference with the base curve results in a positive lens of +1.00 diopter.\n",
      "\n",
      "In this case, the patient's keratometry reading is 44.00/48.00, which means that the flattest meridian of their cornea is 44.00 diopters, and the base curve of the contact lens adapted was 45.00 diopters. Therefore, the difference between the flattest meridian and the base curve is +1.00 diopter, resulting in a positive lens power of +1.00 diopter.\n",
      "\n",
      "Option a is incorrect because the difference between the most curved meridian of the lens and the base curve does not correspond to a value of +3.00 diopters.\n",
      "\n",
      "Option c is incorrect because the patient's keratometry value does not indicate very important corneal ectasia that would prevent them from wearing contact lenses.\n",
      "\n",
      "Option d is incorrect because the value of the most curved meridian of the corneal lens is not called K, and adapted lenses with a base curve more curved than K would not form a lacrimal lens with a dioptric power of -1.00 diopter.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 145: \n",
      "Language: spanish\n",
      "Question: \n",
      "Un paciente tiene una refracción estática de -8,00 dioptrías esféricas en ambos ojos y tiene intención de utilizar lentes de contacto. Respecto a las gafas, la graduación de tus lentes de contacto será:\n",
      "a)-7,50 Dioptrías.\n",
      "b)-8,00 Dioptrías.\n",
      "c)-8,50 Dioptrías.\n",
      "d) No es posible determinar la prescripción del cristalino sin realizar una topografía corneal.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient has a static refraction of -8,00 diopters spherical in both eyes and intends to use contact lenses. The correct answer is d) No es posible determinar la prescripción del cristalino sin realizar una topografía corneal. This is because the prescription for contact lenses cannot be determined without performing a corneal topography, which is a test that maps the surface of the cornea to ensure a proper fit for the contact lens. The other options, a) -7,50 diopters, b) -8,00 diopters, and c) -8,50 diopters, are not the correct prescriptions for the patient's contact lenses.\n",
      "{'response': 'd'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Ang isang pasyente ay may isang static na refraction na -8.00 spherical dioptry sa parehong mga mata ay nagbabalak na magsuot ng mga contact lens. Ang sukat ng salamin na akma para sa kanya ay: \n",
      "a) -7.50 dioptres.\n",
      "b) -8.00 dioptres.\n",
      "c) -8.50 dioptres.\n",
      "d) Hindi posible na matukoy ang grado ng lente nang hindi nagsasagawa ng corneal topography\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "Explanation:\n",
      "\n",
      "The patient has a static refraction of -8.00 spherical dioptry in both eyes, and is considering wearing contact lenses. The appropriate lens power for the patient would be -8.00 dioptres, which is option b.\n",
      "\n",
      "It is not possible to determine the lens power without performing a corneal topography, which is a diagnostic test that maps the surface of the cornea to determine the best fit for contact lenses. Therefore, option d is not correct.\n",
      "\n",
      "Option a is too weak and would not provide adequate correction for the patient's myopia. Option c is too strong and could cause discomfort or eye strain for the patient.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Um paciente apresenta na refração estática -8,00 dioptria esferica em ambos os olhos e pretende utilizar lentes de contato. Com relação aos óculos, o grau da sua lente de contato será:\n",
      "a)-7,50 Dioptrias.\n",
      "b)-8,00 Dioptrias.\n",
      "c)-8,50 Dioptrias.\n",
      "d)Não é possível determinar a graduação da lente sem a realização da topografia de córnea.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The patient's static refraction is -8.00 diopters spherical in both eyes, and they want to use contact lenses. The correct answer is d) Not possible to determine the lens grade without corneal topography. This is because contact lenses are designed to fit the unique shape of an individual's cornea, and a topography is necessary to determine the appropriate lens power and fit.\n",
      "\n",
      "In option a), the lens power is -7.50 diopters, which is not the correct power for the patient's refraction.\n",
      "\n",
      "In option b), the lens power is -8.00 diopters, which is the same as the patient's refraction, but this is not the correct answer because it does not take into account the unique shape of the patient's cornea.\n",
      "\n",
      "In option c), the lens power is -8.50 diopters, which is too strong for the patient's refraction.\n",
      "{'response': 'd'}\n",
      "Language: english\n",
      "Question: \n",
      "A patient has a static refraction of -8.00 spherical dioptry in both eyes and intends to wear contact lenses. With regard to glasses, your contact lens prescription will be:\n",
      "a)-7.50 Dioptres.\n",
      "b)-8.00 Dioptres.\n",
      "c)-8.50 Dioptres.\n",
      "d) It is not possible to determine lens graduation without performing corneal topography.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "When a patient has a static refraction of -8.00 spherical dioptry in both eyes and intends to wear contact lenses, the contact lens prescription will be the same as the glasses prescription, which is -8.00 dioptres. Therefore, the correct answer is b.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 146: \n",
      "Language: spanish\n",
      "Question: \n",
      "En cuanto a la exotropía intermitente, seleccione la alternativa correcta.\n",
      "a) Los ejercicios ortópticos están contraindicados si la convergencia es insuficiente.\n",
      "b) Se resuelve espontáneamente en la gran mayoría de los casos.\n",
      "c) El tratamiento con oclusión está contraindicado si no hay ambliopía.\n",
      "d) El uso de lentes negativas (o hiperopización) proporciona mejores resultados si la relación convergencia/acomodación acomodativa es alta.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "La opción correcta es d) El uso de lentes negativas (o hiperopización) proporciona mejores resultados si la relación convergencia/acomodación acomodativa es alta.\n",
      "\n",
      "La exotropía intermitente es un tipo de desvío de la mirada que ocurre cuando el ojo no puede mantener la alineación propera durante el movimiento. En este caso, la relación convergencia/acomodación acomodativa es importante, ya que la hiperopización puede ayudar a mejorar la convergencia y reducir el desvío.\n",
      "\n",
      "Por lo tanto, la opción d) El uso de lentes negativas (o hiperopización) proporciona mejores resultados si la relación convergencia/acomodación acomodativa es alta es la respuesta correcta.\n",
      "\n",
      "Las otras opciones no son correctas por las siguientes razones:\n",
      "\n",
      "* a) Los ejercicios ortópticos están contraindicados si la convergencia es insuficiente: Esta opción no es correcta, ya que los ejercicios ortópticos pueden ser útiles para mejorar la convergencia en algunos casos de exotropía intermitente.\n",
      "* b) Se resuelve espontáneamente en la gran mayoría de los casos: Esta opción no es correcta, ya que la exotropía intermitente no se resuelve espontáneamente en la mayoría de los casos.\n",
      "* c) El tratamiento con oclusión está contraindicado si no hay ambliopía: Esta opción no es correcta, ya que el tratamiento con oclusión puede ser útil en algunos casos de exotropía intermitente, incluso si no hay ambliopía.\n",
      "{'response': 'd'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Patungkol sa panaka-nakang exotropia, alin sa mga sumusunod na pahayag ang may katotohanan?\n",
      "a) Hindi inirerekomenda ang mga orthoptic exercises kung hindi sapat ang convergence\n",
      "b) Sa karamihan ng mga kaso, ito ay kadalasang kusang nalulutas.\n",
      "c) Ang pagbibigay-lunas gamit ang mga occlusion ay kontraindikado kung walang amblyopia.\n",
      "d) Ang paggamit ng mga negatibong lente (o farsightedness) ay nagbibigay ng mas mainam na mga resulta kung mataas ang accommodative convergence o accommodation ratio.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Sa karamihan ng mga kaso, ito ay kadalasang kusang nalulutas.\n",
      "\n",
      "Exotropia is a type of strabismus or crossed eyes where the eye turns outward. In most cases, exotropia is not caused by a problem with the muscles that control eye movement, but rather by a defect in the brain's ability to coordinate eye movements. Therefore, option b) Sa karamihan ng mga kaso, ito ay kadalasang kusang nalulutas is the correct answer.\n",
      "\n",
      "Option a) Hindi inirerekomenda ang mga orthoptic exercises kung hindi sapat ang convergence is incorrect because while orthoptic exercises may not be recommended if the convergence is not sufficient, it does not necessarily mean that the exotropia is not caused by a defect in the brain's ability to coordinate eye movements.\n",
      "\n",
      "Option c) Ang pagbibigay-lunas gamit ang mga occlusion ay kontraindikado kung walang amblyopia is also incorrect because while occlusion therapy may be contraindicated in cases of amblyopia, it is not necessarily the case that exotropia is caused by a problem with the muscles that control eye movement.\n",
      "\n",
      "Option d) Ang paggamit ng mga negatibong lente (o farsightedness) ay nagbibigay ng mas mainam na mga resulta kung mataas ang accommodative convergence o accommodation ratio is incorrect because while glasses may be prescribed to treat farsightedness, it is not necessarily the case that exotropia is caused by a problem with the muscles that control eye movement.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação à exotropia intermitente, assinale a alternativa correta.\n",
      "a)Exercícios ortópticos são contraindicados se houver insuficiência de convergência.\n",
      "b)Resolve-se espontaneamente na grande maioria dos casos.\n",
      "c)O tratamento com oclusão é contraindicado se não houver ambliopia.\n",
      "d)O uso de lentes negativas (ou hipermetropização), proporciona melhor resultado se a relação convergência acomodativa/acomodação for alta.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option c: \"O tratamento com oclusão é contraindicado se não houver ambliopia.\"\n",
      "\n",
      "Exotropia intermitente is a type of strabismus where the eye turns outward occasionally. In this case, the treatment with occlusion (patching) is contraindicated if there is no amblyopia (lazy eye) present. Amblyopia is a condition where the brain favors one eye over the other, leading to poorer vision in the non-favored eye. If there is no amblyopia, occlusion therapy may not be effective in treating the exotropia.\n",
      "\n",
      "Therefore, option c is the correct answer. Options a, b, and d are incorrect.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "\n",
      "Regarding intermittent exotropia, mark the correct alternative.\n",
      "a) Orthoptic exercises are contraindicated if there is insufficient convergence.\n",
      "b) It resolves spontaneously in the vast majority of cases.\n",
      "c) Treatment with occlusion is contraindicated if there is no amblyopia.\n",
      "d) The use of negative lenses (or farsightedness) provides better results if the accommodative convergence/accommodation ratio is high.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Correct response: b\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "Intermittent exotropia is a type of strabismus where the eye turns outward occasionally, usually when the patient is tired, sick, or has been doing near work for an extended period. In the vast majority of cases, intermittent exotropia resolves spontaneously without treatment. Therefore, the correct answer is b) It resolves spontaneously in the vast majority of cases.\n",
      "\n",
      "Orthoptic exercises may be helpful in some cases of strabismus, but they are not recommended if there is insufficient convergence, as they may worsen the condition. Therefore, option a) Orthoptic exercises are contraindicated if there is insufficient convergence is incorrect.\n",
      "\n",
      "Treatment with occlusion, which involves covering one eye to force the other eye to work, may be recommended in some cases of strabismus. However, occlusion therapy is not always necessary, and its effectiveness depends on various factors, including the age of the patient, the severity of the strabismus, and the presence of amblyopia. Therefore, option c) Treatment with occlusion is contraindicated if there is no amblyopia is incorrect.\n",
      "\n",
      "Negative lenses or farsightedness may be used in some cases of strabismus to help align the eyes. However, the use of negative lenses depends on various factors, including the patient's age, the severity of the strabismus, and the presence of amblyopia. Therefore, option d) The use of negative lenses (or farsightedness) provides better results if the accommodative convergence/accommodation ratio is high is incorrect.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 147: \n",
      "Language: spanish\n",
      "Question: \n",
      "Entre los hallazgos a continuación, el que está asociado con la función sensorial binocular se considera el más refinado:\n",
      "a) Estereopsis.\n",
      "b) Fusión binocular.\n",
      "c) Diplopía.\n",
      "d) Percepción macular simultánea.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is a) Estereopsis.\n",
      "\n",
      "Estereopsis is the ability to perceive depth and distance using the differences between the images seen by each eye. It is a refined form of binocular vision that allows for accurate judgments of distance and depth, and is essential for tasks such as reaching for objects, grasping them, and manipulating them.\n",
      "\n",
      "Fusión binocular (b) refers to the combination of the images seen by each eye into a single image. While this is an important aspect of binocular vision, it is not the most refined form of binocular vision.\n",
      "\n",
      "Diplopía (c) is the perception of double vision, which can occur when the images seen by each eye are not properly aligned. This is not a refined form of binocular vision.\n",
      "\n",
      "Percepción macular simultánea (d) refers to the ability to see a single image simultaneously with both eyes, but this is not a refined form of binocular vision.\n",
      "{'response': 'a'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod ang kaugnay ng sensory binocular function na kinokonsidera bilang pinaka-repinado?\n",
      "a) Stereopsis\n",
      "b) Binocular fusion\n",
      "c) Diplopia\n",
      "d) Simultaneous macular perception\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Stereopsis is the correct answer. It refers to the ability to perceive depth and distance using the differences between the images seen by each eye. This is the most important function of binocular vision and is essential for judging distances and spatial relationships.\n",
      "\n",
      "Binocular fusion refers to the process by which the brain combines the images from both eyes into a single image. While this is an important aspect of binocular vision, it is not the most repined function.\n",
      "\n",
      "Diplopia refers to the appearance of double vision, which can occur when the images seen by each eye are not properly aligned. This is not a normal or desirable aspect of binocular vision.\n",
      "\n",
      "Simultaneous macular perception refers to the ability to see a single image simultaneously with both eyes, even when the image is not in the center of the visual field. While this is an interesting phenomenon, it is not the most repined function of binocular vision.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Entre os achados abaixo, qual está associado a função binocular sensorial considerada como a mais refinada:\n",
      "a)Estereopsia.\n",
      "b)Fusão binocular.\n",
      "c)Diplopia.\n",
      "d)Percepção macular simultânea.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Fusão binocular\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "Fusão binocular is the correct answer. It refers to the ability to combine the images from both eyes into a single, three-dimensional image, allowing for depth perception and improved visual acuity. This is considered the most refined binocular sensory function.\n",
      "\n",
      "Estereopsia (a) refers to the ability to perceive depth using the differences between the images from each eye. While this is a binocular function, it is not the most refined.\n",
      "\n",
      "Diplopia (c) is the term for seeing double, which can occur when the images from each eye are not properly aligned. This is not a binocular function and is not considered refined.\n",
      "\n",
      "Percepção macular simultânea (d) refers to the ability to perceive a single image from both eyes simultaneously. While this is a binocular function, it is not the most refined.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Among the findings below, which one is associated with the sensory binocular function considered to be the most refined:\n",
      "a) Stereopsis.\n",
      "b) Binocular fusion.\n",
      "c) Diplopia.\n",
      "d) Simultaneous macular perception.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "Stereopsis is the ability to perceive depth and distance using the differences between the images seen by each eye. It is the most refined aspect of binocular vision and allows for accurate judgments of distance and depth. Binocular fusion, diplopia, and simultaneous macular perception are all related to binocular vision, but they are not associated with the sensory function of stereopsis.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 148: \n",
      "Language: spanish\n",
      "Question: \n",
      "En caso de correspondencia retiniana anómala, seleccione la alternativa correcta.\n",
      "a) Es un fenómeno de adaptación sensorial monocular.\n",
      "b) Es más común en pequeñas desviaciones de ángulo.\n",
      "c) Se considera un factor protector frente a la diplopía en el postoperatorio de cirugía de estrabismo.\n",
      "d) Se considera un factor protector contra la recurrencia en el postoperatorio de cirugía de estrabismo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option C: \"Se considera un factor protector frente a la diplopía en el postoperatorio de cirugía de estrabismo.\"\n",
      "\n",
      "En caso de correspondencia retiniana anómala, es importante considerar la posibilidad de diplopía en el postoperatorio de cirugía de estrabismo. La correspondencia retiniana anómala se refiere a la falta de correspondencia entre las imágenes visuales que se ven en cada ojo. En este caso, la opción C es la correcta, ya que la correspondencia retiniana anómala se considera un factor protector frente a la diplopía en el postoperatorio de cirugía de estrabismo.\n",
      "\n",
      "La opción A, \"Es un fenómeno de adaptación sensorial monocular\", no es correcta ya que la adaptación sensorial monocular se refiere a la capacidad del cerebro para combinar las imágenes visuales de ambos ojos en una sola imagen. La opción B, \"Es más común en pequeñas desviaciones de ángulo\", tampoco es correcta, ya que la correspondencia retiniana anómala puede ocurrir en cualquier ángulo. La opción D, \"Se considera un factor protector contra la recurrencia en el postoperatorio de cirugía de estrabismo\", no es correcta, ya que no hay evidencia de que la correspondencia retiniana anómala proteja contra la recurrencia de la diplopía en el postoperatorio de cirugía de estrabismo.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na pahayag patungkol sa anomalous retinal correspondence ang nagsasaad ng katotohanan:\n",
      "a) Ito ay isang penomeno ng monocular sensory adaptation\n",
      "b) Ito ay madalas nangyayari sa mga kaso ng small angle deviations\n",
      "c) Ito ay itinuturing na isang protective factor para sa diplopia na dala ng post-operative period ng strabismus surgery.\n",
      "d) Ito ay itinuturing na isang prrotective factor laban sa recurrence sa post-operative period ng strabismus surgery\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Anomalous retinal correspondence refers to the phenomenon where the visual system adapts to a difference in the visual input between the two eyes, resulting in a perceived correspondence between the images seen by each eye that is not accurate. This can occur in cases of strabismus, where the eyes are misaligned and point in different directions.\n",
      "\n",
      "Option C is the correct answer. Anomalous retinal correspondence is indeed considered a protective factor against diplopia, which is the simultaneous perception of two images of a single object, often seen in cases of strabismus. This is because the visual system adapts to the difference in the visual input between the two eyes, allowing the brain to combine the images into a single image and reducing the perception of diplopia.\n",
      "\n",
      "Option A is incorrect because monocular sensory adaptation refers to the ability of the visual system to adapt to changes in the visual environment, such as changes in lighting or color, but not to differences in the visual input between the two eyes.\n",
      "\n",
      "Option B is also incorrect because small angle deviations refer to small differences in the direction of the line of sight between the two eyes, which can occur in cases of strabismus. However, anomalous retinal correspondence refers to the adaptation to a difference in the visual input between the two eyes, not just small angle deviations.\n",
      "\n",
      "Option D is incorrect because while anomalous retinal correspondence can be a protective factor against recurrence of strabismus after surgery, it is not the primary reason for its occurrence.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação à correspondência retiniana anômala, assinale a alternativa correta.\n",
      "a)É um fenômeno de adaptação sensorial monocular.\n",
      "b)É mais frequente nos desvios de pequeno ângulo.\n",
      "c)É considerada fator protetor de diplopia no pós-operatório de cirurgia de estrabismo.\n",
      "d)É considerada fator protetor de recidiva no pós-operatório de cirurgia de estrabismo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option C: É considerada fator protetor de diplopia no pós-operatório de cirurgia de estrabismo.\n",
      "\n",
      "Retinal correspondence anomaly refers to the abnormal correspondence between the retinal images of the two eyes. In the context of strabismus surgery, it is considered a protective factor against diplopia (double vision) in the postoperative period. Therefore, option C is the correct answer.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding the anomalous retinal correspondence, mark the correct alternative.\n",
      "a) It is a phenomenon of monocular sensory adaptation.\n",
      "b) It is more frequent in small angle deviations.\n",
      "c) It is considered a protective factor for diplopia in the postoperative period of strabismus surgery.\n",
      "d) It is considered a protective factor against recurrence in the postoperative period of strabismus surgery.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The anomalous retinal correspondence (ARC) is a phenomenon that occurs in some cases of strabismus, where the visual information from one eye is not properly aligned with the visual information from the other eye, leading to a perception of diplopia or double vision.\n",
      "\n",
      "Option c) It is considered a protective factor for diplopia in the postoperative period of strabismus surgery. is the correct answer.\n",
      "\n",
      "ARC has been found to be associated with a lower incidence of diplopia in the postoperative period of strabismus surgery. This is because the brain is able to use the ARC to maintain a single visual image, even when the eyes are not properly aligned.\n",
      "\n",
      "Option a) It is a phenomenon of monocular sensory adaptation. is incorrect because ARC is not a phenomenon of monocular sensory adaptation, but rather a result of abnormal binocular vision.\n",
      "\n",
      "Option b) It is more frequent in small angle deviations. is incorrect because ARC can occur in both small and large angle deviations.\n",
      "\n",
      "Option d) It is considered a protective factor against recurrence in the postoperative period of strabismus surgery. is incorrect because there is no evidence to suggest that ARC is a protective factor against recurrence in the postoperative period of strabismus surgery.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 149: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Cuál de las siguientes complicaciones es más común después de la inyección de toxina botulínica en el músculo recto medial?\n",
      "a) Blefaroptosis.\n",
      "b) Hemorragia retrobulbar.\n",
      "c) Midriasis.\n",
      "d) Miosis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Blefaroptosis\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Blefaroptosis (option a) is a possible complication after injecting botulinum toxin into the medial rectus muscle, but it is not the most common complication.\n",
      "\n",
      "Hemorragia retrobulbar (option b) is the most common complication after injecting botulinum toxin into the medial rectus muscle. It occurs when the needle punctures a blood vessel during the injection, causing bleeding into the retrobulbar space.\n",
      "\n",
      "Midriasis (option c) is not a complication of botulinum toxin injection. It is a condition where the pupil becomes larger than normal, and it can be caused by various factors, including certain medications, trauma, or disease.\n",
      "\n",
      "Miosis (option d) is also not a complication of botulinum toxin injection. It is a condition where the pupil becomes smaller than normal, and it can be caused by various factors, including certain medications, trauma, or disease.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na komplikasyon ang madalas na aasahan pagkatapos ng pagturok ng botulinum toxin sa medial rectus muscle?\n",
      "a) Blepharoptosis\n",
      "b) Retrobulbar hemorrhage\n",
      "c) Mydriasis\n",
      "d) Miosis\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Retrobulbar hemorrhage\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Retrobulbar hemorrhage is a potential complication that can occur after injecting botulinum toxin into the medial rectus muscle. This is because the toxin can spread to the surrounding tissues, including the retrobulbar area, and cause bleeding.\n",
      "\n",
      "Blepharoptosis (option a) is not a complication of botulinum toxin injection in the medial rectus muscle. It is a potential complication of botulinum toxin injection in the orbicularis oculi muscle, which is used to treat crow's feet.\n",
      "\n",
      "Mydriasis (option c) is not a complication of botulinum toxin injection in the medial rectus muscle. It is a potential side effect of the toxin, but it is not specific to this particular injection site.\n",
      "\n",
      "Miosis (option d) is not a complication of botulinum toxin injection in the medial rectus muscle. It is a potential side effect of the toxin, but it is not specific to this particular injection site.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual das complicações abaixo é mais frequente após injeção de toxina botulínica no músculo reto medial?\n",
      "a)Blefaroptose.\n",
      "b)Hemorragia retrobulbar.\n",
      "c)Midríase.\n",
      "d)Miose.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The most frequent complication after injecting botulinum toxin into the medial rectus muscle is midriasis (option c). This is because the toxin can spread to the nearby muscles, including the iris sphincter muscle, leading to dilated pupils.\n",
      "\n",
      "Blepharoptosis (option a) is a possible complication of botulinum toxin injection, but it is less common than midriasis. Hemorrhagic retrobulbar (option b) and myosis (option d) are not typically associated with botulinum toxin injections.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Which of the following complications is most frequent after injection of botulinum toxin into the medial rectus muscle?\n",
      "a) Blepharoptosis.\n",
      "b) Retrobulbar hemorrhage.\n",
      "c) Mydriasis.\n",
      "d) Miosis.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Retrobulbar hemorrhage is the most frequent complication after injection of botulinum toxin into the medial rectus muscle.\n",
      "}\n",
      "```\n",
      "\n",
      "Injection of botulinum toxin into the medial rectus muscle is commonly used to treat conditions such as uncontrolled blinking or spasms of the eyelid. However, one of the most frequent complications that can occur after this procedure is retrobulbar hemorrhage, which is bleeding in the space behind the eyeball. This can cause symptoms such as pain, swelling, and vision changes. It is important for medical professionals to be aware of this potential complication and to monitor patients closely for signs of bleeding after the injection.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 150: \n",
      "Language: spanish\n",
      "Question: \n",
      "En cuanto a la exotropía causada por una baja agudeza visual monocular (sensorial), seleccione la alternativa correcta.\n",
      "a)Representa aproximadamente el 2% de todos los casos de exotropía en adultos.\n",
      "b)La prescripción de prismas es el tratamiento de elección.\n",
      "c) Generalmente se asocia con estereopsis normal.\n",
      "d) Es común que la desviación aumente con el tiempo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La respuesta correcta es la opción c: Generalmente se asocia con estereopsis normal. La exotropía causada por una baja agudeza visual monocular (sensorial) se asocia con una falta de estereopsis, lo que significa que el paciente no tiene una percepción clara de la profundidad. En lugar de tratarla con prismas, como se haría en el caso de una exotropía esquelética, la terapia de refuerzo de la visión es el tratamiento de elección. La desviación puede aumentar con el tiempo si no se trata adecuadamente.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na pahayag tungkol sa exotropia na sanhi ng mababang monocular (sensory) visual acuity ang nagsasaad ng katotohanan:\n",
      "a) Ito ay kumakatawan sa halos 2% ng lahat ng mga kaso ng exotropia sa matatanda.\n",
      "b) Inirerekomenda ang paggamit ng prismo bilang preskriopsyon.\n",
      "c) Ito ay kadalasang naiuugnay sa normal stereopsis\n",
      "d) Karaniwan ang paglaki ng paglihis ng exotropia sa paglipas ng panahon. \n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\" // This is the option of the correct response. Could be only any of these: A, B, C, D\n",
      "}\n",
      "```\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option C, \"Ito ay kadalasang naiuugnay sa normal stereopsis.\" Exotropia is a type of strabismus or crossed eyes, where one eye turns outward. In the case of exotropia, the outward turn of the eye is usually due to a problem with the muscles that control eye movement.\n",
      "\n",
      "Option A, \"Ito ay kumakatawan sa halos 2% ng lahat ng mga kaso ng exotropia sa matatanda,\" is incorrect. While exotropia can occur in adults, it is not a common condition, and the prevalence is not around 2%.\n",
      "\n",
      "Option B, \"Inirerekomenda ang paggamit ng prismo bilang preskriopsyon,\" is also incorrect. Prism is sometimes used as a treatment for strabismus, but it is not the first line of treatment for exotropia.\n",
      "\n",
      "Option D, \"Karaniwan ang paglaki ng paglihis ng exotropia sa paglipas ng panahon,\" is incorrect. Exotropia can worsen over time if left untreated, but it is not a normal part of aging.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação à exotropia causada por baixa acuidade visual monocular (sensorial), assinale a alternativa correta.\n",
      "a)Representa aproximadamente 2% de todos os casos de exotropia do adulto.\n",
      "b)Prescrição de prismas é o tratamento de escolha.\n",
      "c)Está associada, em geral, a estereopsia normal.\n",
      "d)É comum o aumento do desvio com o passar do tempo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option c: \"Está associada, em geral, a estereopsia normal.\"\n",
      "\n",
      "Exotropia caused by low visual acuity in one eye (sensory exotropia) is generally associated with normal stereopsis. This means that individuals with this condition have a normal ability to perceive depth using their two eyes.\n",
      "\n",
      "Option a is incorrect because the prevalence of sensory exotropia in adults is not necessarily 2%.\n",
      "\n",
      "Option b is incorrect because while prism lenses may be used in the treatment of sensory exotropia, they are not always the first choice of treatment.\n",
      "\n",
      "Option d is incorrect because the deviation in sensory exotropia does not typically increase over time.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding exotropia caused by low monocular (sensory) visual acuity, mark the correct alternative.\n",
      "a) It represents approximately 2% of all cases of adult exotropia.\n",
      "b) Prescription of prisms is the treatment of choice.\n",
      "c) It is usually associated with normal stereopsis.\n",
      "d) It is common for the deviation to increase over time.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Exotropia caused by low monocular (sensory) visual acuity represents approximately 2% of all cases of adult exotropia. Therefore, option a is the correct response.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 151: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿En cuál de las siguientes desviaciones se producen con mayor frecuencia posiciones bruscas de la cabeza para compensar el estrabismo?\n",
      "a) Parcialmente acomodaticia.\n",
      "b) Incomitantes.\n",
      "c) Exotropía intermitente.\n",
      "d) Comprometidos.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Exotropía intermitente es la opción correcta. En esta condición, el paciente puede experimentar una posición brusca de la cabeza para compensar el estrabismo, ya que la mirada se desvía hacia afuera en lugar de mantenerse enfocada en un objeto. Las posiciones bruscas de la cabeza pueden ser una forma de intentar corregir la visión doble o borrosa que se produce debido a la exotropía.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Sa anong uri ng paglihis ang karaniwang nangyayaring posisyon ng ulo bilang kompensasyon sa strabismus?\n",
      "a) Partially accommodative\n",
      "b) Incomitants\n",
      "c) Intermittent exotropia\n",
      "d) Commanders\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c) Intermittent exotropia\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Strabismus, also known as crossed eyes, is a condition where the eyes do not align properly. The posisyon ng ulo (position of the eye) in strabismus can be classified into different types, including:\n",
      "\n",
      "* Partially accommodative: This type of strabismus occurs when the eye has a tendency to turn inward when focusing on near objects, but returns to its normal position when looking at distant objects.\n",
      "* Incomitants: This type of strabismus occurs when the eye has a tendency to turn inward or outward, but not in a consistent manner.\n",
      "* Intermittent exotropia: This type of strabismus occurs when the eye turns outward occasionally, but not consistently.\n",
      "* Commanders: This is not a type of strabismus, but rather a term used to describe a specific type of eye movement disorder where the eyes have a tendency to move in a specific direction (e.g., towards the nose or ear) instead of moving in a coordinated manner.\n",
      "\n",
      "Therefore, the correct answer is c) Intermittent exotropia.\n",
      "{'response': 'c) Intermittent exotropia'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "As posições viciosas da cabeça para compensar os estrabismos ocorrem mais frequentemente em qual dos desvios abaixo?\n",
      "a)Parcialmente acomodativos.\n",
      "b)Incomitantes.\n",
      "c)Exotropia intermitente.\n",
      "d)Comitantes.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the most common positional deviations of the head to compensate for strabismus. The correct answer is c) Exotropia intermitente.\n",
      "\n",
      "Exotropia intermitente is a type of strabismus where the eye turns outward occasionally, often due to a lack of coordination between the muscles that control eye movement. This can cause the head to be positioned in various ways to compensate for the deviation, such as tilting or turning the head to one side.\n",
      "\n",
      "The other options are not correct because they do not relate to positional deviations of the head to compensate for strabismus:\n",
      "\n",
      "a) Parcialmente acomodativos refers to a type of strabismus where the eye is partially accommodative, meaning that it can focus on near objects but not on far objects.\n",
      "\n",
      "b) Incomitantes refers to a type of strabismus where the eye does not move inward or outward, but rather remains in a fixed position.\n",
      "\n",
      "d) Comitantes refers to a type of strabismus where the eye moves inward, often due to a problem with the muscles that control eye movement.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Vicious head positions to compensate for strabismus occur most frequently in which of the following deviations?\n",
      "a) Partially accommodative.\n",
      "b) Incomitants.\n",
      "c) Intermittent exotropia.\n",
      "d) Commanders.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"  // Intermittent exotropia\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Intermittent exotropia is a type of strabismus where the eye turns outward occasionally, usually when the patient is tired, stressed, or looking in a specific direction. Vicious head positions, also known as compensatory head movements, are commonly seen in intermittent exotropia as the patient may tilt or turn their head to see clearly.\n",
      "\n",
      "Partially accommodative strabismus (option a) refers to a type of strabismus where the eye turns inward when focusing on near objects, but not when looking at distant objects. Incomitants (option b) are eye movements that are not coordinated with the direction of gaze. Commanders (option d) are not a recognized term in ophthalmology or strabismus.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 152: \n",
      "Language: spanish\n",
      "Question: \n",
      "Durante la prueba de Maddox, se colocaron cilindros de Maddox frente a los ojos del paciente, con el rojo frente al ojo derecho y el incoloro frente al ojo izquierdo, ambos orientados verticalmente. El paciente, al observar un foco de luz puntual, informó haber visto la línea roja inclinada en sentido antihorario (perspectiva del paciente). Lo más probable es que incluya:\n",
      "a) Inciclotorsión del ojo derecho.\n",
      "b) Exciclotorsión del ojo derecho.\n",
      "c) Inciclotorsión del ojo izquierdo.\n",
      "d) Hiperfunción del músculo oblicuo superior izquierdo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Exciclotorsión del ojo derecho\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "During the Maddox test, the patient was presented with Maddox cylinders in front of their eyes, with the red cylinder in front of the right eye and the clear cylinder in front of the left eye, both oriented vertically. The patient reported seeing the red line inclined in a counterclockwise direction (from their perspective). This suggests that the patient has a excyclotorsion of the right eye, which is a type of strabismus or crossed eyes. Therefore, the correct answer is option b) Exciclotorsión del ojo derecho.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Sa pagsasagawa ng Maddox test, ang mga Maddox cylinders ay inilagay sa harap ng mga mata ng pasyente, ang pula sa harap ng kanang mata at ang walang kulay sa harap ng kaliwang mata, parehong patayo ang tuon. Habang inoobserbahan ng pasyente ang ilaw, sinabi niyang nakikita niya ang pulang lina na nakalihis sa direksyong counterclockwise (perspektibo ng pasyente). Ano ang ipinapahiwatig nito?\n",
      "a) Inciclotorsion ng kanang mata.\n",
      "b) Excyclotorsion ng kanang mata.\n",
      "c) Inciclotorsion ng kaliwang mata.\n",
      "d) Hyperfunction ng kaliwang superior oblique muscle.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Excyclotorsion ng kanang mata.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The Maddox test is a clinical test used to assess the integrity of the vestibular system, particularly the function of the superior semicircular canal. During the test, the Maddox cylinders are placed in front of the patient's eyes, with the red lens in front of the left eye and the green lens in front of the right eye. The patient is then instructed to follow the movement of a light with their eyes, while the examiner observes the movement of the patient's eyes.\n",
      "\n",
      "If the patient reports seeing the red light moving in a counterclockwise direction (as seen from the patient's perspective), it indicates that the left superior semicircular canal is functioning properly, and the patient has a normal vestibular system. This is option b, Excyclotorsion ng kanang mata.\n",
      "\n",
      "Option a, Inciclotorsion ng kanang mata, refers to the inward rotation of the left eye, which is not related to the Maddox test.\n",
      "\n",
      "Option c, Inciclotorsion ng kaliwang mata, refers to the inward rotation of the right eye, which is also not related to the Maddox test.\n",
      "\n",
      "Option d, Hyperfunction ng kaliwang superior oblique muscle, is not a valid option for the Maddox test.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Durante o teste de Maddox, colocou-se cilindros de Maddox diante dos olhos do paciente, sendo o vermelho diante do olho direito e o incolor diante do olho esquerdo, ambos orientados verticalmente. O paciente, ao observar um foco de luz puntiforme, informou ver a linha vermelha inclinada no sentido anti-horário (perspectiva do paciente). Ele apresenta mais provavelmente:\n",
      "a)Inciclotorção do olho direito.\n",
      "b)Exciclotorção do olho direito.\n",
      "c)Inciclotorção do olho esquerdo.\n",
      "d)Hiperfunção de músculo oblíquo superior esquerdo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Exciclotorção do olho direito\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "During the Maddox test, the patient was presented with Maddox cylinders in front of their eyes, with the red cylinder in front of the right eye and the clear cylinder in front of the left eye, both oriented vertically. The patient reported seeing the red line inclined in the anti-clockwise direction (from their perspective). This suggests that the patient has exciclotorption (outward rotation) of the right eye, which is answer option b.\n",
      "\n",
      "Inciclotorption (inward rotation) of the right eye would cause the patient to see the red line inclined in the clockwise direction. Inciclotorption of the left eye would cause the patient to see the red line inclined in the anti-clockwise direction, but with the left eye, not the right eye. Hyperfunction of the left oblique muscle would not affect the patient's perception of the red line.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "During the Maddox test, Maddox cylinders were placed in front of the patient's eyes, the red one in front of the right eye and the colorless one in front of the left eye, both vertically oriented. The patient, upon observing a point of light, reported seeing the red line tilted counterclockwise (patient's perspective). It most likely features:\n",
      "a) Inciclotorsion of the right eye.\n",
      "b) Excyclotorsion of the right eye.\n",
      "c) Inciclotorsion of the left eye.\n",
      "d) Hyperfunction of the left superior oblique muscle.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // Excyclotorsion of the right eye\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "During the Maddox test, the patient reported seeing the red line tilted counterclockwise (patient's perspective). This suggests that the right eye is experiencing excyclotorsion, which is a type of strabismus where the eye turns outward. Therefore, the correct answer is option b) Excyclotorsion of the right eye.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 153: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto al adenoma pleomórfico de la glándula lagrimal, seleccione la alternativa correcta.\n",
      "a) El examen de tomografía computarizada muestra una lesión heterogénea y mal definida.\n",
      "b) La condición más común es una masa rápidamente progresiva.\n",
      "c) A la palpación el tumor es, en general, indoloro.\n",
      "d) Es más común en mujeres.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option a) El examen de tomografía computarizada muestra una lesión heterogénea y mal definida.\n",
      "\n",
      "In English:\n",
      "\n",
      "The correct answer is option a) The computed tomography examination shows a heterogeneous and poorly defined lesion.\n",
      "\n",
      "In Portuguese:\n",
      "\n",
      "A resposta correta é a opção a) O exame de tomografia computadorizada mostra uma lesão heterogênea e mal definida.\n",
      "\n",
      "In Tagalog:\n",
      "\n",
      "Ang korektong sagot ay opsiyon a) Ang examin ng tomografiya ng kompyuter ay nagpapakita ng isang lesyon na heterogenu at hindi kasya-kasya.\n",
      "{'response': 'a'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na pahayag patungkol sa pleomorphic adenoma ng lacrimal gland ang nagsasaad ng katotohanan?\n",
      "a) Ang computed tomography scan ay nagpapakita ng heterogenous at hindi mainam na delimited na lesyon\n",
      "b) Ang pinakakaraniwang kondisyon ay isang mabilis na progresibong paglaki ng bukol\n",
      "c) Kapag ito ay hinipo, walang kirot na nararamdaman ang pasyente.\n",
      "d) Ito ay mas karaniwan sa mga kababaihan.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is (a) Ang computed tomography scan ay nagpapakita ng heterogenous at hindi mainam na delimited na lesyon.\n",
      "\n",
      "Pleomorphic adenoma of the lacrimal gland is a type of benign tumor that can cause various symptoms such as eyelid swelling, pain, and tearing. A computed tomography (CT) scan is a diagnostic imaging tool that can help identify the presence and extent of the tumor. The description of a heterogeneous and irregularly shaped lesion on a CT scan is consistent with the characteristics of pleomorphic adenoma.\n",
      "\n",
      "Therefore, option (a) is the correct answer.\n",
      "{'response': 'a'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação ao adenoma pleomórfico de glândula lacrimal, assinale a alternativa correta.\n",
      "a)O exame de tomografia computadorizada mostra lesão heterogênea e mal delimitada.\n",
      "b)O quadro mais comum é de massa de crescimento rapidamente progressivo.\n",
      "c)À palpação, a tumoração é, em geral, indolor.\n",
      "d)É mais frequente em mulheres.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option a) The computed tomography examination shows a heterogeneous and poorly defined lesion.\n",
      "\n",
      "Adenoma pleomórfico de glândula lacrimal is a type of benign tumor that affects the lacrimal gland. The characteristic imaging feature of this tumor on CT scan is a heterogeneous and poorly defined lesion. Therefore, option a is the correct answer.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding pleomorphic adenoma of the lacrimal gland, mark the correct alternative.\n",
      "a) Computed tomography scan shows heterogeneous and poorly delimited lesion.\n",
      "b) The most common condition is a rapidly progressive growth mass.\n",
      "c) On palpation, the tumor is generally painless.\n",
      "d) It is more common in women.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct alternative for pleomorphic adenoma of the lacrimal gland is a) Computed tomography scan shows heterogeneous and poorly delimited lesion. Pleomorphic adenoma, also known as benign mixed tumor, is a type of tumor that can arise in various parts of the body, including the lacrimal gland. It is characterized by a heterogeneous and poorly delimited lesion on imaging studies such as computed tomography (CT) scan.\n",
      "\n",
      "Therefore, option a is the correct response.\n",
      "\n",
      "Option b, \"The most common condition is a rapidly progressive growth mass,\" is incorrect. While pleomorphic adenoma can grow and cause symptoms, it is not typically a rapidly progressive growth mass.\n",
      "\n",
      "Option c, \"On palpation, the tumor is generally painless,\" is also incorrect. While the tumor may not cause pain, it can cause other symptoms such as proptosis (bulging of the eye), diplopia (double vision), and eyelid swelling.\n",
      "\n",
      "Option d, \"It is more common in women,\" is incorrect. Pleomorphic adenoma can occur in anyone, regardless of gender.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 154: \n",
      "Language: spanish\n",
      "Question: \n",
      "En cuanto a la afectación orbitaria en la leucemia, seleccione la alternativa correcta.\n",
      "a) El tratamiento generalmente no es sensible a la radioterapia.\n",
      "b) El tratamiento generalmente no es sensible a la quimioterapia.\n",
      "c) El sarcoma granulocítico es la infiltración orbitaria más frecuentemente asociada a la leucemia linfoide.\n",
      "d) Los exámenes de imagen muestran una masa orbitaria que generalmente compromete la estructura ósea.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La afectación orbitaria en la leucemia es más frecuentemente asociada con el sarcoma granulocítico, por lo que la opción correcta es la alternativa (c).\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na pahayag patungkol sa orbital involvement sa leukemia ang nagsasaad ng katotohanan?\n",
      "a) Ang paggamot ay kadalasang hindi sensitibo sa radiotherapy.\n",
      "b) Ang paggamot ay kadalasang hindi sensitibo sa chemotherapy.\n",
      "c) Ang granulocytic sarcoma ay isang orbital infiltration  na madalas na nauugnay sa lymphoid leukemia.\n",
      "d) Ang mga resulta ng eksamen sa imaging ay nagpapakita ng isang orbital mass na karaniwang kumukumpromiso sa istraktura ng buto.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Ang granulocytic sarcoma ay isang orbital infiltration na madalas na nauugnay sa lymphoid leukemia.\n",
      "\n",
      "Granulocytic sarcoma is a type of cancer that affects the immature granulocytes, which are a type of white blood cell. It is a rare type of cancer, but it is often associated with orbital involvement in leukemia. The other options are not correct because they do not relate to orbital involvement in leukemia.\n",
      "\n",
      "Option a) is incorrect because it refers to the sensitivity of radiotherapy, which is not related to orbital involvement in leukemia.\n",
      "\n",
      "Option b) is incorrect because it refers to the sensitivity of chemotherapy, which is not related to orbital involvement in leukemia.\n",
      "\n",
      "Option d) is incorrect because it refers to the results of imaging examinations, which may show an orbital mass, but it does not specifically relate to granulocytic sarcoma or its association with lymphoid leukemia.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação ao comprometimento orbitário na leucemia, assinale a alternativa correta.\n",
      "a)O tratamento geralmente não é sensível à radioterapia.\n",
      "b)O tratamento geralmente não é sensível à quimioterapia.\n",
      "c)O sarcoma granulocítico é a infiltração orbitária mais frequentemente associada a leucemia linfoide.\n",
      "d)Exames de imagem mostram massa orbitária que geralmente compromete a estrutura óssea.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) O sarcoma granulocítico é a infiltração orbitária mais frequentemente associada a leucemia linfoide.\n",
      "\n",
      "Sarcoma granulocítico is a type of cancer that affects the orbit, and it is the most common type of orbital infiltration associated with lymphoid leukemia. Therefore, option c is the correct answer.\n",
      "\n",
      "Option a) O tratamento geralmente não é sensível à radioterapia is incorrect because radiation therapy can be effective in treating orbital infiltration in leukemia.\n",
      "\n",
      "Option b) O tratamento geralmente não é sensível à quimioterapia is incorrect because chemotherapy can also be effective in treating orbital infiltration in leukemia.\n",
      "\n",
      "Option d) Exames de imagem mostram massa orbitária que geralmente compromete a estrutura óssea is incorrect because while imaging studies may show a mass in the orbit, it does not necessarily mean that the bony structure is compromised.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding orbital involvement in leukemia, mark the correct alternative.\n",
      "a) The treatment is generally not sensitive to radiotherapy.\n",
      "b) The treatment is generally not sensitive to chemotherapy.\n",
      "c) Granulocytic sarcoma is the orbital infiltration most frequently associated with lymphoid leukemia.\n",
      "d) Imaging exams show an orbital mass that usually compromises the bone structure.\n",
      "Test #0: \n",
      "response\n",
      "  Here's my answer:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Granulocytic sarcoma is the orbital infiltration most frequently associated with lymphoid leukemia.\n",
      "\n",
      "Granulocytic sarcoma, also known as chloroma, is a type of cancer that originates in the myeloid cells of the bone marrow. It can infiltrate the orbit and is commonly associated with lymphoid leukemia. The other options are not accurate statements about orbital involvement in leukemia.\n",
      "\n",
      "Option a) is incorrect because radiotherapy can be effective in treating leukemia, including orbital involvement.\n",
      "\n",
      "Option b) is incorrect because chemotherapy is a common treatment for leukemia, including orbital involvement.\n",
      "\n",
      "Option d) is incorrect because while imaging exams may show an orbital mass, it does not necessarily compromise the bone structure.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 155: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto al neurofibroma orbitario plexiforme, seleccione la respuesta correcta:\n",
      "a) Su degeneración maligna es rara.\n",
      "b) Rara vez se observa en pacientes con neurofibromatosis.\n",
      "c) Tiene buen pronóstico, con baja tasa de recurrencia tras la cirugía.\n",
      "d) Es avascular y el sangrado del tumor durante la cirugía es raro.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option a: Su degeneración maligna es rara.\n",
      "\n",
      "Neurofibroma orbitario plexiforme is a rare benign tumor that originates in the orbit and is associated with neurofibromatosis type 1 (NF1). It is characterized by slow growth and good prognosis, with low recurrence rate after surgery. However, malignant degeneration is rare.\n",
      "\n",
      "Therefore, option a is the correct answer.\n",
      "{'response': 'a'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na pahayag patungkol sa plexiform orbital neurofibroma ang nagsasaad ng katotohanan?\n",
      "a) Ang malignant degeneration nito ay bihira.\n",
      "b) Ito ay bihirang nakikita sa mga pasyente na may neurofibromatosis.\n",
      "c) Ito ay may magandang prognosis at mababang rate ng recurrence pagkatapos ng operasyon.\n",
      "d) Ito ay avascular, at ang pagdurugo mula sa tumor sa operasyon ay bihira.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Ito ay bihirang nakikita sa mga pasyente na may neurofibromatosis.\n",
      "\n",
      "Plexiform orbital neurofibroma is a type of benign tumor that affects the orbit, and it is commonly associated with neurofibromatosis, a genetic disorder that affects the growth and development of nerve tissue. Therefore, option b is the correct answer.\n",
      "\n",
      "Option a, \"Ang malignant degeneration nito ay bihira,\" is incorrect because plexiform orbital neurofibroma is a benign tumor and does not have the potential to degenerate into a malignant tumor.\n",
      "\n",
      "Option c, \"Ito ay may magandang prognosis at mababang rate ng recurrence pagkatapos ng operasyon,\" is incorrect because while the prognosis for plexiform orbital neurofibroma is generally good, the tumor can recur in some cases, especially if it is not completely removed during surgery.\n",
      "\n",
      "Option d, \"Ito ay avascular, at ang pagdurugo mula sa tumor sa operasyon ay bihira,\" is incorrect because plexiform orbital neurofibroma is a vascular tumor, and bleeding from the tumor during surgery is not uncommon.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Com relação ao neurofibroma da órbita tipo plexiforme, assinale a alternativa correta:\n",
      "a)Sua degenerarão maligna é rara.\n",
      "b)É raramente observado em pacientes com neurofibromatose.\n",
      "c)Tem bom prognóstico, com baixa taxa de recorrência após a cirurgia.\n",
      "d)É avascular, sendo raro o sangramento do tumor durante a cirurgia.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option c: \"Tem bom prognóstico, com baixa taxa de recorrência após a cirurgia.\"\n",
      "\n",
      "Neurofibroma of the orbit type plexiforme is a benign tumor that has a good prognosis, with a low recurrence rate after surgery. Therefore, option c is the correct answer.\n",
      "\n",
      "Option a is incorrect because although malignant degeneration of neurofibroma is rare, it can occur.\n",
      "\n",
      "Option b is incorrect because neurofibroma of the orbit type plexiforme is not rare in patients with neurofibromatosis.\n",
      "\n",
      "Option d is incorrect because although neurofibroma is avascular, bleeding from the tumor during surgery is not uncommon.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding plexiform orbital neurofibroma, mark the correct alternative:\n",
      "a) Its malignant degeneration is rare.\n",
      "b) It is rarely seen in patients with neurofibromatosis.\n",
      "c) It has a good prognosis, with a low rate of recurrence after surgery.\n",
      "d) It is avascular, and bleeding from the tumor during surgery is rare.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option a) Its malignant degeneration is rare. Plexiform orbital neurofibroma is a benign tumor that arises from the peripheral nerves, and malignant degeneration is uncommon. It is important to note that while malignant degeneration is rare, it can occur, and close follow-up with regular imaging studies is recommended to monitor for any changes in the tumor.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 156: \n",
      "Language: spanish\n",
      "Question: \n",
      "¿Qué tumor epitelial maligno de la conjuntiva, entre los siguientes, se presenta con mayor frecuencia en la región del limbo?\n",
      "a) Melanoma.\n",
      "b) sarcoma de Kaposi.\n",
      "c) Carcinoma de células escamosas.\n",
      "d) Carcinoma de células basales.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) Carcinoma de células escamosas.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na malignant epithelial tumor ng conjunctiva ang kadalasang nangyayari sa limbal region?\n",
      "a) Melanoma.\n",
      "b) Kaposi's sarcoma\n",
      "c) Squamous cell carcinoma.\n",
      "d) Basal cell carcinoma.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"  // Squamous cell carcinoma is the most common malignant epithelial tumor of the conjunctiva that occurs in the limbal region.\n",
      "}\n",
      "```\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Qual é o tumor epitelial maligno de conjuntiva, dentre os abaixo, que mais comumente ocorre na região do limbo?\n",
      "a)Melanoma.\n",
      "b)Sarcoma de Káposi.\n",
      "c)Carcinoma espinocelular.\n",
      "d)Carcinoma de células basais.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) Carcinoma espinocelular. This type of cancer originates in the squamous cells that line the conjunctiva, which is the mucous membrane that covers the white part of the eye and the inside of the eyelids. It is the most common type of conjunctival cancer and is usually slow-growing and less aggressive than other types of conjunctival cancer.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Which of the following malignant epithelial tumors of the conjunctiva most commonly occurs in the limbal region?\n",
      "a) Melanoma.\n",
      "b) Kaposi's sarcoma.\n",
      "c) squamous cell carcinoma.\n",
      "d) Basal cell carcinoma.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) Squamous cell carcinoma. It is the most common malignant epithelial tumor of the conjunctiva that occurs in the limbal region.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 157: \n",
      "Language: spanish\n",
      "Question: \n",
      "Seleccione la alternativa que contiene tres factores asociados al desarrollo de cataratas.\n",
      "a)Alta miopía, uso prolongado de vitamina C y consumo de alcohol.\n",
      "b) Radiaciones de baja energía, uso prolongado de corticoides y exposición a luz azul.\n",
      "c) Tabaquismo, exposición a luz ultravioleta y vitrectomía previa.\n",
      "d) Traumatismo ocular, diabetes mellitus e hipermetropía elevada.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c: Tabaquismo, exposición a luz ultravioleta y vitrectomía previa.\n",
      "\n",
      "Here's a brief explanation for each option:\n",
      "\n",
      "a) High myopia, prolonged use of vitamin C, and alcohol consumption have been associated with an increased risk of cataracts. However, they are not the three factors most closely associated with cataract development.\n",
      "\n",
      "b) Low-energy radiation, prolonged use of corticosteroids, and exposure to blue light have been linked to an increased risk of cataracts, particularly in children. However, this combination of factors is not the most common association.\n",
      "\n",
      "c) Smoking, exposure to UV light, and previous vitrectomy are well-established risk factors for cataract development.\n",
      "\n",
      "d) Eye trauma, diabetes mellitus, and high hyperopia have been linked to an increased risk of cataracts, but they are not the three factors most closely associated with cataract development.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na pahayag ang naglalaman ng tatlong mga salik na may kaugnayan sa pagbubuo ng katarata?\n",
      "a) Mataas na myopia, matagalang paggamit ng vitamin C at pagkonsumo ng alkohol.\n",
      "b) Low-energy na radyasyon, matagalang paggamit ng corticosteroids, at eksposyur sa blue light\n",
      "c) Paninigarilyo, eksposyur sa UV light, at kasaysayan ng vitrectomy.\n",
      "d) Trauma sa mata, dyabetis, at mataas na hyperopia\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) Paninigarilyo, eksposyur sa UV light, at kasaysayan ng vitrectomy.\n",
      "\n",
      "Paninigarilyo, or cataract, is a condition where the lens of the eye becomes cloudy, affecting vision. Exposure to UV light and a history of vitrectomy, a surgical procedure to remove the vitreous gel from the eye, can contribute to the development of cataracts.\n",
      "\n",
      "The other options do not relate to the three symptoms mentioned in the question:\n",
      "\n",
      "a) Mataas na myopia, matagalang paggamit ng vitamin C at pagkonsumo ng alkohol - High myopia, long-term use of vitamin C, and alcohol consumption do not have a direct relationship with cataracts.\n",
      "\n",
      "b) Low-energy na radyasyon, matagalang paggamit ng corticosteroids, at eksposyur sa blue light - Low-energy radiation, long-term use of corticosteroids, and exposure to blue light may contribute to the development of cataracts, but they are not directly related to the three symptoms mentioned.\n",
      "\n",
      "d) Trauma sa mata, dyabetis, at mataas na hyperopia - Eye trauma, diabetes, and high hyperopia (farsightedness) can also contribute to the development of cataracts, but they are not directly related to the three symptoms mentioned.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Assinale a alternativa que contém três fatores associados ao desenvolvimento de catarata.\n",
      "a)Alta miopia, uso prolongado de vitamina C e consumo de álcool.\n",
      "b)Radiação de baixa energia, uso prolongado de corticoide e exposição à luz azul.\n",
      "c)Tabagismo, exposição à luz ultravioleta e vitrectomia prévia.\n",
      "d)Traumatismo ocular, diabetes melito e alta hipermetropia.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c: Tabagismo, exposição à luz ultravioleta e vitrectomia prévia.\n",
      "\n",
      "Here's a brief explanation for each option:\n",
      "\n",
      "a) Alta miopia, uso prolongado de vitamina C e consumo de álcool: High myopia, prolonged use of vitamin C, and alcohol consumption have been associated with an increased risk of cataract development, but they are not the three factors mentioned in the question.\n",
      "\n",
      "b) Radiação de baixa energia, uso prolongado de corticoide e exposição à luz azul: Low-energy radiation, prolonged use of corticosteroids, and exposure to blue light have been linked to cataract development, but they are not the three factors mentioned in the question.\n",
      "\n",
      "c) Tabagismo, exposição à luz ultravioleta e vitrectomia prévia: Smoking, exposure to UV light, and previous vitrectomy are well-established risk factors for cataract development.\n",
      "\n",
      "d) Traumatismo ocular, diabetes melito e alta hipermetropia: Eye trauma, diabetes mellitus, and high hyperopia have been associated with an increased risk of cataract development, but they are not the three factors mentioned in the question.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "Check the alternative that contains three factors associated with the development of cataracts.\n",
      "a) High myopia, prolonged use of vitamin C and alcohol consumption.\n",
      "b) Low-energy radiation, prolonged use of corticosteroids and exposure to blue light.\n",
      "c) Smoking, exposure to ultraviolet light and previous vitrectomy.\n",
      "d) Eye trauma, diabetes mellitus and high hyperopia.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The three factors associated with the development of cataracts are:\n",
      "\n",
      "* Smoking\n",
      "* Exposure to ultraviolet light\n",
      "* Previous vitrectomy\n",
      "\n",
      "Therefore, the correct answer is option c.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 158: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto a las cataratas congénitas e infantiles, juzgue las siguientes afirmaciones como verdaderas (V) o falsas (F) y seleccione la alternativa correcta.\n",
      "\n",
      "  I - Cuando la opacidad es bilateral y severa, el intervalo entre la cirugía del primer y segundo ojo debe ser mínimo y generalmente no excede una semana.\n",
      "  II - En caso de opacidades totales, la cirugía debe realizarse lo más temprano posible, preferiblemente entre los tres y cuatro meses de edad.\n",
      "  III - La catarata congénita es la causa más común de alteraciones de la prueba del reflejo rojo en las maternidades.\n",
      "  IV - El reflejo rojo normal al nacer es suficiente para la detección precoz de anomalías congénitas durante el seguimiento hasta los dos años de edad.\n",
      "\n",
      "a)I: Verdadero; II: Falso; III: Verdadero; IV: Falso.\n",
      "b)I: Falso; II: Verdadero; III: Falso; IV: Cierto.\n",
      "c)I: Falso; II: Falso; III: Verdadero; IV: Falso.\n",
      "d)I: Verdadero; lI: Verdadero; III: Verdadero; IV: Cierto.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "I - False. The interval between surgeries for bilateral severe cataracts should be at least 2-4 weeks to avoid the risk of amblyopia.\n",
      "\n",
      "II - True. Surgery should be performed as early as possible, preferably between 3-4 months of age, to prevent amblyopia and other complications.\n",
      "\n",
      "III - True. Congenital cataracts are a common cause of abnormal red reflex in newborns, and can be detected through routine neonatal screening.\n",
      "\n",
      "IV - False. The normal red reflex at birth is not sufficient to rule out congenital anomalies, and regular follow-up until the age of 2 is recommended to detect any potential issues.\n",
      "\n",
      "Therefore, the correct answer is b)I: Falso; II: Verdadero; III: Verdadero; IV: Falso.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Suriin ang katotohanan ng mga pahayag patungkol sa konhenital at infantile na katarata:\n",
      "\n",
      " I - Kapag ang opacity ay bilateral at malubha, ang agwat sa pagitan ng operasyon sa una at pangalawang mata ay dapat na minimal at hindi lalampas sa isang linggo.\n",
      " II - Sa kaso ng total opacities, ang operasyon ay dapat gawin nang maaga hangga't maaari, mas mainam na ito ay isagawa sa pagitan ng tatlo at apat na buwan pagkapanganak\n",
      " III - Ang konhenital na katarata ay ang pinaka -karaniwang sanhi ng pagbabago ng pulang reflex test sa mga paanakan.\n",
      " IV - Ang normal red reflex pagkapanganak ay sapat na mekanismo upang maagang malamann ang mga konhenital na anomalya hanggang mag-dalawang taong gulang ang bata.\n",
      "\n",
      "a) I: Tama; II: Mali; III: Tama; IV: Mali.\n",
      "b) I: Mali; II: Tama; III: Mali; IV: Tama.\n",
      "c) I: Mali; II: Mali; III: Tama; IV: Tama.\n",
      "d) I: Tama; II: Tama; III: Tama; IV: Tama.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "I - Incorrect. Bilateral and dense cataracts should be operated on as soon as possible, within the first year of life.\n",
      "\n",
      "II - Correct. Total cataracts should be operated on as early as possible, ideally within the first 3-4 months of life.\n",
      "\n",
      "III - Incorrect. Congenital cataracts are not the most common cause of abnormal red reflex in infants.\n",
      "\n",
      "IV - Incorrect. The normal red reflex in infants is not a reliable mechanism for early detection of congenital anomalies.\n",
      "\n",
      "Therefore, the correct answer is option b: I: Mali; II: Tama; III: Mali; IV: Tama.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Sobre as cataratas congênitas e infantis, julgue as assertivas abaixo como verdadeiras (V) ou falsas (F) e assinale a alternativa correta.\n",
      "\n",
      " I - Quando a opacidade é bilateral e grave, o intervalo entre a cirurgia do primeiro e do segundo olho deve ser apenas o mínimo e geralmente não ultrapassa uma semana.\n",
      " II - No caso de opacidades totais deve-se realizar a cirurgia o mais precocemente possível, de preferência entre os três e os quatro meses de idade.\n",
      " III - A catarata congênita é a causa mais comum de alteração do teste do reflexo vermelho em maternidades.\n",
      " IV - O reflexo vermelho normal ao nascimento é suficiente para a detecção precoce das anomalias congênitas no acompanhamento até os dois anos de idade.\n",
      "\n",
      "a)I: Verdadeiro; II: Falso; III: Verdadeiro; IV: Falso.\n",
      "b)I: Falso; II: Verdadeiro; III: Falso; IV: Verdadeiro.\n",
      "c)I: Falso; II: Falso; III: Verdadeiro; IV: Falso.\n",
      "d)I: Verdadeiro; lI: Verdadeiro; III: Verdadeiro; IV: Verdadeiro.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "I - False. The statement suggests that the interval between surgeries for bilateral and severe cataracts should be as short as possible and generally not exceed a week. However, the correct approach is to perform the surgery on the second eye after the first eye has fully recovered, which can take several weeks.\n",
      "\n",
      "II - True. It is recommended to perform surgery as early as possible, preferably between 3-4 months of age, for total cataracts.\n",
      "\n",
      "III - True. Congenital cataracts are a common cause of alteration of the red reflex test in maternities.\n",
      "\n",
      "IV - False. The normal red reflex at birth is not sufficient for early detection of congenital anomalies, and regular follow-up until the age of 2 is necessary.\n",
      "\n",
      "Therefore, the correct answer is option b: I: Falso; II: Verdadeiro; III: Verdadeiro; IV: Falso.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "About congenital and infantile cataracts, judge the statements below as true (T) or false (F) and mark the correct alternative.\n",
      "\n",
      " I - When the opacity is bilateral and severe, the interval between surgery on the first and second eye should be minimal and generally does not exceed one week.\n",
      " II - In the case of total opacities, surgery should be performed as early as possible, preferably between three and four months of age.\n",
      " III - Congenital cataract is the most common cause of alteration of the red reflex test in maternity hospitals.\n",
      " IV - The normal red reflex at birth is sufficient for the early detection of congenital anomalies in the follow-up up to two years of age.\n",
      "\n",
      "a) I: True; II: False; III: True; IV: False.\n",
      "b) I: False; II: True; III: False; IV: True.\n",
      "c) I: False; II: False; III: True; IV: False.\n",
      "d) I: True; II: True; III: True; IV: True.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "I - False: The interval between surgery on the first and second eye should be minimal, but it may exceed one week in some cases.\n",
      "II - True: Surgery should be performed as early as possible, preferably between three and four months of age, to minimize the risk of amblyopia.\n",
      "III - True: Congenital cataract is a common cause of alteration of the red reflex test in maternity hospitals.\n",
      "IV - False: The normal red reflex at birth is not sufficient for the early detection of congenital anomalies, and regular follow-up is necessary to detect any potential issues.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 159: \n",
      "Language: spanish\n",
      "Question: \n",
      "En caso de anomalías congénitas y fallos en el desarrollo del cristalino, seleccionar la alternativa correcta.\n",
      "a) El bloqueo pupilar intermitente observado en la microesferofaquia se produce debido a que el iris toca la periferia media del cristalino debido al aumento del diámetro de lado a lado.\n",
      "b) La subluxación del cristalino en el síndrome de Marfan es más comúnmente superior y temporal y puede inducir ambliopía causada por asimetría refractiva.\n",
      "c) En la galactosemia se puede observar en la prueba del reflejo rojo una sombra central similar a una “gota de aceite”, lo que no ocurre en otras enfermedades.\n",
      "d) En la homocistinuria, el desplazamiento del cristalino es generalmente bilateral, simétrico y está presente desde el nacimiento.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "La subluxación del cristalino en el síndrome de Marfan es más comúnmente superior y temporal y puede inducir ambliopía causada por asimetría refractiva.\n",
      "\n",
      "La subluxación del cristalino se refiere a la desplazamiento del cristalino desde su posición normal en el ojo. En el síndrome de Marfan, una enfermedad genética que afecta la estructura de los tejidos conectivos, la subluxación del cristalino es una característica común. La subluxación puede ser superior ( hacia arriba) y temporal ( hacia afuera), lo que puede causar una asimetría refractiva y provocar ambliopía.\n",
      "\n",
      "Por lo tanto, la respuesta correcta es la opción b.\n",
      "{'response': 'b'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na pahayag patungkol sa konhenital na anomalya at kakulangan sa pag-develop ng mga lente ang nagsasaad ng katotohanan?\n",
      "a) Ang panaka-nakang pupillary block na nakikita sa microspherophacy ay nangyayari dala ng pagtama ng iris sa medium periphery ng crystalline lens na dulot naman ng side-to-side na paglapad nito\n",
      "b) Ang lens subluxation sa Marfan Syndome ay kadalasang makikita sa superior at temporal na bahagi at maaaring magdulot ng amblyopia na dala ng refractive asymmetry. \n",
      "c) Sa galactosemia, ang isang central shadown na kawangis ng \"oil droop\" ang mamamataan sa red reflex test, na hindi makikitang manipestasyon sa ibang mga karamdaman\n",
      "d) Sa homocystinuria, ang lens displacement ay karaniwang bilateral, simetriko at makikita pagkapanganak.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the correct description of a congenital anomaly and lack of lens development. The correct answer is option b, lens subluxation in Marfan Syndrome, which is commonly seen in the superior and temporal parts and can cause amblyopia due to refractive asymmetry.\n",
      "\n",
      "Option a is incorrect because it describes a different condition, pupillary block, which is caused by the iris touching the crystalline lens and is not related to lens development.\n",
      "\n",
      "Option c is also incorrect because it describes a different condition, galactosemia, which is characterized by a central shadow on the red reflex test and is not related to lens development.\n",
      "\n",
      "Option d is incorrect because it describes a different condition, homocystinuria, which is characterized by bilateral lens displacement that is usually symmetrical and can be seen at birth.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Sobre as anomalias congênitas e falhas do desenvolvimento do cristalino, assinale a alternativa correta.\n",
      "a)O bloqueio pupilar intermitente observado na microesferofacia acontece devido ao toque da íris na média periferia do cristalino em razão do diâmetro látero-lateral aumentado.\n",
      "b)A subluxação do cristalino na síndrome de Marfan é mais comumente superior e temporal e pode induzir ambliopia causada pela assimetria refracional.\n",
      "c)Na galactosemia pode-se observar no teste do reflexo vermelho uma sombra central à semelhança de \"gota de óleo\", o que não ocorre em outras doenças.\n",
      "d)Na homocistinúria, o deslocamento do cristalino é geralmente bilateral, simétrico e presente ao nascimento.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about anomalies and developmental defects of the crystalline lens. The correct answer is b, subluxation of the crystalline lens in Marfan syndrome. This is a congenital condition where the lens is displaced from its normal position, often superiorly and temporally, and can cause amblyopia due to asymmetric refraction.\n",
      "\n",
      "The other options are not correct:\n",
      "\n",
      "a is incorrect because the bloqueio pupilar intermitente (intermittent pupillary block) observed in microespherophakia is due to the touch of the iris on the peripheral edge of the crystalline lens, rather than the lens being displaced.\n",
      "\n",
      "c is incorrect because the presence of a central shadow on the red reflex test, similar to a \"drop of oil,\" is not specific to galactosemia. This can occur in other conditions as well.\n",
      "\n",
      "d is incorrect because homocystinuria is a genetic disorder that affects the metabolism of amino acids, and is not related to developmental defects of the crystalline lens.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding congenital anomalies and failures in the development of the lens, mark the correct alternative.\n",
      "a) The intermittent pupillary block observed in microspherophacy happens due to the touch of the iris in the medium periphery of the crystalline lens due to the increased side-to-side diameter.\n",
      "b) Lens subluxation in Marfan syndrome is most commonly superior and temporal and may induce amblyopia caused by refractive asymmetry.\n",
      "c) In galactosemia, a central shadow resembling an \"oil drop\" can be observed in the red reflex test, which does not occur in other diseases.\n",
      "d) In homocystinuria, lens displacement is usually bilateral, symmetrical and present at birth.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c: In galactosemia, a central shadow resembling an \"oil drop\" can be observed in the red reflex test, which does not occur in other diseases.\n",
      "\n",
      "Galactosemia is a congenital genetic disorder that affects the metabolism of galactose, a sugar found in milk. One of the characteristic features of this condition is the presence of a central shadow or \"oil drop\" appearance in the red reflex test, which is not seen in other diseases. This shadow is caused by the accumulation of galactose in the lens of the eye, leading to a displacement of the lens.\n",
      "\n",
      "Option a is incorrect because the intermittent pupillary block observed in microspherophakia is not caused by the touch of the iris in the medium periphery of the crystalline lens, but rather by the irregular shape of the lens.\n",
      "\n",
      "Option b is incorrect because lens subluxation in Marfan syndrome can occur in various positions, including superior and temporal, but it does not necessarily cause amblyopia due to refractive asymmetry.\n",
      "\n",
      "Option d is incorrect because homocystinuria is a genetic disorder that affects the metabolism of amino acids, and it does not cause lens displacement.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 160: \n",
      "Language: spanish\n",
      "Question: \n",
      "Tras el bloqueo retrobulbar para realizar la cirugía de facoemulsificación, el paciente desarrolla pérdida progresiva de conciencia, convulsiones y paro respiratorio cinco minutos después de la inyección del anestésico. Seleccione la alternativa que describa correctamente la complicación más probable en este caso y una posible medida preventiva.\n",
      "a) Inyección intraocular: observe el movimiento conjunto del globo ocular y la aguja antes de inyectar.\n",
      "b) Inyección intravascular: suspender los anticoagulantes o antiagregantes plaquetarios antes de la cirugía.\n",
      "c) Inyección en el espacio subaracnoideo: introduzca la aguja a menos de 30 mm de profundidad.\n",
      "d) Hemorragia retrobulbar: aspire y compruebe la presencia de contenido sanguíneo antes de inyectar.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La complicación más probable en este caso es la inyección en el espacio subaracnoideo, lo que puede causar convulsiones y pérdida de conciencia. La medida preventiva sería introducir la aguja a menos de 30 mm de profundidad.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Matapos ang retrobulbar block para sa phacoemulsification na operasyon, mabilis na nawalan ng malay ang pasyente, kinombulsyon, at nalagutan ng hininga matapos turukan ng anesthesia. Alin sa mga sumusunod na pahayag ang pinakanaglalarawan ng nasabing komplikasyon at ang posibleng pamamaraan para mapigilan ito?\n",
      "a) Intraocular na pagturok - obserbahan ang sabay na paggalaw ng eyeball maging ang karayom bago magturok.\n",
      "b) Intravascular na pagturok - suspindihin ang mga anticoagulant o  antiplatelet na gamot bago operahan.\n",
      "c) Pagturok sa espasyo ng subarachnoid - ipasok ang karayom na may lalim na hindi lalampas sa 30mm.\n",
      "d) Retrobulbar hemorrhage - I-asperate at tignan kung mayroong mga nakapaligid na dugo bago magturok.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"d\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is d) Retrobulbar hemorrhage - I-asperate at tignan kung mayroong mga nakapaligid na dugo bago magturok.\n",
      "\n",
      "Retrobulbar hemorrhage is a complication that can occur after a retrobulbar block for phacoemulsification surgery. It is characterized by bleeding in the retrobulbar space, which can cause vision loss, pain, and swelling.\n",
      "\n",
      "The other options are not related to retrobulbar hemorrhage:\n",
      "\n",
      "a) Intraocular tumor - This is not related to the complication described in the scenario.\n",
      "\n",
      "b) Intravascular tumor - This is not related to the complication described in the scenario.\n",
      "\n",
      "c) Subarachnoid space tumor - This is not related to the complication described in the scenario.\n",
      "\n",
      "Therefore, the correct answer is d) Retrobulbar hemorrhage - I-asperate at tignan kung mayroong mga nakapaligid na dugo bago magturok.\n",
      "{'response': 'd'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Após bloqueio retrobulbar para realização de cirurgia de facoemulsificação, o paciente evolui com perda progressiva de consciência, convulsões e parada respiratória após cinco minutos da injeção do anestésico. Assinale a alternativa que descreve corretamente a complicação mais provável neste caso e uma possível medida preventiva.\n",
      "a)Injeção intraocular - observar a movimentação conjunta do globo ocular e da agulha antes de injetar.\n",
      "b)Injeção intravascular - suspender anticoagulantes ou antiagregantes plaquetários antes da cirurgia.\n",
      "c)Injeção no espaço subaracnoide - inserir a agulha menos do que 30 mm em profundidade.\n",
      "d)Hemorragia retrobulbar - aspirar e verificar a presença de conteúdo hemático antes de injetar.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c) Injeção no espaço subaracnoide - inserir a agulha menos do que 30 mm em profundidade.\n",
      "\n",
      "The complicação mais provável neste caso é a injeção de anestésico no espaço subaracnoide, o que pode levar a uma parada respiratória. A medida preventiva é inserir a agulha menos do que 30 mm em profundidade, evitando a injeção no espaço subaracnoide e minimizando o risco de parada respiratória.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "After retrobulbar block for phacoemulsification surgery, the patient evolved with progressive loss of consciousness, seizures and respiratory arrest five minutes after anesthetic injection. Check the alternative that correctly describes the most likely complication in this case and a possible preventive measure.\n",
      "a) Intraocular injection - observe the joint movement of the eyeball and the needle before injecting.\n",
      "b) Intravascular injection - suspend anticoagulants or antiplatelet agents before surgery.\n",
      "c) Injection into the subarachnoid space - insert the needle less than 30 mm in depth.\n",
      "d) Retrobulbar hemorrhage - aspirate and check for the presence of hematic content before injecting.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is c) Injection into the subarachnoid space - insert the needle less than 30 mm in depth.\n",
      "\n",
      "Retrobulbar block is a type of regional anesthesia used for eye surgery, where the anesthetic is injected into the retrobulbar space, which is located between the globe and the orbital rim. Injection into the subarachnoid space, which is located deeper than the retrobulbar space, can cause seizures, respiratory arrest, and progressive loss of consciousness, as described in the scenario.\n",
      "\n",
      "A possible preventive measure is to insert the needle less than 30 mm in depth to avoid penetrating the subarachnoid space. This can help prevent the anesthetic from spreading to the brain and causing central nervous system toxicity.\n",
      "\n",
      "Option a is incorrect because intraocular injection is not a complication of retrobulbar block. Option b is also incorrect because intravascular injection is not a complication of retrobulbar block, and suspending anticoagulants or antiplatelet agents before surgery may not prevent this complication. Option d is incorrect because retrobulbar hemorrhage is not a complication of retrobulbar block, and aspirating and checking for the presence of hematic content before injecting may not prevent this complication.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 161: \n",
      "Language: spanish\n",
      "Question: \n",
      "Respecto a la biometría en ojos tamponados con aceite de silicona, es correcto decir:\n",
      "a) La longitud axial medida por ultrasonidos está falsamente reducida respecto al valor real.\n",
      "b) En esta situación no se puede utilizar la reflectometría de baja coherencia.\n",
      "c) La medición de la profundidad de la cámara anterior debe realizarse en decúbito supino.\n",
      "d) En estos casos es preferible la interferometría de coherencia parcial a la ecografía.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "La longitud axial medida por ultrasonidos está falsamente reducida respecto al valor real.\n",
      "\n",
      "La biometría en ojos tamponados con aceite de silicona puede ser un desafío debido a la dificultad de obtener una buena imagen ultrasonográfica. La opción a) es la correcta, ya que la longitud axial medida por ultrasonidos puede aparecer falsamente reducida respecto al valor real debido a la presencia del aceite de silicona. La reflectometría de baja coherencia no es adecuada en esta situación, por lo que la opción b) es incorrecta. La medición de la profundidad de la cámara anterior debe realizarse en decúbito supino, lo que no es relevante para la biometría en ojos tamponados con aceite de silicona, por lo que la opción c) es incorrecta. La interferometría de coherencia parcial a la ecografía no es una técnica adecuada para la biometría en ojos tamponados con aceite de silicona, por lo que la opción d) es incorrecta.\n",
      "{'response': 'a'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na pahayag patungkol sa biometrics ng mata na nababalot ng silicone oil ang nagsasaad ng katotohanan?\n",
      "a) Ang axial na haba na nasusukat ng ultrasound ay maling nababawasan kumpara sa tunay na sukat nito.\n",
      "b) Ang low coherence reflectometry ay hindi maaaring gamitin sa sitwasyong ito\n",
      "c) Ang pagsukat ng anterior chamber depth ay dapat isagawa sa posisyon na supine.\n",
      "d) Ang bahagyang pagkakaugnay na interferometry ay mas kanais -nais sa ultrasonography sa mga kasong ito.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is c) Ang pagsukat ng anterior chamber depth ay dapat isagawa sa posisyon na supine.\n",
      "\n",
      "The question is asking about the measurement of the anterior chamber depth in a patient with silicone oil in the vitreous cavity. Option c is the correct answer because the anterior chamber depth should be measured in the supine position to minimize the effect of the silicone oil on the measurement.\n",
      "\n",
      "Option a is incorrect because the axial length measured by ultrasound may be affected by the silicone oil and may not accurately reflect the true length of the eye.\n",
      "\n",
      "Option b is incorrect because low coherence reflectometry is not a suitable method for measuring the anterior chamber depth in this situation.\n",
      "\n",
      "Option d is incorrect because interferometry, although a useful method for measuring the anterior chamber depth, may not be the best option in cases where there is silicone oil in the vitreous cavity.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Sobre a biometria em olhos tamponados por óleo de silicone é correto afirmar:\n",
      "a)O comprimento axial medido pelo ultrassom é falsamente reduzido em relação ao valor real.\n",
      "b)A reflectometria de baixa coerência não pode ser utilizada nessa situação.\n",
      "c)A medida da profundidade de câmara anterior deve ser realizada em posição supina.\n",
      "d)A interferometria de coerência parcial é preferível à ultrassonografia nesses casos.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is option a) O comprimento axial medido pelo ultrassom é falsamente reduzido em relação ao valor real.\n",
      "\n",
      "When the eye is tamponaded with silicone oil, the ultrasound measurement of the axial length may appear shorter than the actual value due to the oil's refractive properties. This is because the ultrasound waves are refracted by the oil, leading to an incorrect measurement of the eye's length. Therefore, option a is the correct answer.\n",
      "{'response': 'a'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding biometrics in eyes covered with silicone oil, it is correct to state:\n",
      "a) The axial length measured by ultrasound is falsely reduced in relation to the real value.\n",
      "b)Low coherence reflectometry cannot be used in this situation.\n",
      "c) The anterior chamber depth measurement must be performed in the supine position.\n",
      "d) Partial coherence interferometry is preferable to ultrasonography in these cases.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "When silicone oil is present in the eyes, it can affect the accuracy of ultrasound measurements, including axial length. The oil can cause a false reduction in the measured axial length, making it appear shorter than the actual value. Therefore, option a is the correct answer.\n",
      "\n",
      "The other options are not correct for the following reasons:\n",
      "\n",
      "* Option b: Low coherence reflectometry is a technique that uses low-coherence interferometry to measure the backscattering of light from the ocular fundus. It can be used in eyes with silicone oil, but it may not provide accurate results due to the scattering of light by the oil.\n",
      "* Option c: The anterior chamber depth measurement can be performed in various positions, including the supine position. However, the position of the patient does not affect the accuracy of the measurement in cases where silicone oil is present.\n",
      "* Option d: Partial coherence interferometry is a technique that uses interferometry to measure the backscattering of light from the ocular fundus. It can be used in eyes with silicone oil, but it may not provide accurate results due to the scattering of light by the oil. Ultrasonography is generally considered more reliable in these cases.\n",
      "{'response': 'a'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 162: \n",
      "Language: spanish\n",
      "Question: \n",
      "Seleccionar la alternativa que contenga, respectivamente, un medicamento asociado a la aparición del síndrome del iris flácido durante la operación y una intervención adecuada para restablecer la midriasis en estos casos.\n",
      "a) Clorpromazina - retractores del iris.\n",
      "b)Doxasozin - dilatador de Beehler.\n",
      "c) Tamsulosina - esfinterectomía.\n",
      "d)Atropina - anillo expansor del iris.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"a\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is a) Clorpromazina - retractores del iris.\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Clorpromazina is an anticholinergic medication that can cause dilatation of the pupil, which can lead to the flat iris syndrome during surgery. Retractores del iris are used to restore midriasis in these cases.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "* Doxasozin is a vasodilator that can cause a decrease in blood pressure, but it is not associated with the flat iris syndrome. Dilatador de Beehler is not a valid medical term.\n",
      "* Tamsulosina is an alpha-1 adrenergic receptor antagonist used to treat benign prostatic hyperplasia. It is not related to the flat iris syndrome or midriasis. Esfinterectomía is not a valid medical term.\n",
      "* Atropina is an anticholinergic medication that can cause dilatation of the pupil, but it is not associated with the flat iris syndrome. Anillo expansor del iris is not a valid medical term.\n",
      "{'response': 'a'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na tambalan patungkol sa gamot na may kinalaman sa pagkakaroon ng flaccid iris syndrome sa perioperative period at ang mainamna interbensyon upang maibalik ang mydriasis sa mga kasong ito.\n",
      "a) Chlorpromazine - Iris retractors\n",
      "b) Doxasozine - Beehler Dilator\n",
      "c) tamsulosin - Sphincterectomies\n",
      "d) Atropine - iIis expander ring\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Doxasozine - Beehler Dilator.\n",
      "\n",
      "Doxasozin is a medication that is used to dilate the pupil, which can help to treat conditions such as narrow-angle glaucoma and uveitis. It works by increasing the amount of fluid that flows out of the eye, which helps to reduce pressure within the eye. In the perioperative period, doxasozin can be used to prevent or treat mydriasis, which is a condition where the pupil becomes abnormally large.\n",
      "\n",
      "The other options are not correct because:\n",
      "\n",
      "* Chlorpromazine is an antipsychotic medication that is not commonly used to treat mydriasis.\n",
      "* Tamsulosin is a medication that is used to treat benign prostatic hyperplasia (BPH), and it is not related to mydriasis.\n",
      "* Atropine is a medication that is used to dilate the pupil, but it is not typically used in the perioperative period to treat mydriasis.\n",
      "\n",
      "Therefore, the correct answer is b) Doxasozine - Beehler Dilator.\n",
      "{'response': 'b'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Assinale a alternativa que contém, respectivamente, um medicamento associado à ocorrência da síndrome da íris flácida no peroperatório e uma intervenção adequada para restabelecimento da midríase nesses casos.\n",
      "a)Clorpromazina - retratores de íris.\n",
      "b)Doxasozina - dilatador de Beehler.\n",
      "c)Tamsulosina - esfincterectomias.\n",
      "d)Atropina - anel expansor de íris.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The correct answer is b) Doxasozina - dilatador de Beehler.\n",
      "\n",
      "Doxasozina is a medication that is associated with the occurrence of floppy iris syndrome in the peroperative period. It is a vasodilator that is used to treat hypertension and can cause dilatation of the iris, leading to floppy iris syndrome.\n",
      "\n",
      "In cases of floppy iris syndrome, an adequate intervention for restoration of midriasis (pupil dilation) is the use of a dilator, such as a Beehler dilator. This device is inserted into the eye through a small incision and gently dilates the pupil, allowing the surgeon to visualize the fundus and perform the necessary procedures.\n",
      "\n",
      "Therefore, the correct response is b) Doxasozina - dilatador de Beehler.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Check the alternative that contains, respectively, a drug associated with the occurrence of flaccid iris syndrome in the perioperative period and an adequate intervention to restore mydriasis in these cases.\n",
      "a) Chlorpromazine - iris retractors.\n",
      "b) Doxasozine - Beehler dilator.\n",
      "c) Tamsulosin - sphincterectomies.\n",
      "d) Atropine - iris expander ring.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"  // b) Doxasozine - Beehler dilator.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "Flaccid iris syndrome is a condition that occurs in the perioperative period and is characterized by a lack of mydriasis (pupil dilation) in response to usual doses of mydriatic drugs. This can make it difficult or impossible to perform certain eye surgeries.\n",
      "\n",
      "Doxasozine is a drug that has been associated with the occurrence of flaccid iris syndrome in the perioperative period. Beehler dilator is an adequate intervention to restore mydriasis in these cases.\n",
      "\n",
      "Chlorpromazine and tamsulosin have not been associated with flaccid iris syndrome, and iris retractors and sphincterectomies are not appropriate interventions to restore mydriasis. Atropine is a mydriatic drug, but it is not associated with flaccid iris syndrome, and iris expander ring is not a recognized intervention for this condition.\n",
      "{'response': 'b'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 163: \n",
      "Language: spanish\n",
      "Question: \n",
      "En cuanto a la prevención de endoftalmitis en cirugía de cataratas, seleccionar la alternativa correcta.\n",
      "a) En casos de contraindicación para la povidona yodada, se debe utilizar colirio antibiótico tópico durante cinco días antes del procedimiento.\n",
      "b) Los principales factores de riesgo incluyen inmunosupresión, diabetes, blefaritis, conjuntivitis, rotura de la cápsula posterior y pérdida de vítreo.\n",
      "c) Se debe adoptar el uso intracameral de gentamicina, especialmente en los casos asociados a vitrectomía previa.\n",
      "d) Los agentes etiológicos más comunes son las bacterias resultantes de una esterilización inadecuada del material quirúrgico y de las lentes intraoculares.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "La opción correcta es c) Se debe adoptar el uso intracameral de gentamicina, especialmente en los casos asociados a vitrectomía previa.\n",
      "\n",
      "La endoftalmitis es una inflamación grave y potencialmente vista amenazante que puede ocurrir después de una cirugía de cataratas. La prevención de la endoftalmitis es crucial y se han identificado varios factores de riesgo, incluyendo inmunosupresión, diabetes, blefaritis, conjuntivitis, rotura de la cápsula posterior y pérdida de vítreo.\n",
      "\n",
      "La opción a) es incorrecta ya que la povidona yodada no es un tratamiento efectivo para la prevención de la endoftalmitis. La opción b) es incorrecta ya que los principales factores de riesgo no incluyen el uso de colirio antibiótico tópico durante cinco días antes del procedimiento. La opción d) es incorrecta ya que los agentes etiológicos más comunes no son las bacterias resultantes de una esterilización inadecuada del material quirúrgico y de las lentes intraoculares.\n",
      "\n",
      "La opción c) es la correcta ya que el uso intracameral de gentamicina es una medida efectiva para prevenir la endoftalmitis, especialmente en los casos asociados a vitrectomía previa. La gentamicina es un antibiótico que se administra directamente en la cámara ocular durante el procedimiento quirúrgico y ha demostrado ser efectivo en la prevención de la endoftalmitis.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Alin sa mga sumusunod na pamamaraan upang mapigilan ang endophthalmitis sa operasyon sa katarata ang nagsasaad ng katotohanan?\n",
      "a) Sa mga kaso ng mga kontraindikado sa povidone-iodine, ang mga karaniwang pamatak na antibiotic ay dapat gamitin sa loob ng limang araw bago mag-opera\n",
      "b) Ang pangunahing mga kadahilanan ng peligro ay kinabibilangan ng immunosuppression, diabetes, blepharitis, conjunctivitis, pagkawasak ng posterior capsule at pagkawala ng vitreous.\n",
      "c) Ang intracameral na paggamit ng gentamicin ay inirerekomendang gawin, lalo na sa mga kaso na nauugnay sa nakaraang vitrectomy.\n",
      "d) Ang madalas na mga etilolohikal na agents ay mga mikrobyo na mula sa kakulangan sa isterilisasyon ng mga gamit pang-opera at intraocular mga lens.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the best way to prevent endophthalmitis in cataract surgery.\n",
      "\n",
      "Option A is incorrect because using antibiotics for five days before surgery is not a recommended practice.\n",
      "\n",
      "Option B is incorrect because immunosuppression, diabetes, blepharitis, conjunctivitis, posterior capsule rupture, and vitreous loss are not the main risk factors for endophthalmitis.\n",
      "\n",
      "Option C is correct. Intracameral gentamicin is recommended for preventing endophthalmitis, especially in cases following vitrectomy.\n",
      "\n",
      "Option D is incorrect because ethyl alcohol is not a microorganism, and it is not related to the sterilization of surgical instruments or intraocular lenses.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Sobre a prevenção de endoftalmite em cirurgia de catarata, assinale a alternativa correta.\n",
      "a)Em casos de contraindicação à iodopovidona, deve-se utilizar colírio de antibiótico tópico por cinco dias antes do procedimento.\n",
      "b)Os principais fatores de risco incluem imunossupressão, diabetes, blefarite, conjuntivite, rotura da cápsula posterior e perda vítrea.\n",
      "c)O uso intracameral de gentamicina deve ser adotado, principalmente nos casos associados a vitrectomia anterior.\n",
      "d)Os agentes etiológicos mais frequentes são bactérias provenientes da esterilização inadequada dos materiais cirúrgicos e lentes intraoculares.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"b\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The question is asking about the prevention of endophthalmitis in cataract surgery, and the correct answer is b) The main risk factors include immunosuppression, diabetes, blepharitis, conjunctivitis, posterior capsule rupture, and vitreous loss.\n",
      "\n",
      "Endophthalmitis is a serious complication of cataract surgery that can result in vision loss. The risk factors for endophthalmitis include immunosuppression, diabetes, blepharitis, conjunctivitis, posterior capsule rupture, and vitreous loss. It is important to identify and manage these risk factors to prevent the development of endophthalmitis.\n",
      "\n",
      "Option a is incorrect because iodopovidone is not a treatment for endophthalmitis, and using antibiotic eye drops for five days before the procedure is not a standard preventive measure.\n",
      "\n",
      "Option c is incorrect because while intracameral gentamicin is used in some cases of cataract surgery, it is not specifically indicated for the prevention of endophthalmitis.\n",
      "\n",
      "Option d is incorrect because while bacteria can cause endophthalmitis, the main risk factors for the development of endophthalmitis are not related to the sterilization of materials and lenses.\n",
      "{'response': 'b'}\n",
      "Language: english\n",
      "Question: \n",
      "Regarding the prevention of endophthalmitis in cataract surgery, mark the correct alternative.\n",
      "a) In cases of contraindication to povidone-iodine, topical antibiotic eye drops should be used for five days before the procedure.\n",
      "b) The main risk factors include immunosuppression, diabetes, blepharitis, conjunctivitis, rupture of the posterior capsule and vitreous loss.\n",
      "c) The intracameral use of gentamicin should be adopted, especially in cases associated with previous vitrectomy.\n",
      "d) The most frequent etiological agents are bacteria from inadequate sterilization of surgical materials and intraocular lenses. \n",
      "Test #0: \n",
      "response\n",
      "  Here's my answer:\n",
      "```json\n",
      "{\n",
      "\t\"response\": \"c\" // c) The intracameral use of gentamicin should be adopted, especially in cases associated with previous vitrectomy.\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "Endophthalmitis is a sight-threatening complication of cataract surgery that can arise from bacterial contamination during the procedure. The intracameral use of gentamicin, which is a potent antibiotic, has been shown to significantly reduce the risk of endophthalmitis, especially in cases associated with previous vitrectomy.\n",
      "\n",
      "While option a is incorrect because topical antibiotic eye drops are not effective in preventing endophthalmitis, option b is only partially correct because it lists some risk factors for endophthalmitis but does not directly address prevention. Option d is incorrect because while bacteria from inadequate sterilization of surgical materials and intraocular lenses can cause endophthalmitis, the most effective preventive measure is the intracameral use of gentamicin.\n",
      "{'response': 'c'}\n",
      "**************************************************\n",
      "**************************************************\n",
      "Question 164: \n",
      "Language: spanish\n",
      "Question: \n",
      "Después de realizar las fracturas del núcleo con la técnica de divide y vencerás, se nota una porción blanquecina y contracción del tejido en la porción lateral de la incisión corneal, goteando solución de irrigación por el espacio formado. Entre las alternativas siguientes, ¿cuál sería eficaz para prevenir la aparición de la complicación descrita?\n",
      "a) Reducir el caudal de aspiración y realizar una incisión más estrecha.\n",
      "b) Utilice puntas de mayor diámetro y manguitos de irrigación coaxiales de menor diámetro.\n",
      "c) Mantener la punta equidistante de las paredes de la incisión y utilizar ultrasonido pulsado.\n",
      "d) Llenar la cámara anterior con viscoelástico cohesivo y utilizar ultrasonido continuo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "La opción c) Mantener la punta equidistante de las paredes de la incisión y utilizar ultrasonido pulsado es la más adecuada para prevenir la aparición de la complicación descrita. La técnica de divide y vencerás puede causar una lesión en la capa de epitelio pigmentario y la incisión lateral puede causar una contracción del tejido, lo que puede provocar la aparición de una porción blanquecina y goteo de solución de irrigación. La opción c) mantiene la punta de la incisión equidistante de las paredes y utiliza ultrasonido pulsado para minimizar la lesión en la capa de epitelio pigmentario y reducir la contracción del tejido, lo que puede prevenir la aparición de la complicación descrita.\n",
      "{'response': 'c'}\n",
      "Language: tagalog\n",
      "Question: \n",
      "Matapos isagawa ang core fractures gamit ang divide-and-conquer na teknik, may nakitang mamuti-mutlng bahagi at kontraksyon ng tissue sa lateral na bahagi ng corneal incision, at pagtagas ng irrigation solution sa puwang na nabuo. Alin sa mga sumusunod na pahayag ang naglalarawan ng epektibong pamamaraan upang maiwasan ang komplikasyong nabanggit?\n",
      "a) Bawasan ang aspiration flow rate at at gawing mas makitid ang paghiwa.\n",
      "b) Gumamit ng mas malapad na tipis at mas makitid na coaxial irrigation sleeves\n",
      "c) Panatilihin na equidistant ang tip mula sa incision walls at gumamit ng pulsed ultrasound.\n",
      "d) Punan ang anterior chamber ng cohesive viscoelastic na materyal at gumamit ng continuous ultrasound\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c: Panatilihin na equidistant ang tip mula sa incision walls at gumamit ng pulsed ultrasound.\n",
      "\n",
      "This answer choice suggests maintaining a consistent distance between the tip of the instrument and the incision walls, and using pulsed ultrasound to help minimize the risk of complications such as corneal perforation or irregular healing. This approach can help ensure a more controlled and precise dissection, reducing the risk of unintended tissue damage or bleeding.\n",
      "\n",
      "The other options do not accurately address the complications described in the scenario:\n",
      "\n",
      "Option a: Bawasan ang aspiration flow rate at at gawing mas makitid ang paghiwa. - This option suggests reducing the aspiration flow rate and making the incision wider, which may not directly address the issue of corneal perforation or irregular healing.\n",
      "\n",
      "Option b: Gumamit ng mas malapad na tipis at mas makitid na coaxial irrigation sleeves. - This option suggests using a longer and thicker irrigation sleeve, which may not be necessary or effective in preventing complications.\n",
      "\n",
      "Option d: Punan ang anterior chamber ng cohesive viscoelastic na materyal at gumamit ng continuous ultrasound. - This option suggests filling the anterior chamber with a cohesive viscoelastic material and using continuous ultrasound, which may not be directly related to the complications described in the scenario.\n",
      "{'response': 'c'}\n",
      "Language: portuguese\n",
      "Question: \n",
      "Após realizar as fraturas do núcleo com a técnica de dividir e conquistar, nota-se uma porção esbranquiçada e contração do tecido na porção lateral da incisão da córnea, com vazamento da solução de irrigação pelo vão formado. Entre as alternativas abaixo, qual seria eficaz em prevenir a ocorrência da complicação descrita?\n",
      "a)Reduzir a taxa de fluxo de aspiração e fazer incisão mais estreita.\n",
      "b)Usar ponteiras de maior diâmetro e luvas de irrigação coaxial de menor diâmetro.\n",
      "c)Manter a ponteira equidistante das paredes da incisão e utilizar ultrassom pulsado.\n",
      "d)Preencher a câmara anterior com viscoelástico coesivo e utilizar ultrassom contínuo.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "The correct answer is option c: Manter a ponteira equidistante das paredes da incisão e utilizar ultrassom pulsado.\n",
      "\n",
      "This complication is likely due to excessive pressure or trauma to the corneal tissue during the phacoemulsification process, which has caused edema and leakage of the irrigation solution. To prevent this complication, it is important to maintain the ponteira (phacoemulsification handpiece) at a safe distance from the walls of the incision, and to use pulsed ultrasonic energy to break up the nucleus, rather than continuous ultrasonic energy. This will help to reduce the pressure on the corneal tissue and minimize the risk of complications.\n",
      "\n",
      "Therefore, option c is the correct answer. Option a is incorrect because reducing the flow rate and making a narrower incision may not necessarily address the underlying cause of the complication. Option b is also incorrect because using larger ponteiras and coaxial irrigation sleeves may not be effective in preventing the complication. Option d is incorrect because filling the anterior chamber with viscoelastic material and using continuous ultrasonic energy may not be effective in preventing the complication, and may even exacerbate it.\n",
      "{'response': 'c'}\n",
      "Language: english\n",
      "Question: \n",
      "After performing the core fractures with the divide-and-conquer technique, a whitish portion and contraction of the tissue can be seen on the lateral portion of the corneal incision, with leakage of the irrigation solution through the gap formed. Among the alternatives below, which would be effective in preventing the occurrence of the described complication?\n",
      "a) Reduce the aspiration flow rate and make the incision narrower.\n",
      "b)Use larger diameter tips and smaller diameter coaxial irrigation sleeves.\n",
      "c) Keep the tip equidistant from the incision walls and use pulsed ultrasound.\n",
      "d) Fill the anterior chamber with cohesive viscoelastic and use continuous ultrasound.\n",
      "Test #0: \n",
      "response\n",
      "  ```json\n",
      "{\n",
      "\t\"response\": \"c\"\n",
      "}\n",
      "```\n",
      "\n",
      "Explanation:\n",
      "\n",
      "The described complication is likely due to the leakage of irrigation solution through the gap formed between the incision walls and the tip of the phacoemulsification device. To prevent this complication, the tip should be kept equidistant from the incision walls, which can be achieved by using pulsed ultrasound. This will help to maintain a consistent distance between the tip and the incision walls, reducing the risk of leakage.\n",
      "\n",
      "Therefore, option C is the correct answer.\n",
      "\n",
      "Option A is incorrect because reducing the aspiration flow rate and making the incision narrower may not necessarily prevent the leakage of irrigation solution.\n",
      "\n",
      "Option B is incorrect because using larger diameter tips and smaller diameter coaxial irrigation sleeves may not effectively address the issue of leakage.\n",
      "\n",
      "Option D is incorrect because filling the anterior chamber with cohesive viscoelastic and using continuous ultrasound may not provide adequate support to prevent leakage during phacoemulsification.\n",
      "{'response': 'c'}\n",
      "**************************************************\n"
     ]
    }
   ],
   "source": [
    "# Run evaluation:\n",
    "llm_language_evaluation(path=PATH, model=MODEL, temperature=TEMPERATURE, n_repetitions=N_REPETITIONS, reasoning=REASONING, languages=LANGUAGES)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "079dcbc4",
   "metadata": {},
   "source": [
    "#### See the results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "a58184aa",
   "metadata": {
    "height": 30,
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>year</th>\n",
       "      <th>test</th>\n",
       "      <th>theme</th>\n",
       "      <th>subtheme</th>\n",
       "      <th>portuguese</th>\n",
       "      <th>spanish</th>\n",
       "      <th>english</th>\n",
       "      <th>tagalog</th>\n",
       "      <th>answer</th>\n",
       "      <th>responses_spanish</th>\n",
       "      <th>responses_spanish_0</th>\n",
       "      <th>responses_tagalog</th>\n",
       "      <th>responses_tagalog_0</th>\n",
       "      <th>responses_portuguese</th>\n",
       "      <th>responses_portuguese_0</th>\n",
       "      <th>responses_english</th>\n",
       "      <th>responses_english_0</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>2022</td>\n",
       "      <td>Teórica I</td>\n",
       "      <td>Anatomia</td>\n",
       "      <td>cornea</td>\n",
       "      <td>Em qual região ocular células caliciformes são...</td>\n",
       "      <td>¿En qué región ocular se encuentran fisiológic...</td>\n",
       "      <td>In which ocular region are caliciform cells ph...</td>\n",
       "      <td>Aling bahagi ng mata ay kung saan matatagpuan ...</td>\n",
       "      <td>D</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>2022</td>\n",
       "      <td>Teórica I</td>\n",
       "      <td>Anatomia</td>\n",
       "      <td>retina</td>\n",
       "      <td>Assinale a alternativa que melhor correlaciona...</td>\n",
       "      <td>Marque la alternativa que mejor correlaciona l...</td>\n",
       "      <td>Mark the alternative that best correlates the ...</td>\n",
       "      <td>Ipagpares ang bahagi ng retina sa Hanay B sa t...</td>\n",
       "      <td>B</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>c) I: B; II: A; III: C; IV: C.</td>\n",
       "      <td>c) I: B; II: A; III: C; IV: C.</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>2022</td>\n",
       "      <td>Teórica I</td>\n",
       "      <td>Anatomia</td>\n",
       "      <td>cornea</td>\n",
       "      <td>Ordene as três denominações celulares encontra...</td>\n",
       "      <td>Ordene los tres nombres de células que se encu...</td>\n",
       "      <td>Order the three cell names found in the cornea...</td>\n",
       "      <td>Ipagsunud-sunod ang mga cells ng corneal epith...</td>\n",
       "      <td>A</td>\n",
       "      <td>b) Alada, basal, plana.</td>\n",
       "      <td>b) Alada, basal, plana.</td>\n",
       "      <td>b) Wing, basal, flat.</td>\n",
       "      <td>b) Wing, basal, flat.</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>c) Basal, flat, wing.</td>\n",
       "      <td>c) Basal, flat, wing.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>2022</td>\n",
       "      <td>Teórica I</td>\n",
       "      <td>Anatomia</td>\n",
       "      <td>cornea</td>\n",
       "      <td>Sobre a membrana de Descemet da córnea, é corr...</td>\n",
       "      <td>Con respecto a la membrana de la córnea de Des...</td>\n",
       "      <td>Regarding Descemet's membrane of the cornea, i...</td>\n",
       "      <td>Tama tungkol sa Descemet's membrane ng cornea:...</td>\n",
       "      <td>C</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>2022</td>\n",
       "      <td>Teórica I</td>\n",
       "      <td>Anatomia</td>\n",
       "      <td>cornea</td>\n",
       "      <td>Sobre a camada lipídica do filme lacrimal, ass...</td>\n",
       "      <td>Respecto a la capa lipídica de la película lag...</td>\n",
       "      <td>About the lipidic layer of the lacrimal film, ...</td>\n",
       "      <td>Piliin ang tamang sagot tungkol sa lipid layer...</td>\n",
       "      <td>B</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>c</td>\n",
       "      <td>c</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>159</th>\n",
       "      <td>161</td>\n",
       "      <td>2022</td>\n",
       "      <td>Teórica II</td>\n",
       "      <td>Cristalino/Catarata</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Após bloqueio retrobulbar para realização de c...</td>\n",
       "      <td>Tras el bloqueo retrobulbar para realizar la c...</td>\n",
       "      <td>After retrobulbar block for phacoemulsificatio...</td>\n",
       "      <td>Matapos ang retrobulbar block para sa phacoemu...</td>\n",
       "      <td>C</td>\n",
       "      <td>c</td>\n",
       "      <td>c</td>\n",
       "      <td>d</td>\n",
       "      <td>d</td>\n",
       "      <td>c</td>\n",
       "      <td>c</td>\n",
       "      <td>c</td>\n",
       "      <td>c</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>160</th>\n",
       "      <td>162</td>\n",
       "      <td>2022</td>\n",
       "      <td>Teórica II</td>\n",
       "      <td>Cristalino/Catarata</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Sobre a biometria em olhos tamponados por óleo...</td>\n",
       "      <td>Respecto a la biometría en ojos tamponados con...</td>\n",
       "      <td>Regarding biometrics in eyes covered with sili...</td>\n",
       "      <td>Alin sa mga sumusunod na pahayag patungkol sa ...</td>\n",
       "      <td>D</td>\n",
       "      <td>a</td>\n",
       "      <td>a</td>\n",
       "      <td>c</td>\n",
       "      <td>c</td>\n",
       "      <td>a</td>\n",
       "      <td>a</td>\n",
       "      <td>a</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161</th>\n",
       "      <td>163</td>\n",
       "      <td>2022</td>\n",
       "      <td>Teórica II</td>\n",
       "      <td>Cristalino/Catarata</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Assinale a alternativa que contém, respectivam...</td>\n",
       "      <td>Seleccionar la alternativa que contenga, respe...</td>\n",
       "      <td>Check the alternative that contains, respectiv...</td>\n",
       "      <td>Alin sa mga sumusunod na tambalan patungkol sa...</td>\n",
       "      <td>A</td>\n",
       "      <td>a</td>\n",
       "      <td>a</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>162</th>\n",
       "      <td>164</td>\n",
       "      <td>2022</td>\n",
       "      <td>Teórica II</td>\n",
       "      <td>Cristalino/Catarata</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Sobre a prevenção de endoftalmite em cirurgia ...</td>\n",
       "      <td>En cuanto a la prevención de endoftalmitis en ...</td>\n",
       "      <td>Regarding the prevention of endophthalmitis in...</td>\n",
       "      <td>Alin sa mga sumusunod na pamamaraan upang mapi...</td>\n",
       "      <td>B</td>\n",
       "      <td>c</td>\n",
       "      <td>c</td>\n",
       "      <td>c</td>\n",
       "      <td>c</td>\n",
       "      <td>b</td>\n",
       "      <td>b</td>\n",
       "      <td>c</td>\n",
       "      <td>c</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>163</th>\n",
       "      <td>165</td>\n",
       "      <td>2022</td>\n",
       "      <td>Teórica II</td>\n",
       "      <td>Cristalino/Catarata</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Após realizar as fraturas do núcleo com a técn...</td>\n",
       "      <td>Después de realizar las fracturas del núcleo c...</td>\n",
       "      <td>After performing the core fractures with the d...</td>\n",
       "      <td>Matapos isagawa ang core fractures gamit ang d...</td>\n",
       "      <td>C</td>\n",
       "      <td>c</td>\n",
       "      <td>c</td>\n",
       "      <td>c</td>\n",
       "      <td>c</td>\n",
       "      <td>c</td>\n",
       "      <td>c</td>\n",
       "      <td>c</td>\n",
       "      <td>c</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>164 rows × 18 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      ID  year        test                theme subtheme  \\\n",
       "0      1  2022   Teórica I             Anatomia   cornea   \n",
       "1      2  2022   Teórica I             Anatomia   retina   \n",
       "2      3  2022   Teórica I             Anatomia   cornea   \n",
       "3      4  2022   Teórica I             Anatomia   cornea   \n",
       "4      5  2022   Teórica I             Anatomia   cornea   \n",
       "..   ...   ...         ...                  ...      ...   \n",
       "159  161  2022  Teórica II  Cristalino/Catarata      NaN   \n",
       "160  162  2022  Teórica II  Cristalino/Catarata      NaN   \n",
       "161  163  2022  Teórica II  Cristalino/Catarata      NaN   \n",
       "162  164  2022  Teórica II  Cristalino/Catarata      NaN   \n",
       "163  165  2022  Teórica II  Cristalino/Catarata      NaN   \n",
       "\n",
       "                                            portuguese  \\\n",
       "0    Em qual região ocular células caliciformes são...   \n",
       "1    Assinale a alternativa que melhor correlaciona...   \n",
       "2    Ordene as três denominações celulares encontra...   \n",
       "3    Sobre a membrana de Descemet da córnea, é corr...   \n",
       "4    Sobre a camada lipídica do filme lacrimal, ass...   \n",
       "..                                                 ...   \n",
       "159  Após bloqueio retrobulbar para realização de c...   \n",
       "160  Sobre a biometria em olhos tamponados por óleo...   \n",
       "161  Assinale a alternativa que contém, respectivam...   \n",
       "162  Sobre a prevenção de endoftalmite em cirurgia ...   \n",
       "163  Após realizar as fraturas do núcleo com a técn...   \n",
       "\n",
       "                                               spanish  \\\n",
       "0    ¿En qué región ocular se encuentran fisiológic...   \n",
       "1    Marque la alternativa que mejor correlaciona l...   \n",
       "2    Ordene los tres nombres de células que se encu...   \n",
       "3    Con respecto a la membrana de la córnea de Des...   \n",
       "4    Respecto a la capa lipídica de la película lag...   \n",
       "..                                                 ...   \n",
       "159  Tras el bloqueo retrobulbar para realizar la c...   \n",
       "160  Respecto a la biometría en ojos tamponados con...   \n",
       "161  Seleccionar la alternativa que contenga, respe...   \n",
       "162  En cuanto a la prevención de endoftalmitis en ...   \n",
       "163  Después de realizar las fracturas del núcleo c...   \n",
       "\n",
       "                                               english  \\\n",
       "0    In which ocular region are caliciform cells ph...   \n",
       "1    Mark the alternative that best correlates the ...   \n",
       "2    Order the three cell names found in the cornea...   \n",
       "3    Regarding Descemet's membrane of the cornea, i...   \n",
       "4    About the lipidic layer of the lacrimal film, ...   \n",
       "..                                                 ...   \n",
       "159  After retrobulbar block for phacoemulsificatio...   \n",
       "160  Regarding biometrics in eyes covered with sili...   \n",
       "161  Check the alternative that contains, respectiv...   \n",
       "162  Regarding the prevention of endophthalmitis in...   \n",
       "163  After performing the core fractures with the d...   \n",
       "\n",
       "                                               tagalog answer  \\\n",
       "0    Aling bahagi ng mata ay kung saan matatagpuan ...      D   \n",
       "1    Ipagpares ang bahagi ng retina sa Hanay B sa t...      B   \n",
       "2    Ipagsunud-sunod ang mga cells ng corneal epith...      A   \n",
       "3    Tama tungkol sa Descemet's membrane ng cornea:...      C   \n",
       "4    Piliin ang tamang sagot tungkol sa lipid layer...      B   \n",
       "..                                                 ...    ...   \n",
       "159  Matapos ang retrobulbar block para sa phacoemu...      C   \n",
       "160  Alin sa mga sumusunod na pahayag patungkol sa ...      D   \n",
       "161  Alin sa mga sumusunod na tambalan patungkol sa...      A   \n",
       "162  Alin sa mga sumusunod na pamamaraan upang mapi...      B   \n",
       "163  Matapos isagawa ang core fractures gamit ang d...      C   \n",
       "\n",
       "           responses_spanish      responses_spanish_0  \\\n",
       "0                          b                        b   \n",
       "1                          b                        b   \n",
       "2    b) Alada, basal, plana.  b) Alada, basal, plana.   \n",
       "3                          b                        b   \n",
       "4                          b                        b   \n",
       "..                       ...                      ...   \n",
       "159                        c                        c   \n",
       "160                        a                        a   \n",
       "161                        a                        a   \n",
       "162                        c                        c   \n",
       "163                        c                        c   \n",
       "\n",
       "                  responses_tagalog             responses_tagalog_0  \\\n",
       "0                                 b                               b   \n",
       "1    c) I: B; II: A; III: C; IV: C.  c) I: B; II: A; III: C; IV: C.   \n",
       "2             b) Wing, basal, flat.           b) Wing, basal, flat.   \n",
       "3                                 b                               b   \n",
       "4                                 c                               c   \n",
       "..                              ...                             ...   \n",
       "159                               d                               d   \n",
       "160                               c                               c   \n",
       "161                               b                               b   \n",
       "162                               c                               c   \n",
       "163                               c                               c   \n",
       "\n",
       "    responses_portuguese responses_portuguese_0      responses_english  \\\n",
       "0                      b                      b                      b   \n",
       "1                      b                      b                      b   \n",
       "2                      b                      b  c) Basal, flat, wing.   \n",
       "3                      b                      b                      b   \n",
       "4                      b                      b                      b   \n",
       "..                   ...                    ...                    ...   \n",
       "159                    c                      c                      c   \n",
       "160                    a                      a                      a   \n",
       "161                    b                      b                      b   \n",
       "162                    b                      b                      c   \n",
       "163                    c                      c                      c   \n",
       "\n",
       "       responses_english_0  \n",
       "0                        b  \n",
       "1                        b  \n",
       "2    c) Basal, flat, wing.  \n",
       "3                        b  \n",
       "4                        b  \n",
       "..                     ...  \n",
       "159                      c  \n",
       "160                      a  \n",
       "161                      b  \n",
       "162                      c  \n",
       "163                      c  \n",
       "\n",
       "[164 rows x 18 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import os\n",
    "MODEL = os.path.basename(MODEL)\n",
    "\n",
    "if N_REPETITIONS > 1:\n",
    "    df = pd.read_csv(f\"responses/{MODEL}_Temperature{str(TEMPERATURE).replace('.', '_')}_{N_REPETITIONS}Repetitions.csv\")\n",
    "else:\n",
    "    df = pd.read_csv(f\"responses/{MODEL}_Temperature{str(TEMPERATURE).replace('.', '_')}.csv\")\n",
    "\n",
    "df"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "041dc525",
   "metadata": {},
   "source": [
    "### Data Analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "85f6bb97",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "n_repetitions should be a positive integer, not 0\n",
      "n_repetitions will be set to 1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/davidrestrepo/LLMs Bias/Language/src/data_analysis.py:215: UserWarning: FixedFormatter should only be used together with FixedLocator\n",
      "  ax.set_xticklabels(languages, fontsize=16)\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 800x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "     theme  match_spanish  match_tagalog  match_portuguese  match_english  \\\n",
      "0  anatomy              5              4                 4              6   \n",
      "\n",
      "   Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0     21                 23.809524                 19.047619   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                    19.047619                 28.571429  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "    theme  match_spanish  match_tagalog  match_portuguese  match_english  \\\n",
      "0  cornea              4              2                 4              4   \n",
      "\n",
      "   Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0     10                      40.0                      20.0   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                         40.0                      40.0  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "        theme  match_spanish  match_tagalog  match_portuguese  match_english  \\\n",
      "0  embryology              1              1                 1              1   \n",
      "\n",
      "   Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0      2                      50.0                      50.0   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                         50.0                      50.0  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "      theme  match_spanish  match_tagalog  match_portuguese  match_english  \\\n",
      "0  genetics              0              0                 0              1   \n",
      "\n",
      "   Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0      2                       0.0                       0.0   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                          0.0                      50.0  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "      theme  match_spanish  match_tagalog  match_portuguese  match_english  \\\n",
      "0  glaucoma              3              2                 2              3   \n",
      "\n",
      "   Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0      9                 33.333333                 22.222222   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                    22.222222                 33.333333  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "      theme  match_spanish  match_tagalog  match_portuguese  match_english  \\\n",
      "0  oncology              1              0                 0              1   \n",
      "\n",
      "   Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0      1                     100.0                       0.0   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                          0.0                     100.0  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "          theme  match_spanish  match_tagalog  match_portuguese  \\\n",
      "0  pharmacology              3              2                 3   \n",
      "\n",
      "   match_english  Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0              4      9                 33.333333                 22.222222   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                    33.333333                 44.444444  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "        theme  match_spanish  match_tagalog  match_portuguese  match_english  \\\n",
      "0  refraction              9              9                 7              9   \n",
      "\n",
      "   Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0     31                 29.032258                 29.032258   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                    22.580645                 29.032258  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "    theme  match_spanish  match_tagalog  match_portuguese  match_english  \\\n",
      "0  retina              5              4                 4              4   \n",
      "\n",
      "   Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0     12                 41.666667                 33.333333   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                    33.333333                 33.333333  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "            theme  match_spanish  match_tagalog  match_portuguese  \\\n",
      "0  contact lenses              1              0                 1   \n",
      "\n",
      "   match_english  Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0              1      3                 33.333333                       0.0   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                    33.333333                 33.333333  \n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAiQAAAIjCAYAAAAz9gDIAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjcuMywgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy/OQEPoAAAACXBIWXMAAA9hAAAPYQGoP6dpAABcSUlEQVR4nO3dd1QU5/s28GtBWPpSRIoiUizYFaNBFLEgomKJsUcxGhIL1tg19hI7Rglqkq+o0ZgQS2JFUbFrbNhFsMfYFVBQBPZ5//Blfq6LCuvioFyfc/Ycdsoz987szl7MPDOrEEIIEBEREcnIQO4CiIiIiBhIiIiISHYMJERERCQ7BhIiIiKSHQMJERERyY6BhIiIiGTHQEJERESyYyAhIiIi2TGQEBERkewYSOij988//8DY2BjXrl3TS3vnzp1DsWLFcObMGb20Rx+GMmXKoEePHu99uVFRUVAoFDh69Oh7XzbJx9/fH/7+/nKX8V59cIHk0qVL+Oabb+Du7g4TExNYWVnB19cX8+fPx9OnT+UuL9/OnTuHCRMm4OrVq/med/jw4VAoFOjYsaP+C/uIjBkzBp07d4arq6s0bP369ahQoQJUKhWCg4Px33//ac3XqlUrfP3111rDK1asiBYtWmDcuHF5Wn7OF8rLjxIlSqBhw4bYsmWL7i8sF2XKlEHLli312ibp19WrV7XeD6976LJfoPx5l31wfmzevBkTJkwo0GV86IrJXUB+bNq0Ce3bt4dSqUT37t1RuXJlPH/+HPv27cOwYcNw9uxZLFmyRO4y8+XcuXOYOHEi/P39UaZMmTzPJ4TAb7/9hjJlymDDhg14/PgxLC0tC67QD1R8fDxiY2Nx4MABadjly5fRsWNHdOzYET4+PggPD8eXX36JmJgYaZqYmBjs2bMHiYmJubbbu3dvNG/eHJcuXYKHh0eeapk0aRLc3NwghMCdO3cQFRWF5s2bY8OGDQwRH4CEhAQYGLz7/3D29vZYsWKFxrA5c+bg33//xbx587SmpYKl6z44vzZv3oyIiAiGkjf4YALJlStX0KlTJ7i6umLnzp1wcnKSxvXr1w9JSUnYtGnTOy9HCIFnz57B1NRUa9yzZ89gbGysl53Su4qLi8O///6LnTt3IjAwEGvXrkVISIjcZelVVlYW1Go1jI2NdW5j6dKlKF26ND799FNp2LZt21CqVCksW7YMCoUCXl5eaNSoEZ49ewYTExNkZWVh8ODBGDdu3Gu/EJo0aQIbGxssW7YMkyZNylMtQUFBqFWrlvS8V69ecHBwwG+//cZA8gFQKpV6acfc3BxffPGFxrDVq1fj0aNHWsOJihL5v1nzaObMmXjy5Al++eUXjTCSw9PTEwMHDpSeZ2VlYfLkyfDw8IBSqUSZMmUwevRoZGRkaMyXc4g7JiYGtWrVgqmpKRYvXoy4uDgoFAqsXr0aY8eORcmSJWFmZobU1FQAwOHDh9GsWTOoVCqYmZmhQYMG2L9/v1ZdN2/eRK9eveDs7AylUgk3Nzf06dMHz58/R1RUFNq3bw8AaNiwoXSYNi4u7q3rY+XKlahYsSIaNmyIJk2aYOXKlVrT5LyGP/74A1OnTkWpUqVgYmKCxo0bIykpSWPaxMREtGvXDo6OjjAxMUGpUqXQqVMnpKSkAAA+++wz1KxZU2Oe4OBgKBQK/P3339Kww4cPQ6FQaJyKSE5OxqBBg+Di4gKlUglPT0/MmDEDarVamibnMPbs2bMRHh4ubbdz584BABYsWIBKlSrBzMwMNjY2qFWrFlatWvXW9bR+/Xo0atQICoVCGvb06VNYW1tLw2xtbSGEkE75LVy4ENnZ2ejfv/9r2zUyMoK/vz/++uuvt9bwOtbW1jA1NUWxYi/+LxBCoEyZMmjdurXWtM+ePYNKpcI333yj8/Jy7N27F+3bt0fp0qWhVCrh4uKCwYMHa53y7NGjBywsLHDz5k20adMGFhYWsLe3x9ChQ5Gdna0x7YMHD9CtWzdYWVnB2toaISEhOHnyJBQKBaKioqTpXndevEePHlr/nc6ePRt169aFnZ0dTE1N4e3tjT///FNr3qdPn2LAgAEoXrw4LC0t0apVK9y8eRMKhULrv9GbN2+iZ8+ecHBwgFKpRKVKlfC///0vT+vt1T4kOafi9u/fjyFDhsDe3h7m5uZo27Yt7t27l6c28yMjIyNPy9myZQvq168Pc3NzWFpaokWLFjh79qzGNDnb9vr162jZsiUsLCxQsmRJREREAABOnz6NRo0awdzcHK6urrl+1vLyuQaAW7du4cKFC8jMzHzra1Sr1Zg/fz6qVKkCExMT2Nvbo1mzZhr9Z/K7b9+3bx9q164NExMTuLu7Y/ny5dI0b9sH//XXX2jRooW0//bw8MDkyZO13v/Ai31f8+bNYWNjA3Nzc1StWhXz58+X1nfOun35lFx+ZWRkYPz48fD09JQ+u8OHD9d67QqFAmFhYVi/fj0qV64svde3bt2qMd3jx48xaNAglClTBkqlEiVKlEBAQACOHz+u9dre9n2X17beSHwgSpYsKdzd3fM8fUhIiAAgPv/8cxERESG6d+8uAIg2bdpoTOfq6io8PT2FjY2NGDlypFi0aJHYtWuX2LVrlwAgKlasKKpXry7mzp0rpk+fLtLS0sSOHTuEsbGx8PHxEXPmzBHz5s0TVatWFcbGxuLw4cNS2zdv3hTOzs7CzMxMDBo0SCxatEh89913wsvLSzx69EhcunRJDBgwQAAQo0ePFitWrBArVqwQt2/ffuNre/bsmbC2thaTJ08WQgixfPlyYWhoKG7duqUxXc5rqFGjhvD29hbz5s0TEyZMEGZmZqJ27drSdBkZGcLNzU04OzuLKVOmiJ9//llMnDhRfPLJJ+Lq1atCCCHmzp0rDAwMREpKihBCCLVaLWxsbISBgYEYOnSo1NasWbM0pktLSxNVq1YVdnZ2YvTo0WLRokWie/fuQqFQiIEDB0rzXblyRVrf7u7u4vvvvxfz5s0T165dE0uWLJG25eLFi8X8+fNFr169xIABA964nv79918BQPzwww8aw/fu3SsUCoVYtWqVuHz5sujQoYPw9PQUQghx9+5dYW1tLTZu3PjGtoUQYsqUKRqv9XWWLl0qAIjY2Fhx7949cffuXXHmzBnxzTffCAMDA7Ft2zZp2jFjxggjIyPx4MEDjTb++OMPAUDs2bPnjctydXUVLVq0eOM0/fv3F82bNxfTpk0TixcvFr169RKGhobi888/15guJCREmJiYiEqVKomePXuKyMhI0a5dOwFA/Pjjj9J02dnZwsfHRxgaGoqwsDCxcOFCERAQIKpVqyYAiKVLl0rTNmjQQDRo0ECrppCQEOHq6qoxrFSpUqJv375i4cKFYu7cuaJ27doCgNa26dChgwAgunXrJiIiIkSHDh2kZY8fP16a7vbt26JUqVLCxcVFTJo0SURGRopWrVoJAGLevHlvXGdCvFi3ISEh0vOc7VqjRg3RqFEjsWDBAvHtt98KQ0ND0aFDh7e297IWLVpovX5dlrN8+XKhUChEs2bNxIIFC8SMGTNEmTJlhLW1tbhy5Yo0Xc62rVixoujdu7eIiIgQdevWlbaXs7OzGDZsmFiwYIGoVKmSMDQ0FJcvX5bmz+vnOmdZADSW/zo9evQQAERQUJAIDw8Xs2fPFq1btxYLFizQai8v+/by5csLBwcHMXr0aLFw4UJRs2ZNoVAoxJkzZ4QQ4q374DZt2ogOHTqIWbNmicjISNG+fXsBQGOfJ4QQ27ZtE8bGxsLV1VWMHz9eREZGigEDBogmTZoIIYQ4cOCACAgIEACkZaxYseKN6+LVz0p2drZo2rSp9H2yePFiERYWJooVKyZat26tMS8AUa1aNeHk5CQmT54swsPDhbu7uzAzMxP379+XpuvSpYswNjYWQ4YMET///LOYMWOGCA4OFr/++qs0TV6/7/LS1tt8EIEkJSVFANBa6a8THx8vAIivvvpKY/jQoUMFALFz505pmKurqwAgtm7dqjFtzpe5u7u7SE9Pl4ar1WpRtmxZERgYKNRqtTQ8PT1duLm5iYCAAGlY9+7dhYGBgThy5IhWjTnzRkdHCwBi165deXptQgjx559/CgAiMTFRCCFEamqqMDEx0dqp5rwGLy8vkZGRIQ2fP3++ACBOnz4thBDixIkTAoCIjo5+7TKPHDkiAIjNmzcLIYQ4deqUACDat28v6tSpI03XqlUrUaNGDen55MmThbm5ubh48aJGeyNHjhSGhobi+vXrQoj/CyRWVlbi7t27GtO2bt1aVKpUKa+rRxIbGysAiA0bNmiNy9kJARC2trbSeyI0NFQ0a9YsT+2vWrVKAND4UOYm5wvl1YdSqRRRUVEa0yYkJAgAIjIyUmN4q1atRJkyZTTec7nJSyB5+f2cY/r06UKhUIhr165Jw3J2/JMmTdKYNifg5lizZo0AIMLDw6Vh2dnZolGjRu8USF6t8/nz56Jy5cqiUaNG0rBjx44JAGLQoEEa0+Z8sb0cSHr16iWcnJw0dshCCNGpUyehUqlyXS8ve10gadKkicZ2GTx4sDA0NBTJyclvbO9leQkkb1vO48ePhbW1tQgNDdWY//bt20KlUmkMz9m206ZNk4Y9evRImJqaCoVCIVavXi0Nv3Dhgta6zOvn+uVlvS2Q7Ny5UwDI9R+NnNety7795RB/9+5doVQqxbfffisNe9M+OLf3xDfffCPMzMzEs2fPhBBCZGVlCTc3N+Hq6ioePXqUa91CCNGvXz+Rn2MAr35WVqxYIQwMDMTevXs1plu0aJEAIPbv3y8NAyCMjY1FUlKSNOzkyZMCgEa4U6lUol+/fq+tIT/fd29rKy8+iFM2OadJ8tppc/PmzQCAIUOGaAz/9ttvAUCrr4mbmxsCAwNzbSskJESjP0l8fDwSExPRpUsXPHjwAPfv38f9+/eRlpaGxo0bY8+ePVCr1VCr1Vi/fj2Cg4M1+g3k0OVwXY6VK1eiVq1a8PT0BADpsGxup20A4Msvv9Toh1G/fn0ALzp3AoBKpQLwoiNnenp6rm3UqFEDFhYW2LNnD4AXh/1LlSqF7t274/jx40hPT4cQAvv27ZPaB4Do6GjUr18fNjY20rq6f/8+mjRpguzsbKm9HO3atdPqt2FtbY1///0XR44cyfM6Al6cRgAAGxsbrXHz58/HtWvXcPjwYVy7dg0NGzZEfHw8li9fjnnz5iElJQVffPEFSpYsCX9/f5w/f16rjZx279+/n6d6IiIisH37dmzfvh2//vorGjZsiK+++gpr166VpilXrhzq1KmjsS0fPnyILVu2oGvXru/0vsnx8vs5LS0N9+/fR926dSGEwIkTJ7Sm7927t8bz+vXrS+8dANi6dSuMjIwQGhoqDTMwMEC/fv30VuejR4+QkpKC+vXraxwCzjkE3bdvX415Xz3dJoTAmjVrEBwcDCGExnsxMDAQKSkp+Tu0/JKvv/5aY7vUr18f2dnZervMPK/L2b59O5KTk9G5c2eN12doaIg6depg165dWm1+9dVX0t/W1tYoX748zM3N0aFDB2l4+fLlYW1trbHN8/O5joqKkk5HvsmaNWugUCgwfvx4rXE5rzu/+/aKFStq7I/s7e1Rvnx5jdfyJi+/Bx8/foz79++jfv36SE9Px4ULFwAAJ06cwJUrVzBo0CBYW1vnWrc+REdHw8vLCxUqVNBY540aNQIAre3bpEkTjQ73VatWhZWVlcZrt7a2xuHDh3O9yhDI+/ddXtrKiw+iU6uVlRWAF2+IvLh27RoMDAykL+wcjo6OsLa21tpRuLm5vbatV8flXHXxpg6kKSkpeP78OVJTU1G5cuU81ZxXycnJ2Lx5M8LCwjT6gfj6+mLNmjW4ePEiypUrpzFP6dKlNZ7nfJE+evQIwIvXOGTIEMydOxcrV65E/fr10apVK3zxxRdSWDE0NISPjw/27t0L4EUgqV+/PurVq4fs7GwcOnQIDg4OePjwocYOIDExEadOnXpt59C7d+9qPM9tW4wYMQKxsbGoXbs2PD090bRpU3Tp0gW+vr55Wmcv/mHQVrp0aY11M2DAAPTu3RsVKlTAF198gRs3buCvv/7CsmXLEBwcjAsXLkj9PV5uN687ndq1a2uE086dO6NGjRoICwtDy5YtpdDYvXt3hIWF4dq1a3B1dUV0dDQyMzPRrVu3PC3nba5fv45x48bh77//lt4DOXL6DOXIOY//MhsbG435rl27BicnJ5iZmWlM9+rnL782btyIKVOmID4+XuMc+cvrO+ez/ur75tVl37t3D8nJyViyZMlrr8R79b2YV2/7fOnL25aTs2/K+YJ6Vc5+NEdu21alUqFUqVJa72mVSqXxevL7uc6LS5cuwdnZGba2tq+dJr/79lfXGaD9/n2Ts2fPYuzYsdi5c6f0j3GOnM/KpUuXAEDv+/pXJSYm4vz583le53l57TNnzkRISAhcXFzg7e2N5s2bo3v37nB3d5eWCbz9+87GxuatbeXFBxNInJ2d830jqrx+UeR2Rc3rxuWkwVmzZqF69eq5zmNhYYGHDx/mrch8io6ORkZGBubMmYM5c+ZojV+5ciUmTpyoMczQ0DDXtl7+op4zZw569OiBv/76C9u2bcOAAQMwffp0HDp0CKVKlQIA1KtXD1OnTsWzZ8+wd+9ejBkzBtbW1qhcuTL27t0LBwcHANAIJGq1GgEBARg+fHiuNbwannLbFl5eXkhISMDGjRuxdetWrFmzBj/++CPGjRun9VpfZmdnByBvXwy///47zp8/j7///hvZ2dn4448/sG3bNtSqVQuVKlXCTz/9hEOHDqFevXrSPDntFi9e/K3t58bAwAANGzbE/PnzkZiYiEqVKgEAOnXqhMGDB2PlypUYPXo0fv31V9SqVQvly5fXaTkvy87ORkBAAB4+fIgRI0agQoUKMDc3x82bN9GjRw+tDomve+/oSqFQ5BoQX+0kuHfvXrRq1Qp+fn748ccf4eTkBCMjIyxdujRPnZlflfO6vvjii9fuXKtWrZrvdoG8fb704W3LyXmNK1asgKOjo9Z0L4fpN7WXl9eT38+1vuV13/4u2yY5ORkNGjSAlZUVJk2aBA8PD5iYmOD48eMYMWKE1meloKnValSpUgVz587NdbyLi4vG87y89g4dOqB+/fpYt24dtm3bhlmzZmHGjBlYu3YtgoKC8vx9l5e28uKDCCQA0LJlSyxZsgQHDx6Ej4/PG6d1dXWFWq1GYmIivLy8pOF37txBcnKyxg2y8ivnEJiVlRWaNGny2uns7e1hZWX11hCV30N6K1euROXKlXM9rLl48WKsWrXqjV/Sb1KlShVUqVIFY8eOxYEDB+Dr64tFixZhypQpAF4EjefPn+O3337DzZs3peDh5+cnBZJy5cpJwQR4sb6ePHnyxnWVF+bm5tK9Q54/f47PPvsMU6dOxahRo2BiYpLrPBUqVADw4pLxN0lPT8ewYcMwefJkWFtb486dO8jMzISzszOAFyHJxsYGN2/e1JjvypUrMDAweKedb1ZWFgDgyZMn0jBbW1vpFFzXrl2xf/9+hIeH67yMl50+fRoXL17EsmXL0L17d2n49u3bdW7T1dUVu3btQnp6usZRklev5AJe/IeW2+HyV/+zXbNmDUxMTBATE6Nxue3SpUu1lq1Wq3HlyhWULVv2tcu2t7eHpaUlsrOz3/m9WFjl7JtKlChR4K9RX5/rV9uMiYnBw4cPX3uUpCD27a/bB8fFxeHBgwdYu3Yt/Pz8pOGv7k9y1vuZM2feuD7e9fSNh4cHTp48icaNG+v1VJCTkxP69u2Lvn374u7du6hZsyamTp2KoKCgPH/f5aWtvPgg+pAAL+5Kam5ujq+++gp37tzRGn/p0iXpEqvmzZsDgNZOPCdZtmjRQuc6vL294eHhgdmzZ2t8ieTIuQzPwMAAbdq0wYYNG3K95XNOSjU3NwfwIo2/zY0bN7Bnzx506NABn3/+udbjyy+/RFJSEg4fPpyv15Samip9MeaoUqUKDAwMNA6V16lTB0ZGRpgxYwZsbW2l/+jr16+PQ4cOYffu3RpHR4AXqfngwYMaNx3LkZycrLXc3OT0BclhbGyMihUrQgjxxksJS5YsCRcXl7fecnvGjBmwsbGR+kDY2dmhWLFi0jni+/fv4969e1r/dR47dgyVKlWSTmvlV2ZmJrZt2wZjY2ONnSsAdOvWDefOncOwYcNgaGiITp066bSMV+X81/Tyf0lCCOmzo4vAwEBkZmbip59+koap1WrpMseXeXh44MKFCxqXq548eVLrEkJDQ0MoFAqNIydXr17F+vXrtZYNAD/++KPG8AULFmi1165dO6xZsybXfxIK4jLd9y0wMBBWVlaYNm1arp8Lfb7G/Hyu83rZb7t27SCEyPUfqpz3a0Hs21+3D87ts/L8+XOt91rNmjXh5uaG8PBwrTZenjc/+/rcdOjQATdv3tT4nOV4+vQp0tLS8tVedna21inaEiVKwNnZWdrv5/X7Li9t5cUHc4TEw8MDq1atQseOHeHl5aVxp9YDBw4gOjpaukdAtWrVEBISgiVLlkiH3f755x8sW7YMbdq0QcOGDXWuw8DAAD///DOCgoJQqVIlfPnllyhZsiRu3ryJXbt2wcrKChs2bAAATJs2Ddu2bUODBg3w9ddfw8vLC7du3UJ0dDT27dsHa2trVK9eHYaGhpgxYwZSUlKgVCrRqFEjlChRQmvZq1atghACrVq1yrW25s2bo1ixYli5ciXq1KmT59e0c+dOhIWFoX379ihXrhyysrKwYsUKaSeew8zMDN7e3jh06JB0DxLgxRGStLQ0pKWlaQWSYcOG4e+//0bLli3Ro0cPeHt7Iy0tDadPn8aff/6Jq1evvvWUR9OmTeHo6AhfX184ODjg/PnzWLhwIVq0aPHWjs6tW7fGunXrIITI9b+K69evY9asWdi0aZO0AypWrBhat26NQYMG4fr161i3bh2cnZ01jsxlZmZi9+7dWp0p32TLli1SyLl79y5WrVqFxMREjBw5Uuv8fosWLWBnZ4fo6GgEBQXl+n54naSkJOmo1stq1KiBpk2bwsPDA0OHDsXNmzdhZWWFNWvWvFN/hzZt2qB27dr49ttvkZSUhAoVKuDvv/+WTlu+vN579uyJuXPnIjAwEL169cLdu3exaNEiVKpUSeMcfYsWLTB37lw0a9YMXbp0wd27dxEREQFPT0+cOnVKms7b2xvt2rVDeHg4Hjx4gE8//RS7d+/GxYsXtZb9/fffY9euXahTpw5CQ0NRsWJFPHz4EMePH0dsbGyBnWZ9X6ysrBAZGYlu3bqhZs2a6NSpE+zt7XH9+nVs2rQJvr6+WLhwoV6WlZ/P9ahRo7Bs2TJcuXLljR1bGzZsiG7duuGHH35AYmIimjVrBrVajb1796Jhw4YICwsrkH376/bBdevWhY2NDUJCQjBgwAAoFAqsWLFC63SPgYEBIiMjERwcjOrVq+PLL7+Ek5MTLly4gLNnz0qhzdvbG8CLvmqBgYH5/kejW7du+OOPP9C7d2/s2rULvr6+yM7OxoULF/DHH39I99LKq8ePH6NUqVL4/PPPUa1aNVhYWCA2NhZHjhyRugPk9fsuL23lyTtdoyODixcvitDQUFGmTBlhbGwsLC0tha+vr1iwYIF0GZYQQmRmZoqJEycKNzc3YWRkJFxcXMSoUaM0phHi9ZdJ5lwy+7pLYU+cOCE+++wzYWdnJ5RKpXB1dRUdOnQQO3bs0Jju2rVronv37sLe3l4olUrh7u4u+vXrp3EZ7k8//STc3d2FoaHhGy8BrlKliihduvQb14+/v78oUaKEyMzMfO1ryLnENudyzMuXL4uePXsKDw8PYWJiImxtbUXDhg1FbGysVvvDhg0TAMSMGTM0hnt6egoA4tKlS1rzPH78WIwaNUp4enoKY2NjUbx4cVG3bl0xe/Zs8fz5c42aZs2apTX/4sWLhZ+fn7SuPTw8xLBhw956/w8hhDh+/LgAoHWpXI727duLzz77TGv4nTt3RHBwsLC0tBQ1a9YUR48e1Ri/ZcsWjUuv3yS3y35NTExE9erVRWRk5Gsv5e3bt68AIFatWvXWZeTIudQxt0evXr2EEEKcO3dONGnSRFhYWIjixYuL0NBQ6ZLAly/RDQkJEebm5lrLGD9+vNbli/fu3RNdunQRlpaWQqVSiR49eoj9+/cLABqXkAohxK+//irc3d2FsbGxqF69uoiJicn1st9ffvlFlC1bViiVSlGhQgWxdOnSXJedlpYm+vXrJ2xtbYWFhYVo06aNdPn0999/rzHtnTt3RL9+/YSLi4swMjISjo6OonHjxmLJkiV5Wre5Xfb76mX9OZ+7/FzKn5fLfvO6nF27donAwEChUqmEiYmJ8PDwED169NB4D79u2zZo0CDXS+xz20/m5XOdsyzk8T4kWVlZYtasWaJChQrC2NhY2Nvbi6CgIHHs2DFpmnfdt+d26fnr9sH79+8Xn376qTA1NRXOzs5i+PDhIiYmJtf1vm/fPhEQECAsLS2Fubm5qFq1qsYltllZWaJ///7C3t5eKBSKt14CnFudz58/FzNmzBCVKlUSSqVS2NjYCG9vbzFx4kSN/SGAXC/Bffk9nJGRIYYNGyaqVasm1VytWjWNewzleNv3XX7aehPF/y+e6KPVuHFjODs7a/1+yLto06YNFAoF1q1bp7c2XzV48GD88ssvuH37ttYVLB+C9evXo23btti3b1+er4jSl/j4eNSoUQO//vorunbt+l6XTUS6YSChj97hw4dRv359JCYmvlOH5hznz59HlSpVEB8fX2CX+j179gwuLi5o2bKlVkfOwujp06caV0hlZ2ejadOmOHr0KG7fvv3GK9n0vWzgxa26V6xYgatXr2pdfUBEhdMH04eESFd16tTB8+fP9dael5dXnjrj6uLu3buIjY3Fn3/+iQcPHmj8PlNh1r9/fzx9+hQ+Pj7IyMjA2rVrceDAAUybNq1Awwjw4l4Kx44dQ8OGDVGsWDFs2bIFW7Zswddff80wQvQBYSAhKkTOnTuHrl27okSJEvjhhx9ee+1/YdOoUSPMmTMHGzduxLNnz+Dp6YkFCxYgLCyswJddt25dbN++HZMnT8aTJ09QunRpTJgwAWPGjCnwZROR/sh6yiYyMhKRkZG4evUqAKBSpUoYN26cdM2yv78/du/erTHPN998g0WLFr3vUomIiKgAyRpINmzYAENDQ5QtWxZCCCxbtgyzZs3CiRMnUKlSJfj7+6NcuXKYNGmSNI+ZmZnWJZJERET0YZP1lE1wcLDG86lTpyIyMhKHDh2SbrplZmaW622QiYiI6ONRaPqQZGdnIzo6GmlpaRo3oFq5ciV+/fVXODo6Ijg4GN99990bL4HMyMjQuDOcWq3Gw4cPYWdnp9fb7RIREX3shBB4/PgxnJ2dYWBQwDd3z9ddSwrAqVOnhLm5uTA0NBQqlUps2rRJGrd48WKxdetWcerUKfHrr7+KkiVLirZt276xvZwbJ/HBBx988MEHH/p53Lhxo6DjgPw3Rnv+/DmuX7+OlJQU/Pnnn/j555+xe/duVKxYUWvanTt3onHjxkhKSpJ+9OdVrx4hSUlJQenSpXHjxg32PSEiIsqH1NRUuLi4IDk5Weff7cor2QPJq5o0aQIPDw8sXrxYa1xaWhosLCywdetW6Ue13iY1NRUqlQopKSkMJERERPnwPr9DC92v/arV6tf+OmB8fDyAFz9xTERERB8PWTu1jho1CkFBQShdujQeP36MVatWIS4uDjExMbh06RJWrVqF5s2bw87ODqdOncLgwYPh5+eHqlWrylk2ERER6ZmsgeTu3bvo3r07bt26BZVKhapVqyImJgYBAQG4ceMGYmNjER4ejrS0NLi4uKBdu3YYO3asnCUTERFRASh0fUj0jX1IiIiIdFOk+5AQERFR0cNAQkRERLJjICEiIiLZMZAQERGR7BhIiIiISHYMJERERCQ7BhIiIiKSHQMJERERyY6BhIiIiGTHQEJERESyYyAhIiIi2TGQEBERkewYSIiIiEh2DCREREQkOwYSIiIikl0xuQv4UJUZuUnuEj56V79vIXcJVAjxs1fwCuqzx21X8D7k/SaPkBAREZHsGEiIiIhIdgwkREREJDsGEiIiIpIdAwkRERHJjoGEiIiIZMdAQkRERLJjICEiIiLZMZAQERGR7BhIiIiISHYMJERERCQ7BhIiIiKSHQMJERERyY6BhIiIiGTHQEJERESyYyAhIiIi2TGQEBERkewYSIiIiEh2DCREREQkOwYSIiIikh0DCREREcmOgYSIiIhkx0BCREREsmMgISIiItkxkBAREZHsGEiIiIhIdgwkREREJDsGEiIiIpIdAwkRERHJjoGEiIiIZMdAQkRERLJjICEiIiLZMZAQERGR7BhIiIiISHYMJERERCQ7BhIiIiKSHQMJERERyY6BhIiIiGTHQEJERESykzWQREZGomrVqrCysoKVlRV8fHywZcsWafyzZ8/Qr18/2NnZwcLCAu3atcOdO3dkrJiIiIgKgqyBpFSpUvj+++9x7NgxHD16FI0aNULr1q1x9uxZAMDgwYOxYcMGREdHY/fu3fjvv//w2WefyVkyERERFYBici48ODhY4/nUqVMRGRmJQ4cOoVSpUvjll1+watUqNGrUCACwdOlSeHl54dChQ/j000/lKJmIiIgKQKHpQ5KdnY3Vq1cjLS0NPj4+OHbsGDIzM9GkSRNpmgoVKqB06dI4ePDga9vJyMhAamqqxoOIiIgKN9kDyenTp2FhYQGlUonevXtj3bp1qFixIm7fvg1jY2NYW1trTO/g4IDbt2+/tr3p06dDpVJJDxcXlwJ+BURERPSuZA8k5cuXR3x8PA4fPow+ffogJCQE586d07m9UaNGISUlRXrcuHFDj9USERFRQZC1DwkAGBsbw9PTEwDg7e2NI0eOYP78+ejYsSOeP3+O5ORkjaMkd+7cgaOj42vbUyqVUCqVBV02ERER6ZHsR0hepVarkZGRAW9vbxgZGWHHjh3SuISEBFy/fh0+Pj4yVkhERET6JusRklGjRiEoKAilS5fG48ePsWrVKsTFxSEmJgYqlQq9evXCkCFDYGtrCysrK/Tv3x8+Pj68woaIiOgjI2sguXv3Lrp3745bt25BpVKhatWqiImJQUBAAABg3rx5MDAwQLt27ZCRkYHAwED8+OOPcpZMREREBUDWQPLLL7+8cbyJiQkiIiIQERHxnioiIiIiORS6PiRERERU9DCQEBERkewYSIiIiEh2DCREREQkOwYSIiIikh0DCREREcmOgYSIiIhkx0BCREREsmMgISIiItkxkBAREZHsGEiIiIhIdgwkREREJDsGEiIiIpIdAwkRERHJjoGEiIiIZMdAQkRERLJjICEiIiLZMZAQERGR7BhIiIiISHYMJERERCQ7BhIiIiKSHQMJERERyY6BhIiIiGTHQEJERESyYyAhIiIi2TGQEBERkewYSIiIiEh2DCREREQkOwYSIiIikh0DCREREcmOgYSIiIhkx0BCREREsmMgISIiItkxkBAREZHsGEiIiIhIdgwkREREJDsGEiIiIpIdAwkRERHJjoGEiIiIZMdAQkRERLJjICEiIiLZMZAQERGR7BhIiIiISHYMJERERCQ7BhIiIiKSHQMJERERyY6BhIiIiGTHQEJERESyYyAhIiIi2TGQEBERkewYSIiIiEh2DCREREQkOwYSIiIikh0DCREREcmOgYSIiIhkJ2sgmT59Oj755BNYWlqiRIkSaNOmDRISEjSm8ff3h0Kh0Hj07t1bpoqJiIioIMgaSHbv3o1+/frh0KFD2L59OzIzM9G0aVOkpaVpTBcaGopbt25Jj5kzZ8pUMRERERWEYnIufOvWrRrPo6KiUKJECRw7dgx+fn7ScDMzMzg6Or7v8oiIiOg9KVR9SFJSUgAAtra2GsNXrlyJ4sWLo3Llyhg1ahTS09Nf20ZGRgZSU1M1HkRERFS4yXqE5GVqtRqDBg2Cr68vKleuLA3v0qULXF1d4ezsjFOnTmHEiBFISEjA2rVrc21n+vTpmDhx4vsqm4iIiPSg0ASSfv364cyZM9i3b5/G8K+//lr6u0qVKnByckLjxo1x6dIleHh4aLUzatQoDBkyRHqempoKFxeXgiuciIiI3lmhCCRhYWHYuHEj9uzZg1KlSr1x2jp16gAAkpKScg0kSqUSSqWyQOokIiKigiFrIBFCoH///li3bh3i4uLg5ub21nni4+MBAE5OTgVcHREREb0vsgaSfv36YdWqVfjrr79gaWmJ27dvAwBUKhVMTU1x6dIlrFq1Cs2bN4ednR1OnTqFwYMHw8/PD1WrVpWzdCIiItIjWQNJZGQkgBc3P3vZ0qVL0aNHDxgbGyM2Nhbh4eFIS0uDi4sL2rVrh7Fjx8pQLRERERUU2U/ZvImLiwt27979nqohIiIiuRSq+5AQERFR0cRAQkRERLJjICEiIiLZMZAQERGR7BhIiIiISHYMJERERCQ7BhIiIiKSHQMJERERyY6BhIiIiGTHQEJERESyYyAhIiIi2TGQEBERkewYSIiIiEh2DCREREQkOwYSIiIikh0DCREREcmOgYSIiIhkx0BCREREsmMgISIiItkxkBAREZHsGEiIiIhIdgwkREREJDsGEiIiIpJdMV1munLlCvbu3Ytr164hPT0d9vb2qFGjBnx8fGBiYqLvGomIiOgjl69AsnLlSsyfPx9Hjx6Fg4MDnJ2dYWpqiocPH+LSpUswMTFB165dMWLECLi6uhZUzURERPSRyXMgqVGjBoyNjdGjRw+sWbMGLi4uGuMzMjJw8OBBrF69GrVq1cKPP/6I9u3b671gIiIi+vjkOZB8//33CAwMfO14pVIJf39/+Pv7Y+rUqbh69ao+6iMiIqIiIM+B5E1h5FV2dnaws7PTqSAiIiIqenTq1PqyTZs2IS4uDtnZ2fD19UW7du30URcREREVIe902e93332H4cOHQ6FQQAiBwYMHo3///vqqjYiIiIqIfB0hOXr0KGrVqiU9//3333Hy5EmYmpoCAHr06AF/f38sWLBAv1USERHRRy1fR0h69+6NQYMGIT09HQDg7u6OOXPmICEhAadPn0ZkZCTKlStXIIUSERHRxytfgeTw4cNwcnJCzZo1sWHDBvzvf//DiRMnULduXdSvXx///vsvVq1aVVC1EhER0UcqX6dsDA0NMWLECLRv3x59+vSBubk5Fi5cCGdn54Kqj4iIiIoAnTq1uru7IyYmBm3btoWfnx8iIiL0XRcREREVIfkKJMnJyRg+fDiCg4MxduxYtG3bFocPH8aRI0fw6aef4vTp0wVVJxEREX3E8hVIQkJCcPjwYbRo0QIJCQno06cP7OzsEBUVhalTp6Jjx44YMWJEQdVKREREH6l89SHZuXMnTpw4AU9PT4SGhsLT01Ma17hxYxw/fhyTJk3Se5FERET0ccvXEZKyZctiyZIluHjxIhYtWqT1i74mJiaYNm2aXgskIiKij1++Asn//vc/7Ny5EzVq1MCqVasQGRlZUHURERFREZKvUzbVq1fH0aNHC6oWIiIiKqLyfIRECFGQdRAREVERludAUqlSJaxevRrPnz9/43SJiYno06cPvv/++3cujoiIiIqGPJ+yWbBgAUaMGIG+ffsiICAAtWrVgrOzM0xMTPDo0SOcO3cO+/btw9mzZxEWFoY+ffoUZN1ERET0EclzIGncuDGOHj2Kffv24ffff8fKlStx7do1PH36FMWLF0eNGjXQvXt3dO3aFTY2NgVZMxEREX1k8tWpFQDq1auHevXqFUQtREREVETp9Fs2RERERPrEQEJERESyYyAhIiIi2TGQEBERkewYSIiIiEh2OgWS48eP4/Tp09Lzv/76C23atMHo0aPfeuM0IiIiolfpFEi++eYbXLx4EQBw+fJldOrUCWZmZoiOjsbw4cP1WiARERF9/HQKJBcvXkT16tUBANHR0fDz88OqVasQFRWFNWvW6LM+IiIiKgJ0CiRCCKjVagBAbGwsmjdvDgBwcXHB/fv39VcdERERFQk6BZJatWphypQpWLFiBXbv3o0WLVoAAK5cuQIHB4c8tzN9+nR88sknsLS0RIkSJdCmTRskJCRoTPPs2TP069cPdnZ2sLCwQLt27XDnzh1dyiYiIqJCSqdAEh4ejuPHjyMsLAxjxoyBp6cnAODPP/9E3bp189zO7t270a9fPxw6dAjbt29HZmYmmjZtirS0NGmawYMHY8OGDYiOjsbu3bvx33//4bPPPtOlbCIiIiqk8v1bNtnZ2UhOTsaePXu0fkRv1qxZMDQ0zHNbW7du1XgeFRWFEiVK4NixY/Dz80NKSgp++eUXrFq1Co0aNQIALF26FF5eXjh06BA+/fTT/JZPREREhVC+j5AYGhqiadOmSE5O1hpnYmICIyMjnYtJSUkBANja2gIAjh07hszMTDRp0kSapkKFCihdujQOHjyYaxsZGRlITU3VeBAREVHhptMpm8qVK+Py5ct6LUStVmPQoEHw9fVF5cqVAQC3b9+GsbExrK2tNaZ1cHDA7du3c21n+vTpUKlU0sPFxUWvdRIREZH+6RRIpkyZgqFDh2Ljxo24deuWXo5I9OvXD2fOnMHq1at1mj/HqFGjkJKSIj1u3LjxTu0RERFRwct3HxIA0mW+rVq1gkKhkIYLIaBQKJCdnZ2v9sLCwrBx40bs2bMHpUqVkoY7Ojri+fPnSE5O1jhKcufOHTg6OuballKphFKpzNfyiYiISF46BZJdu3bpZeFCCPTv3x/r1q1DXFwc3NzcNMZ7e3vDyMgIO3bsQLt27QAACQkJuH79Onx8fPRSAxEREclPp0DSoEEDvSy8X79+WLVqFf766y9YWlpK/UJUKhVMTU2hUqnQq1cvDBkyBLa2trCyskL//v3h4+PDK2yIiIg+Ijr/2u/evXvxxRdfoG7durh58yYAYMWKFdi3b1+e24iMjERKSgr8/f3h5OQkPX7//Xdpmnnz5qFly5Zo164d/Pz84OjoiLVr1+paNhERERVCOgWSNWvWIDAwEKampjh+/DgyMjIAvLhsd9q0aXluRwiR66NHjx7SNCYmJoiIiMDDhw+RlpaGtWvXvrb/CBEREX2YdL7KZtGiRfjpp5807jvi6+uL48eP6604IiIiKhp0CiQJCQnw8/PTGq5SqXK9YRoRERHRm+gUSBwdHZGUlKQ1fN++fXB3d3/nooiIiKho0SmQhIaGYuDAgTh8+DAUCgX+++8/rFy5EkOHDkWfPn30XSMRERF95HS67HfkyJFQq9Vo3Lgx0tPT4efnB6VSiaFDh6J///76rpGIiIg+cjoFEoVCgTFjxmDYsGFISkrCkydPULFiRVhYWOi7PiIiIioCdAokO3fuRN26dWFiYoKKFSvquyYiIiIqYnQKJK1atUJWVhY++eQT+Pv7o0GDBvD19YWpqam+6yMiIqIiQKdOrY8ePcKOHTsQFBSEf/75B23btoW1tTV8fX0xduxYfddIREREHzmdAomRkRF8fX0xevRoxMTE4NChQ+jcuTP++ecfTJ8+Xd81EhER0UdOp1M2Fy9eRFxcHOLi4rB7925kZGSgfv36mD17Nvz9/fVcIhEREX3sdAokFSpUgL29PQYOHIiRI0eiSpUqUCgU+q6NiIiIigidTtkMGDAAJUuWxKRJk9C7d2+MGTMG27ZtQ3p6ur7rIyIioiJAp0ASHh6O48eP4/bt2xg1ahSeP3+OMWPGoHjx4vD19dV3jURERPSR0ymQ5MjOzkZmZiYyMjLw7NkzZGRkICEhQV+1ERERURGh8ymbqlWrwsHBAd988w3+++8/hIaG4sSJE7h3756+ayQiIqKPnE6dWm/duoWvv/4a/v7+qFy5sr5rIiIioiJGp0ASHR2t7zqIiIioCNPplM2yZcuwadMm6fnw4cNhbW2NunXr4tq1a3orjoiIiIoGnQLJtGnTpN+tOXjwICIiIjBz5kwUL14cgwcP1muBRERE9PHT6ZTNjRs34OnpCQBYv3492rVrh6+//hq+vr68UysRERHlm05HSCwsLPDgwQMAwLZt2xAQEAAAMDExwdOnT/VXHRERERUJOh0hCQgIwFdffYUaNWrg4sWLaN68OQDg7NmzKFOmjD7rIyIioiJApyMkERER8PHxwb1797BmzRrY2dkBAI4dO4bOnTvrtUAiIiL6+Ol0hMTa2hoLFy7UGj5x4sR3LoiIiIiKHp0CCQAkJyfjn3/+wd27d6FWq6XhCoUC3bp100txREREVDToFEg2bNiArl274smTJ7CysoJCoZDGMZAQERFRfunUh+Tbb79Fz5498eTJEyQnJ+PRo0fS4+HDh/qukYiIiD5yOgWSmzdvYsCAATAzM9N3PURERFQE6RRIAgMDcfToUX3XQkREREWUTn1IWrRogWHDhuHcuXOoUqUKjIyMNMa3atVKL8URERFR0aBTIAkNDQUATJo0SWucQqFAdnb2u1VFRERERYpOgeTly3yJiIiI3pVOfUheJzk5OdcbphERERG9iV4CyY4dO9ClSxc4OTlh/Pjx+miSiIiIihCdA8mNGzcwadIkuLm5oWnTplAoFFi3bh1u376tz/qIiIioCMhXIMnMzER0dDQCAwNRvnx5xMfHY9asWTAwMMCYMWPQrFkzrStuiIiIiN4mX51aS5YsiQoVKuCLL77A6tWrYWNjAwD8hV8iIiJ6J/k6QpKVlQWFQgGFQgFDQ8OCqomIiIiKmHwFkv/++w9ff/01fvvtNzg6OqJdu3ZYt26dxo/rEREREeVXvgKJiYkJunbtip07d+L06dPw8vLCgAEDkJWVhalTp2L79u28KRoRERHlm85X2Xh4eGDKlCm4du0aNm3ahIyMDLRs2RIODg76rI+IiIiKAJ3u1PoyAwMDBAUFISgoCPfu3cOKFSv0URcREREVIXq9U6u9vT2GDBmizyaJiIioCNBrICEiIiLSBQMJERERyY6BhIiIiGSnUyCZNGkS0tPTtYY/ffoUkyZNeueiiIiIqGjRKZBMnDgRT5480Rqenp6OiRMnvnNRREREVLToFEiEELnenfXkyZOwtbV956KIiIioaMnXfUhsbGyk37IpV66cRijJzs7GkydP0Lt3b70XSURERB+3fAWS8PBwCCHQs2dPTJw4ESqVShpnbGyMMmXKwMfHR+9FEhER0cctX4EkJCQEAODm5gZfX18UK/bON3olIiIi0q0PSVpaGnbs2KE1PCYmBlu2bHnnooiIiKho0SmQjBw5Mtdf9RVCYOTIke9cFBERERUtOgWSxMREVKxYUWt4hQoVkJSUlOd29uzZg+DgYDg7O0OhUGD9+vUa43v06CF1os15NGvWTJeSiYiIqBDTKZCoVCpcvnxZa3hSUhLMzc3z3E5aWhqqVauGiIiI107TrFkz3Lp1S3r89ttvupRMREREhZhOvVJbt26NQYMGYd26dfDw8ADwIox8++23aNWqVZ7bCQoKQlBQ0BunUSqVcHR01KVMIiIi+kDodIRk5syZMDc3R4UKFeDm5gY3Nzd4eXnBzs4Os2fP1muBcXFxKFGiBMqXL48+ffrgwYMHb5w+IyMDqampGg8iIiIq3HQ6QqJSqXDgwAFs374dJ0+ehKmpKapWrQo/Pz+9FtesWTN89tlncHNzw6VLlzB69GgEBQXh4MGDMDQ0zHWe6dOn8/b1REREHxidbySiUCjQtGlT+Pn5QalU5nor+XfVqVMn6e8qVaqgatWq8PDwQFxcHBo3bpzrPKNGjcKQIUOk56mpqXBxcdF7bURERKQ/Op2yUavVmDx5MkqWLAkLCwtcuXIFAPDdd9/hl19+0WuBL3N3d0fx4sXfeCWPUqmElZWVxoOIiIgKN50CyZQpUxAVFYWZM2fC2NhYGl65cmX8/PPPeivuVf/++y8ePHgAJyenAlsGERERvX86BZLly5djyZIl6Nq1q0ZfjmrVquHChQt5bufJkyeIj49HfHw8AODKlSuIj4/H9evX8eTJEwwbNgyHDh3C1atXsWPHDrRu3Rqenp4IDAzUpWwiIiIqpHTqQ3Lz5k14enpqDVer1cjMzMxzO0ePHkXDhg2l5zl9P0JCQhAZGYlTp05h2bJlSE5OhrOzM5o2bYrJkydDqVTqUjYREREVUjoFkooVK2Lv3r1wdXXVGP7nn3+iRo0aeW7H398fQojXjo+JidGlPCIiIvrA6BRIxo0bh5CQENy8eRNqtRpr165FQkICli9fjo0bN+q7RiIiIvrI6dSHpHXr1tiwYQNiY2Nhbm6OcePG4fz589iwYQMCAgL0XSMRERF95PJ9hCQrKwvTpk1Dz549sX379oKoiYiIiIqYfB8hKVasGGbOnImsrKyCqIeIiIiKIJ1O2TRu3Bi7d+/Wdy1ERERUROnUqTUoKAgjR47E6dOn4e3tDXNzc43x+fnFXyIiIiKdAknfvn0BAHPnztUap1AokJ2d/W5VERERUZGiUyBRq9X6roOIiIiKsHz3IcnMzESxYsVw5syZgqiHiIiIiqB8BxIjIyOULl2ap2WIiIhIb3S6ymbMmDEYPXo0Hj58qO96iIiIqAjSqQ/JwoULkZSUBGdnZ7i6umpdZXP8+HG9FEdERERFg06BpE2bNnoug4iIiIoynQLJ+PHj9V0HERERFWE6BZIcx44dw/nz5wEAlSpVQo0aNfRSFBERERUtOgWSu3fvolOnToiLi4O1tTUAIDk5GQ0bNsTq1athb2+vzxqJiIjoI6fTVTb9+/fH48ePcfbsWTx8+BAPHz7EmTNnkJqaigEDBui7RiIiIvrI6XSEZOvWrYiNjYWXl5c0rGLFioiIiEDTpk31VhwREREVDTodIVGr1TAyMtIabmRkxNvKExERUb7pFEgaNWqEgQMH4r///pOG3bx5E4MHD0bjxo31VhwREREVDToFkoULFyI1NRVlypSBh4cHPDw84ObmhtTUVCxYsEDfNRIREdFHTqc+JC4uLjh+/DhiY2Nx4cIFAICXlxeaNGmi1+KIiIioaND5PiQKhQIBAQEICAjQZz1ERERUBOXrlM3OnTtRsWJFpKamao1LSUlBpUqVsHfvXr0VR0REREVDvgJJeHg4QkNDYWVlpTVOpVLhm2++wdy5c/VWHBERERUN+QokJ0+eRLNmzV47vmnTpjh27Ng7F0VERERFS74CyZ07d3K9/0iOYsWK4d69e+9cFBERERUt+QokJUuWxJkzZ147/tSpU3BycnrnooiIiKhoyVcgad68Ob777js8e/ZMa9zTp08xfvx4tGzZUm/FERERUdGQr8t+x44di7Vr16JcuXIICwtD+fLlAQAXLlxAREQEsrOzMWbMmAIplIiIiD5e+QokDg4OOHDgAPr06YNRo0ZBCAHgxT1JAgMDERERAQcHhwIplIiIiD5e+b4xmqurKzZv3oxHjx4hKSkJQgiULVsWNjY2BVEfERERFQE636nVxsYGn3zyiT5rISIioiJKpx/XIyIiItInBhIiIiKSHQMJERERyY6BhIiIiGTHQEJERESyYyAhIiIi2TGQEBERkewYSIiIiEh2DCREREQkOwYSIiIikh0DCREREcmOgYSIiIhkx0BCREREsmMgISIiItkxkBAREZHsGEiIiIhIdgwkREREJDsGEiIiIpIdAwkRERHJjoGEiIiIZMdAQkRERLJjICEiIiLZyRpI9uzZg+DgYDg7O0OhUGD9+vUa44UQGDduHJycnGBqaoomTZogMTFRnmKJiIiowMgaSNLS0lCtWjVERETkOn7mzJn44YcfsGjRIhw+fBjm5uYIDAzEs2fP3nOlREREVJCKybnwoKAgBAUF5TpOCIHw8HCMHTsWrVu3BgAsX74cDg4OWL9+PTp16vQ+SyUiIqICVGj7kFy5cgW3b99GkyZNpGEqlQp16tTBwYMHXztfRkYGUlNTNR5ERERUuBXaQHL79m0AgIODg8ZwBwcHaVxupk+fDpVKJT1cXFwKtE4iIiJ6d4U2kOhq1KhRSElJkR43btyQuyQiIiJ6i0IbSBwdHQEAd+7c0Rh+584daVxulEolrKysNB5ERERUuBXaQOLm5gZHR0fs2LFDGpaamorDhw/Dx8dHxsqIiIhI32S9yubJkydISkqSnl+5cgXx8fGwtbVF6dKlMWjQIEyZMgVly5aFm5sbvvvuOzg7O6NNmzbyFU1ERER6J2sgOXr0KBo2bCg9HzJkCAAgJCQEUVFRGD58ONLS0vD1118jOTkZ9erVw9atW2FiYiJXyURERFQAZA0k/v7+EEK8drxCocCkSZMwadKk91gVERERvW+Ftg8JERERFR0MJERERCQ7BhIiIiKSHQMJERERyY6BhIiIiGTHQEJERESyYyAhIiIi2TGQEBERkewYSIiIiEh2DCREREQkOwYSIiIikh0DCREREcmOgYSIiIhkx0BCREREsmMgISIiItkxkBAREZHsGEiIiIhIdgwkREREJDsGEiIiIpIdAwkRERHJjoGEiIiIZMdAQkRERLJjICEiIiLZMZAQERGR7BhIiIiISHYMJERERCQ7BhIiIiKSHQMJERERyY6BhIiIiGTHQEJERESyYyAhIiIi2TGQEBERkewYSIiIiEh2DCREREQkOwYSIiIikh0DCREREcmOgYSIiIhkx0BCREREsmMgISIiItkxkBAREZHsGEiIiIhIdgwkREREJDsGEiIiIpIdAwkRERHJjoGEiIiIZMdAQkRERLJjICEiIiLZMZAQERGR7BhIiIiISHYMJERERCQ7BhIiIiKSHQMJERERyY6BhIiIiGTHQEJERESyYyAhIiIi2RXqQDJhwgQoFAqNR4UKFeQui4iIiPSsmNwFvE2lSpUQGxsrPS9WrNCXTERERPlU6L/dixUrBkdHR7nLICIiogJUqE/ZAEBiYiKcnZ3h7u6Orl274vr162+cPiMjA6mpqRoPIiIiKtwKdSCpU6cOoqKisHXrVkRGRuLKlSuoX78+Hj9+/Np5pk+fDpVKJT1cXFzeY8VERESki0IdSIKCgtC+fXtUrVoVgYGB2Lx5M5KTk/HHH3+8dp5Ro0YhJSVFety4ceM9VkxERES6KPR9SF5mbW2NcuXKISkp6bXTKJVKKJXK91gVERERvatCfYTkVU+ePMGlS5fg5OQkdylERESkR4U6kAwdOhS7d+/G1atXceDAAbRt2xaGhobo3Lmz3KURERGRHhXqUzb//vsvOnfujAcPHsDe3h716tXDoUOHYG9vL3dpREREpEeFOpCsXr1a7hKIiIjoPSjUp2yIiIioaGAgISIiItkxkBAREZHsGEiIiIhIdgwkREREJDsGEiIiIpIdAwkRERHJjoGEiIiIZMdAQkRERLJjICEiIiLZMZAQERGR7BhIiIiISHYMJERERCQ7BhIiIiKSHQMJERERyY6BhIiIiGTHQEJERESyYyAhIiIi2TGQEBERkewYSIiIiEh2DCREREQkOwYSIiIikh0DCREREcmOgYSIiIhkx0BCREREsmMgISIiItkxkBAREZHsGEiIiIhIdgwkREREJDsGEiIiIpIdAwkRERHJjoGEiIiIZMdAQkRERLJjICEiIiLZMZAQERGR7BhIiIiISHYMJERERCQ7BhIiIiKSHQMJERERyY6BhIiIiGTHQEJERESyYyAhIiIi2TGQEBERkewYSIiIiEh2DCREREQkOwYSIiIikh0DCREREcmOgYSIiIhkx0BCREREsmMgISIiItkxkBAREZHsGEiIiIhIdgwkREREJDsGEiIiIpIdAwkRERHJ7oMIJBEREShTpgxMTExQp04d/PPPP3KXRERERHpU6APJ77//jiFDhmD8+PE4fvw4qlWrhsDAQNy9e1fu0oiIiEhPCn0gmTt3LkJDQ/Hll1+iYsWKWLRoEczMzPC///1P7tKIiIhIT4rJXcCbPH/+HMeOHcOoUaOkYQYGBmjSpAkOHjyY6zwZGRnIyMiQnqekpAAAUlNT9VqbOiNdr+2RNn1vM/o48LNX8Arqs8dtV/D0ve1y2hNC6LXd3BTqQHL//n1kZ2fDwcFBY7iDgwMuXLiQ6zzTp0/HxIkTtYa7uLgUSI1UcFThcldAVDTxs/fhKqht9/jxY6hUqoJp/P8r1IFEF6NGjcKQIUOk52q1Gg8fPoSdnR0UCoWMlckrNTUVLi4uuHHjBqysrOQuh/KB2+7DxW334eK2e0EIgcePH8PZ2bnAl1WoA0nx4sVhaGiIO3fuaAy/c+cOHB0dc51HqVRCqVRqDLO2ti6oEj84VlZWRfrD9SHjtvtwcdt9uLjtUOBHRnIU6k6txsbG8Pb2xo4dO6RharUaO3bsgI+Pj4yVERERkT4V6iMkADBkyBCEhISgVq1aqF27NsLDw5GWloYvv/xS7tKIiIhITwp9IOnYsSPu3buHcePG4fbt26hevTq2bt2q1dGV3kypVGL8+PFap7Oo8OO2+3Bx2324uO3eP4V4H9fyEBEREb1Boe5DQkREREUDAwkRERHJjoGEiIiIZMdAQgCAqKioPN+vJT/TUsG5evUqFAoF4uPj5S6F6KPWo0cPtGnTRnru7++PQYMG5Wne/Exb1BX6q2zo/ejYsSOaN28udxkfJH9/f1SvXh3h4eFyl0IFoEePHkhOTsb69evlLoUKibVr18LIyEjuMj46DCQEADA1NYWpqancZRAVGtnZ2UX65ybo9WxtbeUu4aPEUzaFxJ9//okqVarA1NQUdnZ2aNKkCdLS0qRDhRMnToS9vT2srKzQu3dvPH/+XJp369atqFevHqytrWFnZ4eWLVvi0qVL0vicQ/tr165Fw4YNYWZmhmrVqmn8YvKrp2FOnjyJhg0bwtLSElZWVvD29sbRo0c1ao6JiYGXlxcsLCzQrFkz3Lp1q+BWUCHVo0cP7N69G/Pnz4dCoYBCocClS5fQq1cvuLm5wdTUFOXLl8f8+fM15svKysKAAQOkbTZixAiEhIRoHBZ+23bNze7du1G7dm0olUo4OTlh5MiRyMrKksY/fvwYXbt2hbm5OZycnDBv3ryP5pCyv78/wsLCEBYWBpVKheLFi+O7776TfqX00aNH6N69O2xsbGBmZoagoCAkJiZK8+d8Bv7++29UrFgRSqUSPXv2xLJly/DXX39J2zcuLg5xcXFQKBRITk6W5o+Pj4dCocDVq1elYT/99BNcXFxgZmaGtm3bYu7cuRqfs1dPBQDAoEGD4O/vLz1Xq9WYPn269H6qVq0a/vzzT2n8o0eP0LVrV9jb28PU1BRly5bF0qVLpfE3btxAhw4dYG1tDVtbW7Ru3Vqjxg/dm9ZPznbasWMHatWqBTMzM9StWxcJCQkabUyZMgUlSpSApaUlvvrqK4wcORLVq1d/7TJf/cz8+OOPKFu2LExMTODg4IDPP/9cq8bhw4fD1tYWjo6OmDBhgr5e/keFgaQQuHXrFjp37oyePXvi/PnziIuLw2effSbtSHfs2CEN/+2337B27VqNXzROS0vDkCFDcPToUezYsQMGBgZo27Yt1Gq1xnLGjBmDoUOHIj4+HuXKlUPnzp01vqxe1rVrV5QqVQpHjhzBsWPHMHLkSI1DlOnp6Zg9ezZWrFiBPXv24Pr16xg6dGgBrJ3Cbf78+fDx8UFoaChu3bqFW7duoVSpUihVqhSio6Nx7tw5jBs3DqNHj8Yff/whzTdjxgysXLkSS5cuxf79+5Gamqp1SiCv2zXHzZs30bx5c3zyySc4efIkIiMj8csvv2DKlCnSNEOGDMH+/fvx999/Y/v27di7dy+OHz9eIOtGDsuWLUOxYsXwzz//YP78+Zg7dy5+/vlnAC++/I8ePYq///4bBw8ehBACzZs3R2ZmpjR/eno6ZsyYgZ9//hlnz57FDz/8gA4dOkiB+9atW6hbt26eatm/fz969+6NgQMHIj4+HgEBAZg6dWq+X9P06dOxfPlyLFq0CGfPnsXgwYPxxRdfYPfu3QCA7777DufOncOWLVtw/vx5REZGonjx4gCAzMxMBAYGwtLSEnv37sX+/fulfyBe/qfmQ/a29QO82PfNmTMHR48eRbFixdCzZ09p3MqVKzF16lTMmDEDx44dQ+nSpREZGZnn5R89ehQDBgzApEmTkJCQgK1bt8LPz09jmmXLlsHc3ByHDx/GzJkzMWnSJGzfvv3dX/zHRpDsjh07JgCIq1evao0LCQkRtra2Ii0tTRoWGRkpLCwsRHZ2dq7t3bt3TwAQp0+fFkIIceXKFQFA/Pzzz9I0Z8+eFQDE+fPnhRBCLF26VKhUKmm8paWliIqKyrX9pUuXCgAiKSlJGhYRESEcHBzy/qI/Ig0aNBADBw584zT9+vUT7dq1k547ODiIWbNmSc+zsrJE6dKlRevWrV/bxuu264kTJ4QQQowePVqUL19eqNVqaZ6IiAjpvZKamiqMjIxEdHS0ND45OVmYmZm9tf4PQYMGDYSXl5fG6x8xYoTw8vISFy9eFADE/v37pXH3798Xpqam4o8//hBC/N/7Oj4+XqPdkJAQre2ya9cuAUA8evRIGnbixAkBQFy5ckUIIUTHjh1FixYtNObr2rWrxucst7YHDhwoGjRoIIQQ4tmzZ8LMzEwcOHBAY5pevXqJzp07CyGECA4OFl9++WWu62TFihVa74mMjAxhamoqYmJicp3nQ/K29ZOznWJjY6VxmzZtEgDE06dPhRBC1KlTR/Tr109jfl9fX1GtWjXp+avb6eXP/Jo1a4SVlZVITU3NtcYGDRqIevXqaQz75JNPxIgRI/L7cj96PEJSCFSrVg2NGzdGlSpV0L59e/z000949OiRxngzMzPpuY+PD548eYIbN24AABITE9G5c2e4u7vDysoKZcqUAQBcv35dYzlVq1aV/nZycgIA3L17N9eahgwZgq+++gpNmjTB999/r3WqwMzMDB4eHhrtva6toigiIgLe3t6wt7eHhYUFlixZIm2PlJQU3LlzB7Vr15amNzQ0hLe3t0Ybed2uOc6fPw8fHx+Nfg++vr548uQJ/v33X1y+fBmZmZkay1WpVChfvry+XrbsPv30U43X7+Pjg8TERJw7dw7FihVDnTp1pHF2dnYoX748zp8/Lw0zNjbW+Jy8i4SEBI11DUDr+dskJSUhPT0dAQEBsLCwkB7Lly+XPpN9+vTB6tWrUb16dQwfPhwHDhyQ5j958iSSkpJgaWkpzWtra4tnz5699fTfhyAv6wd4877vXbdTQEAAXF1d4e7ujm7dumHlypVIT0/XmObV9xT3l7ljp9ZCwNDQENu3b8eBAwewbds2LFiwAGPGjMHhw4fzNH9wcDBcXV3x008/wdnZGWq1GpUrV9Y6JPvyKZecnfbrDv9PmDABXbp0waZNm7BlyxaMHz8eq1evRtu2bbXaymlP8FcIAACrV6/G0KFDMWfOHPj4+MDS0hKzZs3K8/bMkdftSvpjamqap46sBgYv/pd7+T3/8qmfvDIwMND63LzczpMnTwAAmzZtQsmSJTWmy/mNlaCgIFy7dg2bN2/G9u3b0bhxY/Tr1w+zZ8/GkydP4O3tjZUrV2ot297ePt/1FjZvWz85oSQ/+778srS0xPHjxxEXF4dt27Zh3LhxmDBhAo4cOSL1F8ptf6mv5X9MeISkkFAoFPD19cXEiRNx4sQJGBsbY926dQBe/Jfz9OlTadpDhw7BwsICLi4uePDgARISEjB27Fg0btwYXl5eGkdX3kW5cuUwePBgbNu2DZ999plGRzn6P8bGxsjOzpae79+/H3Xr1kXfvn1Ro0YNeHp6avy3plKp4ODggCNHjkjDsrOzNfpy6LJdvby8pL4RL9diaWmJUqVKwd3dHUZGRhrLTUlJwcWLF9/p9Rcmr4a+Q4cOoWzZsqhYsSKysrI0xues44oVK76xzVe3L/B/X+Yvd+R+9X4w5cuX11jXALSe29vba3UGf7mdnM61169fh6enp8bDxcVFo52QkBD8+uuvCA8Px5IlSwAANWvWRGJiIkqUKKE1v0qleuPr/hDkdf28SV6209sUK1YMTZo0wcyZM3Hq1ClcvXoVO3fuzFcbxCMkhcLhw4exY8cONG3aFCVKlMDhw4dx7949eHl54dSpU3j+/Dl69eqFsWPH4urVqxg/fjzCwsJgYGAAGxsb2NnZYcmSJXBycsL169cxcuTId6rn6dOnGDZsGD7//HO4ubnh33//xZEjR9CuXTs9veKPS5kyZXD48GFcvXoVFhYWKFu2LJYvX46YmBi4ublhxYoVOHLkCNzc3KR5+vfvj+nTp8PT0xMVKlTAggUL8OjRI+m/N122a9++fREeHo7+/fsjLCwMCQkJGD9+PIYMGQIDAwNYWloiJCQEw4YNg62tLUqUKIHx48fDwMDgo7m89fr16xgyZAi++eYbHD9+HAsWLMCcOXNQtmxZtG7dGqGhoVi8eDEsLS0xcuRIlCxZEq1bt35jm2XKlEFMTAwSEhJgZ2cHlUolfeFNmDABU6dOxcWLFzFnzhyN+fr37w8/Pz/MnTsXwcHB2LlzJ7Zs2aKxrhs1aoRZs2Zh+fLl8PHxwa+//oozZ86gRo0aAF789z106FAMHjwYarUa9erVQ0pKCvbv3w8rKyuEhIRg3Lhx8Pb2RqVKlZCRkYGNGzfCy8sLwIvO6bNmzULr1q0xadIklCpVCteuXcPatWsxfPhwlCpVSs9b4P162/pxdXV9axv9+/dHaGgoatWqhbp16+L333/HqVOn4O7unqcaNm7ciMuXL8PPzw82NjbYvHkz1Gr1R3Uq9L2RtwsLCSHEuXPnRGBgoLC3txdKpVKUK1dOLFiwQAjxf52pxo0bJ+zs7ISFhYUIDQ0Vz549k+bfvn278PLyEkqlUlStWlXExcUJAGLdunVCCO3Oj0II8ejRIwFA7Nq1Swih2ak1IyNDdOrUSbi4uAhjY2Ph7OwswsLCpE5gr3aAFUKIdevWiaL6dkpISBCffvqpMDU1FQDEhQsXRI8ePYRKpRLW1taiT58+YuTIkRqd5DIzM0VYWJiwsrISNjY2YsSIEaJ9+/aiU6dO0jS6bNe4uDjxySefCGNjY+Ho6ChGjBghMjMzpfGpqamiS5cuwszMTDg6Ooq5c+eK2rVri5EjRxb0aipwDRo0EH379hW9e/eW1uvo0aOlDp0PHz4U3bp1EyqVSpiamorAwEBx8eJFaf7c3tdCCHH37l0REBAgLCwsND4z+/btE1WqVBEmJiaifv36Ijo6WqNTqxBCLFmyRJQsWVKYmpqKNm3aiClTpghHR0eN9seNGyccHByESqUSgwcPFmFhYVKnViGEUKvVIjw8XJQvX14YGRkJe3t7ERgYKHbv3i2EEGLy5MnCy8tLmJqaCltbW9G6dWtx+fJlaf5bt26J7t27i+LFiwulUinc3d1FaGioSElJecc1Xji8af3kpfOxEEJMmjRJFC9eXFhYWIiePXuKAQMGiE8//VQa/6ZOrXv37hUNGjQQNjY2wtTUVFStWlX8/vvvuU6bo3Xr1iIkJESPa+HjoBCCJ/4LM94lsmhQq9Xw8vJChw4dMHny5Pe23LS0NJQsWRJz5sxBr1693ttyC8KHcMfc0NBQXLhwAXv37pW7FHqDgIAAODo6YsWKFXKXUqTwlA2RDK5du4Zt27ahQYMGyMjIwMKFC3HlyhV06dKlQJd74sQJXLhwAbVr10ZKSgomTZoEAG89bUG6mT17NgICAmBubo4tW7Zg2bJl+PHHH+Uui16Snp6ORYsWITAwEIaGhvjtt98QGxvL+4TIgIGESAYGBgaIiorC0KFDIYRA5cqVERsbK537L0izZ89GQkICjI2N4e3tjb1790o30iL9+ueffzBz5kw8fvwY7u7u+OGHH/DVV1/JXRa9RKFQYPPmzZg6dSqePXuG8uXLY82aNWjSpIncpRU5PGVDREREsuNlv0RERCQ7BhIiIiKSHQMJERERyY6BhIiIiGTHQEJERESyYyAhIiIi2TGQEBVhPXr0QJs2beQug4iIgYSIiIjkx0BCRLmaO3cuqlSpAnNzc7i4uKBv37548uSJND4qKgrW1taIiYmBl5cXLCws0KxZM9y6dUuaJisrCwMGDIC1tTXs7OwwYsQIhISEaByVKVOmjNbvz1SvXh0TJkzIcy0A8NNPP8HFxQVmZmZo27Yt5s6dC2tra41p/vrrL9SsWRMmJiZwd3fHxIkTkZWV9c7riojeHQMJEeXKwMAAP/zwA86ePYtly5Zh586dGD58uMY06enpmD17NlasWIE9e/bg+vXrGDp0qDR+xowZWLlyJZYuXYr9+/cjNTVVpx+KfFst+/fvR+/evTFw4EDEx8cjICAAU6dO1Whj79696N69OwYOHIhz585h8eLFiIqK0pqOiGQi628NE5GsXv1Z9TeJjo4WdnZ20vOlS5cKACIpKUkaFhERIRwcHKTnDg4OYtasWdLzrKwsUbp0aY1lurq6innz5mksq1q1amL8+PF5rqVjx46iRYsWGtN07dpVqFQq6Xnjxo3FtGnTNKZZsWKFcHJyeu1yiOj94Y/rEVGuYmNjMX36dFy4cAGpqanIysrCs2fPkJ6eDjMzMwCAmZkZPDw8pHmcnJxw9+5dAEBKSgru3LmD2rVrS+MNDQ3h7e0NtVqt11oSEhLQtm1bjXlq166NjRs3Ss9PnjyJ/fv3axwRyc7O1npNRCQPnrIhIi1Xr15Fy5YtUbVqVaxZswbHjh1DREQEAOD58+fSdEZGRhrzKRQKiHz+XqeBgYHWPJmZmfmu5W2ePHmCiRMnIj4+XnqcPn0aiYmJMDExyVfNRKR/PEJCRFqOHTsGtVqNOXPmwMDgxf8tf/zxR77aUKlUcHBwwJEjR+Dn5wfgxRGJ48ePo3r16tJ09vb2Gh1hU1NTceXKlXzVUr58eRw5ckRj2KvPa9asiYSEBHh6eubrdRDR+8FAQlTEpaSkID4+XmNY8eLFkZmZiQULFiA4OBj79+/HokWL8t12//79MX36dHh6eqJChQpYsGABHj16BIVCIU3TqFEjREVFITg4GNbW1hg3bhwMDQ2l8Z6enm+tpX///vDz88PcuXMRHByMnTt3YsuWLRrLGTduHFq2bInSpUvj888/h4GBAU6ePIkzZ85gypQp+X5tRKRncndiISL5hISECABaj169eom5c+cKJycnYWpqKgIDA8Xy5csFAPHo0SMhxItOrS93GhVCiHXr1omXdyuZmZkiLCxMWFlZCRsbGzFixAjRvn170alTJ2malJQU0bFjR2FlZSVcXFxEVFSUVqfWt9UihBBLliwRJUuWFKampqJNmzZiypQpwtHRUaO+rVu3irp16wpTU1NhZWUlateuLZYsWaK39UlEulMIkc8TvkREOlKr1fDy8kKHDh0wefLkAl1WaGgoLly4gL179xbocohIP3jKhogKzLVr17Bt2zY0aNAAGRkZWLhwIa5cuYIuXbrofVmzZ89GQEAAzM3NsWXLFixbtgw//vij3pdDRAWDgYSICoyBgQGioqIwdOhQCCFQuXJlxMbGwsvLS+/L+ueffzBz5kw8fvwY7u7u+OGHH/DVV1/pfTlEVDB4yoaIiIhkx/uQEBERkewYSIiIiEh2DCREREQkOwYSIiIikh0DCREREcmOgYSIiIhkx0BCREREsmMgISIiItn9P/UHjSPUZZTqAAAAAElFTkSuQmCC",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "    theme  match_spanish  match_tagalog  match_portuguese  match_english  \\\n",
      "0  cornea              4              2                 4              4   \n",
      "\n",
      "   Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0     10                      40.0                      20.0   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                         40.0                      40.0  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "         theme  match_spanish  match_tagalog  match_portuguese  match_english  \\\n",
      "0  cornea/lens              1              1                 1              1   \n",
      "\n",
      "   Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0      1                     100.0                     100.0   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                        100.0                     100.0  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "      theme  match_spanish  match_tagalog  match_portuguese  match_english  \\\n",
      "0  glaucoma              3              2                 2              3   \n",
      "\n",
      "   Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0      9                 33.333333                 22.222222   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                    22.222222                 33.333333  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "              theme  match_spanish  match_tagalog  match_portuguese  \\\n",
      "0  glaucoma/uveitis              0              0                 0   \n",
      "\n",
      "   match_english  Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0              0      1                       0.0                       0.0   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                          0.0                       0.0  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "           theme  match_spanish  match_tagalog  match_portuguese  \\\n",
      "0  lens/cataract              5              3                 5   \n",
      "\n",
      "   match_english  Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0              3      8                      62.5                      37.5   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                         62.5                      37.5  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "        theme  match_spanish  match_tagalog  match_portuguese  match_english  \\\n",
      "0  low vision              1              1                 1              1   \n",
      "\n",
      "   Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0      1                     100.0                     100.0   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                        100.0                     100.0  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                 theme  match_spanish  match_tagalog  match_portuguese  \\\n",
      "0  neuro-ophthalmology              3              3                 3   \n",
      "\n",
      "   match_english  Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0              4      7                 42.857143                 42.857143   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                    42.857143                 57.142857  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                    theme  match_spanish  match_tagalog  match_portuguese  \\\n",
      "0  ocular plastic surgery              4              3                 5   \n",
      "\n",
      "   match_english  Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0              4     16                      25.0                     18.75   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                        31.25                      25.0  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                             theme  match_spanish  match_tagalog  \\\n",
      "0  oncology/ocular plastic surgery              1              0   \n",
      "\n",
      "   match_portuguese  match_english  Total  spanish_ratio_percentage  \\\n",
      "0                 0              1      3                 33.333333   \n",
      "\n",
      "   tagalog_ratio_percentage  portuguese_ratio_percentage  \\\n",
      "0                       0.0                          0.0   \n",
      "\n",
      "   english_ratio_percentage  \n",
      "0                 33.333333  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "    theme  match_spanish  match_tagalog  match_portuguese  match_english  \\\n",
      "0  optics              0              0                 0              0   \n",
      "\n",
      "   Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0      1                       0.0                       0.0   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                          0.0                       0.0  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "               theme  match_spanish  match_tagalog  match_portuguese  \\\n",
      "0  optics/refraction              0              1                 0   \n",
      "\n",
      "   match_english  Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0              0      1                       0.0                     100.0   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                          0.0                       0.0  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "          theme  match_spanish  match_tagalog  match_portuguese  \\\n",
      "0  pharmacology              3              2                 3   \n",
      "\n",
      "   match_english  Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0              4      9                 33.333333                 22.222222   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                    33.333333                 44.444444  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                   theme  match_spanish  match_tagalog  match_portuguese  \\\n",
      "0  pharmacology/glaucoma              0              0                 1   \n",
      "\n",
      "   match_english  Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0              1      1                       0.0                       0.0   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                        100.0                     100.0  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "        theme  match_spanish  match_tagalog  match_portuguese  match_english  \\\n",
      "0  refraction              9              9                 7              9   \n",
      "\n",
      "   Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0     31                 29.032258                 29.032258   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                    22.580645                 29.032258  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                   theme  match_spanish  match_tagalog  match_portuguese  \\\n",
      "0  refraction/low vision              0              0                 0   \n",
      "\n",
      "   match_english  Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0              0      2                       0.0                       0.0   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                          0.0                       0.0  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                theme  match_spanish  match_tagalog  match_portuguese  \\\n",
      "0  refractive surgery              1              1                 1   \n",
      "\n",
      "   match_english  Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0              1      2                      50.0                      50.0   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                         50.0                      50.0  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "    theme  match_spanish  match_tagalog  match_portuguese  match_english  \\\n",
      "0  retina              5              4                 4              4   \n",
      "\n",
      "   Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0     12                 41.666667                 33.333333   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                    33.333333                 33.333333  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "             theme  match_spanish  match_tagalog  match_portuguese  \\\n",
      "0  retina/oncology              0              0                 0   \n",
      "\n",
      "   match_english  Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0              0      1                       0.0                       0.0   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                          0.0                       0.0  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "        theme  match_spanish  match_tagalog  match_portuguese  match_english  \\\n",
      "0  strabismus              4              4                 3              4   \n",
      "\n",
      "   Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0     11                 36.363636                 36.363636   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                    27.272727                 36.363636  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "     theme  match_spanish  match_tagalog  match_portuguese  match_english  \\\n",
      "0  uveitis              2              2                 3              1   \n",
      "\n",
      "   Total  spanish_ratio_percentage  tagalog_ratio_percentage  \\\n",
      "0      8                      25.0                      25.0   \n",
      "\n",
      "   portuguese_ratio_percentage  english_ratio_percentage  \n",
      "0                         37.5                      12.5  \n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "TEMPERATURE = str(TEMPERATURE).replace('.', '_')\n",
    "\n",
    "run_analysis(model=MODEL, temperature=TEMPERATURE, n_repetitions=N_REPETITIONS, languages=LANGUAGES)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "dffeddc1",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>test</th>\n",
       "      <th>year</th>\n",
       "      <th>theme</th>\n",
       "      <th>match_spanish</th>\n",
       "      <th>match_tagalog</th>\n",
       "      <th>match_portuguese</th>\n",
       "      <th>match_english</th>\n",
       "      <th>Total</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Teórica I</td>\n",
       "      <td>2022</td>\n",
       "      <td>anatomy</td>\n",
       "      <td>5</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>6</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Teórica I</td>\n",
       "      <td>2022</td>\n",
       "      <td>cornea</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Teórica I</td>\n",
       "      <td>2022</td>\n",
       "      <td>embryology</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Teórica I</td>\n",
       "      <td>2022</td>\n",
       "      <td>genetics</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Teórica I</td>\n",
       "      <td>2022</td>\n",
       "      <td>glaucoma</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Teórica I</td>\n",
       "      <td>2022</td>\n",
       "      <td>oncology</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Teórica I</td>\n",
       "      <td>2022</td>\n",
       "      <td>pharmacology</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Teórica I</td>\n",
       "      <td>2022</td>\n",
       "      <td>refraction</td>\n",
       "      <td>3</td>\n",
       "      <td>5</td>\n",
       "      <td>3</td>\n",
       "      <td>4</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Teórica I</td>\n",
       "      <td>2022</td>\n",
       "      <td>retina</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>contact lenses</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>cornea</td>\n",
       "      <td>4</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>3</td>\n",
       "      <td>9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>cornea/lens</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>glaucoma</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>glaucoma/uveitis</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>lens/cataract</td>\n",
       "      <td>5</td>\n",
       "      <td>3</td>\n",
       "      <td>5</td>\n",
       "      <td>3</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>low vision</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>neuro-ophthalmology</td>\n",
       "      <td>3</td>\n",
       "      <td>3</td>\n",
       "      <td>3</td>\n",
       "      <td>4</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>ocular plastic surgery</td>\n",
       "      <td>4</td>\n",
       "      <td>3</td>\n",
       "      <td>5</td>\n",
       "      <td>4</td>\n",
       "      <td>16</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>oncology/ocular plastic surgery</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>optics</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>optics/refraction</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>pharmacology</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>pharmacology/glaucoma</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>refraction</td>\n",
       "      <td>6</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>5</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>refraction/low vision</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>refractive surgery</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>retina</td>\n",
       "      <td>5</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>11</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>retina/oncology</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>strabismus</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>3</td>\n",
       "      <td>4</td>\n",
       "      <td>11</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>Teórica II</td>\n",
       "      <td>2022</td>\n",
       "      <td>uveitis</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          test  year                            theme  match_spanish  \\\n",
       "0    Teórica I  2022                          anatomy              5   \n",
       "1    Teórica I  2022                           cornea              0   \n",
       "2    Teórica I  2022                       embryology              1   \n",
       "3    Teórica I  2022                         genetics              0   \n",
       "4    Teórica I  2022                         glaucoma              1   \n",
       "5    Teórica I  2022                         oncology              1   \n",
       "6    Teórica I  2022                     pharmacology              2   \n",
       "7    Teórica I  2022                       refraction              3   \n",
       "8    Teórica I  2022                           retina              0   \n",
       "9   Teórica II  2022                   contact lenses              1   \n",
       "10  Teórica II  2022                           cornea              4   \n",
       "11  Teórica II  2022                      cornea/lens              1   \n",
       "12  Teórica II  2022                         glaucoma              2   \n",
       "13  Teórica II  2022                 glaucoma/uveitis              0   \n",
       "14  Teórica II  2022                    lens/cataract              5   \n",
       "15  Teórica II  2022                       low vision              1   \n",
       "16  Teórica II  2022              neuro-ophthalmology              3   \n",
       "17  Teórica II  2022           ocular plastic surgery              4   \n",
       "18  Teórica II  2022  oncology/ocular plastic surgery              1   \n",
       "19  Teórica II  2022                           optics              0   \n",
       "20  Teórica II  2022                optics/refraction              0   \n",
       "21  Teórica II  2022                     pharmacology              1   \n",
       "22  Teórica II  2022            pharmacology/glaucoma              0   \n",
       "23  Teórica II  2022                       refraction              6   \n",
       "24  Teórica II  2022            refraction/low vision              0   \n",
       "25  Teórica II  2022               refractive surgery              1   \n",
       "26  Teórica II  2022                           retina              5   \n",
       "27  Teórica II  2022                  retina/oncology              0   \n",
       "28  Teórica II  2022                       strabismus              4   \n",
       "29  Teórica II  2022                          uveitis              2   \n",
       "\n",
       "    match_tagalog  match_portuguese  match_english  Total  \n",
       "0               4                 4              6     21  \n",
       "1               0                 1              1      1  \n",
       "2               1                 1              1      2  \n",
       "3               0                 0              1      2  \n",
       "4               0                 0              0      1  \n",
       "5               0                 0              1      1  \n",
       "6               1                 2              2      3  \n",
       "7               5                 3              4     12  \n",
       "8               0                 0              0      1  \n",
       "9               0                 1              1      3  \n",
       "10              2                 3              3      9  \n",
       "11              1                 1              1      1  \n",
       "12              2                 2              3      8  \n",
       "13              0                 0              0      1  \n",
       "14              3                 5              3      8  \n",
       "15              1                 1              1      1  \n",
       "16              3                 3              4      7  \n",
       "17              3                 5              4     16  \n",
       "18              0                 0              1      3  \n",
       "19              0                 0              0      1  \n",
       "20              1                 0              0      1  \n",
       "21              1                 1              2      6  \n",
       "22              0                 1              1      1  \n",
       "23              4                 4              5     19  \n",
       "24              0                 0              0      2  \n",
       "25              1                 1              1      2  \n",
       "26              4                 4              4     11  \n",
       "27              0                 0              0      1  \n",
       "28              4                 3              4     11  \n",
       "29              2                 3              1      8  "
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "N_REPETITIONS = 1 if N_REPETITIONS < 1 else N_REPETITIONS\n",
    "pd.read_csv(f'results/results_{MODEL}_Temperature{TEMPERATURE}_Repetitions{N_REPETITIONS}/matches_results_{MODEL}.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "c23866b3-c0c6-42de-968c-6994b2b8b7fa",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "test                Teórica ITeórica ITeórica ITeórica ITeórica IT...\n",
       "year                                                            60660\n",
       "theme               anatomycorneaembryologygeneticsglaucomaoncolog...\n",
       "match_spanish                                                      54\n",
       "match_tagalog                                                      43\n",
       "match_portuguese                                                   49\n",
       "match_english                                                      55\n",
       "Total                                                             164\n",
       "dtype: object"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.read_csv(f'results/results_{MODEL}_Temperature{TEMPERATURE}_Repetitions{N_REPETITIONS}/matches_results_{MODEL}.csv').sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "1dcad7d6-7647-49c5-9804-17db4dfbc5a3",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "llm_bias",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.-1"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
